Effects	16371368	2	O
of	16371368	2	O
a	16371368	2	O
leukemia	16371368	2	O
-	16371368	2	O
associated	16371368	2	O
gain	16371368	2	O
-	16371368	2	O
of	16371368	2	O
-	16371368	2	O
function	16371368	2	O
mutation	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
phosphatase	16371368	2	O
on	16371368	2	O
interleukin-3	16371368	2	O
signaling	16371368	2	O
.	16371368	2	O
Mutations	16371368	2	B-Var
in	16371368	2	O
SHP-2	16371368	2	B-Gene
phosphatase	16371368	2	B-Enzyme
that	16371368	2	O
cause	16371368	2	O
hyperactivation	16371368	2	B-PosReg
of	16371368	2	O
its	16371368	2	O
catalytic	16371368	2	B-MPA
activity	16371368	2	I-MPA
have	16371368	2	O
been	16371368	2	O
identified	16371368	2	O
in	16371368	2	O
human	16371368	2	B-Disease
leukemias	16371368	2	I-Disease
,	16371368	2	O
particularly	16371368	2	O
juvenile	16371368	2	B-Disease
myelomonocytic	16371368	2	I-Disease
leukemia	16371368	2	I-Disease
,	16371368	2	O
which	16371368	2	O
is	16371368	2	O
characterized	16371368	2	O
by	16371368	2	O
hypersensitivity	16371368	2	O
of	16371368	2	O
myeloid	16371368	2	O
progenitor	16371368	2	O
cells	16371368	2	O
to	16371368	2	O
granulocyte	16371368	2	O
macrophage	16371368	2	O
colony	16371368	2	O
-	16371368	2	O
stimulating	16371368	2	O
factor	16371368	2	O
and	16371368	2	O
interleukin	16371368	2	O
(	16371368	2	O
IL	16371368	2	O
)	16371368	2	O
-	16371368	2	O
3	16371368	2	O
.	16371368	2	O
However	16371368	2	O
,	16371368	2	O
the	16371368	2	O
molecular	16371368	2	O
mechanisms	16371368	2	O
by	16371368	2	O
which	16371368	2	O
gain	16371368	2	O
-	16371368	2	O
of	16371368	2	O
-	16371368	2	O
function	16371368	2	O
(	16371368	2	O
GOF	16371368	2	O
)	16371368	2	O
mutations	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
induce	16371368	2	O
hematopoietic	16371368	2	O
malignancies	16371368	2	O
are	16371368	2	O
not	16371368	2	O
fully	16371368	2	O
understood	16371368	2	O
.	16371368	2	O
Our	16371368	2	O
previous	16371368	2	O
studies	16371368	2	O
have	16371368	2	O
shown	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	O
plays	16371368	2	O
an	16371368	2	O
essential	16371368	2	O
role	16371368	2	O
in	16371368	2	O
IL-3	16371368	2	O
signal	16371368	2	O
transduction	16371368	2	O
in	16371368	2	O
both	16371368	2	O
catalytic	16371368	2	O
-	16371368	2	O
dependent	16371368	2	O
and	16371368	2	O
-	16371368	2	O
independent	16371368	2	O
manners	16371368	2	O
and	16371368	2	O
that	16371368	2	O
overexpression	16371368	2	O
(	16371368	2	O
5	16371368	2	O
-	16371368	2	O
6	16371368	2	O
-	16371368	2	O
fold	16371368	2	O
)	16371368	2	O
of	16371368	2	O
wild	16371368	2	O
type	16371368	2	O
(	16371368	2	O
WT	16371368	2	O
)	16371368	2	O
SHP-2	16371368	2	O
attenuates	16371368	2	O
IL-3	16371368	2	O
-	16371368	2	O
mediated	16371368	2	O
hematopoietic	16371368	2	O
cell	16371368	2	O
function	16371368	2	O
through	16371368	2	O
accelerated	16371368	2	O
dephosphorylation	16371368	2	O
of	16371368	2	O
STAT5	16371368	2	O
.	16371368	2	O
These	16371368	2	O
results	16371368	2	O
raised	16371368	2	O
the	16371368	2	O
possibility	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	O
-	16371368	2	O
associated	16371368	2	O
leukemias	16371368	2	O
are	16371368	2	O
not	16371368	2	O
solely	16371368	2	O
attributed	16371368	2	O
to	16371368	2	O
the	16371368	2	O
increased	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
of	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
.	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
must	16371368	2	O
have	16371368	2	O
gained	16371368	2	O
additional	16371368	2	O
capacities	16371368	2	O
.	16371368	2	O
To	16371368	2	O
test	16371368	2	O
this	16371368	2	O
possibility	16371368	2	O
,	16371368	2	O
we	16371368	2	O
investigated	16371368	2	O
effects	16371368	2	O
of	16371368	2	O
a	16371368	2	O
GOF	16371368	2	O
mutation	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
(	16371368	2	O
SHP-2	16371368	2	O
E76K	16371368	2	O
)	16371368	2	O
on	16371368	2	O
hematopoietic	16371368	2	O
cell	16371368	2	O
function	16371368	2	O
and	16371368	2	O
IL-3	16371368	2	O
signal	16371368	2	O
transduction	16371368	2	O
by	16371368	2	O
comparing	16371368	2	O
with	16371368	2	O
those	16371368	2	O
of	16371368	2	O
overexpressed	16371368	2	O
WT	16371368	2	O
SHP-2	16371368	2	O
.	16371368	2	O
Our	16371368	2	O
results	16371368	2	O
showed	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	B-Gene
E76K	16371368	2	B-Var
mutation	16371368	2	I-Var
caused	16371368	2	O
myeloproliferative	16371368	2	B-Disease
disease	16371368	2	I-Disease
in	16371368	2	I-Disease
mice	16371368	2	I-Disease
,	16371368	2	O
while	16371368	2	O
overexpression	16371368	2	O
of	16371368	2	O
WT	16371368	2	O
SHP-2	16371368	2	O
decreased	16371368	2	O
hematopoietic	16371368	2	O
potential	16371368	2	O
of	16371368	2	O
the	16371368	2	O
transduced	16371368	2	O
cells	16371368	2	O
in	16371368	2	O
recipient	16371368	2	O
animals	16371368	2	O
.	16371368	2	O
The	16371368	2	O
E76K	16371368	2	B-Var
mutation	16371368	2	I-Var
in	16371368	2	I-Var
the	16371368	2	I-Var
N	16371368	2	I-Var
-	16371368	2	I-Var
terminal	16371368	2	I-Var
Src	16371368	2	I-Var
homology	16371368	2	I-Var
2	16371368	2	I-Var
domain	16371368	2	I-Var
increased	16371368	2	B-PosReg
interactions	16371368	2	B-Interaction
of	16371368	2	O
mutant	16371368	2	B-Var
SHP-2	16371368	2	B-Gene
with	16371368	2	O
Grb2	16371368	2	B-Protein
,	16371368	2	O
Gab2	16371368	2	O
,	16371368	2	O
and	16371368	2	O
p85	16371368	2	O
,	16371368	2	O
leading	16371368	2	O
to	16371368	2	O
hyperactivation	16371368	2	B-PosReg
of	16371368	2	O
IL-3	16371368	2	B-Pathway
-	16371368	2	I-Pathway
induced	16371368	2	I-Pathway
Erk	16371368	2	I-Pathway
and	16371368	2	I-Pathway
phosphatidylinositol	16371368	2	I-Pathway
3	16371368	2	I-Pathway
-	16371368	2	I-Pathway
kinase	16371368	2	I-Pathway
(	16371368	2	I-Pathway
PI3K	16371368	2	I-Pathway
)	16371368	2	I-Pathway
pathways	16371368	2	I-Pathway
.	16371368	2	O
In	16371368	2	O
addition	16371368	2	O
,	16371368	2	O
despite	16371368	2	O
the	16371368	2	O
substantial	16371368	2	O
increase	16371368	2	B-PosReg
in	16371368	2	O
the	16371368	2	O
catalytic	16371368	2	B-MPA
activity	16371368	2	I-MPA
,	16371368	2	O
dephosphorylation	16371368	2	B-MPA
of	16371368	2	I-MPA
STAT5	16371368	2	I-MPA
by	16371368	2	O
SHP-2	16371368	2	B-Gene
E76K	16371368	2	B-Var
was	16371368	2	O
dampened	16371368	2	B-NegReg
.	16371368	2	O
Furthermore	16371368	2	O
,	16371368	2	O
catalytically	16371368	2	B-Var
inactive	16371368	2	I-Var
SHP-2	16371368	2	I-Var
E76K	16371368	2	I-Var
with	16371368	2	I-Var
an	16371368	2	I-Var
additional	16371368	2	I-Var
C459S	16371368	2	I-Var
mutation	16371368	2	I-Var
retained	16371368	2	O
the	16371368	2	O
capability	16371368	2	O
to	16371368	2	O
increase	16371368	2	B-PosReg
the	16371368	2	O
interaction	16371368	2	B-Interaction
with	16371368	2	O
Gab2	16371368	2	B-Protein
and	16371368	2	O
to	16371368	2	O
enhance	16371368	2	B-PosReg
the	16371368	2	O
activation	16371368	2	B-Pathway
of	16371368	2	I-Pathway
the	16371368	2	I-Pathway
PI3K	16371368	2	I-Pathway
pathway	16371368	2	I-Pathway
.	16371368	2	O
Taken	16371368	2	O
together	16371368	2	O
,	16371368	2	O
these	16371368	2	O
studies	16371368	2	O
suggest	16371368	2	O
that	16371368	2	O
in	16371368	2	O
addition	16371368	2	O
to	16371368	2	O
the	16371368	2	O
elevated	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
,	16371368	2	O
fundamental	16371368	2	O
changes	16371368	2	O
in	16371368	2	O
physical	16371368	2	O
and	16371368	2	O
functional	16371368	2	O
interactions	16371368	2	O
between	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
and	16371368	2	O
signaling	16371368	2	O
partners	16371368	2	O
also	16371368	2	O
play	16371368	2	O
an	16371368	2	O
important	16371368	2	O
role	16371368	2	O
in	16371368	2	O
SHP-2	16371368	2	O
-	16371368	2	O
related	16371368	2	O
leukemigenesis	16371368	2	O
.	16371368	2	O

Genetic	17435236	0	O
modifiers	17435236	0	O
of	17435236	0	O
the	17435236	0	O
Drosophila	17435236	0	O
blue	17435236	0	O
cheese	17435236	0	O
gene	17435236	0	O
link	17435236	0	O
defects	17435236	0	O
in	17435236	0	O
lysosomal	17435236	0	O
transport	17435236	0	O
with	17435236	0	O
decreased	17435236	0	O
life	17435236	0	O
span	17435236	0	O
and	17435236	0	O
altered	17435236	0	O
ubiquitinated	17435236	0	O
-	17435236	0	O
protein	17435236	0	O
profiles	17435236	0	O
.	17435236	0	O
Defects	17435236	0	O
in	17435236	0	O
lysosomal	17435236	0	O
trafficking	17435236	0	O
pathways	17435236	0	O
lead	17435236	0	O
to	17435236	0	O
decreased	17435236	0	O
cell	17435236	0	O
viability	17435236	0	O
and	17435236	0	O
are	17435236	0	O
associated	17435236	0	O
with	17435236	0	O
progressive	17435236	0	O
disorders	17435236	0	O
in	17435236	0	O
humans	17435236	0	O
.	17435236	0	O
Previously	17435236	0	O
we	17435236	0	O
have	17435236	0	O
found	17435236	0	O
that	17435236	0	O
loss	17435236	0	O
-	17435236	0	O
of	17435236	0	O
-	17435236	0	O
function	17435236	0	O
(	17435236	0	O
LOF	17435236	0	O
)	17435236	0	O
mutations	17435236	0	B-Var
in	17435236	0	O
the	17435236	0	O
Drosophila	17435236	0	B-Gene
gene	17435236	0	I-Gene
blue	17435236	0	I-Gene
cheese	17435236	0	I-Gene
(	17435236	0	O
bchs	17435236	0	O
)	17435236	0	O
lead	17435236	0	O
to	17435236	0	O
reduced	17435236	0	B-NegReg
adult	17435236	0	B-CPA
life	17435236	0	I-CPA
span	17435236	0	I-CPA
,	17435236	0	O
increased	17435236	0	B-PosReg
neuronal	17435236	0	B-CPA
death	17435236	0	I-CPA
,	17435236	0	O
and	17435236	0	O
widespread	17435236	0	B-CPA
CNS	17435236	0	I-CPA
degeneration	17435236	0	B-NegReg
that	17435236	0	O
is	17435236	0	O
associated	17435236	0	O
with	17435236	0	O
the	17435236	0	O
formation	17435236	0	O
of	17435236	0	O
ubiquitinated	17435236	0	O
-	17435236	0	O
protein	17435236	0	O
aggregates	17435236	0	O
.	17435236	0	O
To	17435236	0	O
identify	17435236	0	O
potential	17435236	0	O
genes	17435236	0	O
that	17435236	0	O
participate	17435236	0	O
in	17435236	0	O
the	17435236	0	O
bchs	17435236	0	O
functional	17435236	0	O
pathway	17435236	0	O
,	17435236	0	O
we	17435236	0	O
conducted	17435236	0	O
a	17435236	0	O
genetic	17435236	0	O
modifier	17435236	0	O
screen	17435236	0	O
based	17435236	0	O
on	17435236	0	O
alterations	17435236	0	O
of	17435236	0	O
an	17435236	0	O
eye	17435236	0	O
phenotype	17435236	0	O
that	17435236	0	O
arises	17435236	0	O
from	17435236	0	O
high	17435236	0	O
-	17435236	0	O
level	17435236	0	O
overexpression	17435236	0	O
of	17435236	0	O
Bchs	17435236	0	O
.	17435236	0	O
We	17435236	0	O
found	17435236	0	O
that	17435236	0	O
mutations	17435236	0	O
in	17435236	0	O
select	17435236	0	O
autophagic	17435236	0	O
and	17435236	0	O
endocytic	17435236	0	O
trafficking	17435236	0	O
genes	17435236	0	O
,	17435236	0	O
defects	17435236	0	O
in	17435236	0	O
cytoskeletal	17435236	0	O
and	17435236	0	O
motor	17435236	0	O
proteins	17435236	0	O
,	17435236	0	O
as	17435236	0	O
well	17435236	0	O
as	17435236	0	O
mutations	17435236	0	O
in	17435236	0	O
the	17435236	0	O
SUMO	17435236	0	O
and	17435236	0	O
ubiquitin	17435236	0	O
signaling	17435236	0	O
pathways	17435236	0	O
behave	17435236	0	O
as	17435236	0	O
modifiers	17435236	0	O
of	17435236	0	O
the	17435236	0	O
Bchs	17435236	0	O
gain	17435236	0	O
-	17435236	0	O
of	17435236	0	O
-	17435236	0	O
function	17435236	0	O
(	17435236	0	O
GOF	17435236	0	O
)	17435236	0	O
eye	17435236	0	O
phenotype	17435236	0	O
.	17435236	0	O
Individual	17435236	0	O
mutant	17435236	0	O
alleles	17435236	0	O
that	17435236	0	O
produced	17435236	0	O
viable	17435236	0	O
adults	17435236	0	O
were	17435236	0	O
further	17435236	0	O
examined	17435236	0	O
for	17435236	0	O
bchs	17435236	0	O
-	17435236	0	O
like	17435236	0	O
phenotypes	17435236	0	O
.	17435236	0	O
Mutations	17435236	0	B-Var
in	17435236	0	O
several	17435236	0	O
lysosomal	17435236	0	B-Gene
trafficking	17435236	0	I-Gene
genes	17435236	0	I-Gene
resulted	17435236	0	O
in	17435236	0	O
significantly	17435236	0	O
decreased	17435236	0	B-NegReg
adult	17435236	0	B-CPA
life	17435236	0	I-CPA
spans	17435236	0	I-CPA
and	17435236	0	O
several	17435236	0	O
mutants	17435236	0	O
showed	17435236	0	O
changes	17435236	0	B-Reg
in	17435236	0	O
ubiquitinated	17435236	0	B-MPA
protein	17435236	0	I-MPA
profiles	17435236	0	I-MPA
as	17435236	0	O
young	17435236	0	O
adults	17435236	0	O
.	17435236	0	O
This	17435236	0	O
work	17435236	0	O
represents	17435236	0	O
a	17435236	0	O
novel	17435236	0	O
approach	17435236	0	O
to	17435236	0	O
examine	17435236	0	O
the	17435236	0	O
role	17435236	0	O
that	17435236	0	O
lysosomal	17435236	0	O
transport	17435236	0	O
and	17435236	0	O
function	17435236	0	O
have	17435236	0	O
on	17435236	0	O
adult	17435236	0	O
viability	17435236	0	O
.	17435236	0	O
The	17435236	0	O
genes	17435236	0	O
characterized	17435236	0	O
in	17435236	0	O
this	17435236	0	O
study	17435236	0	O
have	17435236	0	O
direct	17435236	0	O
human	17435236	0	O
homologs	17435236	0	O
,	17435236	0	O
suggesting	17435236	0	O
that	17435236	0	O
similar	17435236	0	O
defects	17435236	0	O
in	17435236	0	O
lysosomal	17435236	0	O
transport	17435236	0	O
may	17435236	0	O
play	17435236	0	O
a	17435236	0	O
role	17435236	0	O
in	17435236	0	O
human	17435236	0	O
health	17435236	0	O
and	17435236	0	O
age	17435236	0	O
-	17435236	0	O
related	17435236	0	O
processes	17435236	0	O
.	17435236	0	O

Isolation	18031991	0	O
and	18031991	0	O
characterization	18031991	0	O
of	18031991	0	O
a	18031991	0	O
novel	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
mutant	18031991	0	O
displaying	18031991	0	O
gain	18031991	0	O
-	18031991	0	O
of	18031991	0	O
-	18031991	0	O
function	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
Regulator	18031991	0	O
of	18031991	0	O
G	18031991	0	O
protein	18031991	0	O
signaling	18031991	0	O
(	18031991	0	O
RGS	18031991	0	O
)	18031991	0	O
proteins	18031991	0	O
play	18031991	0	O
a	18031991	0	O
crucial	18031991	0	O
role	18031991	0	O
in	18031991	0	O
the	18031991	0	O
adaptation	18031991	0	O
of	18031991	0	O
cells	18031991	0	O
to	18031991	0	O
stimulation	18031991	0	B-PosReg
by	18031991	0	O
G	18031991	0	B-Protein
protein	18031991	0	I-Protein
-	18031991	0	I-Protein
coupled	18031991	0	I-Protein
receptors	18031991	0	I-Protein
via	18031991	0	O
heterotrimeric	18031991	0	B-Protein
G	18031991	0	I-Protein
proteins	18031991	0	I-Protein
.	18031991	0	O
Alterations	18031991	0	B-Var
in	18031991	0	O
RGS	18031991	0	B-Protein
function	18031991	0	O
have	18031991	0	O
been	18031991	0	O
implicated	18031991	0	B-Reg
in	18031991	0	O
a	18031991	0	O
wide	18031991	0	O
range	18031991	0	O
of	18031991	0	O
disease	18031991	0	B-Disease
states	18031991	0	O
,	18031991	0	O
leading	18031991	0	O
to	18031991	0	O
many	18031991	0	O
researchers	18031991	0	O
focusing	18031991	0	O
on	18031991	0	O
controlling	18031991	0	O
the	18031991	0	O
action	18031991	0	O
of	18031991	0	O
these	18031991	0	O
regulatory	18031991	0	O
proteins	18031991	0	O
.	18031991	0	O
Previous	18031991	0	O
studies	18031991	0	O
have	18031991	0	O
centered	18031991	0	O
on	18031991	0	O
reducing	18031991	0	B-NegReg
or	18031991	0	O
inhibiting	18031991	0	B-NegReg
the	18031991	0	O
action	18031991	0	O
of	18031991	0	O
RGS	18031991	0	B-Protein
proteins	18031991	0	I-Protein
,	18031991	0	O
utilizing	18031991	0	O
inactive	18031991	0	O
mutants	18031991	0	O
or	18031991	0	O
small	18031991	0	O
molecular	18031991	0	O
RGS	18031991	0	O
inhibitors	18031991	0	O
.	18031991	0	O
Here	18031991	0	O
we	18031991	0	O
describe	18031991	0	O
the	18031991	0	O
isolation	18031991	0	O
and	18031991	0	O
characterization	18031991	0	O
of	18031991	0	O
a	18031991	0	O
novel	18031991	0	O
human	18031991	0	O
RGS4	18031991	0	B-Var
mutant	18031991	0	I-Var
which	18031991	0	O
displays	18031991	0	O
enhanced	18031991	0	B-PosReg
or	18031991	0	O
gain	18031991	0	B-PosReg
-	18031991	0	I-PosReg
of	18031991	0	I-PosReg
-	18031991	0	I-PosReg
function	18031991	0	I-PosReg
(	18031991	0	O
GOF	18031991	0	O
)	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
RGS4	18031991	0	O
(	18031991	0	O
S30C	18031991	0	O
)	18031991	0	O
demonstrates	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
both	18031991	0	O
in	18031991	0	O
an	18031991	0	O
in	18031991	0	O
vivo	18031991	0	O
yeast	18031991	0	B-Pathway
-	18031991	0	I-Pathway
based	18031991	0	I-Pathway
signalling	18031991	0	I-Pathway
pathway	18031991	0	I-Pathway
and	18031991	0	O
in	18031991	0	O
vitro	18031991	0	O
against	18031991	0	O
the	18031991	0	O
Galpha	18031991	0	B-Protein
(	18031991	0	I-Protein
o1	18031991	0	I-Protein
)	18031991	0	I-Protein
subunit	18031991	0	I-Protein
contained	18031991	0	I-Protein
in	18031991	0	I-Protein
an	18031991	0	I-Protein
alpha	18031991	0	I-Protein
(	18031991	0	I-Protein
2	18031991	0	I-Protein
A	18031991	0	I-Protein
)	18031991	0	I-Protein
-	18031991	0	I-Protein
adrenoreceptor	18031991	0	I-Protein
-	18031991	0	I-Protein
Galpha	18031991	0	I-Protein
(	18031991	0	I-Protein
o1	18031991	0	I-Protein
)	18031991	0	I-Protein
(	18031991	0	I-Protein
C351I	18031991	0	I-Protein
)	18031991	0	I-Protein
fusion	18031991	0	I-Protein
protein	18031991	0	I-Protein
.	18031991	0	O
Mutational	18031991	0	O
analysis	18031991	0	O
of	18031991	0	O
serine	18031991	0	O
30	18031991	0	O
identified	18031991	0	O
a	18031991	0	O
number	18031991	0	O
of	18031991	0	O
alternative	18031991	0	O
substitutions	18031991	0	O
that	18031991	0	O
result	18031991	0	O
in	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
was	18031991	0	O
retained	18031991	0	O
upon	18031991	0	O
transposition	18031991	0	O
of	18031991	0	O
the	18031991	0	O
serine	18031991	0	O
30	18031991	0	O
-	18031991	0	O
cysteine	18031991	0	O
mutation	18031991	0	O
to	18031991	0	O
the	18031991	0	O
equivalent	18031991	0	O
serine	18031991	0	O
residue	18031991	0	O
in	18031991	0	O
human	18031991	0	O
RGS16	18031991	0	O
.	18031991	0	O
As	18031991	0	O
with	18031991	0	O
previously	18031991	0	O
identified	18031991	0	O
GOF	18031991	0	O
mutants	18031991	0	O
,	18031991	0	O
RGS4	18031991	0	B-Var
(	18031991	0	I-Var
S30C	18031991	0	I-Var
/	18031991	0	I-Var
S30F	18031991	0	I-Var
/	18031991	0	I-Var
S30K	18031991	0	I-Var
)	18031991	0	I-Var
demonstrate	18031991	0	O
increased	18031991	0	B-PosReg
steady	18031991	0	O
state	18031991	0	O
protein	18031991	0	B-MPA
levels	18031991	0	I-MPA
,	18031991	0	O
however	18031991	0	O
these	18031991	0	O
mutants	18031991	0	O
also	18031991	0	O
demonstrate	18031991	0	O
enhanced	18031991	0	B-PosReg
GAP	18031991	0	B-MPA
activity	18031991	0	I-MPA
through	18031991	0	O
an	18031991	0	O
additional	18031991	0	O
mechanism	18031991	0	O
distinct	18031991	0	O
from	18031991	0	O
the	18031991	0	O
increased	18031991	0	O
protein	18031991	0	O
content	18031991	0	O
.	18031991	0	O
The	18031991	0	O
identification	18031991	0	O
of	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
mutants	18031991	0	O
with	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
may	18031991	0	O
provide	18031991	0	O
novel	18031991	0	O
therapeutic	18031991	0	O
agents	18031991	0	O
for	18031991	0	O
the	18031991	0	O
treatment	18031991	0	O
of	18031991	0	O
signaling	18031991	0	O
-	18031991	0	O
based	18031991	0	O
diseases	18031991	0	O
and	18031991	0	O
the	18031991	0	O
ability	18031991	0	O
to	18031991	0	O
transpose	18031991	0	O
these	18031991	0	O
mutations	18031991	0	O
to	18031991	0	O
other	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
proteins	18031991	0	O
extends	18031991	0	O
their	18031991	0	O
application	18031991	0	O
to	18031991	0	O
multiple	18031991	0	O
pathways	18031991	0	O
.	18031991	0	O

Conditional	18594199	0	O
RNA	18594199	0	O
interference	18594199	0	O
in	18594199	0	O
vivo	18594199	0	O
to	18594199	0	O
study	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
oncogenic	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
on	18594199	0	O
tumor	18594199	0	O
malignancy	18594199	0	O
.	18594199	0	O
Mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
proteins	18594199	0	B-Protein
are	18594199	0	O
thought	18594199	0	O
to	18594199	0	O
have	18594199	0	O
acquired	18594199	0	O
a	18594199	0	O
"	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
"	18594199	0	O
(	18594199	0	O
GOF	18594199	0	O
)	18594199	0	O
activity	18594199	0	O
that	18594199	0	O
mainly	18594199	0	O
contributes	18594199	0	B-PosReg
to	18594199	0	O
tumor	18594199	0	B-CPA
aggressiveness	18594199	0	I-CPA
.	18594199	0	O
Previously	18594199	0	O
we	18594199	0	O
reported	18594199	0	O
that	18594199	0	O
constitutive	18594199	0	O
downregulation	18594199	0	B-NegReg
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
by	18594199	0	O
RNA	18594199	0	B-MPA
interference	18594199	0	I-MPA
reduces	18594199	0	B-NegReg
the	18594199	0	O
tumorigenicity	18594199	0	B-CPA
of	18594199	0	I-CPA
cancer	18594199	0	I-CPA
cells	18594199	0	I-CPA
in	18594199	0	I-CPA
an	18594199	0	I-CPA
animal	18594199	0	I-CPA
model	18594199	0	I-CPA
;	18594199	0	I-CPA
however	18594199	0	O
,	18594199	0	O
effects	18594199	0	O
of	18594199	0	O
adaptation	18594199	0	O
to	18594199	0	O
long	18594199	0	O
-	18594199	0	O
term	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
inhibition	18594199	0	O
could	18594199	0	O
not	18594199	0	O
be	18594199	0	O
excluded	18594199	0	O
.	18594199	0	O
To	18594199	0	O
address	18594199	0	O
this	18594199	0	O
point	18594199	0	O
,	18594199	0	O
mimicking	18594199	0	O
more	18594199	0	O
physiological	18594199	0	O
conditions	18594199	0	O
,	18594199	0	O
we	18594199	0	O
now	18594199	0	O
describe	18594199	0	O
the	18594199	0	O
establishment	18594199	0	O
of	18594199	0	O
a	18594199	0	O
lentiviral	18594199	0	O
-	18594199	0	O
based	18594199	0	O
system	18594199	0	O
for	18594199	0	O
conditional	18594199	0	O
interference	18594199	0	O
with	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
expression	18594199	0	O
.	18594199	0	O
In	18594199	0	O
vivo	18594199	0	O
studies	18594199	0	O
assessed	18594199	0	O
the	18594199	0	O
efficacy	18594199	0	O
of	18594199	0	O
conditional	18594199	0	B-MPA
RNA	18594199	0	I-MPA
interference	18594199	0	I-MPA
in	18594199	0	O
inhibiting	18594199	0	B-NegReg
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
activity	18594199	0	B-MPA
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
proteins	18594199	0	B-Protein
by	18594199	0	O
reducing	18594199	0	O
tumor	18594199	0	O
growth	18594199	0	O
ability	18594199	0	O
.	18594199	0	O
Moreover	18594199	0	O
by	18594199	0	O
using	18594199	0	O
this	18594199	0	O
system	18594199	0	O
,	18594199	0	O
microarray	18594199	0	O
data	18594199	0	O
were	18594199	0	O
validated	18594199	0	O
in	18594199	0	O
vitro	18594199	0	O
and	18594199	0	O
in	18594199	0	O
vivo	18594199	0	O
and	18594199	0	O
putative	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
target	18594199	0	O
genes	18594199	0	O
that	18594199	0	O
may	18594199	0	O
contribute	18594199	0	O
to	18594199	0	O
its	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
effects	18594199	0	O
in	18594199	0	O
cancer	18594199	0	O
were	18594199	0	O
identified	18594199	0	O
.	18594199	0	O
Results	18594199	0	O
are	18594199	0	O
confirmatory	18594199	0	O
that	18594199	0	O
depletion	18594199	0	B-MPA
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
protein	18594199	0	B-Protein
impacts	18594199	0	B-Reg
on	18594199	0	O
tumor	18594199	0	B-CPA
malignancy	18594199	0	I-CPA
and	18594199	0	O
validated	18594199	0	O
the	18594199	0	O
inducible	18594199	0	O
lentiviral	18594199	0	O
-	18594199	0	O
based	18594199	0	O
system	18594199	0	O
as	18594199	0	O
an	18594199	0	O
efficient	18594199	0	O
tool	18594199	0	O
to	18594199	0	O
study	18594199	0	O
the	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
activity	18594199	0	O
of	18594199	0	O
human	18594199	0	O
tumor	18594199	0	O
derived	18594199	0	O
p53	18594199	0	O
mutants	18594199	0	O
.	18594199	0	O

Identification	19338054	1	O
and	19338054	1	O
functional	19338054	1	O
analysis	19338054	1	O
of	19338054	1	O
novel	19338054	1	O
variants	19338054	1	O
of	19338054	1	O
the	19338054	1	O
human	19338054	1	O
melanocortin	19338054	1	O
1	19338054	1	O
receptor	19338054	1	O
found	19338054	1	O
in	19338054	1	O
melanoma	19338054	1	O
patients	19338054	1	O
.	19338054	1	O
The	19338054	1	O
melanocortin	19338054	1	O
1	19338054	1	O
receptor	19338054	1	O
,	19338054	1	O
a	19338054	1	O
Gs	19338054	1	O
protein	19338054	1	O
-	19338054	1	O
coupled	19338054	1	O
receptor	19338054	1	O
expressed	19338054	1	O
in	19338054	1	O
epidermal	19338054	1	O
melanocytes	19338054	1	O
,	19338054	1	O
is	19338054	1	O
a	19338054	1	O
major	19338054	1	O
determinant	19338054	1	O
of	19338054	1	O
skin	19338054	1	O
pigmentation	19338054	1	O
and	19338054	1	O
phototype	19338054	1	O
and	19338054	1	O
an	19338054	1	O
important	19338054	1	O
contributor	19338054	1	O
to	19338054	1	O
melanoma	19338054	1	O
risk	19338054	1	O
.	19338054	1	O
MC1R	19338054	1	O
activation	19338054	1	O
stimulates	19338054	1	O
synthesis	19338054	1	O
of	19338054	1	O
black	19338054	1	O
,	19338054	1	O
strongly	19338054	1	O
photoprotective	19338054	1	O
eumelanin	19338054	1	O
pigments	19338054	1	O
.	19338054	1	O
Several	19338054	1	O
MC1R	19338054	1	O
alleles	19338054	1	O
are	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
red	19338054	1	O
hair	19338054	1	O
,	19338054	1	O
fair	19338054	1	O
skin	19338054	1	O
,	19338054	1	O
increased	19338054	1	O
sensitivity	19338054	1	O
to	19338054	1	O
ultraviolet	19338054	1	O
radiation	19338054	1	O
,	19338054	1	O
and	19338054	1	O
increased	19338054	1	O
skin	19338054	1	O
cancer	19338054	1	O
risk	19338054	1	O
.	19338054	1	O
The	19338054	1	O
MC1R	19338054	1	O
gene	19338054	1	O
is	19338054	1	O
highly	19338054	1	O
polymorphic	19338054	1	O
,	19338054	1	O
but	19338054	1	O
only	19338054	1	O
a	19338054	1	O
few	19338054	1	O
naturally	19338054	1	O
occurring	19338054	1	O
alleles	19338054	1	O
have	19338054	1	O
been	19338054	1	O
functionally	19338054	1	O
characterized	19338054	1	O
,	19338054	1	O
which	19338054	1	O
complicates	19338054	1	O
the	19338054	1	O
establishment	19338054	1	O
of	19338054	1	O
accurate	19338054	1	O
correlations	19338054	1	O
between	19338054	1	O
the	19338054	1	O
signaling	19338054	1	O
properties	19338054	1	O
of	19338054	1	O
mutant	19338054	1	O
alleles	19338054	1	O
and	19338054	1	O
defined	19338054	1	O
cutaneous	19338054	1	O
phenotypes	19338054	1	O
.	19338054	1	O
We	19338054	1	O
report	19338054	1	O
the	19338054	1	O
functional	19338054	1	O
characterization	19338054	1	O
of	19338054	1	O
six	19338054	1	O
MC1R	19338054	1	O
alleles	19338054	1	O
found	19338054	1	O
in	19338054	1	O
Spanish	19338054	1	O
melanoma	19338054	1	B-Disease
patients	19338054	1	O
.	19338054	1	O
Two	19338054	1	O
variants	19338054	1	O
(	19338054	1	O
c.152T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Val51Ala	19338054	1	O
and	19338054	1	O
c.865T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Cys289Arg	19338054	1	O
)	19338054	1	O
have	19338054	1	O
never	19338054	1	O
been	19338054	1	O
described	19338054	1	O
,	19338054	1	O
and	19338054	1	O
the	19338054	1	O
others	19338054	1	O
(	19338054	1	O
c.112G	19338054	1	O
>	19338054	1	O
A	19338054	1	O
,	19338054	1	O
p.Val38Met	19338054	1	O
;	19338054	1	O
c.122C	19338054	1	O
>	19338054	1	O
T	19338054	1	O
,	19338054	1	O
p.Ser41Phe	19338054	1	O
;	19338054	1	O
c.383T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Met128Thr	19338054	1	O
;	19338054	1	O
and	19338054	1	O
c.842A	19338054	1	O
>	19338054	1	O
G	19338054	1	O
,	19338054	1	O
p.Asn281Ser	19338054	1	O
)	19338054	1	O
have	19338054	1	O
not	19338054	1	O
been	19338054	1	O
analyzed	19338054	1	O
for	19338054	1	O
function	19338054	1	O
.	19338054	1	O
p.Asn281Ser	19338054	1	B-Var
corresponds	19338054	1	O
to	19338054	1	O
a	19338054	1	O
functionally	19338054	1	O
silent	19338054	1	B-NegReg
polymorphism	19338054	1	B-MPA
.	19338054	1	O
The	19338054	1	O
other	19338054	1	O
mutations	19338054	1	O
are	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
varying	19338054	1	O
degrees	19338054	1	O
of	19338054	1	O
loss	19338054	1	O
of	19338054	1	O
function	19338054	1	O
(	19338054	1	O
LOF	19338054	1	O
)	19338054	1	O
,	19338054	1	O
from	19338054	1	O
moderate	19338054	1	O
decreases	19338054	1	B-NegReg
in	19338054	1	O
coupling	19338054	1	B-MPA
to	19338054	1	O
the	19338054	1	O
cAMP	19338054	1	B-Pathway
pathway	19338054	1	I-Pathway
(	19338054	1	B-Var
p.Val38Met	19338054	1	I-Var
and	19338054	1	O
p.Val51Ala	19338054	1	B-Var
)	19338054	1	I-Var
to	19338054	1	O
nearly	19338054	1	O
complete	19338054	1	O
absence	19338054	1	B-NegReg
of	19338054	1	O
functional	19338054	1	B-MPA
coupling	19338054	1	I-MPA
(	19338054	1	B-Var
p.Ser41Phe	19338054	1	I-Var
,	19338054	1	O
p.Met128Thr	19338054	1	B-Var
,	19338054	1	O
and	19338054	1	O
p.Cys289Arg	19338054	1	B-Var
)	19338054	1	I-Var
.	19338054	1	O
The	19338054	1	O
LOF	19338054	1	O
p.Met128Thr	19338054	1	B-Var
and	19338054	1	O
p.Cys289Arg	19338054	1	B-Var
mutants	19338054	1	O
are	19338054	1	O
trafficked	19338054	1	O
to	19338054	1	O
the	19338054	1	O
cell	19338054	1	O
surface	19338054	1	O
,	19338054	1	O
but	19338054	1	O
are	19338054	1	O
unable	19338054	1	B-NegReg
to	19338054	1	O
bind	19338054	1	B-Interaction
agonists	19338054	1	O
efficiently	19338054	1	O
.	19338054	1	O
Conversely	19338054	1	O
,	19338054	1	O
LOF	19338054	1	O
of	19338054	1	O
p.Val38Met	19338054	1	B-Var
,	19338054	1	O
p.Ser41Phe	19338054	1	I-Var
,	19338054	1	O
and	19338054	1	I-Var
p.Val51Ala	19338054	1	I-Var
is	19338054	1	O
due	19338054	1	O
to	19338054	1	O
reduced	19338054	1	B-NegReg
cell	19338054	1	B-CPA
surface	19338054	1	I-CPA
expression	19338054	1	I-CPA
as	19338054	1	O
a	19338054	1	O
consequence	19338054	1	O
of	19338054	1	O
retention	19338054	1	O
in	19338054	1	O
the	19338054	1	O
endoplasmic	19338054	1	O
reticulum	19338054	1	O
(	19338054	1	O
ER	19338054	1	O
)	19338054	1	O
.	19338054	1	O
Therefore	19338054	1	O
,	19338054	1	O
LOF	19338054	1	O
of	19338054	1	O
MC1R	19338054	1	O
alleles	19338054	1	O
is	19338054	1	O
frequently	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
aberrant	19338054	1	O
forward	19338054	1	O
trafficking	19338054	1	O
and	19338054	1	O
accumulation	19338054	1	O
within	19338054	1	O
the	19338054	1	O
ER	19338054	1	O
or	19338054	1	O
with	19338054	1	O
inability	19338054	1	O
to	19338054	1	O
bind	19338054	1	O
properly	19338054	1	O
the	19338054	1	O
activatory	19338054	1	O
ligand	19338054	1	O
.	19338054	1	O

Elevated	19917135	2	O
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
mutation	19917135	2	O
R175H	19917135	2	O
in	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
cells	19917135	2	O
can	19917135	2	O
increase	19917135	2	O
the	19917135	2	O
invasive	19917135	2	O
phenotypes	19917135	2	O
by	19917135	2	O
activation	19917135	2	O
of	19917135	2	O
the	19917135	2	O
EGFR	19917135	2	O
/	19917135	2	O
PI3K	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
.	19917135	2	O
BACKGROUND	19917135	2	O
:	19917135	2	O
p53	19917135	2	O
is	19917135	2	O
the	19917135	2	O
most	19917135	2	O
commonly	19917135	2	O
mutated	19917135	2	O
tumor	19917135	2	O
suppressor	19917135	2	O
gene	19917135	2	O
in	19917135	2	O
human	19917135	2	O
cancers	19917135	2	O
.	19917135	2	O
In	19917135	2	O
addition	19917135	2	O
to	19917135	2	O
the	19917135	2	O
loss	19917135	2	O
of	19917135	2	O
tumor	19917135	2	O
suppression	19917135	2	O
function	19917135	2	O
and	19917135	2	O
exertion	19917135	2	O
of	19917135	2	O
dominant	19917135	2	O
-	19917135	2	O
negative	19917135	2	O
effects	19917135	2	O
over	19917135	2	O
the	19917135	2	O
remaining	19917135	2	O
wild	19917135	2	O
-	19917135	2	O
type	19917135	2	O
protein	19917135	2	O
,	19917135	2	O
several	19917135	2	O
p53	19917135	2	O
mutants	19917135	2	O
can	19917135	2	O
gain	19917135	2	O
novel	19917135	2	O
oncogenic	19917135	2	O
functions	19917135	2	O
(	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
,	19917135	2	O
GOF	19917135	2	O
)	19917135	2	O
that	19917135	2	O
actively	19917135	2	O
regulate	19917135	2	O
cancer	19917135	2	O
development	19917135	2	O
and	19917135	2	O
progression	19917135	2	O
.	19917135	2	O
In	19917135	2	O
human	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
,	19917135	2	O
p53	19917135	2	B-Gene
mutation	19917135	2	B-Var
is	19917135	2	O
more	19917135	2	O
often	19917135	2	O
associated	19917135	2	B-Reg
with	19917135	2	O
aggressive	19917135	2	B-Disease
nonendometrioid	19917135	2	I-Disease
cancer	19917135	2	I-Disease
.	19917135	2	O
However	19917135	2	O
,	19917135	2	O
it	19917135	2	O
was	19917135	2	O
unknown	19917135	2	O
if	19917135	2	O
p53	19917135	2	O
mutants	19917135	2	O
contributed	19917135	2	O
to	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
progression	19917135	2	O
through	19917135	2	O
the	19917135	2	O
GOF	19917135	2	O
properties	19917135	2	O
.	19917135	2	O
METHODS	19917135	2	O
:	19917135	2	O
To	19917135	2	O
clarify	19917135	2	O
the	19917135	2	O
relationship	19917135	2	O
between	19917135	2	O
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	O
GOF	19917135	2	O
mutation	19917135	2	O
(	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
)	19917135	2	O
and	19917135	2	O
invasive	19917135	2	O
potential	19917135	2	O
of	19917135	2	O
human	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
KLE	19917135	2	O
cells	19917135	2	O
,	19917135	2	O
we	19917135	2	O
tested	19917135	2	B-Reg
the	19917135	2	O
consequences	19917135	2	O
of	19917135	2	O
up	19917135	2	B-PosReg
-	19917135	2	I-PosReg
regulation	19917135	2	I-PosReg
and	19917135	2	O
down	19917135	2	B-NegReg
-	19917135	2	I-NegReg
regulation	19917135	2	I-NegReg
of	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
in	19917135	2	O
KLE	19917135	2	O
cells	19917135	2	O
by	19917135	2	O
inducing	19917135	2	B-Reg
p53	19917135	2	B-Protein
-	19917135	2	I-Protein
R175H	19917135	2	I-Protein
expression	19917135	2	I-Protein
vector	19917135	2	I-Protein
or	19917135	2	O
suppressing	19917135	2	B-NegReg
the	19917135	2	O
p53	19917135	2	B-Gene
gene	19917135	2	I-Gene
with	19917135	2	O
short	19917135	2	O
hairpin	19917135	2	O
RNA	19917135	2	O
.	19917135	2	O
RESULTS	19917135	2	O
:	19917135	2	O
We	19917135	2	O
found	19917135	2	O
that	19917135	2	O
forced	19917135	2	O
over	19917135	2	B-PosReg
-	19917135	2	I-PosReg
expression	19917135	2	I-PosReg
of	19917135	2	O
p53	19917135	2	B-Var
-	19917135	2	I-Var
R175H	19917135	2	I-Var
significantly	19917135	2	O
promoted	19917135	2	B-PosReg
cell	19917135	2	B-CPA
migration	19917135	2	I-CPA
and	19917135	2	I-CPA
invasion	19917135	2	B-CPA
,	19917135	2	O
and	19917135	2	O
induced	19917135	2	O
activation	19917135	2	B-PosReg
of	19917135	2	O
the	19917135	2	O
epidermal	19917135	2	B-Pathway
growth	19917135	2	I-Pathway
factor	19917135	2	I-Pathway
receptor	19917135	2	I-Pathway
(	19917135	2	I-Pathway
EGFR	19917135	2	I-Pathway
)	19917135	2	I-Pathway
/	19917135	2	I-Pathway
phosphatidylinositol	19917135	2	I-Pathway
3	19917135	2	I-Pathway
-	19917135	2	I-Pathway
kinase	19917135	2	I-Pathway
(	19917135	2	I-Pathway
PI3K	19917135	2	I-Pathway
)	19917135	2	I-Pathway
/	19917135	2	I-Pathway
AKT	19917135	2	I-Pathway
pathway	19917135	2	I-Pathway
.	19917135	2	O
Conversely	19917135	2	O
,	19917135	2	O
suppression	19917135	2	B-NegReg
of	19917135	2	O
p53	19917135	2	B-Protein
-	19917135	2	I-Protein
R175H	19917135	2	I-Protein
with	19917135	2	O
short	19917135	2	B-Gene
hairpin	19917135	2	I-Gene
RNA	19917135	2	I-Gene
significantly	19917135	2	O
inhibited	19917135	2	B-NegReg
cell	19917135	2	B-CPA
migration	19917135	2	I-CPA
and	19917135	2	I-CPA
invasion	19917135	2	I-CPA
,	19917135	2	O
and	19917135	2	O
resulted	19917135	2	O
in	19917135	2	O
attenuation	19917135	2	B-NegReg
of	19917135	2	O
EGFR	19917135	2	B-Pathway
/	19917135	2	I-Pathway
PI3K	19917135	2	I-Pathway
/	19917135	2	I-Pathway
AKT	19917135	2	I-Pathway
pathway	19917135	2	I-Pathway
.	19917135	2	O
CONCLUSION	19917135	2	O
:	19917135	2	O
These	19917135	2	O
findings	19917135	2	O
show	19917135	2	O
for	19917135	2	O
the	19917135	2	O
first	19917135	2	O
time	19917135	2	O
that	19917135	2	O
elevated	19917135	2	B-PosReg
expression	19917135	2	B-MPA
of	19917135	2	O
p53	19917135	2	B-Var
-	19917135	2	I-Var
R175H	19917135	2	I-Var
mutant	19917135	2	O
may	19917135	2	O
exert	19917135	2	O
gain	19917135	2	B-MPA
-	19917135	2	I-MPA
of	19917135	2	I-MPA
-	19917135	2	I-MPA
function	19917135	2	I-MPA
activity	19917135	2	I-MPA
to	19917135	2	O
activate	19917135	2	B-PosReg
the	19917135	2	O
EGFR	19917135	2	B-Pathway
/	19917135	2	I-Pathway
PI3K	19917135	2	I-Pathway
/	19917135	2	I-Pathway
AKT	19917135	2	I-Pathway
pathway	19917135	2	I-Pathway
and	19917135	2	O
thus	19917135	2	O
may	19917135	2	O
contribute	19917135	2	B-Reg
to	19917135	2	O
the	19917135	2	O
invasive	19917135	2	O
phenotype	19917135	2	O
in	19917135	2	O
endometrial	19917135	2	B-Disease
cancer	19917135	2	I-Disease
.	19917135	2	O

The	20399956	3	O
tyrosine	20399956	3	O
phosphatase	20399956	3	O
Shp2	20399956	3	O
in	20399956	3	O
development	20399956	3	O
and	20399956	3	O
cancer	20399956	3	O
.	20399956	3	O
Deregulation	20399956	3	O
of	20399956	3	O
signaling	20399956	3	O
pathways	20399956	3	O
,	20399956	3	O
through	20399956	3	O
mutation	20399956	3	O
or	20399956	3	O
other	20399956	3	O
molecular	20399956	3	O
changes	20399956	3	O
,	20399956	3	O
can	20399956	3	O
ultimately	20399956	3	O
result	20399956	3	O
in	20399956	3	O
disease	20399956	3	O
.	20399956	3	O
The	20399956	3	O
tyrosine	20399956	3	O
phosphatase	20399956	3	O
Shp2	20399956	3	O
has	20399956	3	O
emerged	20399956	3	O
as	20399956	3	O
a	20399956	3	O
major	20399956	3	O
regulator	20399956	3	O
of	20399956	3	O
receptor	20399956	3	O
tyrosine	20399956	3	O
kinase	20399956	3	O
(	20399956	3	O
RTK	20399956	3	O
)	20399956	3	O
and	20399956	3	O
cytokine	20399956	3	O
receptor	20399956	3	O
signaling	20399956	3	O
.	20399956	3	O
In	20399956	3	O
the	20399956	3	O
last	20399956	3	O
decade	20399956	3	O
,	20399956	3	O
germline	20399956	3	O
mutations	20399956	3	O
in	20399956	3	O
the	20399956	3	O
human	20399956	3	O
PTPN11	20399956	3	O
gene	20399956	3	O
,	20399956	3	O
encoding	20399956	3	O
Shp2	20399956	3	O
,	20399956	3	O
were	20399956	3	O
linked	20399956	3	O
to	20399956	3	O
Noonan	20399956	3	O
(	20399956	3	O
NS	20399956	3	O
)	20399956	3	O
and	20399956	3	O
LEOPARD	20399956	3	O
syndromes	20399956	3	O
,	20399956	3	O
two	20399956	3	O
multisymptomatic	20399956	3	O
developmental	20399956	3	O
disorders	20399956	3	O
that	20399956	3	O
are	20399956	3	O
characterized	20399956	3	O
by	20399956	3	O
short	20399956	3	O
stature	20399956	3	O
,	20399956	3	O
craniofacial	20399956	3	O
defects	20399956	3	O
,	20399956	3	O
cardiac	20399956	3	O
defects	20399956	3	O
,	20399956	3	O
and	20399956	3	O
mental	20399956	3	O
retardation	20399956	3	O
.	20399956	3	O
Somatic	20399956	3	O
Shp2	20399956	3	B-Gene
mutations	20399956	3	B-Var
are	20399956	3	O
also	20399956	3	O
associated	20399956	3	B-Reg
with	20399956	3	O
several	20399956	3	O
types	20399956	3	O
of	20399956	3	O
human	20399956	3	O
malignancies	20399956	3	O
,	20399956	3	O
such	20399956	3	O
as	20399956	3	O
the	20399956	3	O
most	20399956	3	O
common	20399956	3	O
juvenile	20399956	3	B-Disease
leukemia	20399956	3	I-Disease
,	20399956	3	O
juvenile	20399956	3	B-Disease
myelomonocytic	20399956	3	I-Disease
leukemia	20399956	3	I-Disease
(	20399956	3	O
JMML	20399956	3	O
)	20399956	3	O
.	20399956	3	O
Whereas	20399956	3	O
NS	20399956	3	B-Disease
and	20399956	3	O
JMML	20399956	3	B-Disease
are	20399956	3	O
caused	20399956	3	O
by	20399956	3	O
gain	20399956	3	B-PosReg
-	20399956	3	I-PosReg
of	20399956	3	I-PosReg
-	20399956	3	I-PosReg
function	20399956	3	I-PosReg
(	20399956	3	O
GOF	20399956	3	O
)	20399956	3	O
mutations	20399956	3	B-Var
of	20399956	3	O
Shp2	20399956	3	B-Gene
,	20399956	3	O
loss	20399956	3	B-NegReg
-	20399956	3	I-NegReg
of	20399956	3	I-NegReg
-	20399956	3	I-NegReg
function	20399956	3	I-NegReg
(	20399956	3	O
LOF	20399956	3	O
)	20399956	3	O
mutations	20399956	3	B-Var
are	20399956	3	O
thought	20399956	3	O
to	20399956	3	O
be	20399956	3	O
associated	20399956	3	O
with	20399956	3	O
LEOPARD	20399956	3	B-Disease
syndrome	20399956	3	I-Disease
.	20399956	3	O
Animal	20399956	3	O
models	20399956	3	O
that	20399956	3	O
carry	20399956	3	O
conditional	20399956	3	O
LOF	20399956	3	O
and	20399956	3	O
GOF	20399956	3	O
mutations	20399956	3	O
have	20399956	3	O
allowed	20399956	3	O
a	20399956	3	O
better	20399956	3	O
understanding	20399956	3	O
of	20399956	3	O
the	20399956	3	O
mechanism	20399956	3	O
of	20399956	3	O
Shp2	20399956	3	O
function	20399956	3	O
in	20399956	3	O
disease	20399956	3	O
,	20399956	3	O
and	20399956	3	O
shed	20399956	3	O
light	20399956	3	O
on	20399956	3	O
the	20399956	3	O
role	20399956	3	O
of	20399956	3	O
Shp2	20399956	3	O
in	20399956	3	O
signaling	20399956	3	O
pathways	20399956	3	O
that	20399956	3	O
control	20399956	3	O
decisive	20399956	3	O
events	20399956	3	O
during	20399956	3	O
embryonic	20399956	3	O
development	20399956	3	O
or	20399956	3	O
during	20399956	3	O
cellular	20399956	3	O
transformation	20399956	3	O
/	20399956	3	O
tumorigenesis	20399956	3	O
.	20399956	3	O

Mutant	20696700	0	B-Var
p53	20696700	0	B-Gene
facilitates	20696700	0	B-PosReg
somatic	20696700	0	B-CPA
cell	20696700	0	I-CPA
reprogramming	20696700	0	I-CPA
and	20696700	0	O
augments	20696700	0	B-NegReg
the	20696700	0	O
malignant	20696700	0	B-CPA
potential	20696700	0	I-CPA
of	20696700	0	I-CPA
reprogrammed	20696700	0	I-CPA
cells	20696700	0	I-CPA
.	20696700	0	O
p53	20696700	0	B-Gene
deficiency	20696700	0	B-Var
enhances	20696700	0	B-PosReg
the	20696700	0	O
efficiency	20696700	0	O
of	20696700	0	O
somatic	20696700	0	B-CPA
cell	20696700	0	I-CPA
reprogramming	20696700	0	I-CPA
to	20696700	0	O
a	20696700	0	O
pluripotent	20696700	0	O
state	20696700	0	O
.	20696700	0	O
As	20696700	0	O
p53	20696700	0	O
is	20696700	0	O
usually	20696700	0	O
mutated	20696700	0	O
in	20696700	0	O
human	20696700	0	O
tumors	20696700	0	O
and	20696700	0	O
many	20696700	0	O
mutated	20696700	0	B-Var
forms	20696700	0	I-Var
of	20696700	0	O
p53	20696700	0	B-Gene
gain	20696700	0	B-PosReg
novel	20696700	0	O
activities	20696700	0	B-MPA
,	20696700	0	O
we	20696700	0	O
studied	20696700	0	O
the	20696700	0	O
influence	20696700	0	O
of	20696700	0	O
mutant	20696700	0	O
p53	20696700	0	O
(	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
)	20696700	0	O
on	20696700	0	O
somatic	20696700	0	O
cell	20696700	0	O
reprogramming	20696700	0	O
.	20696700	0	O
Our	20696700	0	O
data	20696700	0	O
indicate	20696700	0	O
a	20696700	0	O
novel	20696700	0	O
gain	20696700	0	B-PosReg
of	20696700	0	O
function	20696700	0	B-MPA
(	20696700	0	O
GOF	20696700	0	O
)	20696700	0	O
property	20696700	0	O
for	20696700	0	O
mut	20696700	0	B-Var
-	20696700	0	I-Var
p53	20696700	0	I-Var
,	20696700	0	O
which	20696700	0	O
markedly	20696700	0	O
enhanced	20696700	0	B-PosReg
the	20696700	0	O
efficiency	20696700	0	O
of	20696700	0	O
the	20696700	0	O
reprogramming	20696700	0	B-CPA
process	20696700	0	I-CPA
compared	20696700	0	O
with	20696700	0	O
p53	20696700	0	O
deficiency	20696700	0	O
.	20696700	0	O
Importantly	20696700	0	O
,	20696700	0	O
this	20696700	0	O
novel	20696700	0	O
activity	20696700	0	B-MPA
of	20696700	0	O
mut	20696700	0	B-Var
-	20696700	0	I-Var
p53	20696700	0	I-Var
induced	20696700	0	O
alterations	20696700	0	B-Reg
in	20696700	0	O
the	20696700	0	O
characteristics	20696700	0	B-CPA
of	20696700	0	I-CPA
the	20696700	0	I-CPA
reprogrammed	20696700	0	I-CPA
cells	20696700	0	I-CPA
.	20696700	0	O
Although	20696700	0	O
p53	20696700	0	O
knockout	20696700	0	O
(	20696700	0	O
KO	20696700	0	O
)	20696700	0	O
cells	20696700	0	O
reprogrammed	20696700	0	O
with	20696700	0	O
only	20696700	0	O
Oct4	20696700	0	O
and	20696700	0	O
Sox2	20696700	0	O
maintained	20696700	0	O
their	20696700	0	O
pluripotent	20696700	0	B-MPA
capacity	20696700	0	I-MPA
in	20696700	0	O
vivo	20696700	0	O
,	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
expressing	20696700	0	O
mutant	20696700	0	B-Var
p53	20696700	0	B-Gene
lost	20696700	0	B-NegReg
this	20696700	0	O
capability	20696700	0	O
and	20696700	0	O
gave	20696700	0	B-Reg
rise	20696700	0	I-Reg
to	20696700	0	O
malignant	20696700	0	B-CPA
tumors	20696700	0	I-CPA
.	20696700	0	O
This	20696700	0	O
novel	20696700	0	O
GOF	20696700	0	O
of	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
is	20696700	0	O
not	20696700	0	O
attributed	20696700	0	O
to	20696700	0	O
its	20696700	0	O
effect	20696700	0	O
on	20696700	0	O
proliferation	20696700	0	O
,	20696700	0	O
as	20696700	0	O
both	20696700	0	O
p53	20696700	0	O
KO	20696700	0	O
and	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
cells	20696700	0	O
displayed	20696700	0	O
similar	20696700	0	O
proliferation	20696700	0	O
rates	20696700	0	O
.	20696700	0	O
In	20696700	0	O
addition	20696700	0	O
,	20696700	0	O
we	20696700	0	O
demonstrate	20696700	0	O
an	20696700	0	O
oncogenic	20696700	0	B-MPA
activity	20696700	0	I-MPA
of	20696700	0	O
Klf4	20696700	0	O
,	20696700	0	O
as	20696700	0	O
its	20696700	0	O
overexpression	20696700	0	B-PosReg
in	20696700	0	O
either	20696700	0	O
p53	20696700	0	B-Var
KO	20696700	0	I-Var
or	20696700	0	I-Var
mut	20696700	0	I-Var
-	20696700	0	I-Var
p53	20696700	0	I-Var
cells	20696700	0	O
induced	20696700	0	B-PosReg
aggressive	20696700	0	B-CPA
tumors	20696700	0	I-CPA
.	20696700	0	O
Overall	20696700	0	O
,	20696700	0	O
our	20696700	0	O
data	20696700	0	O
show	20696700	0	O
that	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
with	20696700	0	O
the	20696700	0	O
capacity	20696700	0	O
to	20696700	0	O
differentiate	20696700	0	O
into	20696700	0	O
the	20696700	0	O
three	20696700	0	O
germ	20696700	0	O
layers	20696700	0	O
in	20696700	0	O
vitro	20696700	0	O
can	20696700	0	O
form	20696700	0	O
malignant	20696700	0	O
tumors	20696700	0	O
,	20696700	0	O
suggesting	20696700	0	O
that	20696700	0	O
in	20696700	0	O
genetically	20696700	0	O
unstable	20696700	0	O
cells	20696700	0	O
,	20696700	0	O
such	20696700	0	O
as	20696700	0	O
those	20696700	0	O
in	20696700	0	O
which	20696700	0	O
p53	20696700	0	B-Gene
is	20696700	0	O
mutated	20696700	0	B-Var
,	20696700	0	O
reprogramming	20696700	0	B-CPA
may	20696700	0	O
result	20696700	0	B-Reg
in	20696700	0	I-Reg
the	20696700	0	O
generation	20696700	0	O
of	20696700	0	O
cells	20696700	0	B-CPA
with	20696700	0	I-CPA
malignant	20696700	0	I-CPA
tumor	20696700	0	I-CPA
-	20696700	0	I-CPA
forming	20696700	0	I-CPA
potential	20696700	0	I-CPA
.	20696700	0	O

The	21175440	0	O
combined	21175440	0	O
impact	21175440	0	O
of	21175440	0	O
CYP2C19	21175440	0	O
and	21175440	0	O
CYP2B6	21175440	0	O
pharmacogenetics	21175440	0	O
on	21175440	0	O
cyclophosphamide	21175440	0	O
bioactivation	21175440	0	O
.	21175440	0	O
AIMS	21175440	0	O
:	21175440	0	O
The	21175440	0	O
role	21175440	0	O
of	21175440	0	O
CYP	21175440	0	O
pharmacogenetics	21175440	0	O
in	21175440	0	O
the	21175440	0	O
bioactivation	21175440	0	O
of	21175440	0	O
cyclophosphamide	21175440	0	O
is	21175440	0	O
still	21175440	0	O
controversial	21175440	0	O
.	21175440	0	O
Recent	21175440	0	O
clinical	21175440	0	O
studies	21175440	0	O
have	21175440	0	O
suggested	21175440	0	O
a	21175440	0	O
role	21175440	0	O
for	21175440	0	O
either	21175440	0	O
CYP2C19	21175440	0	O
or	21175440	0	O
CYP2B6	21175440	0	O
.	21175440	0	O
The	21175440	0	O
aim	21175440	0	O
of	21175440	0	O
this	21175440	0	O
study	21175440	0	O
was	21175440	0	O
to	21175440	0	O
clarify	21175440	0	O
the	21175440	0	O
role	21175440	0	O
of	21175440	0	O
these	21175440	0	O
pharmacogenes	21175440	0	O
.	21175440	0	O
METHODS	21175440	0	O
:	21175440	0	O
We	21175440	0	O
used	21175440	0	O
a	21175440	0	O
combined	21175440	0	O
in	21175440	0	O
vitro	21175440	0	O
-	21175440	0	O
in	21175440	0	O
vivo	21175440	0	O
approach	21175440	0	O
to	21175440	0	O
determine	21175440	0	O
the	21175440	0	O
role	21175440	0	O
of	21175440	0	O
these	21175440	0	O
pharmacogenes	21175440	0	O
in	21175440	0	O
the	21175440	0	O
bioactivation	21175440	0	O
of	21175440	0	O
the	21175440	0	O
prodrug	21175440	0	O
to	21175440	0	O
4	21175440	0	O
-	21175440	0	O
hydroxy	21175440	0	O
cyclophosphamide	21175440	0	O
(	21175440	0	O
4	21175440	0	O
-	21175440	0	O
OHCP	21175440	0	O
)	21175440	0	O
.	21175440	0	O
Cyclophosphamide	21175440	0	O
metabolism	21175440	0	O
was	21175440	0	O
determined	21175440	0	O
in	21175440	0	O
a	21175440	0	O
human	21175440	0	O
liver	21175440	0	O
biobank	21175440	0	O
(	21175440	0	O
n	21175440	0	O
=	21175440	0	O
14	21175440	0	O
)	21175440	0	O
and	21175440	0	O
in	21175440	0	O
patients	21175440	0	O
receiving	21175440	0	O
the	21175440	0	O
drug	21175440	0	O
for	21175440	0	O
treatment	21175440	0	O
of	21175440	0	O
lupus	21175440	0	O
nephritis	21175440	0	O
(	21175440	0	O
n	21175440	0	O
=	21175440	0	O
16	21175440	0	O
)	21175440	0	O
RESULTS	21175440	0	O
:	21175440	0	O
In	21175440	0	O
livers	21175440	0	O
of	21175440	0	O
known	21175440	0	O
CYP2C19	21175440	0	O
and	21175440	0	O
CYP2B6	21175440	0	O
genotype	21175440	0	O
and	21175440	0	O
protein	21175440	0	O
expression	21175440	0	O
we	21175440	0	O
observed	21175440	0	O
that	21175440	0	O
there	21175440	0	O
was	21175440	0	O
a	21175440	0	O
combined	21175440	0	B-Interaction
role	21175440	0	O
for	21175440	0	O
both	21175440	0	O
CYP2C19	21175440	0	B-Var
and	21175440	0	O
CYP2B6	21175440	0	B-Var
in	21175440	0	O
the	21175440	0	O
bioactivation	21175440	0	B-MPA
of	21175440	0	I-MPA
cyclophosphamide	21175440	0	I-MPA
in	21175440	0	I-MPA
vitro	21175440	0	I-MPA
.	21175440	0	O
The	21175440	0	O
presence	21175440	0	O
of	21175440	0	O
at	21175440	0	O
least	21175440	0	O
one	21175440	0	O
loss	21175440	0	O
of	21175440	0	O
function	21175440	0	O
(	21175440	0	O
LoF	21175440	0	O
)	21175440	0	O
allele	21175440	0	O
at	21175440	0	O
either	21175440	0	O
CYP2C19	21175440	0	B-Var
or	21175440	0	O
CYP2B6	21175440	0	B-Var
resulted	21175440	0	O
in	21175440	0	O
a	21175440	0	O
significant	21175440	0	O
decrease	21175440	0	B-NegReg
in	21175440	0	O
both	21175440	0	O
V	21175440	0	B-MPA
(	21175440	0	I-MPA
max	21175440	0	I-MPA
)	21175440	0	I-MPA
(	21175440	0	I-MPA
P	21175440	0	I-MPA
=	21175440	0	I-MPA
0.028	21175440	0	I-MPA
)	21175440	0	I-MPA
and	21175440	0	I-MPA
CL	21175440	0	I-MPA
(	21175440	0	I-MPA
int	21175440	0	I-MPA
)	21175440	0	I-MPA
(	21175440	0	I-MPA
P	21175440	0	I-MPA
=	21175440	0	I-MPA
0.0017	21175440	0	I-MPA
)	21175440	0	I-MPA
compared	21175440	0	O
with	21175440	0	O
livers	21175440	0	O
with	21175440	0	O
no	21175440	0	O
LoF	21175440	0	O
alleles	21175440	0	O
.	21175440	0	O
This	21175440	0	O
dual	21175440	0	O
genotype	21175440	0	O
relationship	21175440	0	O
was	21175440	0	O
also	21175440	0	O
observed	21175440	0	O
in	21175440	0	O
a	21175440	0	O
preliminary	21175440	0	O
clinical	21175440	0	O
study	21175440	0	O
,	21175440	0	O
with	21175440	0	O
patients	21175440	0	O
who	21175440	0	O
had	21175440	0	O
1	21175440	0	O
LoF	21175440	0	O
allele	21175440	0	O
at	21175440	0	O
either	21175440	0	O
CYP2C19	21175440	0	B-Var
or	21175440	0	O
CYP2B6	21175440	0	B-Var
also	21175440	0	O
displaying	21175440	0	O
significantly	21175440	0	O
(	21175440	0	O
P	21175440	0	O
=	21175440	0	O
0.0316	21175440	0	O
)	21175440	0	O
lower	21175440	0	B-NegReg
bioactivation	21175440	0	B-MPA
of	21175440	0	I-MPA
cyclophosphamide	21175440	0	I-MPA
.	21175440	0	O
The	21175440	0	O
mean	21175440	0	O
4	21175440	0	O
-	21175440	0	O
OHCP	21175440	0	O
:	21175440	0	O
CP	21175440	0	O
bioactivation	21175440	0	O
ratio	21175440	0	O
was	21175440	0	O
0.0014	21175440	0	O
(	21175440	0	O
95%	21175440	0	O
CI	21175440	0	O
0.0007	21175440	0	O
,	21175440	0	O
0.002	21175440	0	O
)	21175440	0	O
compared	21175440	0	O
with	21175440	0	O
0.0071	21175440	0	O
(	21175440	0	O
95%	21175440	0	O
CI	21175440	0	O
0.0001	21175440	0	O
,	21175440	0	O
0.014	21175440	0	O
)	21175440	0	O
in	21175440	0	O
patients	21175440	0	O
with	21175440	0	O
no	21175440	0	O
LoF	21175440	0	O
alleles	21175440	0	O
at	21175440	0	O
either	21175440	0	O
of	21175440	0	O
these	21175440	0	O
genes	21175440	0	O
.	21175440	0	O
CONCLUSIONS	21175440	0	O
:	21175440	0	O
The	21175440	0	O
presence	21175440	0	O
of	21175440	0	O
1	21175440	0	O
LoF	21175440	0	O
allele	21175440	0	O
(	21175440	0	O
s	21175440	0	O
)	21175440	0	O
at	21175440	0	O
either	21175440	0	O
CYP2B6	21175440	0	B-Var
or	21175440	0	O
CYP2C19	21175440	0	B-Var
appeared	21175440	0	O
to	21175440	0	O
result	21175440	0	O
in	21175440	0	O
decreased	21175440	0	B-NegReg
bioactivation	21175440	0	B-MPA
of	21175440	0	I-MPA
cyclophosphamide	21175440	0	I-MPA
both	21175440	0	O
in	21175440	0	O
vitro	21175440	0	O
and	21175440	0	O
in	21175440	0	O
patients	21175440	0	O
.	21175440	0	O
Further	21175440	0	O
clinical	21175440	0	O
studies	21175440	0	O
to	21175440	0	O
confirm	21175440	0	O
this	21175440	0	O
relationship	21175440	0	O
are	21175440	0	O
warranted	21175440	0	O
.	21175440	0	O

Mutant	21187651	0	O
p53	21187651	0	O
R248Q	21187651	0	O
but	21187651	0	O
not	21187651	0	O
R248W	21187651	0	O
enhances	21187651	0	O
in	21187651	0	O
vitro	21187651	0	O
invasiveness	21187651	0	O
of	21187651	0	O
human	21187651	0	O
lung	21187651	0	O
cancer	21187651	0	O
NCI	21187651	0	O
-	21187651	0	O
H1299	21187651	0	O
cells	21187651	0	O
.	21187651	0	O
More	21187651	0	O
than	21187651	0	O
half	21187651	0	O
of	21187651	0	O
all	21187651	0	O
human	21187651	0	B-Disease
cancers	21187651	0	I-Disease
are	21187651	0	O
associated	21187651	0	B-Reg
with	21187651	0	O
mutations	21187651	0	B-Var
of	21187651	0	O
the	21187651	0	O
TP53	21187651	0	B-Gene
gene	21187651	0	O
.	21187651	0	O
In	21187651	0	O
regard	21187651	0	O
to	21187651	0	O
the	21187651	0	O
functional	21187651	0	O
interaction	21187651	0	O
with	21187651	0	O
the	21187651	0	O
remaining	21187651	0	O
wild	21187651	0	O
-	21187651	0	O
type	21187651	0	O
(	21187651	0	O
WT	21187651	0	O
)	21187651	0	O
p53	21187651	0	O
allele	21187651	0	O
,	21187651	0	O
p53	21187651	0	O
mutations	21187651	0	O
are	21187651	0	O
classified	21187651	0	O
into	21187651	0	O
two	21187651	0	O
types	21187651	0	O
,	21187651	0	O
recessive	21187651	0	O
and	21187651	0	O
dominant	21187651	0	B-Var
-	21187651	0	I-Var
negative	21187651	0	I-Var
(	21187651	0	I-Var
DN	21187651	0	I-Var
)	21187651	0	I-Var
mutations	21187651	0	I-Var
.	21187651	0	O
The	21187651	0	O
latter	21187651	0	O
mutant	21187651	0	O
protein	21187651	0	O
has	21187651	0	O
a	21187651	0	O
DN	21187651	0	B-MPA
activity	21187651	0	I-MPA
over	21187651	0	B-PosReg
the	21187651	0	I-PosReg
remaining	21187651	0	I-PosReg
WT	21187651	0	I-PosReg
allele	21187651	0	I-PosReg
.	21187651	0	O
We	21187651	0	O
previously	21187651	0	O
showed	21187651	0	O
that	21187651	0	O
the	21187651	0	O
DN	21187651	0	O
p53	21187651	0	O
mutant	21187651	0	O
was	21187651	0	O
useful	21187651	0	O
as	21187651	0	O
a	21187651	0	O
predictor	21187651	0	O
of	21187651	0	O
poor	21187651	0	O
outcome	21187651	0	O
or	21187651	0	O
a	21187651	0	O
risk	21187651	0	O
factor	21187651	0	O
for	21187651	0	O
metastatic	21187651	0	O
recurrence	21187651	0	O
in	21187651	0	O
patients	21187651	0	O
with	21187651	0	O
some	21187651	0	O
types	21187651	0	O
of	21187651	0	O
cancers	21187651	0	O
,	21187651	0	O
regardless	21187651	0	O
of	21187651	0	O
the	21187651	0	O
presence	21187651	0	O
or	21187651	0	O
absence	21187651	0	O
of	21187651	0	O
loss	21187651	0	O
of	21187651	0	O
heterozygosity	21187651	0	O
(	21187651	0	O
LOH	21187651	0	O
)	21187651	0	O
of	21187651	0	O
WT	21187651	0	O
p53	21187651	0	O
,	21187651	0	O
suggesting	21187651	0	O
that	21187651	0	O
the	21187651	0	O
DN	21187651	0	B-Var
p53	21187651	0	B-Gene
had	21187651	0	O
'	21187651	0	B-PosReg
gain	21187651	0	I-PosReg
-	21187651	0	I-PosReg
of	21187651	0	I-PosReg
-	21187651	0	I-PosReg
function	21187651	0	I-PosReg
(	21187651	0	I-PosReg
GOF	21187651	0	I-PosReg
)	21187651	0	I-PosReg
'	21187651	0	I-PosReg
activity	21187651	0	I-PosReg
besides	21187651	0	O
the	21187651	0	O
transdominance	21187651	0	O
function	21187651	0	O
.	21187651	0	O
In	21187651	0	O
this	21187651	0	O
study	21187651	0	O
,	21187651	0	O
we	21187651	0	O
investigated	21187651	0	O
GOF	21187651	0	O
activity	21187651	0	O
of	21187651	0	O
two	21187651	0	O
DN	21187651	0	O
p53	21187651	0	O
mutants	21187651	0	O
which	21187651	0	O
had	21187651	0	O
a	21187651	0	O
point	21187651	0	O
mutation	21187651	0	O
at	21187651	0	O
codon	21187651	0	O
248	21187651	0	O
(	21187651	0	O
R248Q	21187651	0	O
and	21187651	0	O
R248W	21187651	0	O
)	21187651	0	O
,	21187651	0	O
one	21187651	0	O
of	21187651	0	O
the	21187651	0	O
hot	21187651	0	O
spots	21187651	0	O
,	21187651	0	O
by	21187651	0	O
transfecting	21187651	0	O
them	21187651	0	O
respectively	21187651	0	O
into	21187651	0	O
H1299	21187651	0	O
cells	21187651	0	O
which	21187651	0	O
originally	21187651	0	O
expressed	21187651	0	O
no	21187651	0	O
p53	21187651	0	O
protein	21187651	0	O
.	21187651	0	O
Growth	21187651	0	O
activity	21187651	0	O
of	21187651	0	O
the	21187651	0	O
transfectants	21187651	0	O
with	21187651	0	O
the	21187651	0	O
two	21187651	0	O
mutants	21187651	0	O
was	21187651	0	O
not	21187651	0	O
different	21187651	0	O
from	21187651	0	O
that	21187651	0	O
of	21187651	0	O
parent	21187651	0	O
or	21187651	0	O
Mock	21187651	0	O
transfectants	21187651	0	O
.	21187651	0	O
Meanwhile	21187651	0	O
,	21187651	0	O
in	21187651	0	O
vitro	21187651	0	B-CPA
invasions	21187651	0	I-CPA
of	21187651	0	I-CPA
Matrigel	21187651	0	I-CPA
and	21187651	0	I-CPA
type	21187651	0	I-CPA
I	21187651	0	I-CPA
collagen	21187651	0	I-CPA
gel	21187651	0	I-CPA
by	21187651	0	O
R248Q	21187651	0	B-Var
-	21187651	0	I-Var
transfectants	21187651	0	I-Var
were	21187651	0	O
significantly	21187651	0	O
higher	21187651	0	B-PosReg
than	21187651	0	O
those	21187651	0	O
by	21187651	0	O
R248W	21187651	0	O
-	21187651	0	O
transfectants	21187651	0	O
or	21187651	0	O
the	21187651	0	O
control	21187651	0	O
cells	21187651	0	O
.	21187651	0	O
However	21187651	0	O
,	21187651	0	O
there	21187651	0	O
were	21187651	0	O
no	21187651	0	O
differences	21187651	0	O
in	21187651	0	O
cell	21187651	0	O
motile	21187651	0	O
activities	21187651	0	O
,	21187651	0	O
expressions	21187651	0	O
of	21187651	0	O
extracellular	21187651	0	O
matrix	21187651	0	O
-	21187651	0	O
degradative	21187651	0	O
enzymes	21187651	0	O
such	21187651	0	O
as	21187651	0	O
matrix	21187651	0	O
metalloproteinases	21187651	0	O
,	21187651	0	O
urokinase	21187651	0	O
-	21187651	0	O
type	21187651	0	O
plasminogen	21187651	0	O
activator	21187651	0	O
and	21187651	0	O
heparanase	21187651	0	O
,	21187651	0	O
and	21187651	0	O
their	21187651	0	O
inhibitors	21187651	0	O
,	21187651	0	O
between	21187651	0	O
R248Q	21187651	0	O
-	21187651	0	O
and	21187651	0	O
R248W	21187651	0	O
-	21187651	0	O
transfectants	21187651	0	O
.	21187651	0	O
These	21187651	0	O
findings	21187651	0	O
indicate	21187651	0	O
that	21187651	0	O
the	21187651	0	O
p53	21187651	0	O
mutants	21187651	0	O
have	21187651	0	O
a	21187651	0	O
different	21187651	0	O
quality	21187651	0	O
in	21187651	0	O
GOF	21187651	0	O
activities	21187651	0	O
even	21187651	0	O
if	21187651	0	O
the	21187651	0	O
mutations	21187651	0	O
occurred	21187651	0	O
at	21187651	0	O
the	21187651	0	O
same	21187651	0	O
codon	21187651	0	O
.	21187651	0	O
And	21187651	0	O
detailed	21187651	0	O
information	21187651	0	O
of	21187651	0	O
the	21187651	0	O
status	21187651	0	O
of	21187651	0	O
p53	21187651	0	O
,	21187651	0	O
including	21187651	0	O
transdominancy	21187651	0	O
and	21187651	0	O
GOF	21187651	0	O
activity	21187651	0	O
,	21187651	0	O
is	21187651	0	O
expected	21187651	0	O
to	21187651	0	O
be	21187651	0	O
useful	21187651	0	O
for	21187651	0	O
diagnosis	21187651	0	O
and	21187651	0	O
therapeutic	21187651	0	O
strategy	21187651	0	O
fitting	21187651	0	O
the	21187651	0	O
individual	21187651	0	O
patients	21187651	0	O
.	21187651	0	O

Gain	22114072	2	O
-	22114072	2	O
of	22114072	2	O
-	22114072	2	O
function	22114072	2	O
mutant	22114072	2	B-Var
p53	22114072	2	B-Gene
upregulates	22114072	2	B-PosReg
CXC	22114072	2	B-MPA
chemokines	22114072	2	I-MPA
and	22114072	2	O
enhances	22114072	2	B-PosReg
cell	22114072	2	B-CPA
migration	22114072	2	I-CPA
.	22114072	2	O
The	22114072	2	O
role	22114072	2	O
of	22114072	2	O
dominant	22114072	2	O
transforming	22114072	2	O
p53	22114072	2	O
in	22114072	2	O
carcinogenesis	22114072	2	O
is	22114072	2	O
poorly	22114072	2	O
understood	22114072	2	O
.	22114072	2	O
Our	22114072	2	O
previous	22114072	2	O
data	22114072	2	O
suggested	22114072	2	O
that	22114072	2	O
aberrant	22114072	2	B-Var
p53	22114072	2	B-Protein
proteins	22114072	2	I-Protein
can	22114072	2	O
enhance	22114072	2	B-PosReg
tumorigenesis	22114072	2	B-CPA
and	22114072	2	I-CPA
metastasis	22114072	2	I-CPA
.	22114072	2	O
Here	22114072	2	O
,	22114072	2	O
we	22114072	2	O
examined	22114072	2	O
potential	22114072	2	O
mechanisms	22114072	2	O
through	22114072	2	O
which	22114072	2	O
gain	22114072	2	O
-	22114072	2	O
of	22114072	2	O
-	22114072	2	O
function	22114072	2	O
(	22114072	2	O
GOF	22114072	2	O
)	22114072	2	O
p53	22114072	2	O
proteins	22114072	2	O
can	22114072	2	O
induce	22114072	2	O
motility	22114072	2	O
.	22114072	2	O
Cells	22114072	2	O
expressing	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	B-Var
-	22114072	2	I-Var
R175H	22114072	2	I-Var
,	22114072	2	O
-	22114072	2	I-Var
R273H	22114072	2	I-Var
and	22114072	2	I-Var
-	22114072	2	I-Var
D281G	22114072	2	I-Var
showed	22114072	2	O
enhanced	22114072	2	B-PosReg
migration	22114072	2	B-CPA
,	22114072	2	O
which	22114072	2	O
was	22114072	2	O
reversed	22114072	2	O
by	22114072	2	O
RNA	22114072	2	O
interference	22114072	2	O
(	22114072	2	O
RNAi	22114072	2	O
)	22114072	2	O
or	22114072	2	O
transactivation	22114072	2	O
-	22114072	2	O
deficient	22114072	2	O
mutants	22114072	2	O
.	22114072	2	O
In	22114072	2	O
cells	22114072	2	O
with	22114072	2	O
engineered	22114072	2	O
or	22114072	2	O
endogenous	22114072	2	O
p53	22114072	2	O
mutants	22114072	2	O
,	22114072	2	O
enhanced	22114072	2	O
migration	22114072	2	O
was	22114072	2	O
reduced	22114072	2	O
by	22114072	2	O
downregulation	22114072	2	O
of	22114072	2	O
nuclear	22114072	2	O
factor	22114072	2	O
-	22114072	2	O
kappaB2	22114072	2	O
,	22114072	2	O
a	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	O
target	22114072	2	O
.	22114072	2	O
We	22114072	2	O
found	22114072	2	O
that	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
proteins	22114072	2	O
upregulate	22114072	2	B-PosReg
CXC	22114072	2	B-MPA
-	22114072	2	I-MPA
chemokine	22114072	2	I-MPA
expression	22114072	2	I-MPA
,	22114072	2	O
the	22114072	2	O
inflammatory	22114072	2	O
mediators	22114072	2	O
that	22114072	2	O
contribute	22114072	2	O
to	22114072	2	O
multiple	22114072	2	O
aspects	22114072	2	O
of	22114072	2	O
tumorigenesis	22114072	2	O
.	22114072	2	O
Elevated	22114072	2	B-PosReg
expression	22114072	2	B-MPA
of	22114072	2	O
CXCL5	22114072	2	O
,	22114072	2	O
CXCL8	22114072	2	O
and	22114072	2	O
CXCL12	22114072	2	O
was	22114072	2	O
found	22114072	2	O
in	22114072	2	O
cells	22114072	2	O
expressing	22114072	2	O
oncogenic	22114072	2	B-Var
p53	22114072	2	I-Var
.	22114072	2	O
Transcription	22114072	2	B-MPA
was	22114072	2	O
elevated	22114072	2	B-PosReg
as	22114072	2	O
CXCL5	22114072	2	B-MPA
and	22114072	2	I-MPA
CXCL8	22114072	2	I-MPA
promoter	22114072	2	I-MPA
activity	22114072	2	I-MPA
was	22114072	2	O
higher	22114072	2	B-PosReg
in	22114072	2	O
cells	22114072	2	O
expressing	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
,	22114072	2	O
whereas	22114072	2	O
wild	22114072	2	O
-	22114072	2	O
type	22114072	2	O
p53	22114072	2	O
repressed	22114072	2	O
promoter	22114072	2	O
activity	22114072	2	O
.	22114072	2	O
Chromatin	22114072	2	O
immunoprecipitation	22114072	2	O
assays	22114072	2	O
revealed	22114072	2	O
enhanced	22114072	2	O
presence	22114072	2	O
of	22114072	2	O
acetylated	22114072	2	O
histone	22114072	2	O
H3	22114072	2	O
on	22114072	2	O
the	22114072	2	O
CXCL5	22114072	2	O
promoter	22114072	2	O
in	22114072	2	O
H1299	22114072	2	O
/	22114072	2	O
R273H	22114072	2	O
cells	22114072	2	O
,	22114072	2	O
in	22114072	2	O
agreement	22114072	2	O
with	22114072	2	O
increased	22114072	2	O
transcriptional	22114072	2	O
activity	22114072	2	O
of	22114072	2	O
the	22114072	2	O
promoter	22114072	2	O
,	22114072	2	O
whereas	22114072	2	O
RNAi	22114072	2	O
-	22114072	2	O
mediated	22114072	2	O
repression	22114072	2	O
of	22114072	2	O
CXCL5	22114072	2	O
inhibited	22114072	2	O
cell	22114072	2	O
migration	22114072	2	O
.	22114072	2	O
Consistent	22114072	2	O
with	22114072	2	O
this	22114072	2	O
,	22114072	2	O
knockdown	22114072	2	O
of	22114072	2	O
the	22114072	2	O
endogenous	22114072	2	B-Var
mutant	22114072	2	I-Var
p53	22114072	2	B-Gene
in	22114072	2	O
lung	22114072	2	O
cancer	22114072	2	O
or	22114072	2	O
melanoma	22114072	2	O
cells	22114072	2	O
reduced	22114072	2	B-NegReg
CXCL5	22114072	2	B-MPA
expression	22114072	2	I-MPA
and	22114072	2	O
cell	22114072	2	B-CPA
migration	22114072	2	I-CPA
.	22114072	2	O
Furthermore	22114072	2	O
,	22114072	2	O
short	22114072	2	O
hairpin	22114072	2	O
RNA	22114072	2	O
knockdown	22114072	2	O
of	22114072	2	O
mutant	22114072	2	B-Var
p53	22114072	2	B-Gene
in	22114072	2	O
MDA	22114072	2	O
-	22114072	2	O
MB-231	22114072	2	O
cells	22114072	2	O
reduced	22114072	2	B-NegReg
expression	22114072	2	B-MPA
of	22114072	2	I-MPA
a	22114072	2	I-MPA
number	22114072	2	I-MPA
of	22114072	2	I-MPA
key	22114072	2	I-MPA
targets	22114072	2	I-MPA
,	22114072	2	O
including	22114072	2	O
several	22114072	2	O
chemokines	22114072	2	O
and	22114072	2	O
other	22114072	2	O
inflammatory	22114072	2	O
mediators	22114072	2	O
.	22114072	2	O
Finally	22114072	2	O
,	22114072	2	O
CXCL5	22114072	2	B-MPA
expression	22114072	2	I-MPA
was	22114072	2	O
also	22114072	2	O
elevated	22114072	2	B-PosReg
in	22114072	2	O
lung	22114072	2	B-Disease
tumor	22114072	2	I-Disease
samples	22114072	2	O
containing	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
,	22114072	2	O
indicating	22114072	2	O
relevance	22114072	2	O
to	22114072	2	O
human	22114072	2	O
cancer	22114072	2	O
.	22114072	2	O
The	22114072	2	O
data	22114072	2	O
suggest	22114072	2	O
a	22114072	2	O
mechanistic	22114072	2	O
link	22114072	2	O
between	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	O
proteins	22114072	2	O
and	22114072	2	O
chemokines	22114072	2	O
in	22114072	2	O
enhanced	22114072	2	O
cell	22114072	2	O
motility	22114072	2	O
.	22114072	2	O

Allele	22989750	2	O
specific	22989750	2	O
gain	22989750	2	B-PosReg
-	22989750	2	I-PosReg
of	22989750	2	I-PosReg
-	22989750	2	I-PosReg
function	22989750	2	I-PosReg
activity	22989750	2	B-MPA
of	22989750	2	O
p53	22989750	2	B-Gene
mutants	22989750	2	B-Var
in	22989750	2	O
lung	22989750	2	B-Disease
cancer	22989750	2	I-Disease
cells	22989750	2	O
.	22989750	2	O
p53	22989750	2	B-Gene
mutations	22989750	2	B-Var
are	22989750	2	O
mostly	22989750	2	O
single	22989750	2	O
amino	22989750	2	O
acid	22989750	2	O
changes	22989750	2	O
resulting	22989750	2	B-Reg
in	22989750	2	I-Reg
expression	22989750	2	B-MPA
of	22989750	2	O
a	22989750	2	O
stable	22989750	2	O
mutant	22989750	2	O
protein	22989750	2	O
with	22989750	2	O
"	22989750	2	B-PosReg
gain	22989750	2	I-PosReg
of	22989750	2	I-PosReg
function	22989750	2	I-PosReg
"	22989750	2	I-PosReg
(	22989750	2	O
GOF	22989750	2	O
)	22989750	2	O
activity	22989750	2	B-MPA
having	22989750	2	O
a	22989750	2	O
dominant	22989750	2	O
oncogenic	22989750	2	O
role	22989750	2	O
rather	22989750	2	O
than	22989750	2	O
simple	22989750	2	O
loss	22989750	2	O
of	22989750	2	O
function	22989750	2	O
of	22989750	2	O
wild	22989750	2	O
-	22989750	2	O
type	22989750	2	O
p53	22989750	2	O
.	22989750	2	O
Knock	22989750	2	O
-	22989750	2	O
down	22989750	2	O
of	22989750	2	O
mutant	22989750	2	O
p53	22989750	2	O
in	22989750	2	O
human	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
lines	22989750	2	O
with	22989750	2	O
different	22989750	2	O
endogenous	22989750	2	O
p53	22989750	2	B-Gene
mutants	22989750	2	B-Var
results	22989750	2	O
in	22989750	2	O
loss	22989750	2	B-NegReg
of	22989750	2	O
GOF	22989750	2	O
activity	22989750	2	B-MPA
as	22989750	2	O
shown	22989750	2	O
by	22989750	2	O
lowering	22989750	2	B-NegReg
of	22989750	2	O
cell	22989750	2	B-CPA
growth	22989750	2	I-CPA
rate	22989750	2	I-CPA
.	22989750	2	O
Two	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
lines	22989750	2	O
,	22989750	2	O
ABC1	22989750	2	O
and	22989750	2	O
H1437	22989750	2	O
,	22989750	2	O
carrying	22989750	2	O
endogenous	22989750	2	O
mutants	22989750	2	B-Var
p53	22989750	2	I-Var
-	22989750	2	I-Var
P278S	22989750	2	I-Var
and	22989750	2	I-Var
-	22989750	2	I-Var
R267P	22989750	2	I-Var
,	22989750	2	O
show	22989750	2	O
reduction	22989750	2	B-NegReg
in	22989750	2	O
growth	22989750	2	B-MPA
rate	22989750	2	I-MPA
on	22989750	2	O
knock	22989750	2	O
-	22989750	2	O
down	22989750	2	O
on	22989750	2	O
p53	22989750	2	O
levels	22989750	2	O
.	22989750	2	O
However	22989750	2	O
,	22989750	2	O
whereas	22989750	2	O
reduction	22989750	2	B-NegReg
of	22989750	2	O
the	22989750	2	O
p53	22989750	2	B-Var
level	22989750	2	O
induces	22989750	2	O
loss	22989750	2	B-NegReg
of	22989750	2	O
tumorigenicity	22989750	2	B-MPA
in	22989750	2	O
nude	22989750	2	O
mice	22989750	2	O
for	22989750	2	O
ABC1	22989750	2	O
cells	22989750	2	O
,	22989750	2	O
it	22989750	2	O
escalates	22989750	2	B-PosReg
tumorigenicity	22989750	2	B-MPA
for	22989750	2	O
H1437	22989750	2	O
cells	22989750	2	O
.	22989750	2	O
We	22989750	2	O
have	22989750	2	O
tested	22989750	2	O
their	22989750	2	O
transactivation	22989750	2	O
potential	22989750	2	O
on	22989750	2	O
p53	22989750	2	O
target	22989750	2	O
gene	22989750	2	O
promoters	22989750	2	O
by	22989750	2	O
performing	22989750	2	O
transient	22989750	2	O
transcriptional	22989750	2	O
assays	22989750	2	O
in	22989750	2	O
the	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
null	22989750	2	O
H1299	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
line	22989750	2	O
.	22989750	2	O
Interestingly	22989750	2	O
,	22989750	2	O
while	22989750	2	O
the	22989750	2	O
mutant	22989750	2	O
p53	22989750	2	O
target	22989750	2	O
promoter	22989750	2	O
Axl	22989750	2	O
was	22989750	2	O
activated	22989750	2	O
by	22989750	2	O
both	22989750	2	O
the	22989750	2	O
mutants	22989750	2	O
,	22989750	2	O
the	22989750	2	O
p21	22989750	2	O
promoter	22989750	2	O
was	22989750	2	O
activated	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
R267P	22989750	2	O
and	22989750	2	O
wild	22989750	2	O
-	22989750	2	O
type	22989750	2	O
p53	22989750	2	O
but	22989750	2	O
not	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
P278S	22989750	2	O
;	22989750	2	O
showing	22989750	2	O
a	22989750	2	O
clear	22989750	2	O
difference	22989750	2	O
in	22989750	2	O
transcriptional	22989750	2	O
activity	22989750	2	O
between	22989750	2	O
the	22989750	2	O
two	22989750	2	O
mutants	22989750	2	O
.	22989750	2	O
Our	22989750	2	O
results	22989750	2	O
demonstrate	22989750	2	O
allele	22989750	2	O
specificity	22989750	2	O
between	22989750	2	O
GOF	22989750	2	O
p53	22989750	2	O
mutants	22989750	2	O
and	22989750	2	O
attempt	22989750	2	O
to	22989750	2	O
show	22989750	2	O
that	22989750	2	O
the	22989750	2	O
specificity	22989750	2	O
is	22989750	2	O
dependent	22989750	2	O
on	22989750	2	O
the	22989750	2	O
transactivation	22989750	2	O
property	22989750	2	O
of	22989750	2	O
GOF	22989750	2	O
p53	22989750	2	O
;	22989750	2	O
it	22989750	2	O
also	22989750	2	O
suggests	22989750	2	O
importance	22989750	2	O
of	22989750	2	O
p21	22989750	2	O
activation	22989750	2	O
in	22989750	2	O
tumor	22989750	2	O
suppression	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
.	22989750	2	O

Gain	23264849	0	O
-	23264849	0	O
of	23264849	0	O
-	23264849	0	O
Function	23264849	0	O
Activity	23264849	0	O
of	23264849	0	O
Mutant	23264849	0	O
p53	23264849	0	O
in	23264849	0	O
Lung	23264849	0	O
Cancer	23264849	0	O
through	23264849	0	O
Up	23264849	0	O
-	23264849	0	O
Regulation	23264849	0	O
of	23264849	0	O
Receptor	23264849	0	O
Protein	23264849	0	O
Tyrosine	23264849	0	O
Kinase	23264849	0	O
Axl	23264849	0	O
.	23264849	0	O
p53	23264849	0	O
mutations	23264849	0	O
are	23264849	0	O
present	23264849	0	O
in	23264849	0	O
up	23264849	0	O
to	23264849	0	O
70%	23264849	0	O
of	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
.	23264849	0	O
Cancer	23264849	0	O
cells	23264849	0	O
with	23264849	0	O
p53	23264849	0	B-Gene
mutations	23264849	0	B-Var
,	23264849	0	O
in	23264849	0	O
general	23264849	0	O
,	23264849	0	O
grow	23264849	0	B-CPA
more	23264849	0	O
aggressively	23264849	0	B-PosReg
than	23264849	0	O
those	23264849	0	O
with	23264849	0	O
wild	23264849	0	O
-	23264849	0	O
type	23264849	0	O
p53	23264849	0	O
or	23264849	0	O
no	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
Expression	23264849	0	O
of	23264849	0	O
tumor	23264849	0	O
-	23264849	0	O
derived	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
in	23264849	0	O
cells	23264849	0	O
leads	23264849	0	O
to	23264849	0	O
up	23264849	0	B-PosReg
-	23264849	0	I-PosReg
regulated	23264849	0	I-PosReg
expression	23264849	0	B-MPA
of	23264849	0	I-MPA
genes	23264849	0	I-MPA
that	23264849	0	O
may	23264849	0	O
affect	23264849	0	B-Reg
cell	23264849	0	B-CPA
growth	23264849	0	I-CPA
and	23264849	0	O
oncogenesis	23264849	0	B-CPA
.	23264849	0	O
In	23264849	0	O
our	23264849	0	O
study	23264849	0	O
of	23264849	0	O
this	23264849	0	O
aggressive	23264849	0	O
phenotype	23264849	0	O
,	23264849	0	O
we	23264849	0	O
have	23264849	0	O
investigated	23264849	0	O
the	23264849	0	O
receptor	23264849	0	O
protein	23264849	0	O
tyrosine	23264849	0	B-Enzyme
kinase	23264849	0	I-Enzyme
Axl	23264849	0	I-Enzyme
,	23264849	0	O
which	23264849	0	O
is	23264849	0	O
up	23264849	0	B-PosReg
-	23264849	0	I-PosReg
regulated	23264849	0	I-PosReg
by	23264849	0	O
p53	23264849	0	B-Gene
mutants	23264849	0	B-Var
at	23264849	0	O
both	23264849	0	O
RNA	23264849	0	O
and	23264849	0	O
protein	23264849	0	O
levels	23264849	0	O
in	23264849	0	O
H1299	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
expressing	23264849	0	O
mutants	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R175H	23264849	0	O
,	23264849	0	O
-	23264849	0	O
R273H	23264849	0	O
,	23264849	0	O
and	23264849	0	O
-	23264849	0	O
D281G	23264849	0	O
.	23264849	0	O
Knockdown	23264849	0	O
of	23264849	0	O
endogenous	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
levels	23264849	0	O
in	23264849	0	O
human	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
H1048	23264849	0	O
(	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R273C	23264849	0	O
)	23264849	0	O
and	23264849	0	O
H1437	23264849	0	O
(	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R267P	23264849	0	O
)	23264849	0	O
led	23264849	0	O
to	23264849	0	O
a	23264849	0	O
reduction	23264849	0	O
in	23264849	0	O
the	23264849	0	O
level	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
as	23264849	0	O
well	23264849	0	O
.	23264849	0	O
This	23264849	0	O
effect	23264849	0	O
on	23264849	0	O
Axl	23264849	0	O
expression	23264849	0	O
is	23264849	0	O
refractory	23264849	0	O
to	23264849	0	O
the	23264849	0	O
mutations	23264849	0	O
at	23264849	0	O
positions	23264849	0	O
22	23264849	0	O
and	23264849	0	O
23	23264849	0	O
of	23264849	0	O
p53	23264849	0	O
,	23264849	0	O
suggesting	23264849	0	O
that	23264849	0	O
p53	23264849	0	O
'	23264849	0	O
s	23264849	0	O
transactivation	23264849	0	O
domain	23264849	0	O
may	23264849	0	O
not	23264849	0	O
play	23264849	0	O
a	23264849	0	O
critical	23264849	0	O
role	23264849	0	O
in	23264849	0	O
the	23264849	0	O
up	23264849	0	O
-	23264849	0	O
regulation	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
gene	23264849	0	O
expression	23264849	0	O
.	23264849	0	O
Chromatin	23264849	0	O
immunoprecipitation	23264849	0	O
(	23264849	0	O
ChIP	23264849	0	O
)	23264849	0	O
assays	23264849	0	O
carried	23264849	0	O
out	23264849	0	O
with	23264849	0	O
acetylated	23264849	0	O
histone	23264849	0	O
antibodies	23264849	0	O
demonstrated	23264849	0	O
induced	23264849	0	O
histone	23264849	0	B-Reg
acetylation	23264849	0	B-MPA
on	23264849	0	I-MPA
the	23264849	0	I-MPA
Axl	23264849	0	I-MPA
promoter	23264849	0	I-MPA
region	23264849	0	I-MPA
by	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
.	23264849	0	O
Direct	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
nucleation	23264849	0	O
on	23264849	0	O
the	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
was	23264849	0	O
demonstrated	23264849	0	O
by	23264849	0	O
ChIP	23264849	0	O
assays	23264849	0	O
using	23264849	0	O
antibodies	23264849	0	O
against	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
The	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
has	23264849	0	O
a	23264849	0	O
p53	23264849	0	O
/	23264849	0	O
p63	23264849	0	O
binding	23264849	0	O
site	23264849	0	O
,	23264849	0	O
which	23264849	0	O
however	23264849	0	O
is	23264849	0	O
not	23264849	0	O
required	23264849	0	O
for	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
mediated	23264849	0	O
transactivation	23264849	0	O
.	23264849	0	O
Knockdown	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
by	23264849	0	O
Axl	23264849	0	O
-	23264849	0	O
specific	23264849	0	O
RNAi	23264849	0	O
caused	23264849	0	O
a	23264849	0	O
reduction	23264849	0	O
of	23264849	0	O
gain	23264849	0	O
-	23264849	0	O
of	23264849	0	O
-	23264849	0	O
function	23264849	0	O
(	23264849	0	O
GOF	23264849	0	O
)	23264849	0	O
activities	23264849	0	O
,	23264849	0	O
reducing	23264849	0	O
the	23264849	0	O
cell	23264849	0	O
growth	23264849	0	O
rate	23264849	0	O
and	23264849	0	O
motility	23264849	0	O
rate	23264849	0	O
in	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
expressing	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
This	23264849	0	O
indicates	23264849	0	O
that	23264849	0	O
for	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cell	23264849	0	O
lines	23264849	0	O
with	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
,	23264849	0	O
GOF	23264849	0	O
activities	23264849	0	B-MPA
are	23264849	0	O
mediated	23264849	0	B-Reg
in	23264849	0	O
part	23264849	0	O
through	23264849	0	O
Axl	23264849	0	B-Protein
.	23264849	0	O

Gain	23460523	0	O
-	23460523	0	O
of	23460523	0	O
-	23460523	0	O
function	23460523	0	O
mutations	23460523	0	O
in	23460523	0	O
PDR1	23460523	0	O
,	23460523	0	O
a	23460523	0	O
regulator	23460523	0	O
of	23460523	0	O
antifungal	23460523	0	O
drug	23460523	0	O
resistance	23460523	0	O
in	23460523	0	O
Candida	23460523	0	O
glabrata	23460523	0	O
,	23460523	0	O
control	23460523	0	O
adherence	23460523	0	O
to	23460523	0	O
host	23460523	0	O
cells	23460523	0	O
.	23460523	0	O
Candida	23460523	0	O
glabrata	23460523	0	O
is	23460523	0	O
an	23460523	0	O
emerging	23460523	0	O
opportunistic	23460523	0	O
pathogen	23460523	0	O
that	23460523	0	O
is	23460523	0	O
known	23460523	0	O
to	23460523	0	O
develop	23460523	0	O
resistance	23460523	0	O
to	23460523	0	O
azole	23460523	0	O
drugs	23460523	0	O
due	23460523	0	O
to	23460523	0	O
increased	23460523	0	O
drug	23460523	0	O
efflux	23460523	0	O
.	23460523	0	O
The	23460523	0	O
mechanism	23460523	0	O
consists	23460523	0	O
of	23460523	0	O
CgPDR1	23460523	0	O
-	23460523	0	O
mediated	23460523	0	O
upregulation	23460523	0	O
of	23460523	0	O
ATP	23460523	0	O
-	23460523	0	O
binding	23460523	0	O
cassette	23460523	0	O
transporters	23460523	0	O
.	23460523	0	O
A	23460523	0	O
range	23460523	0	O
of	23460523	0	O
gain	23460523	0	B-PosReg
-	23460523	0	I-PosReg
of	23460523	0	I-PosReg
-	23460523	0	I-PosReg
function	23460523	0	I-PosReg
(	23460523	0	O
GOF	23460523	0	O
)	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
have	23460523	0	O
been	23460523	0	O
found	23460523	0	O
to	23460523	0	O
lead	23460523	0	B-PosReg
not	23460523	0	O
only	23460523	0	O
to	23460523	0	O
azole	23460523	0	B-MPA
resistance	23460523	0	I-MPA
but	23460523	0	O
also	23460523	0	O
to	23460523	0	O
enhanced	23460523	0	B-PosReg
virulence	23460523	0	B-MPA
.	23460523	0	O
This	23460523	0	O
implicates	23460523	0	B-Reg
CgPDR1	23460523	0	B-Gene
in	23460523	0	O
the	23460523	0	O
regulation	23460523	0	B-MPA
of	23460523	0	O
the	23460523	0	O
interaction	23460523	0	B-Interaction
of	23460523	0	O
C.	23460523	0	O
glabrata	23460523	0	O
with	23460523	0	O
the	23460523	0	O
host	23460523	0	O
.	23460523	0	O
To	23460523	0	O
identify	23460523	0	O
specific	23460523	0	O
CgPDR1	23460523	0	O
-	23460523	0	O
regulated	23460523	0	O
steps	23460523	0	O
of	23460523	0	O
the	23460523	0	O
host	23460523	0	O
-	23460523	0	O
pathogen	23460523	0	O
interaction	23460523	0	O
,	23460523	0	O
we	23460523	0	O
investigated	23460523	0	O
in	23460523	0	O
this	23460523	0	O
work	23460523	0	O
the	23460523	0	O
interaction	23460523	0	O
of	23460523	0	O
selected	23460523	0	O
CgPDR1	23460523	0	O
GOF	23460523	0	O
mutants	23460523	0	O
with	23460523	0	O
murine	23460523	0	O
bone	23460523	0	O
marrow	23460523	0	O
-	23460523	0	O
derived	23460523	0	O
macrophages	23460523	0	O
and	23460523	0	O
human	23460523	0	O
acute	23460523	0	O
monocytic	23460523	0	O
leukemia	23460523	0	O
cell	23460523	0	O
line	23460523	0	O
(	23460523	0	O
THP-1	23460523	0	O
)	23460523	0	O
-	23460523	0	O
derived	23460523	0	O
macrophages	23460523	0	O
,	23460523	0	O
as	23460523	0	O
well	23460523	0	O
as	23460523	0	O
different	23460523	0	O
epithelial	23460523	0	O
cell	23460523	0	O
lines	23460523	0	O
.	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
did	23460523	0	O
not	23460523	0	O
influence	23460523	0	O
survival	23460523	0	O
and	23460523	0	O
replication	23460523	0	O
within	23460523	0	O
macrophages	23460523	0	O
following	23460523	0	O
phagocytosis	23460523	0	O
but	23460523	0	O
led	23460523	0	O
to	23460523	0	O
decreased	23460523	0	B-NegReg
adherence	23460523	0	B-CPA
to	23460523	0	I-CPA
and	23460523	0	I-CPA
uptake	23460523	0	I-CPA
by	23460523	0	I-CPA
macrophages	23460523	0	I-CPA
.	23460523	0	O
This	23460523	0	O
may	23460523	0	O
allow	23460523	0	O
evasion	23460523	0	O
from	23460523	0	O
the	23460523	0	O
host	23460523	0	O
'	23460523	0	O
s	23460523	0	O
innate	23460523	0	O
cellular	23460523	0	O
immune	23460523	0	O
response	23460523	0	O
.	23460523	0	O
The	23460523	0	O
interaction	23460523	0	O
with	23460523	0	O
epithelial	23460523	0	O
cells	23460523	0	O
revealed	23460523	0	O
an	23460523	0	O
opposite	23460523	0	O
trend	23460523	0	O
,	23460523	0	O
suggesting	23460523	0	O
that	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
may	23460523	0	O
favor	23460523	0	B-PosReg
epithelial	23460523	0	B-CPA
colonization	23460523	0	I-CPA
of	23460523	0	O
the	23460523	0	O
host	23460523	0	O
by	23460523	0	O
C.	23460523	0	O
glabrata	23460523	0	O
through	23460523	0	O
increased	23460523	0	B-PosReg
adherence	23460523	0	B-CPA
to	23460523	0	O
epithelial	23460523	0	O
cell	23460523	0	O
layers	23460523	0	O
.	23460523	0	O
These	23460523	0	O
data	23460523	0	O
reveal	23460523	0	O
that	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
modulate	23460523	0	B-Reg
the	23460523	0	O
interaction	23460523	0	B-Interaction
with	23460523	0	O
host	23460523	0	O
cells	23460523	0	O
in	23460523	0	O
ways	23460523	0	O
that	23460523	0	O
may	23460523	0	O
contribute	23460523	0	O
to	23460523	0	O
increased	23460523	0	B-PosReg
virulence	23460523	0	B-MPA
.	23460523	0	O

Mutant	23680148	2	O
p53	23680148	2	O
prolongs	23680148	2	O
NF	23680148	2	O
-	23680148	2	O
κB	23680148	2	O
activation	23680148	2	O
and	23680148	2	O
promotes	23680148	2	O
chronic	23680148	2	O
inflammation	23680148	2	O
and	23680148	2	O
inflammation	23680148	2	O
-	23680148	2	O
associated	23680148	2	O
colorectal	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
The	23680148	2	O
tumor	23680148	2	O
suppressor	23680148	2	O
p53	23680148	2	O
is	23680148	2	O
frequently	23680148	2	O
mutated	23680148	2	O
in	23680148	2	O
human	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
Common	23680148	2	O
mutant	23680148	2	O
p53	23680148	2	O
(	23680148	2	O
mutp53	23680148	2	O
)	23680148	2	O
isoforms	23680148	2	O
can	23680148	2	O
actively	23680148	2	O
promote	23680148	2	O
cancer	23680148	2	O
through	23680148	2	O
gain	23680148	2	O
-	23680148	2	O
of	23680148	2	O
-	23680148	2	O
function	23680148	2	O
(	23680148	2	O
GOF	23680148	2	O
)	23680148	2	O
mechanisms	23680148	2	O
.	23680148	2	O
We	23680148	2	O
report	23680148	2	O
that	23680148	2	O
mutp53	23680148	2	O
prolongs	23680148	2	O
TNF	23680148	2	O
-	23680148	2	O
α	23680148	2	O
-	23680148	2	O
induced	23680148	2	O
NF	23680148	2	O
-	23680148	2	O
κB	23680148	2	O
activation	23680148	2	O
in	23680148	2	O
cultured	23680148	2	O
cells	23680148	2	O
and	23680148	2	O
intestinal	23680148	2	O
organoid	23680148	2	O
cultures	23680148	2	O
.	23680148	2	O
Remarkably	23680148	2	O
,	23680148	2	O
when	23680148	2	O
exposed	23680148	2	O
to	23680148	2	O
dextran	23680148	2	O
sulfate	23680148	2	O
sodium	23680148	2	O
,	23680148	2	O
mice	23680148	2	O
harboring	23680148	2	O
a	23680148	2	O
germline	23680148	2	O
p53	23680148	2	O
mutation	23680148	2	O
develop	23680148	2	O
severe	23680148	2	O
chronic	23680148	2	O
inflammation	23680148	2	O
and	23680148	2	O
persistent	23680148	2	O
tissue	23680148	2	O
damage	23680148	2	O
,	23680148	2	O
and	23680148	2	O
are	23680148	2	O
highly	23680148	2	O
prone	23680148	2	O
to	23680148	2	O
inflammation	23680148	2	O
-	23680148	2	O
associated	23680148	2	O
colon	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
This	23680148	2	O
mutp53	23680148	2	O
GOF	23680148	2	O
is	23680148	2	O
manifested	23680148	2	O
by	23680148	2	O
rapid	23680148	2	O
onset	23680148	2	O
of	23680148	2	O
flat	23680148	2	O
dysplastic	23680148	2	O
lesions	23680148	2	O
that	23680148	2	O
progress	23680148	2	B-PosReg
to	23680148	2	O
invasive	23680148	2	B-Disease
carcinoma	23680148	2	I-Disease
with	23680148	2	O
mutp53	23680148	2	B-Var
accumulation	23680148	2	B-PosReg
and	23680148	2	O
augmented	23680148	2	O
NF	23680148	2	B-Protein
-	23680148	2	I-Protein
κB	23680148	2	I-Protein
activation	23680148	2	B-PosReg
,	23680148	2	O
faithfully	23680148	2	O
recapitulating	23680148	2	O
features	23680148	2	O
frequently	23680148	2	O
observed	23680148	2	O
in	23680148	2	O
human	23680148	2	O
colitis	23680148	2	B-Disease
-	23680148	2	I-Disease
associated	23680148	2	I-Disease
colorectal	23680148	2	I-Disease
cancer	23680148	2	I-Disease
(	23680148	2	O
CAC	23680148	2	O
)	23680148	2	O
.	23680148	2	O
These	23680148	2	O
findings	23680148	2	O
might	23680148	2	O
explain	23680148	2	O
the	23680148	2	O
early	23680148	2	O
appearance	23680148	2	O
of	23680148	2	O
p53	23680148	2	O
mutations	23680148	2	O
in	23680148	2	O
human	23680148	2	O
CAC	23680148	2	O
.	23680148	2	O

Clinical	23967324	2	O
relevance	23967324	2	O
of	23967324	2	O
gain	23967324	2	B-PosReg
-	23967324	2	I-PosReg
of	23967324	2	I-PosReg
-	23967324	2	I-PosReg
function	23967324	2	I-PosReg
mutations	23967324	2	B-Var
of	23967324	2	O
p53	23967324	2	B-Gene
in	23967324	2	O
high	23967324	2	B-Disease
-	23967324	2	I-Disease
grade	23967324	2	I-Disease
serous	23967324	2	I-Disease
ovarian	23967324	2	I-Disease
carcinoma	23967324	2	I-Disease
.	23967324	2	O
PURPOSE	23967324	2	O
:	23967324	2	O
Inactivation	23967324	2	O
of	23967324	2	O
TP53	23967324	2	O
,	23967324	2	O
which	23967324	2	O
occurs	23967324	2	O
predominantly	23967324	2	O
by	23967324	2	O
missense	23967324	2	O
mutations	23967324	2	O
in	23967324	2	O
exons	23967324	2	O
4	23967324	2	O
-	23967324	2	O
9	23967324	2	O
,	23967324	2	O
is	23967324	2	O
a	23967324	2	O
major	23967324	2	O
genetic	23967324	2	O
alteration	23967324	2	O
in	23967324	2	O
a	23967324	2	O
subset	23967324	2	O
of	23967324	2	O
human	23967324	2	O
cancer	23967324	2	O
.	23967324	2	O
In	23967324	2	O
spite	23967324	2	O
of	23967324	2	O
growing	23967324	2	O
evidence	23967324	2	O
that	23967324	2	O
gain	23967324	2	B-PosReg
-	23967324	2	I-PosReg
of	23967324	2	I-PosReg
-	23967324	2	I-PosReg
function	23967324	2	I-PosReg
(	23967324	2	O
GOF	23967324	2	O
)	23967324	2	O
mutations	23967324	2	B-Var
of	23967324	2	O
p53	23967324	2	B-Gene
also	23967324	2	O
have	23967324	2	O
oncogenic	23967324	2	B-CPA
activity	23967324	2	I-CPA
,	23967324	2	O
little	23967324	2	O
is	23967324	2	O
known	23967324	2	O
about	23967324	2	O
the	23967324	2	O
clinical	23967324	2	O
relevance	23967324	2	O
of	23967324	2	O
these	23967324	2	O
mutations	23967324	2	O
.	23967324	2	O
METHODS	23967324	2	O
:	23967324	2	O
The	23967324	2	O
clinicopathological	23967324	2	O
features	23967324	2	O
of	23967324	2	O
high	23967324	2	O
-	23967324	2	O
grade	23967324	2	O
serous	23967324	2	O
ovarian	23967324	2	O
carcinoma	23967324	2	O
(	23967324	2	O
HGS	23967324	2	O
-	23967324	2	O
OvCa	23967324	2	O
)	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
p53	23967324	2	O
mutations	23967324	2	O
were	23967324	2	O
evaluated	23967324	2	O
according	23967324	2	O
to	23967324	2	O
a	23967324	2	O
comprehensive	23967324	2	O
somatic	23967324	2	O
mutation	23967324	2	O
profile	23967324	2	O
comprised	23967324	2	O
of	23967324	2	O
whole	23967324	2	O
exome	23967324	2	O
sequencing	23967324	2	O
,	23967324	2	O
mRNA	23967324	2	O
expression	23967324	2	O
,	23967324	2	O
and	23967324	2	O
protein	23967324	2	O
expression	23967324	2	O
profiles	23967324	2	O
obtained	23967324	2	O
from	23967324	2	O
the	23967324	2	O
Cancer	23967324	2	O
Genome	23967324	2	O
Atlas	23967324	2	O
(	23967324	2	O
TCGA	23967324	2	O
)	23967324	2	O
.	23967324	2	O
RESULTS	23967324	2	O
:	23967324	2	O
Patients	23967324	2	O
with	23967324	2	O
a	23967324	2	O
mutant	23967324	2	O
p53	23967324	2	B-Protein
protein	23967324	2	I-Protein
(	23967324	2	O
mutp53	23967324	2	O
)	23967324	2	O
with	23967324	2	O
a	23967324	2	O
GOF	23967324	2	O
mutation	23967324	2	B-Var
showed	23967324	2	O
higher	23967324	2	B-PosReg
p53	23967324	2	B-MPA
mRNA	23967324	2	I-MPA
and	23967324	2	I-MPA
protein	23967324	2	I-MPA
expression	23967324	2	I-MPA
levels	23967324	2	I-MPA
than	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
p53	23967324	2	O
mutation	23967324	2	O
with	23967324	2	O
no	23967324	2	O
evidence	23967324	2	O
of	23967324	2	O
GOF	23967324	2	O
(	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
)	23967324	2	O
.	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
were	23967324	2	O
more	23967324	2	O
likely	23967324	2	O
to	23967324	2	O
occur	23967324	2	O
within	23967324	2	O
mutational	23967324	2	O
hotspots	23967324	2	O
,	23967324	2	O
and	23967324	2	O
at	23967324	2	O
CpG	23967324	2	O
sites	23967324	2	O
,	23967324	2	O
and	23967324	2	O
resulted	23967324	2	O
in	23967324	2	O
mutp53	23967324	2	O
with	23967324	2	O
higher	23967324	2	O
functional	23967324	2	O
severity	23967324	2	O
(	23967324	2	O
FS	23967324	2	O
)	23967324	2	O
scores	23967324	2	O
.	23967324	2	O
Clinically	23967324	2	O
,	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	B-Var
showed	23967324	2	O
a	23967324	2	O
higher	23967324	2	B-PosReg
frequency	23967324	2	O
of	23967324	2	O
platinum	23967324	2	B-CPA
resistance	23967324	2	I-CPA
(	23967324	2	O
22	23967324	2	O
/	23967324	2	O
58	23967324	2	O
,	23967324	2	O
37.9%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
(	23967324	2	O
12	23967324	2	O
/	23967324	2	O
56	23967324	2	O
,	23967324	2	O
21.4%	23967324	2	O
)	23967324	2	O
(	23967324	2	O
p	23967324	2	O
=	23967324	2	O
0.054	23967324	2	O
)	23967324	2	O
.	23967324	2	O
Furthermore	23967324	2	O
,	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	B-Var
were	23967324	2	O
more	23967324	2	O
likely	23967324	2	O
to	23967324	2	O
develop	23967324	2	B-PosReg
distant	23967324	2	B-CPA
metastasis	23967324	2	I-CPA
(	23967324	2	O
36	23967324	2	O
/	23967324	2	O
55	23967324	2	O
,	23967324	2	O
65.5%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
local	23967324	2	O
recurrence	23967324	2	O
(	23967324	2	O
19	23967324	2	O
/	23967324	2	O
55	23967324	2	O
,	23967324	2	O
34.5%	23967324	2	O
)	23967324	2	O
,	23967324	2	O
whereas	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
showed	23967324	2	O
a	23967324	2	O
higher	23967324	2	O
frequency	23967324	2	O
of	23967324	2	O
locoregional	23967324	2	O
recurrence	23967324	2	O
(	23967324	2	O
26	23967324	2	O
/	23967324	2	O
47	23967324	2	O
,	23967324	2	O
55.3%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
distant	23967324	2	O
metastasis	23967324	2	O
(	23967324	2	O
21	23967324	2	O
/	23967324	2	O
47	23967324	2	O
,	23967324	2	O
44.7%	23967324	2	O
)	23967324	2	O
(	23967324	2	O
p	23967324	2	O
=	23967324	2	O
0.035	23967324	2	O
)	23967324	2	O
.	23967324	2	O
There	23967324	2	O
were	23967324	2	O
no	23967324	2	O
differences	23967324	2	O
in	23967324	2	O
overall	23967324	2	O
or	23967324	2	O
progression	23967324	2	O
-	23967324	2	O
free	23967324	2	O
survival	23967324	2	O
between	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
or	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutp53	23967324	2	O
.	23967324	2	O
CONCLUSION	23967324	2	O
:	23967324	2	O
This	23967324	2	O
study	23967324	2	O
demonstrates	23967324	2	O
that	23967324	2	O
patient	23967324	2	O
with	23967324	2	O
GOF	23967324	2	B-PosReg
mutp53	23967324	2	B-Var
is	23967324	2	O
characterized	23967324	2	O
by	23967324	2	O
a	23967324	2	O
greater	23967324	2	B-PosReg
likelihood	23967324	2	O
of	23967324	2	O
platinum	23967324	2	B-CPA
treatment	23967324	2	I-CPA
resistance	23967324	2	I-CPA
and	23967324	2	O
distant	23967324	2	B-CPA
metastatic	23967324	2	I-CPA
properties	23967324	2	I-CPA
in	23967324	2	O
HGS	23967324	2	B-Disease
-	23967324	2	I-Disease
OvCa	23967324	2	I-Disease
.	23967324	2	O

Spliced	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promote	24356649	0	O
mutant	24356649	0	O
p53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
gain	24356649	0	O
-	24356649	0	O
of	24356649	0	O
-	24356649	0	O
function	24356649	0	O
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
The	24356649	0	O
tumour	24356649	0	O
suppressor	24356649	0	O
p53	24356649	0	O
is	24356649	0	O
frequently	24356649	0	O
mutated	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
.	24356649	0	O
Mutant	24356649	0	B-Var
p53	24356649	0	B-Protein
(	24356649	0	O
Mutp53	24356649	0	O
)	24356649	0	O
proteins	24356649	0	O
often	24356649	0	O
gain	24356649	0	B-PosReg
new	24356649	0	I-PosReg
activities	24356649	0	I-PosReg
in	24356649	0	O
promoting	24356649	0	B-CPA
tumorigenesis	24356649	0	I-CPA
,	24356649	0	O
defined	24356649	0	O
as	24356649	0	O
gain	24356649	0	O
-	24356649	0	O
of	24356649	0	O
-	24356649	0	O
function	24356649	0	O
(	24356649	0	O
GOF	24356649	0	O
)	24356649	0	O
.	24356649	0	O
Mutp53	24356649	0	O
can	24356649	0	O
accumulate	24356649	0	O
to	24356649	0	O
high	24356649	0	O
levels	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
which	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	B-Var
GOF	24356649	0	B-PosReg
in	24356649	0	O
tumorigenesis	24356649	0	B-CPA
.	24356649	0	O
The	24356649	0	O
mechanism	24356649	0	O
of	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
is	24356649	0	O
poorly	24356649	0	O
understood	24356649	0	O
.	24356649	0	O
Here	24356649	0	O
we	24356649	0	O
find	24356649	0	O
that	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promote	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
.	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
B	24356649	0	O
(	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
B	24356649	0	O
)	24356649	0	O
,	24356649	0	O
the	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
most	24356649	0	O
frequently	24356649	0	O
over	24356649	0	O
-	24356649	0	O
expressed	24356649	0	O
in	24356649	0	O
human	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
interacts	24356649	0	O
with	24356649	0	O
full	24356649	0	O
-	24356649	0	O
length	24356649	0	O
MDM2	24356649	0	O
to	24356649	0	O
inhibit	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
mediated	24356649	0	O
mutp53	24356649	0	O
degradation	24356649	0	O
,	24356649	0	O
promoting	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
GOF	24356649	0	O
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
Furthermore	24356649	0	O
,	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
B	24356649	0	O
overexpression	24356649	0	O
correlates	24356649	0	O
with	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
in	24356649	0	O
human	24356649	0	O
tumours	24356649	0	O
.	24356649	0	O
In	24356649	0	O
mutp53	24356649	0	O
knock	24356649	0	O
-	24356649	0	O
in	24356649	0	O
mice	24356649	0	O
,	24356649	0	O
a	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
similar	24356649	0	O
to	24356649	0	O
human	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
B	24356649	0	O
is	24356649	0	O
overexpressed	24356649	0	O
in	24356649	0	O
the	24356649	0	O
majority	24356649	0	O
of	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
which	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
Thus	24356649	0	O
,	24356649	0	O
overexpression	24356649	0	O
of	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
contributing	24356649	0	O
to	24356649	0	O
mutp53	24356649	0	B-Var
GOF	24356649	0	B-PosReg
in	24356649	0	O
tumorigenesis	24356649	0	B-CPA
.	24356649	0	O
This	24356649	0	O
may	24356649	0	O
be	24356649	0	O
an	24356649	0	O
important	24356649	0	O
mechanism	24356649	0	O
by	24356649	0	O
which	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promote	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O

Mutant	24373920	2	B-Var
p53	24373920	2	B-Gene
gain	24373920	2	B-PosReg
of	24373920	2	I-PosReg
function	24373920	2	I-PosReg
can	24373920	2	O
be	24373920	2	O
at	24373920	2	O
the	24373920	2	O
root	24373920	2	O
of	24373920	2	O
dedifferentiation	24373920	2	O
of	24373920	2	O
human	24373920	2	B-Disease
osteosarcoma	24373920	2	I-Disease
MG63	24373920	2	O
cells	24373920	2	O
into	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cancer	24373920	2	O
stem	24373920	2	O
cells	24373920	2	O
.	24373920	2	O
Osteosarcoma	24373920	2	O
is	24373920	2	O
a	24373920	2	O
highly	24373920	2	O
metastatic	24373920	2	O
tumor	24373920	2	O
affecting	24373920	2	O
adolescents	24373920	2	O
,	24373920	2	O
for	24373920	2	O
which	24373920	2	O
there	24373920	2	O
is	24373920	2	O
no	24373920	2	O
second	24373920	2	O
-	24373920	2	O
line	24373920	2	O
chemotherapy	24373920	2	O
.	24373920	2	O
As	24373920	2	O
suggested	24373920	2	O
for	24373920	2	O
most	24373920	2	O
tumors	24373920	2	O
,	24373920	2	O
its	24373920	2	O
capability	24373920	2	O
to	24373920	2	O
overgrow	24373920	2	O
is	24373920	2	O
probably	24373920	2	O
driven	24373920	2	O
by	24373920	2	O
cancer	24373920	2	O
stem	24373920	2	O
cells	24373920	2	O
(	24373920	2	O
CSCs	24373920	2	O
)	24373920	2	O
,	24373920	2	O
and	24373920	2	O
finding	24373920	2	O
new	24373920	2	O
targets	24373920	2	O
to	24373920	2	O
kill	24373920	2	O
CSCs	24373920	2	O
may	24373920	2	O
be	24373920	2	O
critical	24373920	2	O
for	24373920	2	O
improving	24373920	2	O
patient	24373920	2	O
survival	24373920	2	O
.	24373920	2	O
TP53	24373920	2	O
is	24373920	2	O
the	24373920	2	O
most	24373920	2	O
frequently	24373920	2	O
mutated	24373920	2	O
tumor	24373920	2	O
suppressor	24373920	2	O
gene	24373920	2	O
in	24373920	2	O
cancers	24373920	2	O
and	24373920	2	O
mutant	24373920	2	O
p53	24373920	2	O
protein	24373920	2	O
(	24373920	2	O
mutp53	24373920	2	O
)	24373920	2	O
can	24373920	2	O
acquire	24373920	2	O
gain	24373920	2	O
of	24373920	2	O
function	24373920	2	O
(	24373920	2	O
GOF	24373920	2	O
)	24373920	2	O
strongly	24373920	2	O
contributing	24373920	2	O
to	24373920	2	O
malignancy	24373920	2	O
.	24373920	2	O
Studies	24373920	2	O
thus	24373920	2	O
far	24373920	2	O
have	24373920	2	O
not	24373920	2	O
shown	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
GOF	24373920	2	O
in	24373920	2	O
osteosarcoma	24373920	2	O
.	24373920	2	O
Here	24373920	2	O
,	24373920	2	O
we	24373920	2	O
investigated	24373920	2	O
TP53	24373920	2	O
gene	24373920	2	O
status	24373920	2	O
/	24373920	2	O
role	24373920	2	O
in	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
-	24373920	2	O
a	24373920	2	O
highly	24373920	2	O
aggressive	24373920	2	O
CSC	24373920	2	O
line	24373920	2	O
previously	24373920	2	O
selected	24373920	2	O
from	24373920	2	O
human	24373920	2	O
osteosarcoma	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
-	24373920	2	O
to	24373920	2	O
evaluate	24373920	2	O
its	24373920	2	O
involvement	24373920	2	O
in	24373920	2	O
promoting	24373920	2	O
proliferation	24373920	2	O
,	24373920	2	O
invasiveness	24373920	2	O
,	24373920	2	O
resistance	24373920	2	O
to	24373920	2	O
apoptosis	24373920	2	O
and	24373920	2	O
stemness	24373920	2	O
.	24373920	2	O
By	24373920	2	O
RT	24373920	2	O
-	24373920	2	O
PCR	24373920	2	O
,	24373920	2	O
methylation	24373920	2	O
-	24373920	2	O
specific	24373920	2	O
PCR	24373920	2	O
,	24373920	2	O
fluorescent	24373920	2	O
in	24373920	2	O
situ	24373920	2	O
hybridization	24373920	2	O
,	24373920	2	O
DNA	24373920	2	O
sequence	24373920	2	O
,	24373920	2	O
western	24373920	2	O
blot	24373920	2	O
and	24373920	2	O
immunofluorescence	24373920	2	O
analyses	24373920	2	O
,	24373920	2	O
we	24373920	2	O
have	24373920	2	O
shown	24373920	2	O
that	24373920	2	O
-	24373920	2	O
in	24373920	2	O
comparison	24373920	2	O
with	24373920	2	O
parental	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
where	24373920	2	O
TP53	24373920	2	O
gene	24373920	2	O
is	24373920	2	O
hypermethylated	24373920	2	O
,	24373920	2	O
rearranged	24373920	2	O
and	24373920	2	O
in	24373920	2	O
single	24373920	2	O
copy	24373920	2	O
-	24373920	2	O
in	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
,	24373920	2	O
TP53	24373920	2	O
is	24373920	2	O
unmethylated	24373920	2	O
,	24373920	2	O
rearranged	24373920	2	O
and	24373920	2	O
in	24373920	2	O
multiple	24373920	2	O
copies	24373920	2	O
,	24373920	2	O
and	24373920	2	O
mutp53	24373920	2	O
(	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
R248W	24373920	2	O
/	24373920	2	O
P72R	24373920	2	O
)	24373920	2	O
is	24373920	2	O
post	24373920	2	O
-	24373920	2	O
translationally	24373920	2	O
modified	24373920	2	O
and	24373920	2	O
with	24373920	2	O
nuclear	24373920	2	O
localization	24373920	2	O
.	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
R248W	24373920	2	O
/	24373920	2	O
P72R	24373920	2	O
-	24373920	2	O
knockdown	24373920	2	O
by	24373920	2	O
short	24373920	2	O
-	24373920	2	O
interfering	24373920	2	O
RNA	24373920	2	O
reduced	24373920	2	O
the	24373920	2	O
growth	24373920	2	O
and	24373920	2	O
replication	24373920	2	O
rate	24373920	2	O
of	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
,	24373920	2	O
markedly	24373920	2	O
increasing	24373920	2	O
cell	24373920	2	O
cycle	24373920	2	O
inhibitor	24373920	2	O
levels	24373920	2	O
and	24373920	2	O
sensitized	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
to	24373920	2	O
TRAIL	24373920	2	O
-	24373920	2	O
induced	24373920	2	O
apoptosis	24373920	2	O
by	24373920	2	O
DR5	24373920	2	O
up	24373920	2	O
-	24373920	2	O
regulation	24373920	2	O
;	24373920	2	O
moreover	24373920	2	O
,	24373920	2	O
it	24373920	2	O
strongly	24373920	2	O
decreased	24373920	2	O
the	24373920	2	O
levels	24373920	2	O
of	24373920	2	O
stemness	24373920	2	O
and	24373920	2	O
invasiveness	24373920	2	O
genes	24373920	2	O
.	24373920	2	O
We	24373920	2	O
have	24373920	2	O
also	24373920	2	O
found	24373920	2	O
that	24373920	2	O
the	24373920	2	O
ectopic	24373920	2	O
expression	24373920	2	O
of	24373920	2	O
p53	24373920	2	B-Var
-	24373920	2	I-Var
R248W	24373920	2	I-Var
/	24373920	2	I-Var
P72R	24373920	2	I-Var
in	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
promoted	24373920	2	B-PosReg
cancer	24373920	2	B-CPA
stem	24373920	2	I-CPA
-	24373920	2	I-CPA
like	24373920	2	I-CPA
features	24373920	2	I-CPA
,	24373920	2	O
as	24373920	2	O
high	24373920	2	B-CPA
proliferation	24373920	2	I-CPA
rate	24373920	2	I-CPA
,	24373920	2	O
sphere	24373920	2	B-CPA
formation	24373920	2	I-CPA
,	24373920	2	O
clonogenic	24373920	2	B-CPA
growth	24373920	2	I-CPA
,	24373920	2	O
high	24373920	2	B-CPA
migration	24373920	2	I-CPA
and	24373920	2	O
invasive	24373920	2	B-CPA
ability	24373920	2	I-CPA
;	24373920	2	I-CPA
furthermore	24373920	2	O
,	24373920	2	O
it	24373920	2	O
strongly	24373920	2	O
increased	24373920	2	B-PosReg
the	24373920	2	O
levels	24373920	2	B-MPA
of	24373920	2	I-MPA
stemness	24373920	2	I-MPA
proteins	24373920	2	I-MPA
.	24373920	2	O
Overall	24373920	2	O
,	24373920	2	O
the	24373920	2	O
findings	24373920	2	O
suggest	24373920	2	O
the	24373920	2	O
involvement	24373920	2	B-Reg
of	24373920	2	O
p53	24373920	2	B-Var
-	24373920	2	I-Var
R248W	24373920	2	I-Var
/	24373920	2	I-Var
P72R	24373920	2	I-Var
at	24373920	2	O
the	24373920	2	O
origin	24373920	2	B-CPA
of	24373920	2	I-CPA
the	24373920	2	I-CPA
aberrant	24373920	2	I-CPA
characters	24373920	2	I-CPA
of	24373920	2	I-CPA
the	24373920	2	I-CPA
3	24373920	2	I-CPA
AB	24373920	2	I-CPA
-	24373920	2	I-CPA
OS	24373920	2	I-CPA
cells	24373920	2	I-CPA
with	24373920	2	O
the	24373920	2	O
hypothesis	24373920	2	O
that	24373920	2	O
its	24373920	2	O
GOF	24373920	2	O
can	24373920	2	O
be	24373920	2	O
at	24373920	2	O
the	24373920	2	O
root	24373920	2	O
of	24373920	2	O
the	24373920	2	O
dedifferentiation	24373920	2	O
of	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
into	24373920	2	O
CSCs	24373920	2	O
.	24373920	2	O

Unequal	24603336	0	O
prognostic	24603336	0	O
potentials	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
gain	24603336	0	O
-	24603336	0	O
of	24603336	0	O
-	24603336	0	O
function	24603336	0	O
mutations	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
associate	24603336	0	O
with	24603336	0	O
drug	24603336	0	O
-	24603336	0	O
metabolizing	24603336	0	O
activity	24603336	0	O
.	24603336	0	O
Mutation	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
is	24603336	0	O
the	24603336	0	O
most	24603336	0	O
common	24603336	0	O
genetic	24603336	0	O
change	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancer	24603336	0	O
,	24603336	0	O
causing	24603336	0	O
complex	24603336	0	O
effects	24603336	0	O
including	24603336	0	O
not	24603336	0	O
only	24603336	0	O
loss	24603336	0	O
of	24603336	0	O
wild	24603336	0	O
-	24603336	0	O
type	24603336	0	O
function	24603336	0	O
but	24603336	0	O
also	24603336	0	O
gain	24603336	0	O
of	24603336	0	O
novel	24603336	0	O
oncogenic	24603336	0	O
functions	24603336	0	O
(	24603336	0	O
GOF	24603336	0	O
)	24603336	0	O
.	24603336	0	O
It	24603336	0	O
is	24603336	0	O
increasingly	24603336	0	O
likely	24603336	0	O
that	24603336	0	O
p53	24603336	0	O
-	24603336	0	O
hotspot	24603336	0	O
mutations	24603336	0	O
may	24603336	0	O
confer	24603336	0	O
different	24603336	0	O
types	24603336	0	O
and	24603336	0	O
magnitudes	24603336	0	O
of	24603336	0	O
GOF	24603336	0	O
,	24603336	0	O
but	24603336	0	O
the	24603336	0	O
evidences	24603336	0	O
are	24603336	0	O
mainly	24603336	0	O
supported	24603336	0	O
by	24603336	0	O
cellular	24603336	0	O
and	24603336	0	O
transgenic	24603336	0	O
animal	24603336	0	O
models	24603336	0	O
.	24603336	0	O
Here	24603336	0	O
we	24603336	0	O
combine	24603336	0	O
large	24603336	0	O
-	24603336	0	O
scale	24603336	0	O
cancer	24603336	0	O
genomic	24603336	0	O
data	24603336	0	O
to	24603336	0	O
characterize	24603336	0	O
the	24603336	0	O
prognostic	24603336	0	O
significance	24603336	0	O
of	24603336	0	O
different	24603336	0	O
p53	24603336	0	B-Gene
mutations	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
.	24603336	0	O
Unexpectedly	24603336	0	O
,	24603336	0	O
only	24603336	0	O
mutations	24603336	0	B-Var
on	24603336	0	I-Var
the	24603336	0	I-Var
Arg248	24603336	0	I-Var
and	24603336	0	I-Var
Arg282	24603336	0	I-Var
positions	24603336	0	O
displayed	24603336	0	O
significant	24603336	0	O
association	24603336	0	O
with	24603336	0	O
shorter	24603336	0	B-NegReg
patient	24603336	0	B-CPA
survival	24603336	0	I-CPA
,	24603336	0	O
but	24603336	0	O
such	24603336	0	O
association	24603336	0	O
was	24603336	0	O
not	24603336	0	O
evident	24603336	0	O
for	24603336	0	O
other	24603336	0	O
hotspot	24603336	0	O
GOF	24603336	0	O
mutations	24603336	0	O
.	24603336	0	O
Gene	24603336	0	O
set	24603336	0	O
enrichment	24603336	0	O
analysis	24603336	0	O
on	24603336	0	O
these	24603336	0	O
mutations	24603336	0	B-Var
revealed	24603336	0	O
higher	24603336	0	B-PosReg
activity	24603336	0	B-MPA
of	24603336	0	O
drug	24603336	0	B-Enzyme
-	24603336	0	I-Enzyme
metabolizing	24603336	0	I-Enzyme
enzymes	24603336	0	I-Enzyme
,	24603336	0	O
including	24603336	0	O
the	24603336	0	O
CYP3A4	24603336	0	B-Enzyme
cytochrome	24603336	0	I-Enzyme
P450	24603336	0	I-Enzyme
.	24603336	0	O
Ectopic	24603336	0	B-MPA
expression	24603336	0	I-MPA
of	24603336	0	O
p53	24603336	0	B-Gene
mutant	24603336	0	B-Var
R282W	24603336	0	I-Var
in	24603336	0	O
H1299	24603336	0	O
and	24603336	0	O
SaOS2	24603336	0	O
cells	24603336	0	O
significantly	24603336	0	O
upregulated	24603336	0	B-PosReg
CYP3A4	24603336	0	B-MPA
mRNA	24603336	0	I-MPA
and	24603336	0	I-MPA
protein	24603336	0	I-MPA
levels	24603336	0	I-MPA
,	24603336	0	O
and	24603336	0	O
cancer	24603336	0	O
cell	24603336	0	O
lines	24603336	0	O
bearing	24603336	0	O
mortality	24603336	0	O
-	24603336	0	O
associated	24603336	0	O
p53	24603336	0	B-Gene
mutations	24603336	0	B-Var
display	24603336	0	O
higher	24603336	0	B-PosReg
CYP3A4	24603336	0	B-Enzyme
expression	24603336	0	B-MPA
and	24603336	0	O
resistance	24603336	0	B-CPA
to	24603336	0	I-CPA
several	24603336	0	I-CPA
CYP3A4	24603336	0	I-CPA
-	24603336	0	I-CPA
metabolized	24603336	0	I-CPA
chemotherapeutic	24603336	0	I-CPA
drugs	24603336	0	I-CPA
.	24603336	0	O
Our	24603336	0	O
results	24603336	0	O
suggest	24603336	0	O
that	24603336	0	O
p53	24603336	0	O
mutations	24603336	0	O
have	24603336	0	O
unequal	24603336	0	O
GOF	24603336	0	O
activities	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
,	24603336	0	O
and	24603336	0	O
future	24603336	0	O
evaluation	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
as	24603336	0	O
a	24603336	0	O
cancer	24603336	0	O
biomarker	24603336	0	O
should	24603336	0	O
consider	24603336	0	O
which	24603336	0	O
mutation	24603336	0	O
is	24603336	0	O
present	24603336	0	O
in	24603336	0	O
the	24603336	0	O
tumor	24603336	0	O
,	24603336	0	O
rather	24603336	0	O
than	24603336	0	O
having	24603336	0	O
comparison	24603336	0	O
between	24603336	0	O
wild	24603336	0	O
-	24603336	0	O
type	24603336	0	O
and	24603336	0	O
mutant	24603336	0	O
genotypes	24603336	0	O
.	24603336	0	O

Disruption	24632946	2	O
of	24632946	2	O
the	24632946	2	O
temporally	24632946	2	O
regulated	24632946	2	O
cloaca	24632946	2	O
endodermal	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
signaling	24632946	2	O
causes	24632946	2	O
anorectal	24632946	2	O
malformations	24632946	2	O
.	24632946	2	O
The	24632946	2	O
cloaca	24632946	2	O
is	24632946	2	O
temporally	24632946	2	O
formed	24632946	2	O
and	24632946	2	O
eventually	24632946	2	O
divided	24632946	2	O
by	24632946	2	O
the	24632946	2	O
urorectal	24632946	2	O
septum	24632946	2	O
(	24632946	2	O
URS	24632946	2	O
)	24632946	2	O
during	24632946	2	O
urogenital	24632946	2	O
and	24632946	2	O
anorectal	24632946	2	O
organ	24632946	2	O
development	24632946	2	O
.	24632946	2	O
Although	24632946	2	O
congenital	24632946	2	O
malformations	24632946	2	O
,	24632946	2	O
such	24632946	2	O
as	24632946	2	O
anorectal	24632946	2	O
malformations	24632946	2	O
(	24632946	2	O
ARMs	24632946	2	O
)	24632946	2	O
,	24632946	2	O
are	24632946	2	O
frequently	24632946	2	O
observed	24632946	2	O
during	24632946	2	O
this	24632946	2	O
process	24632946	2	O
,	24632946	2	O
the	24632946	2	O
underlying	24632946	2	O
pathogenic	24632946	2	O
mechanisms	24632946	2	O
remain	24632946	2	O
unclear	24632946	2	O
.	24632946	2	O
β	24632946	2	O
-	24632946	2	O
Catenin	24632946	2	O
is	24632946	2	O
a	24632946	2	O
critical	24632946	2	O
component	24632946	2	O
of	24632946	2	O
canonical	24632946	2	O
Wnt	24632946	2	O
signaling	24632946	2	O
and	24632946	2	O
is	24632946	2	O
essential	24632946	2	O
for	24632946	2	O
the	24632946	2	O
regulation	24632946	2	O
of	24632946	2	O
cell	24632946	2	O
differentiation	24632946	2	O
and	24632946	2	O
morphogenesis	24632946	2	O
during	24632946	2	O
embryogenesis	24632946	2	O
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	O
of	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
is	24632946	2	O
observed	24632946	2	O
in	24632946	2	O
endodermal	24632946	2	O
epithelia	24632946	2	O
,	24632946	2	O
including	24632946	2	O
URS	24632946	2	O
epithelia	24632946	2	O
.	24632946	2	O
We	24632946	2	O
modulated	24632946	2	O
the	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
gene	24632946	2	O
conditionally	24632946	2	O
in	24632946	2	O
endodermal	24632946	2	O
epithelia	24632946	2	O
by	24632946	2	O
utilizing	24632946	2	O
tamoxifen	24632946	2	O
-	24632946	2	O
inducible	24632946	2	O
Cre	24632946	2	O
driver	24632946	2	O
line	24632946	2	O
(	24632946	2	O
Shh	24632946	2	O
(	24632946	2	O
CreERT2	24632946	2	O
)	24632946	2	O
)	24632946	2	O
.	24632946	2	O
Both	24632946	2	O
β	24632946	2	B-Protein
-	24632946	2	I-Protein
catenin	24632946	2	I-Protein
loss	24632946	2	B-NegReg
-	24632946	2	I-NegReg
and	24632946	2	O
gain	24632946	2	B-PosReg
-	24632946	2	I-PosReg
of	24632946	2	I-PosReg
-	24632946	2	I-PosReg
function	24632946	2	I-PosReg
(	24632946	2	O
LOF	24632946	2	O
and	24632946	2	O
GOF	24632946	2	O
)	24632946	2	O
mutants	24632946	2	B-Var
displayed	24632946	2	O
abnormal	24632946	2	O
clefts	24632946	2	B-CPA
in	24632946	2	I-CPA
the	24632946	2	I-CPA
perineal	24632946	2	I-CPA
region	24632946	2	I-CPA
and	24632946	2	O
hypoplastic	24632946	2	B-CPA
elongation	24632946	2	I-CPA
of	24632946	2	I-CPA
the	24632946	2	I-CPA
URS	24632946	2	I-CPA
.	24632946	2	O
The	24632946	2	O
mutants	24632946	2	B-Var
also	24632946	2	O
displayed	24632946	2	O
reduced	24632946	2	B-NegReg
cell	24632946	2	B-CPA
proliferation	24632946	2	I-CPA
in	24632946	2	I-CPA
the	24632946	2	I-CPA
URS	24632946	2	I-CPA
mesenchyme	24632946	2	I-CPA
.	24632946	2	O
In	24632946	2	O
addition	24632946	2	O
,	24632946	2	O
the	24632946	2	O
β	24632946	2	B-Protein
-	24632946	2	I-Protein
catenin	24632946	2	I-Protein
GOF	24632946	2	O
mutants	24632946	2	B-Var
displayed	24632946	2	O
reduced	24632946	2	O
apoptosis	24632946	2	O
and	24632946	2	O
subsequently	24632946	2	O
increased	24632946	2	O
apoptosis	24632946	2	O
in	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
epithelium	24632946	2	O
.	24632946	2	O
This	24632946	2	O
instability	24632946	2	O
possibly	24632946	2	O
resulted	24632946	2	O
in	24632946	2	O
reduced	24632946	2	B-NegReg
expression	24632946	2	B-MPA
levels	24632946	2	I-MPA
of	24632946	2	O
differentiation	24632946	2	O
markers	24632946	2	O
,	24632946	2	O
such	24632946	2	O
as	24632946	2	O
keratin	24632946	2	B-Protein
1	24632946	2	I-Protein
and	24632946	2	O
filaggrin	24632946	2	B-Protein
,	24632946	2	O
in	24632946	2	O
the	24632946	2	O
perineal	24632946	2	O
epithelia	24632946	2	O
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	B-MPA
of	24632946	2	O
bone	24632946	2	B-Gene
morphogenetic	24632946	2	I-Gene
protein	24632946	2	I-Gene
(	24632946	2	I-Gene
Bmp	24632946	2	I-Gene
)	24632946	2	I-Gene
genes	24632946	2	I-Gene
,	24632946	2	O
such	24632946	2	O
as	24632946	2	O
Bmp4	24632946	2	B-Gene
and	24632946	2	O
Bmp7	24632946	2	B-Gene
,	24632946	2	O
was	24632946	2	O
also	24632946	2	O
ectopically	24632946	2	O
induced	24632946	2	B-PosReg
in	24632946	2	O
the	24632946	2	O
epithelia	24632946	2	O
of	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
in	24632946	2	O
the	24632946	2	O
β	24632946	2	B-Protein
-	24632946	2	I-Protein
catenin	24632946	2	I-Protein
GOF	24632946	2	O
mutants	24632946	2	B-Var
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	B-MPA
of	24632946	2	O
the	24632946	2	O
Msx2	24632946	2	B-Gene
gene	24632946	2	I-Gene
and	24632946	2	O
phosphorylated	24632946	2	O
-	24632946	2	O
Smad1	24632946	2	O
/	24632946	2	O
5	24632946	2	O
/	24632946	2	O
8	24632946	2	O
,	24632946	2	O
possible	24632946	2	O
readouts	24632946	2	B-MPA
of	24632946	2	I-MPA
Bmp	24632946	2	I-MPA
signaling	24632946	2	I-MPA
,	24632946	2	O
was	24632946	2	O
also	24632946	2	O
increased	24632946	2	B-PosReg
in	24632946	2	O
the	24632946	2	O
mutants	24632946	2	B-Var
.	24632946	2	O
Moreover	24632946	2	O
,	24632946	2	O
we	24632946	2	O
introduced	24632946	2	O
an	24632946	2	O
additional	24632946	2	O
mutation	24632946	2	O
for	24632946	2	O
a	24632946	2	O
Bmp	24632946	2	O
receptor	24632946	2	O
gene	24632946	2	O
:	24632946	2	O
BmprIA	24632946	2	O
.	24632946	2	O
The	24632946	2	O
Shh	24632946	2	O
(	24632946	2	O
CreERT2	24632946	2	O
/	24632946	2	O
)	24632946	2	O
;	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
(	24632946	2	O
flox	24632946	2	O
(	24632946	2	O
ex3	24632946	2	O
)	24632946	2	O
/	24632946	2	O
)	24632946	2	O
;	24632946	2	O
BmprIA	24632946	2	O
(	24632946	2	O
flox	24632946	2	O
/	24632946	2	O
-	24632946	2	O
)	24632946	2	O
mutants	24632946	2	O
displayed	24632946	2	O
partial	24632946	2	O
restoration	24632946	2	O
of	24632946	2	O
URS	24632946	2	O
elongation	24632946	2	O
compared	24632946	2	O
with	24632946	2	O
the	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	O
mutants	24632946	2	O
.	24632946	2	O
These	24632946	2	O
results	24632946	2	O
indicate	24632946	2	O
that	24632946	2	O
some	24632946	2	O
ARM	24632946	2	B-Disease
phenotypes	24632946	2	O
in	24632946	2	O
the	24632946	2	O
β	24632946	2	B-Protein
-	24632946	2	I-Protein
catenin	24632946	2	I-Protein
GOF	24632946	2	B-PosReg
mutants	24632946	2	B-Var
were	24632946	2	O
caused	24632946	2	B-Reg
by	24632946	2	I-Reg
abnormal	24632946	2	O
Bmp	24632946	2	B-MPA
signaling	24632946	2	I-MPA
.	24632946	2	O
The	24632946	2	O
current	24632946	2	O
analysis	24632946	2	O
revealed	24632946	2	O
the	24632946	2	O
close	24632946	2	O
relation	24632946	2	O
of	24632946	2	O
endodermal	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
signaling	24632946	2	O
to	24632946	2	O
the	24632946	2	O
ARM	24632946	2	O
phenotypes	24632946	2	O
.	24632946	2	O
These	24632946	2	O
results	24632946	2	O
are	24632946	2	O
considered	24632946	2	O
to	24632946	2	O
shed	24632946	2	O
light	24632946	2	O
on	24632946	2	O
the	24632946	2	O
pathogenic	24632946	2	O
mechanisms	24632946	2	O
of	24632946	2	O
human	24632946	2	O
ARMs	24632946	2	O
.	24632946	2	O

Dysregulation	24632949	0	O
of	24632949	0	O
Wnt	24632949	0	O
inhibitory	24632949	0	O
factor	24632949	0	O
1	24632949	0	O
(	24632949	0	O
Wif1	24632949	0	O
)	24632949	0	O
expression	24632949	0	O
resulted	24632949	0	O
in	24632949	0	O
aberrant	24632949	0	O
Wnt	24632949	0	O
-	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signaling	24632949	0	O
and	24632949	0	O
cell	24632949	0	O
death	24632949	0	O
of	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
endoderm	24632949	0	O
,	24632949	0	O
and	24632949	0	O
anorectal	24632949	0	O
malformations	24632949	0	O
.	24632949	0	O
In	24632949	0	O
mammalian	24632949	0	O
urorectal	24632949	0	O
development	24632949	0	O
,	24632949	0	O
the	24632949	0	O
urorectal	24632949	0	O
septum	24632949	0	O
(	24632949	0	O
urs	24632949	0	O
)	24632949	0	O
descends	24632949	0	O
from	24632949	0	O
the	24632949	0	O
ventral	24632949	0	O
body	24632949	0	O
wall	24632949	0	O
to	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
membrane	24632949	0	O
(	24632949	0	O
cm	24632949	0	O
)	24632949	0	O
to	24632949	0	O
partition	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
into	24632949	0	O
urogenital	24632949	0	O
sinus	24632949	0	O
and	24632949	0	O
rectum	24632949	0	O
.	24632949	0	O
Defective	24632949	0	O
urs	24632949	0	O
growth	24632949	0	O
results	24632949	0	O
in	24632949	0	O
human	24632949	0	O
congenital	24632949	0	O
anorectal	24632949	0	O
malformations	24632949	0	O
(	24632949	0	O
ARMs	24632949	0	O
)	24632949	0	O
,	24632949	0	O
and	24632949	0	O
their	24632949	0	O
pathogenic	24632949	0	O
mechanisms	24632949	0	O
are	24632949	0	O
unclear	24632949	0	O
.	24632949	0	O
Recent	24632949	0	O
studies	24632949	0	O
only	24632949	0	O
focused	24632949	0	O
on	24632949	0	O
the	24632949	0	O
importance	24632949	0	O
of	24632949	0	O
urs	24632949	0	O
mesenchyme	24632949	0	O
proliferation	24632949	0	O
,	24632949	0	O
which	24632949	0	O
is	24632949	0	O
induced	24632949	0	O
by	24632949	0	O
endoderm	24632949	0	O
-	24632949	0	O
derived	24632949	0	O
Sonic	24632949	0	O
Hedgehog	24632949	0	O
(	24632949	0	O
Shh	24632949	0	O
)	24632949	0	O
.	24632949	0	O
Here	24632949	0	O
,	24632949	0	O
we	24632949	0	O
showed	24632949	0	O
that	24632949	0	O
the	24632949	0	O
programmed	24632949	0	O
cell	24632949	0	O
death	24632949	0	O
of	24632949	0	O
the	24632949	0	O
apical	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
proximal	24632949	0	O
cm	24632949	0	O
endoderm	24632949	0	O
is	24632949	0	O
particularly	24632949	0	O
crucial	24632949	0	O
for	24632949	0	O
the	24632949	0	O
growth	24632949	0	O
of	24632949	0	O
urs	24632949	0	O
during	24632949	0	O
septation	24632949	0	O
.	24632949	0	O
The	24632949	0	O
apoptotic	24632949	0	O
endoderm	24632949	0	O
was	24632949	0	O
closely	24632949	0	O
associated	24632949	0	O
with	24632949	0	O
the	24632949	0	O
tempo	24632949	0	O
-	24632949	0	O
spatial	24632949	0	O
expression	24632949	0	O
of	24632949	0	O
Wnt	24632949	0	O
inhibitory	24632949	0	O
factor	24632949	0	O
1	24632949	0	O
(	24632949	0	O
Wif1	24632949	0	O
)	24632949	0	O
,	24632949	0	O
which	24632949	0	O
is	24632949	0	O
an	24632949	0	O
inhibitor	24632949	0	O
of	24632949	0	O
Wnt	24632949	0	O
-	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signaling	24632949	0	O
.	24632949	0	O
In	24632949	0	O
Wif1	24632949	0	O
(	24632949	0	O
lacZ	24632949	0	O
/	24632949	0	O
lacZ	24632949	0	O
)	24632949	0	O
mutant	24632949	0	O
mice	24632949	0	O
and	24632949	0	O
cultured	24632949	0	O
urorectum	24632949	0	O
with	24632949	0	O
exogenous	24632949	0	O
Wif1	24632949	0	O
,	24632949	0	O
cloaca	24632949	0	O
septation	24632949	0	O
was	24632949	0	O
defective	24632949	0	O
with	24632949	0	O
undescended	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
hypospadias	24632949	0	O
-	24632949	0	O
like	24632949	0	O
phenotypes	24632949	0	O
,	24632949	0	O
and	24632949	0	O
such	24632949	0	O
septation	24632949	0	O
defects	24632949	0	O
were	24632949	0	O
also	24632949	0	O
observed	24632949	0	O
in	24632949	0	O
Shh	24632949	0	O
(	24632949	0	O
-	24632949	0	O
/	24632949	0	O
-	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
and	24632949	0	O
in	24632949	0	O
endodermal	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
gain	24632949	0	O
-	24632949	0	O
of	24632949	0	O
-	24632949	0	O
function	24632949	0	O
(	24632949	0	O
GOF	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
.	24632949	0	O
In	24632949	0	O
addition	24632949	0	O
,	24632949	0	O
Wif1	24632949	0	O
and	24632949	0	O
Shh	24632949	0	O
were	24632949	0	O
expressed	24632949	0	O
in	24632949	0	O
a	24632949	0	O
complementary	24632949	0	O
manner	24632949	0	O
in	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
endoderm	24632949	0	O
,	24632949	0	O
and	24632949	0	O
Wif1	24632949	0	O
was	24632949	0	O
ectopically	24632949	0	O
expressed	24632949	0	O
in	24632949	0	O
the	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
cm	24632949	0	O
associated	24632949	0	O
with	24632949	0	O
excessive	24632949	0	O
endodermal	24632949	0	O
apoptosis	24632949	0	O
and	24632949	0	O
septation	24632949	0	O
defects	24632949	0	O
in	24632949	0	O
Shh	24632949	0	O
(	24632949	0	O
-	24632949	0	O
/	24632949	0	O
-	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
.	24632949	0	O
Furthermore	24632949	0	O
,	24632949	0	O
apoptotic	24632949	0	B-CPA
cells	24632949	0	I-CPA
were	24632949	0	O
markedly	24632949	0	O
reduced	24632949	0	B-NegReg
in	24632949	0	O
the	24632949	0	O
endodermal	24632949	0	B-Protein
β	24632949	0	I-Protein
-	24632949	0	I-Protein
catenin	24632949	0	I-Protein
GOF	24632949	0	B-PosReg
mutant	24632949	0	B-Var
embryos	24632949	0	O
,	24632949	0	O
which	24632949	0	O
counteracted	24632949	0	O
the	24632949	0	O
inhibitory	24632949	0	O
effects	24632949	0	O
of	24632949	0	O
Wif1	24632949	0	O
.	24632949	0	O
Taken	24632949	0	O
altogether	24632949	0	O
,	24632949	0	O
these	24632949	0	O
data	24632949	0	O
suggest	24632949	0	O
that	24632949	0	O
regulated	24632949	0	O
expression	24632949	0	O
of	24632949	0	O
Wif1	24632949	0	O
is	24632949	0	O
critical	24632949	0	O
for	24632949	0	O
the	24632949	0	O
growth	24632949	0	O
of	24632949	0	O
the	24632949	0	O
urs	24632949	0	O
during	24632949	0	O
cloaca	24632949	0	O
septation	24632949	0	O
.	24632949	0	O
Hence	24632949	0	O
,	24632949	0	O
Wif1	24632949	0	O
governs	24632949	0	O
cell	24632949	0	O
apoptosis	24632949	0	O
of	24632949	0	O
urs	24632949	0	O
endoderm	24632949	0	O
by	24632949	0	O
repressing	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signal	24632949	0	O
,	24632949	0	O
which	24632949	0	O
may	24632949	0	O
facilitate	24632949	0	O
the	24632949	0	O
protrusion	24632949	0	O
of	24632949	0	O
the	24632949	0	O
underlying	24632949	0	O
proliferating	24632949	0	O
mesenchymal	24632949	0	O
cells	24632949	0	O
towards	24632949	0	O
the	24632949	0	O
cm	24632949	0	O
for	24632949	0	O
cloaca	24632949	0	O
septation	24632949	0	O
.	24632949	0	O
Dysregulation	24632949	0	O
of	24632949	0	O
this	24632949	0	O
endodermal	24632949	0	O
Shh	24632949	0	O
-	24632949	0	O
Wif1	24632949	0	O
-	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signaling	24632949	0	O
axis	24632949	0	O
contributes	24632949	0	O
to	24632949	0	O
ARM	24632949	0	O
pathogenesis	24632949	0	O
.	24632949	0	O

Significance	24730569	0	O
of	24730569	0	O
the	24730569	0	O
melanocortin	24730569	0	O
1	24730569	0	O
receptor	24730569	0	O
in	24730569	0	O
the	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
response	24730569	0	O
of	24730569	0	O
human	24730569	0	O
melanocytes	24730569	0	O
to	24730569	0	O
ultraviolet	24730569	0	O
radiation	24730569	0	O
.	24730569	0	O
Activation	24730569	0	O
of	24730569	0	O
the	24730569	0	O
melanocortin	24730569	0	O
1	24730569	0	O
receptor	24730569	0	O
(	24730569	0	O
MC1R	24730569	0	O
)	24730569	0	O
by	24730569	0	O
α	24730569	0	O
-	24730569	0	O
melanocortin	24730569	0	O
(	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
)	24730569	0	O
stimulates	24730569	0	O
eumelanin	24730569	0	O
synthesis	24730569	0	O
and	24730569	0	O
enhances	24730569	0	O
repair	24730569	0	O
of	24730569	0	O
ultraviolet	24730569	0	O
radiation	24730569	0	O
(	24730569	0	O
UV	24730569	0	O
)	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
.	24730569	0	O
We	24730569	0	O
report	24730569	0	O
on	24730569	0	O
the	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
response	24730569	0	O
(	24730569	0	O
DDR	24730569	0	O
)	24730569	0	O
of	24730569	0	O
human	24730569	0	O
melanocytes	24730569	0	O
to	24730569	0	O
UV	24730569	0	O
and	24730569	0	O
its	24730569	0	O
enhancement	24730569	0	O
by	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
.	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
up	24730569	0	O
-	24730569	0	O
regulated	24730569	0	O
the	24730569	0	O
levels	24730569	0	O
of	24730569	0	O
XPC	24730569	0	O
,	24730569	0	O
the	24730569	0	O
enzyme	24730569	0	O
that	24730569	0	O
recognizes	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
sites	24730569	0	O
,	24730569	0	O
enhanced	24730569	0	O
the	24730569	0	O
UV	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
phosphorylation	24730569	0	O
of	24730569	0	O
the	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
sensors	24730569	0	O
ataxia	24730569	0	O
telangiectasia	24730569	0	O
and	24730569	0	O
Rad3	24730569	0	O
-	24730569	0	O
related	24730569	0	O
(	24730569	0	O
ATR	24730569	0	O
)	24730569	0	O
and	24730569	0	O
ataxia	24730569	0	O
telangiectasia	24730569	0	O
mutated	24730569	0	O
(	24730569	0	O
ATM	24730569	0	O
)	24730569	0	O
and	24730569	0	O
their	24730569	0	O
respect	24730569	0	O
-	24730569	0	O
ive	24730569	0	O
substrates	24730569	0	O
checkpoint	24730569	0	O
kinases	24730569	0	O
1	24730569	0	O
and	24730569	0	O
2	24730569	0	O
,	24730569	0	O
and	24730569	0	O
increased	24730569	0	O
phosphorylated	24730569	0	O
H2AX	24730569	0	O
(	24730569	0	O
γH2AX	24730569	0	O
)	24730569	0	O
formation	24730569	0	O
.	24730569	0	O
These	24730569	0	O
effects	24730569	0	O
required	24730569	0	O
functional	24730569	0	O
MC1R	24730569	0	O
and	24730569	0	O
were	24730569	0	O
absent	24730569	0	O
in	24730569	0	O
melanocytes	24730569	0	O
expressing	24730569	0	O
loss	24730569	0	O
of	24730569	0	O
function	24730569	0	O
(	24730569	0	O
LOF	24730569	0	O
)	24730569	0	O
MC1R	24730569	0	O
.	24730569	0	O
The	24730569	0	O
levels	24730569	0	O
of	24730569	0	O
wild	24730569	0	O
-	24730569	0	O
type	24730569	0	O
p53	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
phosphatase	24730569	0	O
1	24730569	0	O
(	24730569	0	O
Wip1	24730569	0	O
)	24730569	0	O
,	24730569	0	O
which	24730569	0	O
dephosphorylates	24730569	0	O
γH2AX	24730569	0	O
,	24730569	0	O
correlated	24730569	0	O
inversely	24730569	0	O
with	24730569	0	O
γH2AX	24730569	0	O
.	24730569	0	O
We	24730569	0	O
propose	24730569	0	O
that	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
increases	24730569	0	O
UV	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
γH2AX	24730569	0	O
to	24730569	0	O
facilitate	24730569	0	O
formation	24730569	0	O
of	24730569	0	O
DNA	24730569	0	O
repair	24730569	0	O
complexes	24730569	0	O
and	24730569	0	O
repair	24730569	0	O
of	24730569	0	O
DNA	24730569	0	O
photoproducts	24730569	0	O
,	24730569	0	O
and	24730569	0	O
LOF	24730569	0	B-Var
of	24730569	0	O
MC1R	24730569	0	B-Protein
compromises	24730569	0	B-NegReg
the	24730569	0	O
DDR	24730569	0	B-MPA
and	24730569	0	O
genomic	24730569	0	B-CPA
stability	24730569	0	I-CPA
of	24730569	0	I-CPA
melanocytes	24730569	0	I-CPA
.	24730569	0	O

Assessing	24808909	1	O
the	24808909	1	O
functional	24808909	1	O
consequence	24808909	1	O
of	24808909	1	O
loss	24808909	1	O
of	24808909	1	O
function	24808909	1	O
variants	24808909	1	O
using	24808909	1	O
electronic	24808909	1	O
medical	24808909	1	O
record	24808909	1	O
and	24808909	1	O
large	24808909	1	O
-	24808909	1	O
scale	24808909	1	O
genomics	24808909	1	O
consortium	24808909	1	O
efforts	24808909	1	O
.	24808909	1	O
Estimates	24808909	1	O
from	24808909	1	O
large	24808909	1	O
scale	24808909	1	O
genome	24808909	1	O
sequencing	24808909	1	O
studies	24808909	1	O
indicate	24808909	1	O
that	24808909	1	O
each	24808909	1	O
human	24808909	1	O
carries	24808909	1	O
up	24808909	1	O
to	24808909	1	O
20	24808909	1	O
genetic	24808909	1	O
variants	24808909	1	O
that	24808909	1	O
are	24808909	1	O
predicted	24808909	1	O
to	24808909	1	O
results	24808909	1	O
in	24808909	1	O
loss	24808909	1	O
of	24808909	1	O
function	24808909	1	O
(	24808909	1	O
LOF	24808909	1	O
)	24808909	1	O
of	24808909	1	O
protein	24808909	1	O
-	24808909	1	O
coding	24808909	1	O
genes	24808909	1	O
.	24808909	1	O
While	24808909	1	O
some	24808909	1	O
are	24808909	1	O
known	24808909	1	O
disease	24808909	1	O
-	24808909	1	O
causing	24808909	1	O
variants	24808909	1	O
or	24808909	1	O
common	24808909	1	O
,	24808909	1	O
tolerated	24808909	1	O
,	24808909	1	O
LOFs	24808909	1	O
in	24808909	1	O
non	24808909	1	O
-	24808909	1	O
essential	24808909	1	O
genes	24808909	1	O
,	24808909	1	O
the	24808909	1	O
majority	24808909	1	O
remain	24808909	1	O
of	24808909	1	O
unknown	24808909	1	O
consequence	24808909	1	O
.	24808909	1	O
We	24808909	1	O
explore	24808909	1	O
the	24808909	1	O
possibility	24808909	1	O
of	24808909	1	O
using	24808909	1	O
imputed	24808909	1	O
GWAS	24808909	1	O
data	24808909	1	O
from	24808909	1	O
large	24808909	1	O
biorepositories	24808909	1	O
such	24808909	1	O
as	24808909	1	O
the	24808909	1	O
electronic	24808909	1	O
medical	24808909	1	O
record	24808909	1	O
and	24808909	1	O
genomics	24808909	1	O
(	24808909	1	O
eMERGE	24808909	1	O
)	24808909	1	O
consortium	24808909	1	O
to	24808909	1	O
determine	24808909	1	O
the	24808909	1	O
effects	24808909	1	O
of	24808909	1	O
rare	24808909	1	O
LOFs	24808909	1	O
.	24808909	1	O
Here	24808909	1	O
,	24808909	1	O
we	24808909	1	O
show	24808909	1	O
that	24808909	1	O
two	24808909	1	O
hypocholesterolemia	24808909	1	B-Disease
-	24808909	1	I-Disease
associated	24808909	1	I-Disease
LOF	24808909	1	B-NegReg
mutations	24808909	1	B-Var
in	24808909	1	O
the	24808909	1	O
PCSK9	24808909	1	B-Gene
gene	24808909	1	O
can	24808909	1	O
be	24808909	1	O
accurately	24808909	1	O
imputed	24808909	1	O
into	24808909	1	O
large	24808909	1	O
-	24808909	1	O
scale	24808909	1	O
GWAS	24808909	1	O
datasets	24808909	1	O
which	24808909	1	O
raises	24808909	1	O
the	24808909	1	O
possibility	24808909	1	O
of	24808909	1	O
assessing	24808909	1	O
LOFs	24808909	1	O
through	24808909	1	O
genomics	24808909	1	O
-	24808909	1	O
linked	24808909	1	O
medical	24808909	1	O
records	24808909	1	O
.	24808909	1	O

PDGF	24946076	1	O
,	24946076	1	O
pericytes	24946076	1	O
and	24946076	1	O
the	24946076	1	O
pathogenesis	24946076	1	O
of	24946076	1	O
idiopathic	24946076	1	O
basal	24946076	1	O
ganglia	24946076	1	O
calcification	24946076	1	O
(	24946076	1	O
IBGC	24946076	1	O
)	24946076	1	O
.	24946076	1	O
Platelet	24946076	1	O
-	24946076	1	O
derived	24946076	1	O
growth	24946076	1	O
factors	24946076	1	O
(	24946076	1	O
PDGFs	24946076	1	O
)	24946076	1	O
are	24946076	1	O
important	24946076	1	O
mitogens	24946076	1	O
for	24946076	1	O
various	24946076	1	O
types	24946076	1	O
of	24946076	1	O
mesenchymal	24946076	1	O
cells	24946076	1	O
,	24946076	1	O
and	24946076	1	O
as	24946076	1	O
such	24946076	1	O
,	24946076	1	O
they	24946076	1	O
exert	24946076	1	O
critical	24946076	1	O
functions	24946076	1	O
during	24946076	1	O
organogenesis	24946076	1	O
in	24946076	1	O
mammalian	24946076	1	O
embryonic	24946076	1	O
and	24946076	1	O
early	24946076	1	O
postnatal	24946076	1	O
development	24946076	1	O
.	24946076	1	O
Increased	24946076	1	O
or	24946076	1	O
ectopic	24946076	1	B-Var
PDGF	24946076	1	B-Protein
activity	24946076	1	B-MPA
may	24946076	1	O
also	24946076	1	O
cause	24946076	1	B-Reg
or	24946076	1	O
contribute	24946076	1	B-Reg
to	24946076	1	O
diseases	24946076	1	O
such	24946076	1	O
as	24946076	1	O
cancer	24946076	1	B-Disease
and	24946076	1	O
tissue	24946076	1	B-Disease
fibrosis	24946076	1	I-Disease
.	24946076	1	O
Until	24946076	1	O
recently	24946076	1	O
,	24946076	1	O
no	24946076	1	O
loss	24946076	1	O
-	24946076	1	O
of	24946076	1	O
-	24946076	1	O
function	24946076	1	O
(	24946076	1	O
LOF	24946076	1	O
)	24946076	1	O
mutations	24946076	1	O
in	24946076	1	O
PDGF	24946076	1	O
or	24946076	1	O
PDGF	24946076	1	O
receptor	24946076	1	O
genes	24946076	1	O
were	24946076	1	O
reported	24946076	1	O
as	24946076	1	O
causally	24946076	1	O
linked	24946076	1	O
to	24946076	1	O
a	24946076	1	O
human	24946076	1	O
disease	24946076	1	O
.	24946076	1	O
This	24946076	1	O
changed	24946076	1	O
in	24946076	1	O
2013	24946076	1	O
when	24946076	1	O
reports	24946076	1	O
appeared	24946076	1	O
on	24946076	1	O
presumed	24946076	1	O
LOF	24946076	1	B-NegReg
mutations	24946076	1	B-Var
in	24946076	1	O
the	24946076	1	O
genes	24946076	1	O
encoding	24946076	1	O
PDGF	24946076	1	B-Gene
-	24946076	1	I-Gene
B	24946076	1	I-Gene
and	24946076	1	O
its	24946076	1	O
receptor	24946076	1	O
PDGF	24946076	1	O
receptor	24946076	1	O
-	24946076	1	O
beta	24946076	1	O
(	24946076	1	B-Gene
PDGF	24946076	1	I-Gene
-	24946076	1	I-Gene
Rβ	24946076	1	I-Gene
)	24946076	1	I-Gene
in	24946076	1	O
familial	24946076	1	B-Disease
idiopathic	24946076	1	I-Disease
basal	24946076	1	I-Disease
ganglia	24946076	1	I-Disease
calcification	24946076	1	I-Disease
(	24946076	1	O
IBGC	24946076	1	O
)	24946076	1	O
,	24946076	1	O
a	24946076	1	O
brain	24946076	1	O
disease	24946076	1	O
characterized	24946076	1	O
by	24946076	1	O
anatomically	24946076	1	O
localized	24946076	1	O
calcifications	24946076	1	O
in	24946076	1	O
or	24946076	1	O
near	24946076	1	O
the	24946076	1	O
blood	24946076	1	O
microvessels	24946076	1	O
.	24946076	1	O
Here	24946076	1	O
,	24946076	1	O
we	24946076	1	O
review	24946076	1	O
PDGF	24946076	1	O
-	24946076	1	O
B	24946076	1	O
and	24946076	1	O
PDGF	24946076	1	O
-	24946076	1	O
Rβ	24946076	1	O
biology	24946076	1	O
with	24946076	1	O
special	24946076	1	O
reference	24946076	1	O
to	24946076	1	O
their	24946076	1	O
functions	24946076	1	O
in	24946076	1	O
brain	24946076	1	O
-	24946076	1	O
blood	24946076	1	O
vessel	24946076	1	O
development	24946076	1	O
,	24946076	1	O
pericyte	24946076	1	O
recruitment	24946076	1	O
and	24946076	1	O
the	24946076	1	O
regulation	24946076	1	O
of	24946076	1	O
the	24946076	1	O
blood	24946076	1	O
-	24946076	1	O
brain	24946076	1	O
barrier	24946076	1	O
.	24946076	1	O
We	24946076	1	O
also	24946076	1	O
discuss	24946076	1	O
various	24946076	1	O
scenarios	24946076	1	O
for	24946076	1	O
IBGC	24946076	1	O
pathogenesis	24946076	1	O
suggested	24946076	1	O
by	24946076	1	O
observations	24946076	1	O
in	24946076	1	O
patients	24946076	1	O
and	24946076	1	O
genetically	24946076	1	O
engineered	24946076	1	O
animal	24946076	1	O
models	24946076	1	O
of	24946076	1	O
the	24946076	1	O
disease	24946076	1	O
.	24946076	1	O

Mutant	24998848	0	O
p53	24998848	0	O
gains	24998848	0	O
new	24998848	0	O
function	24998848	0	O
in	24998848	0	O
promoting	24998848	0	O
inflammatory	24998848	0	O
signals	24998848	0	O
by	24998848	0	O
repression	24998848	0	O
of	24998848	0	O
the	24998848	0	O
secreted	24998848	0	O
interleukin-1	24998848	0	O
receptor	24998848	0	O
antagonist	24998848	0	O
.	24998848	0	O
The	24998848	0	O
TP53	24998848	0	B-Gene
tumor	24998848	0	I-Gene
-	24998848	0	I-Gene
suppressor	24998848	0	I-Gene
gene	24998848	0	I-Gene
is	24998848	0	O
frequently	24998848	0	O
mutated	24998848	0	O
in	24998848	0	O
human	24998848	0	O
cancer	24998848	0	O
.	24998848	0	O
Missense	24998848	0	B-Var
mutations	24998848	0	I-Var
can	24998848	0	O
add	24998848	0	O
novel	24998848	0	O
functions	24998848	0	O
(	24998848	0	O
gain	24998848	0	O
-	24998848	0	O
of	24998848	0	O
-	24998848	0	O
function	24998848	0	O
,	24998848	0	O
GOF	24998848	0	O
)	24998848	0	O
that	24998848	0	O
promote	24998848	0	B-PosReg
tumor	24998848	0	B-CPA
malignancy	24998848	0	I-CPA
.	24998848	0	O
Here	24998848	0	O
we	24998848	0	O
report	24998848	0	O
that	24998848	0	O
mutant	24998848	0	B-Var
(	24998848	0	O
mut	24998848	0	O
)	24998848	0	O
p53	24998848	0	B-Gene
promotes	24998848	0	B-PosReg
tumor	24998848	0	B-CPA
malignancy	24998848	0	I-CPA
by	24998848	0	O
suppressing	24998848	0	B-NegReg
the	24998848	0	O
expression	24998848	0	B-MPA
of	24998848	0	I-MPA
a	24998848	0	I-MPA
natural	24998848	0	I-MPA
occurring	24998848	0	I-MPA
anti	24998848	0	I-MPA
-	24998848	0	I-MPA
inflammatory	24998848	0	I-MPA
cytokine	24998848	0	I-MPA
,	24998848	0	O
the	24998848	0	O
secreted	24998848	0	O
interleukin-1	24998848	0	O
receptor	24998848	0	O
antagonist	24998848	0	O
(	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
,	24998848	0	O
IL1RN	24998848	0	O
)	24998848	0	O
.	24998848	0	O
We	24998848	0	O
show	24998848	0	O
that	24998848	0	O
mutp53	24998848	0	B-Var
but	24998848	0	O
not	24998848	0	O
wild	24998848	0	O
-	24998848	0	O
type	24998848	0	O
(	24998848	0	O
wt	24998848	0	O
)	24998848	0	O
p53	24998848	0	O
suppresses	24998848	0	B-NegReg
the	24998848	0	O
sIL-1	24998848	0	B-MPA
Ra	24998848	0	I-MPA
production	24998848	0	I-MPA
in	24998848	0	O
conditioned	24998848	0	O
media	24998848	0	O
of	24998848	0	O
cancer	24998848	0	O
cells	24998848	0	O
.	24998848	0	O
Moreover	24998848	0	O
,	24998848	0	O
mutp53	24998848	0	O
,	24998848	0	O
but	24998848	0	O
not	24998848	0	O
wtp53	24998848	0	O
,	24998848	0	O
binds	24998848	0	O
physically	24998848	0	O
the	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
promoter	24998848	0	O
and	24998848	0	O
the	24998848	0	O
protein	24998848	0	O
-	24998848	0	O
protein	24998848	0	O
interaction	24998848	0	O
with	24998848	0	O
the	24998848	0	O
transcriptional	24998848	0	O
co	24998848	0	O
-	24998848	0	O
repressor	24998848	0	O
MAFF	24998848	0	O
(	24998848	0	O
v	24998848	0	O
-	24998848	0	O
MAF	24998848	0	O
musculoaponeurotic	24998848	0	O
fibrosarcoma	24998848	0	O
oncogene	24998848	0	O
family	24998848	0	O
,	24998848	0	O
protein	24998848	0	O
F	24998848	0	O
)	24998848	0	O
is	24998848	0	O
required	24998848	0	O
for	24998848	0	O
mutp53	24998848	0	O
-	24998848	0	O
induced	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
suppression	24998848	0	O
.	24998848	0	O
Remarkably	24998848	0	O
,	24998848	0	O
when	24998848	0	O
exposed	24998848	0	O
to	24998848	0	O
IL-1	24998848	0	O
beta	24998848	0	O
(	24998848	0	O
IL-1	24998848	0	O
β	24998848	0	O
)	24998848	0	O
inflammatory	24998848	0	O
stimuli	24998848	0	O
,	24998848	0	O
mutp53	24998848	0	O
sustains	24998848	0	O
a	24998848	0	O
ready	24998848	0	O
-	24998848	0	O
to	24998848	0	O
-	24998848	0	O
be	24998848	0	O
-	24998848	0	O
activated	24998848	0	O
in	24998848	0	O
vitro	24998848	0	O
and	24998848	0	O
in	24998848	0	O
vivo	24998848	0	O
cancer	24998848	0	O
cells	24998848	0	O
'	24998848	0	O
response	24998848	0	O
through	24998848	0	O
the	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
repression	24998848	0	O
.	24998848	0	O
Taken	24998848	0	O
together	24998848	0	O
,	24998848	0	O
these	24998848	0	O
results	24998848	0	O
identify	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
as	24998848	0	O
a	24998848	0	O
novel	24998848	0	O
mutp53	24998848	0	O
target	24998848	0	O
gene	24998848	0	O
,	24998848	0	O
whose	24998848	0	O
suppression	24998848	0	O
might	24998848	0	O
be	24998848	0	O
required	24998848	0	O
to	24998848	0	O
generate	24998848	0	O
a	24998848	0	O
chronic	24998848	0	O
pro	24998848	0	O
-	24998848	0	O
inflammatory	24998848	0	O
tumor	24998848	0	O
microenvironment	24998848	0	O
through	24998848	0	O
which	24998848	0	O
mutp53	24998848	0	O
promotes	24998848	0	O
tumor	24998848	0	O
malignancy	24998848	0	O
.	24998848	0	O

Rare	25157153	1	O
variants	25157153	1	O
in	25157153	1	O
PPARG	25157153	1	O
with	25157153	1	O
decreased	25157153	1	O
activity	25157153	1	O
in	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
are	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
increased	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
type	25157153	1	O
2	25157153	1	O
diabetes	25157153	1	O
.	25157153	1	O
Peroxisome	25157153	1	O
proliferator	25157153	1	O
-	25157153	1	O
activated	25157153	1	O
receptor	25157153	1	O
gamma	25157153	1	O
(	25157153	1	O
PPARG	25157153	1	O
)	25157153	1	O
is	25157153	1	O
a	25157153	1	O
master	25157153	1	O
transcriptional	25157153	1	O
regulator	25157153	1	O
of	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
and	25157153	1	O
a	25157153	1	O
canonical	25157153	1	O
target	25157153	1	O
of	25157153	1	O
antidiabetic	25157153	1	O
thiazolidinedione	25157153	1	O
medications	25157153	1	O
.	25157153	1	O
In	25157153	1	O
rare	25157153	1	O
families	25157153	1	O
,	25157153	1	O
loss	25157153	1	B-NegReg
-	25157153	1	I-NegReg
of	25157153	1	I-NegReg
-	25157153	1	I-NegReg
function	25157153	1	I-NegReg
(	25157153	1	O
LOF	25157153	1	O
)	25157153	1	O
mutations	25157153	1	B-Var
in	25157153	1	O
PPARG	25157153	1	B-Gene
are	25157153	1	O
known	25157153	1	O
to	25157153	1	O
cosegregate	25157153	1	O
with	25157153	1	O
lipodystrophy	25157153	1	B-Disease
and	25157153	1	O
insulin	25157153	1	B-Disease
resistance	25157153	1	I-Disease
;	25157153	1	I-Disease
in	25157153	1	O
the	25157153	1	O
general	25157153	1	O
population	25157153	1	O
,	25157153	1	O
the	25157153	1	O
common	25157153	1	O
P12A	25157153	1	B-Var
variant	25157153	1	I-Var
is	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
a	25157153	1	O
decreased	25157153	1	B-NegReg
risk	25157153	1	O
of	25157153	1	O
type	25157153	1	B-Disease
2	25157153	1	I-Disease
diabetes	25157153	1	I-Disease
(	25157153	1	O
T2D	25157153	1	O
)	25157153	1	O
.	25157153	1	O
Whether	25157153	1	O
and	25157153	1	O
how	25157153	1	O
rare	25157153	1	O
variants	25157153	1	O
in	25157153	1	O
PPARG	25157153	1	O
and	25157153	1	O
defects	25157153	1	O
in	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
influence	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
T2D	25157153	1	O
in	25157153	1	O
the	25157153	1	O
general	25157153	1	O
population	25157153	1	O
remains	25157153	1	O
undetermined	25157153	1	O
.	25157153	1	O
By	25157153	1	O
sequencing	25157153	1	O
PPARG	25157153	1	O
in	25157153	1	O
19	25157153	1	O
,	25157153	1	O
752	25157153	1	O
T2D	25157153	1	O
cases	25157153	1	O
and	25157153	1	O
controls	25157153	1	O
drawn	25157153	1	O
from	25157153	1	O
multiple	25157153	1	O
studies	25157153	1	O
and	25157153	1	O
ethnic	25157153	1	O
groups	25157153	1	O
,	25157153	1	O
we	25157153	1	O
identified	25157153	1	O
49	25157153	1	O
previously	25157153	1	O
unidentified	25157153	1	O
,	25157153	1	O
nonsynonymous	25157153	1	O
PPARG	25157153	1	O
variants	25157153	1	O
(	25157153	1	O
MAF	25157153	1	O
<	25157153	1	O
0.5%	25157153	1	O
)	25157153	1	O
.	25157153	1	O
Considered	25157153	1	O
in	25157153	1	O
aggregate	25157153	1	O
(	25157153	1	O
with	25157153	1	O
or	25157153	1	O
without	25157153	1	O
computational	25157153	1	O
prediction	25157153	1	O
of	25157153	1	O
functional	25157153	1	O
consequence	25157153	1	O
)	25157153	1	O
,	25157153	1	O
these	25157153	1	O
rare	25157153	1	O
variants	25157153	1	O
showed	25157153	1	O
no	25157153	1	O
association	25157153	1	O
with	25157153	1	O
T2D	25157153	1	O
(	25157153	1	O
OR	25157153	1	O
=	25157153	1	O
1.35	25157153	1	O
;	25157153	1	O
P	25157153	1	O
=	25157153	1	O
0.17	25157153	1	O
)	25157153	1	O
.	25157153	1	O
The	25157153	1	O
function	25157153	1	O
of	25157153	1	O
the	25157153	1	O
49	25157153	1	O
variants	25157153	1	O
was	25157153	1	O
experimentally	25157153	1	O
tested	25157153	1	O
in	25157153	1	O
a	25157153	1	O
novel	25157153	1	O
high	25157153	1	O
-	25157153	1	O
throughput	25157153	1	O
human	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
assay	25157153	1	O
,	25157153	1	O
and	25157153	1	O
nine	25157153	1	O
were	25157153	1	O
found	25157153	1	O
to	25157153	1	O
have	25157153	1	O
reduced	25157153	1	O
activity	25157153	1	O
in	25157153	1	O
the	25157153	1	O
assay	25157153	1	O
.	25157153	1	O
Carrying	25157153	1	O
any	25157153	1	O
of	25157153	1	O
these	25157153	1	O
nine	25157153	1	O
LOF	25157153	1	O
variants	25157153	1	O
was	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
a	25157153	1	O
substantial	25157153	1	O
increase	25157153	1	O
in	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
T2D	25157153	1	O
(	25157153	1	O
OR	25157153	1	O
=	25157153	1	O
7.22	25157153	1	O
;	25157153	1	O
P	25157153	1	O
=	25157153	1	O
0.005	25157153	1	O
)	25157153	1	O
.	25157153	1	O
The	25157153	1	O
combination	25157153	1	O
of	25157153	1	O
large	25157153	1	O
-	25157153	1	O
scale	25157153	1	O
DNA	25157153	1	O
sequencing	25157153	1	O
and	25157153	1	O
functional	25157153	1	O
testing	25157153	1	O
in	25157153	1	O
the	25157153	1	O
laboratory	25157153	1	O
reveals	25157153	1	O
that	25157153	1	O
approximately	25157153	1	O
1	25157153	1	O
in	25157153	1	O
1	25157153	1	O
,	25157153	1	O
000	25157153	1	O
individuals	25157153	1	O
carries	25157153	1	O
a	25157153	1	O
variant	25157153	1	B-Var
in	25157153	1	O
PPARG	25157153	1	B-Gene
that	25157153	1	O
reduces	25157153	1	B-NegReg
function	25157153	1	B-CPA
in	25157153	1	I-CPA
a	25157153	1	I-CPA
human	25157153	1	I-CPA
adipocyte	25157153	1	I-CPA
differentiation	25157153	1	I-CPA
assay	25157153	1	I-CPA
and	25157153	1	O
is	25157153	1	O
associated	25157153	1	B-Reg
with	25157153	1	O
a	25157153	1	O
substantial	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
T2D	25157153	1	B-Disease
.	25157153	1	O

Loss	25805808	1	O
-	25805808	1	O
of	25805808	1	O
-	25805808	1	O
function	25805808	1	O
de	25805808	1	O
novo	25805808	1	O
mutations	25805808	1	O
play	25805808	1	O
an	25805808	1	O
important	25805808	1	O
role	25805808	1	O
in	25805808	1	O
severe	25805808	1	O
human	25805808	1	O
neural	25805808	1	O
tube	25805808	1	O
defects	25805808	1	O
.	25805808	1	O
BACKGROUND	25805808	1	O
:	25805808	1	O
Neural	25805808	1	O
tube	25805808	1	O
defects	25805808	1	O
(	25805808	1	O
NTDs	25805808	1	O
)	25805808	1	O
are	25805808	1	O
very	25805808	1	O
common	25805808	1	O
and	25805808	1	O
severe	25805808	1	O
birth	25805808	1	O
defects	25805808	1	O
that	25805808	1	O
are	25805808	1	O
caused	25805808	1	O
by	25805808	1	O
failure	25805808	1	O
of	25805808	1	O
neural	25805808	1	O
tube	25805808	1	O
closure	25805808	1	O
and	25805808	1	O
that	25805808	1	O
have	25805808	1	O
a	25805808	1	O
complex	25805808	1	O
aetiology	25805808	1	O
.	25805808	1	O
Anencephaly	25805808	1	O
and	25805808	1	O
spina	25805808	1	O
bifida	25805808	1	O
are	25805808	1	O
severe	25805808	1	O
NTDs	25805808	1	O
that	25805808	1	O
affect	25805808	1	O
reproductive	25805808	1	O
fitness	25805808	1	O
and	25805808	1	O
suggest	25805808	1	O
a	25805808	1	O
role	25805808	1	O
for	25805808	1	O
de	25805808	1	O
novo	25805808	1	O
mutations	25805808	1	O
(	25805808	1	O
DNMs	25805808	1	O
)	25805808	1	O
in	25805808	1	O
their	25805808	1	O
aetiology	25805808	1	O
.	25805808	1	O
METHODS	25805808	1	O
:	25805808	1	O
We	25805808	1	O
used	25805808	1	O
whole	25805808	1	O
-	25805808	1	O
exome	25805808	1	O
sequencing	25805808	1	O
in	25805808	1	O
43	25805808	1	O
sporadic	25805808	1	O
cases	25805808	1	O
affected	25805808	1	O
with	25805808	1	O
myelomeningocele	25805808	1	O
or	25805808	1	O
anencephaly	25805808	1	O
and	25805808	1	O
their	25805808	1	O
unaffected	25805808	1	O
parents	25805808	1	O
to	25805808	1	O
identify	25805808	1	O
DNMs	25805808	1	O
in	25805808	1	O
their	25805808	1	O
exomes	25805808	1	O
.	25805808	1	O
RESULTS	25805808	1	O
:	25805808	1	O
We	25805808	1	O
identified	25805808	1	O
42	25805808	1	O
coding	25805808	1	O
DNMs	25805808	1	O
in	25805808	1	O
25	25805808	1	O
cases	25805808	1	O
,	25805808	1	O
of	25805808	1	O
which	25805808	1	O
6	25805808	1	O
were	25805808	1	O
loss	25805808	1	O
of	25805808	1	O
function	25805808	1	O
(	25805808	1	O
LoF	25805808	1	O
)	25805808	1	O
showing	25805808	1	O
a	25805808	1	O
higher	25805808	1	O
rate	25805808	1	O
of	25805808	1	O
LoF	25805808	1	O
DNM	25805808	1	O
in	25805808	1	O
our	25805808	1	O
cohort	25805808	1	O
compared	25805808	1	O
with	25805808	1	O
control	25805808	1	O
cohorts	25805808	1	O
.	25805808	1	O
Notably	25805808	1	O
,	25805808	1	O
we	25805808	1	O
identified	25805808	1	O
two	25805808	1	O
protein	25805808	1	B-NegReg
-	25805808	1	I-NegReg
truncating	25805808	1	I-NegReg
DNMs	25805808	1	B-Var
in	25805808	1	O
two	25805808	1	O
independent	25805808	1	O
cases	25805808	1	O
in	25805808	1	O
SHROOM3	25805808	1	B-Gene
,	25805808	1	O
previously	25805808	1	O
associated	25805808	1	O
with	25805808	1	O
NTDs	25805808	1	O
only	25805808	1	O
in	25805808	1	O
animal	25805808	1	O
models	25805808	1	O
.	25805808	1	O
We	25805808	1	O
have	25805808	1	O
demonstrated	25805808	1	O
a	25805808	1	O
significant	25805808	1	O
enrichment	25805808	1	O
of	25805808	1	O
LoF	25805808	1	B-NegReg
DNMs	25805808	1	B-Var
in	25805808	1	O
this	25805808	1	O
gene	25805808	1	O
in	25805808	1	O
NTDs	25805808	1	B-Disease
compared	25805808	1	O
with	25805808	1	O
the	25805808	1	O
gene	25805808	1	O
specific	25805808	1	O
DNM	25805808	1	O
rate	25805808	1	O
and	25805808	1	O
to	25805808	1	O
the	25805808	1	O
DNM	25805808	1	O
rate	25805808	1	O
estimated	25805808	1	O
from	25805808	1	O
control	25805808	1	O
cohorts	25805808	1	O
.	25805808	1	O
We	25805808	1	O
also	25805808	1	O
identified	25805808	1	O
one	25805808	1	O
nonsense	25805808	1	O
DNM	25805808	1	O
in	25805808	1	O
PAX3	25805808	1	O
and	25805808	1	O
two	25805808	1	O
potentially	25805808	1	O
causative	25805808	1	O
missense	25805808	1	O
DNMs	25805808	1	O
in	25805808	1	O
GRHL3	25805808	1	O
and	25805808	1	O
PTPRS	25805808	1	O
.	25805808	1	O
CONCLUSIONS	25805808	1	O
:	25805808	1	O
Our	25805808	1	O
study	25805808	1	O
demonstrates	25805808	1	O
an	25805808	1	O
important	25805808	1	O
role	25805808	1	O
of	25805808	1	O
LoF	25805808	1	B-NegReg
DNMs	25805808	1	B-Var
in	25805808	1	O
the	25805808	1	O
development	25805808	1	O
of	25805808	1	O
NTDs	25805808	1	B-Disease
and	25805808	1	O
strongly	25805808	1	O
implicates	25805808	1	O
SHROOM3	25805808	1	B-Gene
in	25805808	1	O
its	25805808	1	O
aetiology	25805808	1	O
.	25805808	1	O

Analysis	25915599	0	O
of	25915599	0	O
loss	25915599	0	O
-	25915599	0	O
of	25915599	0	O
-	25915599	0	O
function	25915599	0	O
variants	25915599	0	O
and	25915599	0	O
20	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
phenotypes	25915599	0	O
in	25915599	0	O
8	25915599	0	O
,	25915599	0	O
554	25915599	0	O
individuals	25915599	0	O
identifies	25915599	0	O
loci	25915599	0	O
influencing	25915599	0	O
chronic	25915599	0	O
disease	25915599	0	O
.	25915599	0	O
A	25915599	0	O
typical	25915599	0	O
human	25915599	0	O
exome	25915599	0	O
harbors	25915599	0	O
dozens	25915599	0	O
of	25915599	0	O
loss	25915599	0	O
-	25915599	0	O
of	25915599	0	O
-	25915599	0	O
function	25915599	0	O
(	25915599	0	O
LOF	25915599	0	O
)	25915599	0	O
variants	25915599	0	O
,	25915599	0	O
which	25915599	0	O
can	25915599	0	O
lower	25915599	0	O
disease	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
levels	25915599	0	O
and	25915599	0	O
affect	25915599	0	O
drug	25915599	0	O
efficacy	25915599	0	O
.	25915599	0	O
We	25915599	0	O
hypothesized	25915599	0	O
that	25915599	0	O
LOF	25915599	0	O
variants	25915599	0	O
are	25915599	0	O
enriched	25915599	0	O
in	25915599	0	O
genes	25915599	0	O
influencing	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
levels	25915599	0	O
and	25915599	0	O
the	25915599	0	O
onset	25915599	0	O
of	25915599	0	O
common	25915599	0	O
chronic	25915599	0	O
diseases	25915599	0	O
,	25915599	0	O
such	25915599	0	O
as	25915599	0	O
cardiovascular	25915599	0	O
disease	25915599	0	O
and	25915599	0	O
diabetes	25915599	0	O
.	25915599	0	O
To	25915599	0	O
test	25915599	0	O
this	25915599	0	O
hypothesis	25915599	0	O
,	25915599	0	O
we	25915599	0	O
sequenced	25915599	0	O
the	25915599	0	O
exomes	25915599	0	O
of	25915599	0	O
8	25915599	0	O
,	25915599	0	O
554	25915599	0	O
individuals	25915599	0	O
and	25915599	0	O
analyzed	25915599	0	O
the	25915599	0	O
effects	25915599	0	O
of	25915599	0	O
predicted	25915599	0	O
LOF	25915599	0	O
variants	25915599	0	O
on	25915599	0	O
20	25915599	0	O
chronic	25915599	0	O
disease	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
phenotypes	25915599	0	O
.	25915599	0	O
Analysis	25915599	0	O
of	25915599	0	O
this	25915599	0	O
sample	25915599	0	O
as	25915599	0	O
discovery	25915599	0	O
and	25915599	0	O
replication	25915599	0	O
strata	25915599	0	O
of	25915599	0	O
equal	25915599	0	O
size	25915599	0	O
verified	25915599	0	O
two	25915599	0	O
relationships	25915599	0	O
in	25915599	0	O
well	25915599	0	O
-	25915599	0	O
studied	25915599	0	O
genes	25915599	0	O
(	25915599	0	O
PCSK9	25915599	0	O
and	25915599	0	O
APOC3	25915599	0	O
)	25915599	0	O
and	25915599	0	O
identified	25915599	0	O
eight	25915599	0	O
new	25915599	0	O
loci	25915599	0	O
.	25915599	0	O
Previously	25915599	0	O
unknown	25915599	0	O
relationships	25915599	0	O
included	25915599	0	O
elevated	25915599	0	B-PosReg
fasting	25915599	0	O
glucose	25915599	0	B-MPA
in	25915599	0	O
carriers	25915599	0	O
of	25915599	0	O
heterozygous	25915599	0	O
LOF	25915599	0	B-NegReg
variation	25915599	0	B-Var
in	25915599	0	O
TXNDC5	25915599	0	B-Gene
,	25915599	0	O
which	25915599	0	O
encodes	25915599	0	O
a	25915599	0	O
biomarker	25915599	0	O
for	25915599	0	O
type	25915599	0	O
1	25915599	0	O
diabetes	25915599	0	O
progression	25915599	0	O
,	25915599	0	O
and	25915599	0	O
apparent	25915599	0	O
recessive	25915599	0	B-NegReg
effects	25915599	0	I-NegReg
of	25915599	0	O
C1QTNF8	25915599	0	B-Gene
on	25915599	0	O
serum	25915599	0	B-MPA
magnesium	25915599	0	I-MPA
levels	25915599	0	I-MPA
.	25915599	0	O
These	25915599	0	O
data	25915599	0	O
demonstrate	25915599	0	O
the	25915599	0	O
utility	25915599	0	O
of	25915599	0	O
functional	25915599	0	O
-	25915599	0	O
variant	25915599	0	O
annotation	25915599	0	O
within	25915599	0	O
a	25915599	0	O
large	25915599	0	O
sample	25915599	0	O
of	25915599	0	O
deeply	25915599	0	O
phenotyped	25915599	0	O
individuals	25915599	0	O
for	25915599	0	O
gene	25915599	0	O
discovery	25915599	0	O
.	25915599	0	O

Mutant	25954247	0	O
p53	25954247	0	O
-	25954247	0	O
Heat	25954247	0	O
Shock	25954247	0	O
Response	25954247	0	O
Oncogenic	25954247	0	O
Cooperation	25954247	0	O
:	25954247	0	O
A	25954247	0	O
New	25954247	0	O
Mechanism	25954247	0	O
of	25954247	0	O
Cancer	25954247	0	O
Cell	25954247	0	O
Survival	25954247	0	O
.	25954247	0	O
The	25954247	0	O
main	25954247	0	O
tumor	25954247	0	O
suppressor	25954247	0	O
function	25954247	0	O
of	25954247	0	O
p53	25954247	0	O
as	25954247	0	O
a	25954247	0	O
"	25954247	0	O
guardian	25954247	0	O
of	25954247	0	O
the	25954247	0	O
genome	25954247	0	O
"	25954247	0	O
is	25954247	0	O
to	25954247	0	O
respond	25954247	0	O
to	25954247	0	O
cellular	25954247	0	O
stress	25954247	0	O
by	25954247	0	O
transcriptional	25954247	0	O
activation	25954247	0	O
of	25954247	0	O
apoptosis	25954247	0	O
,	25954247	0	O
growth	25954247	0	O
arrest	25954247	0	O
,	25954247	0	O
or	25954247	0	O
senescence	25954247	0	O
in	25954247	0	O
damaged	25954247	0	O
cells	25954247	0	O
.	25954247	0	O
Not	25954247	0	O
surprisingly	25954247	0	O
,	25954247	0	O
mutations	25954247	0	O
in	25954247	0	O
the	25954247	0	O
p53	25954247	0	O
gene	25954247	0	O
are	25954247	0	O
the	25954247	0	O
most	25954247	0	O
frequent	25954247	0	O
genetic	25954247	0	O
alteration	25954247	0	O
in	25954247	0	O
human	25954247	0	O
cancers	25954247	0	O
.	25954247	0	O
Importantly	25954247	0	O
,	25954247	0	O
mutant	25954247	0	B-Var
p53	25954247	0	B-Gene
(	25954247	0	O
mutp53	25954247	0	O
)	25954247	0	O
proteins	25954247	0	B-Protein
not	25954247	0	O
only	25954247	0	O
lose	25954247	0	B-NegReg
their	25954247	0	O
wild	25954247	0	O
-	25954247	0	O
type	25954247	0	O
tumor	25954247	0	B-CPA
suppressor	25954247	0	I-CPA
activity	25954247	0	I-CPA
but	25954247	0	O
also	25954247	0	O
can	25954247	0	O
actively	25954247	0	B-PosReg
promote	25954247	0	I-PosReg
tumor	25954247	0	B-CPA
development	25954247	0	I-CPA
.	25954247	0	O
Two	25954247	0	O
main	25954247	0	O
mechanisms	25954247	0	O
accounting	25954247	0	O
for	25954247	0	O
mutp53	25954247	0	B-Var
proto	25954247	0	O
-	25954247	0	O
oncogenic	25954247	0	O
activity	25954247	0	O
are	25954247	0	O
inhibition	25954247	0	O
of	25954247	0	O
the	25954247	0	O
wild	25954247	0	O
-	25954247	0	O
type	25954247	0	O
p53	25954247	0	O
in	25954247	0	O
a	25954247	0	O
dominant	25954247	0	O
-	25954247	0	O
negative	25954247	0	O
fashion	25954247	0	O
and	25954247	0	O
gain	25954247	0	B-PosReg
of	25954247	0	O
additional	25954247	0	B-CPA
oncogenic	25954247	0	I-CPA
activities	25954247	0	I-CPA
known	25954247	0	O
as	25954247	0	O
gain	25954247	0	O
-	25954247	0	O
of	25954247	0	O
-	25954247	0	O
function	25954247	0	O
(	25954247	0	O
GOF	25954247	0	O
)	25954247	0	O
.	25954247	0	O
Here	25954247	0	O
,	25954247	0	O
we	25954247	0	O
discuss	25954247	0	O
a	25954247	0	O
novel	25954247	0	O
mechanism	25954247	0	O
of	25954247	0	O
mutp53	25954247	0	B-Var
GOF	25954247	0	O
,	25954247	0	O
which	25954247	0	O
relies	25954247	0	O
on	25954247	0	O
its	25954247	0	O
oncogenic	25954247	0	O
cooperation	25954247	0	O
with	25954247	0	O
the	25954247	0	O
heat	25954247	0	O
shock	25954247	0	O
machinery	25954247	0	O
.	25954247	0	O
This	25954247	0	O
coordinated	25954247	0	O
adaptive	25954247	0	O
mechanism	25954247	0	O
renders	25954247	0	O
cancer	25954247	0	O
cells	25954247	0	O
more	25954247	0	B-PosReg
resistant	25954247	0	B-CPA
to	25954247	0	I-CPA
proteotoxic	25954247	0	I-CPA
stress	25954247	0	I-CPA
and	25954247	0	O
provides	25954247	0	O
both	25954247	0	O
,	25954247	0	O
a	25954247	0	O
strong	25954247	0	O
survival	25954247	0	B-CPA
advantage	25954247	0	I-CPA
to	25954247	0	O
cancer	25954247	0	O
cells	25954247	0	O
and	25954247	0	O
a	25954247	0	O
promising	25954247	0	O
means	25954247	0	O
for	25954247	0	O
therapeutic	25954247	0	O
intervention	25954247	0	O
.	25954247	0	O

Identification	26197705	0	O
and	26197705	0	O
functional	26197705	0	O
characterization	26197705	0	O
of	26197705	0	O
natural	26197705	0	O
human	26197705	0	O
melanocortin	26197705	0	O
1	26197705	0	O
receptor	26197705	0	O
mutant	26197705	0	O
alleles	26197705	0	O
in	26197705	0	O
Pakistani	26197705	0	O
population	26197705	0	O
.	26197705	0	O
Melanocortin	26197705	0	O
1	26197705	0	O
receptor	26197705	0	O
(	26197705	0	O
MC1R	26197705	0	O
)	26197705	0	O
,	26197705	0	O
a	26197705	0	O
Gs	26197705	0	O
protein	26197705	0	O
-	26197705	0	O
coupled	26197705	0	O
receptor	26197705	0	O
of	26197705	0	O
the	26197705	0	O
melanocyte	26197705	0	O
'	26197705	0	O
s	26197705	0	O
plasma	26197705	0	O
membrane	26197705	0	O
,	26197705	0	O
is	26197705	0	O
a	26197705	0	O
major	26197705	0	O
determinant	26197705	0	O
of	26197705	0	O
skin	26197705	0	O
pigmentation	26197705	0	O
and	26197705	0	O
phototype	26197705	0	O
.	26197705	0	O
Upon	26197705	0	O
activation	26197705	0	O
by	26197705	0	O
α	26197705	0	O
-	26197705	0	O
melanocyte	26197705	0	O
stimulating	26197705	0	O
hormone	26197705	0	O
,	26197705	0	O
MC1R	26197705	0	O
triggers	26197705	0	O
the	26197705	0	O
cAMP	26197705	0	O
cascade	26197705	0	O
to	26197705	0	O
stimulate	26197705	0	O
eumelanogenesis	26197705	0	O
.	26197705	0	O
We	26197705	0	O
used	26197705	0	O
whole	26197705	0	O
-	26197705	0	O
exome	26197705	0	O
sequencing	26197705	0	O
to	26197705	0	O
identify	26197705	0	O
causative	26197705	0	O
alleles	26197705	0	O
in	26197705	0	O
Pakistani	26197705	0	O
families	26197705	0	O
with	26197705	0	O
skin	26197705	0	O
and	26197705	0	O
hair	26197705	0	O
hypopigmentation	26197705	0	O
.	26197705	0	O
Six	26197705	0	O
MC1R	26197705	0	O
mutations	26197705	0	O
segregated	26197705	0	O
with	26197705	0	O
the	26197705	0	O
phenotype	26197705	0	O
in	26197705	0	O
seven	26197705	0	O
families	26197705	0	O
,	26197705	0	O
including	26197705	0	O
a	26197705	0	O
p.Val174del	26197705	0	O
in	26197705	0	O
-	26197705	0	O
frame	26197705	0	O
deletion	26197705	0	O
and	26197705	0	O
a	26197705	0	O
p.Tyr298	26197705	0	O
nonsense	26197705	0	O
mutation	26197705	0	O
,	26197705	0	O
that	26197705	0	O
were	26197705	0	O
analyzed	26197705	0	O
for	26197705	0	O
function	26197705	0	O
in	26197705	0	O
heterologous	26197705	0	O
HEK293	26197705	0	O
cells	26197705	0	O
.	26197705	0	O
p.Tyr298	26197705	0	B-Var
MC1R	26197705	0	B-Gene
showed	26197705	0	O
no	26197705	0	B-NegReg
agonist	26197705	0	B-MPA
-	26197705	0	I-MPA
induced	26197705	0	I-MPA
signaling	26197705	0	I-MPA
to	26197705	0	O
the	26197705	0	O
cAMP	26197705	0	B-Pathway
or	26197705	0	O
ERK	26197705	0	B-Pathway
pathways	26197705	0	I-Pathway
,	26197705	0	O
nor	26197705	0	B-NegReg
detectable	26197705	0	O
agonist	26197705	0	B-Interaction
binding	26197705	0	I-Interaction
.	26197705	0	O
Conversely	26197705	0	O
,	26197705	0	O
signaling	26197705	0	O
was	26197705	0	O
comparable	26197705	0	O
for	26197705	0	O
p.Val174del	26197705	0	B-Var
and	26197705	0	O
wild	26197705	0	O
-	26197705	0	O
type	26197705	0	O
in	26197705	0	O
HEK	26197705	0	O
cells	26197705	0	O
overexpressing	26197705	0	O
the	26197705	0	O
proteins	26197705	0	O
,	26197705	0	O
but	26197705	0	O
binding	26197705	0	O
analysis	26197705	0	O
suggested	26197705	0	O
impaired	26197705	0	B-NegReg
cell	26197705	0	B-MPA
surface	26197705	0	I-MPA
expression	26197705	0	I-MPA
.	26197705	0	O
Flow	26197705	0	O
cytometry	26197705	0	O
and	26197705	0	O
confocal	26197705	0	O
imaging	26197705	0	O
studies	26197705	0	O
revealed	26197705	0	O
reduced	26197705	0	B-NegReg
plasma	26197705	0	B-MPA
membrane	26197705	0	I-MPA
expression	26197705	0	I-MPA
of	26197705	0	O
p.Val174del	26197705	0	B-Var
and	26197705	0	O
p.Tyr298	26197705	0	B-Var
.	26197705	0	O
Therefore	26197705	0	O
,	26197705	0	O
p.Tyr298	26197705	0	B-Var
was	26197705	0	O
a	26197705	0	O
total	26197705	0	O
loss	26197705	0	B-NegReg
-	26197705	0	I-NegReg
of	26197705	0	I-NegReg
-	26197705	0	I-NegReg
function	26197705	0	I-NegReg
(	26197705	0	O
LOF	26197705	0	O
)	26197705	0	O
allele	26197705	0	O
,	26197705	0	O
while	26197705	0	O
p.Val174del	26197705	0	B-Var
displayed	26197705	0	O
a	26197705	0	O
partial	26197705	0	B-NegReg
LOF	26197705	0	I-NegReg
attribute	26197705	0	O
.	26197705	0	O

Gain	26331536	0	O
-	26331536	0	O
of	26331536	0	O
-	26331536	0	O
function	26331536	0	O
p53	26331536	0	O
mutants	26331536	0	O
co	26331536	0	O
-	26331536	0	O
opt	26331536	0	O
chromatin	26331536	0	O
pathways	26331536	0	O
to	26331536	0	O
drive	26331536	0	O
cancer	26331536	0	O
growth	26331536	0	O
.	26331536	0	O
TP53	26331536	0	O
(	26331536	0	O
which	26331536	0	O
encodes	26331536	0	O
p53	26331536	0	O
protein	26331536	0	O
)	26331536	0	O
is	26331536	0	O
the	26331536	0	O
most	26331536	0	O
frequently	26331536	0	O
mutated	26331536	0	O
gene	26331536	0	O
among	26331536	0	O
all	26331536	0	O
human	26331536	0	O
cancers	26331536	0	O
.	26331536	0	O
Prevalent	26331536	0	O
p53	26331536	0	B-Gene
missense	26331536	0	B-Var
mutations	26331536	0	I-Var
abrogate	26331536	0	B-NegReg
its	26331536	0	O
tumour	26331536	0	B-CPA
suppressive	26331536	0	I-CPA
function	26331536	0	I-CPA
and	26331536	0	O
lead	26331536	0	O
to	26331536	0	O
a	26331536	0	O
'	26331536	0	B-PosReg
gain	26331536	0	I-PosReg
-	26331536	0	I-PosReg
of	26331536	0	I-PosReg
-	26331536	0	I-PosReg
function	26331536	0	I-PosReg
'	26331536	0	I-PosReg
(	26331536	0	O
GOF	26331536	0	O
)	26331536	0	O
that	26331536	0	O
promotes	26331536	0	B-PosReg
cancer	26331536	0	B-Disease
.	26331536	0	O
Here	26331536	0	O
we	26331536	0	O
show	26331536	0	O
that	26331536	0	O
p53	26331536	0	B-Gene
GOF	26331536	0	B-PosReg
mutants	26331536	0	B-Var
bind	26331536	0	O
to	26331536	0	O
and	26331536	0	O
upregulate	26331536	0	B-PosReg
chromatin	26331536	0	B-Gene
regulatory	26331536	0	I-Gene
genes	26331536	0	I-Gene
,	26331536	0	O
including	26331536	0	O
the	26331536	0	O
methyltransferases	26331536	0	B-Enzyme
MLL1	26331536	0	I-Enzyme
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KMT2A	26331536	0	O
)	26331536	0	O
,	26331536	0	O
MLL2	26331536	0	B-Enzyme
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KMT2D	26331536	0	O
)	26331536	0	O
,	26331536	0	O
and	26331536	0	O
acetyltransferase	26331536	0	B-Enzyme
MOZ	26331536	0	I-Enzyme
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KAT6A	26331536	0	O
or	26331536	0	O
MYST3	26331536	0	O
)	26331536	0	O
,	26331536	0	O
resulting	26331536	0	O
in	26331536	0	O
genome	26331536	0	O
-	26331536	0	O
wide	26331536	0	O
increases	26331536	0	B-PosReg
of	26331536	0	O
histone	26331536	0	B-MPA
methylation	26331536	0	I-MPA
and	26331536	0	O
acetylation	26331536	0	B-MPA
.	26331536	0	O
Analysis	26331536	0	O
of	26331536	0	O
The	26331536	0	O
Cancer	26331536	0	O
Genome	26331536	0	O
Atlas	26331536	0	O
shows	26331536	0	O
specific	26331536	0	O
upregulation	26331536	0	B-PosReg
of	26331536	0	O
MLL1	26331536	0	B-Enzyme
,	26331536	0	O
MLL2	26331536	0	B-Enzyme
,	26331536	0	O
and	26331536	0	O
MOZ	26331536	0	B-Enzyme
in	26331536	0	O
p53	26331536	0	B-Gene
GOF	26331536	0	B-Var
patient	26331536	0	O
-	26331536	0	O
derived	26331536	0	O
tumours	26331536	0	O
,	26331536	0	O
but	26331536	0	O
not	26331536	0	O
in	26331536	0	O
wild	26331536	0	O
-	26331536	0	O
type	26331536	0	O
p53	26331536	0	O
or	26331536	0	O
p53	26331536	0	O
null	26331536	0	O
tumours	26331536	0	O
.	26331536	0	O
Cancer	26331536	0	O
cell	26331536	0	O
proliferation	26331536	0	O
is	26331536	0	O
markedly	26331536	0	O
lowered	26331536	0	O
by	26331536	0	O
genetic	26331536	0	O
knockdown	26331536	0	O
of	26331536	0	O
MLL1	26331536	0	O
or	26331536	0	O
by	26331536	0	O
pharmacological	26331536	0	O
inhibition	26331536	0	O
of	26331536	0	O
the	26331536	0	O
MLL1	26331536	0	O
methyltransferase	26331536	0	O
complex	26331536	0	O
.	26331536	0	O
Our	26331536	0	O
study	26331536	0	O
reveals	26331536	0	O
a	26331536	0	O
novel	26331536	0	O
chromatin	26331536	0	O
mechanism	26331536	0	O
underlying	26331536	0	O
the	26331536	0	O
progression	26331536	0	O
of	26331536	0	O
tumours	26331536	0	O
with	26331536	0	O
GOF	26331536	0	O
p53	26331536	0	O
,	26331536	0	O
and	26331536	0	O
suggests	26331536	0	O
new	26331536	0	O
possibilities	26331536	0	O
for	26331536	0	O
designing	26331536	0	O
combinatorial	26331536	0	O
chromatin	26331536	0	O
-	26331536	0	O
based	26331536	0	O
therapies	26331536	0	O
for	26331536	0	O
treating	26331536	0	O
individual	26331536	0	O
cancers	26331536	0	O
driven	26331536	0	O
by	26331536	0	O
prevalent	26331536	0	O
GOF	26331536	0	O
p53	26331536	0	O
mutations	26331536	0	O
.	26331536	0	O

DNA	26494468	0	O
damage	26494468	0	O
-	26494468	0	O
induced	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
promotes	26494468	0	O
chemoresistance	26494468	0	O
and	26494468	0	O
drives	26494468	0	O
EMT	26494468	0	O
in	26494468	0	O
colorectal	26494468	0	O
carcinoma	26494468	0	O
harboring	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
.	26494468	0	O
Mutation	26494468	0	O
in	26494468	0	O
the	26494468	0	O
TP53	26494468	0	O
gene	26494468	0	O
positively	26494468	0	O
correlates	26494468	0	O
with	26494468	0	O
increased	26494468	0	O
incidence	26494468	0	O
of	26494468	0	O
chemoresistance	26494468	0	O
in	26494468	0	O
different	26494468	0	O
cancers	26494468	0	O
.	26494468	0	O
In	26494468	0	O
this	26494468	0	O
study	26494468	0	O
,	26494468	0	O
we	26494468	0	O
investigated	26494468	0	O
the	26494468	0	O
mechanism	26494468	0	O
of	26494468	0	O
chemoresistance	26494468	0	O
and	26494468	0	O
epithelial	26494468	0	O
-	26494468	0	O
to	26494468	0	O
-	26494468	0	O
mesenchymal	26494468	0	O
transition	26494468	0	O
(	26494468	0	O
EMT	26494468	0	O
)	26494468	0	O
in	26494468	0	O
colorectal	26494468	0	O
cancer	26494468	0	O
involving	26494468	0	O
the	26494468	0	O
gain	26494468	0	O
-	26494468	0	O
of	26494468	0	O
-	26494468	0	O
function	26494468	0	O
(	26494468	0	O
GOF	26494468	0	O
)	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
/	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
signaling	26494468	0	O
axis	26494468	0	O
.	26494468	0	O
Bioinformatic	26494468	0	O
analysis	26494468	0	O
of	26494468	0	O
the	26494468	0	O
NCI-60	26494468	0	O
data	26494468	0	O
set	26494468	0	O
and	26494468	0	O
subsequent	26494468	0	O
hub	26494468	0	O
prediction	26494468	0	O
identified	26494468	0	O
EFNB2	26494468	0	O
as	26494468	0	O
a	26494468	0	O
possible	26494468	0	O
GOF	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
target	26494468	0	O
gene	26494468	0	O
,	26494468	0	O
responsible	26494468	0	O
for	26494468	0	O
chemoresistance	26494468	0	O
.	26494468	0	O
We	26494468	0	O
show	26494468	0	O
that	26494468	0	O
the	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
-	26494468	0	I-Gene
NF	26494468	0	I-Gene
-	26494468	0	I-Gene
Y	26494468	0	I-Gene
complex	26494468	0	O
transcriptionally	26494468	0	O
upregulates	26494468	0	B-PosReg
EFNB2	26494468	0	B-Gene
expression	26494468	0	B-MPA
in	26494468	0	O
response	26494468	0	B-MPA
to	26494468	0	I-MPA
DNA	26494468	0	I-MPA
damage	26494468	0	I-MPA
.	26494468	0	O
Moreover	26494468	0	O
,	26494468	0	O
the	26494468	0	O
acetylated	26494468	0	O
form	26494468	0	O
of	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
protein	26494468	0	B-Protein
is	26494468	0	O
recruited	26494468	0	B-PosReg
on	26494468	0	O
the	26494468	0	O
EFNB2	26494468	0	O
promoter	26494468	0	O
and	26494468	0	O
positively	26494468	0	O
regulates	26494468	0	B-Reg
its	26494468	0	O
expression	26494468	0	B-MPA
in	26494468	0	O
conjunction	26494468	0	O
with	26494468	0	O
coactivator	26494468	0	O
p300	26494468	0	O
.	26494468	0	O
In	26494468	0	O
vitro	26494468	0	O
cell	26494468	0	O
line	26494468	0	O
and	26494468	0	O
in	26494468	0	O
vivo	26494468	0	O
nude	26494468	0	O
mice	26494468	0	O
data	26494468	0	O
show	26494468	0	O
that	26494468	0	O
EFNB2	26494468	0	O
silencing	26494468	0	O
restores	26494468	0	O
chemosensitivity	26494468	0	O
in	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
-	26494468	0	O
harboring	26494468	0	O
tumors	26494468	0	O
.	26494468	0	O
In	26494468	0	O
addition	26494468	0	O
,	26494468	0	O
we	26494468	0	O
observed	26494468	0	O
high	26494468	0	O
expression	26494468	0	O
of	26494468	0	O
EFNB2	26494468	0	O
in	26494468	0	O
patients	26494468	0	O
having	26494468	0	O
neoadjuvant	26494468	0	O
non	26494468	0	O
-	26494468	0	O
responder	26494468	0	O
colorectal	26494468	0	O
carcinoma	26494468	0	O
compared	26494468	0	O
with	26494468	0	O
those	26494468	0	O
having	26494468	0	O
responder	26494468	0	O
version	26494468	0	O
of	26494468	0	O
the	26494468	0	O
disease	26494468	0	O
.	26494468	0	O
In	26494468	0	O
the	26494468	0	O
course	26494468	0	O
of	26494468	0	O
deciphering	26494468	0	O
the	26494468	0	O
drug	26494468	0	O
resistance	26494468	0	O
mechanism	26494468	0	O
,	26494468	0	O
we	26494468	0	O
also	26494468	0	O
show	26494468	0	O
that	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
induces	26494468	0	B-PosReg
ABCG2	26494468	0	B-Gene
expression	26494468	0	B-MPA
after	26494468	0	O
drug	26494468	0	O
treatment	26494468	0	O
that	26494468	0	O
involves	26494468	0	O
JNK	26494468	0	B-MPA
-	26494468	0	I-MPA
c	26494468	0	I-MPA
-	26494468	0	I-MPA
Jun	26494468	0	I-MPA
signaling	26494468	0	I-MPA
in	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
cells	26494468	0	O
.	26494468	0	O
Moreover	26494468	0	O
,	26494468	0	O
5	26494468	0	O
-	26494468	0	O
fluorouracil	26494468	0	O
-	26494468	0	O
induced	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
promotes	26494468	0	O
tumorigenesis	26494468	0	O
through	26494468	0	O
the	26494468	0	O
Src	26494468	0	O
-	26494468	0	O
ERK	26494468	0	O
pathway	26494468	0	O
,	26494468	0	O
and	26494468	0	O
drives	26494468	0	O
EMT	26494468	0	O
via	26494468	0	O
the	26494468	0	O
Src	26494468	0	O
-	26494468	0	O
FAK	26494468	0	O
pathway	26494468	0	O
.	26494468	0	O
We	26494468	0	O
thus	26494468	0	O
conclude	26494468	0	O
that	26494468	0	O
targeting	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
might	26494468	0	O
enhance	26494468	0	O
the	26494468	0	O
therapeutic	26494468	0	O
potential	26494468	0	O
of	26494468	0	O
DNA	26494468	0	O
-	26494468	0	O
damaging	26494468	0	O
chemotherapeutic	26494468	0	O
agents	26494468	0	O
in	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
-	26494468	0	O
bearing	26494468	0	O
human	26494468	0	O
tumors	26494468	0	O
.	26494468	0	O
Cell	26494468	0	O
Death	26494468	0	O
and	26494468	0	O
Differentiation	26494468	0	O
advance	26494468	0	O
online	26494468	0	O
publication	26494468	0	O
,	26494468	0	O
23	26494468	0	O
October	26494468	0	O
2015	26494468	0	O
;	26494468	0	O
doi	26494468	0	O
:	26494468	0	O
10.1038	26494468	0	O
/	26494468	0	O
cdd.2015	26494468	0	O
.133	26494468	0	O
.	26494468	0	O

Urine	26586530	3	O
-	26586530	3	O
sample	26586530	3	O
-	26586530	3	O
derived	26586530	3	O
human	26586530	3	O
induced	26586530	3	O
pluripotent	26586530	3	O
stem	26586530	3	O
cells	26586530	3	O
as	26586530	3	O
a	26586530	3	O
model	26586530	3	O
to	26586530	3	O
study	26586530	3	O
PCSK9	26586530	3	O
-	26586530	3	O
mediated	26586530	3	O
autosomal	26586530	3	O
dominant	26586530	3	O
hypercholesterolemia	26586530	3	O
.	26586530	3	O
Proprotein	26586530	3	O
convertase	26586530	3	O
subtilisin	26586530	3	O
kexin	26586530	3	O
type	26586530	3	O
9	26586530	3	O
(	26586530	3	O
PCSK9	26586530	3	O
)	26586530	3	O
is	26586530	3	O
a	26586530	3	O
critical	26586530	3	O
modulator	26586530	3	O
of	26586530	3	O
cholesterol	26586530	3	O
homeostasis	26586530	3	O
.	26586530	3	O
Whereas	26586530	3	O
PCSK9	26586530	3	B-Gene
gain	26586530	3	B-PosReg
-	26586530	3	I-PosReg
of	26586530	3	I-PosReg
-	26586530	3	I-PosReg
function	26586530	3	I-PosReg
(	26586530	3	O
GOF	26586530	3	O
)	26586530	3	O
mutations	26586530	3	B-Var
are	26586530	3	O
associated	26586530	3	O
with	26586530	3	O
autosomal	26586530	3	B-Disease
dominant	26586530	3	I-Disease
hypercholesterolemia	26586530	3	I-Disease
(	26586530	3	O
ADH	26586530	3	O
)	26586530	3	O
and	26586530	3	O
premature	26586530	3	B-Disease
atherosclerosis	26586530	3	I-Disease
,	26586530	3	O
PCSK9	26586530	3	B-Gene
loss	26586530	3	B-NegReg
-	26586530	3	I-NegReg
of	26586530	3	I-NegReg
-	26586530	3	I-NegReg
function	26586530	3	I-NegReg
(	26586530	3	O
LOF	26586530	3	O
)	26586530	3	O
mutations	26586530	3	B-Var
have	26586530	3	B-PosReg
a	26586530	3	O
cardio	26586530	3	B-CPA
-	26586530	3	I-CPA
protective	26586530	3	I-CPA
effect	26586530	3	I-CPA
and	26586530	3	O
in	26586530	3	O
some	26586530	3	O
cases	26586530	3	O
can	26586530	3	O
lead	26586530	3	O
to	26586530	3	O
familial	26586530	3	B-Disease
hypobetalipoproteinemia	26586530	3	I-Disease
(	26586530	3	O
FHBL	26586530	3	O
)	26586530	3	O
.	26586530	3	O
However	26586530	3	O
,	26586530	3	O
limitations	26586530	3	O
of	26586530	3	O
the	26586530	3	O
currently	26586530	3	O
available	26586530	3	O
cellular	26586530	3	O
models	26586530	3	O
preclude	26586530	3	O
deciphering	26586530	3	O
the	26586530	3	O
consequences	26586530	3	O
of	26586530	3	O
PCSK9	26586530	3	O
mutation	26586530	3	O
further	26586530	3	O
.	26586530	3	O
We	26586530	3	O
aimed	26586530	3	O
to	26586530	3	O
validate	26586530	3	O
urine	26586530	3	O
-	26586530	3	O
sample	26586530	3	O
-	26586530	3	O
derived	26586530	3	O
human	26586530	3	O
induced	26586530	3	O
pluripotent	26586530	3	O
stem	26586530	3	O
cells	26586530	3	O
(	26586530	3	O
UhiPSCs	26586530	3	O
)	26586530	3	O
as	26586530	3	O
an	26586530	3	O
appropriate	26586530	3	O
tool	26586530	3	O
to	26586530	3	O
model	26586530	3	O
PCSK9	26586530	3	O
-	26586530	3	O
mediated	26586530	3	O
ADH	26586530	3	O
and	26586530	3	O
FHBL	26586530	3	O
.	26586530	3	O
To	26586530	3	O
achieve	26586530	3	O
our	26586530	3	O
goal	26586530	3	O
,	26586530	3	O
urine	26586530	3	O
-	26586530	3	O
sample	26586530	3	O
-	26586530	3	O
derived	26586530	3	O
somatic	26586530	3	O
cells	26586530	3	O
were	26586530	3	O
reprogrammed	26586530	3	O
into	26586530	3	O
hiPSCs	26586530	3	O
by	26586530	3	O
using	26586530	3	O
episomal	26586530	3	O
vectors	26586530	3	O
.	26586530	3	O
UhiPSC	26586530	3	O
were	26586530	3	O
efficiently	26586530	3	O
differentiated	26586530	3	O
into	26586530	3	O
hepatocyte	26586530	3	O
-	26586530	3	O
like	26586530	3	O
cells	26586530	3	O
(	26586530	3	O
HLCs	26586530	3	O
)	26586530	3	O
.	26586530	3	O
Compared	26586530	3	O
to	26586530	3	O
control	26586530	3	O
cells	26586530	3	O
,	26586530	3	O
cells	26586530	3	O
originally	26586530	3	O
derived	26586530	3	O
from	26586530	3	O
an	26586530	3	O
individual	26586530	3	O
with	26586530	3	O
ADH	26586530	3	O
(	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
S127R	26586530	3	O
)	26586530	3	O
secreted	26586530	3	O
less	26586530	3	O
PCSK9	26586530	3	O
in	26586530	3	O
the	26586530	3	O
media	26586530	3	O
(	26586530	3	O
-	26586530	3	O
38.5%	26586530	3	O
;	26586530	3	O
P	26586530	3	O
=	26586530	3	O
0.038	26586530	3	O
)	26586530	3	O
and	26586530	3	O
had	26586530	3	O
a	26586530	3	O
71%	26586530	3	O
decrease	26586530	3	O
(	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.001	26586530	3	O
)	26586530	3	O
of	26586530	3	O
low	26586530	3	O
-	26586530	3	O
density	26586530	3	O
lipoprotein	26586530	3	O
(	26586530	3	O
LDL	26586530	3	O
)	26586530	3	O
uptake	26586530	3	O
,	26586530	3	O
whereas	26586530	3	O
cells	26586530	3	O
originally	26586530	3	O
derived	26586530	3	O
from	26586530	3	O
an	26586530	3	O
individual	26586530	3	O
with	26586530	3	O
FHBL	26586530	3	O
(	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
R104C	26586530	3	O
/	26586530	3	O
V114A	26586530	3	O
)	26586530	3	O
displayed	26586530	3	O
a	26586530	3	O
strong	26586530	3	O
decrease	26586530	3	O
in	26586530	3	O
PCSK9	26586530	3	O
secretion	26586530	3	O
(	26586530	3	O
-	26586530	3	O
89.7%	26586530	3	O
;	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.001	26586530	3	O
)	26586530	3	O
and	26586530	3	O
had	26586530	3	O
a	26586530	3	O
106%	26586530	3	O
increase	26586530	3	O
(	26586530	3	O
P	26586530	3	O
=	26586530	3	O
0.0104	26586530	3	O
)	26586530	3	O
of	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
.	26586530	3	O
Pravastatin	26586530	3	O
treatment	26586530	3	O
significantly	26586530	3	O
enhanced	26586530	3	O
LDL	26586530	3	O
receptor	26586530	3	O
(	26586530	3	O
LDLR	26586530	3	O
)	26586530	3	O
and	26586530	3	O
PCSK9	26586530	3	O
mRNA	26586530	3	O
gene	26586530	3	O
expression	26586530	3	O
,	26586530	3	O
as	26586530	3	O
well	26586530	3	O
as	26586530	3	O
PCSK9	26586530	3	O
secretion	26586530	3	O
and	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
in	26586530	3	O
both	26586530	3	O
control	26586530	3	O
and	26586530	3	O
S127R	26586530	3	O
HLCs	26586530	3	O
.	26586530	3	O
Pravastatin	26586530	3	O
treatment	26586530	3	O
of	26586530	3	O
multiple	26586530	3	O
clones	26586530	3	O
led	26586530	3	O
to	26586530	3	O
an	26586530	3	O
average	26586530	3	O
increase	26586530	3	O
of	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
of	26586530	3	O
2.19	26586530	3	O
0.77	26586530	3	O
-	26586530	3	O
fold	26586530	3	O
in	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
S127R	26586530	3	O
compared	26586530	3	O
to	26586530	3	O
1.38	26586530	3	O
0.49	26586530	3	O
fold	26586530	3	O
in	26586530	3	O
control	26586530	3	O
HLCs	26586530	3	O
(	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.01	26586530	3	O
)	26586530	3	O
,	26586530	3	O
in	26586530	3	O
line	26586530	3	O
with	26586530	3	O
the	26586530	3	O
good	26586530	3	O
response	26586530	3	O
to	26586530	3	O
statin	26586530	3	O
treatment	26586530	3	O
of	26586530	3	O
individuals	26586530	3	O
carrying	26586530	3	O
the	26586530	3	O
S127R	26586530	3	O
mutation	26586530	3	O
(	26586530	3	O
mean	26586530	3	O
LDL	26586530	3	O
cholesterol	26586530	3	O
reduction	26586530	3	O
=	26586530	3	O
60.4%	26586530	3	O
,	26586530	3	O
n	26586530	3	O
=	26586530	3	O
5	26586530	3	O
)	26586530	3	O
.	26586530	3	O
In	26586530	3	O
conclusion	26586530	3	O
,	26586530	3	O
urine	26586530	3	O
samples	26586530	3	O
provide	26586530	3	O
an	26586530	3	O
attractive	26586530	3	O
and	26586530	3	O
convenient	26586530	3	O
source	26586530	3	O
of	26586530	3	O
somatic	26586530	3	O
cells	26586530	3	O
for	26586530	3	O
reprogramming	26586530	3	O
and	26586530	3	O
hepatocyte	26586530	3	O
differentiation	26586530	3	O
,	26586530	3	O
but	26586530	3	O
also	26586530	3	O
a	26586530	3	O
powerful	26586530	3	O
tool	26586530	3	O
to	26586530	3	O
further	26586530	3	O
decipher	26586530	3	O
PCSK9	26586530	3	O
mutations	26586530	3	O
and	26586530	3	O
function	26586530	3	O
.	26586530	3	O

Recurrent	26637668	1	O
MLK4	26637668	1	B-Gene
Loss	26637668	1	B-NegReg
-	26637668	1	I-NegReg
of	26637668	1	I-NegReg
-	26637668	1	I-NegReg
Function	26637668	1	I-NegReg
Mutations	26637668	1	B-Var
Suppress	26637668	1	B-NegReg
JNK	26637668	1	B-Pathway
Signaling	26637668	1	I-Pathway
to	26637668	1	O
Promote	26637668	1	B-PosReg
Colon	26637668	1	B-Disease
Tumorigenesis	26637668	1	I-Disease
.	26637668	1	O
MLK4	26637668	1	O
is	26637668	1	O
a	26637668	1	O
member	26637668	1	O
of	26637668	1	O
the	26637668	1	O
mixed	26637668	1	O
-	26637668	1	O
lineage	26637668	1	O
family	26637668	1	O
of	26637668	1	O
kinases	26637668	1	O
that	26637668	1	O
regulate	26637668	1	O
the	26637668	1	O
JNK	26637668	1	O
,	26637668	1	O
p38	26637668	1	O
,	26637668	1	O
and	26637668	1	O
ERK	26637668	1	O
kinase	26637668	1	O
signaling	26637668	1	O
pathways	26637668	1	O
.	26637668	1	O
MLK4	26637668	1	O
mutations	26637668	1	O
have	26637668	1	O
been	26637668	1	O
identified	26637668	1	O
in	26637668	1	O
various	26637668	1	O
human	26637668	1	O
cancers	26637668	1	O
,	26637668	1	O
including	26637668	1	O
frequently	26637668	1	O
in	26637668	1	O
colorectal	26637668	1	O
cancer	26637668	1	O
,	26637668	1	O
where	26637668	1	O
their	26637668	1	O
function	26637668	1	O
and	26637668	1	O
pathobiological	26637668	1	O
importance	26637668	1	O
have	26637668	1	O
been	26637668	1	O
uncertain	26637668	1	O
.	26637668	1	O
In	26637668	1	O
this	26637668	1	O
study	26637668	1	O
,	26637668	1	O
we	26637668	1	O
assessed	26637668	1	O
the	26637668	1	O
functional	26637668	1	O
consequences	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	O
mutations	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
tumorigenesis	26637668	1	O
.	26637668	1	O
Biochemical	26637668	1	O
data	26637668	1	O
indicated	26637668	1	O
that	26637668	1	O
a	26637668	1	O
majority	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	B-Gene
mutations	26637668	1	B-Var
are	26637668	1	O
loss	26637668	1	B-NegReg
-	26637668	1	I-NegReg
of	26637668	1	I-NegReg
-	26637668	1	I-NegReg
function	26637668	1	I-NegReg
(	26637668	1	O
LOF	26637668	1	O
)	26637668	1	O
mutations	26637668	1	O
that	26637668	1	O
can	26637668	1	O
exert	26637668	1	O
dominant	26637668	1	O
-	26637668	1	O
negative	26637668	1	O
effects	26637668	1	O
.	26637668	1	O
In	26637668	1	O
seeking	26637668	1	O
to	26637668	1	O
understand	26637668	1	O
the	26637668	1	O
abrogated	26637668	1	O
activity	26637668	1	O
of	26637668	1	O
these	26637668	1	O
mutants	26637668	1	O
,	26637668	1	O
we	26637668	1	O
elucidated	26637668	1	O
a	26637668	1	O
new	26637668	1	O
MLK4	26637668	1	O
catalytic	26637668	1	O
domain	26637668	1	O
structure	26637668	1	O
.	26637668	1	O
To	26637668	1	O
determine	26637668	1	O
whether	26637668	1	O
MLK4	26637668	1	O
is	26637668	1	O
required	26637668	1	O
to	26637668	1	O
maintain	26637668	1	O
tumorigenic	26637668	1	O
phenotypes	26637668	1	O
,	26637668	1	O
we	26637668	1	O
reconstituted	26637668	1	O
its	26637668	1	O
signaling	26637668	1	O
axis	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
cancer	26637668	1	O
cells	26637668	1	O
harboring	26637668	1	O
MLK4	26637668	1	O
-	26637668	1	O
inactivating	26637668	1	O
mutations	26637668	1	O
.	26637668	1	O
We	26637668	1	O
found	26637668	1	O
that	26637668	1	O
restoring	26637668	1	O
MLK4	26637668	1	O
activity	26637668	1	O
reduced	26637668	1	O
cell	26637668	1	O
viability	26637668	1	O
,	26637668	1	O
proliferation	26637668	1	O
,	26637668	1	O
and	26637668	1	O
colony	26637668	1	O
formation	26637668	1	O
in	26637668	1	O
vitro	26637668	1	O
and	26637668	1	O
delayed	26637668	1	O
tumor	26637668	1	O
growth	26637668	1	O
in	26637668	1	O
vivo	26637668	1	O
.	26637668	1	O
Mechanistic	26637668	1	O
investigations	26637668	1	O
established	26637668	1	O
that	26637668	1	O
restoring	26637668	1	O
the	26637668	1	O
function	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	O
selectively	26637668	1	O
induced	26637668	1	O
the	26637668	1	O
JNK	26637668	1	O
pathway	26637668	1	O
and	26637668	1	O
its	26637668	1	O
downstream	26637668	1	O
targets	26637668	1	O
,	26637668	1	O
cJUN	26637668	1	O
,	26637668	1	O
ATF3	26637668	1	O
,	26637668	1	O
and	26637668	1	O
the	26637668	1	O
cyclin	26637668	1	O
-	26637668	1	O
dependent	26637668	1	O
kinase	26637668	1	O
inhibitors	26637668	1	O
CDKN1A	26637668	1	O
and	26637668	1	O
CDKN2B	26637668	1	O
.	26637668	1	O
Our	26637668	1	O
work	26637668	1	O
indicates	26637668	1	O
that	26637668	1	O
MLK4	26637668	1	B-Gene
is	26637668	1	O
a	26637668	1	O
novel	26637668	1	O
tumor	26637668	1	O
-	26637668	1	O
suppressing	26637668	1	O
kinase	26637668	1	O
harboring	26637668	1	O
frequent	26637668	1	O
LOF	26637668	1	B-NegReg
mutations	26637668	1	B-Var
that	26637668	1	O
lead	26637668	1	O
to	26637668	1	O
diminished	26637668	1	B-NegReg
signaling	26637668	1	B-MPA
in	26637668	1	O
the	26637668	1	O
JNK	26637668	1	B-Pathway
pathway	26637668	1	I-Pathway
and	26637668	1	O
enhanced	26637668	1	B-PosReg
proliferation	26637668	1	B-CPA
in	26637668	1	O
colon	26637668	1	O
cancer	26637668	1	O
.	26637668	1	O
Cancer	26637668	1	O
Res	26637668	1	O
;	26637668	1	O
76	26637668	1	O
(	26637668	1	O
3	26637668	1	O
)	26637668	1	O
;	26637668	1	O
1	26637668	1	O
-	26637668	1	O
12	26637668	1	O
.	26637668	1	O
2015	26637668	1	O
AACR	26637668	1	O
.	26637668	1	O

Transcriptome	27114909	0	O
profiling	27114909	0	O
identifies	27114909	0	O
genes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
deregulated	27114909	0	O
upon	27114909	0	O
floxuridine	27114909	0	O
treatment	27114909	0	O
in	27114909	0	O
colorectal	27114909	0	O
cancer	27114909	0	O
cells	27114909	0	O
harboring	27114909	0	O
GOF	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
.	27114909	0	O
Mutation	27114909	0	O
in	27114909	0	O
TP53	27114909	0	O
is	27114909	0	O
a	27114909	0	O
common	27114909	0	O
genetic	27114909	0	O
alteration	27114909	0	O
in	27114909	0	O
human	27114909	0	O
cancers	27114909	0	O
.	27114909	0	O
Certain	27114909	0	O
tumor	27114909	0	O
associated	27114909	0	O
p53	27114909	0	B-Gene
missense	27114909	0	B-Var
mutants	27114909	0	I-Var
acquire	27114909	0	O
gain	27114909	0	B-PosReg
-	27114909	0	I-PosReg
of	27114909	0	I-PosReg
-	27114909	0	I-PosReg
function	27114909	0	I-PosReg
(	27114909	0	O
GOF	27114909	0	O
)	27114909	0	O
properties	27114909	0	O
and	27114909	0	O
confer	27114909	0	O
oncogenic	27114909	0	O
phenotypes	27114909	0	O
including	27114909	0	O
enhanced	27114909	0	B-PosReg
chemoresistance	27114909	0	B-CPA
.	27114909	0	O
The	27114909	0	O
colorectal	27114909	0	O
cancers	27114909	0	O
(	27114909	0	O
CRC	27114909	0	O
)	27114909	0	O
harboring	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
are	27114909	0	O
generally	27114909	0	O
aggressive	27114909	0	O
in	27114909	0	O
nature	27114909	0	O
and	27114909	0	O
difficult	27114909	0	O
to	27114909	0	O
treat	27114909	0	O
.	27114909	0	O
To	27114909	0	O
identify	27114909	0	O
a	27114909	0	O
potential	27114909	0	O
gene	27114909	0	O
expression	27114909	0	O
signature	27114909	0	O
of	27114909	0	O
GOF	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
-	27114909	0	O
driven	27114909	0	O
acquired	27114909	0	O
chemoresistance	27114909	0	O
in	27114909	0	O
CRC	27114909	0	O
,	27114909	0	O
we	27114909	0	O
performed	27114909	0	O
transcriptome	27114909	0	O
profiling	27114909	0	O
of	27114909	0	O
floxuridine	27114909	0	O
(	27114909	0	O
FUdR	27114909	0	O
)	27114909	0	O
treated	27114909	0	O
SW480	27114909	0	O
cells	27114909	0	O
expressing	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
(	27114909	0	O
R273H	27114909	0	O
)	27114909	0	O
(	27114909	0	O
GEO	27114909	0	O
:	27114909	0	O
GSE77533	27114909	0	O
)	27114909	0	O
.	27114909	0	O
We	27114909	0	O
obtained	27114909	0	O
several	27114909	0	O
genes	27114909	0	O
differentially	27114909	0	O
regulated	27114909	0	O
between	27114909	0	O
FUdR	27114909	0	O
treated	27114909	0	O
and	27114909	0	O
untreated	27114909	0	O
cells	27114909	0	O
.	27114909	0	O
Further	27114909	0	O
,	27114909	0	O
functional	27114909	0	O
characterization	27114909	0	O
and	27114909	0	O
pathway	27114909	0	O
analysis	27114909	0	O
revealed	27114909	0	O
significant	27114909	0	O
enrichment	27114909	0	O
of	27114909	0	O
crucial	27114909	0	O
biological	27114909	0	O
processes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
upon	27114909	0	O
FUdR	27114909	0	O
treatment	27114909	0	O
in	27114909	0	O
SW480	27114909	0	O
cells	27114909	0	O
.	27114909	0	O
Our	27114909	0	O
data	27114909	0	O
suggest	27114909	0	O
that	27114909	0	O
in	27114909	0	O
response	27114909	0	O
to	27114909	0	O
chemotherapeutics	27114909	0	O
treatment	27114909	0	O
,	27114909	0	O
cancer	27114909	0	O
cells	27114909	0	O
with	27114909	0	O
GOF	27114909	0	B-PosReg
mutant	27114909	0	B-Var
p53	27114909	0	B-Gene
can	27114909	0	O
modulate	27114909	0	B-Reg
key	27114909	0	B-Pathway
cellular	27114909	0	I-Pathway
pathways	27114909	0	I-Pathway
to	27114909	0	O
withstand	27114909	0	B-CPA
the	27114909	0	I-CPA
cytotoxic	27114909	0	I-CPA
effect	27114909	0	I-CPA
of	27114909	0	I-CPA
the	27114909	0	I-CPA
drugs	27114909	0	I-CPA
.	27114909	0	O
The	27114909	0	O
genes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
identified	27114909	0	O
in	27114909	0	O
the	27114909	0	O
present	27114909	0	O
study	27114909	0	O
can	27114909	0	O
be	27114909	0	O
further	27114909	0	O
validated	27114909	0	O
and	27114909	0	O
targeted	27114909	0	O
for	27114909	0	O
better	27114909	0	O
chemotherapy	27114909	0	O
response	27114909	0	O
in	27114909	0	O
colorectal	27114909	0	O
cancer	27114909	0	O
patients	27114909	0	O
harboring	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
.	27114909	0	O

TBR1	27325115	1	O
regulates	27325115	1	O
autism	27325115	1	O
risk	27325115	1	O
genes	27325115	1	O
in	27325115	1	O
the	27325115	1	O
developing	27325115	1	O
neocortex	27325115	1	O
.	27325115	1	O
Exome	27325115	1	O
sequencing	27325115	1	O
studies	27325115	1	O
have	27325115	1	O
identified	27325115	1	O
multiple	27325115	1	O
genes	27325115	1	O
harboring	27325115	1	O
de	27325115	1	O
novo	27325115	1	O
loss	27325115	1	B-NegReg
-	27325115	1	I-NegReg
of	27325115	1	I-NegReg
-	27325115	1	I-NegReg
function	27325115	1	I-NegReg
(	27325115	1	O
LoF	27325115	1	O
)	27325115	1	O
variants	27325115	1	B-Var
in	27325115	1	O
individuals	27325115	1	O
with	27325115	1	O
autism	27325115	1	B-Disease
spectrum	27325115	1	I-Disease
disorders	27325115	1	I-Disease
(	27325115	1	O
ASD	27325115	1	O
)	27325115	1	O
,	27325115	1	O
including	27325115	1	O
TBR1	27325115	1	B-Gene
,	27325115	1	O
a	27325115	1	O
master	27325115	1	O
regulator	27325115	1	O
of	27325115	1	O
cortical	27325115	1	O
development	27325115	1	O
.	27325115	1	O
We	27325115	1	O
performed	27325115	1	O
ChIP	27325115	1	O
-	27325115	1	O
seq	27325115	1	O
for	27325115	1	O
TBR1	27325115	1	O
during	27325115	1	O
mouse	27325115	1	O
cortical	27325115	1	O
neurogenesis	27325115	1	O
and	27325115	1	O
show	27325115	1	O
that	27325115	1	O
TBR1	27325115	1	O
-	27325115	1	O
bound	27325115	1	O
regions	27325115	1	O
are	27325115	1	O
enriched	27325115	1	O
adjacent	27325115	1	O
to	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
.	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
were	27325115	1	O
also	27325115	1	O
enriched	27325115	1	O
among	27325115	1	O
genes	27325115	1	O
that	27325115	1	O
are	27325115	1	O
differentially	27325115	1	O
expressed	27325115	1	O
in	27325115	1	O
Tbr1	27325115	1	O
knockouts	27325115	1	O
,	27325115	1	O
which	27325115	1	O
together	27325115	1	O
with	27325115	1	O
the	27325115	1	O
ChIP	27325115	1	O
-	27325115	1	O
seq	27325115	1	O
data	27325115	1	O
,	27325115	1	O
suggests	27325115	1	O
direct	27325115	1	O
transcriptional	27325115	1	O
regulation	27325115	1	O
.	27325115	1	O
Of	27325115	1	O
the	27325115	1	O
nine	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
examined	27325115	1	O
,	27325115	1	O
seven	27325115	1	O
were	27325115	1	O
misexpressed	27325115	1	O
in	27325115	1	O
the	27325115	1	O
cortices	27325115	1	O
of	27325115	1	O
Tbr1	27325115	1	O
knockout	27325115	1	O
mice	27325115	1	O
,	27325115	1	O
including	27325115	1	O
six	27325115	1	O
with	27325115	1	O
increased	27325115	1	O
expression	27325115	1	O
in	27325115	1	O
the	27325115	1	O
deep	27325115	1	O
cortical	27325115	1	O
layers	27325115	1	O
.	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
with	27325115	1	O
adjacent	27325115	1	O
cortical	27325115	1	O
TBR1	27325115	1	O
ChIP	27325115	1	O
-	27325115	1	O
seq	27325115	1	O
peaks	27325115	1	O
also	27325115	1	O
showed	27325115	1	O
unusually	27325115	1	O
low	27325115	1	O
levels	27325115	1	O
of	27325115	1	O
LoF	27325115	1	O
mutations	27325115	1	O
in	27325115	1	O
a	27325115	1	O
reference	27325115	1	O
human	27325115	1	O
population	27325115	1	O
and	27325115	1	O
among	27325115	1	O
Icelanders	27325115	1	O
.	27325115	1	O
We	27325115	1	O
then	27325115	1	O
leveraged	27325115	1	O
TBR1	27325115	1	O
binding	27325115	1	O
to	27325115	1	O
identify	27325115	1	O
an	27325115	1	O
appealing	27325115	1	O
subset	27325115	1	O
of	27325115	1	O
candidate	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
.	27325115	1	O
Our	27325115	1	O
findings	27325115	1	O
highlight	27325115	1	O
a	27325115	1	O
TBR1	27325115	1	O
-	27325115	1	O
regulated	27325115	1	O
network	27325115	1	O
of	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
in	27325115	1	O
the	27325115	1	O
developing	27325115	1	O
neocortex	27325115	1	O
that	27325115	1	O
are	27325115	1	O
relatively	27325115	1	O
intolerant	27325115	1	O
to	27325115	1	O
LoF	27325115	1	O
mutations	27325115	1	O
,	27325115	1	O
indicating	27325115	1	O
that	27325115	1	O
these	27325115	1	O
genes	27325115	1	O
may	27325115	1	O
play	27325115	1	O
critical	27325115	1	O
roles	27325115	1	O
in	27325115	1	O
normal	27325115	1	O
cortical	27325115	1	O
development	27325115	1	O
.	27325115	1	O

A	27341992	0	O
rare	27341992	0	O
DNA	27341992	0	O
contact	27341992	0	O
mutation	27341992	0	B-Var
in	27341992	0	O
cancer	27341992	0	O
confers	27341992	0	B-PosReg
p53	27341992	0	B-Gene
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
and	27341992	0	O
tumor	27341992	0	B-CPA
cell	27341992	0	I-CPA
survival	27341992	0	I-CPA
via	27341992	0	O
TNFAIP8	27341992	0	B-Gene
induction	27341992	0	O
.	27341992	0	O
The	27341992	0	O
p53	27341992	0	O
tumor	27341992	0	O
suppressor	27341992	0	O
gene	27341992	0	O
encodes	27341992	0	O
a	27341992	0	O
sequence	27341992	0	O
-	27341992	0	O
specific	27341992	0	O
transcription	27341992	0	O
factor	27341992	0	O
.	27341992	0	O
Mutations	27341992	0	B-Var
in	27341992	0	O
the	27341992	0	O
coding	27341992	0	O
sequence	27341992	0	O
of	27341992	0	O
p53	27341992	0	B-Gene
occur	27341992	0	O
frequently	27341992	0	O
in	27341992	0	O
human	27341992	0	O
cancer	27341992	0	O
and	27341992	0	O
often	27341992	0	O
result	27341992	0	B-Reg
in	27341992	0	I-Reg
single	27341992	0	B-Var
amino	27341992	0	I-Var
acid	27341992	0	I-Var
substitutions	27341992	0	I-Var
(	27341992	0	I-Var
missense	27341992	0	I-Var
mutations	27341992	0	I-Var
)	27341992	0	I-Var
in	27341992	0	I-Var
the	27341992	0	I-Var
DNA	27341992	0	I-Var
binding	27341992	0	I-Var
domain	27341992	0	I-Var
(	27341992	0	O
DBD	27341992	0	O
)	27341992	0	O
,	27341992	0	O
blocking	27341992	0	B-NegReg
normal	27341992	0	O
tumor	27341992	0	B-CPA
suppressive	27341992	0	I-CPA
functions	27341992	0	I-CPA
.	27341992	0	O
In	27341992	0	O
addition	27341992	0	O
to	27341992	0	O
the	27341992	0	O
loss	27341992	0	O
of	27341992	0	O
canonical	27341992	0	O
functions	27341992	0	O
,	27341992	0	O
some	27341992	0	O
missense	27341992	0	B-Var
mutations	27341992	0	I-Var
in	27341992	0	O
p53	27341992	0	B-Gene
confer	27341992	0	O
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
(	27341992	0	O
GOF	27341992	0	O
)	27341992	0	O
activities	27341992	0	B-CPA
to	27341992	0	I-CPA
tumor	27341992	0	I-CPA
cells	27341992	0	I-CPA
.	27341992	0	O
While	27341992	0	O
many	27341992	0	O
missense	27341992	0	O
mutations	27341992	0	O
in	27341992	0	O
p53	27341992	0	O
cluster	27341992	0	O
at	27341992	0	O
six	27341992	0	O
"	27341992	0	O
hotspot	27341992	0	O
"	27341992	0	O
amino	27341992	0	O
acids	27341992	0	O
,	27341992	0	O
the	27341992	0	O
majority	27341992	0	O
of	27341992	0	O
mutations	27341992	0	O
in	27341992	0	O
human	27341992	0	O
cancer	27341992	0	O
occur	27341992	0	O
elsewhere	27341992	0	O
in	27341992	0	O
the	27341992	0	O
DBD	27341992	0	O
and	27341992	0	O
at	27341992	0	O
a	27341992	0	O
much	27341992	0	O
lower	27341992	0	O
frequency	27341992	0	O
.	27341992	0	O
We	27341992	0	O
report	27341992	0	O
here	27341992	0	O
that	27341992	0	O
mutations	27341992	0	B-Var
at	27341992	0	I-Var
K120	27341992	0	I-Var
,	27341992	0	O
a	27341992	0	O
non	27341992	0	O
-	27341992	0	O
hotspot	27341992	0	O
DNA	27341992	0	O
contact	27341992	0	O
residue	27341992	0	O
,	27341992	0	O
confer	27341992	0	B-PosReg
p53	27341992	0	B-Gene
with	27341992	0	O
the	27341992	0	O
previously	27341992	0	O
unrecognized	27341992	0	O
ability	27341992	0	B-MPA
to	27341992	0	O
bind	27341992	0	B-Interaction
and	27341992	0	O
activate	27341992	0	B-PosReg
the	27341992	0	O
transcription	27341992	0	B-MPA
of	27341992	0	O
the	27341992	0	O
pro	27341992	0	O
-	27341992	0	O
survival	27341992	0	O
TNFAIP8	27341992	0	B-Gene
gene	27341992	0	O
.	27341992	0	O
Mutant	27341992	0	O
K120	27341992	0	O
p53	27341992	0	O
binds	27341992	0	O
the	27341992	0	O
TNFAIP8	27341992	0	O
locus	27341992	0	O
at	27341992	0	O
a	27341992	0	O
cryptic	27341992	0	O
p53	27341992	0	O
response	27341992	0	O
element	27341992	0	O
that	27341992	0	O
is	27341992	0	O
not	27341992	0	O
occupied	27341992	0	O
by	27341992	0	O
wild	27341992	0	O
-	27341992	0	O
type	27341992	0	O
p53	27341992	0	O
.	27341992	0	O
Furthermore	27341992	0	O
,	27341992	0	O
induction	27341992	0	O
of	27341992	0	O
TNFAIP8	27341992	0	O
is	27341992	0	O
critical	27341992	0	O
for	27341992	0	O
the	27341992	0	O
evasion	27341992	0	O
of	27341992	0	O
apoptosis	27341992	0	O
by	27341992	0	O
tumor	27341992	0	O
cells	27341992	0	O
expressing	27341992	0	O
the	27341992	0	O
K120R	27341992	0	O
variant	27341992	0	O
of	27341992	0	O
p53	27341992	0	O
.	27341992	0	O
These	27341992	0	O
findings	27341992	0	O
identify	27341992	0	O
induction	27341992	0	O
of	27341992	0	O
pro	27341992	0	O
-	27341992	0	O
survival	27341992	0	O
targets	27341992	0	O
as	27341992	0	O
a	27341992	0	O
mechanism	27341992	0	O
of	27341992	0	O
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
activity	27341992	0	B-MPA
for	27341992	0	O
mutant	27341992	0	B-Var
p53	27341992	0	B-Gene
and	27341992	0	O
will	27341992	0	O
likely	27341992	0	O
broaden	27341992	0	O
our	27341992	0	O
understanding	27341992	0	O
of	27341992	0	O
this	27341992	0	O
phenomenon	27341992	0	O
beyond	27341992	0	O
the	27341992	0	O
limited	27341992	0	O
number	27341992	0	O
of	27341992	0	O
GOF	27341992	0	O
activities	27341992	0	O
currently	27341992	0	O
reported	27341992	0	O
for	27341992	0	O
hotspot	27341992	0	O
mutants	27341992	0	O
.	27341992	0	O

De	27545680	1	O
Novo	27545680	1	O
Mutations	27545680	1	B-Var
in	27545680	1	O
SON	27545680	1	B-Gene
Disrupt	27545680	1	O
RNA	27545680	1	O
Splicing	27545680	1	O
of	27545680	1	O
Genes	27545680	1	O
Essential	27545680	1	O
for	27545680	1	O
Brain	27545680	1	O
Development	27545680	1	O
and	27545680	1	O
Metabolism	27545680	1	O
,	27545680	1	O
Causing	27545680	1	B-Reg
an	27545680	1	O
Intellectual	27545680	1	B-Disease
-	27545680	1	I-Disease
Disability	27545680	1	I-Disease
Syndrome	27545680	1	I-Disease
.	27545680	1	O
The	27545680	1	O
overall	27545680	1	O
understanding	27545680	1	O
of	27545680	1	O
the	27545680	1	O
molecular	27545680	1	O
etiologies	27545680	1	O
of	27545680	1	O
intellectual	27545680	1	O
disability	27545680	1	O
(	27545680	1	O
ID	27545680	1	O
)	27545680	1	O
and	27545680	1	O
developmental	27545680	1	O
delay	27545680	1	O
(	27545680	1	O
DD	27545680	1	O
)	27545680	1	O
is	27545680	1	O
increasing	27545680	1	O
as	27545680	1	O
next	27545680	1	O
-	27545680	1	O
generation	27545680	1	O
sequencing	27545680	1	O
technologies	27545680	1	O
identify	27545680	1	O
genetic	27545680	1	O
variants	27545680	1	O
in	27545680	1	O
individuals	27545680	1	O
with	27545680	1	O
such	27545680	1	O
disorders	27545680	1	O
.	27545680	1	O
However	27545680	1	O
,	27545680	1	O
detailed	27545680	1	O
analyses	27545680	1	O
conclusively	27545680	1	O
confirming	27545680	1	O
these	27545680	1	O
variants	27545680	1	O
,	27545680	1	O
as	27545680	1	O
well	27545680	1	O
as	27545680	1	O
the	27545680	1	O
underlying	27545680	1	O
molecular	27545680	1	O
mechanisms	27545680	1	O
explaining	27545680	1	O
the	27545680	1	O
diseases	27545680	1	O
,	27545680	1	O
are	27545680	1	O
often	27545680	1	O
lacking	27545680	1	O
.	27545680	1	O
Here	27545680	1	O
,	27545680	1	O
we	27545680	1	O
report	27545680	1	O
on	27545680	1	O
an	27545680	1	O
ID	27545680	1	B-Disease
syndrome	27545680	1	I-Disease
caused	27545680	1	O
by	27545680	1	O
de	27545680	1	O
novo	27545680	1	O
heterozygous	27545680	1	O
loss	27545680	1	B-NegReg
-	27545680	1	I-NegReg
of	27545680	1	I-NegReg
-	27545680	1	I-NegReg
function	27545680	1	I-NegReg
(	27545680	1	O
LoF	27545680	1	O
)	27545680	1	O
mutations	27545680	1	B-Var
in	27545680	1	O
SON	27545680	1	B-Gene
.	27545680	1	O
The	27545680	1	O
syndrome	27545680	1	O
is	27545680	1	O
characterized	27545680	1	O
by	27545680	1	O
ID	27545680	1	O
and	27545680	1	O
/	27545680	1	O
or	27545680	1	O
DD	27545680	1	O
,	27545680	1	O
malformations	27545680	1	O
of	27545680	1	O
the	27545680	1	O
cerebral	27545680	1	O
cortex	27545680	1	O
,	27545680	1	O
epilepsy	27545680	1	O
,	27545680	1	O
vision	27545680	1	O
problems	27545680	1	O
,	27545680	1	O
musculoskeletal	27545680	1	O
abnormalities	27545680	1	O
,	27545680	1	O
and	27545680	1	O
congenital	27545680	1	O
malformations	27545680	1	O
.	27545680	1	O
Knockdown	27545680	1	O
of	27545680	1	O
son	27545680	1	O
in	27545680	1	O
zebrafish	27545680	1	O
resulted	27545680	1	O
in	27545680	1	O
severe	27545680	1	O
malformation	27545680	1	O
of	27545680	1	O
the	27545680	1	O
spine	27545680	1	O
,	27545680	1	O
brain	27545680	1	O
,	27545680	1	O
and	27545680	1	O
eyes	27545680	1	O
.	27545680	1	O
Importantly	27545680	1	O
,	27545680	1	O
analyses	27545680	1	O
of	27545680	1	O
RNA	27545680	1	O
from	27545680	1	O
affected	27545680	1	O
individuals	27545680	1	O
revealed	27545680	1	O
that	27545680	1	O
genes	27545680	1	O
critical	27545680	1	O
for	27545680	1	O
neuronal	27545680	1	B-CPA
migration	27545680	1	I-CPA
and	27545680	1	O
cortex	27545680	1	B-CPA
organization	27545680	1	I-CPA
(	27545680	1	O
TUBG1	27545680	1	O
,	27545680	1	O
FLNA	27545680	1	O
,	27545680	1	O
PNKP	27545680	1	O
,	27545680	1	O
WDR62	27545680	1	O
,	27545680	1	O
PSMD3	27545680	1	O
,	27545680	1	O
and	27545680	1	O
HDAC6	27545680	1	O
)	27545680	1	O
and	27545680	1	O
metabolism	27545680	1	B-CPA
(	27545680	1	O
PCK2	27545680	1	O
,	27545680	1	O
PFKL	27545680	1	O
,	27545680	1	O
IDH2	27545680	1	O
,	27545680	1	O
ACY1	27545680	1	O
,	27545680	1	O
and	27545680	1	O
ADA	27545680	1	O
)	27545680	1	O
are	27545680	1	O
significantly	27545680	1	O
downregulated	27545680	1	B-NegReg
because	27545680	1	O
of	27545680	1	O
the	27545680	1	O
accumulation	27545680	1	B-PosReg
of	27545680	1	O
mis	27545680	1	O
-	27545680	1	O
spliced	27545680	1	O
transcripts	27545680	1	O
resulting	27545680	1	O
from	27545680	1	O
erroneous	27545680	1	B-Var
SON	27545680	1	I-Var
-	27545680	1	I-Var
mediated	27545680	1	I-Var
RNA	27545680	1	I-Var
splicing	27545680	1	I-Var
.	27545680	1	O
Our	27545680	1	O
data	27545680	1	O
highlight	27545680	1	O
SON	27545680	1	O
as	27545680	1	O
a	27545680	1	O
master	27545680	1	O
regulator	27545680	1	O
governing	27545680	1	O
neurodevelopment	27545680	1	O
and	27545680	1	O
demonstrate	27545680	1	O
the	27545680	1	O
importance	27545680	1	O
of	27545680	1	O
SON	27545680	1	O
-	27545680	1	O
mediated	27545680	1	O
RNA	27545680	1	O
splicing	27545680	1	O
in	27545680	1	O
human	27545680	1	O
development	27545680	1	O
.	27545680	1	O

The	27662822	0	O
anti	27662822	0	B-MPA
-	27662822	0	I-MPA
adipogenic	27662822	0	I-MPA
effect	27662822	0	I-MPA
of	27662822	0	O
peripheral	27662822	0	O
blood	27662822	0	O
mononuclear	27662822	0	O
cells	27662822	0	O
is	27662822	0	O
absent	27662822	0	B-NegReg
with	27662822	0	O
PCSK9	27662822	0	B-Gene
loss	27662822	0	B-NegReg
-	27662822	0	I-NegReg
of	27662822	0	I-NegReg
-	27662822	0	I-NegReg
function	27662822	0	I-NegReg
variants	27662822	0	B-Var
.	27662822	0	O
OBJECTIVE	27662822	0	O
:	27662822	0	O
To	27662822	0	O
determine	27662822	0	O
the	27662822	0	O
effect	27662822	0	O
of	27662822	0	O
(	27662822	0	O
1	27662822	0	O
)	27662822	0	O
an	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
and	27662822	0	O
(	27662822	0	O
2	27662822	0	O
)	27662822	0	O
pro	27662822	0	O
-	27662822	0	O
protein	27662822	0	O
convertase	27662822	0	O
subtilisin	27662822	0	O
/	27662822	0	O
kexin	27662822	0	O
type	27662822	0	O
(	27662822	0	O
PCSK	27662822	0	O
)	27662822	0	O
9	27662822	0	O
loss	27662822	0	B-NegReg
-	27662822	0	I-NegReg
of	27662822	0	I-NegReg
-	27662822	0	I-NegReg
function	27662822	0	I-NegReg
(	27662822	0	O
LOF	27662822	0	O
)	27662822	0	O
variant	27662822	0	B-Var
status	27662822	0	O
on	27662822	0	O
the	27662822	0	O
ability	27662822	0	O
of	27662822	0	O
peripheral	27662822	0	O
blood	27662822	0	O
mononuclear	27662822	0	O
cells	27662822	0	O
(	27662822	0	O
PBMC	27662822	0	O
)	27662822	0	O
to	27662822	0	O
inhibit	27662822	0	B-NegReg
human	27662822	0	B-MPA
adipogenesis	27662822	0	I-MPA
.	27662822	0	O
METHODS	27662822	0	O
:	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
subjects	27662822	0	O
with	27662822	0	O
one	27662822	0	O
or	27662822	0	O
more	27662822	0	O
PCSK9	27662822	0	O
LOF	27662822	0	O
variants	27662822	0	O
versus	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
were	27662822	0	O
compared	27662822	0	O
in	27662822	0	O
the	27662822	0	O
fasting	27662822	0	O
state	27662822	0	O
and	27662822	0	O
after	27662822	0	O
an	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
.	27662822	0	O
RESULTS	27662822	0	O
:	27662822	0	O
Fasting	27662822	0	O
triglyceride	27662822	0	O
(	27662822	0	O
TG	27662822	0	O
)	27662822	0	O
levels	27662822	0	O
were	27662822	0	O
lower	27662822	0	O
in	27662822	0	O
the	27662822	0	O
LOF	27662822	0	O
variant	27662822	0	O
versus	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
group	27662822	0	O
but	27662822	0	O
rose	27662822	0	O
to	27662822	0	O
the	27662822	0	O
same	27662822	0	O
level	27662822	0	O
after	27662822	0	O
the	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
.	27662822	0	O
Conditioned	27662822	0	O
medium	27662822	0	O
from	27662822	0	O
PBMC	27662822	0	O
was	27662822	0	O
obtained	27662822	0	O
in	27662822	0	O
fasting	27662822	0	O
(	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F	27662822	0	O
)	27662822	0	O
and	27662822	0	O
4	27662822	0	O
-	27662822	0	O
h	27662822	0	O
postprandial	27662822	0	O
(	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
)	27662822	0	O
states	27662822	0	O
.	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
from	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
inhibited	27662822	0	O
adipogenesis	27662822	0	O
of	27662822	0	O
human	27662822	0	O
preadipocytes	27662822	0	O
more	27662822	0	O
than	27662822	0	O
did	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F.	27662822	0	O
In	27662822	0	O
contrast	27662822	0	O
,	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F	27662822	0	O
or	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	B-NegReg
variant	27662822	0	B-Var
subjects	27662822	0	O
had	27662822	0	O
no	27662822	0	O
effect	27662822	0	O
on	27662822	0	O
adipogenesis	27662822	0	B-MPA
.	27662822	0	O
After	27662822	0	O
the	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
,	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	B-NegReg
variant	27662822	0	B-Var
subjects	27662822	0	O
showed	27662822	0	O
significant	27662822	0	O
increases	27662822	0	B-PosReg
in	27662822	0	O
mRNA	27662822	0	B-MPA
levels	27662822	0	I-MPA
of	27662822	0	I-MPA
interleukin-1	27662822	0	I-MPA
β	27662822	0	I-MPA
,	27662822	0	O
tumor	27662822	0	B-MPA
necrosis	27662822	0	I-MPA
factor	27662822	0	I-MPA
-	27662822	0	I-MPA
α	27662822	0	I-MPA
,	27662822	0	O
sterol	27662822	0	B-MPA
regulatory	27662822	0	I-MPA
element	27662822	0	I-MPA
binding	27662822	0	I-MPA
protein-1	27662822	0	I-MPA
c	27662822	0	I-MPA
,	27662822	0	O
CD36	27662822	0	B-MPA
,	27662822	0	O
and	27662822	0	O
monocyte	27662822	0	O
chemoattractant	27662822	0	O
protein-1	27662822	0	O
(	27662822	0	O
MCP-1	27662822	0	O
)	27662822	0	O
,	27662822	0	O
only	27662822	0	O
MCP-1	27662822	0	O
mRNA	27662822	0	O
levels	27662822	0	O
increased	27662822	0	O
in	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
.	27662822	0	O
CONCLUSIONS	27662822	0	O
:	27662822	0	O
The	27662822	0	O
absence	27662822	0	B-NegReg
of	27662822	0	O
anti	27662822	0	B-MPA
-	27662822	0	I-MPA
adipogenic	27662822	0	I-MPA
action	27662822	0	I-MPA
of	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	O
variant	27662822	0	B-Var
subjects	27662822	0	O
points	27662822	0	O
to	27662822	0	O
a	27662822	0	O
novel	27662822	0	B-PosReg
role	27662822	0	I-PosReg
for	27662822	0	O
PCSK9	27662822	0	O
in	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
adipose	27662822	0	O
cell	27662822	0	O
interactions	27662822	0	B-Interaction
.	27662822	0	O

Atopic	27678121	1	O
Dermatitis	27678121	1	O
Susceptibility	27678121	1	O
Variants	27678121	1	O
in	27678121	1	O
Filaggrin	27678121	1	O
Hitchhike	27678121	1	O
Hornerin	27678121	1	O
Selective	27678121	1	O
Sweep	27678121	1	O
.	27678121	1	O
Human	27678121	1	O
skin	27678121	1	O
has	27678121	1	O
evolved	27678121	1	O
rapidly	27678121	1	O
,	27678121	1	O
leaving	27678121	1	O
evolutionary	27678121	1	O
signatures	27678121	1	O
in	27678121	1	O
the	27678121	1	O
genome	27678121	1	O
.	27678121	1	O
The	27678121	1	O
filaggrin	27678121	1	O
(	27678121	1	B-Gene
FLG	27678121	1	I-Gene
)	27678121	1	I-Gene
gene	27678121	1	O
is	27678121	1	O
widely	27678121	1	O
studied	27678121	1	O
for	27678121	1	O
its	27678121	1	O
skin	27678121	1	O
-	27678121	1	O
barrier	27678121	1	O
function	27678121	1	O
in	27678121	1	O
humans	27678121	1	O
.	27678121	1	O
The	27678121	1	O
extensive	27678121	1	B-Var
genetic	27678121	1	I-Var
variation	27678121	1	I-Var
in	27678121	1	O
this	27678121	1	O
gene	27678121	1	O
,	27678121	1	O
especially	27678121	1	O
common	27678121	1	O
loss	27678121	1	B-NegReg
-	27678121	1	I-NegReg
of	27678121	1	I-NegReg
-	27678121	1	I-NegReg
function	27678121	1	I-NegReg
(	27678121	1	O
LoF	27678121	1	O
)	27678121	1	O
mutations	27678121	1	B-Var
,	27678121	1	O
has	27678121	1	O
been	27678121	1	O
established	27678121	1	O
as	27678121	1	O
primary	27678121	1	O
risk	27678121	1	O
factors	27678121	1	O
for	27678121	1	O
atopic	27678121	1	B-Disease
dermatitis	27678121	1	I-Disease
.	27678121	1	O
To	27678121	1	O
investigate	27678121	1	O
the	27678121	1	O
evolution	27678121	1	O
of	27678121	1	O
this	27678121	1	O
gene	27678121	1	O
,	27678121	1	O
we	27678121	1	O
analyzed	27678121	1	O
2	27678121	1	O
,	27678121	1	O
504	27678121	1	O
human	27678121	1	O
genomes	27678121	1	O
and	27678121	1	O
genotyped	27678121	1	O
the	27678121	1	O
copy	27678121	1	O
number	27678121	1	O
variation	27678121	1	O
of	27678121	1	O
filaggrin	27678121	1	O
repeats	27678121	1	O
within	27678121	1	O
FLG	27678121	1	O
in	27678121	1	O
126	27678121	1	O
individuals	27678121	1	O
from	27678121	1	O
diverse	27678121	1	O
ancestral	27678121	1	O
backgrounds	27678121	1	O
.	27678121	1	O
We	27678121	1	O
were	27678121	1	O
unable	27678121	1	O
to	27678121	1	O
replicate	27678121	1	O
a	27678121	1	O
recent	27678121	1	O
study	27678121	1	O
claiming	27678121	1	O
that	27678121	1	O
LoF	27678121	1	O
of	27678121	1	O
FLG	27678121	1	O
is	27678121	1	O
adaptive	27678121	1	O
in	27678121	1	O
northern	27678121	1	O
latitudes	27678121	1	O
with	27678121	1	O
lower	27678121	1	O
ultraviolet	27678121	1	O
light	27678121	1	O
exposure	27678121	1	O
.	27678121	1	O
Instead	27678121	1	O
,	27678121	1	O
we	27678121	1	O
present	27678121	1	O
multiple	27678121	1	O
lines	27678121	1	O
of	27678121	1	O
evidence	27678121	1	O
suggesting	27678121	1	O
that	27678121	1	O
FLG	27678121	1	O
genetic	27678121	1	O
variation	27678121	1	O
,	27678121	1	O
including	27678121	1	O
LoF	27678121	1	O
variants	27678121	1	O
,	27678121	1	O
have	27678121	1	O
little	27678121	1	O
or	27678121	1	O
no	27678121	1	O
effect	27678121	1	O
on	27678121	1	O
fitness	27678121	1	O
in	27678121	1	O
modern	27678121	1	O
humans	27678121	1	O
.	27678121	1	O
Haplotype	27678121	1	O
-	27678121	1	O
level	27678121	1	O
scrutinization	27678121	1	O
of	27678121	1	O
the	27678121	1	O
locus	27678121	1	O
revealed	27678121	1	O
signatures	27678121	1	O
of	27678121	1	O
a	27678121	1	O
recent	27678121	1	O
selective	27678121	1	O
sweep	27678121	1	O
in	27678121	1	O
Asia	27678121	1	O
,	27678121	1	O
which	27678121	1	O
increased	27678121	1	O
the	27678121	1	O
allele	27678121	1	O
frequency	27678121	1	O
of	27678121	1	O
a	27678121	1	O
haplotype	27678121	1	O
group	27678121	1	O
(	27678121	1	O
Huxian	27678121	1	O
haplogroup	27678121	1	O
)	27678121	1	O
in	27678121	1	O
Asian	27678121	1	O
populations	27678121	1	O
.	27678121	1	O
Functionally	27678121	1	O
,	27678121	1	O
we	27678121	1	O
found	27678121	1	O
that	27678121	1	O
the	27678121	1	O
Huxian	27678121	1	O
haplogroup	27678121	1	O
carries	27678121	1	O
dozens	27678121	1	O
of	27678121	1	O
functional	27678121	1	O
variants	27678121	1	O
in	27678121	1	O
FLG	27678121	1	O
and	27678121	1	O
hornerin	27678121	1	O
(	27678121	1	O
HRNR	27678121	1	O
)	27678121	1	O
genes	27678121	1	O
,	27678121	1	O
including	27678121	1	O
those	27678121	1	O
that	27678121	1	O
are	27678121	1	O
associated	27678121	1	O
with	27678121	1	O
atopic	27678121	1	O
dermatitis	27678121	1	O
susceptibility	27678121	1	O
,	27678121	1	O
HRNR	27678121	1	O
expression	27678121	1	O
levels	27678121	1	O
and	27678121	1	O
microbiome	27678121	1	O
diversity	27678121	1	O
on	27678121	1	O
the	27678121	1	O
skin	27678121	1	O
.	27678121	1	O
Our	27678121	1	O
results	27678121	1	O
suggest	27678121	1	O
that	27678121	1	O
the	27678121	1	O
target	27678121	1	O
of	27678121	1	O
the	27678121	1	O
adaptive	27678121	1	O
sweep	27678121	1	O
is	27678121	1	O
HRNR	27678121	1	O
gene	27678121	1	O
function	27678121	1	O
,	27678121	1	O
and	27678121	1	O
the	27678121	1	O
functional	27678121	1	O
FLG	27678121	1	O
variants	27678121	1	O
that	27678121	1	O
involve	27678121	1	O
susceptibility	27678121	1	O
to	27678121	1	O
atopic	27678121	1	O
dermatitis	27678121	1	O
,	27678121	1	O
seem	27678121	1	O
to	27678121	1	O
hitchhike	27678121	1	O
the	27678121	1	O
selective	27678121	1	O
sweep	27678121	1	O
on	27678121	1	O
HRNR	27678121	1	O
.	27678121	1	O
Our	27678121	1	O
study	27678121	1	O
presents	27678121	1	O
a	27678121	1	O
novel	27678121	1	O
case	27678121	1	O
of	27678121	1	O
a	27678121	1	O
locus	27678121	1	O
that	27678121	1	O
harbors	27678121	1	O
clinically	27678121	1	O
relevant	27678121	1	O
common	27678121	1	O
genetic	27678121	1	O
variation	27678121	1	O
with	27678121	1	O
complex	27678121	1	O
evolutionary	27678121	1	O
trajectories	27678121	1	O
.	27678121	1	O

Variants	27975164	4	O
of	27975164	4	O
genes	27975164	4	O
encoding	27975164	4	O
collagens	27975164	4	O
and	27975164	4	O
matrix	27975164	4	O
metalloproteinase	27975164	4	O
system	27975164	4	O
increased	27975164	4	O
the	27975164	4	O
risk	27975164	4	O
of	27975164	4	O
aortic	27975164	4	O
dissection	27975164	4	O
.	27975164	4	O
Aortic	27975164	4	O
dissection	27975164	4	O
(	27975164	4	O
AD	27975164	4	O
)	27975164	4	O
is	27975164	4	O
a	27975164	4	O
devastating	27975164	4	O
,	27975164	4	O
heterogeneous	27975164	4	O
condition	27975164	4	O
of	27975164	4	O
aorta	27975164	4	O
.	27975164	4	O
The	27975164	4	O
homeostasis	27975164	4	O
between	27975164	4	O
collagens	27975164	4	O
and	27975164	4	O
matrix	27975164	4	O
metalloproteases	27975164	4	O
(	27975164	4	O
MMPs	27975164	4	O
)	27975164	4	O
/	27975164	4	O
tissue	27975164	4	O
inhibitors	27975164	4	O
of	27975164	4	O
MMPs	27975164	4	O
(	27975164	4	O
TIMPs	27975164	4	O
)	27975164	4	O
system	27975164	4	O
in	27975164	4	O
the	27975164	4	O
extracellular	27975164	4	O
matrix	27975164	4	O
plays	27975164	4	O
an	27975164	4	O
important	27975164	4	O
role	27975164	4	O
for	27975164	4	O
structure	27975164	4	O
and	27975164	4	O
functions	27975164	4	O
of	27975164	4	O
aorta	27975164	4	O
.	27975164	4	O
However	27975164	4	O
,	27975164	4	O
our	27975164	4	O
knowledge	27975164	4	O
on	27975164	4	O
association	27975164	4	O
between	27975164	4	O
variants	27975164	4	O
of	27975164	4	O
genes	27975164	4	O
in	27975164	4	O
this	27975164	4	O
system	27975164	4	O
and	27975164	4	O
pathogenesis	27975164	4	O
of	27975164	4	O
AD	27975164	4	O
is	27975164	4	O
very	27975164	4	O
limited	27975164	4	O
.	27975164	4	O
We	27975164	4	O
analyzed	27975164	4	O
all	27975164	4	O
yet	27975164	4	O
known	27975164	4	O
coding	27975164	4	O
human	27975164	4	O
genes	27975164	4	O
of	27975164	4	O
collagens	27975164	4	O
(	27975164	4	O
45	27975164	4	O
genes	27975164	4	O
)	27975164	4	O
,	27975164	4	O
MMPs	27975164	4	O
/	27975164	4	O
TIMPs	27975164	4	O
(	27975164	4	O
27	27975164	4	O
genes	27975164	4	O
)	27975164	4	O
in	27975164	4	O
702	27975164	4	O
sporadic	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
and	27975164	4	O
in	27975164	4	O
163	27975164	4	O
matched	27975164	4	O
healthy	27975164	4	O
controls	27975164	4	O
,	27975164	4	O
by	27975164	4	O
using	27975164	4	O
massively	27975164	4	O
targeted	27975164	4	O
next	27975164	4	O
-	27975164	4	O
generation	27975164	4	O
and	27975164	4	O
Sanger	27975164	4	O
sequencing	27975164	4	O
.	27975164	4	O
To	27975164	4	O
define	27975164	4	O
the	27975164	4	O
pathogenesis	27975164	4	O
of	27975164	4	O
potential	27975164	4	O
disease	27975164	4	O
-	27975164	4	O
causing	27975164	4	O
candidate	27975164	4	O
genes	27975164	4	O
,	27975164	4	O
we	27975164	4	O
performed	27975164	4	O
transcriptome	27975164	4	O
sequencing	27975164	4	O
and	27975164	4	O
pedigree	27975164	4	O
co	27975164	4	O
-	27975164	4	O
segregation	27975164	4	O
analysis	27975164	4	O
in	27975164	4	O
some	27975164	4	O
genes	27975164	4	O
and	27975164	4	O
generated	27975164	4	O
Col5a2	27975164	4	O
knockout	27975164	4	O
rats	27975164	4	O
.	27975164	4	O
We	27975164	4	O
identified	27975164	4	O
257	27975164	4	O
pathogenic	27975164	4	O
or	27975164	4	O
likely	27975164	4	O
pathogenic	27975164	4	O
variants	27975164	4	O
which	27975164	4	O
involved	27975164	4	O
88.89%	27975164	4	O
(	27975164	4	O
64	27975164	4	O
/	27975164	4	O
72	27975164	4	O
)	27975164	4	O
genes	27975164	4	O
in	27975164	4	O
collagens	27975164	4	O
-	27975164	4	O
MMPs	27975164	4	O
/	27975164	4	O
TIMPs	27975164	4	O
system	27975164	4	O
and	27975164	4	O
accounted	27975164	4	O
for	27975164	4	O
31.05%	27975164	4	O
(	27975164	4	O
218	27975164	4	O
/	27975164	4	O
702	27975164	4	O
)	27975164	4	O
sporadic	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
.	27975164	4	O
In	27975164	4	O
them	27975164	4	O
,	27975164	4	O
84.86%	27975164	4	O
patients	27975164	4	O
(	27975164	4	O
185	27975164	4	O
/	27975164	4	O
218	27975164	4	O
)	27975164	4	O
carried	27975164	4	O
one	27975164	4	O
variant	27975164	4	O
,	27975164	4	O
12.84%	27975164	4	O
two	27975164	4	O
variants	27975164	4	O
and	27975164	4	O
2.30%	27975164	4	O
more	27975164	4	O
than	27975164	4	O
two	27975164	4	O
variants	27975164	4	O
.	27975164	4	O
Importantly	27975164	4	O
,	27975164	4	O
we	27975164	4	O
identified	27975164	4	O
52	27975164	4	O
novel	27975164	4	O
probably	27975164	4	O
pathogenic	27975164	4	O
loss	27975164	4	O
-	27975164	4	O
of	27975164	4	O
-	27975164	4	O
function	27975164	4	O
(	27975164	4	O
LOF	27975164	4	O
)	27975164	4	O
variants	27975164	4	O
(	27975164	4	O
20	27975164	4	O
nonsense	27975164	4	O
,	27975164	4	O
16	27975164	4	O
frameshift	27975164	4	O
,	27975164	4	O
14	27975164	4	O
splice	27975164	4	O
sites	27975164	4	O
,	27975164	4	O
one	27975164	4	O
stop	27975164	4	O
-	27975164	4	O
loss	27975164	4	O
,	27975164	4	O
one	27975164	4	O
initiation	27975164	4	O
codon	27975164	4	O
)	27975164	4	O
in	27975164	4	O
11.06%	27975164	4	O
(	27975164	4	O
50	27975164	4	O
/	27975164	4	O
452	27975164	4	O
)	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
,	27975164	4	O
which	27975164	4	O
were	27975164	4	O
absent	27975164	4	O
in	27975164	4	O
163	27975164	4	O
controls	27975164	4	O
(	27975164	4	O
P	27975164	4	O
=	27975164	4	O
2.5	27975164	4	O
10	27975164	4	O
(	27975164	4	O
-	27975164	4	O
5	27975164	4	O
)	27975164	4	O
)	27975164	4	O
.	27975164	4	O
Transcriptome	27975164	4	O
sequencing	27975164	4	O
revealed	27975164	4	O
that	27975164	4	O
identified	27975164	4	O
variants	27975164	4	B-Var
induced	27975164	4	O
dyshomeostasis	27975164	4	B-Reg
in	27975164	4	O
expression	27975164	4	B-CPA
of	27975164	4	I-CPA
collagens	27975164	4	I-CPA
-	27975164	4	I-CPA
TIMPs	27975164	4	I-CPA
/	27975164	4	I-CPA
MMPs	27975164	4	I-CPA
systems	27975164	4	I-CPA
.	27975164	4	O
The	27975164	4	O
Col5a2	27975164	4	B-Gene
(	27975164	4	O
-	27975164	4	O
/	27975164	4	O
-	27975164	4	O
)	27975164	4	O
rats	27975164	4	O
manifested	27975164	4	O
growth	27975164	4	B-CPA
retardation	27975164	4	I-CPA
and	27975164	4	O
aortic	27975164	4	B-CPA
dysplasia	27975164	4	I-CPA
.	27975164	4	O
Our	27975164	4	O
study	27975164	4	O
provides	27975164	4	O
a	27975164	4	O
first	27975164	4	O
comprehensive	27975164	4	O
map	27975164	4	O
of	27975164	4	O
genetic	27975164	4	O
alterations	27975164	4	O
in	27975164	4	O
collagens	27975164	4	O
-	27975164	4	O
MMPs	27975164	4	O
/	27975164	4	O
TIMPs	27975164	4	O
system	27975164	4	O
in	27975164	4	O
sporadic	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
and	27975164	4	O
suggests	27975164	4	O
that	27975164	4	O
variants	27975164	4	O
of	27975164	4	O
these	27975164	4	O
genes	27975164	4	O
contribute	27975164	4	O
largely	27975164	4	O
to	27975164	4	O
AD	27975164	4	O
pathogenesis	27975164	4	O
.	27975164	4	O

Alanine	28011069	3	O
-	28011069	3	O
scanning	28011069	3	O
mutagenesis	28011069	3	O
of	28011069	3	O
human	28011069	3	O
signal	28011069	3	O
transducer	28011069	3	O
and	28011069	3	O
activator	28011069	3	O
of	28011069	3	O
transcription	28011069	3	O
1	28011069	3	O
to	28011069	3	O
estimate	28011069	3	O
loss	28011069	3	O
-	28011069	3	O
or	28011069	3	O
gain	28011069	3	O
-	28011069	3	O
of	28011069	3	O
-	28011069	3	O
function	28011069	3	O
variants	28011069	3	O
.	28011069	3	O
BACKGROUND	28011069	3	O
:	28011069	3	O
Germline	28011069	3	B-Var
heterozygous	28011069	3	I-Var
mutations	28011069	3	I-Var
in	28011069	3	O
human	28011069	3	O
signal	28011069	3	B-Gene
transducer	28011069	3	I-Gene
and	28011069	3	O
activator	28011069	3	B-Gene
of	28011069	3	I-Gene
transcription	28011069	3	I-Gene
1	28011069	3	I-Gene
(	28011069	3	O
STAT1	28011069	3	O
)	28011069	3	O
can	28011069	3	O
cause	28011069	3	O
loss	28011069	3	B-NegReg
of	28011069	3	I-NegReg
function	28011069	3	I-NegReg
(	28011069	3	O
LOF	28011069	3	O
)	28011069	3	O
,	28011069	3	O
as	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
Mendelian	28011069	3	O
susceptibility	28011069	3	O
to	28011069	3	O
mycobacterial	28011069	3	B-Disease
diseases	28011069	3	I-Disease
,	28011069	3	O
or	28011069	3	O
gain	28011069	3	B-PosReg
of	28011069	3	I-PosReg
function	28011069	3	I-PosReg
(	28011069	3	O
GOF	28011069	3	O
)	28011069	3	O
,	28011069	3	O
as	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
chronic	28011069	3	B-Disease
mucocutaneous	28011069	3	I-Disease
candidiasis	28011069	3	I-Disease
.	28011069	3	O
LOF	28011069	3	O
and	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	B-Var
are	28011069	3	O
equally	28011069	3	O
rare	28011069	3	O
and	28011069	3	O
can	28011069	3	O
affect	28011069	3	B-Reg
the	28011069	3	O
same	28011069	3	O
domains	28011069	3	B-MPA
of	28011069	3	O
STAT1	28011069	3	B-Gene
,	28011069	3	O
especially	28011069	3	O
the	28011069	3	O
coiled	28011069	3	B-MPA
-	28011069	3	I-MPA
coil	28011069	3	I-MPA
domain	28011069	3	I-MPA
(	28011069	3	O
CCD	28011069	3	O
)	28011069	3	O
and	28011069	3	O
DNA	28011069	3	B-MPA
-	28011069	3	I-MPA
binding	28011069	3	I-MPA
domain	28011069	3	I-MPA
(	28011069	3	O
DBD	28011069	3	O
)	28011069	3	O
.	28011069	3	O
Moreover	28011069	3	O
,	28011069	3	O
6%	28011069	3	O
of	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
chronic	28011069	3	O
mucocutaneous	28011069	3	O
candidiasis	28011069	3	O
with	28011069	3	O
a	28011069	3	O
GOF	28011069	3	O
STAT1	28011069	3	O
mutation	28011069	3	O
have	28011069	3	O
mycobacterial	28011069	3	O
disease	28011069	3	O
,	28011069	3	O
obscuring	28011069	3	O
the	28011069	3	O
functional	28011069	3	O
significance	28011069	3	O
of	28011069	3	O
the	28011069	3	O
identified	28011069	3	O
STAT1	28011069	3	O
mutations	28011069	3	O
.	28011069	3	O
Current	28011069	3	O
computational	28011069	3	O
approaches	28011069	3	O
,	28011069	3	O
such	28011069	3	O
as	28011069	3	O
combined	28011069	3	O
annotation	28011069	3	O
-	28011069	3	O
dependent	28011069	3	O
depletion	28011069	3	O
,	28011069	3	O
do	28011069	3	O
not	28011069	3	O
distinguish	28011069	3	O
LOF	28011069	3	O
and	28011069	3	O
GOF	28011069	3	O
variants	28011069	3	O
.	28011069	3	O
OBJECTIVE	28011069	3	O
:	28011069	3	O
We	28011069	3	O
estimated	28011069	3	O
variations	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
.	28011069	3	O
METHODS	28011069	3	O
:	28011069	3	O
We	28011069	3	O
mutagenized	28011069	3	O
342	28011069	3	O
individual	28011069	3	O
wild	28011069	3	O
-	28011069	3	O
type	28011069	3	O
amino	28011069	3	O
acids	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
(	28011069	3	O
45.6%	28011069	3	O
of	28011069	3	O
full	28011069	3	O
-	28011069	3	O
length	28011069	3	O
STAT1	28011069	3	O
)	28011069	3	O
to	28011069	3	O
alanine	28011069	3	O
and	28011069	3	O
tested	28011069	3	O
the	28011069	3	O
mutants	28011069	3	O
for	28011069	3	O
STAT1	28011069	3	O
transcriptional	28011069	3	O
activity	28011069	3	O
.	28011069	3	O
RESULTS	28011069	3	O
:	28011069	3	O
Of	28011069	3	O
these	28011069	3	O
342	28011069	3	O
mutants	28011069	3	O
,	28011069	3	O
201	28011069	3	O
were	28011069	3	O
neutral	28011069	3	O
,	28011069	3	O
30	28011069	3	O
were	28011069	3	O
LOF	28011069	3	O
,	28011069	3	O
and	28011069	3	O
111	28011069	3	O
were	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	O
in	28011069	3	O
a	28011069	3	O
luciferase	28011069	3	O
assay	28011069	3	O
.	28011069	3	O
This	28011069	3	O
assay	28011069	3	O
system	28011069	3	O
correctly	28011069	3	O
estimated	28011069	3	O
all	28011069	3	O
previously	28011069	3	O
reported	28011069	3	O
LOF	28011069	3	O
mutations	28011069	3	O
(	28011069	3	O
100%	28011069	3	O
)	28011069	3	O
and	28011069	3	O
slightly	28011069	3	O
fewer	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	O
(	28011069	3	O
78.1%	28011069	3	O
)	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
.	28011069	3	O
We	28011069	3	O
found	28011069	3	O
that	28011069	3	O
GOF	28011069	3	O
alanine	28011069	3	O
mutants	28011069	3	O
occurred	28011069	3	O
at	28011069	3	O
the	28011069	3	O
interface	28011069	3	O
of	28011069	3	O
the	28011069	3	O
antiparallel	28011069	3	O
STAT1	28011069	3	O
dimer	28011069	3	O
,	28011069	3	O
suggesting	28011069	3	O
that	28011069	3	O
they	28011069	3	O
destabilize	28011069	3	O
this	28011069	3	O
dimer	28011069	3	O
.	28011069	3	O
This	28011069	3	O
assay	28011069	3	O
also	28011069	3	O
precisely	28011069	3	O
predicted	28011069	3	O
the	28011069	3	O
effect	28011069	3	O
of	28011069	3	O
2	28011069	3	O
hypomorphic	28011069	3	O
and	28011069	3	O
dominant	28011069	3	O
negative	28011069	3	O
mutations	28011069	3	O
,	28011069	3	O
E157K	28011069	3	O
and	28011069	3	O
G250E	28011069	3	O
,	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
that	28011069	3	O
we	28011069	3	O
found	28011069	3	O
in	28011069	3	O
2	28011069	3	O
unrelated	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
Mendelian	28011069	3	O
susceptibility	28011069	3	O
to	28011069	3	O
mycobacterial	28011069	3	O
diseases	28011069	3	O
.	28011069	3	O
CONCLUSION	28011069	3	O
:	28011069	3	O
The	28011069	3	O
systematic	28011069	3	O
alanine	28011069	3	O
-	28011069	3	O
scanning	28011069	3	O
assay	28011069	3	O
is	28011069	3	O
a	28011069	3	O
useful	28011069	3	O
tool	28011069	3	O
to	28011069	3	O
estimate	28011069	3	O
the	28011069	3	O
GOF	28011069	3	O
or	28011069	3	O
LOF	28011069	3	O
status	28011069	3	O
and	28011069	3	O
the	28011069	3	O
effect	28011069	3	O
of	28011069	3	O
heterozygous	28011069	3	O
missense	28011069	3	O
mutations	28011069	3	O
in	28011069	3	O
STAT1	28011069	3	O
identified	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
severe	28011069	3	O
infectious	28011069	3	O
diseases	28011069	3	O
,	28011069	3	O
including	28011069	3	O
mycobacterial	28011069	3	O
and	28011069	3	O
fungal	28011069	3	O
diseases	28011069	3	O
.	28011069	3	O

Ruxolitinib	28139313	2	O
reverses	28139313	2	O
dysregulated	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
and	28139313	2	O
controls	28139313	2	O
autoimmunity	28139313	2	O
caused	28139313	2	O
by	28139313	2	O
a	28139313	2	O
novel	28139313	2	O
signal	28139313	2	O
transducer	28139313	2	O
and	28139313	2	O
activator	28139313	2	O
of	28139313	2	O
transcription	28139313	2	O
1	28139313	2	O
(	28139313	2	O
STAT1	28139313	2	O
)	28139313	2	O
gain	28139313	2	O
-	28139313	2	O
of	28139313	2	O
-	28139313	2	O
function	28139313	2	O
mutation	28139313	2	O
.	28139313	2	O
BACKGROUND	28139313	2	O
:	28139313	2	O
Gain	28139313	2	B-PosReg
-	28139313	2	I-PosReg
of	28139313	2	I-PosReg
-	28139313	2	I-PosReg
function	28139313	2	I-PosReg
(	28139313	2	O
GOF	28139313	2	O
)	28139313	2	O
mutations	28139313	2	B-Var
in	28139313	2	O
the	28139313	2	O
human	28139313	2	B-Gene
signal	28139313	2	I-Gene
transducer	28139313	2	I-Gene
and	28139313	2	I-Gene
activator	28139313	2	I-Gene
of	28139313	2	I-Gene
transcription	28139313	2	I-Gene
1	28139313	2	I-Gene
(	28139313	2	O
STAT1	28139313	2	O
)	28139313	2	O
manifest	28139313	2	O
in	28139313	2	O
immunodeficiency	28139313	2	O
and	28139313	2	O
autoimmunity	28139313	2	O
with	28139313	2	O
impaired	28139313	2	B-NegReg
TH17	28139313	2	B-CPA
cell	28139313	2	I-CPA
differentiation	28139313	2	I-CPA
and	28139313	2	O
exaggerated	28139313	2	B-PosReg
responsiveness	28139313	2	B-Interaction
to	28139313	2	I-Interaction
type	28139313	2	I-Interaction
I	28139313	2	I-Interaction
and	28139313	2	I-Interaction
II	28139313	2	I-Interaction
interferons	28139313	2	I-Interaction
.	28139313	2	O
Allogeneic	28139313	2	O
bone	28139313	2	O
marrow	28139313	2	O
transplantation	28139313	2	O
has	28139313	2	O
been	28139313	2	O
attempted	28139313	2	O
in	28139313	2	O
severely	28139313	2	O
affected	28139313	2	O
patients	28139313	2	O
,	28139313	2	O
but	28139313	2	O
outcomes	28139313	2	O
have	28139313	2	O
been	28139313	2	O
poor	28139313	2	O
.	28139313	2	O
OBJECTIVE	28139313	2	O
:	28139313	2	O
We	28139313	2	O
sought	28139313	2	O
to	28139313	2	O
define	28139313	2	O
the	28139313	2	O
effect	28139313	2	O
of	28139313	2	O
increased	28139313	2	O
STAT1	28139313	2	O
activity	28139313	2	O
on	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
polarization	28139313	2	O
and	28139313	2	O
to	28139313	2	O
investigate	28139313	2	O
the	28139313	2	O
therapeutic	28139313	2	O
potential	28139313	2	O
of	28139313	2	O
ruxolitinib	28139313	2	O
in	28139313	2	O
treating	28139313	2	O
autoimmunity	28139313	2	O
secondary	28139313	2	O
to	28139313	2	O
STAT1	28139313	2	O
GOF	28139313	2	O
mutations	28139313	2	O
.	28139313	2	O
METHODS	28139313	2	O
:	28139313	2	O
We	28139313	2	O
used	28139313	2	O
in	28139313	2	O
vitro	28139313	2	O
polarization	28139313	2	O
assays	28139313	2	O
,	28139313	2	O
as	28139313	2	O
well	28139313	2	O
as	28139313	2	O
phenotypic	28139313	2	O
and	28139313	2	O
functional	28139313	2	O
analysis	28139313	2	O
of	28139313	2	O
STAT1	28139313	2	O
-	28139313	2	O
mutated	28139313	2	O
patient	28139313	2	O
cells	28139313	2	O
.	28139313	2	O
RESULTS	28139313	2	O
:	28139313	2	O
We	28139313	2	O
report	28139313	2	O
a	28139313	2	O
child	28139313	2	O
with	28139313	2	O
a	28139313	2	O
novel	28139313	2	O
mutation	28139313	2	B-Var
in	28139313	2	I-Var
the	28139313	2	I-Var
linker	28139313	2	I-Var
domain	28139313	2	I-Var
of	28139313	2	O
STAT1	28139313	2	B-Gene
who	28139313	2	O
had	28139313	2	O
life	28139313	2	O
-	28139313	2	O
threatening	28139313	2	O
autoimmune	28139313	2	O
cytopenias	28139313	2	O
and	28139313	2	O
chronic	28139313	2	O
mucocutaneous	28139313	2	O
candidiasis	28139313	2	O
.	28139313	2	O
Naive	28139313	2	O
lymphocytes	28139313	2	O
from	28139313	2	O
the	28139313	2	O
affected	28139313	2	O
patient	28139313	2	O
displayed	28139313	2	O
increased	28139313	2	B-PosReg
TH1	28139313	2	B-CPA
and	28139313	2	I-CPA
follicular	28139313	2	I-CPA
T	28139313	2	I-CPA
helper	28139313	2	I-CPA
cell	28139313	2	I-CPA
and	28139313	2	O
suppressed	28139313	2	B-NegReg
TH17	28139313	2	B-CPA
cell	28139313	2	I-CPA
responses	28139313	2	I-CPA
.	28139313	2	O
The	28139313	2	O
mutation	28139313	2	B-Var
augmented	28139313	2	B-PosReg
cytokine	28139313	2	B-MPA
-	28139313	2	I-MPA
induced	28139313	2	I-MPA
STAT1	28139313	2	I-MPA
phosphorylation	28139313	2	I-MPA
without	28139313	2	O
affecting	28139313	2	O
dephosphorylation	28139313	2	O
kinetics	28139313	2	O
.	28139313	2	O
Treatment	28139313	2	O
with	28139313	2	O
the	28139313	2	O
Janus	28139313	2	O
kinase	28139313	2	O
1	28139313	2	O
/	28139313	2	O
2	28139313	2	O
inhibitor	28139313	2	O
ruxolitinib	28139313	2	O
reduced	28139313	2	O
hyperresponsiveness	28139313	2	O
to	28139313	2	O
type	28139313	2	O
I	28139313	2	O
and	28139313	2	O
II	28139313	2	O
interferons	28139313	2	O
,	28139313	2	O
normalized	28139313	2	O
TH1	28139313	2	O
and	28139313	2	O
follicular	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
,	28139313	2	O
improved	28139313	2	O
TH17	28139313	2	O
differentiation	28139313	2	O
,	28139313	2	O
cured	28139313	2	O
mucocutaneous	28139313	2	O
candidiasis	28139313	2	O
,	28139313	2	O
and	28139313	2	O
maintained	28139313	2	O
remission	28139313	2	O
of	28139313	2	O
immune	28139313	2	O
-	28139313	2	O
mediated	28139313	2	O
cytopenias	28139313	2	O
.	28139313	2	O
CONCLUSIONS	28139313	2	O
:	28139313	2	O
Autoimmunity	28139313	2	O
and	28139313	2	O
infection	28139313	2	O
caused	28139313	2	O
by	28139313	2	O
STAT1	28139313	2	B-Gene
GOF	28139313	2	B-PosReg
mutations	28139313	2	B-Var
are	28139313	2	O
the	28139313	2	O
result	28139313	2	O
of	28139313	2	O
dysregulated	28139313	2	O
T	28139313	2	B-CPA
helper	28139313	2	I-CPA
cell	28139313	2	I-CPA
responses	28139313	2	I-CPA
.	28139313	2	O
Janus	28139313	2	O
kinase	28139313	2	O
inhibitor	28139313	2	O
therapy	28139313	2	O
could	28139313	2	O
represent	28139313	2	O
an	28139313	2	O
effective	28139313	2	O
targeted	28139313	2	O
treatment	28139313	2	O
for	28139313	2	O
long	28139313	2	O
-	28139313	2	O
term	28139313	2	O
disease	28139313	2	O
control	28139313	2	O
in	28139313	2	O
severely	28139313	2	O
affected	28139313	2	O
patients	28139313	2	O
for	28139313	2	O
whom	28139313	2	O
hematopoietic	28139313	2	O
stem	28139313	2	O
cell	28139313	2	O
transplantation	28139313	2	O
is	28139313	2	O
not	28139313	2	O
available	28139313	2	O
.	28139313	2	O

Complexity	28157721	3	O
of	28157721	3	O
mechanisms	28157721	3	O
among	28157721	3	O
human	28157721	3	O
proprotein	28157721	3	O
convertase	28157721	3	O
subtilisin	28157721	3	O
-	28157721	3	O
kexin	28157721	3	O
type	28157721	3	O
9	28157721	3	O
variants	28157721	3	O
.	28157721	3	O
PURPOSE	28157721	3	O
OF	28157721	3	O
REVIEW	28157721	3	O
:	28157721	3	O
There	28157721	3	O
are	28157721	3	O
many	28157721	3	O
reports	28157721	3	O
of	28157721	3	O
human	28157721	3	O
variants	28157721	3	B-Var
in	28157721	3	O
proprotein	28157721	3	O
convertase	28157721	3	O
subtilisin	28157721	3	O
-	28157721	3	O
kexin	28157721	3	O
type	28157721	3	O
9	28157721	3	O
(	28157721	3	B-Gene
PCSK9	28157721	3	I-Gene
)	28157721	3	I-Gene
that	28157721	3	O
are	28157721	3	O
either	28157721	3	O
gain	28157721	3	B-PosReg
-	28157721	3	I-PosReg
of	28157721	3	I-PosReg
-	28157721	3	I-PosReg
function	28157721	3	I-PosReg
(	28157721	3	O
GOF	28157721	3	O
)	28157721	3	O
or	28157721	3	O
loss	28157721	3	B-NegReg
-	28157721	3	I-NegReg
of	28157721	3	I-NegReg
-	28157721	3	I-NegReg
function	28157721	3	I-NegReg
(	28157721	3	O
LOF	28157721	3	O
)	28157721	3	O
,	28157721	3	O
with	28157721	3	O
downstream	28157721	3	O
effects	28157721	3	B-Reg
on	28157721	3	O
LDL	28157721	3	B-Disease
cholesterol	28157721	3	I-Disease
and	28157721	3	O
cardiovascular	28157721	3	B-Disease
disease	28157721	3	I-Disease
(	28157721	3	O
CVD	28157721	3	O
)	28157721	3	O
risk	28157721	3	O
.	28157721	3	O
However	28157721	3	O
,	28157721	3	O
data	28157721	3	O
on	28157721	3	O
particular	28157721	3	O
mechanisms	28157721	3	O
have	28157721	3	O
only	28157721	3	O
been	28157721	3	O
minimally	28157721	3	O
curated	28157721	3	O
.	28157721	3	O
RECENT	28157721	3	O
FINDINGS	28157721	3	O
:	28157721	3	O
GOF	28157721	3	B-PosReg
variants	28157721	3	B-Var
are	28157721	3	O
individually	28157721	3	O
ultrarare	28157721	3	O
,	28157721	3	O
affect	28157721	3	B-Reg
all	28157721	3	O
domains	28157721	3	B-Protein
of	28157721	3	I-Protein
the	28157721	3	I-Protein
protein	28157721	3	I-Protein
,	28157721	3	O
act	28157721	3	O
to	28157721	3	O
reduce	28157721	3	B-NegReg
LDL	28157721	3	B-Protein
receptor	28157721	3	I-Protein
expression	28157721	3	B-MPA
through	28157721	3	O
several	28157721	3	O
mechanisms	28157721	3	O
,	28157721	3	O
are	28157721	3	O
a	28157721	3	O
minor	28157721	3	O
cause	28157721	3	B-Reg
of	28157721	3	O
familial	28157721	3	B-Disease
hypercholesterolemia	28157721	3	I-Disease
,	28157721	3	O
have	28157721	3	O
been	28157721	3	O
reported	28157721	3	O
mainly	28157721	3	O
within	28157721	3	O
families	28157721	3	O
,	28157721	3	O
have	28157721	3	O
variable	28157721	3	O
LDL	28157721	3	O
cholesterol	28157721	3	O
-	28157721	3	O
raising	28157721	3	O
effects	28157721	3	O
,	28157721	3	O
and	28157721	3	O
are	28157721	3	O
associated	28157721	3	O
with	28157721	3	O
increased	28157721	3	O
CVD	28157721	3	O
risk	28157721	3	O
mainly	28157721	3	O
through	28157721	3	O
observational	28157721	3	O
studies	28157721	3	O
in	28157721	3	O
families	28157721	3	O
and	28157721	3	O
small	28157721	3	O
cohorts	28157721	3	O
.	28157721	3	O
In	28157721	3	O
contrast	28157721	3	O
,	28157721	3	O
LOF	28157721	3	B-NegReg
variants	28157721	3	B-Var
can	28157721	3	O
be	28157721	3	O
either	28157721	3	O
ultrarare	28157721	3	O
mutations	28157721	3	O
or	28157721	3	O
relatively	28157721	3	O
more	28157721	3	O
common	28157721	3	O
polymorphisms	28157721	3	O
seen	28157721	3	O
in	28157721	3	O
populations	28157721	3	O
,	28157721	3	O
affect	28157721	3	B-Reg
all	28157721	3	O
domains	28157721	3	B-Protein
of	28157721	3	I-Protein
the	28157721	3	I-Protein
protein	28157721	3	I-Protein
,	28157721	3	O
act	28157721	3	O
to	28157721	3	O
increase	28157721	3	B-PosReg
LDL	28157721	3	B-Protein
receptor	28157721	3	I-Protein
expression	28157721	3	B-MPA
through	28157721	3	O
several	28157721	3	O
mechanisms	28157721	3	O
,	28157721	3	O
have	28157721	3	O
variable	28157721	3	O
LDL	28157721	3	B-MPA
cholesterol	28157721	3	B-NegReg
-	28157721	3	I-NegReg
lowering	28157721	3	I-NegReg
effects	28157721	3	O
,	28157721	3	O
and	28157721	3	O
have	28157721	3	O
been	28157721	3	O
associated	28157721	3	O
with	28157721	3	O
decreased	28157721	3	B-NegReg
CVD	28157721	3	B-Disease
risk	28157721	3	O
mainly	28157721	3	O
through	28157721	3	O
Mendelian	28157721	3	O
randomization	28157721	3	O
studies	28157721	3	O
in	28157721	3	O
epidemiologic	28157721	3	O
populations	28157721	3	O
.	28157721	3	O
SUMMARY	28157721	3	O
:	28157721	3	O
There	28157721	3	O
is	28157721	3	O
considerable	28157721	3	O
complexity	28157721	3	O
underlying	28157721	3	O
the	28157721	3	O
clinical	28157721	3	O
concept	28157721	3	O
of	28157721	3	O
both	28157721	3	O
LOF	28157721	3	O
and	28157721	3	O
GOF	28157721	3	O
variants	28157721	3	O
of	28157721	3	O
PCSK9	28157721	3	O
.	28157721	3	O
But	28157721	3	O
despite	28157721	3	O
the	28157721	3	O
underlying	28157721	3	O
mechanistic	28157721	3	O
heterogeneity	28157721	3	O
,	28157721	3	O
altered	28157721	3	O
PCSK9	28157721	3	O
secretion	28157721	3	O
or	28157721	3	O
function	28157721	3	O
is	28157721	3	O
ultimately	28157721	3	O
correlated	28157721	3	O
with	28157721	3	O
plasma	28157721	3	O
LDL	28157721	3	O
cholesterol	28157721	3	O
level	28157721	3	O
,	28157721	3	O
which	28157721	3	O
is	28157721	3	O
also	28157721	3	O
the	28157721	3	O
driver	28157721	3	O
of	28157721	3	O
CVD	28157721	3	O
outcomes	28157721	3	O
.	28157721	3	O

Towards	28167616	0	O
trans	28167616	0	O
-	28167616	0	O
diagnostic	28167616	0	O
mechanisms	28167616	0	O
in	28167616	0	O
psychiatry	28167616	0	O
:	28167616	0	O
neurobehavioral	28167616	0	O
profile	28167616	0	O
of	28167616	0	O
rats	28167616	0	O
with	28167616	0	O
a	28167616	0	O
loss	28167616	0	O
-	28167616	0	O
of	28167616	0	O
-	28167616	0	O
function	28167616	0	O
point	28167616	0	O
mutation	28167616	0	O
in	28167616	0	O
the	28167616	0	O
dopamine	28167616	0	O
transporter	28167616	0	O
gene	28167616	0	O
.	28167616	0	O
The	28167616	0	O
research	28167616	0	O
domain	28167616	0	O
criteria	28167616	0	O
(	28167616	0	O
RDoC	28167616	0	O
)	28167616	0	O
matrix	28167616	0	O
has	28167616	0	O
been	28167616	0	O
developed	28167616	0	O
to	28167616	0	O
reorient	28167616	0	O
psychiatric	28167616	0	O
research	28167616	0	O
towards	28167616	0	O
measurable	28167616	0	O
behavioral	28167616	0	O
dimensions	28167616	0	O
and	28167616	0	O
underlying	28167616	0	O
mechanisms	28167616	0	O
.	28167616	0	O
Here	28167616	0	O
,	28167616	0	O
we	28167616	0	O
used	28167616	0	O
a	28167616	0	O
new	28167616	0	O
genetic	28167616	0	O
rat	28167616	0	O
model	28167616	0	O
with	28167616	0	O
a	28167616	0	O
loss	28167616	0	O
-	28167616	0	O
of	28167616	0	O
-	28167616	0	O
function	28167616	0	O
point	28167616	0	O
mutation	28167616	0	O
in	28167616	0	O
the	28167616	0	O
dopamine	28167616	0	O
transporter	28167616	0	O
(	28167616	0	O
DAT	28167616	0	O
)	28167616	0	O
gene	28167616	0	O
(	28167616	0	O
Slc6a3_N157K	28167616	0	O
)	28167616	0	O
to	28167616	0	O
systematically	28167616	0	O
study	28167616	0	O
the	28167616	0	O
RDoC	28167616	0	O
matrix	28167616	0	O
.	28167616	0	O
First	28167616	0	O
,	28167616	0	O
we	28167616	0	O
examined	28167616	0	O
the	28167616	0	O
impact	28167616	0	O
of	28167616	0	O
the	28167616	0	O
Slc6a3_N157K	28167616	0	O
mutation	28167616	0	O
on	28167616	0	O
monoaminergic	28167616	0	O
signaling	28167616	0	O
.	28167616	0	O
We	28167616	0	O
then	28167616	0	O
performed	28167616	0	O
behavioral	28167616	0	O
tests	28167616	0	O
representing	28167616	0	O
each	28167616	0	O
of	28167616	0	O
the	28167616	0	O
five	28167616	0	O
RDoC	28167616	0	O
domains	28167616	0	O
:	28167616	0	O
negative	28167616	0	O
and	28167616	0	O
positive	28167616	0	O
valence	28167616	0	O
systems	28167616	0	O
,	28167616	0	O
cognitive	28167616	0	O
,	28167616	0	O
social	28167616	0	O
and	28167616	0	O
arousal	28167616	0	O
/	28167616	0	O
regulatory	28167616	0	O
systems	28167616	0	O
.	28167616	0	O
The	28167616	0	O
use	28167616	0	O
of	28167616	0	O
RDoC	28167616	0	O
may	28167616	0	O
be	28167616	0	O
particularly	28167616	0	O
helpful	28167616	0	O
for	28167616	0	O
drug	28167616	0	O
development	28167616	0	O
.	28167616	0	O
We	28167616	0	O
studied	28167616	0	O
the	28167616	0	O
effects	28167616	0	O
of	28167616	0	O
a	28167616	0	O
novel	28167616	0	O
pharmacological	28167616	0	O
approach	28167616	0	O
metabotropic	28167616	0	O
glutamate	28167616	0	O
receptor	28167616	0	O
mGluR2	28167616	0	O
/	28167616	0	O
3	28167616	0	O
antagonism	28167616	0	O
,	28167616	0	O
in	28167616	0	O
DAT	28167616	0	O
mutants	28167616	0	O
in	28167616	0	O
a	28167616	0	O
comparative	28167616	0	O
way	28167616	0	O
with	28167616	0	O
standard	28167616	0	O
medications	28167616	0	O
.	28167616	0	O
Loss	28167616	0	B-NegReg
of	28167616	0	O
DAT	28167616	0	B-Gene
functionality	28167616	0	O
in	28167616	0	O
mutant	28167616	0	B-Var
rats	28167616	0	O
not	28167616	0	O
only	28167616	0	O
elevated	28167616	0	B-PosReg
subcortical	28167616	0	B-MPA
extracellular	28167616	0	I-MPA
dopamine	28167616	0	I-MPA
concentration	28167616	0	I-MPA
but	28167616	0	O
also	28167616	0	O
altered	28167616	0	B-Reg
the	28167616	0	O
balance	28167616	0	B-MPA
of	28167616	0	I-MPA
monoaminergic	28167616	0	I-MPA
transmission	28167616	0	I-MPA
.	28167616	0	O
DAT	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
showed	28167616	0	O
deficits	28167616	0	O
in	28167616	0	O
all	28167616	0	O
five	28167616	0	O
RDoC	28167616	0	O
domains	28167616	0	O
.	28167616	0	O
Thus	28167616	0	O
,	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
failed	28167616	0	O
to	28167616	0	O
show	28167616	0	O
conditioned	28167616	0	O
fear	28167616	0	O
responses	28167616	0	O
,	28167616	0	O
were	28167616	0	O
anhedonic	28167616	0	O
,	28167616	0	O
were	28167616	0	O
unable	28167616	0	O
to	28167616	0	O
learn	28167616	0	O
stimulus	28167616	0	O
-	28167616	0	O
reward	28167616	0	O
associations	28167616	0	O
,	28167616	0	O
showed	28167616	0	O
impaired	28167616	0	O
cognition	28167616	0	O
and	28167616	0	O
social	28167616	0	O
behavior	28167616	0	O
,	28167616	0	O
and	28167616	0	O
were	28167616	0	O
hyperactive	28167616	0	O
.	28167616	0	O
Hyperactivity	28167616	0	O
in	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
was	28167616	0	O
reduced	28167616	0	O
by	28167616	0	O
amphetamine	28167616	0	O
and	28167616	0	O
atomoxetine	28167616	0	O
,	28167616	0	O
which	28167616	0	O
are	28167616	0	O
well	28167616	0	O
-	28167616	0	O
established	28167616	0	O
medications	28167616	0	O
to	28167616	0	O
reduce	28167616	0	O
hyperactivity	28167616	0	O
in	28167616	0	O
humans	28167616	0	O
.	28167616	0	O
The	28167616	0	O
mGluR2	28167616	0	O
/	28167616	0	O
3	28167616	0	O
antagonist	28167616	0	O
LY341495	28167616	0	O
also	28167616	0	O
normalized	28167616	0	O
hyperactivity	28167616	0	O
in	28167616	0	O
DAT	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
without	28167616	0	O
affecting	28167616	0	O
extracellular	28167616	0	O
dopamine	28167616	0	O
levels	28167616	0	O
.	28167616	0	O
We	28167616	0	O
systematically	28167616	0	O
characterized	28167616	0	O
an	28167616	0	O
altered	28167616	0	O
dopamine	28167616	0	O
system	28167616	0	O
within	28167616	0	O
the	28167616	0	O
context	28167616	0	O
of	28167616	0	O
the	28167616	0	O
RDoC	28167616	0	O
matrix	28167616	0	O
and	28167616	0	O
studied	28167616	0	O
mGluR2	28167616	0	O
/	28167616	0	O
3	28167616	0	O
antagonism	28167616	0	O
as	28167616	0	O
a	28167616	0	O
new	28167616	0	O
pharmacological	28167616	0	O
strategy	28167616	0	O
to	28167616	0	O
treat	28167616	0	O
mental	28167616	0	O
disorders	28167616	0	O
with	28167616	0	O
underlying	28167616	0	O
subcortical	28167616	0	O
dopaminergic	28167616	0	O
hyperactivity	28167616	0	O
.	28167616	0	O

Conformational	28167755	4	O
disruption	28167755	4	O
of	28167755	4	O
PI3Kδ	28167755	4	O
regulation	28167755	4	O
by	28167755	4	O
immunodeficiency	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
PIK3CD	28167755	4	O
and	28167755	4	O
PIK3R1	28167755	4	O
.	28167755	4	O
Activated	28167755	4	B-Disease
PI3K	28167755	4	I-Disease
Delta	28167755	4	I-Disease
Syndrome	28167755	4	I-Disease
(	28167755	4	O
APDS	28167755	4	O
)	28167755	4	O
is	28167755	4	O
a	28167755	4	O
primary	28167755	4	O
immunodeficiency	28167755	4	O
disease	28167755	4	O
caused	28167755	4	B-Reg
by	28167755	4	O
activating	28167755	4	O
mutations	28167755	4	B-Var
in	28167755	4	O
either	28167755	4	O
the	28167755	4	O
leukocyte	28167755	4	O
-	28167755	4	O
restricted	28167755	4	O
p110δ	28167755	4	O
catalytic	28167755	4	O
(	28167755	4	B-Gene
PIK3CD	28167755	4	I-Gene
)	28167755	4	I-Gene
subunit	28167755	4	O
or	28167755	4	O
the	28167755	4	O
ubiquitously	28167755	4	O
expressed	28167755	4	O
p85α	28167755	4	O
regulatory	28167755	4	O
(	28167755	4	O
PIK3R1	28167755	4	O
)	28167755	4	O
subunit	28167755	4	O
of	28167755	4	O
class	28167755	4	O
IA	28167755	4	O
phosphoinositide	28167755	4	O
3	28167755	4	O
-	28167755	4	O
kinases	28167755	4	O
(	28167755	4	O
PI3Ks	28167755	4	O
)	28167755	4	O
.	28167755	4	O
There	28167755	4	O
are	28167755	4	O
two	28167755	4	O
classes	28167755	4	O
of	28167755	4	O
APDS	28167755	4	O
:	28167755	4	O
APDS1	28167755	4	O
that	28167755	4	O
arises	28167755	4	O
from	28167755	4	O
p110δ	28167755	4	O
mutations	28167755	4	O
that	28167755	4	O
are	28167755	4	O
analogous	28167755	4	O
to	28167755	4	O
oncogenic	28167755	4	O
mutations	28167755	4	O
found	28167755	4	O
in	28167755	4	O
the	28167755	4	O
broadly	28167755	4	O
expressed	28167755	4	O
p110α	28167755	4	O
subunit	28167755	4	O
and	28167755	4	O
APDS2	28167755	4	O
that	28167755	4	O
occurs	28167755	4	O
from	28167755	4	O
a	28167755	4	O
splice	28167755	4	O
mutation	28167755	4	O
resulting	28167755	4	O
in	28167755	4	O
p85α	28167755	4	O
with	28167755	4	O
a	28167755	4	O
central	28167755	4	O
deletion	28167755	4	O
(	28167755	4	O
Δ434-475	28167755	4	O
)	28167755	4	O
.	28167755	4	O
As	28167755	4	O
p85	28167755	4	O
regulatory	28167755	4	O
subunits	28167755	4	O
associate	28167755	4	O
with	28167755	4	O
and	28167755	4	O
inhibit	28167755	4	O
all	28167755	4	O
class	28167755	4	O
IA	28167755	4	O
catalytic	28167755	4	O
subunits	28167755	4	O
,	28167755	4	O
APDS2	28167755	4	O
mutations	28167755	4	O
are	28167755	4	O
expected	28167755	4	O
to	28167755	4	O
similarly	28167755	4	O
activate	28167755	4	O
p110α	28167755	4	O
,	28167755	4	O
β	28167755	4	O
,	28167755	4	O
and	28167755	4	O
δ	28167755	4	O
,	28167755	4	O
yet	28167755	4	O
APDS2	28167755	4	O
largely	28167755	4	O
phenocopies	28167755	4	O
APDS1	28167755	4	O
without	28167755	4	O
dramatic	28167755	4	O
effects	28167755	4	O
outside	28167755	4	O
the	28167755	4	O
immune	28167755	4	O
system	28167755	4	O
.	28167755	4	O
We	28167755	4	O
have	28167755	4	O
examined	28167755	4	O
the	28167755	4	O
molecular	28167755	4	O
mechanism	28167755	4	O
of	28167755	4	O
activation	28167755	4	O
of	28167755	4	O
both	28167755	4	O
classes	28167755	4	O
of	28167755	4	O
APDS	28167755	4	O
mutations	28167755	4	O
using	28167755	4	O
a	28167755	4	O
combination	28167755	4	O
of	28167755	4	O
biochemical	28167755	4	O
assays	28167755	4	O
and	28167755	4	O
hydrogen	28167755	4	O
-	28167755	4	O
deuterium	28167755	4	O
exchange	28167755	4	O
mass	28167755	4	O
spectrometry	28167755	4	O
.	28167755	4	O
Intriguingly	28167755	4	O
,	28167755	4	O
we	28167755	4	O
find	28167755	4	O
that	28167755	4	O
an	28167755	4	O
APDS2	28167755	4	B-Gene
mutation	28167755	4	B-Var
in	28167755	4	O
p85α	28167755	4	O
leads	28167755	4	O
to	28167755	4	O
substantial	28167755	4	O
basal	28167755	4	O
activation	28167755	4	B-PosReg
of	28167755	4	O
p110δ	28167755	4	B-MPA
(	28167755	4	I-MPA
>	28167755	4	I-MPA
300	28167755	4	I-MPA
-	28167755	4	I-MPA
fold	28167755	4	I-MPA
)	28167755	4	I-MPA
and	28167755	4	O
disrupts	28167755	4	B-NegReg
inhibitory	28167755	4	B-MPA
interactions	28167755	4	I-MPA
from	28167755	4	O
the	28167755	4	O
nSH2	28167755	4	O
,	28167755	4	O
iSH2	28167755	4	O
,	28167755	4	O
and	28167755	4	O
cSH2	28167755	4	O
domains	28167755	4	O
of	28167755	4	O
p85	28167755	4	O
,	28167755	4	O
whereas	28167755	4	O
p110α	28167755	4	O
is	28167755	4	O
only	28167755	4	O
minimally	28167755	4	O
basally	28167755	4	O
activated	28167755	4	O
(	28167755	4	O
2	28167755	4	O
-	28167755	4	O
fold	28167755	4	O
)	28167755	4	O
when	28167755	4	O
associated	28167755	4	O
with	28167755	4	O
mutated	28167755	4	O
p85α	28167755	4	O
.	28167755	4	O
APDS1	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
p110δ	28167755	4	O
(	28167755	4	O
N334K	28167755	4	O
,	28167755	4	O
E525K	28167755	4	O
,	28167755	4	O
E1021K	28167755	4	O
)	28167755	4	O
mimic	28167755	4	O
the	28167755	4	O
activation	28167755	4	O
mechanisms	28167755	4	O
previously	28167755	4	O
discovered	28167755	4	O
for	28167755	4	O
oncogenic	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
p110α	28167755	4	O
.	28167755	4	O
All	28167755	4	O
APDS	28167755	4	O
mutations	28167755	4	O
were	28167755	4	O
potently	28167755	4	O
inhibited	28167755	4	O
by	28167755	4	O
the	28167755	4	O
Food	28167755	4	O
and	28167755	4	O
Drug	28167755	4	O
Administration	28167755	4	O
-	28167755	4	O
approved	28167755	4	O
p110δ	28167755	4	O
inhibitor	28167755	4	O
idelalisib	28167755	4	O
.	28167755	4	O
Our	28167755	4	O
results	28167755	4	O
define	28167755	4	O
the	28167755	4	O
molecular	28167755	4	O
basis	28167755	4	O
of	28167755	4	O
how	28167755	4	O
PIK3CD	28167755	4	O
and	28167755	4	O
PIK3R1	28167755	4	O
mutations	28167755	4	O
result	28167755	4	O
in	28167755	4	O
APDS	28167755	4	O
and	28167755	4	O
reveal	28167755	4	O
a	28167755	4	O
potential	28167755	4	O
path	28167755	4	O
to	28167755	4	O
treatment	28167755	4	O
for	28167755	4	O
all	28167755	4	O
APDS	28167755	4	O
patients	28167755	4	O
.	28167755	4	O

N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
Regulation	28240364	0	O
of	28240364	0	O
Bone	28240364	0	O
Growth	28240364	0	O
and	28240364	0	O
Homeostasis	28240364	0	O
Is	28240364	0	O
Osteolineage	28240364	0	O
Stage	28240364	0	O
-	28240364	0	O
Specific	28240364	0	O
.	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
inhibits	28240364	0	O
osteogenic	28240364	0	O
cell	28240364	0	O
differentiation	28240364	0	O
and	28240364	0	O
canonical	28240364	0	O
Wnt	28240364	0	O
/	28240364	0	O
β	28240364	0	O
-	28240364	0	O
catenin	28240364	0	O
signaling	28240364	0	O
in	28240364	0	O
vitro	28240364	0	O
.	28240364	0	O
However	28240364	0	O
,	28240364	0	O
in	28240364	0	O
vivo	28240364	0	O
both	28240364	0	O
conditional	28240364	0	O
Cdh2	28240364	0	O
ablation	28240364	0	O
and	28240364	0	O
overexpression	28240364	0	O
in	28240364	0	O
osteoblasts	28240364	0	O
lead	28240364	0	O
to	28240364	0	O
low	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
.	28240364	0	O
We	28240364	0	O
tested	28240364	0	O
the	28240364	0	O
hypothesis	28240364	0	O
that	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
has	28240364	0	O
different	28240364	0	O
effects	28240364	0	O
on	28240364	0	O
osteolineage	28240364	0	O
cells	28240364	0	O
depending	28240364	0	O
upon	28240364	0	O
their	28240364	0	O
differentiation	28240364	0	O
stage	28240364	0	O
.	28240364	0	O
Embryonic	28240364	0	O
conditional	28240364	0	O
osteolineage	28240364	0	O
Cdh2	28240364	0	B-Gene
deletion	28240364	0	B-Var
in	28240364	0	O
mice	28240364	0	O
results	28240364	0	O
in	28240364	0	O
defective	28240364	0	B-NegReg
growth	28240364	0	B-MPA
,	28240364	0	O
low	28240364	0	B-NegReg
bone	28240364	0	B-MPA
mass	28240364	0	I-MPA
,	28240364	0	O
and	28240364	0	O
reduced	28240364	0	B-NegReg
osteoprogenitor	28240364	0	B-MPA
number	28240364	0	I-MPA
.	28240364	0	O
These	28240364	0	O
abnormalities	28240364	0	O
are	28240364	0	O
prevented	28240364	0	O
by	28240364	0	O
delaying	28240364	0	O
Cdh2	28240364	0	O
ablation	28240364	0	O
until	28240364	0	O
1	28240364	0	O
month	28240364	0	O
of	28240364	0	O
age	28240364	0	O
,	28240364	0	O
thus	28240364	0	O
targeting	28240364	0	O
only	28240364	0	O
committed	28240364	0	O
and	28240364	0	O
mature	28240364	0	O
osteoblasts	28240364	0	O
,	28240364	0	O
suggesting	28240364	0	O
they	28240364	0	O
are	28240364	0	O
the	28240364	0	O
consequence	28240364	0	O
of	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
deficiency	28240364	0	O
in	28240364	0	O
osteoprogenitors	28240364	0	O
.	28240364	0	O
Indeed	28240364	0	O
,	28240364	0	O
diaphyseal	28240364	0	O
trabecularization	28240364	0	O
actually	28240364	0	O
increases	28240364	0	O
when	28240364	0	O
Cdh2	28240364	0	O
is	28240364	0	O
ablated	28240364	0	O
postnatally	28240364	0	O
.	28240364	0	O
The	28240364	0	O
sclerostin	28240364	0	O
-	28240364	0	O
insensitive	28240364	0	O
Lrp5	28240364	0	O
(	28240364	0	O
A214V	28240364	0	O
)	28240364	0	O
mutant	28240364	0	O
,	28240364	0	O
associated	28240364	0	O
with	28240364	0	O
high	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
,	28240364	0	O
does	28240364	0	O
not	28240364	0	O
rescue	28240364	0	O
the	28240364	0	O
growth	28240364	0	O
defect	28240364	0	O
,	28240364	0	O
but	28240364	0	O
it	28240364	0	O
overrides	28240364	0	O
the	28240364	0	O
low	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
of	28240364	0	O
embryonically	28240364	0	O
Cdh2	28240364	0	O
-	28240364	0	O
deleted	28240364	0	O
mice	28240364	0	O
,	28240364	0	O
suggesting	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
interacts	28240364	0	O
with	28240364	0	O
Wnt	28240364	0	O
signaling	28240364	0	O
to	28240364	0	O
control	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
.	28240364	0	O
Finally	28240364	0	O
,	28240364	0	O
bone	28240364	0	O
accrual	28240364	0	O
and	28240364	0	O
β	28240364	0	O
-	28240364	0	O
catenin	28240364	0	O
accumulation	28240364	0	O
after	28240364	0	O
administration	28240364	0	O
of	28240364	0	O
an	28240364	0	O
anti	28240364	0	O
-	28240364	0	O
Dkk1	28240364	0	O
antibody	28240364	0	O
are	28240364	0	O
enhanced	28240364	0	O
in	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
-	28240364	0	O
deficient	28240364	0	O
mice	28240364	0	O
.	28240364	0	O
Thus	28240364	0	O
,	28240364	0	O
although	28240364	0	O
lack	28240364	0	O
of	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
in	28240364	0	O
embryonic	28240364	0	O
and	28240364	0	O
perinatal	28240364	0	O
age	28240364	0	O
is	28240364	0	O
detrimental	28240364	0	O
to	28240364	0	O
bone	28240364	0	O
growth	28240364	0	O
and	28240364	0	O
bone	28240364	0	O
accrual	28240364	0	O
,	28240364	0	O
in	28240364	0	O
adult	28240364	0	O
mice	28240364	0	O
loss	28240364	0	O
of	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
in	28240364	0	O
osteolineage	28240364	0	O
cells	28240364	0	O
favors	28240364	0	O
bone	28240364	0	O
formation	28240364	0	O
.	28240364	0	O
Hence	28240364	0	O
,	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
inhibition	28240364	0	O
may	28240364	0	O
widen	28240364	0	O
the	28240364	0	O
therapeutic	28240364	0	O
window	28240364	0	O
of	28240364	0	O
osteoanabolic	28240364	0	O
agents	28240364	0	O
.	28240364	0	O
2017	28240364	0	O
American	28240364	0	O
Society	28240364	0	O
for	28240364	0	O
Bone	28240364	0	O
and	28240364	0	O
Mineral	28240364	0	O
Research	28240364	0	O
.	28240364	0	O

MAX	28270683	4	O
inactivation	28270683	4	O
is	28270683	4	O
an	28270683	4	O
early	28270683	4	O
event	28270683	4	O
in	28270683	4	O
GIST	28270683	4	O
development	28270683	4	O
that	28270683	4	O
regulates	28270683	4	O
p16	28270683	4	O
and	28270683	4	O
cell	28270683	4	O
proliferation	28270683	4	O
.	28270683	4	O
KIT	28270683	4	B-Gene
,	28270683	4	O
PDGFRA	28270683	4	B-Gene
,	28270683	4	O
NF1	28270683	4	B-Gene
and	28270683	4	O
SDH	28270683	4	B-Gene
mutations	28270683	4	B-Var
are	28270683	4	O
alternate	28270683	4	O
initiating	28270683	4	O
events	28270683	4	O
,	28270683	4	O
fostering	28270683	4	B-Reg
hyperplasia	28270683	4	O
in	28270683	4	O
gastrointestinal	28270683	4	B-MPA
stromal	28270683	4	I-MPA
tumours	28270683	4	I-MPA
(	28270683	4	O
GISTs	28270683	4	O
)	28270683	4	O
,	28270683	4	O
and	28270683	4	O
additional	28270683	4	O
genetic	28270683	4	O
alterations	28270683	4	O
are	28270683	4	O
required	28270683	4	O
for	28270683	4	O
progression	28270683	4	O
to	28270683	4	O
malignancy	28270683	4	O
.	28270683	4	O
The	28270683	4	O
most	28270683	4	O
frequent	28270683	4	O
secondary	28270683	4	O
alteration	28270683	4	O
,	28270683	4	O
demonstrated	28270683	4	O
in	28270683	4	O
70%	28270683	4	O
of	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
is	28270683	4	O
chromosome	28270683	4	O
14	28270683	4	O
q	28270683	4	O
deletion	28270683	4	O
.	28270683	4	O
Here	28270683	4	O
we	28270683	4	O
report	28270683	4	O
hemizygous	28270683	4	O
or	28270683	4	O
homozygous	28270683	4	O
inactivating	28270683	4	O
mutations	28270683	4	O
of	28270683	4	O
the	28270683	4	O
chromosome	28270683	4	O
14	28270683	4	O
q	28270683	4	O
MAX	28270683	4	O
gene	28270683	4	O
in	28270683	4	O
16	28270683	4	O
of	28270683	4	O
76	28270683	4	O
GISTs	28270683	4	O
(	28270683	4	O
21%	28270683	4	O
)	28270683	4	O
.	28270683	4	O
We	28270683	4	O
find	28270683	4	O
MAX	28270683	4	O
mutations	28270683	4	O
in	28270683	4	O
17%	28270683	4	O
and	28270683	4	O
50%	28270683	4	O
of	28270683	4	O
sporadic	28270683	4	O
and	28270683	4	O
NF1	28270683	4	O
-	28270683	4	O
syndromic	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
respectively	28270683	4	O
,	28270683	4	O
and	28270683	4	O
we	28270683	4	O
find	28270683	4	O
loss	28270683	4	O
of	28270683	4	O
MAX	28270683	4	O
protein	28270683	4	O
expression	28270683	4	O
in	28270683	4	O
48%	28270683	4	O
and	28270683	4	O
90%	28270683	4	O
of	28270683	4	O
sporadic	28270683	4	O
and	28270683	4	O
NF1	28270683	4	O
-	28270683	4	O
syndromic	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
respectively	28270683	4	O
,	28270683	4	O
and	28270683	4	O
in	28270683	4	O
three	28270683	4	O
of	28270683	4	O
eight	28270683	4	O
micro	28270683	4	O
-	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
which	28270683	4	O
are	28270683	4	O
early	28270683	4	O
GISTs	28270683	4	O
.	28270683	4	O
MAX	28270683	4	O
genomic	28270683	4	O
inactivation	28270683	4	O
is	28270683	4	O
associated	28270683	4	O
with	28270683	4	O
p16	28270683	4	O
silencing	28270683	4	O
in	28270683	4	O
the	28270683	4	O
absence	28270683	4	O
of	28270683	4	O
p16	28270683	4	O
coding	28270683	4	O
sequence	28270683	4	O
deletion	28270683	4	O
and	28270683	4	O
MAX	28270683	4	O
induction	28270683	4	O
restores	28270683	4	O
p16	28270683	4	O
expression	28270683	4	O
and	28270683	4	O
inhibits	28270683	4	O
GIST	28270683	4	O
proliferation	28270683	4	O
.	28270683	4	O
Hence	28270683	4	O
,	28270683	4	O
MAX	28270683	4	O
inactivation	28270683	4	O
is	28270683	4	O
a	28270683	4	O
common	28270683	4	O
event	28270683	4	O
in	28270683	4	O
GIST	28270683	4	O
progression	28270683	4	O
,	28270683	4	O
fostering	28270683	4	O
cell	28270683	4	O
cycle	28270683	4	O
activity	28270683	4	O
in	28270683	4	O
early	28270683	4	O
GISTs	28270683	4	O
.	28270683	4	O

ATR	28273450	1	B-Gene
Mutations	28273450	1	B-Var
Promote	28273450	1	B-PosReg
the	28273450	1	O
Growth	28273450	1	B-MPA
of	28273450	1	O
Melanoma	28273450	1	B-Disease
Tumors	28273450	1	I-Disease
by	28273450	1	O
Modulating	28273450	1	O
the	28273450	1	O
Immune	28273450	1	O
Microenvironment	28273450	1	O
.	28273450	1	O
Melanomas	28273450	1	O
accumulate	28273450	1	O
a	28273450	1	O
high	28273450	1	O
burden	28273450	1	O
of	28273450	1	O
mutations	28273450	1	B-Var
that	28273450	1	O
could	28273450	1	O
potentially	28273450	1	O
generate	28273450	1	B-Reg
neoantigens	28273450	1	B-MPA
,	28273450	1	O
yet	28273450	1	O
somehow	28273450	1	O
suppress	28273450	1	B-NegReg
the	28273450	1	O
immune	28273450	1	B-MPA
response	28273450	1	I-MPA
to	28273450	1	I-MPA
facilitate	28273450	1	I-MPA
continued	28273450	1	I-MPA
growth	28273450	1	I-MPA
.	28273450	1	O
In	28273450	1	O
this	28273450	1	O
study	28273450	1	O
,	28273450	1	O
we	28273450	1	O
identify	28273450	1	O
a	28273450	1	O
subset	28273450	1	O
of	28273450	1	O
human	28273450	1	O
melanomas	28273450	1	O
that	28273450	1	O
have	28273450	1	O
loss	28273450	1	O
-	28273450	1	O
of	28273450	1	O
-	28273450	1	O
function	28273450	1	O
mutations	28273450	1	O
in	28273450	1	O
ATR	28273450	1	O
,	28273450	1	O
a	28273450	1	O
kinase	28273450	1	O
that	28273450	1	O
recognizes	28273450	1	O
and	28273450	1	O
repairs	28273450	1	O
UV	28273450	1	O
-	28273450	1	O
induced	28273450	1	O
DNA	28273450	1	O
damage	28273450	1	O
and	28273450	1	O
is	28273450	1	O
required	28273450	1	O
for	28273450	1	O
cellular	28273450	1	O
proliferation	28273450	1	O
.	28273450	1	O
ATR	28273450	1	B-Gene
mutant	28273450	1	B-Var
tumors	28273450	1	O
exhibit	28273450	1	O
both	28273450	1	O
the	28273450	1	O
accumulation	28273450	1	O
of	28273450	1	O
multiple	28273450	1	O
mutations	28273450	1	O
and	28273450	1	O
the	28273450	1	O
altered	28273450	1	O
expression	28273450	1	O
of	28273450	1	O
inflammatory	28273450	1	O
genes	28273450	1	O
,	28273450	1	O
resulting	28273450	1	O
in	28273450	1	O
decreased	28273450	1	B-NegReg
T	28273450	1	B-MPA
cell	28273450	1	I-MPA
recruitment	28273450	1	I-MPA
and	28273450	1	O
increased	28273450	1	B-PosReg
recruitment	28273450	1	B-MPA
of	28273450	1	I-MPA
macrophages	28273450	1	I-MPA
known	28273450	1	O
to	28273450	1	O
spur	28273450	1	O
tumor	28273450	1	O
invasion	28273450	1	O
.	28273450	1	O
Taken	28273450	1	O
together	28273450	1	O
,	28273450	1	O
these	28273450	1	O
studies	28273450	1	O
identify	28273450	1	O
a	28273450	1	O
mechanism	28273450	1	O
by	28273450	1	O
which	28273450	1	O
melanoma	28273450	1	O
cells	28273450	1	O
modulate	28273450	1	O
the	28273450	1	O
immune	28273450	1	O
microenvironment	28273450	1	O
to	28273450	1	O
promote	28273450	1	O
continued	28273450	1	O
growth	28273450	1	O
.	28273450	1	O

Regulation	28277116	0	O
of	28277116	0	O
endometrial	28277116	0	O
cell	28277116	0	O
proliferation	28277116	0	O
by	28277116	0	O
estrogen	28277116	0	O
-	28277116	0	O
induced	28277116	0	O
BDNF	28277116	0	O
signaling	28277116	0	O
pathway	28277116	0	O
.	28277116	0	O
Brain	28277116	0	O
-	28277116	0	O
derived	28277116	0	O
neurotrophic	28277116	0	O
factor	28277116	0	O
(	28277116	0	O
BDNF	28277116	0	O
)	28277116	0	O
is	28277116	0	O
a	28277116	0	O
member	28277116	0	O
of	28277116	0	O
the	28277116	0	O
neurotrophin	28277116	0	O
growth	28277116	0	O
factors	28277116	0	O
family	28277116	0	O
.	28277116	0	O
Recent	28277116	0	O
studies	28277116	0	O
indicated	28277116	0	O
that	28277116	0	O
the	28277116	0	O
level	28277116	0	O
of	28277116	0	O
BDNF	28277116	0	O
in	28277116	0	O
follicular	28277116	0	O
fluid	28277116	0	O
is	28277116	0	O
a	28277116	0	O
marker	28277116	0	O
for	28277116	0	O
oocyte	28277116	0	O
quality	28277116	0	O
and	28277116	0	O
infertility	28277116	0	O
.	28277116	0	O
Here	28277116	0	O
,	28277116	0	O
we	28277116	0	O
intend	28277116	0	O
to	28277116	0	O
further	28277116	0	O
investigate	28277116	0	O
the	28277116	0	O
function	28277116	0	O
of	28277116	0	O
BDNF	28277116	0	O
and	28277116	0	O
its	28277116	0	O
signaling	28277116	0	O
pathway	28277116	0	O
in	28277116	0	O
the	28277116	0	O
regulation	28277116	0	O
of	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
proliferation	28277116	0	O
.	28277116	0	O
We	28277116	0	O
found	28277116	0	O
that	28277116	0	O
BDNF	28277116	0	O
is	28277116	0	O
a	28277116	0	O
critical	28277116	0	O
growth	28277116	0	O
factor	28277116	0	O
in	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
.	28277116	0	O
Activation	28277116	0	O
of	28277116	0	O
signal	28277116	0	O
transducer	28277116	0	O
and	28277116	0	O
activator	28277116	0	O
of	28277116	0	O
transcription	28277116	0	O
3	28277116	0	O
signaling	28277116	0	O
pathway	28277116	0	O
is	28277116	0	O
required	28277116	0	O
for	28277116	0	O
BNDF	28277116	0	O
-	28277116	0	O
regulated	28277116	0	O
endometrial	28277116	0	O
cell	28277116	0	O
proliferation	28277116	0	O
.	28277116	0	O
Furthermore	28277116	0	O
,	28277116	0	O
BDNF	28277116	0	O
is	28277116	0	O
an	28277116	0	O
effector	28277116	0	O
of	28277116	0	O
estrogen	28277116	0	O
in	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
.	28277116	0	O
Finally	28277116	0	O
,	28277116	0	O
we	28277116	0	O
investigated	28277116	0	O
the	28277116	0	O
different	28277116	0	O
role	28277116	0	O
of	28277116	0	O
Val66Met	28277116	0	O
,	28277116	0	O
a	28277116	0	O
single	28277116	0	O
-	28277116	0	O
nucleotide	28277116	0	O
polymorphism	28277116	0	O
of	28277116	0	O
the	28277116	0	O
BDNF	28277116	0	O
gene	28277116	0	O
,	28277116	0	O
in	28277116	0	O
regulating	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
proliferation	28277116	0	O
.	28277116	0	O
The	28277116	0	O
results	28277116	0	O
showed	28277116	0	O
that	28277116	0	O
BDNF	28277116	0	B-Gene
(	28277116	0	I-Gene
V66M	28277116	0	I-Gene
)	28277116	0	I-Gene
polymorphism	28277116	0	B-Var
is	28277116	0	O
a	28277116	0	O
loss	28277116	0	B-NegReg
-	28277116	0	I-NegReg
of	28277116	0	I-NegReg
-	28277116	0	I-NegReg
function	28277116	0	I-NegReg
polymorphism	28277116	0	B-Var
in	28277116	0	O
the	28277116	0	O
regulation	28277116	0	B-MPA
of	28277116	0	I-MPA
endometrial	28277116	0	I-MPA
cells	28277116	0	I-MPA
growth	28277116	0	I-MPA
.	28277116	0	O
Given	28277116	0	O
the	28277116	0	O
correlation	28277116	0	O
between	28277116	0	O
endometriosis	28277116	0	O
and	28277116	0	O
infertility	28277116	0	O
,	28277116	0	O
it	28277116	0	O
is	28277116	0	O
important	28277116	0	O
to	28277116	0	O
understand	28277116	0	O
the	28277116	0	O
role	28277116	0	O
of	28277116	0	O
BDNF	28277116	0	O
in	28277116	0	O
regulating	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
proliferation	28277116	0	O
and	28277116	0	O
to	28277116	0	O
develop	28277116	0	O
new	28277116	0	O
therapeutic	28277116	0	O
strategies	28277116	0	O
for	28277116	0	O
the	28277116	0	O
treatment	28277116	0	O
of	28277116	0	O
endometriosis	28277116	0	O
-	28277116	0	O
related	28277116	0	O
infertility	28277116	0	O
.	28277116	0	O

Impact	28283687	0	O
of	28283687	0	O
gain	28283687	0	B-PosReg
-	28283687	0	I-PosReg
of	28283687	0	I-PosReg
-	28283687	0	I-PosReg
function	28283687	0	I-PosReg
mutations	28283687	0	B-Var
in	28283687	0	O
the	28283687	0	O
low	28283687	0	O
-	28283687	0	O
density	28283687	0	O
lipoprotein	28283687	0	O
receptor	28283687	0	O
-	28283687	0	O
related	28283687	0	O
protein	28283687	0	O
5	28283687	0	O
(	28283687	0	B-Gene
LRP5	28283687	0	I-Gene
)	28283687	0	I-Gene
on	28283687	0	O
glucose	28283687	0	B-MPA
and	28283687	0	I-MPA
lipid	28283687	0	I-MPA
homeostasis	28283687	0	I-MPA
.	28283687	0	O
LRP5	28283687	0	B-Gene
loss	28283687	0	B-NegReg
-	28283687	0	I-NegReg
of	28283687	0	I-NegReg
-	28283687	0	I-NegReg
function	28283687	0	I-NegReg
mutations	28283687	0	B-Var
have	28283687	0	O
been	28283687	0	O
shown	28283687	0	O
to	28283687	0	O
cause	28283687	0	O
profound	28283687	0	B-MPA
osteoporosis	28283687	0	I-MPA
and	28283687	0	O
have	28283687	0	O
been	28283687	0	O
associated	28283687	0	O
with	28283687	0	O
impaired	28283687	0	B-MPA
insulin	28283687	0	I-MPA
sensitivity	28283687	0	I-MPA
and	28283687	0	O
dysregulated	28283687	0	B-MPA
lipid	28283687	0	I-MPA
metabolism	28283687	0	I-MPA
.	28283687	0	O
We	28283687	0	O
hypothesized	28283687	0	O
that	28283687	0	O
gain	28283687	0	O
-	28283687	0	O
of	28283687	0	O
-	28283687	0	O
function	28283687	0	O
mutations	28283687	0	O
in	28283687	0	O
LRP5	28283687	0	O
would	28283687	0	O
also	28283687	0	O
affect	28283687	0	O
these	28283687	0	O
parameters	28283687	0	O
.	28283687	0	O
We	28283687	0	O
therefore	28283687	0	O
studied	28283687	0	O
individuals	28283687	0	O
with	28283687	0	O
LRP5	28283687	0	B-Gene
gain	28283687	0	B-PosReg
-	28283687	0	I-PosReg
of	28283687	0	I-PosReg
-	28283687	0	I-PosReg
function	28283687	0	I-PosReg
mutations	28283687	0	B-Var
exhibiting	28283687	0	O
high	28283687	0	O
bone	28283687	0	O
mass	28283687	0	O
(	28283687	0	O
HBM	28283687	0	O
)	28283687	0	O
phenotypes	28283687	0	O
and	28283687	0	O
found	28283687	0	O
that	28283687	0	O
while	28283687	0	O
there	28283687	0	O
was	28283687	0	O
no	28283687	0	O
detected	28283687	0	O
change	28283687	0	O
in	28283687	0	O
insulin	28283687	0	O
sensitivity	28283687	0	O
,	28283687	0	O
there	28283687	0	O
was	28283687	0	O
a	28283687	0	O
significant	28283687	0	O
reduction	28283687	0	B-NegReg
in	28283687	0	O
serum	28283687	0	B-MPA
LDL	28283687	0	I-MPA
.	28283687	0	O
INTRODUCTION	28283687	0	O
:	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
through	28283687	0	O
LRP5	28283687	0	O
represents	28283687	0	O
a	28283687	0	O
newly	28283687	0	O
appreciated	28283687	0	O
metabolic	28283687	0	O
pathway	28283687	0	O
,	28283687	0	O
which	28283687	0	O
potentially	28283687	0	O
represents	28283687	0	O
a	28283687	0	O
target	28283687	0	O
for	28283687	0	O
drug	28283687	0	O
discovery	28283687	0	O
in	28283687	0	O
type	28283687	0	O
2	28283687	0	O
diabetes	28283687	0	O
and	28283687	0	O
hyperlipidemia	28283687	0	O
.	28283687	0	O
Studies	28283687	0	O
in	28283687	0	O
animal	28283687	0	O
models	28283687	0	O
suggest	28283687	0	O
a	28283687	0	O
physiologic	28283687	0	O
link	28283687	0	O
between	28283687	0	O
LRP5	28283687	0	O
and	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
homeostasis	28283687	0	O
;	28283687	0	O
however	28283687	0	O
,	28283687	0	O
whether	28283687	0	O
it	28283687	0	O
plays	28283687	0	O
a	28283687	0	O
similar	28283687	0	O
role	28283687	0	O
in	28283687	0	O
humans	28283687	0	O
is	28283687	0	O
unclear	28283687	0	O
.	28283687	0	O
As	28283687	0	O
current	28283687	0	O
literature	28283687	0	O
links	28283687	0	O
loss	28283687	0	O
-	28283687	0	O
of	28283687	0	O
-	28283687	0	O
function	28283687	0	O
LRP5	28283687	0	O
to	28283687	0	O
impaired	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
metabolism	28283687	0	O
,	28283687	0	O
we	28283687	0	O
hypothesized	28283687	0	O
that	28283687	0	O
individuals	28283687	0	O
with	28283687	0	O
an	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
mutation	28283687	0	O
in	28283687	0	O
LRP5	28283687	0	O
would	28283687	0	O
exhibit	28283687	0	O
improved	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
homeostasis	28283687	0	O
.	28283687	0	O
Since	28283687	0	O
studies	28283687	0	O
in	28283687	0	O
animal	28283687	0	O
models	28283687	0	O
have	28283687	0	O
suggested	28283687	0	O
that	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
augments	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
,	28283687	0	O
we	28283687	0	O
also	28283687	0	O
examined	28283687	0	O
the	28283687	0	O
effect	28283687	0	O
of	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
on	28283687	0	O
glucose	28283687	0	O
-	28283687	0	O
stimulated	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
on	28283687	0	O
human	28283687	0	O
pancreatic	28283687	0	O
islets	28283687	0	O
.	28283687	0	O
METHODS	28283687	0	O
:	28283687	0	O
This	28283687	0	O
was	28283687	0	O
a	28283687	0	O
matched	28283687	0	O
case	28283687	0	O
-	28283687	0	O
control	28283687	0	O
study	28283687	0	O
.	28283687	0	O
We	28283687	0	O
used	28283687	0	O
several	28283687	0	O
methods	28283687	0	O
to	28283687	0	O
assess	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
metabolism	28283687	0	O
in	28283687	0	O
11	28283687	0	O
individuals	28283687	0	O
with	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
mutations	28283687	0	O
in	28283687	0	O
LRP5	28283687	0	O
.	28283687	0	O
Affected	28283687	0	O
study	28283687	0	O
participants	28283687	0	O
were	28283687	0	O
recruited	28283687	0	O
from	28283687	0	O
previously	28283687	0	O
identified	28283687	0	O
kindreds	28283687	0	O
with	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
LRP5	28283687	0	O
mutations	28283687	0	O
and	28283687	0	O
included	28283687	0	O
9	28283687	0	O
males	28283687	0	O
and	28283687	0	O
2	28283687	0	O
females	28283687	0	O
.	28283687	0	O
Two	28283687	0	O
subjects	28283687	0	O
that	28283687	0	O
were	28283687	0	O
being	28283687	0	O
treated	28283687	0	O
with	28283687	0	O
insulin	28283687	0	O
for	28283687	0	O
type	28283687	0	O
2	28283687	0	O
diabetes	28283687	0	O
were	28283687	0	O
excluded	28283687	0	O
from	28283687	0	O
our	28283687	0	O
analysis	28283687	0	O
,	28283687	0	O
as	28283687	0	O
this	28283687	0	O
would	28283687	0	O
have	28283687	0	O
obscured	28283687	0	O
our	28283687	0	O
ability	28283687	0	O
to	28283687	0	O
determine	28283687	0	O
the	28283687	0	O
impact	28283687	0	O
of	28283687	0	O
gain	28283687	0	O
-	28283687	0	O
of	28283687	0	O
-	28283687	0	O
function	28283687	0	O
LRP5	28283687	0	O
mutations	28283687	0	O
on	28283687	0	O
glucose	28283687	0	O
metabolism	28283687	0	O
.	28283687	0	O
The	28283687	0	O
mean	28283687	0	O
age	28283687	0	O
of	28283687	0	O
the	28283687	0	O
evaluated	28283687	0	O
study	28283687	0	O
subjects	28283687	0	O
was	28283687	0	O
55	28283687	0	O
7	28283687	0	O
with	28283687	0	O
a	28283687	0	O
mean	28283687	0	O
BMI	28283687	0	O
of	28283687	0	O
27.2	28283687	0	O
2.0	28283687	0	O
.	28283687	0	O
Control	28283687	0	O
subjects	28283687	0	O
were	28283687	0	O
matched	28283687	0	O
and	28283687	0	O
recruited	28283687	0	O
from	28283687	0	O
the	28283687	0	O
general	28283687	0	O
community	28283687	0	O
at	28283687	0	O
an	28283687	0	O
equivalent	28283687	0	O
ratio	28283687	0	O
,	28283687	0	O
with	28283687	0	O
18	28283687	0	O
males	28283687	0	O
and	28283687	0	O
4	28283687	0	O
females	28283687	0	O
(	28283687	0	O
mean	28283687	0	O
age	28283687	0	O
56	28283687	0	O
4	28283687	0	O
;	28283687	0	O
mean	28283687	0	O
BMI	28283687	0	O
27.2	28283687	0	O
1.0	28283687	0	O
)	28283687	0	O
.	28283687	0	O
Study	28283687	0	O
testing	28283687	0	O
was	28283687	0	O
conducted	28283687	0	O
at	28283687	0	O
an	28283687	0	O
academic	28283687	0	O
medical	28283687	0	O
center	28283687	0	O
.	28283687	0	O
RESULTS	28283687	0	O
:	28283687	0	O
There	28283687	0	O
were	28283687	0	O
no	28283687	0	O
statistically	28283687	0	O
significant	28283687	0	O
differences	28283687	0	O
between	28283687	0	O
affected	28283687	0	O
and	28283687	0	O
matched	28283687	0	O
control	28283687	0	O
populations	28283687	0	O
for	28283687	0	O
HbA1c	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.06	28283687	0	O
)	28283687	0	O
,	28283687	0	O
eAG	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.06	28283687	0	O
)	28283687	0	O
,	28283687	0	O
insulin	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.82	28283687	0	O
)	28283687	0	O
,	28283687	0	O
HOMA	28283687	0	O
-	28283687	0	O
B	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.34	28283687	0	O
)	28283687	0	O
,	28283687	0	O
or	28283687	0	O
HOMA	28283687	0	O
-	28283687	0	O
IR	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.66	28283687	0	O
)	28283687	0	O
.	28283687	0	O
The	28283687	0	O
mean	28283687	0	O
Insulin	28283687	0	O
Sensitivity	28283687	0	O
Index	28283687	0	O
(	28283687	0	O
ISI	28283687	0	O
)	28283687	0	O
was	28283687	0	O
also	28283687	0	O
similar	28283687	0	O
between	28283687	0	O
control	28283687	0	O
and	28283687	0	O
affected	28283687	0	O
individuals	28283687	0	O
.	28283687	0	O
Total	28283687	0	O
cholesterol	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.43	28283687	0	O
)	28283687	0	O
,	28283687	0	O
triglycerides	28283687	0	O
(	28283687	0	O
TG	28283687	0	O
)	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.56	28283687	0	O
)	28283687	0	O
,	28283687	0	O
and	28283687	0	O
HDL	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.32	28283687	0	O
)	28283687	0	O
were	28283687	0	O
not	28283687	0	O
different	28283687	0	O
between	28283687	0	O
the	28283687	0	O
same	28283687	0	O
two	28283687	0	O
groups	28283687	0	O
.	28283687	0	O
In	28283687	0	O
a	28283687	0	O
small	28283687	0	O
subset	28283687	0	O
of	28283687	0	O
studied	28283687	0	O
subjects	28283687	0	O
,	28283687	0	O
intramyocellular	28283687	0	O
and	28283687	0	O
hepatic	28283687	0	O
lipid	28283687	0	O
content	28283687	0	O
were	28283687	0	O
similar	28283687	0	O
in	28283687	0	O
the	28283687	0	O
affected	28283687	0	O
individuals	28283687	0	O
and	28283687	0	O
controls	28283687	0	O
when	28283687	0	O
quantified	28283687	0	O
by	28283687	0	O
proton	28283687	0	O
magnetic	28283687	0	O
resonance	28283687	0	O
spectroscopy	28283687	0	O
(	28283687	0	O
MRS	28283687	0	O
)	28283687	0	O
.	28283687	0	O
However	28283687	0	O
,	28283687	0	O
the	28283687	0	O
mean	28283687	0	O
value	28283687	0	O
for	28283687	0	O
serum	28283687	0	O
LDL	28283687	0	O
was	28283687	0	O
significantly	28283687	0	O
lower	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.04	28283687	0	O
)	28283687	0	O
in	28283687	0	O
affected	28283687	0	O
individuals	28283687	0	O
.	28283687	0	O
In	28283687	0	O
primary	28283687	0	O
human	28283687	0	O
islets	28283687	0	O
,	28283687	0	O
there	28283687	0	O
were	28283687	0	O
no	28283687	0	O
differences	28283687	0	O
between	28283687	0	O
control	28283687	0	O
and	28283687	0	O
Wnt	28283687	0	O
treatment	28283687	0	O
groups	28283687	0	O
for	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
measured	28283687	0	O
as	28283687	0	O
area	28283687	0	O
under	28283687	0	O
the	28283687	0	O
curve	28283687	0	O
(	28283687	0	O
AUC	28283687	0	O
)	28283687	0	O
for	28283687	0	O
first	28283687	0	O
phase	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.17	28283687	0	O
)	28283687	0	O
or	28283687	0	O
second	28283687	0	O
phase	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.33	28283687	0	O
)	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
.	28283687	0	O
CONCLUSIONS	28283687	0	O
:	28283687	0	O
Although	28283687	0	O
our	28283687	0	O
sample	28283687	0	O
size	28283687	0	O
was	28283687	0	O
small	28283687	0	O
,	28283687	0	O
our	28283687	0	O
data	28283687	0	O
do	28283687	0	O
not	28283687	0	O
support	28283687	0	O
the	28283687	0	O
hypothesis	28283687	0	O
that	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
LRP5	28283687	0	O
mutations	28283687	0	O
,	28283687	0	O
associated	28283687	0	O
with	28283687	0	O
increased	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
,	28283687	0	O
improve	28283687	0	O
glucose	28283687	0	O
metabolism	28283687	0	O
in	28283687	0	O
humans	28283687	0	O
.	28283687	0	O
However	28283687	0	O
,	28283687	0	O
it	28283687	0	O
does	28283687	0	O
appear	28283687	0	O
that	28283687	0	O
LRP5	28283687	0	B-Gene
variants	28283687	0	B-Var
may	28283687	0	O
affect	28283687	0	B-Reg
LDL	28283687	0	B-MPA
metabolism	28283687	0	I-MPA
,	28283687	0	O
a	28283687	0	O
major	28283687	0	O
risk	28283687	0	O
factor	28283687	0	O
for	28283687	0	O
coronary	28283687	0	O
artery	28283687	0	O
disease	28283687	0	O
.	28283687	0	O
The	28283687	0	O
molecular	28283687	0	O
mechanisms	28283687	0	O
underpinning	28283687	0	O
this	28283687	0	O
effect	28283687	0	O
warrant	28283687	0	O
further	28283687	0	O
study	28283687	0	O
.	28283687	0	O

The	28314794	0	O
Microtubule	28314794	0	O
-	28314794	0	O
Associated	28314794	0	O
Protein	28314794	0	O
MAP18	28314794	0	O
Affects	28314794	0	O
ROP2	28314794	0	O
GTPase	28314794	0	O
Activity	28314794	0	O
during	28314794	0	O
Root	28314794	0	O
Hair	28314794	0	O
Growth	28314794	0	O
.	28314794	0	O
Establishment	28314794	0	O
and	28314794	0	O
maintenance	28314794	0	O
of	28314794	0	O
the	28314794	0	O
polar	28314794	0	O
site	28314794	0	O
are	28314794	0	O
important	28314794	0	O
for	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
tip	28314794	0	O
growth	28314794	0	O
.	28314794	0	O
We	28314794	0	O
previously	28314794	0	O
reported	28314794	0	O
that	28314794	0	O
Arabidopsis	28314794	0	O
(	28314794	0	O
Arabidopsis	28314794	0	O
thaliana	28314794	0	O
)	28314794	0	O
MICROTUBULE	28314794	0	O
-	28314794	0	O
ASSOCIATED	28314794	0	O
PROTEIN18	28314794	0	O
(	28314794	0	O
MAP18	28314794	0	O
)	28314794	0	O
functions	28314794	0	O
in	28314794	0	O
controlling	28314794	0	O
the	28314794	0	O
direction	28314794	0	O
of	28314794	0	O
pollen	28314794	0	O
tube	28314794	0	O
growth	28314794	0	O
and	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
elongation	28314794	0	O
.	28314794	0	O
Additionally	28314794	0	O
,	28314794	0	O
the	28314794	0	O
Rop	28314794	0	O
GTPase	28314794	0	O
ROP2	28314794	0	O
was	28314794	0	O
reported	28314794	0	O
as	28314794	0	O
a	28314794	0	O
positive	28314794	0	O
regulator	28314794	0	O
of	28314794	0	O
both	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
initiation	28314794	0	O
and	28314794	0	O
tip	28314794	0	O
growth	28314794	0	O
in	28314794	0	O
Arabidopsis	28314794	0	O
.	28314794	0	O
Both	28314794	0	O
loss	28314794	0	B-NegReg
of	28314794	0	I-NegReg
function	28314794	0	I-NegReg
of	28314794	0	O
ROP2	28314794	0	B-Gene
and	28314794	0	O
knockdown	28314794	0	B-Var
of	28314794	0	O
MAP18	28314794	0	B-Gene
lead	28314794	0	O
to	28314794	0	O
a	28314794	0	O
decrease	28314794	0	B-NegReg
in	28314794	0	O
root	28314794	0	B-MPA
hair	28314794	0	I-MPA
length	28314794	0	I-MPA
,	28314794	0	O
whereas	28314794	0	O
overexpression	28314794	0	O
of	28314794	0	O
either	28314794	0	O
MAP18	28314794	0	O
or	28314794	0	O
ROP2	28314794	0	O
causes	28314794	0	O
multiple	28314794	0	O
tips	28314794	0	O
or	28314794	0	O
a	28314794	0	O
branching	28314794	0	O
hair	28314794	0	O
phenotype	28314794	0	O
.	28314794	0	O
However	28314794	0	O
,	28314794	0	O
it	28314794	0	O
is	28314794	0	O
unclear	28314794	0	O
whether	28314794	0	O
MAP18	28314794	0	O
and	28314794	0	O
ROP2	28314794	0	O
coordinately	28314794	0	O
regulate	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
growth	28314794	0	O
.	28314794	0	O
In	28314794	0	O
this	28314794	0	O
study	28314794	0	O
,	28314794	0	O
we	28314794	0	O
demonstrate	28314794	0	O
that	28314794	0	O
MAP18	28314794	0	O
and	28314794	0	O
ROP2	28314794	0	O
interact	28314794	0	O
genetically	28314794	0	O
and	28314794	0	O
functionally	28314794	0	O
.	28314794	0	O
MAP18	28314794	0	O
interacts	28314794	0	O
physically	28314794	0	O
with	28314794	0	O
ROP2	28314794	0	O
in	28314794	0	O
vitro	28314794	0	O
and	28314794	0	O
in	28314794	0	O
vivo	28314794	0	O
and	28314794	0	O
preferentially	28314794	0	O
binds	28314794	0	O
to	28314794	0	O
the	28314794	0	O
inactive	28314794	0	O
form	28314794	0	O
of	28314794	0	O
the	28314794	0	O
ROP2	28314794	0	O
protein	28314794	0	O
.	28314794	0	O
MAP18	28314794	0	O
promotes	28314794	0	O
ROP2	28314794	0	O
activity	28314794	0	O
during	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
tip	28314794	0	O
growth	28314794	0	O
.	28314794	0	O
Further	28314794	0	O
investigation	28314794	0	O
revealed	28314794	0	O
that	28314794	0	O
MAP18	28314794	0	O
competes	28314794	0	O
with	28314794	0	O
RhoGTPase	28314794	0	O
GDP	28314794	0	O
DISSOCIATION	28314794	0	O
INHIBITOR1	28314794	0	O
/	28314794	0	O
SUPERCENTIPEDE1	28314794	0	O
for	28314794	0	O
binding	28314794	0	O
to	28314794	0	O
ROP2	28314794	0	O
,	28314794	0	O
in	28314794	0	O
turn	28314794	0	O
affecting	28314794	0	O
the	28314794	0	O
localization	28314794	0	O
of	28314794	0	O
active	28314794	0	O
ROP2	28314794	0	O
in	28314794	0	O
the	28314794	0	O
plasma	28314794	0	O
membrane	28314794	0	O
of	28314794	0	O
the	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
tip	28314794	0	O
.	28314794	0	O
These	28314794	0	O
results	28314794	0	O
reveal	28314794	0	O
a	28314794	0	O
novel	28314794	0	O
function	28314794	0	O
of	28314794	0	O
MAP18	28314794	0	O
in	28314794	0	O
the	28314794	0	O
regulation	28314794	0	O
of	28314794	0	O
ROP2	28314794	0	O
activation	28314794	0	O
during	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
growth	28314794	0	O
.	28314794	0	O

A	28322269	0	O
Ras	28322269	0	O
GTPase	28322269	0	O
associated	28322269	0	O
protein	28322269	0	O
is	28322269	0	O
involved	28322269	0	O
in	28322269	0	O
the	28322269	0	O
phototropic	28322269	0	O
and	28322269	0	O
circadian	28322269	0	O
photobiology	28322269	0	O
responses	28322269	0	O
in	28322269	0	O
fungi	28322269	0	O
.	28322269	0	O
Light	28322269	0	O
is	28322269	0	O
an	28322269	0	O
environmental	28322269	0	O
signal	28322269	0	O
perceived	28322269	0	O
by	28322269	0	O
most	28322269	0	O
eukaryotic	28322269	0	O
organisms	28322269	0	O
and	28322269	0	O
that	28322269	0	O
can	28322269	0	O
have	28322269	0	O
major	28322269	0	O
impacts	28322269	0	O
on	28322269	0	O
their	28322269	0	O
growth	28322269	0	O
and	28322269	0	O
development	28322269	0	O
.	28322269	0	O
The	28322269	0	O
MadC	28322269	0	O
protein	28322269	0	O
in	28322269	0	O
the	28322269	0	O
fungus	28322269	0	O
Phycomyces	28322269	0	O
blakesleeanus	28322269	0	O
(	28322269	0	O
Mucoromycotina	28322269	0	O
)	28322269	0	O
has	28322269	0	O
been	28322269	0	O
postulated	28322269	0	O
to	28322269	0	O
form	28322269	0	O
part	28322269	0	O
of	28322269	0	O
the	28322269	0	O
photosensory	28322269	0	O
input	28322269	0	O
for	28322269	0	O
phototropism	28322269	0	O
of	28322269	0	O
the	28322269	0	O
fruiting	28322269	0	O
body	28322269	0	O
sporangiophores	28322269	0	O
,	28322269	0	O
but	28322269	0	O
the	28322269	0	O
madC	28322269	0	O
gene	28322269	0	O
has	28322269	0	O
remained	28322269	0	O
unidentified	28322269	0	O
since	28322269	0	O
the	28322269	0	O
1960	28322269	0	O
s	28322269	0	O
when	28322269	0	O
madC	28322269	0	O
mutants	28322269	0	O
were	28322269	0	O
first	28322269	0	O
isolated	28322269	0	O
.	28322269	0	O
In	28322269	0	O
this	28322269	0	O
study	28322269	0	O
the	28322269	0	O
madC	28322269	0	O
gene	28322269	0	O
was	28322269	0	O
identified	28322269	0	O
by	28322269	0	O
positional	28322269	0	O
cloning	28322269	0	O
.	28322269	0	O
All	28322269	0	O
madC	28322269	0	O
mutant	28322269	0	O
strains	28322269	0	O
contain	28322269	0	O
loss	28322269	0	O
-	28322269	0	O
of	28322269	0	O
-	28322269	0	O
function	28322269	0	O
point	28322269	0	O
mutations	28322269	0	O
within	28322269	0	O
a	28322269	0	O
gene	28322269	0	O
predicted	28322269	0	O
to	28322269	0	O
encode	28322269	0	O
a	28322269	0	O
GTPase	28322269	0	O
activating	28322269	0	O
protein	28322269	0	O
(	28322269	0	O
GAP	28322269	0	O
)	28322269	0	O
for	28322269	0	O
Ras	28322269	0	O
.	28322269	0	O
The	28322269	0	O
madC	28322269	0	O
gene	28322269	0	O
complements	28322269	0	O
the	28322269	0	O
Saccharomyces	28322269	0	O
cerevisiae	28322269	0	O
Ras	28322269	0	O
-	28322269	0	O
GAP	28322269	0	O
ira1	28322269	0	O
mutant	28322269	0	O
and	28322269	0	O
the	28322269	0	O
encoded	28322269	0	O
MadC	28322269	0	O
protein	28322269	0	O
interacts	28322269	0	O
with	28322269	0	O
P.	28322269	0	O
blakesleeanus	28322269	0	O
Ras	28322269	0	O
homologs	28322269	0	O
in	28322269	0	O
yeast	28322269	0	O
two	28322269	0	O
-	28322269	0	O
hybrid	28322269	0	O
assays	28322269	0	O
,	28322269	0	O
indicating	28322269	0	O
that	28322269	0	O
MadC	28322269	0	O
is	28322269	0	O
a	28322269	0	O
regulator	28322269	0	O
of	28322269	0	O
Ras	28322269	0	O
signaling	28322269	0	O
.	28322269	0	O
Deletion	28322269	0	B-Var
of	28322269	0	O
the	28322269	0	O
homolog	28322269	0	O
in	28322269	0	O
the	28322269	0	O
filamentous	28322269	0	O
ascomycete	28322269	0	O
Neurospora	28322269	0	O
crassa	28322269	0	O
affects	28322269	0	B-Reg
the	28322269	0	O
circadian	28322269	0	B-MPA
clock	28322269	0	I-MPA
output	28322269	0	I-MPA
,	28322269	0	O
yielding	28322269	0	B-Reg
a	28322269	0	O
pattern	28322269	0	O
of	28322269	0	O
asexual	28322269	0	B-MPA
conidiation	28322269	0	I-MPA
similar	28322269	0	O
to	28322269	0	O
a	28322269	0	O
ras-1	28322269	0	O
mutant	28322269	0	O
that	28322269	0	O
is	28322269	0	O
used	28322269	0	O
in	28322269	0	O
circadian	28322269	0	O
studies	28322269	0	O
in	28322269	0	O
N.	28322269	0	O
crassa	28322269	0	O
.	28322269	0	O
Thus	28322269	0	O
,	28322269	0	O
MadC	28322269	0	O
is	28322269	0	O
unlikely	28322269	0	O
to	28322269	0	O
be	28322269	0	O
a	28322269	0	O
photosensor	28322269	0	O
,	28322269	0	O
yet	28322269	0	O
is	28322269	0	O
a	28322269	0	O
fundamental	28322269	0	O
link	28322269	0	O
in	28322269	0	O
the	28322269	0	O
photoresponses	28322269	0	O
from	28322269	0	O
blue	28322269	0	O
light	28322269	0	O
perceived	28322269	0	O
by	28322269	0	O
the	28322269	0	O
conserved	28322269	0	O
White	28322269	0	O
Collar	28322269	0	O
complex	28322269	0	O
with	28322269	0	O
Ras	28322269	0	O
signaling	28322269	0	O
in	28322269	0	O
two	28322269	0	O
distantly	28322269	0	O
-	28322269	0	O
related	28322269	0	O
filamentous	28322269	0	O
fungal	28322269	0	O
species	28322269	0	O
.	28322269	0	O

Paradoxical	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
mutant	28338294	0	O
of	28338294	0	O
the	28338294	0	O
G	28338294	0	O
-	28338294	0	O
protein	28338294	0	O
-	28338294	0	O
coupled	28338294	0	O
receptor	28338294	0	O
PROKR2	28338294	0	O
promotes	28338294	0	O
early	28338294	0	O
puberty	28338294	0	O
.	28338294	0	O
The	28338294	0	O
human	28338294	0	O
genome	28338294	0	O
encodes	28338294	0	O
750	28338294	0	O
G	28338294	0	O
-	28338294	0	O
protein	28338294	0	O
-	28338294	0	O
coupled	28338294	0	O
receptors	28338294	0	O
(	28338294	0	O
GPCRs	28338294	0	O
)	28338294	0	O
,	28338294	0	O
including	28338294	0	O
prokineticin	28338294	0	O
receptor	28338294	0	O
2	28338294	0	O
(	28338294	0	O
PROKR2	28338294	0	O
)	28338294	0	O
involved	28338294	0	O
in	28338294	0	O
the	28338294	0	O
regulation	28338294	0	O
of	28338294	0	O
sexual	28338294	0	O
maturation	28338294	0	O
.	28338294	0	O
Previously	28338294	0	O
reported	28338294	0	O
pathogenic	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
mutations	28338294	0	O
of	28338294	0	O
GPCR	28338294	0	O
genes	28338294	0	O
invariably	28338294	0	O
encoded	28338294	0	O
aberrant	28338294	0	O
receptors	28338294	0	O
with	28338294	0	O
excessive	28338294	0	O
signal	28338294	0	O
transduction	28338294	0	O
activity	28338294	0	O
.	28338294	0	O
Although	28338294	0	O
in	28338294	0	O
vitro	28338294	0	O
assays	28338294	0	O
demonstrated	28338294	0	O
that	28338294	0	O
an	28338294	0	O
artificially	28338294	0	O
created	28338294	0	O
inactive	28338294	0	O
mutant	28338294	0	O
of	28338294	0	O
PROKR2	28338294	0	O
exerted	28338294	0	O
paradoxical	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
effects	28338294	0	O
when	28338294	0	O
co	28338294	0	O
-	28338294	0	O
transfected	28338294	0	O
with	28338294	0	O
wild	28338294	0	O
-	28338294	0	O
type	28338294	0	O
proteins	28338294	0	O
,	28338294	0	O
such	28338294	0	O
a	28338294	0	O
phenomenon	28338294	0	O
has	28338294	0	O
not	28338294	0	O
been	28338294	0	O
observed	28338294	0	O
in	28338294	0	O
vivo	28338294	0	O
.	28338294	0	O
Here	28338294	0	O
,	28338294	0	O
we	28338294	0	O
report	28338294	0	O
a	28338294	0	O
heterozygous	28338294	0	O
frameshift	28338294	0	O
mutation	28338294	0	O
of	28338294	0	O
PROKR2	28338294	0	O
identified	28338294	0	O
in	28338294	0	O
a	28338294	0	O
3.5	28338294	0	O
-	28338294	0	O
year	28338294	0	O
-	28338294	0	O
old	28338294	0	O
girl	28338294	0	O
with	28338294	0	O
central	28338294	0	O
precocious	28338294	0	O
puberty	28338294	0	O
.	28338294	0	O
The	28338294	0	O
mutant	28338294	0	B-Var
mRNA	28338294	0	O
escaped	28338294	0	B-NegReg
nonsense	28338294	0	B-MPA
-	28338294	0	I-MPA
mediated	28338294	0	I-MPA
decay	28338294	0	I-MPA
and	28338294	0	O
generated	28338294	0	O
a	28338294	0	O
GPCR	28338294	0	O
lacking	28338294	0	B-NegReg
two	28338294	0	B-MPA
transmembrane	28338294	0	I-MPA
domains	28338294	0	I-MPA
and	28338294	0	O
the	28338294	0	O
carboxyl	28338294	0	O
-	28338294	0	O
terminal	28338294	0	O
tail	28338294	0	O
.	28338294	0	O
The	28338294	0	O
mutant	28338294	0	O
protein	28338294	0	O
had	28338294	0	O
no	28338294	0	O
in	28338294	0	O
vitro	28338294	0	O
signal	28338294	0	O
transduction	28338294	0	O
activity	28338294	0	O
;	28338294	0	O
however	28338294	0	O
,	28338294	0	O
cells	28338294	0	O
co	28338294	0	O
-	28338294	0	O
expressing	28338294	0	O
the	28338294	0	O
mutant	28338294	0	O
and	28338294	0	O
wild	28338294	0	O
-	28338294	0	O
type	28338294	0	O
PROKR2	28338294	0	O
exhibited	28338294	0	O
markedly	28338294	0	O
exaggerated	28338294	0	O
ligand	28338294	0	O
-	28338294	0	O
induced	28338294	0	O
Ca	28338294	0	O
(	28338294	0	O
2	28338294	0	O
)	28338294	0	O
responses	28338294	0	O
.	28338294	0	O
The	28338294	0	O
results	28338294	0	O
indicate	28338294	0	O
that	28338294	0	O
certain	28338294	0	O
inactive	28338294	0	O
PROKR2	28338294	0	B-Gene
mutants	28338294	0	B-Var
can	28338294	0	O
cause	28338294	0	O
early	28338294	0	O
puberty	28338294	0	O
by	28338294	0	O
enhancing	28338294	0	B-PosReg
the	28338294	0	O
functional	28338294	0	B-MPA
property	28338294	0	I-MPA
of	28338294	0	I-MPA
coexisting	28338294	0	I-MPA
wild	28338294	0	I-MPA
-	28338294	0	I-MPA
type	28338294	0	I-MPA
proteins	28338294	0	I-MPA
.	28338294	0	O
Considering	28338294	0	O
the	28338294	0	O
structural	28338294	0	O
similarity	28338294	0	O
among	28338294	0	O
GPCRs	28338294	0	O
,	28338294	0	O
this	28338294	0	O
paradoxical	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
mechanism	28338294	0	O
may	28338294	0	O
underlie	28338294	0	O
various	28338294	0	O
human	28338294	0	O
disorders	28338294	0	O
.	28338294	0	O

The	28339550	0	O
Tension	28339550	0	O
-	28339550	0	O
sensitive	28339550	0	O
Ion	28339550	0	O
Transport	28339550	0	O
Activity	28339550	0	O
of	28339550	0	O
MSL8	28339550	0	O
is	28339550	0	O
Critical	28339550	0	O
for	28339550	0	O
its	28339550	0	O
Function	28339550	0	O
in	28339550	0	O
Pollen	28339550	0	O
Hydration	28339550	0	O
and	28339550	0	O
Germination	28339550	0	O
.	28339550	0	O
All	28339550	0	O
cells	28339550	0	O
respond	28339550	0	O
to	28339550	0	O
osmotic	28339550	0	O
challenges	28339550	0	O
,	28339550	0	O
including	28339550	0	O
those	28339550	0	O
imposed	28339550	0	O
during	28339550	0	O
normal	28339550	0	O
growth	28339550	0	O
and	28339550	0	O
development	28339550	0	O
.	28339550	0	O
Mechanosensitive	28339550	0	O
(	28339550	0	O
MS	28339550	0	O
)	28339550	0	O
ion	28339550	0	O
channels	28339550	0	O
provide	28339550	0	O
a	28339550	0	O
conserved	28339550	0	O
mechanism	28339550	0	O
for	28339550	0	O
regulating	28339550	0	O
osmotic	28339550	0	O
forces	28339550	0	O
by	28339550	0	O
conducting	28339550	0	O
ions	28339550	0	O
in	28339550	0	O
response	28339550	0	O
to	28339550	0	O
increased	28339550	0	O
membrane	28339550	0	O
tension	28339550	0	O
.	28339550	0	O
We	28339550	0	O
previously	28339550	0	O
demonstrated	28339550	0	O
that	28339550	0	O
the	28339550	0	O
MS	28339550	0	O
ion	28339550	0	O
channel	28339550	0	O
MscS	28339550	0	O
-	28339550	0	O
Like	28339550	0	O
8	28339550	0	O
(	28339550	0	O
MSL8	28339550	0	O
)	28339550	0	O
is	28339550	0	O
required	28339550	0	O
for	28339550	0	O
pollen	28339550	0	O
to	28339550	0	O
survive	28339550	0	O
multiple	28339550	0	O
osmotic	28339550	0	O
challenges	28339550	0	O
that	28339550	0	O
occur	28339550	0	O
during	28339550	0	O
the	28339550	0	O
normal	28339550	0	O
process	28339550	0	O
of	28339550	0	O
fertilization	28339550	0	O
,	28339550	0	O
and	28339550	0	O
that	28339550	0	O
it	28339550	0	O
can	28339550	0	O
inhibit	28339550	0	O
pollen	28339550	0	O
germination	28339550	0	O
.	28339550	0	O
However	28339550	0	O
,	28339550	0	O
it	28339550	0	O
remained	28339550	0	O
unclear	28339550	0	O
whether	28339550	0	O
these	28339550	0	O
physiological	28339550	0	O
functions	28339550	0	O
required	28339550	0	O
ion	28339550	0	O
flux	28339550	0	O
through	28339550	0	O
a	28339550	0	O
mechanically	28339550	0	O
gated	28339550	0	O
channel	28339550	0	O
provided	28339550	0	O
by	28339550	0	O
MSL8	28339550	0	O
.	28339550	0	O
We	28339550	0	O
introduced	28339550	0	O
two	28339550	0	O
point	28339550	0	O
mutations	28339550	0	B-Var
into	28339550	0	O
the	28339550	0	O
predicted	28339550	0	O
pore	28339550	0	O
-	28339550	0	O
lining	28339550	0	O
domain	28339550	0	O
of	28339550	0	O
MSL8	28339550	0	B-Gene
that	28339550	0	O
disrupted	28339550	0	B-NegReg
normal	28339550	0	B-Pathway
channel	28339550	0	I-Pathway
function	28339550	0	I-Pathway
in	28339550	0	O
different	28339550	0	O
ways	28339550	0	O
.	28339550	0	O
The	28339550	0	O
Ile711Ser	28339550	0	B-Var
mutation	28339550	0	I-Var
increased	28339550	0	B-PosReg
the	28339550	0	O
tension	28339550	0	B-MPA
threshold	28339550	0	I-MPA
of	28339550	0	O
the	28339550	0	O
MSL8	28339550	0	B-Gene
channel	28339550	0	O
while	28339550	0	O
leaving	28339550	0	B-Reg
conductance	28339550	0	B-MPA
unchanged	28339550	0	I-MPA
,	28339550	0	O
and	28339550	0	O
the	28339550	0	O
Phe720Leu	28339550	0	B-Var
mutation	28339550	0	I-Var
severely	28339550	0	O
disrupted	28339550	0	B-NegReg
the	28339550	0	O
MSL8	28339550	0	B-Gene
channel	28339550	0	B-Pathway
.	28339550	0	O
Both	28339550	0	O
of	28339550	0	O
these	28339550	0	O
mutations	28339550	0	B-Var
impaired	28339550	0	B-NegReg
the	28339550	0	O
ability	28339550	0	B-MPA
of	28339550	0	I-MPA
MSL8	28339550	0	I-MPA
to	28339550	0	I-MPA
preserve	28339550	0	I-MPA
pollen	28339550	0	I-MPA
viability	28339550	0	I-MPA
during	28339550	0	I-MPA
hydration	28339550	0	I-MPA
and	28339550	0	O
to	28339550	0	O
maintain	28339550	0	B-Reg
the	28339550	0	O
integrity	28339550	0	B-MPA
of	28339550	0	I-MPA
the	28339550	0	I-MPA
pollen	28339550	0	I-MPA
tube	28339550	0	I-MPA
when	28339550	0	O
expressed	28339550	0	O
at	28339550	0	O
endogenous	28339550	0	O
levels	28339550	0	O
.	28339550	0	O
When	28339550	0	O
overexpressed	28339550	0	O
in	28339550	0	O
an	28339550	0	O
msl8-4	28339550	0	O
null	28339550	0	O
background	28339550	0	O
,	28339550	0	O
MSL8I711S	28339550	0	O
could	28339550	0	O
partially	28339550	0	O
rescue	28339550	0	O
loss	28339550	0	O
-	28339550	0	O
of	28339550	0	O
-	28339550	0	O
function	28339550	0	O
phenotypes	28339550	0	O
,	28339550	0	O
while	28339550	0	O
MSL8F720L	28339550	0	O
could	28339550	0	O
not	28339550	0	O
.	28339550	0	O
When	28339550	0	O
overexpressed	28339550	0	O
in	28339550	0	O
the	28339550	0	O
wild	28339550	0	O
-	28339550	0	O
type	28339550	0	O
Ler	28339550	0	O
background	28339550	0	O
,	28339550	0	O
MSL8I711S	28339550	0	O
suppressed	28339550	0	O
pollen	28339550	0	O
germination	28339550	0	O
,	28339550	0	O
similar	28339550	0	O
to	28339550	0	O
wild	28339550	0	O
-	28339550	0	O
type	28339550	0	O
MSL8	28339550	0	O
.	28339550	0	O
In	28339550	0	O
contrast	28339550	0	O
,	28339550	0	O
MSL8F720L	28339550	0	O
failed	28339550	0	O
to	28339550	0	O
suppress	28339550	0	O
pollen	28339550	0	O
germination	28339550	0	O
and	28339550	0	O
increased	28339550	0	O
pollen	28339550	0	O
bursting	28339550	0	O
,	28339550	0	O
thereby	28339550	0	O
phenocopying	28339550	0	O
the	28339550	0	O
msl8-4	28339550	0	O
mutant	28339550	0	O
.	28339550	0	O
Thus	28339550	0	O
,	28339550	0	O
an	28339550	0	O
intact	28339550	0	O
MSL8	28339550	0	O
channel	28339550	0	O
is	28339550	0	O
required	28339550	0	O
for	28339550	0	O
normal	28339550	0	O
pollen	28339550	0	O
function	28339550	0	O
during	28339550	0	O
hydration	28339550	0	O
and	28339550	0	O
germination	28339550	0	O
.	28339550	0	O
These	28339550	0	O
data	28339550	0	O
establish	28339550	0	O
MSL8	28339550	0	O
as	28339550	0	O
the	28339550	0	O
first	28339550	0	O
plant	28339550	0	O
MS	28339550	0	O
channel	28339550	0	O
to	28339550	0	O
fulfill	28339550	0	O
previously	28339550	0	O
established	28339550	0	O
criteria	28339550	0	O
for	28339550	0	O
assignment	28339550	0	O
as	28339550	0	O
a	28339550	0	O
mechanotransducer	28339550	0	O
.	28339550	0	O

RACK1	28343944	0	O
cooperates	28343944	0	O
with	28343944	0	O
NRAS	28343944	0	O
(	28343944	0	O
Q61K	28343944	0	O
)	28343944	0	O
to	28343944	0	O
promote	28343944	0	O
melanoma	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
.	28343944	0	O
Melanoma	28343944	0	O
is	28343944	0	O
the	28343944	0	O
deadliest	28343944	0	O
skin	28343944	0	O
cancer	28343944	0	O
.	28343944	0	O
RACK1	28343944	0	O
(	28343944	0	O
Receptor	28343944	0	O
for	28343944	0	O
activated	28343944	0	O
protein	28343944	0	O
kinase	28343944	0	O
C	28343944	0	O
)	28343944	0	O
protein	28343944	0	O
was	28343944	0	O
proposed	28343944	0	O
as	28343944	0	O
a	28343944	0	O
biological	28343944	0	O
marker	28343944	0	O
of	28343944	0	O
melanoma	28343944	0	O
in	28343944	0	O
human	28343944	0	O
and	28343944	0	O
domestic	28343944	0	O
animal	28343944	0	O
species	28343944	0	O
harboring	28343944	0	O
spontaneous	28343944	0	O
melanomas	28343944	0	O
.	28343944	0	O
As	28343944	0	O
a	28343944	0	O
scaffold	28343944	0	O
protein	28343944	0	O
,	28343944	0	O
RACK1	28343944	0	O
is	28343944	0	O
able	28343944	0	O
to	28343944	0	O
coordinate	28343944	0	O
the	28343944	0	O
interaction	28343944	0	O
of	28343944	0	O
key	28343944	0	O
signaling	28343944	0	O
molecules	28343944	0	O
implicated	28343944	0	O
in	28343944	0	O
both	28343944	0	O
physiological	28343944	0	O
cellular	28343944	0	O
functions	28343944	0	O
and	28343944	0	O
tumorigenesis	28343944	0	O
.	28343944	0	O
A	28343944	0	O
role	28343944	0	O
for	28343944	0	O
RACK1	28343944	0	O
in	28343944	0	O
rewiring	28343944	0	O
ERK	28343944	0	O
and	28343944	0	O
JNK	28343944	0	O
signaling	28343944	0	O
pathways	28343944	0	O
in	28343944	0	O
melanoma	28343944	0	O
cell	28343944	0	O
lines	28343944	0	O
had	28343944	0	O
been	28343944	0	O
proposed	28343944	0	O
.	28343944	0	O
Here	28343944	0	O
,	28343944	0	O
we	28343944	0	O
used	28343944	0	O
a	28343944	0	O
genetic	28343944	0	O
approach	28343944	0	O
to	28343944	0	O
test	28343944	0	O
this	28343944	0	O
hypothesis	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
in	28343944	0	O
the	28343944	0	O
mouse	28343944	0	O
.	28343944	0	O
We	28343944	0	O
show	28343944	0	O
that	28343944	0	O
Rack1	28343944	0	B-Gene
knock	28343944	0	B-Var
-	28343944	0	I-Var
down	28343944	0	I-Var
in	28343944	0	O
the	28343944	0	O
mouse	28343944	0	O
melanoma	28343944	0	O
cell	28343944	0	O
line	28343944	0	O
B16	28343944	0	O
reduces	28343944	0	B-NegReg
invasiveness	28343944	0	B-MPA
and	28343944	0	O
induces	28343944	0	B-Reg
cell	28343944	0	B-MPA
differentiation	28343944	0	I-MPA
.	28343944	0	O
We	28343944	0	O
have	28343944	0	O
developed	28343944	0	O
the	28343944	0	O
first	28343944	0	O
mouse	28343944	0	O
model	28343944	0	O
for	28343944	0	O
RACK1	28343944	0	O
gain	28343944	0	O
of	28343944	0	O
function	28343944	0	O
,	28343944	0	O
Tyr	28343944	0	O
:	28343944	0	O
:	28343944	0	O
Rack1	28343944	0	O
-	28343944	0	O
HA	28343944	0	O
transgenic	28343944	0	O
mice	28343944	0	O
,	28343944	0	O
targeting	28343944	0	O
RACK1	28343944	0	O
to	28343944	0	O
melanocytes	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
.	28343944	0	O
RACK1	28343944	0	O
overexpression	28343944	0	O
was	28343944	0	O
not	28343944	0	O
sufficient	28343944	0	O
to	28343944	0	O
initiate	28343944	0	O
melanomas	28343944	0	O
despite	28343944	0	O
activated	28343944	0	O
ERK	28343944	0	O
and	28343944	0	O
AKT	28343944	0	O
.	28343944	0	O
However	28343944	0	O
,	28343944	0	O
in	28343944	0	O
a	28343944	0	O
context	28343944	0	O
of	28343944	0	O
melanoma	28343944	0	O
predisposition	28343944	0	O
,	28343944	0	O
RACK1	28343944	0	O
overexpression	28343944	0	O
reduced	28343944	0	O
latency	28343944	0	O
and	28343944	0	O
increased	28343944	0	O
incidence	28343944	0	O
and	28343944	0	O
metastatic	28343944	0	O
rate	28343944	0	O
.	28343944	0	O
In	28343944	0	O
primary	28343944	0	O
melanoma	28343944	0	O
cells	28343944	0	O
from	28343944	0	O
Tyr	28343944	0	O
:	28343944	0	O
:	28343944	0	O
Rack1	28343944	0	O
-	28343944	0	O
HA	28343944	0	O
,	28343944	0	O
Tyr	28343944	0	O
:	28343944	0	O
:	28343944	0	O
NRas	28343944	0	O
(	28343944	0	O
Q61K	28343944	0	O
)	28343944	0	O
mice	28343944	0	O
,	28343944	0	O
activated	28343944	0	O
JNK	28343944	0	O
(	28343944	0	O
c	28343944	0	O
-	28343944	0	O
Jun	28343944	0	O
N	28343944	0	O
-	28343944	0	O
terminal	28343944	0	O
kinase	28343944	0	O
)	28343944	0	O
and	28343944	0	O
activated	28343944	0	O
STAT3	28343944	0	O
(	28343944	0	O
signal	28343944	0	O
transducer	28343944	0	O
and	28343944	0	O
activator	28343944	0	O
of	28343944	0	O
transcription	28343944	0	O
3	28343944	0	O
)	28343944	0	O
acted	28343944	0	O
as	28343944	0	O
RACK1	28343944	0	O
oncogenic	28343944	0	O
partners	28343944	0	O
in	28343944	0	O
tumoral	28343944	0	O
progression	28343944	0	O
.	28343944	0	O
A	28343944	0	O
sequential	28343944	0	O
and	28343944	0	O
coordinated	28343944	0	O
activation	28343944	0	O
of	28343944	0	O
ERK	28343944	0	O
,	28343944	0	O
JNK	28343944	0	O
and	28343944	0	O
STAT3	28343944	0	O
with	28343944	0	O
RACK1	28343944	0	O
is	28343944	0	O
shown	28343944	0	O
to	28343944	0	O
accelerate	28343944	0	O
aggressive	28343944	0	O
melanoma	28343944	0	O
development	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
.	28343944	0	O

Identification	28373485	1	O
and	28373485	1	O
characterization	28373485	1	O
of	28373485	1	O
a	28373485	1	O
novel	28373485	1	O
DGAT1	28373485	1	O
missense	28373485	1	O
mutation	28373485	1	O
associated	28373485	1	O
with	28373485	1	O
congenital	28373485	1	O
diarrhea	28373485	1	O
.	28373485	1	O
Acyl	28373485	1	O
-	28373485	1	O
CoA	28373485	1	O
:	28373485	1	O
diacylglycerol	28373485	1	O
acyltransferase	28373485	1	O
(	28373485	1	O
DGAT	28373485	1	O
)	28373485	1	O
1	28373485	1	O
and	28373485	1	O
DGAT2	28373485	1	O
catalyze	28373485	1	O
triglyceride	28373485	1	O
(	28373485	1	O
TG	28373485	1	O
)	28373485	1	O
biosynthesis	28373485	1	O
in	28373485	1	O
humans	28373485	1	O
.	28373485	1	O
Biallelic	28373485	1	O
loss	28373485	1	B-NegReg
-	28373485	1	I-NegReg
of	28373485	1	I-NegReg
-	28373485	1	I-NegReg
function	28373485	1	I-NegReg
mutations	28373485	1	B-Var
in	28373485	1	O
human	28373485	1	O
DGAT1	28373485	1	B-Gene
result	28373485	1	O
in	28373485	1	O
severe	28373485	1	O
congenital	28373485	1	B-Disease
diarrhea	28373485	1	I-Disease
and	28373485	1	O
protein	28373485	1	B-Disease
-	28373485	1	I-Disease
losing	28373485	1	I-Disease
enteropathy	28373485	1	I-Disease
.	28373485	1	O
Additionally	28373485	1	O
,	28373485	1	O
pharmacologic	28373485	1	O
inhibition	28373485	1	O
of	28373485	1	O
DGAT1	28373485	1	O
led	28373485	1	O
to	28373485	1	O
dose	28373485	1	O
-	28373485	1	O
related	28373485	1	O
diarrhea	28373485	1	O
in	28373485	1	O
human	28373485	1	O
clinical	28373485	1	O
trials	28373485	1	O
.	28373485	1	O
Here	28373485	1	O
we	28373485	1	O
identify	28373485	1	O
a	28373485	1	O
previously	28373485	1	O
unknown	28373485	1	O
DGAT1	28373485	1	O
mutation	28373485	1	O
in	28373485	1	O
identical	28373485	1	O
twins	28373485	1	O
of	28373485	1	O
South	28373485	1	O
Asian	28373485	1	O
descent	28373485	1	O
.	28373485	1	O
These	28373485	1	O
male	28373485	1	O
patients	28373485	1	O
developed	28373485	1	O
watery	28373485	1	O
diarrhea	28373485	1	O
shortly	28373485	1	O
after	28373485	1	O
birth	28373485	1	O
,	28373485	1	O
with	28373485	1	O
protein	28373485	1	O
-	28373485	1	O
losing	28373485	1	O
enteropathy	28373485	1	O
and	28373485	1	O
failure	28373485	1	O
to	28373485	1	O
thrive	28373485	1	O
.	28373485	1	O
Exome	28373485	1	O
sequencing	28373485	1	O
revealed	28373485	1	O
a	28373485	1	O
homozygous	28373485	1	O
recessive	28373485	1	O
mutation	28373485	1	O
in	28373485	1	O
DGAT1	28373485	1	O
,	28373485	1	O
c.314T	28373485	1	O
>	28373485	1	O
C	28373485	1	O
,	28373485	1	O
p.L105P	28373485	1	O
.	28373485	1	O
We	28373485	1	O
show	28373485	1	O
here	28373485	1	O
that	28373485	1	O
the	28373485	1	O
p.L105P	28373485	1	B-Var
DGAT1	28373485	1	B-Gene
enzyme	28373485	1	O
produced	28373485	1	O
from	28373485	1	O
the	28373485	1	O
mutant	28373485	1	B-Var
allele	28373485	1	O
is	28373485	1	O
less	28373485	1	B-NegReg
abundant	28373485	1	O
,	28373485	1	O
resulting	28373485	1	O
in	28373485	1	O
partial	28373485	1	O
loss	28373485	1	B-NegReg
of	28373485	1	O
TG	28373485	1	B-MPA
synthesis	28373485	1	I-MPA
activity	28373485	1	I-MPA
and	28373485	1	O
decreased	28373485	1	B-NegReg
formation	28373485	1	B-MPA
of	28373485	1	I-MPA
lipid	28373485	1	I-MPA
droplets	28373485	1	I-MPA
in	28373485	1	O
patient	28373485	1	O
-	28373485	1	O
derived	28373485	1	O
primary	28373485	1	O
dermal	28373485	1	O
fibroblasts	28373485	1	O
.	28373485	1	O
Thus	28373485	1	O
,	28373485	1	O
in	28373485	1	O
contrast	28373485	1	O
with	28373485	1	O
complete	28373485	1	O
loss	28373485	1	O
-	28373485	1	O
of	28373485	1	O
-	28373485	1	O
function	28373485	1	O
alleles	28373485	1	O
of	28373485	1	O
DGAT1	28373485	1	O
,	28373485	1	O
the	28373485	1	O
p.L105P	28373485	1	B-Var
missense	28373485	1	I-Var
allele	28373485	1	O
partially	28373485	1	O
reduces	28373485	1	B-NegReg
TG	28373485	1	B-MPA
synthesis	28373485	1	I-MPA
activity	28373485	1	I-MPA
and	28373485	1	O
causes	28373485	1	B-Reg
a	28373485	1	O
less	28373485	1	B-MPA
severe	28373485	1	I-MPA
clinical	28373485	1	I-MPA
phenotype	28373485	1	I-MPA
.	28373485	1	O
Our	28373485	1	O
findings	28373485	1	O
add	28373485	1	O
to	28373485	1	O
the	28373485	1	O
growing	28373485	1	O
recognition	28373485	1	O
of	28373485	1	O
DGAT1	28373485	1	B-Gene
deficiency	28373485	1	B-Var
as	28373485	1	O
a	28373485	1	O
cause	28373485	1	B-Reg
of	28373485	1	O
congenital	28373485	1	B-Disease
diarrhea	28373485	1	I-Disease
with	28373485	1	O
protein	28373485	1	B-Disease
-	28373485	1	I-Disease
losing	28373485	1	I-Disease
enteropathy	28373485	1	I-Disease
and	28373485	1	O
indicate	28373485	1	O
that	28373485	1	O
DGAT1	28373485	1	B-Gene
mutations	28373485	1	B-Var
result	28373485	1	B-Reg
in	28373485	1	I-Reg
a	28373485	1	O
spectrum	28373485	1	B-Disease
of	28373485	1	I-Disease
diseases	28373485	1	I-Disease
.	28373485	1	O

Hydrocephalus	28460636	4	B-Disease
due	28460636	4	O
to	28460636	4	O
multiple	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
is	28460636	4	O
caused	28460636	4	B-Reg
by	28460636	4	I-Reg
mutations	28460636	4	B-Var
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	B-Gene
gene	28460636	4	O
.	28460636	4	O
Congenital	28460636	4	O
hydrocephalus	28460636	4	O
is	28460636	4	O
considered	28460636	4	O
as	28460636	4	O
either	28460636	4	O
acquired	28460636	4	O
due	28460636	4	O
to	28460636	4	O
haemorrhage	28460636	4	O
,	28460636	4	O
infection	28460636	4	O
or	28460636	4	O
neoplasia	28460636	4	O
or	28460636	4	O
as	28460636	4	O
of	28460636	4	O
developmental	28460636	4	O
nature	28460636	4	O
and	28460636	4	O
is	28460636	4	O
divided	28460636	4	O
into	28460636	4	O
two	28460636	4	O
subgroups	28460636	4	O
,	28460636	4	O
communicating	28460636	4	O
and	28460636	4	O
obstructive	28460636	4	O
.	28460636	4	O
Congenital	28460636	4	O
hydrocephalus	28460636	4	O
is	28460636	4	O
either	28460636	4	O
syndromic	28460636	4	O
or	28460636	4	O
non	28460636	4	O
-	28460636	4	O
syndromic	28460636	4	O
,	28460636	4	O
and	28460636	4	O
in	28460636	4	O
the	28460636	4	O
latter	28460636	4	O
no	28460636	4	O
cause	28460636	4	O
is	28460636	4	O
found	28460636	4	O
in	28460636	4	O
more	28460636	4	O
than	28460636	4	O
half	28460636	4	O
of	28460636	4	O
the	28460636	4	O
patients	28460636	4	O
.	28460636	4	O
In	28460636	4	O
patients	28460636	4	O
with	28460636	4	O
isolated	28460636	4	B-Disease
hydrocephalus	28460636	4	I-Disease
,	28460636	4	O
L1CAM	28460636	4	B-Gene
mutations	28460636	4	B-Var
represent	28460636	4	O
the	28460636	4	O
most	28460636	4	O
common	28460636	4	B-Reg
aetiology	28460636	4	O
.	28460636	4	O
More	28460636	4	O
recently	28460636	4	O
,	28460636	4	O
a	28460636	4	O
founder	28460636	4	O
mutation	28460636	4	O
has	28460636	4	O
also	28460636	4	O
been	28460636	4	O
reported	28460636	4	O
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	O
gene	28460636	4	O
in	28460636	4	O
foetuses	28460636	4	O
presenting	28460636	4	O
massive	28460636	4	O
hydrocephalus	28460636	4	O
,	28460636	4	O
but	28460636	4	O
the	28460636	4	O
neuropathology	28460636	4	O
remains	28460636	4	O
unknown	28460636	4	O
.	28460636	4	O
We	28460636	4	O
describe	28460636	4	O
here	28460636	4	O
three	28460636	4	O
novel	28460636	4	O
homozygous	28460636	4	O
null	28460636	4	O
mutations	28460636	4	O
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	O
gene	28460636	4	O
in	28460636	4	O
foetuses	28460636	4	O
whose	28460636	4	O
post	28460636	4	O
-	28460636	4	O
mortem	28460636	4	O
examination	28460636	4	O
has	28460636	4	O
revealed	28460636	4	O
a	28460636	4	O
homogeneous	28460636	4	O
phenotype	28460636	4	O
characterized	28460636	4	O
by	28460636	4	O
multiple	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
along	28460636	4	O
the	28460636	4	O
aqueduct	28460636	4	O
of	28460636	4	O
Sylvius	28460636	4	O
,	28460636	4	O
the	28460636	4	O
third	28460636	4	O
and	28460636	4	O
fourth	28460636	4	O
ventricles	28460636	4	O
as	28460636	4	O
well	28460636	4	O
as	28460636	4	O
the	28460636	4	O
central	28460636	4	O
canal	28460636	4	O
of	28460636	4	O
the	28460636	4	O
medulla	28460636	4	O
,	28460636	4	O
consisting	28460636	4	O
in	28460636	4	O
multifocal	28460636	4	O
rosettes	28460636	4	O
with	28460636	4	O
immature	28460636	4	O
cell	28460636	4	O
accumulation	28460636	4	O
in	28460636	4	O
the	28460636	4	O
vicinity	28460636	4	O
of	28460636	4	O
ependymal	28460636	4	O
lining	28460636	4	O
early	28460636	4	O
detached	28460636	4	O
from	28460636	4	O
the	28460636	4	O
ventricular	28460636	4	O
zone	28460636	4	O
.	28460636	4	O
MPDZ	28460636	4	O
also	28460636	4	O
named	28460636	4	O
MUPP1	28460636	4	O
is	28460636	4	O
an	28460636	4	O
essential	28460636	4	O
component	28460636	4	O
of	28460636	4	O
tight	28460636	4	O
junctions	28460636	4	O
which	28460636	4	O
are	28460636	4	O
expressed	28460636	4	O
from	28460636	4	O
early	28460636	4	O
brain	28460636	4	O
development	28460636	4	O
in	28460636	4	O
the	28460636	4	O
choroid	28460636	4	O
plexuses	28460636	4	O
and	28460636	4	O
ependyma	28460636	4	O
.	28460636	4	O
Alterations	28460636	4	O
in	28460636	4	O
the	28460636	4	O
formation	28460636	4	O
of	28460636	4	O
tight	28460636	4	O
junctions	28460636	4	O
within	28460636	4	O
the	28460636	4	O
ependyma	28460636	4	O
very	28460636	4	O
likely	28460636	4	O
account	28460636	4	O
for	28460636	4	O
the	28460636	4	O
lesions	28460636	4	O
observed	28460636	4	O
and	28460636	4	O
highlight	28460636	4	O
for	28460636	4	O
the	28460636	4	O
first	28460636	4	O
time	28460636	4	O
that	28460636	4	O
primary	28460636	4	O
multifocal	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
of	28460636	4	O
the	28460636	4	O
ventricular	28460636	4	O
system	28460636	4	O
is	28460636	4	O
genetically	28460636	4	O
determined	28460636	4	O
in	28460636	4	O
humans	28460636	4	O
.	28460636	4	O
Therefore	28460636	4	O
,	28460636	4	O
MPDZ	28460636	4	O
sequencing	28460636	4	O
should	28460636	4	O
be	28460636	4	O
performed	28460636	4	O
when	28460636	4	O
neuropathological	28460636	4	O
examination	28460636	4	O
reveals	28460636	4	O
multifocal	28460636	4	O
ependymal	28460636	4	O
rosette	28460636	4	O
formation	28460636	4	O
within	28460636	4	O
the	28460636	4	O
aqueduct	28460636	4	O
of	28460636	4	O
Sylvius	28460636	4	O
,	28460636	4	O
of	28460636	4	O
the	28460636	4	O
third	28460636	4	O
and	28460636	4	O
fourth	28460636	4	O
ventricles	28460636	4	O
and	28460636	4	O
of	28460636	4	O
the	28460636	4	O
central	28460636	4	O
canal	28460636	4	O
of	28460636	4	O
the	28460636	4	O
medulla	28460636	4	O
.	28460636	4	O

Short	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
is	28464429	0	O
more	28464429	0	O
effective	28464429	0	O
than	28464429	0	O
long	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
in	28464429	0	O
eliciting	28464429	0	O
pointed	28464429	0	O
loss	28464429	0	O
-	28464429	0	O
of	28464429	0	O
-	28464429	0	O
function	28464429	0	O
phenotypes	28464429	0	O
in	28464429	0	O
Drosophila	28464429	0	O
.	28464429	0	O
Pointed	28464429	0	O
(	28464429	0	O
Pnt	28464429	0	O
)	28464429	0	O
is	28464429	0	O
a	28464429	0	O
transcriptional	28464429	0	O
activator	28464429	0	O
that	28464429	0	O
functions	28464429	0	O
downstream	28464429	0	O
of	28464429	0	O
the	28464429	0	O
highly	28464429	0	O
conserved	28464429	0	O
Receptor	28464429	0	O
Tyrosine	28464429	0	O
Kinase	28464429	0	O
(	28464429	0	O
RTK	28464429	0	O
)	28464429	0	O
signaling	28464429	0	O
pathway	28464429	0	O
.	28464429	0	O
Pnt	28464429	0	O
is	28464429	0	O
an	28464429	0	O
ETS	28464429	0	O
family	28464429	0	O
transcription	28464429	0	O
factor	28464429	0	O
and	28464429	0	O
encodes	28464429	0	O
for	28464429	0	O
two	28464429	0	O
proteins	28464429	0	O
,	28464429	0	O
PntP1	28464429	0	O
and	28464429	0	O
PntP2	28464429	0	O
.	28464429	0	O
However	28464429	0	O
,	28464429	0	O
while	28464429	0	O
PntP1	28464429	0	O
is	28464429	0	O
constitutively	28464429	0	O
active	28464429	0	O
,	28464429	0	O
PntP2	28464429	0	O
is	28464429	0	O
only	28464429	0	O
active	28464429	0	O
after	28464429	0	O
being	28464429	0	O
phosphorylated	28464429	0	O
by	28464429	0	O
MAPK	28464429	0	O
in	28464429	0	O
the	28464429	0	O
RTK	28464429	0	O
pathway	28464429	0	O
.	28464429	0	O
As	28464429	0	O
mutations	28464429	0	B-Var
in	28464429	0	O
pnt	28464429	0	B-Gene
perturb	28464429	0	B-Reg
the	28464429	0	O
development	28464429	0	B-CPA
of	28464429	0	I-CPA
several	28464429	0	I-CPA
tissues	28464429	0	I-CPA
,	28464429	0	O
we	28464429	0	O
wanted	28464429	0	O
to	28464429	0	O
examine	28464429	0	O
the	28464429	0	O
effect	28464429	0	O
and	28464429	0	O
efficacy	28464429	0	O
of	28464429	0	O
using	28464429	0	O
RNAi	28464429	0	O
to	28464429	0	O
target	28464429	0	O
Pnt	28464429	0	O
.	28464429	0	O
We	28464429	0	O
have	28464429	0	O
expressed	28464429	0	O
pnt	28464429	0	O
RNAi	28464429	0	O
in	28464429	0	O
the	28464429	0	O
eyes	28464429	0	O
,	28464429	0	O
oocyte	28464429	0	O
,	28464429	0	O
and	28464429	0	O
heart	28464429	0	O
cells	28464429	0	O
using	28464429	0	O
three	28464429	0	O
different	28464429	0	O
RNAi	28464429	0	O
lines	28464429	0	O
:	28464429	0	O
Valium20	28464429	0	O
,	28464429	0	O
Valium10	28464429	0	O
,	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
.	28464429	0	O
Valium20	28464429	0	O
is	28464429	0	O
distinct	28464429	0	O
since	28464429	0	O
it	28464429	0	O
generates	28464429	0	O
a	28464429	0	O
short	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
(	28464429	0	O
shRNA	28464429	0	O
)	28464429	0	O
,	28464429	0	O
while	28464429	0	O
Valium10	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
produce	28464429	0	O
long	28464429	0	O
hairpin	28464429	0	O
dsRNA	28464429	0	O
.	28464429	0	O
We	28464429	0	O
found	28464429	0	O
that	28464429	0	O
for	28464429	0	O
each	28464429	0	O
tissue	28464429	0	O
examined	28464429	0	O
Valium20	28464429	0	O
exhibited	28464429	0	O
the	28464429	0	O
strongest	28464429	0	O
phenotype	28464429	0	O
while	28464429	0	O
the	28464429	0	O
Valium10	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
lines	28464429	0	O
produced	28464429	0	O
varying	28464429	0	O
levels	28464429	0	O
of	28464429	0	O
severity	28464429	0	O
and	28464429	0	O
that	28464429	0	O
the	28464429	0	O
long	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
produced	28464429	0	O
by	28464429	0	O
the	28464429	0	O
Valium10	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
lines	28464429	0	O
are	28464429	0	O
unable	28464429	0	O
to	28464429	0	O
effectively	28464429	0	O
knockdown	28464429	0	O
pnt	28464429	0	O
in	28464429	0	O
embryonic	28464429	0	O
tissues	28464429	0	O
.	28464429	0	O

New	28472301	2	O
gain	28472301	2	B-PosReg
-	28472301	2	I-PosReg
of	28472301	2	I-PosReg
-	28472301	2	I-PosReg
function	28472301	2	I-PosReg
mutation	28472301	2	B-Var
shows	28472301	2	O
CACNA1D	28472301	2	B-Gene
as	28472301	2	O
recurrently	28472301	2	O
mutated	28472301	2	O
gene	28472301	2	O
in	28472301	2	O
autism	28472301	2	B-Disease
spectrum	28472301	2	I-Disease
disorders	28472301	2	I-Disease
and	28472301	2	O
epilepsy	28472301	2	B-Disease
.	28472301	2	O
CACNA1D	28472301	2	O
encodes	28472301	2	O
the	28472301	2	O
pore	28472301	2	O
-	28472301	2	O
forming	28472301	2	O
α1	28472301	2	O
-	28472301	2	O
subunit	28472301	2	O
of	28472301	2	O
Cav1.3	28472301	2	O
,	28472301	2	O
an	28472301	2	O
L	28472301	2	O
-	28472301	2	O
type	28472301	2	O
voltage	28472301	2	O
-	28472301	2	O
gated	28472301	2	O
Ca2	28472301	2	O
-	28472301	2	O
channel	28472301	2	O
.	28472301	2	O
Despite	28472301	2	O
the	28472301	2	O
recent	28472301	2	O
discovery	28472301	2	O
of	28472301	2	O
two	28472301	2	O
de	28472301	2	O
novo	28472301	2	O
missense	28472301	2	O
gain	28472301	2	O
-	28472301	2	O
of	28472301	2	O
-	28472301	2	O
function	28472301	2	O
mutations	28472301	2	O
in	28472301	2	O
Cav1.3	28472301	2	O
in	28472301	2	O
two	28472301	2	O
individuals	28472301	2	O
with	28472301	2	O
autism	28472301	2	O
spectrum	28472301	2	O
disorder	28472301	2	O
(	28472301	2	O
ASD	28472301	2	O
)	28472301	2	O
and	28472301	2	O
intellectual	28472301	2	O
disability	28472301	2	O
CACNA1D	28472301	2	O
has	28472301	2	O
not	28472301	2	O
been	28472301	2	O
considered	28472301	2	O
a	28472301	2	O
prominent	28472301	2	O
ASD	28472301	2	O
-	28472301	2	O
risk	28472301	2	O
gene	28472301	2	O
in	28472301	2	O
large	28472301	2	O
scale	28472301	2	O
genetic	28472301	2	O
analyses	28472301	2	O
,	28472301	2	O
since	28472301	2	O
such	28472301	2	O
studies	28472301	2	O
primarly	28472301	2	O
focus	28472301	2	O
on	28472301	2	O
likely	28472301	2	O
-	28472301	2	O
disruptive	28472301	2	O
genetic	28472301	2	O
variants	28472301	2	O
.	28472301	2	O
Here	28472301	2	O
we	28472301	2	O
report	28472301	2	O
the	28472301	2	O
discovery	28472301	2	O
and	28472301	2	O
characterization	28472301	2	O
of	28472301	2	O
a	28472301	2	O
third	28472301	2	O
de	28472301	2	O
novo	28472301	2	O
missense	28472301	2	O
mutation	28472301	2	O
in	28472301	2	O
CACNA1D	28472301	2	O
(	28472301	2	O
V401L	28472301	2	O
)	28472301	2	O
in	28472301	2	O
a	28472301	2	O
patient	28472301	2	O
with	28472301	2	O
ASD	28472301	2	O
and	28472301	2	O
epilepsy	28472301	2	O
.	28472301	2	O
For	28472301	2	O
the	28472301	2	O
functional	28472301	2	O
characterization	28472301	2	O
we	28472301	2	O
introduced	28472301	2	O
mutation	28472301	2	O
V401L	28472301	2	O
into	28472301	2	O
two	28472301	2	O
major	28472301	2	O
C	28472301	2	O
-	28472301	2	O
terminal	28472301	2	O
long	28472301	2	O
and	28472301	2	O
short	28472301	2	O
Cav1.3	28472301	2	O
splice	28472301	2	O
variants	28472301	2	O
,	28472301	2	O
expressed	28472301	2	O
wild	28472301	2	O
-	28472301	2	O
type	28472301	2	O
or	28472301	2	O
mutant	28472301	2	O
channel	28472301	2	O
complexes	28472301	2	O
in	28472301	2	O
tsA-201	28472301	2	O
cells	28472301	2	O
and	28472301	2	O
performed	28472301	2	O
whole	28472301	2	O
-	28472301	2	O
cell	28472301	2	O
patch	28472301	2	O
-	28472301	2	O
clamp	28472301	2	O
recordings	28472301	2	O
.	28472301	2	O
Mutation	28472301	2	O
V401L	28472301	2	B-Var
,	28472301	2	O
localized	28472301	2	O
within	28472301	2	O
the	28472301	2	O
channel	28472301	2	O
'	28472301	2	O
s	28472301	2	O
activation	28472301	2	O
gate	28472301	2	O
,	28472301	2	O
significantly	28472301	2	O
enhanced	28472301	2	B-PosReg
current	28472301	2	B-MPA
densities	28472301	2	I-MPA
,	28472301	2	O
shifted	28472301	2	O
voltage	28472301	2	O
dependence	28472301	2	O
of	28472301	2	O
activation	28472301	2	O
and	28472301	2	O
inactivation	28472301	2	O
to	28472301	2	O
more	28472301	2	O
negative	28472301	2	O
voltages	28472301	2	O
and	28472301	2	O
reduced	28472301	2	O
channel	28472301	2	O
inactivation	28472301	2	O
in	28472301	2	O
both	28472301	2	O
Cav1.3	28472301	2	O
splice	28472301	2	O
variants	28472301	2	O
.	28472301	2	O
Altogether	28472301	2	O
these	28472301	2	O
gating	28472301	2	O
changes	28472301	2	B-Var
are	28472301	2	O
expected	28472301	2	O
to	28472301	2	O
result	28472301	2	O
in	28472301	2	O
enhanced	28472301	2	B-PosReg
Ca2	28472301	2	B-MPA
-	28472301	2	I-MPA
influx	28472301	2	I-MPA
through	28472301	2	I-MPA
the	28472301	2	I-MPA
channel	28472301	2	I-MPA
,	28472301	2	O
thus	28472301	2	O
representing	28472301	2	O
a	28472301	2	O
strong	28472301	2	O
gain	28472301	2	O
-	28472301	2	O
of	28472301	2	O
-	28472301	2	O
function	28472301	2	O
phenotype	28472301	2	O
.	28472301	2	O
Additionally	28472301	2	O
,	28472301	2	O
we	28472301	2	O
also	28472301	2	O
found	28472301	2	O
that	28472301	2	O
mutant	28472301	2	O
channels	28472301	2	O
retained	28472301	2	O
full	28472301	2	O
sensitivity	28472301	2	O
towards	28472301	2	O
the	28472301	2	O
clinically	28472301	2	O
available	28472301	2	O
Ca2	28472301	2	O
-	28472301	2	O
channel	28472301	2	O
blocker	28472301	2	O
isradipine	28472301	2	O
.	28472301	2	O
Our	28472301	2	O
findings	28472301	2	O
strengthen	28472301	2	O
the	28472301	2	O
evidence	28472301	2	O
for	28472301	2	O
CACNA1D	28472301	2	O
as	28472301	2	O
a	28472301	2	O
novel	28472301	2	O
candidate	28472301	2	O
autism	28472301	2	O
risk	28472301	2	O
gene	28472301	2	O
and	28472301	2	O
encourage	28472301	2	O
experimental	28472301	2	O
therapy	28472301	2	O
with	28472301	2	O
available	28472301	2	O
channel	28472301	2	O
-	28472301	2	O
blockers	28472301	2	O
for	28472301	2	O
this	28472301	2	O
mutation	28472301	2	O
.	28472301	2	O
The	28472301	2	O
additional	28472301	2	O
presence	28472301	2	O
of	28472301	2	O
seizures	28472301	2	O
and	28472301	2	O
neurological	28472301	2	O
abnormalities	28472301	2	O
in	28472301	2	O
our	28472301	2	O
patient	28472301	2	O
define	28472301	2	O
a	28472301	2	O
novel	28472301	2	O
phenotype	28472301	2	O
partially	28472301	2	O
overlapping	28472301	2	O
with	28472301	2	O
symptoms	28472301	2	O
in	28472301	2	O
two	28472301	2	O
individuals	28472301	2	O
with	28472301	2	O
PASNA	28472301	2	O
(	28472301	2	O
congential	28472301	2	O
primary	28472301	2	O
aldosteronism	28472301	2	O
,	28472301	2	O
seizures	28472301	2	O
and	28472301	2	O
neurological	28472301	2	O
abnormalities	28472301	2	O
)	28472301	2	O
caused	28472301	2	O
by	28472301	2	O
similar	28472301	2	O
Cav1.3	28472301	2	O
gain	28472301	2	O
-	28472301	2	O
of	28472301	2	O
-	28472301	2	O
function	28472301	2	O
mutations	28472301	2	O
.	28472301	2	O

Proteomic	28479159	2	O
analysis	28479159	2	O
of	28479159	2	O
filaggrin	28479159	2	O
deficiency	28479159	2	O
identifies	28479159	2	O
molecular	28479159	2	O
signatures	28479159	2	O
characteristic	28479159	2	O
of	28479159	2	O
atopic	28479159	2	O
eczema	28479159	2	O
.	28479159	2	O
BACKGROUND	28479159	2	O
:	28479159	2	O
Atopic	28479159	2	B-Disease
eczema	28479159	2	I-Disease
(	28479159	2	O
AE	28479159	2	O
)	28479159	2	O
is	28479159	2	O
characterized	28479159	2	O
by	28479159	2	O
skin	28479159	2	O
barrier	28479159	2	O
and	28479159	2	O
immune	28479159	2	O
dysfunction	28479159	2	O
.	28479159	2	O
Null	28479159	2	B-Var
mutations	28479159	2	I-Var
in	28479159	2	O
filaggrin	28479159	2	O
(	28479159	2	B-Gene
FLG	28479159	2	I-Gene
)	28479159	2	I-Gene
,	28479159	2	O
a	28479159	2	O
key	28479159	2	O
epidermal	28479159	2	O
barrier	28479159	2	O
protein	28479159	2	O
,	28479159	2	O
strongly	28479159	2	O
predispose	28479159	2	B-Reg
to	28479159	2	O
AE	28479159	2	B-Disease
;	28479159	2	I-Disease
however	28479159	2	O
,	28479159	2	O
the	28479159	2	O
precise	28479159	2	O
role	28479159	2	O
of	28479159	2	O
FLG	28479159	2	O
deficiency	28479159	2	O
in	28479159	2	O
AE	28479159	2	O
pathogenesis	28479159	2	O
remains	28479159	2	O
incompletely	28479159	2	O
understood	28479159	2	O
.	28479159	2	O
OBJECTIVES	28479159	2	O
:	28479159	2	O
We	28479159	2	O
sought	28479159	2	O
to	28479159	2	O
identify	28479159	2	O
global	28479159	2	O
proteomic	28479159	2	O
changes	28479159	2	O
downstream	28479159	2	O
of	28479159	2	O
FLG	28479159	2	O
deficiency	28479159	2	O
in	28479159	2	O
human	28479159	2	O
epidermal	28479159	2	O
living	28479159	2	O
skin	28479159	2	O
-	28479159	2	O
equivalent	28479159	2	O
(	28479159	2	O
LSE	28479159	2	O
)	28479159	2	O
models	28479159	2	O
and	28479159	2	O
validate	28479159	2	O
findings	28479159	2	O
in	28479159	2	O
skin	28479159	2	O
of	28479159	2	O
patients	28479159	2	O
with	28479159	2	O
AE	28479159	2	O
.	28479159	2	O
METHODS	28479159	2	O
:	28479159	2	O
Differentially	28479159	2	O
expressed	28479159	2	O
proteins	28479159	2	O
from	28479159	2	O
paired	28479159	2	O
control	28479159	2	O
(	28479159	2	O
nontargeting	28479159	2	O
control	28479159	2	O
short	28479159	2	O
hairpin	28479159	2	O
RNA	28479159	2	O
[	28479159	2	O
shNT	28479159	2	O
]	28479159	2	O
)	28479159	2	O
and	28479159	2	O
FLG	28479159	2	O
knockdown	28479159	2	O
(	28479159	2	O
FLG	28479159	2	O
knockdown	28479159	2	O
short	28479159	2	O
hairpin	28479159	2	O
RNA	28479159	2	O
[	28479159	2	O
shFLG	28479159	2	O
]	28479159	2	O
)	28479159	2	O
LSEs	28479159	2	O
were	28479159	2	O
identified	28479159	2	O
by	28479159	2	O
means	28479159	2	O
of	28479159	2	O
proteomic	28479159	2	O
analysis	28479159	2	O
(	28479159	2	O
liquid	28479159	2	O
chromatography	28479159	2	O
-	28479159	2	O
mass	28479159	2	O
spectrometry	28479159	2	O
)	28479159	2	O
and	28479159	2	O
Ingenuity	28479159	2	O
Pathway	28479159	2	O
Analysis	28479159	2	O
.	28479159	2	O
Expression	28479159	2	O
of	28479159	2	O
key	28479159	2	O
targets	28479159	2	O
was	28479159	2	O
validated	28479159	2	O
in	28479159	2	O
independent	28479159	2	O
LSE	28479159	2	O
samples	28479159	2	O
(	28479159	2	O
quantitative	28479159	2	O
RT	28479159	2	O
-	28479159	2	O
PCR	28479159	2	O
and	28479159	2	O
Western	28479159	2	O
blotting	28479159	2	O
)	28479159	2	O
and	28479159	2	O
in	28479159	2	O
normal	28479159	2	O
and	28479159	2	O
AE	28479159	2	O
skin	28479159	2	O
biopsy	28479159	2	O
specimens	28479159	2	O
(	28479159	2	O
immunofluorescence	28479159	2	O
)	28479159	2	O
.	28479159	2	O
RESULTS	28479159	2	O
:	28479159	2	O
Proteomic	28479159	2	O
analysis	28479159	2	O
identified	28479159	2	O
17	28479159	2	O
(	28479159	2	O
P	28479159	2	O
.05	28479159	2	O
)	28479159	2	O
differentially	28479159	2	O
expressed	28479159	2	O
proteins	28479159	2	O
after	28479159	2	O
FLG	28479159	2	O
knockdown	28479159	2	O
,	28479159	2	O
including	28479159	2	O
kallikrein-7	28479159	2	O
(	28479159	2	O
KLK7	28479159	2	O
;	28479159	2	O
2.2	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
,	28479159	2	O
cyclophilin	28479159	2	O
A	28479159	2	O
(	28479159	2	O
PPIA	28479159	2	O
;	28479159	2	O
0.9	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
,	28479159	2	O
and	28479159	2	O
cofilin-1	28479159	2	O
(	28479159	2	O
CFL1	28479159	2	O
,	28479159	2	O
1.3	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
.	28479159	2	O
Differential	28479159	2	O
protein	28479159	2	O
expression	28479159	2	O
was	28479159	2	O
confirmed	28479159	2	O
in	28479159	2	O
shNT	28479159	2	O
/	28479159	2	O
shFLG	28479159	2	O
LSEs	28479159	2	O
;	28479159	2	O
however	28479159	2	O
,	28479159	2	O
only	28479159	2	O
KLK7	28479159	2	O
was	28479159	2	O
transcriptionally	28479159	2	O
dysregulated	28479159	2	O
.	28479159	2	O
Molecular	28479159	2	B-Pathway
pathways	28479159	2	I-Pathway
overrepresented	28479159	2	B-PosReg
after	28479159	2	O
FLG	28479159	2	B-Gene
knockdown	28479159	2	B-Var
included	28479159	2	O
inflammation	28479159	2	O
,	28479159	2	O
protease	28479159	2	O
activity	28479159	2	O
,	28479159	2	O
cell	28479159	2	O
structure	28479159	2	O
,	28479159	2	O
and	28479159	2	O
stress	28479159	2	O
.	28479159	2	O
Furthermore	28479159	2	O
,	28479159	2	O
KLK7	28479159	2	O
(	28479159	2	O
1.8	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
and	28479159	2	O
PPIA	28479159	2	O
(	28479159	2	O
0.65	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
proteins	28479159	2	O
were	28479159	2	O
differentially	28479159	2	O
expressed	28479159	2	O
in	28479159	2	O
lesional	28479159	2	O
biopsy	28479159	2	O
specimens	28479159	2	O
from	28479159	2	O
patients	28479159	2	O
with	28479159	2	O
AE	28479159	2	O
relative	28479159	2	O
to	28479159	2	O
normal	28479159	2	O
skin	28479159	2	O
.	28479159	2	O
CONCLUSIONS	28479159	2	O
:	28479159	2	O
For	28479159	2	O
the	28479159	2	O
first	28479159	2	O
time	28479159	2	O
,	28479159	2	O
we	28479159	2	O
show	28479159	2	O
that	28479159	2	O
loss	28479159	2	B-Var
of	28479159	2	O
FLG	28479159	2	B-Gene
in	28479159	2	O
the	28479159	2	O
absence	28479159	2	O
of	28479159	2	O
inflammation	28479159	2	O
is	28479159	2	O
sufficient	28479159	2	O
to	28479159	2	O
alter	28479159	2	B-Reg
the	28479159	2	O
expression	28479159	2	B-MPA
level	28479159	2	I-MPA
of	28479159	2	I-MPA
proteins	28479159	2	I-MPA
relevant	28479159	2	O
to	28479159	2	O
the	28479159	2	O
pathogenesis	28479159	2	O
of	28479159	2	O
AE	28479159	2	O
.	28479159	2	O
These	28479159	2	O
include	28479159	2	O
proteins	28479159	2	O
regulating	28479159	2	O
inflammatory	28479159	2	O
,	28479159	2	O
proteolytic	28479159	2	O
,	28479159	2	O
and	28479159	2	O
cytoskeletal	28479159	2	O
functions	28479159	2	O
.	28479159	2	O
We	28479159	2	O
identify	28479159	2	O
PPIA	28479159	2	O
as	28479159	2	O
a	28479159	2	O
novel	28479159	2	O
protein	28479159	2	O
with	28479159	2	O
levels	28479159	2	O
that	28479159	2	O
are	28479159	2	O
decreased	28479159	2	O
in	28479159	2	O
clinically	28479159	2	O
active	28479159	2	O
AE	28479159	2	O
skin	28479159	2	O
and	28479159	2	O
show	28479159	2	O
that	28479159	2	O
the	28479159	2	O
characteristic	28479159	2	O
upregulation	28479159	2	O
of	28479159	2	O
KLK7	28479159	2	O
expression	28479159	2	O
in	28479159	2	O
patients	28479159	2	O
with	28479159	2	O
AE	28479159	2	O
occurs	28479159	2	O
downstream	28479159	2	O
of	28479159	2	O
FLG	28479159	2	O
loss	28479159	2	O
.	28479159	2	O
Importantly	28479159	2	O
,	28479159	2	O
we	28479159	2	O
highlight	28479159	2	O
disconnect	28479159	2	O
between	28479159	2	O
the	28479159	2	O
epidermal	28479159	2	O
proteome	28479159	2	O
and	28479159	2	O
transcriptome	28479159	2	O
,	28479159	2	O
emphasizing	28479159	2	O
the	28479159	2	O
utility	28479159	2	O
of	28479159	2	O
global	28479159	2	O
proteomic	28479159	2	O
studies	28479159	2	O
.	28479159	2	O

TREM2	28483841	1	O
deficiency	28483841	1	O
impairs	28483841	1	O
chemotaxis	28483841	1	O
and	28483841	1	O
microglial	28483841	1	O
responses	28483841	1	O
to	28483841	1	O
neuronal	28483841	1	O
injury	28483841	1	O
.	28483841	1	O
Sequence	28483841	1	O
variations	28483841	1	B-Var
in	28483841	1	O
the	28483841	1	O
triggering	28483841	1	O
receptor	28483841	1	O
expressed	28483841	1	O
on	28483841	1	O
myeloid	28483841	1	O
cells	28483841	1	O
2	28483841	1	O
(	28483841	1	B-Gene
TREM2	28483841	1	I-Gene
)	28483841	1	I-Gene
have	28483841	1	O
been	28483841	1	O
linked	28483841	1	B-Reg
to	28483841	1	I-Reg
an	28483841	1	O
increased	28483841	1	O
risk	28483841	1	O
for	28483841	1	O
neurodegenerative	28483841	1	O
disorders	28483841	1	O
such	28483841	1	O
as	28483841	1	O
Alzheimer	28483841	1	B-Disease
'	28483841	1	I-Disease
s	28483841	1	I-Disease
disease	28483841	1	I-Disease
and	28483841	1	O
frontotemporal	28483841	1	B-Disease
lobar	28483841	1	I-Disease
degeneration	28483841	1	I-Disease
.	28483841	1	O
In	28483841	1	O
the	28483841	1	O
brain	28483841	1	O
,	28483841	1	O
TREM2	28483841	1	O
is	28483841	1	O
predominantly	28483841	1	O
expressed	28483841	1	O
in	28483841	1	O
microglia	28483841	1	O
.	28483841	1	O
Several	28483841	1	O
disease	28483841	1	O
-	28483841	1	O
associated	28483841	1	O
TREM2	28483841	1	B-Gene
variants	28483841	1	B-Var
result	28483841	1	O
in	28483841	1	O
a	28483841	1	O
loss	28483841	1	O
of	28483841	1	O
function	28483841	1	O
by	28483841	1	O
reducing	28483841	1	B-NegReg
microglial	28483841	1	B-CPA
phagocytosis	28483841	1	I-CPA
,	28483841	1	O
impairing	28483841	1	B-NegReg
lipid	28483841	1	B-MPA
sensing	28483841	1	I-MPA
,	28483841	1	O
preventing	28483841	1	B-NegReg
binding	28483841	1	B-Interaction
of	28483841	1	O
lipoproteins	28483841	1	B-Protein
and	28483841	1	O
affecting	28483841	1	B-Reg
shielding	28483841	1	B-MPA
of	28483841	1	I-MPA
amyloid	28483841	1	I-MPA
plaques	28483841	1	I-MPA
.	28483841	1	O
We	28483841	1	O
here	28483841	1	O
investigate	28483841	1	O
the	28483841	1	O
consequences	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
loss	28483841	1	O
of	28483841	1	O
function	28483841	1	O
on	28483841	1	O
the	28483841	1	O
microglia	28483841	1	O
transcriptome	28483841	1	O
.	28483841	1	O
Among	28483841	1	O
the	28483841	1	O
differentially	28483841	1	O
expressed	28483841	1	O
messenger	28483841	1	O
RNAs	28483841	1	O
in	28483841	1	O
wild	28483841	1	O
-	28483841	1	O
type	28483841	1	O
and	28483841	1	O
Trem2	28483841	1	O
(	28483841	1	O
-	28483841	1	O
/	28483841	1	O
-	28483841	1	O
)	28483841	1	O
microglia	28483841	1	O
,	28483841	1	O
gene	28483841	1	O
clusters	28483841	1	O
are	28483841	1	O
identified	28483841	1	O
which	28483841	1	O
represent	28483841	1	O
gene	28483841	1	O
functions	28483841	1	O
in	28483841	1	O
chemotaxis	28483841	1	O
,	28483841	1	O
migration	28483841	1	O
and	28483841	1	O
mobility	28483841	1	O
.	28483841	1	O
Functional	28483841	1	O
analyses	28483841	1	O
confirm	28483841	1	O
that	28483841	1	O
loss	28483841	1	B-Var
of	28483841	1	O
TREM2	28483841	1	B-Gene
impairs	28483841	1	B-NegReg
appropriate	28483841	1	O
microglial	28483841	1	B-CPA
responses	28483841	1	I-CPA
to	28483841	1	I-CPA
injury	28483841	1	I-CPA
and	28483841	1	I-CPA
signals	28483841	1	I-CPA
that	28483841	1	O
normally	28483841	1	O
evoke	28483841	1	O
chemotaxis	28483841	1	O
on	28483841	1	O
multiple	28483841	1	O
levels	28483841	1	O
.	28483841	1	O
In	28483841	1	O
an	28483841	1	O
ex	28483841	1	O
vivo	28483841	1	O
organotypic	28483841	1	O
brain	28483841	1	O
slice	28483841	1	O
assay	28483841	1	O
,	28483841	1	O
absence	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
reduces	28483841	1	O
the	28483841	1	O
distance	28483841	1	O
migrated	28483841	1	O
by	28483841	1	O
microglia	28483841	1	O
.	28483841	1	O
Moreover	28483841	1	O
,	28483841	1	O
migration	28483841	1	O
towards	28483841	1	O
defined	28483841	1	O
chemo	28483841	1	O
-	28483841	1	O
attractants	28483841	1	O
is	28483841	1	O
reduced	28483841	1	O
upon	28483841	1	O
ablation	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
and	28483841	1	O
can	28483841	1	O
be	28483841	1	O
rescued	28483841	1	O
by	28483841	1	O
TREM2	28483841	1	O
re	28483841	1	O
-	28483841	1	O
expression	28483841	1	O
.	28483841	1	O
In	28483841	1	O
vivo	28483841	1	O
,	28483841	1	O
microglia	28483841	1	O
lacking	28483841	1	O
TREM2	28483841	1	O
migrate	28483841	1	O
less	28483841	1	O
towards	28483841	1	O
injected	28483841	1	O
apoptotic	28483841	1	O
neurons	28483841	1	O
,	28483841	1	O
and	28483841	1	O
outgrowth	28483841	1	O
of	28483841	1	O
microglial	28483841	1	O
processes	28483841	1	O
towards	28483841	1	O
sites	28483841	1	O
of	28483841	1	O
laser	28483841	1	O
-	28483841	1	O
induced	28483841	1	O
focal	28483841	1	O
CNS	28483841	1	O
damage	28483841	1	O
in	28483841	1	O
the	28483841	1	O
somatosensory	28483841	1	O
cortex	28483841	1	O
is	28483841	1	O
slowed	28483841	1	O
.	28483841	1	O
The	28483841	1	O
apparent	28483841	1	O
lack	28483841	1	O
of	28483841	1	O
chemotactic	28483841	1	O
stimulation	28483841	1	O
upon	28483841	1	O
depletion	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
is	28483841	1	O
consistent	28483841	1	O
with	28483841	1	O
a	28483841	1	O
stable	28483841	1	O
expression	28483841	1	O
profile	28483841	1	O
of	28483841	1	O
genes	28483841	1	O
characterizing	28483841	1	O
the	28483841	1	O
homoeostatic	28483841	1	O
signature	28483841	1	O
of	28483841	1	O
microglia	28483841	1	O
.	28483841	1	O

Novel	28488085	1	O
loss	28488085	1	B-NegReg
of	28488085	1	I-NegReg
function	28488085	1	I-NegReg
mutation	28488085	1	B-Var
in	28488085	1	O
KRIT1	28488085	1	B-Gene
/	28488085	1	I-Gene
CCM1	28488085	1	I-Gene
is	28488085	1	O
associated	28488085	1	B-Reg
with	28488085	1	I-Reg
distinctly	28488085	1	O
progressive	28488085	1	O
cerebral	28488085	1	B-Disease
and	28488085	1	I-Disease
spinal	28488085	1	I-Disease
cavernous	28488085	1	I-Disease
malformations	28488085	1	I-Disease
after	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
intracranial	28488085	1	O
malignant	28488085	1	O
germ	28488085	1	O
cell	28488085	1	O
tumor	28488085	1	O
.	28488085	1	O
PURPOSE	28488085	1	O
:	28488085	1	O
Cerebrospinal	28488085	1	B-Disease
cavernous	28488085	1	I-Disease
malformations	28488085	1	I-Disease
(	28488085	1	O
CCMs	28488085	1	O
)	28488085	1	O
are	28488085	1	O
vascular	28488085	1	O
lesions	28488085	1	O
characterized	28488085	1	O
by	28488085	1	O
dilated	28488085	1	O
and	28488085	1	O
leaky	28488085	1	O
capillary	28488085	1	O
caverns	28488085	1	O
.	28488085	1	O
CCMs	28488085	1	O
can	28488085	1	O
cause	28488085	1	O
seizures	28488085	1	O
,	28488085	1	O
focal	28488085	1	O
neurological	28488085	1	O
deficits	28488085	1	O
or	28488085	1	O
acute	28488085	1	O
intracranial	28488085	1	O
hemorrhage	28488085	1	O
;	28488085	1	O
however	28488085	1	O
,	28488085	1	O
most	28488085	1	O
patients	28488085	1	O
are	28488085	1	O
asymptomatic	28488085	1	O
.	28488085	1	O
CCMs	28488085	1	O
occur	28488085	1	O
either	28488085	1	O
sporadically	28488085	1	O
or	28488085	1	O
as	28488085	1	O
a	28488085	1	O
familial	28488085	1	O
autosomal	28488085	1	O
-	28488085	1	O
dominant	28488085	1	O
disorder	28488085	1	O
.	28488085	1	O
We	28488085	1	O
present	28488085	1	O
a	28488085	1	O
clinical	28488085	1	O
and	28488085	1	O
molecular	28488085	1	O
study	28488085	1	O
of	28488085	1	O
a	28488085	1	O
patient	28488085	1	O
with	28488085	1	O
distinctive	28488085	1	O
cerebral	28488085	1	O
and	28488085	1	O
spinal	28488085	1	O
cavernous	28488085	1	O
malformations	28488085	1	O
following	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
a	28488085	1	O
malignant	28488085	1	O
brain	28488085	1	O
tumor	28488085	1	O
.	28488085	1	O
METHODS	28488085	1	O
:	28488085	1	O
The	28488085	1	O
patient	28488085	1	O
had	28488085	1	O
multiple	28488085	1	O
magnet	28488085	1	O
resonance	28488085	1	O
imaging	28488085	1	O
(	28488085	1	O
MRI	28488085	1	O
)	28488085	1	O
examinations	28488085	1	O
of	28488085	1	O
his	28488085	1	O
brain	28488085	1	O
and	28488085	1	O
spine	28488085	1	O
following	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
a	28488085	1	O
primary	28488085	1	O
intracranial	28488085	1	O
germ	28488085	1	O
cell	28488085	1	O
tumor	28488085	1	O
(	28488085	1	O
GCT	28488085	1	O
)	28488085	1	O
,	28488085	1	O
as	28488085	1	O
part	28488085	1	O
of	28488085	1	O
his	28488085	1	O
oncologic	28488085	1	O
follow	28488085	1	O
-	28488085	1	O
up	28488085	1	O
.	28488085	1	O
The	28488085	1	O
MRI	28488085	1	O
sequences	28488085	1	O
included	28488085	1	O
susceptibility	28488085	1	O
-	28488085	1	O
weighted	28488085	1	O
imaging	28488085	1	O
(	28488085	1	O
SWI	28488085	1	O
)	28488085	1	O
.	28488085	1	O
The	28488085	1	O
coding	28488085	1	O
exons	28488085	1	O
and	28488085	1	O
their	28488085	1	O
flanking	28488085	1	O
intronic	28488085	1	O
regions	28488085	1	O
of	28488085	1	O
KRIT1	28488085	1	O
/	28488085	1	O
CCM1	28488085	1	O
gene	28488085	1	O
were	28488085	1	O
analyzed	28488085	1	O
for	28488085	1	O
mutations	28488085	1	O
by	28488085	1	O
polymerase	28488085	1	O
chain	28488085	1	O
reaction	28488085	1	O
(	28488085	1	O
PCR	28488085	1	O
)	28488085	1	O
and	28488085	1	O
direct	28488085	1	O
sequencing	28488085	1	O
.	28488085	1	O
RESULTS	28488085	1	O
:	28488085	1	O
MRI	28488085	1	O
revealed	28488085	1	O
numerous	28488085	1	O
cerebral	28488085	1	O
and	28488085	1	O
spinal	28488085	1	O
microhemorrhages	28488085	1	O
and	28488085	1	O
pronounced	28488085	1	O
cavernous	28488085	1	O
malformations	28488085	1	O
that	28488085	1	O
progressed	28488085	1	O
with	28488085	1	O
subsequent	28488085	1	O
follow	28488085	1	O
-	28488085	1	O
up	28488085	1	O
imaging	28488085	1	O
.	28488085	1	O
Genetic	28488085	1	O
analysis	28488085	1	O
demonstrated	28488085	1	O
a	28488085	1	O
novel	28488085	1	O
heterozygous	28488085	1	O
KRIT1	28488085	1	B-Gene
/	28488085	1	I-Gene
CCM1	28488085	1	I-Gene
two	28488085	1	O
base	28488085	1	O
pair	28488085	1	O
deletion	28488085	1	O
(	28488085	1	B-Var
c.1535_1536delTG	28488085	1	I-Var
)	28488085	1	I-Var
in	28488085	1	O
exon	28488085	1	O
14	28488085	1	O
.	28488085	1	O
This	28488085	1	O
deletion	28488085	1	O
leads	28488085	1	B-Reg
to	28488085	1	I-Reg
a	28488085	1	O
frameshift	28488085	1	B-Var
with	28488085	1	O
a	28488085	1	O
premature	28488085	1	B-MPA
stop	28488085	1	I-MPA
codon	28488085	1	I-MPA
at	28488085	1	O
nucleotide	28488085	1	O
position	28488085	1	O
1553	28488085	1	O
and	28488085	1	O
a	28488085	1	O
highly	28488085	1	O
likely	28488085	1	O
loss	28488085	1	B-NegReg
of	28488085	1	I-NegReg
function	28488085	1	I-NegReg
of	28488085	1	O
the	28488085	1	O
KRIT1	28488085	1	B-Protein
protein	28488085	1	I-Protein
.	28488085	1	O
CONCLUSION	28488085	1	O
:	28488085	1	O
We	28488085	1	O
describe	28488085	1	O
a	28488085	1	O
patient	28488085	1	O
with	28488085	1	O
a	28488085	1	O
novel	28488085	1	O
heterozygous	28488085	1	O
germ	28488085	1	O
line	28488085	1	O
loss	28488085	1	B-NegReg
of	28488085	1	I-NegReg
function	28488085	1	I-NegReg
mutation	28488085	1	B-Var
in	28488085	1	O
KRIT1	28488085	1	B-Gene
,	28488085	1	O
which	28488085	1	O
is	28488085	1	O
associated	28488085	1	B-Reg
with	28488085	1	I-Reg
rapid	28488085	1	O
-	28488085	1	O
onset	28488085	1	O
and	28488085	1	O
highly	28488085	1	O
progressive	28488085	1	O
CCMs	28488085	1	B-Disease
after	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
a	28488085	1	O
malignant	28488085	1	O
brain	28488085	1	O
tumor	28488085	1	O
.	28488085	1	O

Real	28507206	4	O
-	28507206	4	O
World	28507206	4	O
Data	28507206	4	O
on	28507206	4	O
Prognostic	28507206	4	O
Factors	28507206	4	O
for	28507206	4	O
Overall	28507206	4	O
Survival	28507206	4	O
in	28507206	4	O
EGFR	28507206	4	B-Gene
Mutation	28507206	4	B-Reg
-	28507206	4	I-Reg
Positive	28507206	4	I-Reg
Advanced	28507206	4	O
Non	28507206	4	B-Disease
-	28507206	4	I-Disease
Small	28507206	4	I-Disease
Cell	28507206	4	I-Disease
Lung	28507206	4	I-Disease
Cancer	28507206	4	I-Disease
Patients	28507206	4	O
Treated	28507206	4	O
with	28507206	4	O
First	28507206	4	O
-	28507206	4	O
Line	28507206	4	O
Gefitinib	28507206	4	O
.	28507206	4	O
BACKGROUND	28507206	4	O
:	28507206	4	O
This	28507206	4	O
study	28507206	4	O
aimed	28507206	4	O
to	28507206	4	O
identify	28507206	4	O
independent	28507206	4	O
prognostic	28507206	4	O
factors	28507206	4	O
for	28507206	4	O
overall	28507206	4	O
survival	28507206	4	O
(	28507206	4	O
OS	28507206	4	O
)	28507206	4	O
of	28507206	4	O
patients	28507206	4	O
with	28507206	4	O
advanced	28507206	4	O
non	28507206	4	O
-	28507206	4	O
small	28507206	4	O
cell	28507206	4	O
lung	28507206	4	O
cancer	28507206	4	O
(	28507206	4	O
NSCLC	28507206	4	O
)	28507206	4	O
harboring	28507206	4	O
an	28507206	4	O
activating	28507206	4	O
epidermal	28507206	4	O
growth	28507206	4	O
factor	28507206	4	O
receptor	28507206	4	O
(	28507206	4	O
EGFR	28507206	4	O
)	28507206	4	O
mutation	28507206	4	O
and	28507206	4	O
receiving	28507206	4	O
gefitinib	28507206	4	O
as	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
treatment	28507206	4	O
in	28507206	4	O
real	28507206	4	O
-	28507206	4	O
world	28507206	4	O
practice	28507206	4	O
.	28507206	4	O
MATERIALS	28507206	4	O
AND	28507206	4	O
METHODS	28507206	4	O
:	28507206	4	O
We	28507206	4	O
enrolled	28507206	4	O
226	28507206	4	O
patients	28507206	4	O
from	28507206	4	O
June	28507206	4	O
2011	28507206	4	O
to	28507206	4	O
May	28507206	4	O
2013	28507206	4	O
.	28507206	4	O
During	28507206	4	O
this	28507206	4	O
period	28507206	4	O
,	28507206	4	O
gefitinib	28507206	4	O
was	28507206	4	O
the	28507206	4	O
only	28507206	4	O
EGFR	28507206	4	O
-	28507206	4	O
tyrosine	28507206	4	O
kinase	28507206	4	O
inhibitor	28507206	4	O
reimbursed	28507206	4	O
by	28507206	4	O
the	28507206	4	O
Bureau	28507206	4	O
of	28507206	4	O
National	28507206	4	O
Health	28507206	4	O
Insurance	28507206	4	O
of	28507206	4	O
Taiwan	28507206	4	O
.	28507206	4	O
RESULTS	28507206	4	O
:	28507206	4	O
The	28507206	4	O
median	28507206	4	O
progression	28507206	4	O
-	28507206	4	O
free	28507206	4	O
survival	28507206	4	O
and	28507206	4	O
median	28507206	4	O
OS	28507206	4	O
were	28507206	4	O
11.9	28507206	4	O
months	28507206	4	O
(	28507206	4	O
95%	28507206	4	O
confidence	28507206	4	O
interval	28507206	4	O
[	28507206	4	O
CI	28507206	4	O
]	28507206	4	O
:	28507206	4	O
9.7	28507206	4	O
-	28507206	4	O
14.2	28507206	4	O
)	28507206	4	O
and	28507206	4	O
26.9	28507206	4	O
months	28507206	4	O
(	28507206	4	O
21.2	28507206	4	O
-	28507206	4	O
32.5	28507206	4	O
)	28507206	4	O
,	28507206	4	O
respectively	28507206	4	O
.	28507206	4	O
The	28507206	4	O
Cox	28507206	4	O
proportional	28507206	4	O
hazards	28507206	4	O
regression	28507206	4	O
model	28507206	4	O
revealed	28507206	4	O
that	28507206	4	O
postoperative	28507206	4	O
recurrence	28507206	4	O
,	28507206	4	O
performance	28507206	4	O
status	28507206	4	O
(	28507206	4	O
Eastern	28507206	4	O
Cooperative	28507206	4	O
Oncology	28507206	4	O
Grade	28507206	4	O
[	28507206	4	O
ECOG	28507206	4	O
]	28507206	4	O
2	28507206	4	O
)	28507206	4	O
,	28507206	4	O
smoking	28507206	4	O
index	28507206	4	O
(	28507206	4	O
20	28507206	4	O
pack	28507206	4	O
-	28507206	4	O
years	28507206	4	O
)	28507206	4	O
,	28507206	4	O
liver	28507206	4	O
metastasis	28507206	4	O
at	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
,	28507206	4	O
and	28507206	4	O
chronic	28507206	4	O
hepatitis	28507206	4	O
C	28507206	4	O
virus	28507206	4	O
(	28507206	4	O
HCV	28507206	4	O
)	28507206	4	O
infection	28507206	4	O
were	28507206	4	O
independent	28507206	4	O
prognostic	28507206	4	O
factors	28507206	4	O
for	28507206	4	O
OS	28507206	4	O
(	28507206	4	O
hazard	28507206	4	O
ratio	28507206	4	O
[	28507206	4	O
95%	28507206	4	O
CI	28507206	4	O
]	28507206	4	O
0.3	28507206	4	O
[	28507206	4	O
0.11	28507206	4	O
-	28507206	4	O
0.83	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.02	28507206	4	O
;	28507206	4	O
2.69	28507206	4	O
[	28507206	4	O
1.60	28507206	4	O
-	28507206	4	O
4.51	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
<	28507206	4	O
.001	28507206	4	O
;	28507206	4	O
1.92	28507206	4	O
[	28507206	4	O
1.24	28507206	4	O
-	28507206	4	O
2.97	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.003	28507206	4	O
;	28507206	4	O
2.26	28507206	4	O
[	28507206	4	O
1.34	28507206	4	O
-	28507206	4	O
3.82	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.002	28507206	4	O
;	28507206	4	O
3.38	28507206	4	O
[	28507206	4	O
1.85	28507206	4	O
-	28507206	4	O
7.78	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
<	28507206	4	O
.001	28507206	4	O
,	28507206	4	O
respectively	28507206	4	O
)	28507206	4	O
.	28507206	4	O
However	28507206	4	O
,	28507206	4	O
brain	28507206	4	O
metastasis	28507206	4	O
(	28507206	4	O
BM	28507206	4	O
)	28507206	4	O
at	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
or	28507206	4	O
intracranial	28507206	4	O
progression	28507206	4	O
during	28507206	4	O
gefitinib	28507206	4	O
treatment	28507206	4	O
had	28507206	4	O
no	28507206	4	O
impact	28507206	4	O
on	28507206	4	O
OS	28507206	4	O
(	28507206	4	O
1.266	28507206	4	O
[	28507206	4	O
0.83	28507206	4	O
-	28507206	4	O
1.93	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.275	28507206	4	O
and	28507206	4	O
0.75	28507206	4	O
[	28507206	4	O
0.48	28507206	4	O
-	28507206	4	O
1.19	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.211	28507206	4	O
,	28507206	4	O
respectively	28507206	4	O
)	28507206	4	O
.	28507206	4	O
CONCLUSION	28507206	4	O
:	28507206	4	O
HCV	28507206	4	O
infection	28507206	4	O
,	28507206	4	O
performance	28507206	4	O
status	28507206	4	O
(	28507206	4	O
ECOG	28507206	4	O
2	28507206	4	O
)	28507206	4	O
,	28507206	4	O
newly	28507206	4	O
diagnosed	28507206	4	O
advanced	28507206	4	O
NSCLC	28507206	4	O
without	28507206	4	O
prior	28507206	4	O
operation	28507206	4	O
,	28507206	4	O
and	28507206	4	O
liver	28507206	4	O
metastasis	28507206	4	O
predicted	28507206	4	O
poor	28507206	4	O
OS	28507206	4	O
in	28507206	4	O
EGFR	28507206	4	O
mutation	28507206	4	O
-	28507206	4	O
positive	28507206	4	O
advanced	28507206	4	O
NSCLC	28507206	4	O
patients	28507206	4	O
treated	28507206	4	O
with	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
gefitinib	28507206	4	O
;	28507206	4	O
however	28507206	4	O
,	28507206	4	O
neither	28507206	4	O
BM	28507206	4	O
at	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
nor	28507206	4	O
intracranial	28507206	4	O
progression	28507206	4	O
during	28507206	4	O
gefitinib	28507206	4	O
treatment	28507206	4	O
had	28507206	4	O
an	28507206	4	O
impact	28507206	4	O
on	28507206	4	O
OS	28507206	4	O
.	28507206	4	O
The	28507206	4	O
Oncologist	28507206	4	O
2017	28507206	4	O
;	28507206	4	O
22	28507206	4	O
:	28507206	4	O
1	28507206	4	O
-	28507206	4	O
9	28507206	4	O
IMPLICATIONS	28507206	4	O
FOR	28507206	4	O
PRACTICE	28507206	4	O
:	28507206	4	O
The	28507206	4	O
finding	28507206	4	O
that	28507206	4	O
chronic	28507206	4	O
hepatitis	28507206	4	O
C	28507206	4	O
virus	28507206	4	O
(	28507206	4	O
HCV	28507206	4	O
)	28507206	4	O
infection	28507206	4	O
might	28507206	4	O
predict	28507206	4	O
poor	28507206	4	O
overall	28507206	4	O
survival	28507206	4	O
(	28507206	4	O
OS	28507206	4	O
)	28507206	4	O
in	28507206	4	O
epidermal	28507206	4	O
growth	28507206	4	O
factor	28507206	4	O
receptor	28507206	4	O
mutation	28507206	4	O
-	28507206	4	O
positive	28507206	4	O
advanced	28507206	4	O
non	28507206	4	O
-	28507206	4	O
small	28507206	4	O
cell	28507206	4	O
lung	28507206	4	O
cancer	28507206	4	O
(	28507206	4	O
NSCLC	28507206	4	O
)	28507206	4	O
patients	28507206	4	O
treated	28507206	4	O
with	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
gefitinib	28507206	4	O
may	28507206	4	O
raise	28507206	4	O
awareness	28507206	4	O
of	28507206	4	O
benefit	28507206	4	O
from	28507206	4	O
anti	28507206	4	O
-	28507206	4	O
HCV	28507206	4	O
treatment	28507206	4	O
in	28507206	4	O
this	28507206	4	O
patient	28507206	4	O
population	28507206	4	O
.	28507206	4	O
Brain	28507206	4	O
metastasis	28507206	4	O
in	28507206	4	O
the	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
or	28507206	4	O
intracranial	28507206	4	O
progression	28507206	4	O
during	28507206	4	O
gefitinib	28507206	4	O
treatment	28507206	4	O
is	28507206	4	O
not	28507206	4	O
a	28507206	4	O
prognostic	28507206	4	O
factor	28507206	4	O
for	28507206	4	O
OS	28507206	4	O
.	28507206	4	O
This	28507206	4	O
study	28507206	4	O
,	28507206	4	O
which	28507206	4	O
enrolled	28507206	4	O
a	28507206	4	O
real	28507206	4	O
-	28507206	4	O
world	28507206	4	O
population	28507206	4	O
of	28507206	4	O
NSCLC	28507206	4	O
patients	28507206	4	O
,	28507206	4	O
including	28507206	4	O
sicker	28507206	4	O
patients	28507206	4	O
who	28507206	4	O
were	28507206	4	O
not	28507206	4	O
eligible	28507206	4	O
for	28507206	4	O
a	28507206	4	O
clinical	28507206	4	O
trial	28507206	4	O
,	28507206	4	O
may	28507206	4	O
have	28507206	4	O
impact	28507206	4	O
on	28507206	4	O
guiding	28507206	4	O
usual	28507206	4	O
clinical	28507206	4	O
practice	28507206	4	O
.	28507206	4	O

Loss	28512217	1	B-Var
of	28512217	1	O
the	28512217	1	O
homologous	28512217	1	O
recombination	28512217	1	O
gene	28512217	1	O
rad51	28512217	1	B-Gene
leads	28512217	1	B-Reg
to	28512217	1	O
Fanconi	28512217	1	B-Disease
anemia	28512217	1	I-Disease
-	28512217	1	I-Disease
like	28512217	1	I-Disease
symptoms	28512217	1	I-Disease
in	28512217	1	O
zebrafish	28512217	1	O
.	28512217	1	O
RAD51	28512217	1	O
is	28512217	1	O
an	28512217	1	O
indispensable	28512217	1	O
homologous	28512217	1	O
recombination	28512217	1	O
protein	28512217	1	O
,	28512217	1	O
necessary	28512217	1	O
for	28512217	1	O
strand	28512217	1	O
invasion	28512217	1	O
and	28512217	1	O
crossing	28512217	1	O
over	28512217	1	O
.	28512217	1	O
It	28512217	1	O
has	28512217	1	O
recently	28512217	1	O
been	28512217	1	O
designated	28512217	1	O
as	28512217	1	O
a	28512217	1	O
Fanconi	28512217	1	B-Disease
anemia	28512217	1	I-Disease
(	28512217	1	O
FA	28512217	1	O
)	28512217	1	O
gene	28512217	1	O
,	28512217	1	O
following	28512217	1	O
the	28512217	1	O
discovery	28512217	1	O
of	28512217	1	O
two	28512217	1	O
patients	28512217	1	O
carrying	28512217	1	O
dominant	28512217	1	O
-	28512217	1	O
negative	28512217	1	O
mutations	28512217	1	O
.	28512217	1	O
FA	28512217	1	O
is	28512217	1	O
a	28512217	1	O
hereditary	28512217	1	O
DNA	28512217	1	O
-	28512217	1	O
repair	28512217	1	O
disorder	28512217	1	O
characterized	28512217	1	O
by	28512217	1	O
various	28512217	1	O
congenital	28512217	1	O
abnormalities	28512217	1	O
,	28512217	1	O
progressive	28512217	1	O
bone	28512217	1	O
marrow	28512217	1	O
failure	28512217	1	O
,	28512217	1	O
and	28512217	1	O
cancer	28512217	1	O
predisposition	28512217	1	O
.	28512217	1	O
In	28512217	1	O
this	28512217	1	O
report	28512217	1	O
,	28512217	1	O
we	28512217	1	O
describe	28512217	1	O
a	28512217	1	O
viable	28512217	1	O
vertebrate	28512217	1	O
model	28512217	1	O
of	28512217	1	O
RAD51	28512217	1	O
loss	28512217	1	O
.	28512217	1	O
Zebrafish	28512217	1	O
rad51	28512217	1	B-Gene
loss	28512217	1	B-NegReg
-	28512217	1	I-NegReg
of	28512217	1	I-NegReg
-	28512217	1	I-NegReg
function	28512217	1	I-NegReg
mutants	28512217	1	B-Var
developed	28512217	1	O
key	28512217	1	O
features	28512217	1	O
of	28512217	1	O
FA	28512217	1	B-Disease
,	28512217	1	O
including	28512217	1	O
hypocellular	28512217	1	O
kidney	28512217	1	O
marrow	28512217	1	O
,	28512217	1	O
sensitivity	28512217	1	O
to	28512217	1	O
cross	28512217	1	O
-	28512217	1	O
linking	28512217	1	O
agents	28512217	1	O
,	28512217	1	O
and	28512217	1	O
decreased	28512217	1	O
size	28512217	1	O
.	28512217	1	O
We	28512217	1	O
show	28512217	1	O
that	28512217	1	O
some	28512217	1	O
of	28512217	1	O
these	28512217	1	O
symptoms	28512217	1	O
stem	28512217	1	O
from	28512217	1	O
both	28512217	1	O
decreased	28512217	1	O
proliferation	28512217	1	O
and	28512217	1	O
increased	28512217	1	O
apoptosis	28512217	1	O
of	28512217	1	O
embryonic	28512217	1	O
hematopoietic	28512217	1	O
stem	28512217	1	O
and	28512217	1	O
progenitor	28512217	1	O
cells	28512217	1	O
.	28512217	1	O
Comutation	28512217	1	O
of	28512217	1	O
p53	28512217	1	O
was	28512217	1	O
able	28512217	1	O
to	28512217	1	O
rescue	28512217	1	O
the	28512217	1	O
hematopoietic	28512217	1	O
defects	28512217	1	O
seen	28512217	1	O
in	28512217	1	O
the	28512217	1	O
single	28512217	1	O
mutants	28512217	1	O
,	28512217	1	O
but	28512217	1	O
led	28512217	1	O
to	28512217	1	O
tumor	28512217	1	O
development	28512217	1	O
.	28512217	1	O
We	28512217	1	O
further	28512217	1	O
demonstrate	28512217	1	O
that	28512217	1	O
prolonged	28512217	1	O
inflammatory	28512217	1	O
stress	28512217	1	O
can	28512217	1	O
exacerbate	28512217	1	O
the	28512217	1	O
hematological	28512217	1	O
impairment	28512217	1	O
,	28512217	1	O
leading	28512217	1	O
to	28512217	1	O
an	28512217	1	O
additional	28512217	1	O
decrease	28512217	1	O
in	28512217	1	O
kidney	28512217	1	O
marrow	28512217	1	O
cell	28512217	1	O
numbers	28512217	1	O
.	28512217	1	O
These	28512217	1	O
findings	28512217	1	O
strengthen	28512217	1	O
the	28512217	1	O
assignment	28512217	1	O
of	28512217	1	O
RAD51	28512217	1	O
as	28512217	1	O
a	28512217	1	O
Fanconi	28512217	1	O
gene	28512217	1	O
and	28512217	1	O
provide	28512217	1	O
more	28512217	1	O
evidence	28512217	1	O
for	28512217	1	O
the	28512217	1	O
notion	28512217	1	O
that	28512217	1	O
aberrant	28512217	1	O
p53	28512217	1	O
signaling	28512217	1	O
during	28512217	1	O
embryogenesis	28512217	1	O
leads	28512217	1	O
to	28512217	1	O
the	28512217	1	O
hematological	28512217	1	O
defects	28512217	1	O
seen	28512217	1	O
later	28512217	1	O
in	28512217	1	O
life	28512217	1	O
in	28512217	1	O
FA	28512217	1	O
.	28512217	1	O
Further	28512217	1	O
research	28512217	1	O
on	28512217	1	O
this	28512217	1	O
zebrafish	28512217	1	O
FA	28512217	1	O
model	28512217	1	O
will	28512217	1	O
lead	28512217	1	O
to	28512217	1	O
a	28512217	1	O
deeper	28512217	1	O
understanding	28512217	1	O
of	28512217	1	O
the	28512217	1	O
molecular	28512217	1	O
basis	28512217	1	O
of	28512217	1	O
bone	28512217	1	O
marrow	28512217	1	O
failure	28512217	1	O
in	28512217	1	O
FA	28512217	1	O
and	28512217	1	O
the	28512217	1	O
cellular	28512217	1	O
role	28512217	1	O
of	28512217	1	O
RAD51	28512217	1	O
.	28512217	1	O

Gene	28525545	4	O
Co	28525545	4	O
-	28525545	4	O
Expression	28525545	4	O
Network	28525545	4	O
Analysis	28525545	4	O
for	28525545	4	O
Identifying	28525545	4	O
Modules	28525545	4	O
and	28525545	4	O
Functionally	28525545	4	O
Enriched	28525545	4	O
Pathways	28525545	4	O
in	28525545	4	O
SCA2	28525545	4	O
.	28525545	4	O
Spinocerebellar	28525545	4	B-Disease
ataxia	28525545	4	I-Disease
type	28525545	4	I-Disease
2	28525545	4	I-Disease
(	28525545	4	O
SCA2	28525545	4	O
)	28525545	4	O
is	28525545	4	O
an	28525545	4	O
autosomal	28525545	4	O
dominant	28525545	4	O
neurodegenerative	28525545	4	O
disease	28525545	4	O
caused	28525545	4	B-Reg
by	28525545	4	I-Reg
CAG	28525545	4	B-Var
repeat	28525545	4	I-Var
expansion	28525545	4	I-Var
in	28525545	4	O
the	28525545	4	O
ATXN2	28525545	4	B-Gene
gene	28525545	4	O
.	28525545	4	O
The	28525545	4	O
repeat	28525545	4	O
resides	28525545	4	O
in	28525545	4	O
an	28525545	4	O
encoded	28525545	4	O
region	28525545	4	O
of	28525545	4	O
the	28525545	4	O
gene	28525545	4	O
resulting	28525545	4	O
in	28525545	4	O
polyglutamine	28525545	4	O
(	28525545	4	O
polyQ	28525545	4	O
)	28525545	4	O
expansion	28525545	4	O
which	28525545	4	O
has	28525545	4	O
been	28525545	4	O
assumed	28525545	4	O
to	28525545	4	O
result	28525545	4	O
in	28525545	4	O
gain	28525545	4	O
of	28525545	4	O
function	28525545	4	O
,	28525545	4	O
predominantly	28525545	4	O
,	28525545	4	O
for	28525545	4	O
the	28525545	4	O
ATXN2	28525545	4	O
protein	28525545	4	O
.	28525545	4	O
We	28525545	4	O
evaluated	28525545	4	O
temporal	28525545	4	O
cerebellar	28525545	4	O
expression	28525545	4	O
profiles	28525545	4	O
by	28525545	4	O
RNA	28525545	4	O
sequencing	28525545	4	O
of	28525545	4	O
ATXN2Q127	28525545	4	O
mice	28525545	4	O
vs	28525545	4	O
wildtype	28525545	4	O
littermates	28525545	4	O
.	28525545	4	O
ATXN2Q127	28525545	4	O
mice	28525545	4	O
are	28525545	4	O
characterized	28525545	4	O
by	28525545	4	O
a	28525545	4	O
progressive	28525545	4	O
motor	28525545	4	O
phenotype	28525545	4	O
onset	28525545	4	O
,	28525545	4	O
and	28525545	4	O
have	28525545	4	O
progressive	28525545	4	O
cerebellar	28525545	4	O
molecular	28525545	4	O
and	28525545	4	O
neurophysiological	28525545	4	O
(	28525545	4	O
Purkinje	28525545	4	O
cell	28525545	4	O
firing	28525545	4	O
frequency	28525545	4	O
)	28525545	4	O
phenotypes	28525545	4	O
.	28525545	4	O
Our	28525545	4	O
analysis	28525545	4	O
revealed	28525545	4	O
previously	28525545	4	O
uncharacterized	28525545	4	O
early	28525545	4	O
and	28525545	4	O
progressive	28525545	4	O
abnormal	28525545	4	O
patterning	28525545	4	O
of	28525545	4	O
cerebellar	28525545	4	O
gene	28525545	4	O
expression	28525545	4	O
.	28525545	4	O
Weighted	28525545	4	O
Gene	28525545	4	O
Coexpression	28525545	4	O
Network	28525545	4	O
Analysis	28525545	4	O
(	28525545	4	O
WGCNA	28525545	4	O
)	28525545	4	O
revealed	28525545	4	O
four	28525545	4	O
gene	28525545	4	O
modules	28525545	4	O
that	28525545	4	O
were	28525545	4	O
significantly	28525545	4	O
correlated	28525545	4	O
with	28525545	4	O
disease	28525545	4	O
status	28525545	4	O
,	28525545	4	O
composed	28525545	4	O
primarily	28525545	4	O
of	28525545	4	O
genes	28525545	4	O
associated	28525545	4	O
with	28525545	4	O
GTPase	28525545	4	O
signaling	28525545	4	O
,	28525545	4	O
calcium	28525545	4	O
signaling	28525545	4	O
,	28525545	4	O
and	28525545	4	O
cell	28525545	4	O
death	28525545	4	O
.	28525545	4	O
Of	28525545	4	O
these	28525545	4	O
genes	28525545	4	O
,	28525545	4	O
few	28525545	4	O
overlapped	28525545	4	O
with	28525545	4	O
differentially	28525545	4	O
expressed	28525545	4	O
cerebellar	28525545	4	O
genes	28525545	4	O
that	28525545	4	O
we	28525545	4	O
identified	28525545	4	O
in	28525545	4	O
Atxn2	28525545	4	O
-	28525545	4	O
/	28525545	4	O
-	28525545	4	O
knockout	28525545	4	O
mice	28525545	4	O
vs	28525545	4	O
wildtype	28525545	4	O
littermates	28525545	4	O
,	28525545	4	O
suggesting	28525545	4	O
that	28525545	4	O
loss	28525545	4	O
-	28525545	4	O
of	28525545	4	O
-	28525545	4	O
function	28525545	4	O
is	28525545	4	O
not	28525545	4	O
a	28525545	4	O
significant	28525545	4	O
component	28525545	4	O
of	28525545	4	O
disease	28525545	4	O
pathology	28525545	4	O
.	28525545	4	O
We	28525545	4	O
conclude	28525545	4	O
that	28525545	4	O
SCA2	28525545	4	O
is	28525545	4	O
a	28525545	4	O
disease	28525545	4	O
characterized	28525545	4	O
by	28525545	4	O
gain	28525545	4	O
of	28525545	4	O
function	28525545	4	O
for	28525545	4	O
ATXN2	28525545	4	O
.	28525545	4	O

Exposure	28525834	0	O
to	28525834	0	O
phenols	28525834	0	O
,	28525834	0	O
parabens	28525834	0	O
and	28525834	0	O
UV	28525834	0	O
filters	28525834	0	O
:	28525834	0	O
Associations	28525834	0	O
with	28525834	0	O
loss	28525834	0	O
-	28525834	0	O
of	28525834	0	O
-	28525834	0	O
function	28525834	0	O
mutations	28525834	0	O
in	28525834	0	O
the	28525834	0	O
filaggrin	28525834	0	O
gene	28525834	0	O
in	28525834	0	O
men	28525834	0	O
from	28525834	0	O
the	28525834	0	O
general	28525834	0	O
population	28525834	0	O
.	28525834	0	O
BACKGROUND	28525834	0	O
:	28525834	0	O
Filaggrin	28525834	0	O
is	28525834	0	O
an	28525834	0	O
epidermal	28525834	0	O
protein	28525834	0	O
that	28525834	0	O
is	28525834	0	O
important	28525834	0	O
for	28525834	0	O
normal	28525834	0	O
skin	28525834	0	O
barrier	28525834	0	O
functions	28525834	0	O
.	28525834	0	O
Up	28525834	0	O
to	28525834	0	O
10%	28525834	0	O
of	28525834	0	O
Europeans	28525834	0	O
and	28525834	0	O
Asians	28525834	0	O
carry	28525834	0	O
filaggrin	28525834	0	O
gene	28525834	0	O
(	28525834	0	B-Gene
FLG	28525834	0	I-Gene
)	28525834	0	I-Gene
loss	28525834	0	B-NegReg
-	28525834	0	I-NegReg
of	28525834	0	I-NegReg
function	28525834	0	I-NegReg
mutations	28525834	0	B-Var
that	28525834	0	O
appear	28525834	0	O
to	28525834	0	O
facilitate	28525834	0	B-PosReg
trans	28525834	0	B-CPA
-	28525834	0	I-CPA
epidermal	28525834	0	I-CPA
penetration	28525834	0	I-CPA
of	28525834	0	I-CPA
certain	28525834	0	I-CPA
chemicals	28525834	0	I-CPA
.	28525834	0	O
We	28525834	0	O
previously	28525834	0	O
showed	28525834	0	O
that	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
have	28525834	0	O
higher	28525834	0	O
internal	28525834	0	O
exposure	28525834	0	O
to	28525834	0	O
certain	28525834	0	O
phthalates	28525834	0	O
,	28525834	0	O
compared	28525834	0	O
to	28525834	0	O
controls	28525834	0	O
,	28525834	0	O
and	28525834	0	O
hypothesized	28525834	0	O
that	28525834	0	O
they	28525834	0	O
could	28525834	0	O
have	28525834	0	O
increased	28525834	0	O
trans	28525834	0	O
-	28525834	0	O
epidermal	28525834	0	O
penetration	28525834	0	O
of	28525834	0	O
other	28525834	0	O
chemicals	28525834	0	O
.	28525834	0	O
OBJECTIVES	28525834	0	O
:	28525834	0	O
We	28525834	0	O
investigated	28525834	0	O
exposure	28525834	0	O
to	28525834	0	O
non	28525834	0	O
-	28525834	0	O
persistent	28525834	0	O
chemicals	28525834	0	O
in	28525834	0	O
young	28525834	0	O
Danish	28525834	0	O
men	28525834	0	O
with	28525834	0	O
and	28525834	0	O
without	28525834	0	O
FLG	28525834	0	O
mutations	28525834	0	O
.	28525834	0	O
METHODS	28525834	0	O
:	28525834	0	O
Concentrations	28525834	0	O
of	28525834	0	O
eight	28525834	0	O
simple	28525834	0	O
phenols	28525834	0	O
,	28525834	0	O
six	28525834	0	O
parabens	28525834	0	O
and	28525834	0	O
nine	28525834	0	O
UV	28525834	0	O
filters	28525834	0	O
were	28525834	0	O
analysed	28525834	0	O
in	28525834	0	O
urine	28525834	0	O
from	28525834	0	O
65	28525834	0	O
FLG	28525834	0	O
loss	28525834	0	O
-	28525834	0	O
of	28525834	0	O
-	28525834	0	O
function	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
and	28525834	0	O
130	28525834	0	O
non	28525834	0	O
-	28525834	0	O
carriers	28525834	0	O
(	28525834	0	O
controls	28525834	0	O
)	28525834	0	O
.	28525834	0	O
Regression	28525834	0	O
analyses	28525834	0	O
,	28525834	0	O
controlling	28525834	0	O
for	28525834	0	O
urinary	28525834	0	O
dilution	28525834	0	O
and	28525834	0	O
confounders	28525834	0	O
,	28525834	0	O
were	28525834	0	O
performed	28525834	0	O
to	28525834	0	O
estimate	28525834	0	O
associations	28525834	0	O
between	28525834	0	O
FLG	28525834	0	O
mutation	28525834	0	O
status	28525834	0	O
and	28525834	0	O
chemical	28525834	0	O
concentrations	28525834	0	O
in	28525834	0	O
urine	28525834	0	O
.	28525834	0	O
RESULTS	28525834	0	O
:	28525834	0	O
FLG	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
had	28525834	0	O
80%	28525834	0	O
(	28525834	0	O
13	28525834	0	O
-	28525834	0	O
180%	28525834	0	O
)	28525834	0	O
higher	28525834	0	O
urinary	28525834	0	O
concentrations	28525834	0	O
of	28525834	0	O
methyl	28525834	0	O
paraben	28525834	0	O
(	28525834	0	O
MeP	28525834	0	O
)	28525834	0	O
and	28525834	0	O
91%	28525834	0	O
(	28525834	0	O
13	28525834	0	O
-	28525834	0	O
219%	28525834	0	O
)	28525834	0	O
higher	28525834	0	O
concentrations	28525834	0	O
of	28525834	0	O
n	28525834	0	O
-	28525834	0	O
propyl	28525834	0	O
paraben	28525834	0	O
(	28525834	0	O
n	28525834	0	O
-	28525834	0	O
PrP	28525834	0	O
)	28525834	0	O
than	28525834	0	O
controls	28525834	0	O
.	28525834	0	O
For	28525834	0	O
13	28525834	0	O
compounds	28525834	0	O
,	28525834	0	O
levels	28525834	0	O
were	28525834	0	O
higher	28525834	0	O
in	28525834	0	O
FLG	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
,	28525834	0	O
although	28525834	0	O
differences	28525834	0	O
were	28525834	0	O
only	28525834	0	O
statistically	28525834	0	O
significant	28525834	0	O
for	28525834	0	O
MeP	28525834	0	O
and	28525834	0	O
n	28525834	0	O
-	28525834	0	O
PrP	28525834	0	O
.	28525834	0	O
Combined	28525834	0	O
statistical	28525834	0	O
analysis	28525834	0	O
of	28525834	0	O
concentrations	28525834	0	O
of	28525834	0	O
all	28525834	0	O
the	28525834	0	O
18	28525834	0	O
compounds	28525834	0	O
that	28525834	0	O
were	28525834	0	O
detectable	28525834	0	O
in	28525834	0	O
>	28525834	0	O
10%	28525834	0	O
of	28525834	0	O
subjects	28525834	0	O
,	28525834	0	O
suggested	28525834	0	O
that	28525834	0	O
concentrations	28525834	0	O
were	28525834	0	O
generally	28525834	0	O
higher	28525834	0	O
in	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
(	28525834	0	O
p	28525834	0	O
=	28525834	0	O
0.03	28525834	0	O
)	28525834	0	O
.	28525834	0	O
CONCLUSION	28525834	0	O
:	28525834	0	O
FLG	28525834	0	O
loss	28525834	0	O
-	28525834	0	O
of	28525834	0	O
-	28525834	0	O
function	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
have	28525834	0	O
a	28525834	0	O
higher	28525834	0	O
internal	28525834	0	O
exposure	28525834	0	O
to	28525834	0	O
some	28525834	0	O
non	28525834	0	O
-	28525834	0	O
persistent	28525834	0	O
chemicals	28525834	0	O
,	28525834	0	O
independently	28525834	0	O
of	28525834	0	O
atopic	28525834	0	O
dermatitis	28525834	0	O
.	28525834	0	O
This	28525834	0	O
may	28525834	0	O
be	28525834	0	O
due	28525834	0	O
to	28525834	0	O
increased	28525834	0	O
trans	28525834	0	O
-	28525834	0	O
epidermal	28525834	0	O
absorption	28525834	0	O
and	28525834	0	O
/	28525834	0	O
or	28525834	0	O
higher	28525834	0	O
exposure	28525834	0	O
,	28525834	0	O
and	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
may	28525834	0	O
constitute	28525834	0	O
a	28525834	0	O
group	28525834	0	O
susceptible	28525834	0	O
to	28525834	0	O
increased	28525834	0	O
absorption	28525834	0	O
of	28525834	0	O
chemicals	28525834	0	O
and	28525834	0	O
topical	28525834	0	O
medication	28525834	0	O
.	28525834	0	O

GRIN2B	28533163	2	O
gain	28533163	2	O
of	28533163	2	O
function	28533163	2	O
mutations	28533163	2	O
are	28533163	2	O
sensitive	28533163	2	O
to	28533163	2	O
radiprodil	28533163	2	O
,	28533163	2	O
a	28533163	2	O
negative	28533163	2	O
allosteric	28533163	2	O
modulator	28533163	2	O
of	28533163	2	O
GluN2B	28533163	2	O
-	28533163	2	O
containing	28533163	2	O
NMDA	28533163	2	O
receptors	28533163	2	O
.	28533163	2	O
De	28533163	2	O
novo	28533163	2	O
gain	28533163	2	B-PosReg
of	28533163	2	I-PosReg
function	28533163	2	I-PosReg
mutations	28533163	2	B-Var
in	28533163	2	O
GRIN2B	28533163	2	B-Gene
encoding	28533163	2	O
the	28533163	2	O
GluN2B	28533163	2	O
subunit	28533163	2	O
of	28533163	2	O
the	28533163	2	O
N	28533163	2	O
-	28533163	2	O
methyl	28533163	2	O
-	28533163	2	O
d	28533163	2	O
-	28533163	2	O
aspartate	28533163	2	O
(	28533163	2	O
NMDA	28533163	2	O
)	28533163	2	O
receptor	28533163	2	O
have	28533163	2	O
been	28533163	2	O
linked	28533163	2	O
with	28533163	2	O
epileptic	28533163	2	B-Disease
encephalopathies	28533163	2	I-Disease
,	28533163	2	O
including	28533163	2	O
infantile	28533163	2	B-Disease
spasms	28533163	2	I-Disease
.	28533163	2	O
We	28533163	2	O
investigated	28533163	2	O
the	28533163	2	O
effects	28533163	2	O
of	28533163	2	O
radiprodil	28533163	2	O
,	28533163	2	O
a	28533163	2	O
selective	28533163	2	O
GluN2B	28533163	2	O
negative	28533163	2	O
allosteric	28533163	2	O
modulator	28533163	2	O
and	28533163	2	O
other	28533163	2	O
non	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
NMDA	28533163	2	O
receptor	28533163	2	O
inhibitors	28533163	2	O
on	28533163	2	O
glutamate	28533163	2	O
currents	28533163	2	O
mediated	28533163	2	O
by	28533163	2	O
NMDA	28533163	2	O
receptors	28533163	2	O
containing	28533163	2	O
mutated	28533163	2	O
GluN2B	28533163	2	O
subunits	28533163	2	O
.	28533163	2	O
The	28533163	2	O
experiments	28533163	2	O
were	28533163	2	O
performed	28533163	2	O
in	28533163	2	O
Xenopus	28533163	2	O
oocytes	28533163	2	O
co	28533163	2	O
-	28533163	2	O
injected	28533163	2	O
with	28533163	2	O
the	28533163	2	O
following	28533163	2	O
human	28533163	2	O
mRNAs	28533163	2	O
:	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
,	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
-	28533163	2	O
R540H	28533163	2	O
,	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
-	28533163	2	O
N615I	28533163	2	O
and	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
-	28533163	2	O
V618G	28533163	2	O
.	28533163	2	O
Glutamate	28533163	2	O
displayed	28533163	2	O
slightly	28533163	2	O
increased	28533163	2	O
potency	28533163	2	O
in	28533163	2	O
the	28533163	2	O
R540H	28533163	2	O
variant	28533163	2	O
,	28533163	2	O
but	28533163	2	O
not	28533163	2	O
in	28533163	2	O
N615I	28533163	2	O
and	28533163	2	O
V618G	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
However	28533163	2	O
,	28533163	2	O
the	28533163	2	O
inhibition	28533163	2	O
by	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
was	28533163	2	O
completely	28533163	2	O
abolished	28533163	2	O
in	28533163	2	O
N615I	28533163	2	O
and	28533163	2	O
V618G	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
In	28533163	2	O
fact	28533163	2	O
,	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
enhanced	28533163	2	O
glutamate	28533163	2	O
responses	28533163	2	O
in	28533163	2	O
those	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
The	28533163	2	O
potency	28533163	2	O
of	28533163	2	O
radiprodil	28533163	2	O
to	28533163	2	O
block	28533163	2	O
glutamate	28533163	2	O
-	28533163	2	O
evoked	28533163	2	O
currents	28533163	2	O
was	28533163	2	O
not	28533163	2	O
affected	28533163	2	O
in	28533163	2	O
any	28533163	2	O
of	28533163	2	O
the	28533163	2	O
variants	28533163	2	O
,	28533163	2	O
while	28533163	2	O
the	28533163	2	O
effects	28533163	2	O
by	28533163	2	O
non	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
NMDA	28533163	2	O
inhibitors	28533163	2	O
were	28533163	2	O
greatly	28533163	2	O
reduced	28533163	2	O
in	28533163	2	O
some	28533163	2	O
of	28533163	2	O
the	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
Additionally	28533163	2	O
,	28533163	2	O
in	28533163	2	O
the	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
insensitive	28533163	2	O
variants	28533163	2	O
,	28533163	2	O
radiprodil	28533163	2	O
blocked	28533163	2	O
glutamate	28533163	2	O
-	28533163	2	O
activated	28533163	2	O
currents	28533163	2	O
with	28533163	2	O
the	28533163	2	O
same	28533163	2	O
potency	28533163	2	O
as	28533163	2	O
in	28533163	2	O
the	28533163	2	O
absence	28533163	2	O
of	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
.	28533163	2	O
The	28533163	2	O
gain	28533163	2	O
of	28533163	2	O
function	28533163	2	O
observed	28533163	2	O
in	28533163	2	O
the	28533163	2	O
reported	28533163	2	O
GRIN2B	28533163	2	O
variants	28533163	2	O
could	28533163	2	O
be	28533163	2	O
a	28533163	2	O
key	28533163	2	O
pathophysiological	28533163	2	O
factor	28533163	2	O
leading	28533163	2	O
to	28533163	2	O
neuronal	28533163	2	O
hyper	28533163	2	O
-	28533163	2	O
excitability	28533163	2	O
in	28533163	2	O
epileptic	28533163	2	O
encephalopathies	28533163	2	O
.	28533163	2	O
The	28533163	2	O
GluN2B	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
inhibitor	28533163	2	O
radiprodil	28533163	2	O
fully	28533163	2	O
retained	28533163	2	O
its	28533163	2	O
pharmacological	28533163	2	O
profile	28533163	2	O
under	28533163	2	O
these	28533163	2	O
conditions	28533163	2	O
,	28533163	2	O
while	28533163	2	O
other	28533163	2	O
non	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
NMDA	28533163	2	O
receptor	28533163	2	O
antagonists	28533163	2	O
lost	28533163	2	O
their	28533163	2	O
potency	28533163	2	O
.	28533163	2	O
Consequently	28533163	2	O
,	28533163	2	O
our	28533163	2	O
data	28533163	2	O
suggest	28533163	2	O
that	28533163	2	O
radiprodil	28533163	2	O
may	28533163	2	O
be	28533163	2	O
a	28533163	2	O
valuable	28533163	2	O
therapeutic	28533163	2	O
option	28533163	2	O
for	28533163	2	O
treatment	28533163	2	O
of	28533163	2	O
pediatric	28533163	2	O
epileptic	28533163	2	O
encephalopathies	28533163	2	O
associated	28533163	2	O
with	28533163	2	O
GRIN2B	28533163	2	O
mutations	28533163	2	O
.	28533163	2	O

PAI-1	28543872	4	O
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
genotype	28543872	4	O
,	28543872	4	O
factors	28543872	4	O
increasing	28543872	4	O
PAI-1	28543872	4	O
levels	28543872	4	O
,	28543872	4	O
and	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
:	28543872	4	O
The	28543872	4	O
GALA	28543872	4	O
II	28543872	4	O
Cohort	28543872	4	O
.	28543872	4	O
BACKGROUND	28543872	4	O
:	28543872	4	O
PAI-1	28543872	4	B-Gene
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
variants	28543872	4	B-Var
promote	28543872	4	B-PosReg
airway	28543872	4	B-CPA
fibrosis	28543872	4	I-CPA
and	28543872	4	O
are	28543872	4	O
associated	28543872	4	B-Reg
with	28543872	4	I-Reg
asthma	28543872	4	B-Disease
and	28543872	4	O
with	28543872	4	O
worse	28543872	4	O
lung	28543872	4	O
function	28543872	4	O
in	28543872	4	O
subjects	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
.	28543872	4	O
OBJECTIVE	28543872	4	O
:	28543872	4	O
We	28543872	4	O
sought	28543872	4	O
to	28543872	4	O
determine	28543872	4	O
whether	28543872	4	O
the	28543872	4	O
association	28543872	4	O
of	28543872	4	O
a	28543872	4	O
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
polymorphism	28543872	4	O
in	28543872	4	O
plasminogen	28543872	4	O
activator	28543872	4	O
inhibitor-1	28543872	4	O
(	28543872	4	O
PAI-1	28543872	4	O
)	28543872	4	O
with	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
is	28543872	4	O
modified	28543872	4	O
by	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
,	28543872	4	O
and	28543872	4	O
whether	28543872	4	O
any	28543872	4	O
genotype	28543872	4	O
effect	28543872	4	O
persists	28543872	4	O
after	28543872	4	O
accounting	28543872	4	O
for	28543872	4	O
common	28543872	4	O
exposures	28543872	4	O
that	28543872	4	O
increase	28543872	4	O
PAI-1	28543872	4	O
level	28543872	4	O
.	28543872	4	O
METHODS	28543872	4	O
:	28543872	4	O
We	28543872	4	O
studied	28543872	4	O
2070	28543872	4	O
Latino	28543872	4	O
children	28543872	4	O
(	28543872	4	O
8	28543872	4	O
-	28543872	4	O
21	28543872	4	O
y	28543872	4	O
)	28543872	4	O
with	28543872	4	O
genotypic	28543872	4	O
and	28543872	4	O
pulmonary	28543872	4	O
function	28543872	4	O
data	28543872	4	O
from	28543872	4	O
the	28543872	4	O
GALA	28543872	4	O
II	28543872	4	O
cohort	28543872	4	O
.	28543872	4	O
We	28543872	4	O
estimated	28543872	4	O
the	28543872	4	O
relationship	28543872	4	O
of	28543872	4	O
the	28543872	4	O
PAI-1	28543872	4	O
risk	28543872	4	O
allele	28543872	4	O
with	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
by	28543872	4	O
multivariate	28543872	4	O
linear	28543872	4	O
regression	28543872	4	O
,	28543872	4	O
stratified	28543872	4	O
by	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
.	28543872	4	O
We	28543872	4	O
examined	28543872	4	O
the	28543872	4	O
association	28543872	4	O
of	28543872	4	O
the	28543872	4	O
polymorphism	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
and	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
within	28543872	4	O
asthmatics	28543872	4	O
via	28543872	4	O
multivariate	28543872	4	O
logistic	28543872	4	O
regression	28543872	4	O
.	28543872	4	O
We	28543872	4	O
replicated	28543872	4	O
associations	28543872	4	O
in	28543872	4	O
the	28543872	4	O
SAPPHIRE	28543872	4	O
cohort	28543872	4	O
of	28543872	4	O
African	28543872	4	O
Americans	28543872	4	O
(	28543872	4	O
n	28543872	4	O
=	28543872	4	O
1056	28543872	4	O
)	28543872	4	O
.	28543872	4	O
Secondary	28543872	4	O
analysis	28543872	4	O
included	28543872	4	O
the	28543872	4	O
effect	28543872	4	O
of	28543872	4	O
the	28543872	4	O
at	28543872	4	O
-	28543872	4	O
risk	28543872	4	O
polymorphism	28543872	4	O
on	28543872	4	O
postbronchodilator	28543872	4	O
lung	28543872	4	O
function	28543872	4	O
.	28543872	4	O
RESULTS	28543872	4	O
:	28543872	4	O
There	28543872	4	O
was	28543872	4	O
an	28543872	4	O
interaction	28543872	4	O
between	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
and	28543872	4	O
the	28543872	4	O
PAI-1	28543872	4	O
polymorphism	28543872	4	O
on	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
(	28543872	4	O
P	28543872	4	O
=	28543872	4	O
.03	28543872	4	O
)	28543872	4	O
.	28543872	4	O
The	28543872	4	O
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
variants	28543872	4	O
,	28543872	4	O
genotypes	28543872	4	O
(	28543872	4	O
AA	28543872	4	O
/	28543872	4	O
AG	28543872	4	O
)	28543872	4	O
,	28543872	4	O
were	28543872	4	O
associated	28543872	4	O
with	28543872	4	O
lower	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
in	28543872	4	O
subjects	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
(	28543872	4	O
β	28543872	4	O
=	28543872	4	O
-	28543872	4	O
1.25	28543872	4	O
,	28543872	4	O
CI	28543872	4	O
:	28543872	4	O
-	28543872	4	O
2.14	28543872	4	O
,	28543872	4	O
-	28543872	4	O
0.35	28543872	4	O
,	28543872	4	O
P	28543872	4	O
=	28543872	4	O
.006	28543872	4	O
)	28543872	4	O
,	28543872	4	O
but	28543872	4	O
not	28543872	4	O
in	28543872	4	O
controls	28543872	4	O
.	28543872	4	O
Subjects	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
and	28543872	4	O
the	28543872	4	O
AA	28543872	4	O
/	28543872	4	O
AG	28543872	4	O
genotypes	28543872	4	O
had	28543872	4	O
a	28543872	4	O
5%	28543872	4	O
decrease	28543872	4	O
in	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
(	28543872	4	O
P	28543872	4	O
<	28543872	4	O
.001	28543872	4	O
)	28543872	4	O
.	28543872	4	O
In	28543872	4	O
asthmatics	28543872	4	O
,	28543872	4	O
the	28543872	4	O
risk	28543872	4	O
genotype	28543872	4	O
(	28543872	4	O
AA	28543872	4	O
/	28543872	4	O
AG	28543872	4	O
)	28543872	4	O
was	28543872	4	O
associated	28543872	4	O
with	28543872	4	O
a	28543872	4	O
39%	28543872	4	O
increase	28543872	4	O
in	28543872	4	O
risk	28543872	4	O
of	28543872	4	O
clinically	28543872	4	O
relevant	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
(	28543872	4	O
OR	28543872	4	O
=	28543872	4	O
1.39	28543872	4	O
,	28543872	4	O
CI	28543872	4	O
:	28543872	4	O
1.01	28543872	4	O
,	28543872	4	O
1.92	28543872	4	O
,	28543872	4	O
P	28543872	4	O
=	28543872	4	O
.04	28543872	4	O
)	28543872	4	O
.	28543872	4	O
These	28543872	4	O
associations	28543872	4	O
persisted	28543872	4	O
after	28543872	4	O
exclusion	28543872	4	O
of	28543872	4	O
factors	28543872	4	O
that	28543872	4	O
increase	28543872	4	O
PAI-1	28543872	4	O
including	28543872	4	O
tobacco	28543872	4	O
exposure	28543872	4	O
and	28543872	4	O
obesity	28543872	4	O
.	28543872	4	O
CONCLUSIONS	28543872	4	O
AND	28543872	4	O
CLINICAL	28543872	4	O
RELEVANCE	28543872	4	O
:	28543872	4	O
The	28543872	4	O
decrease	28543872	4	O
in	28543872	4	O
the	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
ratio	28543872	4	O
associated	28543872	4	O
with	28543872	4	O
the	28543872	4	O
risk	28543872	4	O
genotype	28543872	4	O
was	28543872	4	O
modified	28543872	4	O
by	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
.	28543872	4	O
The	28543872	4	O
genotype	28543872	4	O
increased	28543872	4	O
the	28543872	4	O
odds	28543872	4	O
of	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
by	28543872	4	O
75%	28543872	4	O
within	28543872	4	O
asthmatics	28543872	4	O
only	28543872	4	O
.	28543872	4	O
As	28543872	4	O
exposures	28543872	4	O
known	28543872	4	O
to	28543872	4	O
increase	28543872	4	O
PAI-1	28543872	4	O
levels	28543872	4	O
did	28543872	4	O
not	28543872	4	O
mitigate	28543872	4	O
this	28543872	4	O
association	28543872	4	O
,	28543872	4	O
PAI-1	28543872	4	O
may	28543872	4	O
contribute	28543872	4	O
to	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
in	28543872	4	O
the	28543872	4	O
context	28543872	4	O
of	28543872	4	O
chronic	28543872	4	O
asthmatic	28543872	4	O
airway	28543872	4	O
inflammation	28543872	4	O
.	28543872	4	O

Severe	28548960	1	O
hypertriglyceridemia	28548960	1	B-Disease
due	28548960	1	O
to	28548960	1	O
two	28548960	1	O
novel	28548960	1	O
loss	28548960	1	B-NegReg
-	28548960	1	I-NegReg
of	28548960	1	I-NegReg
-	28548960	1	I-NegReg
function	28548960	1	I-NegReg
lipoprotein	28548960	1	B-Enzyme
lipase	28548960	1	I-Enzyme
gene	28548960	1	O
mutations	28548960	1	O
(	28548960	1	B-Var
C310R	28548960	1	I-Var
/	28548960	1	I-Var
E396V	28548960	1	I-Var
)	28548960	1	I-Var
in	28548960	1	O
a	28548960	1	O
Chinese	28548960	1	O
family	28548960	1	O
associated	28548960	1	B-Reg
with	28548960	1	I-Reg
recurrent	28548960	1	B-Disease
acute	28548960	1	I-Disease
pancreatitis	28548960	1	I-Disease
.	28548960	1	O
Lipoprotein	28548960	1	O
lipase	28548960	1	O
(	28548960	1	O
LPL	28548960	1	O
)	28548960	1	O
is	28548960	1	O
widely	28548960	1	O
expressed	28548960	1	O
in	28548960	1	O
skeletal	28548960	1	O
muscles	28548960	1	O
,	28548960	1	O
cardiac	28548960	1	O
muscles	28548960	1	O
as	28548960	1	O
well	28548960	1	O
as	28548960	1	O
adipose	28548960	1	O
tissue	28548960	1	O
and	28548960	1	O
involved	28548960	1	O
in	28548960	1	O
the	28548960	1	O
catabolism	28548960	1	O
of	28548960	1	O
triglyceride	28548960	1	O
.	28548960	1	O
Herein	28548960	1	O
we	28548960	1	O
have	28548960	1	O
systematically	28548960	1	O
characterized	28548960	1	O
two	28548960	1	O
novel	28548960	1	O
loss	28548960	1	O
-	28548960	1	O
of	28548960	1	O
-	28548960	1	O
function	28548960	1	O
mutations	28548960	1	O
in	28548960	1	O
LPL	28548960	1	O
from	28548960	1	O
a	28548960	1	O
Chinese	28548960	1	O
family	28548960	1	O
in	28548960	1	O
which	28548960	1	O
afflicted	28548960	1	O
members	28548960	1	O
were	28548960	1	O
manifested	28548960	1	O
by	28548960	1	O
severe	28548960	1	O
hypertriglyceridemia	28548960	1	O
and	28548960	1	O
recurrent	28548960	1	O
pancreatitis	28548960	1	O
.	28548960	1	O
DNA	28548960	1	O
sequencing	28548960	1	O
revealed	28548960	1	O
that	28548960	1	O
the	28548960	1	O
proband	28548960	1	O
was	28548960	1	O
a	28548960	1	O
heterozygote	28548960	1	O
carrying	28548960	1	O
a	28548960	1	O
novel	28548960	1	O
c.T928C	28548960	1	O
(	28548960	1	O
p.C310R	28548960	1	O
)	28548960	1	O
mutation	28548960	1	O
in	28548960	1	O
exon	28548960	1	O
6	28548960	1	O
of	28548960	1	O
the	28548960	1	O
LPL	28548960	1	O
gene	28548960	1	O
.	28548960	1	O
Another	28548960	1	O
member	28548960	1	O
of	28548960	1	O
the	28548960	1	O
family	28548960	1	O
was	28548960	1	O
detected	28548960	1	O
to	28548960	1	O
be	28548960	1	O
a	28548960	1	O
compound	28548960	1	O
heterozygote	28548960	1	O
who	28548960	1	O
along	28548960	1	O
with	28548960	1	O
the	28548960	1	O
c.T928C	28548960	1	O
mutation	28548960	1	O
also	28548960	1	O
carried	28548960	1	O
a	28548960	1	O
novel	28548960	1	O
missense	28548960	1	O
mutation	28548960	1	O
c.A1187T	28548960	1	O
(	28548960	1	O
p.E396V	28548960	1	O
)	28548960	1	O
in	28548960	1	O
exon	28548960	1	O
8	28548960	1	O
of	28548960	1	O
the	28548960	1	O
LPL	28548960	1	O
gene	28548960	1	O
.	28548960	1	O
Furthermore	28548960	1	O
,	28548960	1	O
COS-1	28548960	1	O
cells	28548960	1	O
were	28548960	1	O
transfected	28548960	1	O
with	28548960	1	O
lentiviruses	28548960	1	O
containing	28548960	1	O
the	28548960	1	O
mutant	28548960	1	O
LPL	28548960	1	O
genes	28548960	1	O
.	28548960	1	O
While	28548960	1	O
C310R	28548960	1	B-Var
markedly	28548960	1	O
reduced	28548960	1	B-NegReg
the	28548960	1	O
overall	28548960	1	O
LPL	28548960	1	B-MPA
protein	28548960	1	I-MPA
level	28548960	1	I-MPA
,	28548960	1	O
COS-1	28548960	1	O
cells	28548960	1	O
carrying	28548960	1	O
E396V	28548960	1	O
or	28548960	1	O
double	28548960	1	O
mutations	28548960	1	O
contained	28548960	1	O
similar	28548960	1	O
overall	28548960	1	O
LPL	28548960	1	O
protein	28548960	1	O
levels	28548960	1	O
to	28548960	1	O
the	28548960	1	O
wild	28548960	1	O
-	28548960	1	O
type	28548960	1	O
.	28548960	1	O
The	28548960	1	O
specific	28548960	1	O
activity	28548960	1	O
of	28548960	1	O
the	28548960	1	O
LPL	28548960	1	O
mutants	28548960	1	O
remained	28548960	1	O
at	28548960	1	O
comparable	28548960	1	O
magnitude	28548960	1	O
to	28548960	1	O
the	28548960	1	O
wild	28548960	1	O
-	28548960	1	O
type	28548960	1	O
.	28548960	1	O
However	28548960	1	O
,	28548960	1	O
few	28548960	1	O
LPL	28548960	1	O
were	28548960	1	O
detected	28548960	1	O
in	28548960	1	O
the	28548960	1	O
culture	28548960	1	O
medium	28548960	1	O
for	28548960	1	O
the	28548960	1	O
mutants	28548960	1	O
,	28548960	1	O
suggesting	28548960	1	O
that	28548960	1	O
both	28548960	1	O
mutations	28548960	1	B-Var
caused	28548960	1	B-Reg
aberrant	28548960	1	O
triglyceride	28548960	1	B-MPA
catabolism	28548960	1	I-MPA
.	28548960	1	O
More	28548960	1	O
specifically	28548960	1	O
,	28548960	1	O
E396V	28548960	1	B-Var
and	28548960	1	O
double	28548960	1	B-Var
mutations	28548960	1	I-Var
dampened	28548960	1	B-NegReg
the	28548960	1	O
transport	28548960	1	B-MPA
of	28548960	1	I-MPA
LPL	28548960	1	I-MPA
to	28548960	1	I-MPA
the	28548960	1	I-MPA
cell	28548960	1	I-MPA
surface	28548960	1	I-MPA
,	28548960	1	O
while	28548960	1	O
for	28548960	1	O
the	28548960	1	O
C310R	28548960	1	B-Var
mutation	28548960	1	O
,	28548960	1	O
reducing	28548960	1	B-NegReg
LPL	28548960	1	B-MPA
protein	28548960	1	I-MPA
level	28548960	1	I-MPA
might	28548960	1	O
be	28548960	1	O
involved	28548960	1	O
.	28548960	1	O
By	28548960	1	O
characterizing	28548960	1	O
these	28548960	1	O
two	28548960	1	O
novel	28548960	1	O
LPL	28548960	1	O
mutations	28548960	1	O
,	28548960	1	O
this	28548960	1	O
study	28548960	1	O
has	28548960	1	O
expanded	28548960	1	O
our	28548960	1	O
understanding	28548960	1	O
on	28548960	1	O
the	28548960	1	O
pathogenesis	28548960	1	O
of	28548960	1	O
familial	28548960	1	O
hypertriglyceridemia	28548960	1	O
(	28548960	1	O
FHTG	28548960	1	O
)	28548960	1	O
.	28548960	1	O

WNT10A	28589954	1	B-Gene
mutation	28589954	1	B-Var
causes	28589954	1	B-Reg
ectodermal	28589954	1	B-Disease
dysplasia	28589954	1	I-Disease
by	28589954	1	O
impairing	28589954	1	B-NegReg
progenitor	28589954	1	B-CPA
cell	28589954	1	I-CPA
proliferation	28589954	1	I-CPA
and	28589954	1	O
KLF4	28589954	1	B-CPA
-	28589954	1	I-CPA
mediated	28589954	1	I-CPA
differentiation	28589954	1	I-CPA
.	28589954	1	O
Human	28589954	1	O
WNT10A	28589954	1	O
mutations	28589954	1	O
are	28589954	1	O
associated	28589954	1	O
with	28589954	1	O
developmental	28589954	1	O
tooth	28589954	1	O
abnormalities	28589954	1	O
and	28589954	1	O
adolescent	28589954	1	O
onset	28589954	1	O
of	28589954	1	O
a	28589954	1	O
broad	28589954	1	O
range	28589954	1	O
of	28589954	1	O
ectodermal	28589954	1	O
defects	28589954	1	O
.	28589954	1	O
Here	28589954	1	O
we	28589954	1	O
show	28589954	1	O
that	28589954	1	O
β	28589954	1	O
-	28589954	1	O
catenin	28589954	1	O
pathway	28589954	1	O
activity	28589954	1	O
and	28589954	1	O
adult	28589954	1	O
epithelial	28589954	1	O
progenitor	28589954	1	O
proliferation	28589954	1	O
are	28589954	1	O
reduced	28589954	1	O
in	28589954	1	O
the	28589954	1	O
absence	28589954	1	O
of	28589954	1	O
WNT10A	28589954	1	O
,	28589954	1	O
and	28589954	1	O
identify	28589954	1	O
Wnt	28589954	1	O
-	28589954	1	O
active	28589954	1	O
self	28589954	1	O
-	28589954	1	O
renewing	28589954	1	O
stem	28589954	1	O
cells	28589954	1	O
in	28589954	1	O
affected	28589954	1	O
tissues	28589954	1	O
including	28589954	1	O
hair	28589954	1	O
follicles	28589954	1	O
,	28589954	1	O
sebaceous	28589954	1	O
glands	28589954	1	O
,	28589954	1	O
taste	28589954	1	O
buds	28589954	1	O
,	28589954	1	O
nails	28589954	1	O
and	28589954	1	O
sweat	28589954	1	O
ducts	28589954	1	O
.	28589954	1	O
Human	28589954	1	O
and	28589954	1	O
mouse	28589954	1	O
WNT10A	28589954	1	O
mutant	28589954	1	O
palmoplantar	28589954	1	O
and	28589954	1	O
tongue	28589954	1	O
epithelia	28589954	1	O
also	28589954	1	O
display	28589954	1	O
specific	28589954	1	O
differentiation	28589954	1	O
defects	28589954	1	O
that	28589954	1	O
are	28589954	1	O
mimicked	28589954	1	O
by	28589954	1	O
loss	28589954	1	O
of	28589954	1	O
the	28589954	1	O
transcription	28589954	1	O
factor	28589954	1	O
KLF4	28589954	1	O
.	28589954	1	O
We	28589954	1	O
find	28589954	1	O
that	28589954	1	O
β	28589954	1	O
-	28589954	1	O
catenin	28589954	1	O
interacts	28589954	1	O
directly	28589954	1	O
with	28589954	1	O
region	28589954	1	O
-	28589954	1	O
specific	28589954	1	O
LEF	28589954	1	O
/	28589954	1	O
TCF	28589954	1	O
factors	28589954	1	O
,	28589954	1	O
and	28589954	1	O
with	28589954	1	O
KLF4	28589954	1	O
in	28589954	1	O
differentiating	28589954	1	O
,	28589954	1	O
but	28589954	1	O
not	28589954	1	O
proliferating	28589954	1	O
,	28589954	1	O
cells	28589954	1	O
to	28589954	1	O
promote	28589954	1	O
expression	28589954	1	O
of	28589954	1	O
specialized	28589954	1	O
keratins	28589954	1	O
required	28589954	1	O
for	28589954	1	O
normal	28589954	1	O
tissue	28589954	1	O
structure	28589954	1	O
and	28589954	1	O
integrity	28589954	1	O
.	28589954	1	O
Our	28589954	1	O
data	28589954	1	O
identify	28589954	1	O
WNT10A	28589954	1	O
as	28589954	1	O
a	28589954	1	O
critical	28589954	1	O
ligand	28589954	1	O
controlling	28589954	1	O
adult	28589954	1	O
epithelial	28589954	1	O
proliferation	28589954	1	O
and	28589954	1	O
region	28589954	1	O
-	28589954	1	O
specific	28589954	1	O
differentiation	28589954	1	O
,	28589954	1	O
and	28589954	1	O
suggest	28589954	1	O
downstream	28589954	1	O
β	28589954	1	O
-	28589954	1	O
catenin	28589954	1	O
pathway	28589954	1	O
activation	28589954	1	O
as	28589954	1	O
a	28589954	1	O
potential	28589954	1	O
approach	28589954	1	O
to	28589954	1	O
ameliorate	28589954	1	O
regenerative	28589954	1	O
defects	28589954	1	O
in	28589954	1	O
WNT10A	28589954	1	O
patients	28589954	1	O
.	28589954	1	O

Loss	28592524	1	B-Var
of	28592524	1	I-Var
function	28592524	1	I-Var
in	28592524	1	O
ROBO1	28592524	1	B-Gene
is	28592524	1	O
associated	28592524	1	B-Reg
with	28592524	1	O
tetralogy	28592524	1	B-Disease
of	28592524	1	I-Disease
Fallot	28592524	1	I-Disease
and	28592524	1	O
septal	28592524	1	B-Disease
defects	28592524	1	I-Disease
.	28592524	1	O
BACKGROUND	28592524	1	O
:	28592524	1	O
Congenital	28592524	1	O
heart	28592524	1	O
disease	28592524	1	O
(	28592524	1	O
CHD	28592524	1	O
)	28592524	1	O
is	28592524	1	O
a	28592524	1	O
common	28592524	1	O
birth	28592524	1	O
defect	28592524	1	O
affecting	28592524	1	O
approximately	28592524	1	O
1%	28592524	1	O
of	28592524	1	O
newborns	28592524	1	O
.	28592524	1	O
Great	28592524	1	O
progress	28592524	1	O
has	28592524	1	O
been	28592524	1	O
made	28592524	1	O
in	28592524	1	O
elucidating	28592524	1	O
the	28592524	1	O
genetic	28592524	1	O
aetiology	28592524	1	O
of	28592524	1	O
CHD	28592524	1	O
with	28592524	1	O
advances	28592524	1	O
in	28592524	1	O
genomic	28592524	1	O
technology	28592524	1	O
,	28592524	1	O
which	28592524	1	O
we	28592524	1	O
leveraged	28592524	1	O
in	28592524	1	O
recovering	28592524	1	O
a	28592524	1	O
new	28592524	1	O
pathway	28592524	1	O
affecting	28592524	1	O
heart	28592524	1	O
development	28592524	1	O
in	28592524	1	O
humans	28592524	1	O
previously	28592524	1	O
known	28592524	1	O
to	28592524	1	O
affect	28592524	1	O
heart	28592524	1	O
development	28592524	1	O
in	28592524	1	O
an	28592524	1	O
animal	28592524	1	O
model	28592524	1	O
.	28592524	1	O
METHODS	28592524	1	O
:	28592524	1	O
Four	28592524	1	O
hundred	28592524	1	O
and	28592524	1	O
sixteen	28592524	1	O
individuals	28592524	1	O
from	28592524	1	O
Thailand	28592524	1	O
and	28592524	1	O
the	28592524	1	O
USA	28592524	1	O
diagnosed	28592524	1	O
with	28592524	1	O
CHD	28592524	1	O
and	28592524	1	O
/	28592524	1	O
or	28592524	1	O
congenital	28592524	1	O
diaphragmatic	28592524	1	O
hernia	28592524	1	O
were	28592524	1	O
evaluated	28592524	1	O
with	28592524	1	O
chromosomal	28592524	1	O
microarray	28592524	1	O
and	28592524	1	O
whole	28592524	1	O
exome	28592524	1	O
sequencing	28592524	1	O
.	28592524	1	O
The	28592524	1	O
DECIPHER	28592524	1	O
Consortium	28592524	1	O
and	28592524	1	O
medical	28592524	1	O
literature	28592524	1	O
were	28592524	1	O
searched	28592524	1	O
for	28592524	1	O
additional	28592524	1	O
patients	28592524	1	O
.	28592524	1	O
Murine	28592524	1	O
hearts	28592524	1	O
from	28592524	1	O
ENU	28592524	1	O
-	28592524	1	O
induced	28592524	1	O
mouse	28592524	1	O
mutants	28592524	1	O
and	28592524	1	O
transgenic	28592524	1	O
mice	28592524	1	O
were	28592524	1	O
evaluated	28592524	1	O
using	28592524	1	O
both	28592524	1	O
episcopic	28592524	1	O
confocal	28592524	1	O
histopathology	28592524	1	O
and	28592524	1	O
troponin	28592524	1	O
I	28592524	1	O
stained	28592524	1	O
sections	28592524	1	O
.	28592524	1	O
RESULTS	28592524	1	O
:	28592524	1	O
Loss	28592524	1	O
of	28592524	1	O
function	28592524	1	O
ROBO1	28592524	1	O
variants	28592524	1	O
were	28592524	1	O
identified	28592524	1	O
in	28592524	1	O
three	28592524	1	O
families	28592524	1	O
;	28592524	1	O
each	28592524	1	O
proband	28592524	1	O
had	28592524	1	O
a	28592524	1	O
ventricular	28592524	1	O
septal	28592524	1	O
defect	28592524	1	O
,	28592524	1	O
and	28592524	1	O
one	28592524	1	O
proband	28592524	1	O
had	28592524	1	O
tetralogy	28592524	1	O
of	28592524	1	O
Fallot	28592524	1	O
.	28592524	1	O
Additionally	28592524	1	O
,	28592524	1	O
a	28592524	1	O
microdeletion	28592524	1	O
in	28592524	1	O
an	28592524	1	O
individual	28592524	1	O
with	28592524	1	O
CHD	28592524	1	O
was	28592524	1	O
found	28592524	1	O
in	28592524	1	O
the	28592524	1	O
medical	28592524	1	O
literature	28592524	1	O
.	28592524	1	O
Mouse	28592524	1	O
models	28592524	1	O
showed	28592524	1	O
perturbation	28592524	1	O
of	28592524	1	O
the	28592524	1	O
Slit	28592524	1	O
-	28592524	1	O
Robo	28592524	1	O
signalling	28592524	1	O
pathway	28592524	1	O
,	28592524	1	O
causing	28592524	1	O
septation	28592524	1	O
and	28592524	1	O
outflow	28592524	1	O
tract	28592524	1	O
defects	28592524	1	O
and	28592524	1	O
craniofacial	28592524	1	O
anomalies	28592524	1	O
.	28592524	1	O
Two	28592524	1	O
probands	28592524	1	O
had	28592524	1	O
variable	28592524	1	O
facial	28592524	1	O
features	28592524	1	O
consistent	28592524	1	O
with	28592524	1	O
the	28592524	1	O
mouse	28592524	1	O
model	28592524	1	O
.	28592524	1	O
CONCLUSION	28592524	1	O
:	28592524	1	O
Our	28592524	1	O
findings	28592524	1	O
identify	28592524	1	O
Slit	28592524	1	O
-	28592524	1	O
Robo	28592524	1	O
as	28592524	1	O
a	28592524	1	O
significant	28592524	1	O
pathway	28592524	1	O
in	28592524	1	O
human	28592524	1	O
heart	28592524	1	O
development	28592524	1	O
and	28592524	1	O
CHD	28592524	1	O
.	28592524	1	O

Human	28597146	2	O
IκBα	28597146	2	O
Gain	28597146	2	O
of	28597146	2	O
Function	28597146	2	O
:	28597146	2	O
a	28597146	2	O
Severe	28597146	2	O
and	28597146	2	O
Syndromic	28597146	2	O
Immunodeficiency	28597146	2	O
.	28597146	2	O
Germline	28597146	2	O
heterozygous	28597146	2	O
gain	28597146	2	B-PosReg
-	28597146	2	I-PosReg
of	28597146	2	I-PosReg
-	28597146	2	I-PosReg
function	28597146	2	I-PosReg
(	28597146	2	O
GOF	28597146	2	O
)	28597146	2	O
mutations	28597146	2	B-Var
of	28597146	2	O
NFKBIA	28597146	2	B-Gene
,	28597146	2	O
encoding	28597146	2	O
IκBα	28597146	2	O
,	28597146	2	O
cause	28597146	2	O
an	28597146	2	O
autosomal	28597146	2	O
dominant	28597146	2	O
(	28597146	2	O
AD	28597146	2	O
)	28597146	2	O
form	28597146	2	O
of	28597146	2	O
anhidrotic	28597146	2	B-Disease
ectodermal	28597146	2	I-Disease
dysplasia	28597146	2	I-Disease
with	28597146	2	I-Disease
immunodeficiency	28597146	2	I-Disease
(	28597146	2	O
EDA	28597146	2	O
-	28597146	2	O
ID	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Fourteen	28597146	2	O
unrelated	28597146	2	O
patients	28597146	2	O
have	28597146	2	O
been	28597146	2	O
reported	28597146	2	O
since	28597146	2	O
the	28597146	2	O
identification	28597146	2	O
of	28597146	2	O
the	28597146	2	O
first	28597146	2	O
case	28597146	2	O
in	28597146	2	O
2003	28597146	2	O
.	28597146	2	O
All	28597146	2	O
mutations	28597146	2	B-Var
enhanced	28597146	2	B-PosReg
the	28597146	2	O
inhibitory	28597146	2	B-MPA
activity	28597146	2	I-MPA
of	28597146	2	O
IκBα	28597146	2	B-Protein
,	28597146	2	O
by	28597146	2	O
preventing	28597146	2	B-NegReg
its	28597146	2	O
phosphorylation	28597146	2	B-MPA
on	28597146	2	I-MPA
serine	28597146	2	I-MPA
32	28597146	2	I-MPA
or	28597146	2	I-MPA
36	28597146	2	I-MPA
and	28597146	2	O
its	28597146	2	O
subsequent	28597146	2	O
degradation	28597146	2	B-MPA
.	28597146	2	O
The	28597146	2	O
mutation	28597146	2	O
certainly	28597146	2	O
or	28597146	2	O
probably	28597146	2	O
occurred	28597146	2	O
de	28597146	2	O
novo	28597146	2	O
in	28597146	2	O
13	28597146	2	O
patients	28597146	2	O
,	28597146	2	O
whereas	28597146	2	O
it	28597146	2	O
was	28597146	2	O
inherited	28597146	2	O
from	28597146	2	O
a	28597146	2	O
parent	28597146	2	O
with	28597146	2	O
somatic	28597146	2	O
mosaicism	28597146	2	O
in	28597146	2	O
one	28597146	2	O
patient	28597146	2	O
.	28597146	2	O
Eleven	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
belonging	28597146	2	O
to	28597146	2	O
two	28597146	2	O
groups	28597146	2	O
,	28597146	2	O
were	28597146	2	O
identified	28597146	2	O
:	28597146	2	O
(	28597146	2	O
i	28597146	2	O
)	28597146	2	O
missense	28597146	2	O
mutations	28597146	2	O
affecting	28597146	2	O
S32	28597146	2	O
,	28597146	2	O
S36	28597146	2	O
,	28597146	2	O
or	28597146	2	O
neighboring	28597146	2	O
residues	28597146	2	O
(	28597146	2	O
8	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
11	28597146	2	O
patients	28597146	2	O
)	28597146	2	O
and	28597146	2	O
(	28597146	2	O
ii	28597146	2	O
)	28597146	2	O
nonsense	28597146	2	O
mutations	28597146	2	O
upstream	28597146	2	O
from	28597146	2	O
S32	28597146	2	O
associated	28597146	2	O
with	28597146	2	O
the	28597146	2	O
reinitiation	28597146	2	O
of	28597146	2	O
translation	28597146	2	O
downstream	28597146	2	O
from	28597146	2	O
S36	28597146	2	O
(	28597146	2	O
3	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
3	28597146	2	O
patients	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Thirteen	28597146	2	O
patients	28597146	2	O
had	28597146	2	O
developmental	28597146	2	O
features	28597146	2	O
of	28597146	2	O
EDA	28597146	2	O
,	28597146	2	O
the	28597146	2	O
severity	28597146	2	O
and	28597146	2	O
nature	28597146	2	O
of	28597146	2	O
which	28597146	2	O
differed	28597146	2	O
between	28597146	2	O
cases	28597146	2	O
.	28597146	2	O
All	28597146	2	O
patient	28597146	2	O
cells	28597146	2	O
tested	28597146	2	O
displayed	28597146	2	O
impaired	28597146	2	O
NF	28597146	2	O
-	28597146	2	O
κB	28597146	2	O
-	28597146	2	O
mediated	28597146	2	O
responses	28597146	2	O
to	28597146	2	O
the	28597146	2	O
stimulation	28597146	2	O
of	28597146	2	O
various	28597146	2	O
surface	28597146	2	O
receptors	28597146	2	O
involved	28597146	2	O
in	28597146	2	O
cell	28597146	2	O
-	28597146	2	O
intrinsic	28597146	2	O
(	28597146	2	O
fibroblasts	28597146	2	O
)	28597146	2	O
,	28597146	2	O
innate	28597146	2	O
(	28597146	2	O
monocytes	28597146	2	O
)	28597146	2	O
,	28597146	2	O
and	28597146	2	O
adaptive	28597146	2	O
(	28597146	2	O
B	28597146	2	O
and	28597146	2	O
T	28597146	2	O
cells	28597146	2	O
)	28597146	2	O
immunity	28597146	2	O
,	28597146	2	O
including	28597146	2	O
TLRs	28597146	2	O
,	28597146	2	O
IL-1	28597146	2	O
Rs	28597146	2	O
,	28597146	2	O
TNFRs	28597146	2	O
,	28597146	2	O
TCR	28597146	2	O
,	28597146	2	O
and	28597146	2	O
BCR	28597146	2	O
.	28597146	2	O
All	28597146	2	O
patients	28597146	2	O
had	28597146	2	O
profound	28597146	2	O
B	28597146	2	O
-	28597146	2	O
cell	28597146	2	O
deficiency	28597146	2	O
.	28597146	2	O
Specific	28597146	2	O
immunological	28597146	2	O
features	28597146	2	O
,	28597146	2	O
found	28597146	2	O
in	28597146	2	O
some	28597146	2	O
,	28597146	2	O
but	28597146	2	O
not	28597146	2	O
all	28597146	2	O
patients	28597146	2	O
,	28597146	2	O
included	28597146	2	O
a	28597146	2	O
lack	28597146	2	O
of	28597146	2	O
peripheral	28597146	2	O
lymph	28597146	2	O
nodes	28597146	2	O
,	28597146	2	O
lymphocytosis	28597146	2	O
,	28597146	2	O
dysfunctional	28597146	2	O
α	28597146	2	O
/	28597146	2	O
β	28597146	2	O
T	28597146	2	O
cells	28597146	2	O
,	28597146	2	O
and	28597146	2	O
a	28597146	2	O
lack	28597146	2	O
of	28597146	2	O
circulating	28597146	2	O
γ	28597146	2	O
/	28597146	2	O
δ	28597146	2	O
T	28597146	2	O
cells	28597146	2	O
.	28597146	2	O
The	28597146	2	O
patients	28597146	2	O
had	28597146	2	O
various	28597146	2	O
pyogenic	28597146	2	O
,	28597146	2	O
mycobacterial	28597146	2	O
,	28597146	2	O
fungal	28597146	2	O
,	28597146	2	O
and	28597146	2	O
viral	28597146	2	O
severe	28597146	2	O
infections	28597146	2	O
.	28597146	2	O
Patients	28597146	2	O
with	28597146	2	O
a	28597146	2	O
missense	28597146	2	O
mutation	28597146	2	O
tended	28597146	2	O
to	28597146	2	O
display	28597146	2	O
more	28597146	2	O
severe	28597146	2	O
phenotypes	28597146	2	O
,	28597146	2	O
probably	28597146	2	O
due	28597146	2	O
to	28597146	2	O
higher	28597146	2	O
levels	28597146	2	O
of	28597146	2	O
GOF	28597146	2	O
proteins	28597146	2	O
.	28597146	2	O
In	28597146	2	O
the	28597146	2	O
absence	28597146	2	O
of	28597146	2	O
hematopoietic	28597146	2	O
stem	28597146	2	O
cell	28597146	2	O
transplantation	28597146	2	O
(	28597146	2	O
HSCT	28597146	2	O
)	28597146	2	O
,	28597146	2	O
this	28597146	2	O
condition	28597146	2	O
cause	28597146	2	O
death	28597146	2	O
before	28597146	2	O
the	28597146	2	O
age	28597146	2	O
of	28597146	2	O
1	28597146	2	O
year	28597146	2	O
(	28597146	2	O
one	28597146	2	O
child	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Two	28597146	2	O
survivors	28597146	2	O
have	28597146	2	O
been	28597146	2	O
on	28597146	2	O
prophylaxis	28597146	2	O
(	28597146	2	O
at	28597146	2	O
9	28597146	2	O
and	28597146	2	O
22	28597146	2	O
years	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Six	28597146	2	O
children	28597146	2	O
died	28597146	2	O
after	28597146	2	O
HSCT	28597146	2	O
.	28597146	2	O
Five	28597146	2	O
survived	28597146	2	O
,	28597146	2	O
four	28597146	2	O
of	28597146	2	O
whom	28597146	2	O
have	28597146	2	O
been	28597146	2	O
on	28597146	2	O
prophylaxis	28597146	2	O
(	28597146	2	O
3	28597146	2	O
to	28597146	2	O
21	28597146	2	O
years	28597146	2	O
post	28597146	2	O
HSCT	28597146	2	O
)	28597146	2	O
,	28597146	2	O
whereas	28597146	2	O
one	28597146	2	O
has	28597146	2	O
been	28597146	2	O
well	28597146	2	O
with	28597146	2	O
no	28597146	2	O
prophylaxis	28597146	2	O
.	28597146	2	O
Heterozygous	28597146	2	O
GOF	28597146	2	O
mutations	28597146	2	O
in	28597146	2	O
IκBα	28597146	2	O
underlie	28597146	2	O
a	28597146	2	O
severe	28597146	2	O
and	28597146	2	O
syndromic	28597146	2	O
immunodeficiency	28597146	2	O
,	28597146	2	O
the	28597146	2	O
interindividual	28597146	2	O
variability	28597146	2	O
of	28597146	2	O
which	28597146	2	O
might	28597146	2	O
partly	28597146	2	O
be	28597146	2	O
ascribed	28597146	2	O
to	28597146	2	O
the	28597146	2	O
dichotomy	28597146	2	O
of	28597146	2	O
missense	28597146	2	O
and	28597146	2	O
nonsense	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
and	28597146	2	O
the	28597146	2	O
hematopoietic	28597146	2	O
component	28597146	2	O
of	28597146	2	O
which	28597146	2	O
can	28597146	2	O
be	28597146	2	O
rescued	28597146	2	O
by	28597146	2	O
HSCT	28597146	2	O
.	28597146	2	O

ARX	28627419	0	B-Gene
polyalanine	28627419	0	B-Var
expansion	28627419	0	I-Var
mutations	28627419	0	I-Var
lead	28627419	0	B-Reg
to	28627419	0	I-Reg
migration	28627419	0	B-CPA
impediment	28627419	0	I-CPA
in	28627419	0	I-CPA
the	28627419	0	I-CPA
rostral	28627419	0	I-CPA
cortex	28627419	0	I-CPA
coupled	28627419	0	I-CPA
with	28627419	0	O
a	28627419	0	O
developmental	28627419	0	B-CPA
deficit	28627419	0	I-CPA
of	28627419	0	I-CPA
calbindin	28627419	0	I-CPA
-	28627419	0	I-CPA
positive	28627419	0	I-CPA
cortical	28627419	0	I-CPA
GABAergic	28627419	0	I-CPA
interneurons	28627419	0	I-CPA
.	28627419	0	O
The	28627419	0	O
Aristaless	28627419	0	O
-	28627419	0	O
related	28627419	0	O
homeobox	28627419	0	O
gene	28627419	0	O
(	28627419	0	O
ARX	28627419	0	O
)	28627419	0	O
is	28627419	0	O
indispensable	28627419	0	O
for	28627419	0	O
interneuron	28627419	0	O
development	28627419	0	O
.	28627419	0	O
Patients	28627419	0	O
with	28627419	0	O
ARX	28627419	0	O
polyalanine	28627419	0	O
expansion	28627419	0	O
mutations	28627419	0	O
of	28627419	0	O
the	28627419	0	O
first	28627419	0	O
two	28627419	0	O
tracts	28627419	0	O
(	28627419	0	O
namely	28627419	0	O
PA1	28627419	0	O
and	28627419	0	O
PA2	28627419	0	O
)	28627419	0	O
suffer	28627419	0	O
from	28627419	0	O
intellectual	28627419	0	O
disability	28627419	0	O
of	28627419	0	O
varying	28627419	0	O
severity	28627419	0	O
,	28627419	0	O
with	28627419	0	O
seizures	28627419	0	O
a	28627419	0	O
frequent	28627419	0	O
comorbidity	28627419	0	O
.	28627419	0	O
The	28627419	0	O
impact	28627419	0	O
of	28627419	0	O
PA1	28627419	0	O
and	28627419	0	O
PA2	28627419	0	O
mutations	28627419	0	O
on	28627419	0	O
the	28627419	0	O
brain	28627419	0	O
development	28627419	0	O
is	28627419	0	O
unknown	28627419	0	O
,	28627419	0	O
hindering	28627419	0	O
the	28627419	0	O
search	28627419	0	O
for	28627419	0	O
therapeutic	28627419	0	O
interventions	28627419	0	O
.	28627419	0	O
Here	28627419	0	O
,	28627419	0	O
we	28627419	0	O
characterized	28627419	0	O
the	28627419	0	O
disturbances	28627419	0	O
to	28627419	0	O
cortical	28627419	0	O
interneuron	28627419	0	O
development	28627419	0	O
in	28627419	0	O
mice	28627419	0	O
modeling	28627419	0	O
the	28627419	0	O
two	28627419	0	O
most	28627419	0	O
common	28627419	0	O
ARX	28627419	0	O
polyalanine	28627419	0	O
expansion	28627419	0	O
mutations	28627419	0	O
in	28627419	0	O
human	28627419	0	O
.	28627419	0	O
We	28627419	0	O
found	28627419	0	O
a	28627419	0	O
consistent	28627419	0	O
40	28627419	0	O
-	28627419	0	O
50%	28627419	0	O
reduction	28627419	0	O
of	28627419	0	O
calbindin	28627419	0	O
-	28627419	0	O
positive	28627419	0	O
interneurons	28627419	0	O
,	28627419	0	O
but	28627419	0	O
not	28627419	0	O
Stt	28627419	0	O
or	28627419	0	O
Cr	28627419	0	O
interneurons	28627419	0	O
,	28627419	0	O
within	28627419	0	O
the	28627419	0	O
cortex	28627419	0	O
of	28627419	0	O
newborn	28627419	0	O
hemizygous	28627419	0	O
mice	28627419	0	O
(	28627419	0	O
p	28627419	0	O
=	28627419	0	O
0.024	28627419	0	O
)	28627419	0	O
for	28627419	0	O
both	28627419	0	O
mutant	28627419	0	O
strains	28627419	0	O
compared	28627419	0	O
to	28627419	0	O
wildtype	28627419	0	O
(	28627419	0	O
p	28627419	0	O
=	28627419	0	O
0.011	28627419	0	O
)	28627419	0	O
.	28627419	0	O
We	28627419	0	O
demonstrate	28627419	0	O
that	28627419	0	O
this	28627419	0	O
was	28627419	0	O
a	28627419	0	O
consequence	28627419	0	O
of	28627419	0	O
calbindin	28627419	0	O
precursor	28627419	0	O
cells	28627419	0	O
being	28627419	0	O
arrested	28627419	0	O
or	28627419	0	O
delayed	28627419	0	O
at	28627419	0	O
the	28627419	0	O
ventral	28627419	0	O
subpallium	28627419	0	O
en	28627419	0	O
route	28627419	0	O
of	28627419	0	O
tangential	28627419	0	O
migration	28627419	0	O
.	28627419	0	O
Ex	28627419	0	O
-	28627419	0	O
vivo	28627419	0	O
assay	28627419	0	O
validated	28627419	0	O
this	28627419	0	O
migration	28627419	0	O
deficit	28627419	0	O
in	28627419	0	O
PA1	28627419	0	O
cells	28627419	0	O
(	28627419	0	O
p	28627419	0	O
=	28627419	0	O
0.0002	28627419	0	O
)	28627419	0	O
suggesting	28627419	0	O
that	28627419	0	O
the	28627419	0	O
defect	28627419	0	O
is	28627419	0	O
contributed	28627419	0	O
by	28627419	0	O
intrinsic	28627419	0	O
loss	28627419	0	O
of	28627419	0	O
Arx	28627419	0	O
function	28627419	0	O
within	28627419	0	O
migrating	28627419	0	O
cells	28627419	0	O
.	28627419	0	O
Both	28627419	0	O
humans	28627419	0	O
and	28627419	0	O
mice	28627419	0	O
with	28627419	0	O
PA1	28627419	0	O
mutations	28627419	0	O
present	28627419	0	O
with	28627419	0	O
severe	28627419	0	O
clinical	28627419	0	O
features	28627419	0	O
,	28627419	0	O
including	28627419	0	O
intellectual	28627419	0	O
disability	28627419	0	O
and	28627419	0	O
infantile	28627419	0	O
spasms	28627419	0	O
.	28627419	0	O
Our	28627419	0	O
data	28627419	0	O
further	28627419	0	O
demonstrated	28627419	0	O
the	28627419	0	O
pathogenic	28627419	0	O
mechanism	28627419	0	O
was	28627419	0	O
robustly	28627419	0	O
shared	28627419	0	O
between	28627419	0	O
PA1	28627419	0	O
and	28627419	0	O
PA2	28627419	0	O
mutations	28627419	0	O
,	28627419	0	O
as	28627419	0	O
previously	28627419	0	O
reported	28627419	0	O
including	28627419	0	O
Arx	28627419	0	O
protein	28627419	0	O
reduction	28627419	0	O
and	28627419	0	O
overlapping	28627419	0	O
transcriptome	28627419	0	O
profiles	28627419	0	O
within	28627419	0	O
the	28627419	0	O
developing	28627419	0	O
mouse	28627419	0	O
brains	28627419	0	O
.	28627419	0	O
Data	28627419	0	O
from	28627419	0	O
our	28627419	0	O
study	28627419	0	O
demonstrated	28627419	0	O
that	28627419	0	O
cortical	28627419	0	B-CPA
calbindin	28627419	0	I-CPA
interneuron	28627419	0	I-CPA
development	28627419	0	B-CPA
and	28627419	0	O
migration	28627419	0	B-CPA
is	28627419	0	O
negatively	28627419	0	B-NegReg
affected	28627419	0	O
by	28627419	0	O
ARX	28627419	0	B-Gene
polyalanine	28627419	0	B-Var
expansion	28627419	0	I-Var
mutations	28627419	0	I-Var
.	28627419	0	O
Understanding	28627419	0	O
the	28627419	0	O
cellular	28627419	0	O
pathogenesis	28627419	0	O
contributing	28627419	0	O
to	28627419	0	O
disease	28627419	0	O
manifestation	28627419	0	O
is	28627419	0	O
necessary	28627419	0	O
to	28627419	0	O
screen	28627419	0	O
efficacy	28627419	0	O
of	28627419	0	O
potential	28627419	0	O
therapeutic	28627419	0	O
interventions	28627419	0	O
.	28627419	0	O

Inducible	28650109	2	O
activation	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
in	28650109	2	O
adult	28650109	2	O
mice	28650109	2	O
promotes	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
after	28650109	2	O
bone	28650109	2	O
marrow	28650109	2	O
ablation	28650109	2	O
.	28650109	2	O
Apert	28650109	2	B-Disease
syndrome	28650109	2	I-Disease
is	28650109	2	O
one	28650109	2	O
of	28650109	2	O
the	28650109	2	O
most	28650109	2	O
severe	28650109	2	O
craniosynostoses	28650109	2	O
,	28650109	2	O
resulting	28650109	2	O
from	28650109	2	O
gain	28650109	2	B-PosReg
-	28650109	2	I-PosReg
of	28650109	2	I-PosReg
-	28650109	2	I-PosReg
function	28650109	2	I-PosReg
mutations	28650109	2	B-Var
in	28650109	2	O
fibroblast	28650109	2	O
growth	28650109	2	O
factor	28650109	2	O
receptor	28650109	2	O
2	28650109	2	O
(	28650109	2	B-Gene
FGFR2	28650109	2	I-Gene
)	28650109	2	I-Gene
.	28650109	2	O
Previous	28650109	2	O
studies	28650109	2	O
have	28650109	2	O
shown	28650109	2	O
that	28650109	2	O
gain	28650109	2	O
-	28650109	2	O
of	28650109	2	O
-	28650109	2	O
function	28650109	2	O
mutations	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
(	28650109	2	O
S252W	28650109	2	O
or	28650109	2	O
P253R	28650109	2	O
)	28650109	2	O
cause	28650109	2	O
skull	28650109	2	O
malformation	28650109	2	O
of	28650109	2	O
human	28650109	2	O
Apert	28650109	2	O
syndrome	28650109	2	O
by	28650109	2	O
affecting	28650109	2	O
both	28650109	2	O
chondrogenesis	28650109	2	O
and	28650109	2	O
osteogenesis	28650109	2	O
,	28650109	2	O
underscoring	28650109	2	O
the	28650109	2	O
key	28650109	2	O
role	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
in	28650109	2	O
bone	28650109	2	O
development	28650109	2	O
.	28650109	2	O
However	28650109	2	O
,	28650109	2	O
the	28650109	2	O
effects	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
on	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
at	28650109	2	O
the	28650109	2	O
adult	28650109	2	O
stage	28650109	2	O
have	28650109	2	O
not	28650109	2	O
been	28650109	2	O
fully	28650109	2	O
investigated	28650109	2	O
.	28650109	2	O
To	28650109	2	O
investigate	28650109	2	O
the	28650109	2	O
role	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
in	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
,	28650109	2	O
we	28650109	2	O
generated	28650109	2	O
mice	28650109	2	O
with	28650109	2	O
tamoxifen	28650109	2	O
-	28650109	2	O
inducible	28650109	2	O
expression	28650109	2	O
of	28650109	2	O
mutant	28650109	2	O
FGFR2	28650109	2	O
(	28650109	2	O
P253R	28650109	2	O
)	28650109	2	O
at	28650109	2	O
the	28650109	2	O
adult	28650109	2	O
stage	28650109	2	O
.	28650109	2	O
Mechanical	28650109	2	O
bone	28650109	2	O
marrow	28650109	2	O
ablation	28650109	2	O
(	28650109	2	O
BMX	28650109	2	O
)	28650109	2	O
was	28650109	2	O
performed	28650109	2	O
in	28650109	2	O
both	28650109	2	O
wild	28650109	2	O
-	28650109	2	O
type	28650109	2	O
and	28650109	2	O
Fgfr2	28650109	2	B-Gene
mutant	28650109	2	B-Var
(	28650109	2	O
MT	28650109	2	O
)	28650109	2	O
mice	28650109	2	O
.	28650109	2	O
Changes	28650109	2	O
in	28650109	2	O
newly	28650109	2	O
formed	28650109	2	O
trabecular	28650109	2	O
bone	28650109	2	O
were	28650109	2	O
assessed	28650109	2	O
by	28650109	2	O
micro	28650109	2	O
-	28650109	2	O
computed	28650109	2	O
tomography	28650109	2	O
and	28650109	2	O
bone	28650109	2	O
histomorphometry	28650109	2	O
.	28650109	2	O
We	28650109	2	O
found	28650109	2	O
that	28650109	2	O
MT	28650109	2	O
mice	28650109	2	O
exhibited	28650109	2	O
increased	28650109	2	B-PosReg
trabecular	28650109	2	B-CPA
bone	28650109	2	I-CPA
formation	28650109	2	I-CPA
and	28650109	2	O
decreased	28650109	2	B-NegReg
bone	28650109	2	B-CPA
resorption	28650109	2	I-CPA
after	28650109	2	O
BMX	28650109	2	O
accompanied	28650109	2	O
with	28650109	2	O
a	28650109	2	O
remarkable	28650109	2	O
increase	28650109	2	B-PosReg
in	28650109	2	O
bone	28650109	2	B-CPA
marrow	28650109	2	I-CPA
stromal	28650109	2	I-CPA
cell	28650109	2	I-CPA
recruitment	28650109	2	B-CPA
and	28650109	2	O
proliferation	28650109	2	B-CPA
,	28650109	2	O
osteoblast	28650109	2	B-CPA
proliferation	28650109	2	B-CPA
and	28650109	2	O
differentiation	28650109	2	B-CPA
,	28650109	2	O
and	28650109	2	O
enhanced	28650109	2	B-PosReg
Wnt	28650109	2	B-CPA
/	28650109	2	I-CPA
?	28650109	2	I-CPA
-	28650109	2	I-CPA
catenin	28650109	2	I-CPA
activity	28650109	2	I-CPA
.	28650109	2	O
Furthermore	28650109	2	O
,	28650109	2	O
pharmacologically	28650109	2	O
inhibiting	28650109	2	O
Wnt	28650109	2	O
/	28650109	2	O
β	28650109	2	O
-	28650109	2	O
catenin	28650109	2	O
signaling	28650109	2	O
can	28650109	2	O
partially	28650109	2	O
reverse	28650109	2	O
the	28650109	2	O
increased	28650109	2	O
trabecular	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
and	28650109	2	O
decreased	28650109	2	O
bone	28650109	2	O
resorption	28650109	2	O
in	28650109	2	O
MT	28650109	2	O
mice	28650109	2	O
after	28650109	2	O
BMX	28650109	2	O
.	28650109	2	O
Our	28650109	2	O
data	28650109	2	O
demonstrate	28650109	2	O
that	28650109	2	O
gain	28650109	2	B-PosReg
-	28650109	2	I-PosReg
of	28650109	2	I-PosReg
-	28650109	2	I-PosReg
function	28650109	2	I-PosReg
mutation	28650109	2	B-Var
in	28650109	2	O
FGFR2	28650109	2	B-Gene
exerts	28650109	2	B-MPA
a	28650109	2	I-MPA
Wnt	28650109	2	I-MPA
/	28650109	2	I-MPA
β	28650109	2	I-MPA
-	28650109	2	I-MPA
catenin	28650109	2	I-MPA
-	28650109	2	I-MPA
dependent	28650109	2	I-MPA
anabolic	28650109	2	I-MPA
effect	28650109	2	I-MPA
on	28650109	2	O
trabecular	28650109	2	O
bone	28650109	2	O
by	28650109	2	O
promoting	28650109	2	B-PosReg
bone	28650109	2	B-CPA
formation	28650109	2	I-CPA
and	28650109	2	O
inhibiting	28650109	2	B-NegReg
bone	28650109	2	B-CPA
resorption	28650109	2	I-CPA
at	28650109	2	I-CPA
the	28650109	2	I-CPA
adult	28650109	2	I-CPA
stage	28650109	2	I-CPA
.	28650109	2	O
This	28650109	2	O
article	28650109	2	O
is	28650109	2	O
protected	28650109	2	O
by	28650109	2	O
copyright	28650109	2	O
.	28650109	2	O
All	28650109	2	O
rights	28650109	2	O
reserved	28650109	2	O
.	28650109	2	O

Early	28659290	1	B-Disease
-	28659290	1	I-Disease
onset	28659290	1	I-Disease
autoimmune	28659290	1	I-Disease
disease	28659290	1	I-Disease
due	28659290	1	O
to	28659290	1	O
a	28659290	1	O
heterozygous	28659290	1	O
loss	28659290	1	B-NegReg
-	28659290	1	I-NegReg
of	28659290	1	I-NegReg
-	28659290	1	I-NegReg
function	28659290	1	I-NegReg
mutation	28659290	1	B-Var
in	28659290	1	O
TNFAIP3	28659290	1	B-Gene
(	28659290	1	O
A20	28659290	1	O
)	28659290	1	O
.	28659290	1	O

The	28662729	0	O
moving	28662729	0	O
junction	28662729	0	O
protein	28662729	0	O
RON4	28662729	0	O
,	28662729	0	O
although	28662729	0	O
not	28662729	0	O
critical	28662729	0	O
,	28662729	0	O
facilitates	28662729	0	O
host	28662729	0	O
cell	28662729	0	O
invasion	28662729	0	O
and	28662729	0	O
stabilizes	28662729	0	O
MJ	28662729	0	O
members	28662729	0	O
.	28662729	0	O
Toxoplasma	28662729	0	O
gondii	28662729	0	O
is	28662729	0	O
an	28662729	0	O
obligate	28662729	0	O
intracellular	28662729	0	O
parasite	28662729	0	O
of	28662729	0	O
phylum	28662729	0	O
Apicomplexa	28662729	0	O
.	28662729	0	O
To	28662729	0	O
facilitate	28662729	0	O
high	28662729	0	O
-	28662729	0	O
efficiency	28662729	0	O
invasion	28662729	0	O
of	28662729	0	O
host	28662729	0	O
cells	28662729	0	O
,	28662729	0	O
T.	28662729	0	O
gondii	28662729	0	O
secretes	28662729	0	O
various	28662729	0	O
proteins	28662729	0	O
related	28662729	0	O
to	28662729	0	O
the	28662729	0	O
moving	28662729	0	O
junction	28662729	0	O
(	28662729	0	O
MJ	28662729	0	O
)	28662729	0	O
complex	28662729	0	O
from	28662729	0	O
rhoptries	28662729	0	O
and	28662729	0	O
micronemes	28662729	0	O
into	28662729	0	O
the	28662729	0	O
interface	28662729	0	O
between	28662729	0	O
the	28662729	0	O
parasite	28662729	0	O
and	28662729	0	O
host	28662729	0	O
.	28662729	0	O
AMA1	28662729	0	O
/	28662729	0	O
RON2	28662729	0	O
/	28662729	0	O
4	28662729	0	O
/	28662729	0	O
5	28662729	0	O
/	28662729	0	O
8	28662729	0	O
is	28662729	0	O
an	28662729	0	O
important	28662729	0	O
MJ	28662729	0	O
complex	28662729	0	O
,	28662729	0	O
but	28662729	0	O
its	28662729	0	O
mechanism	28662729	0	O
of	28662729	0	O
assembly	28662729	0	O
remains	28662729	0	O
unclear	28662729	0	O
.	28662729	0	O
In	28662729	0	O
this	28662729	0	O
study	28662729	0	O
,	28662729	0	O
we	28662729	0	O
used	28662729	0	O
the	28662729	0	O
CRISPR	28662729	0	O
-	28662729	0	O
Cas9	28662729	0	O
system	28662729	0	O
to	28662729	0	O
generate	28662729	0	O
a	28662729	0	O
derivative	28662729	0	O
of	28662729	0	O
T.	28662729	0	O
gondii	28662729	0	O
strain	28662729	0	O
RH	28662729	0	O
with	28662729	0	O
a	28662729	0	O
null	28662729	0	B-Var
mutation	28662729	0	I-Var
in	28662729	0	O
TgRON4	28662729	0	B-Gene
,	28662729	0	O
thought	28662729	0	O
to	28662729	0	O
be	28662729	0	O
an	28662729	0	O
essential	28662729	0	O
MJ	28662729	0	O
component	28662729	0	O
.	28662729	0	O
Deficiency	28662729	0	B-NegReg
of	28662729	0	O
TgRON4	28662729	0	B-Protein
moderately	28662729	0	O
decreased	28662729	0	B-NegReg
invasion	28662729	0	B-CPA
ability	28662729	0	I-CPA
relative	28662729	0	O
to	28662729	0	O
that	28662729	0	O
of	28662729	0	O
the	28662729	0	O
wild	28662729	0	O
-	28662729	0	O
type	28662729	0	O
parasite	28662729	0	O
.	28662729	0	O
In	28662729	0	O
addition	28662729	0	O
,	28662729	0	O
expression	28662729	0	B-MPA
of	28662729	0	I-MPA
the	28662729	0	I-MPA
endogenous	28662729	0	I-MPA
N	28662729	0	I-MPA
-	28662729	0	I-MPA
terminal	28662729	0	I-MPA
fragment	28662729	0	I-MPA
of	28662729	0	O
RON5	28662729	0	B-Protein
decreased	28662729	0	B-NegReg
in	28662729	0	O
the	28662729	0	O
mutant	28662729	0	B-Var
.	28662729	0	O
Together	28662729	0	O
,	28662729	0	O
the	28662729	0	O
results	28662729	0	O
improve	28662729	0	O
our	28662729	0	O
understanding	28662729	0	O
of	28662729	0	O
the	28662729	0	O
assembly	28662729	0	O
mechanism	28662729	0	O
of	28662729	0	O
the	28662729	0	O
MJ	28662729	0	O
complex	28662729	0	O
of	28662729	0	O
T.	28662729	0	O
gondii	28662729	0	O
and	28662729	0	O
raise	28662729	0	O
the	28662729	0	O
possibility	28662729	0	O
of	28662729	0	O
developing	28662729	0	O
new	28662729	0	O
therapeutic	28662729	0	O
drugs	28662729	0	O
that	28662729	0	O
target	28662729	0	O
this	28662729	0	O
complex	28662729	0	O
.	28662729	0	O

Natural	28667273	0	O
and	28667273	0	O
induced	28667273	0	O
loss	28667273	0	B-NegReg
of	28667273	0	I-NegReg
function	28667273	0	I-NegReg
mutations	28667273	0	B-Var
in	28667273	0	O
SlMBP21	28667273	0	B-Gene
MADS	28667273	0	O
-	28667273	0	O
box	28667273	0	O
gene	28667273	0	O
led	28667273	0	O
to	28667273	0	O
jointless-2	28667273	0	B-CPA
phenotype	28667273	0	I-CPA
in	28667273	0	O
tomato	28667273	0	O
.	28667273	0	O
Abscission	28667273	0	O
is	28667273	0	O
the	28667273	0	O
mechanism	28667273	0	O
by	28667273	0	O
which	28667273	0	O
plants	28667273	0	O
disconnect	28667273	0	O
unfertilized	28667273	0	O
flowers	28667273	0	O
,	28667273	0	O
ripe	28667273	0	O
fruits	28667273	0	O
,	28667273	0	O
senescent	28667273	0	O
or	28667273	0	O
diseased	28667273	0	O
organs	28667273	0	O
from	28667273	0	O
the	28667273	0	O
plant	28667273	0	O
.	28667273	0	O
In	28667273	0	O
tomato	28667273	0	O
,	28667273	0	O
pedicel	28667273	0	O
abscission	28667273	0	O
is	28667273	0	O
an	28667273	0	O
important	28667273	0	O
agronomic	28667273	0	O
factor	28667273	0	O
that	28667273	0	O
controls	28667273	0	O
yield	28667273	0	O
and	28667273	0	O
post	28667273	0	O
-	28667273	0	O
harvest	28667273	0	O
fruit	28667273	0	O
quality	28667273	0	O
.	28667273	0	O
Two	28667273	0	O
non	28667273	0	O
-	28667273	0	O
allelic	28667273	0	O
mutations	28667273	0	O
,	28667273	0	O
jointless	28667273	0	O
(	28667273	0	O
j	28667273	0	O
)	28667273	0	O
and	28667273	0	O
jointless-2	28667273	0	O
(	28667273	0	O
j-2	28667273	0	O
)	28667273	0	O
,	28667273	0	O
controlling	28667273	0	O
pedicel	28667273	0	O
abscission	28667273	0	O
zone	28667273	0	O
formation	28667273	0	O
have	28667273	0	O
been	28667273	0	O
documented	28667273	0	O
but	28667273	0	O
only	28667273	0	O
j-2	28667273	0	O
has	28667273	0	O
been	28667273	0	O
extensively	28667273	0	O
used	28667273	0	O
in	28667273	0	O
breeding	28667273	0	O
.	28667273	0	O
J	28667273	0	O
was	28667273	0	O
shown	28667273	0	O
to	28667273	0	O
encode	28667273	0	O
a	28667273	0	O
MADS	28667273	0	O
-	28667273	0	O
box	28667273	0	O
protein	28667273	0	O
.	28667273	0	O
Using	28667273	0	O
a	28667273	0	O
combination	28667273	0	O
of	28667273	0	O
physical	28667273	0	O
mapping	28667273	0	O
and	28667273	0	O
gene	28667273	0	O
expression	28667273	0	O
analysis	28667273	0	O
we	28667273	0	O
identified	28667273	0	O
a	28667273	0	O
positional	28667273	0	O
candidate	28667273	0	O
,	28667273	0	O
Solyc12g038510	28667273	0	O
,	28667273	0	O
associated	28667273	0	O
with	28667273	0	O
j-2	28667273	0	O
phenotype	28667273	0	O
.	28667273	0	O
Targeted	28667273	0	O
knockout	28667273	0	O
of	28667273	0	O
Solyc12g038510	28667273	0	O
,	28667273	0	O
using	28667273	0	O
CRISPR	28667273	0	O
/	28667273	0	O
Cas9	28667273	0	O
system	28667273	0	O
,	28667273	0	O
validated	28667273	0	O
our	28667273	0	O
hypothesis	28667273	0	O
.	28667273	0	O
Solyc12g038510	28667273	0	O
encodes	28667273	0	O
the	28667273	0	O
MADS	28667273	0	O
-	28667273	0	O
box	28667273	0	O
protein	28667273	0	O
SlMBP21	28667273	0	O
.	28667273	0	O
Molecular	28667273	0	O
analysis	28667273	0	O
of	28667273	0	O
j-2	28667273	0	O
natural	28667273	0	O
variation	28667273	0	O
revealed	28667273	0	O
two	28667273	0	O
independent	28667273	0	O
loss	28667273	0	O
-	28667273	0	O
of	28667273	0	O
-	28667273	0	O
function	28667273	0	O
mutants	28667273	0	O
.	28667273	0	O
The	28667273	0	O
first	28667273	0	O
results	28667273	0	O
of	28667273	0	O
an	28667273	0	O
insertion	28667273	0	O
of	28667273	0	O
a	28667273	0	O
Rider	28667273	0	O
retrotransposable	28667273	0	O
element	28667273	0	O
.	28667273	0	O
The	28667273	0	O
second	28667273	0	O
results	28667273	0	O
of	28667273	0	O
a	28667273	0	O
stop	28667273	0	O
codon	28667273	0	O
mutation	28667273	0	O
that	28667273	0	O
leads	28667273	0	O
to	28667273	0	O
a	28667273	0	O
truncated	28667273	0	O
protein	28667273	0	O
form	28667273	0	O
.	28667273	0	O
To	28667273	0	O
bring	28667273	0	O
new	28667273	0	O
insights	28667273	0	O
into	28667273	0	O
the	28667273	0	O
role	28667273	0	O
of	28667273	0	O
J	28667273	0	O
and	28667273	0	O
J-2	28667273	0	O
in	28667273	0	O
abscission	28667273	0	O
zone	28667273	0	O
formation	28667273	0	O
,	28667273	0	O
we	28667273	0	O
phenotyped	28667273	0	O
the	28667273	0	O
single	28667273	0	O
and	28667273	0	O
the	28667273	0	O
double	28667273	0	O
mutants	28667273	0	O
and	28667273	0	O
the	28667273	0	O
engineered	28667273	0	O
alleles	28667273	0	O
.	28667273	0	O
We	28667273	0	O
showed	28667273	0	O
that	28667273	0	O
J	28667273	0	O
is	28667273	0	O
epistatic	28667273	0	O
to	28667273	0	O
J-2	28667273	0	O
and	28667273	0	O
that	28667273	0	O
the	28667273	0	O
branched	28667273	0	O
inflorescences	28667273	0	O
and	28667273	0	O
the	28667273	0	O
leafy	28667273	0	O
sepals	28667273	0	O
observed	28667273	0	O
in	28667273	0	O
accessions	28667273	0	O
harboring	28667273	0	O
j-2	28667273	0	O
alleles	28667273	0	O
are	28667273	0	O
likely	28667273	0	O
the	28667273	0	O
consequences	28667273	0	O
of	28667273	0	O
linkage	28667273	0	O
drags	28667273	0	O
.	28667273	0	O

Nephron	28683731	0	B-CPA
development	28683731	0	I-CPA
and	28683731	0	O
extrarenal	28683731	0	B-CPA
features	28683731	0	I-CPA
in	28683731	0	O
a	28683731	0	O
child	28683731	0	O
with	28683731	0	O
congenital	28683731	0	O
nephrotic	28683731	0	O
syndrome	28683731	0	O
caused	28683731	0	B-Reg
by	28683731	0	I-Reg
null	28683731	0	O
LAMB2	28683731	0	B-Gene
mutations	28683731	0	B-Var
.	28683731	0	O
BACKGROUND	28683731	0	O
:	28683731	0	O
Congenital	28683731	0	O
nephrotic	28683731	0	O
syndrome	28683731	0	O
(	28683731	0	O
CNS	28683731	0	O
)	28683731	0	O
is	28683731	0	O
a	28683731	0	O
rare	28683731	0	O
disorder	28683731	0	O
caused	28683731	0	O
by	28683731	0	O
various	28683731	0	O
structural	28683731	0	O
and	28683731	0	O
developmental	28683731	0	O
defects	28683731	0	O
of	28683731	0	O
glomeruli	28683731	0	O
.	28683731	0	O
It	28683731	0	O
occurs	28683731	0	O
typically	28683731	0	O
as	28683731	0	O
an	28683731	0	O
isolated	28683731	0	O
kidney	28683731	0	O
disorder	28683731	0	O
but	28683731	0	O
associates	28683731	0	O
sometimes	28683731	0	O
with	28683731	0	O
other	28683731	0	O
systemic	28683731	0	O
,	28683731	0	O
extrarenal	28683731	0	O
manifestations	28683731	0	O
.	28683731	0	O
CASE	28683731	0	O
PRESENTATIONS	28683731	0	O
:	28683731	0	O
An	28683731	0	O
infant	28683731	0	O
presented	28683731	0	O
with	28683731	0	O
severe	28683731	0	O
CNS	28683731	0	O
,	28683731	0	O
which	28683731	0	O
progressed	28683731	0	O
rapidly	28683731	0	O
to	28683731	0	O
renal	28683731	0	O
failure	28683731	0	O
at	28683731	0	O
age	28683731	0	O
of	28683731	0	O
3	28683731	0	O
months	28683731	0	O
and	28683731	0	O
death	28683731	0	O
at	28683731	0	O
27	28683731	0	O
months	28683731	0	O
.	28683731	0	O
The	28683731	0	O
clinical	28683731	0	O
phenotypes	28683731	0	O
and	28683731	0	O
genetic	28683731	0	O
causes	28683731	0	O
were	28683731	0	O
studied	28683731	0	O
,	28683731	0	O
including	28683731	0	O
the	28683731	0	O
renal	28683731	0	O
pathology	28683731	0	O
at	28683731	0	O
autopsy	28683731	0	O
.	28683731	0	O
Besides	28683731	0	O
the	28683731	0	O
CNS	28683731	0	O
,	28683731	0	O
the	28683731	0	O
affected	28683731	0	O
child	28683731	0	O
had	28683731	0	O
remarkable	28683731	0	O
right	28683731	0	O
-	28683731	0	O
side	28683731	0	O
predominant	28683731	0	O
eye	28683731	0	O
-	28683731	0	O
ball	28683731	0	O
hypoplasia	28683731	0	O
with	28683731	0	O
bilateral	28683731	0	O
anterior	28683731	0	O
chamber	28683731	0	O
dysgenesis	28683731	0	O
(	28683731	0	O
microcoria	28683731	0	O
)	28683731	0	O
.	28683731	0	O
Brain	28683731	0	O
MRI	28683731	0	O
revealed	28683731	0	O
grossly	28683731	0	O
normal	28683731	0	O
development	28683731	0	O
in	28683731	0	O
the	28683731	0	O
cerebrum	28683731	0	O
,	28683731	0	O
cerebellum	28683731	0	O
,	28683731	0	O
and	28683731	0	O
brain	28683731	0	O
stem	28683731	0	O
.	28683731	0	O
Auditory	28683731	0	O
brainstem	28683731	0	O
responses	28683731	0	O
were	28683731	0	O
bilaterally	28683731	0	O
blunted	28683731	0	O
,	28683731	0	O
suggesting	28683731	0	O
a	28683731	0	O
defective	28683731	0	O
auditory	28683731	0	O
system	28683731	0	O
.	28683731	0	O
At	28683731	0	O
autopsy	28683731	0	O
,	28683731	0	O
both	28683731	0	O
kidneys	28683731	0	O
were	28683731	0	O
mildly	28683731	0	O
atrophied	28683731	0	O
with	28683731	0	O
persistent	28683731	0	O
fetal	28683731	0	O
lobulation	28683731	0	O
.	28683731	0	O
Microscopic	28683731	0	O
examination	28683731	0	O
showed	28683731	0	O
a	28683731	0	O
diffuse	28683731	0	O
global	28683731	0	O
sclerosis	28683731	0	O
.	28683731	0	O
However	28683731	0	O
,	28683731	0	O
despite	28683731	0	O
of	28683731	0	O
the	28683731	0	O
smaller	28683731	0	O
size	28683731	0	O
of	28683731	0	O
glomeruli	28683731	0	O
,	28683731	0	O
the	28683731	0	O
nephron	28683731	0	O
number	28683731	0	O
remained	28683731	0	O
similar	28683731	0	O
to	28683731	0	O
that	28683731	0	O
of	28683731	0	O
the	28683731	0	O
age	28683731	0	O
-	28683731	0	O
matched	28683731	0	O
control	28683731	0	O
.	28683731	0	O
Whole	28683731	0	O
-	28683731	0	O
exome	28683731	0	O
sequencing	28683731	0	O
revealed	28683731	0	O
that	28683731	0	O
the	28683731	0	O
affected	28683731	0	O
child	28683731	0	O
was	28683731	0	O
compound	28683731	0	O
heterozygous	28683731	0	O
for	28683731	0	O
novel	28683731	0	O
truncating	28683731	0	O
LAMB2	28683731	0	O
mutations	28683731	0	O
:	28683731	0	O
a	28683731	0	O
4	28683731	0	O
-	28683731	0	O
bp	28683731	0	O
insertion	28683731	0	O
(	28683731	0	O
p.Gly1693Alafs	28683731	0	O
8	28683731	0	O
)	28683731	0	O
and	28683731	0	O
a	28683731	0	O
splicing	28683731	0	O
donor	28683731	0	O
-	28683731	0	O
site	28683731	0	O
substitution	28683731	0	O
(	28683731	0	O
c.1225	28683731	0	O
1	28683731	0	O
G	28683731	0	O
>	28683731	0	O
A	28683731	0	O
)	28683731	0	O
,	28683731	0	O
presumably	28683731	0	O
deleting	28683731	0	O
the	28683731	0	O
coiled	28683731	0	O
-	28683731	0	O
coil	28683731	0	O
domains	28683731	0	O
that	28683731	0	O
form	28683731	0	O
the	28683731	0	O
laminin	28683731	0	O
5	28683731	0	O
-	28683731	0	O
2	28683731	0	O
-	28683731	0	O
1	28683731	0	O
heterotrimer	28683731	0	O
complex	28683731	0	O
.	28683731	0	O
CONCLUSIONS	28683731	0	O
:	28683731	0	O
Our	28683731	0	O
case	28683731	0	O
represents	28683731	0	O
a	28683731	0	O
variation	28683731	0	O
of	28683731	0	O
Pierson	28683731	0	O
syndrome	28683731	0	O
that	28683731	0	O
accompanies	28683731	0	O
CNS	28683731	0	O
with	28683731	0	O
unilateral	28683731	0	O
ocular	28683731	0	O
hypoplasia	28683731	0	O
.	28683731	0	O
The	28683731	0	O
average	28683731	0	O
number	28683731	0	O
but	28683731	0	O
smaller	28683731	0	O
glomeruli	28683731	0	O
could	28683731	0	O
reflect	28683731	0	O
either	28683731	0	O
mal	28683731	0	O
-	28683731	0	O
development	28683731	0	O
or	28683731	0	O
glomerulosclerosis	28683731	0	O
.	28683731	0	O
Heterogeneous	28683731	0	O
clinical	28683731	0	O
expression	28683731	0	O
of	28683731	0	O
LAMB2	28683731	0	O
defects	28683731	0	O
may	28683731	0	O
associate	28683731	0	O
with	28683731	0	O
the	28683731	0	O
difference	28683731	0	O
in	28683731	0	O
fetal	28683731	0	O
β1	28683731	0	O
subtype	28683731	0	O
compensation	28683731	0	O
among	28683731	0	O
affected	28683731	0	O
tissues	28683731	0	O
.	28683731	0	O
Further	28683731	0	O
study	28683731	0	O
is	28683731	0	O
necessary	28683731	0	O
to	28683731	0	O
evaluate	28683731	0	O
incidence	28683731	0	O
and	28683731	0	O
features	28683731	0	O
of	28683731	0	O
auditory	28683731	0	O
defect	28683731	0	O
under	28683731	0	O
LAMB2	28683731	0	O
deficiency	28683731	0	O
.	28683731	0	O

Exome	28697784	1	O
sequencing	28697784	1	O
reveals	28697784	1	O
independent	28697784	1	O
SGCD	28697784	1	B-Gene
deletions	28697784	1	B-Var
causing	28697784	1	B-Reg
limb	28697784	1	B-Disease
girdle	28697784	1	I-Disease
muscular	28697784	1	I-Disease
dystrophy	28697784	1	I-Disease
in	28697784	1	O
Boston	28697784	1	O
terriers	28697784	1	O
.	28697784	1	O
BACKGROUND	28697784	1	O
:	28697784	1	O
Limb	28697784	1	O
-	28697784	1	O
girdle	28697784	1	O
muscular	28697784	1	O
dystrophies	28697784	1	O
(	28697784	1	O
LGMDs	28697784	1	O
)	28697784	1	O
are	28697784	1	O
a	28697784	1	O
heterogeneous	28697784	1	O
group	28697784	1	O
of	28697784	1	O
inherited	28697784	1	O
autosomal	28697784	1	O
myopathies	28697784	1	O
that	28697784	1	O
preferentially	28697784	1	O
affect	28697784	1	O
voluntary	28697784	1	O
muscles	28697784	1	O
of	28697784	1	O
the	28697784	1	O
shoulders	28697784	1	O
and	28697784	1	O
hips	28697784	1	O
.	28697784	1	O
LGMD	28697784	1	O
has	28697784	1	O
been	28697784	1	O
clinically	28697784	1	O
described	28697784	1	O
in	28697784	1	O
several	28697784	1	O
breeds	28697784	1	O
of	28697784	1	O
dogs	28697784	1	O
,	28697784	1	O
but	28697784	1	O
the	28697784	1	O
responsible	28697784	1	O
mutations	28697784	1	O
are	28697784	1	O
unknown	28697784	1	O
.	28697784	1	O
The	28697784	1	O
clinical	28697784	1	O
presentation	28697784	1	O
in	28697784	1	O
dogs	28697784	1	O
is	28697784	1	O
characterized	28697784	1	O
by	28697784	1	O
marked	28697784	1	O
muscle	28697784	1	O
weakness	28697784	1	O
and	28697784	1	O
atrophy	28697784	1	O
in	28697784	1	O
the	28697784	1	O
shoulder	28697784	1	O
and	28697784	1	O
hips	28697784	1	O
during	28697784	1	O
puppyhood	28697784	1	O
.	28697784	1	O
METHODS	28697784	1	O
:	28697784	1	O
Following	28697784	1	O
clinical	28697784	1	O
evaluation	28697784	1	O
,	28697784	1	O
the	28697784	1	O
identification	28697784	1	O
of	28697784	1	O
the	28697784	1	O
dystrophic	28697784	1	O
histological	28697784	1	O
phenotype	28697784	1	O
on	28697784	1	O
muscle	28697784	1	O
histology	28697784	1	O
,	28697784	1	O
and	28697784	1	O
demonstration	28697784	1	O
of	28697784	1	O
the	28697784	1	O
absence	28697784	1	O
of	28697784	1	O
sarcoglycan	28697784	1	O
-	28697784	1	O
sarcospan	28697784	1	O
complex	28697784	1	O
by	28697784	1	O
immunostaining	28697784	1	O
,	28697784	1	O
whole	28697784	1	O
exome	28697784	1	O
sequencing	28697784	1	O
was	28697784	1	O
performed	28697784	1	O
on	28697784	1	O
five	28697784	1	O
Boston	28697784	1	O
terriers	28697784	1	O
:	28697784	1	O
one	28697784	1	O
affected	28697784	1	O
dog	28697784	1	O
and	28697784	1	O
its	28697784	1	O
three	28697784	1	O
family	28697784	1	O
members	28697784	1	O
and	28697784	1	O
one	28697784	1	O
unrelated	28697784	1	O
affected	28697784	1	O
dog	28697784	1	O
.	28697784	1	O
RESULTS	28697784	1	O
:	28697784	1	O
Within	28697784	1	O
sarcoglycan	28697784	1	O
-	28697784	1	O
δ	28697784	1	O
(	28697784	1	B-Gene
SGCD	28697784	1	I-Gene
)	28697784	1	I-Gene
,	28697784	1	O
a	28697784	1	O
two	28697784	1	O
base	28697784	1	O
pair	28697784	1	O
deletion	28697784	1	O
segregating	28697784	1	O
with	28697784	1	O
LGMD	28697784	1	O
in	28697784	1	O
the	28697784	1	O
family	28697784	1	O
was	28697784	1	O
discovered	28697784	1	O
,	28697784	1	O
and	28697784	1	O
a	28697784	1	O
deletion	28697784	1	O
encompassing	28697784	1	O
exons	28697784	1	O
7	28697784	1	O
and	28697784	1	O
8	28697784	1	O
was	28697784	1	O
found	28697784	1	O
in	28697784	1	O
the	28697784	1	O
unrelated	28697784	1	O
dog	28697784	1	O
.	28697784	1	O
Both	28697784	1	O
mutations	28697784	1	B-Var
are	28697784	1	O
predicted	28697784	1	O
to	28697784	1	O
cause	28697784	1	O
an	28697784	1	O
absence	28697784	1	B-NegReg
of	28697784	1	O
SGCD	28697784	1	B-Gene
protein	28697784	1	B-Protein
,	28697784	1	O
confirmed	28697784	1	O
by	28697784	1	O
immunohistochemistry	28697784	1	O
.	28697784	1	O
The	28697784	1	O
mutations	28697784	1	O
are	28697784	1	O
private	28697784	1	O
to	28697784	1	O
each	28697784	1	O
family	28697784	1	O
.	28697784	1	O
CONCLUSIONS	28697784	1	O
:	28697784	1	O
Here	28697784	1	O
,	28697784	1	O
we	28697784	1	O
describe	28697784	1	O
the	28697784	1	O
first	28697784	1	O
cases	28697784	1	O
of	28697784	1	O
canine	28697784	1	O
LGMD	28697784	1	O
characterized	28697784	1	O
at	28697784	1	O
the	28697784	1	O
molecular	28697784	1	O
level	28697784	1	O
with	28697784	1	O
the	28697784	1	O
classification	28697784	1	O
of	28697784	1	O
LGMD2F	28697784	1	O
.	28697784	1	O

Calcium	28701352	0	O
pumps	28701352	0	O
and	28701352	0	O
interacting	28701352	0	O
BON1	28701352	0	O
protein	28701352	0	O
modulate	28701352	0	O
calcium	28701352	0	O
signature	28701352	0	O
,	28701352	0	O
stomatal	28701352	0	O
closure	28701352	0	O
,	28701352	0	O
and	28701352	0	O
plant	28701352	0	O
immunity	28701352	0	O
.	28701352	0	O
Calcium	28701352	0	O
signaling	28701352	0	O
is	28701352	0	O
essential	28701352	0	O
for	28701352	0	O
environmental	28701352	0	O
responses	28701352	0	O
including	28701352	0	O
immune	28701352	0	O
responses	28701352	0	O
.	28701352	0	O
Here	28701352	0	O
we	28701352	0	O
provide	28701352	0	O
evidence	28701352	0	O
that	28701352	0	O
the	28701352	0	O
evolutionarily	28701352	0	O
conserved	28701352	0	O
protein	28701352	0	O
BONZAI1	28701352	0	O
(	28701352	0	O
BON1	28701352	0	O
)	28701352	0	O
functions	28701352	0	O
together	28701352	0	O
with	28701352	0	O
autoinhibited	28701352	0	O
calcium	28701352	0	O
ATPase	28701352	0	O
10	28701352	0	O
(	28701352	0	O
ACA10	28701352	0	O
)	28701352	0	O
and	28701352	0	O
ACA8	28701352	0	O
to	28701352	0	O
regulate	28701352	0	O
calcium	28701352	0	O
signals	28701352	0	O
in	28701352	0	O
Arabidopsis	28701352	0	O
.	28701352	0	O
BON1	28701352	0	O
is	28701352	0	O
a	28701352	0	O
plasma	28701352	0	O
membrane	28701352	0	O
localized	28701352	0	O
protein	28701352	0	O
that	28701352	0	O
negatively	28701352	0	O
regulates	28701352	0	O
the	28701352	0	O
expression	28701352	0	O
of	28701352	0	O
immune	28701352	0	O
receptor	28701352	0	O
genes	28701352	0	O
and	28701352	0	O
positively	28701352	0	O
regulates	28701352	0	O
stomatal	28701352	0	O
closure	28701352	0	O
.	28701352	0	O
We	28701352	0	O
found	28701352	0	O
that	28701352	0	O
BON1	28701352	0	O
interacts	28701352	0	O
with	28701352	0	O
the	28701352	0	O
autoinhibitory	28701352	0	O
domains	28701352	0	O
of	28701352	0	O
ACA10	28701352	0	O
and	28701352	0	O
ACA8	28701352	0	O
,	28701352	0	O
and	28701352	0	O
the	28701352	0	O
aca10	28701352	0	B-Gene
loss	28701352	0	B-NegReg
of	28701352	0	I-NegReg
function	28701352	0	I-NegReg
(	28701352	0	O
LOF	28701352	0	O
)	28701352	0	O
mutants	28701352	0	B-Var
have	28701352	0	O
an	28701352	0	O
autoimmune	28701352	0	O
phenotype	28701352	0	O
similar	28701352	0	O
to	28701352	0	O
that	28701352	0	O
of	28701352	0	O
the	28701352	0	O
bon1	28701352	0	B-Gene
LOF	28701352	0	B-NegReg
mutants	28701352	0	B-Var
.	28701352	0	O
Genetic	28701352	0	O
evidences	28701352	0	O
indicate	28701352	0	O
that	28701352	0	O
BON1	28701352	0	O
positively	28701352	0	O
regulates	28701352	0	O
the	28701352	0	O
activities	28701352	0	O
of	28701352	0	O
ACA10	28701352	0	O
and	28701352	0	O
ACA8	28701352	0	O
.	28701352	0	O
Consistent	28701352	0	O
with	28701352	0	O
this	28701352	0	O
idea	28701352	0	O
,	28701352	0	O
the	28701352	0	O
steady	28701352	0	B-MPA
level	28701352	0	I-MPA
of	28701352	0	I-MPA
calcium	28701352	0	I-MPA
concentration	28701352	0	I-MPA
is	28701352	0	O
increased	28701352	0	B-PosReg
in	28701352	0	O
both	28701352	0	O
aca10	28701352	0	B-Gene
and	28701352	0	O
bon1	28701352	0	B-Gene
mutants	28701352	0	B-Var
.	28701352	0	O
Most	28701352	0	O
strikingly	28701352	0	O
,	28701352	0	O
cytosolic	28701352	0	O
calcium	28701352	0	O
oscillation	28701352	0	O
imposed	28701352	0	O
by	28701352	0	O
external	28701352	0	O
calcium	28701352	0	O
treatment	28701352	0	O
was	28701352	0	O
altered	28701352	0	O
in	28701352	0	O
aca10	28701352	0	O
,	28701352	0	O
aca8	28701352	0	O
,	28701352	0	O
and	28701352	0	O
bon1	28701352	0	O
mutants	28701352	0	O
in	28701352	0	O
guard	28701352	0	O
cells	28701352	0	O
.	28701352	0	O
In	28701352	0	O
addition	28701352	0	O
,	28701352	0	O
calcium	28701352	0	B-CPA
and	28701352	0	I-CPA
pathogen	28701352	0	I-CPA
induced	28701352	0	I-CPA
stomatal	28701352	0	I-CPA
closure	28701352	0	I-CPA
was	28701352	0	O
compromised	28701352	0	B-NegReg
in	28701352	0	O
the	28701352	0	O
aca10	28701352	0	B-Gene
and	28701352	0	O
bon1	28701352	0	B-Gene
mutants	28701352	0	B-Var
.	28701352	0	O
Taken	28701352	0	O
together	28701352	0	O
,	28701352	0	O
this	28701352	0	O
study	28701352	0	O
indicates	28701352	0	O
that	28701352	0	O
ACA10	28701352	0	O
/	28701352	0	O
8	28701352	0	O
and	28701352	0	O
BON1	28701352	0	O
physically	28701352	0	O
interact	28701352	0	O
on	28701352	0	O
plasma	28701352	0	O
membrane	28701352	0	O
and	28701352	0	O
function	28701352	0	O
in	28701352	0	O
the	28701352	0	O
generation	28701352	0	O
of	28701352	0	O
cytosol	28701352	0	O
calcium	28701352	0	O
signatures	28701352	0	O
that	28701352	0	O
are	28701352	0	O
critical	28701352	0	O
for	28701352	0	O
stomatal	28701352	0	O
movement	28701352	0	O
and	28701352	0	O
impact	28701352	0	O
plant	28701352	0	O
immunity	28701352	0	O
.	28701352	0	O

Extracellular	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
attenuate	28708837	1	O
tumorigenic	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
adenomatous	28708837	1	O
polyposis	28708837	1	O
coli	28708837	1	O
mutants	28708837	1	O
:	28708837	1	O
Predictions	28708837	1	O
of	28708837	1	O
a	28708837	1	O
validated	28708837	1	O
mathematical	28708837	1	O
model	28708837	1	O
.	28708837	1	O
BACKGROUND	28708837	1	O
:	28708837	1	O
Despite	28708837	1	O
considerable	28708837	1	O
investigational	28708837	1	O
efforts	28708837	1	O
,	28708837	1	O
no	28708837	1	O
method	28708837	1	O
to	28708837	1	O
overcome	28708837	1	O
the	28708837	1	O
pathogenesis	28708837	1	O
caused	28708837	1	O
by	28708837	1	O
loss	28708837	1	O
of	28708837	1	O
function	28708837	1	O
(	28708837	1	O
LoF	28708837	1	O
)	28708837	1	O
mutations	28708837	1	O
in	28708837	1	O
tumor	28708837	1	O
suppressor	28708837	1	O
genes	28708837	1	O
has	28708837	1	O
been	28708837	1	O
successfully	28708837	1	O
translated	28708837	1	O
to	28708837	1	O
the	28708837	1	O
clinic	28708837	1	O
.	28708837	1	O
The	28708837	1	O
most	28708837	1	O
frequent	28708837	1	O
LoF	28708837	1	B-NegReg
mutation	28708837	1	B-Var
in	28708837	1	O
human	28708837	1	O
cancers	28708837	1	O
is	28708837	1	O
Adenomatous	28708837	1	B-Gene
polyposis	28708837	1	I-Gene
coli	28708837	1	I-Gene
(	28708837	1	O
APC	28708837	1	O
)	28708837	1	O
,	28708837	1	O
causing	28708837	1	O
aberrant	28708837	1	O
activation	28708837	1	B-PosReg
of	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	B-Pathway
pathway	28708837	1	I-Pathway
.	28708837	1	O
In	28708837	1	O
nearly	28708837	1	O
all	28708837	1	O
colon	28708837	1	B-Disease
cancer	28708837	1	I-Disease
tumors	28708837	1	I-Disease
,	28708837	1	O
the	28708837	1	O
APC	28708837	1	B-Protein
protein	28708837	1	I-Protein
is	28708837	1	O
truncated	28708837	1	O
,	28708837	1	O
but	28708837	1	O
still	28708837	1	O
retains	28708837	1	B-NegReg
partial	28708837	1	I-NegReg
binding	28708837	1	B-Interaction
abilities	28708837	1	B-MPA
.	28708837	1	O
OBJECTIVE	28708837	1	O
METHODS	28708837	1	O
:	28708837	1	O
Here	28708837	1	O
,	28708837	1	O
we	28708837	1	O
tested	28708837	1	O
the	28708837	1	O
hypothesis	28708837	1	O
that	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
of	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
,	28708837	1	O
although	28708837	1	O
acting	28708837	1	O
upstream	28708837	1	O
of	28708837	1	O
the	28708837	1	O
APC	28708837	1	O
mutation	28708837	1	O
,	28708837	1	O
can	28708837	1	O
restore	28708837	1	O
normal	28708837	1	O
levels	28708837	1	O
of	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
colon	28708837	1	O
cancer	28708837	1	O
cells	28708837	1	O
.	28708837	1	O
To	28708837	1	O
this	28708837	1	O
end	28708837	1	O
,	28708837	1	O
we	28708837	1	O
developed	28708837	1	O
and	28708837	1	O
simulated	28708837	1	O
a	28708837	1	O
mathematical	28708837	1	O
model	28708837	1	O
for	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
in	28708837	1	O
different	28708837	1	O
APC	28708837	1	O
mutants	28708837	1	O
,	28708837	1	O
with	28708837	1	O
or	28708837	1	O
without	28708837	1	O
the	28708837	1	O
effects	28708837	1	O
of	28708837	1	O
the	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
,	28708837	1	O
Secreted	28708837	1	O
Frizzled	28708837	1	O
-	28708837	1	O
Related	28708837	1	O
Protein1	28708837	1	O
(	28708837	1	O
sFRP1	28708837	1	O
)	28708837	1	O
and	28708837	1	O
Dickhopf1	28708837	1	O
(	28708837	1	O
Dkk1	28708837	1	O
)	28708837	1	O
.	28708837	1	O
We	28708837	1	O
compared	28708837	1	O
our	28708837	1	O
model	28708837	1	O
predictions	28708837	1	O
to	28708837	1	O
experimental	28708837	1	O
data	28708837	1	O
in	28708837	1	O
the	28708837	1	O
literature	28708837	1	O
.	28708837	1	O
RESULTS	28708837	1	O
:	28708837	1	O
Our	28708837	1	O
model	28708837	1	O
accurately	28708837	1	O
predicts	28708837	1	O
T	28708837	1	O
-	28708837	1	O
cell	28708837	1	O
factor	28708837	1	O
(	28708837	1	O
TCF	28708837	1	O
)	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
mutant	28708837	1	O
cells	28708837	1	O
that	28708837	1	O
vary	28708837	1	O
in	28708837	1	O
APC	28708837	1	O
mutation	28708837	1	O
.	28708837	1	O
Model	28708837	1	O
simulations	28708837	1	O
suggest	28708837	1	O
that	28708837	1	O
both	28708837	1	O
sFRP1	28708837	1	O
and	28708837	1	O
DKK1	28708837	1	O
can	28708837	1	O
reduce	28708837	1	O
TCF	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
APC1638N	28708837	1	O
/	28708837	1	O
1572	28708837	1	O
T	28708837	1	O
and	28708837	1	O
Apcmin	28708837	1	O
/	28708837	1	O
min	28708837	1	O
mutants	28708837	1	O
,	28708837	1	O
but	28708837	1	O
restoration	28708837	1	O
of	28708837	1	O
normal	28708837	1	O
activity	28708837	1	O
levels	28708837	1	O
is	28708837	1	O
possible	28708837	1	O
only	28708837	1	O
in	28708837	1	O
the	28708837	1	O
former	28708837	1	O
.	28708837	1	O
When	28708837	1	O
applied	28708837	1	O
in	28708837	1	O
combination	28708837	1	O
,	28708837	1	O
synergism	28708837	1	O
between	28708837	1	O
the	28708837	1	O
two	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
reduce	28708837	1	O
their	28708837	1	O
effective	28708837	1	O
doses	28708837	1	O
to	28708837	1	O
one	28708837	1	O
-	28708837	1	O
fourth	28708837	1	O
of	28708837	1	O
the	28708837	1	O
doses	28708837	1	O
required	28708837	1	O
under	28708837	1	O
single	28708837	1	O
inhibitor	28708837	1	O
application	28708837	1	O
.	28708837	1	O
Overall	28708837	1	O
,	28708837	1	O
re	28708837	1	O
-	28708837	1	O
establishment	28708837	1	O
of	28708837	1	O
normal	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
is	28708837	1	O
predicted	28708837	1	O
for	28708837	1	O
every	28708837	1	O
APC	28708837	1	O
mutant	28708837	1	O
in	28708837	1	O
whom	28708837	1	O
TCF	28708837	1	O
activity	28708837	1	O
is	28708837	1	O
increased	28708837	1	O
by	28708837	1	O
up	28708837	1	O
to	28708837	1	O
11	28708837	1	O
fold	28708837	1	O
.	28708837	1	O
CONCLUSIONS	28708837	1	O
:	28708837	1	O
Our	28708837	1	O
work	28708837	1	O
suggests	28708837	1	O
that	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
effectively	28708837	1	O
restore	28708837	1	O
normal	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
APC	28708837	1	O
-	28708837	1	O
truncated	28708837	1	O
cancer	28708837	1	O
cells	28708837	1	O
,	28708837	1	O
even	28708837	1	O
though	28708837	1	O
these	28708837	1	O
LoF	28708837	1	O
mutations	28708837	1	O
occur	28708837	1	O
downstream	28708837	1	O
of	28708837	1	O
the	28708837	1	O
inhibitory	28708837	1	O
action	28708837	1	O
.	28708837	1	O
The	28708837	1	O
insufficient	28708837	1	O
activity	28708837	1	O
of	28708837	1	O
the	28708837	1	O
truncated	28708837	1	O
APC	28708837	1	O
can	28708837	1	O
be	28708837	1	O
quantitatively	28708837	1	O
balanced	28708837	1	O
by	28708837	1	O
the	28708837	1	O
upstream	28708837	1	O
intervention	28708837	1	O
.	28708837	1	O
This	28708837	1	O
new	28708837	1	O
concept	28708837	1	O
of	28708837	1	O
upstream	28708837	1	O
intervention	28708837	1	O
to	28708837	1	O
control	28708837	1	O
the	28708837	1	O
effects	28708837	1	O
of	28708837	1	O
downstream	28708837	1	O
mutations	28708837	1	O
may	28708837	1	O
be	28708837	1	O
considered	28708837	1	O
also	28708837	1	O
for	28708837	1	O
other	28708837	1	O
partial	28708837	1	O
LoF	28708837	1	O
mutations	28708837	1	O
in	28708837	1	O
other	28708837	1	O
signaling	28708837	1	O
pathways	28708837	1	O
.	28708837	1	O

A	28711549	1	O
case	28711549	1	O
of	28711549	1	O
hypocholesterolemia	28711549	1	B-Disease
and	28711549	1	O
steatosis	28711549	1	B-Disease
in	28711549	1	O
a	28711549	1	O
carrier	28711549	1	O
of	28711549	1	O
a	28711549	1	O
PCSK9	28711549	1	B-Gene
loss	28711549	1	B-NegReg
-	28711549	1	I-NegReg
of	28711549	1	I-NegReg
-	28711549	1	I-NegReg
function	28711549	1	I-NegReg
mutation	28711549	1	B-Var
and	28711549	1	O
polymorphisms	28711549	1	O
predisposing	28711549	1	O
to	28711549	1	O
nonalcoholic	28711549	1	O
fatty	28711549	1	O
liver	28711549	1	O
disease	28711549	1	O
.	28711549	1	O
We	28711549	1	O
report	28711549	1	O
a	28711549	1	O
new	28711549	1	O
case	28711549	1	O
of	28711549	1	O
hypobetalipoproteinemia	28711549	1	O
in	28711549	1	O
a	28711549	1	O
44	28711549	1	O
-	28711549	1	O
year	28711549	1	O
-	28711549	1	O
old	28711549	1	O
man	28711549	1	O
of	28711549	1	O
Peruvian	28711549	1	O
origin	28711549	1	O
exhibiting	28711549	1	O
a	28711549	1	O
heterozygous	28711549	1	O
PCSK9	28711549	1	O
missense	28711549	1	O
mutation	28711549	1	O
(	28711549	1	B-Var
c.946	28711549	1	I-Var
G	28711549	1	I-Var
>	28711549	1	I-Var
T	28711549	1	I-Var
,	28711549	1	O
p.Gly316Cys	28711549	1	O
)	28711549	1	O
.	28711549	1	O
In	28711549	1	O
vitro	28711549	1	O
functional	28711549	1	O
studies	28711549	1	O
demonstrated	28711549	1	O
that	28711549	1	O
this	28711549	1	O
mutation	28711549	1	O
leads	28711549	1	O
to	28711549	1	O
a	28711549	1	O
loss	28711549	1	O
of	28711549	1	O
function	28711549	1	B-NegReg
of	28711549	1	I-NegReg
PCSK9	28711549	1	I-NegReg
on	28711549	1	O
low	28711549	1	B-Gene
-	28711549	1	O
density	28711549	1	B-MPA
lipoprotein	28711549	1	I-MPA
receptor	28711549	1	I-MPA
degradation	28711549	1	I-MPA
.	28711549	1	I-MPA
This	28711549	1	I-MPA
patient	28711549	1	O
exhibited	28711549	1	O
liver	28711549	1	O
steatosis	28711549	1	O
;	28711549	1	O
he	28711549	1	O
was	28711549	1	O
neither	28711549	1	O
diabetic	28711549	1	O
,	28711549	1	O
nor	28711549	1	O
obese	28711549	1	O
or	28711549	1	O
alcoholic	28711549	1	O
,	28711549	1	O
but	28711549	1	O
is	28711549	1	O
a	28711549	1	O
carrier	28711549	1	O
of	28711549	1	O
2	28711549	1	O
polymorphisms	28711549	1	O
,	28711549	1	O
p.Ile148Met	28711549	1	O
(	28711549	1	O
rs738409	28711549	1	O
)	28711549	1	O
and	28711549	1	O
p.Glu167Lys	28711549	1	O
(	28711549	1	O
rs58542926	28711549	1	O
)	28711549	1	O
on	28711549	1	O
PNPLA3	28711549	1	O
and	28711549	1	O
TM6SF2	28711549	1	O
gene	28711549	1	O
,	28711549	1	O
respectively	28711549	1	O
,	28711549	1	O
previously	28711549	1	O
shown	28711549	1	O
to	28711549	1	O
be	28711549	1	O
associated	28711549	1	O
with	28711549	1	O
nonalcoholic	28711549	1	O
steatosis	28711549	1	O
and	28711549	1	O
fibrosis	28711549	1	O
evolution	28711549	1	O
.	28711549	1	O
These	28711549	1	O
data	28711549	1	O
suggested	28711549	1	O
that	28711549	1	O
if	28711549	1	O
a	28711549	1	O
resistance	28711549	1	O
to	28711549	1	O
hepatic	28711549	1	O
steatosis	28711549	1	O
mediated	28711549	1	O
by	28711549	1	O
the	28711549	1	O
PCSK9	28711549	1	O
deficiency	28711549	1	O
exists	28711549	1	O
,	28711549	1	O
as	28711549	1	O
demonstrated	28711549	1	O
in	28711549	1	O
mice	28711549	1	O
,	28711549	1	O
it	28711549	1	O
is	28711549	1	O
not	28711549	1	O
sufficient	28711549	1	O
to	28711549	1	O
prevent	28711549	1	O
hepatic	28711549	1	O
fatty	28711549	1	O
accumulation	28711549	1	O
in	28711549	1	O
the	28711549	1	O
case	28711549	1	O
of	28711549	1	O
genetic	28711549	1	O
factors	28711549	1	O
predisposing	28711549	1	O
to	28711549	1	O
nonalcoholic	28711549	1	O
fatty	28711549	1	O
liver	28711549	1	O
disease	28711549	1	O
.	28711549	1	O

Ovarian	28711606	0	B-Protein
aromatase	28711606	0	I-Protein
loss	28711606	0	B-NegReg
-	28711606	0	I-NegReg
of	28711606	0	I-NegReg
-	28711606	0	I-NegReg
function	28711606	0	I-NegReg
mutant	28711606	0	B-Var
medaka	28711606	0	O
undergo	28711606	0	B-Reg
ovary	28711606	0	B-CPA
degeneration	28711606	0	I-CPA
and	28711606	0	O
partial	28711606	0	B-CPA
female	28711606	0	I-CPA
-	28711606	0	I-CPA
to	28711606	0	I-CPA
-	28711606	0	I-CPA
male	28711606	0	I-CPA
sex	28711606	0	I-CPA
reversal	28711606	0	I-CPA
after	28711606	0	O
puberty	28711606	0	O
.	28711606	0	O
Although	28711606	0	O
estrogens	28711606	0	O
have	28711606	0	O
been	28711606	0	O
generally	28711606	0	O
considered	28711606	0	O
to	28711606	0	O
play	28711606	0	O
a	28711606	0	O
critical	28711606	0	O
role	28711606	0	O
in	28711606	0	O
ovarian	28711606	0	O
differentiation	28711606	0	O
in	28711606	0	O
non	28711606	0	O
-	28711606	0	O
mammalian	28711606	0	O
vertebrates	28711606	0	O
,	28711606	0	O
the	28711606	0	O
specific	28711606	0	O
functions	28711606	0	O
of	28711606	0	O
estrogens	28711606	0	O
during	28711606	0	O
ovarian	28711606	0	O
differentiation	28711606	0	O
remain	28711606	0	O
unclear	28711606	0	O
.	28711606	0	O
We	28711606	0	O
isolated	28711606	0	O
two	28711606	0	O
mutants	28711606	0	O
with	28711606	0	O
premature	28711606	0	O
stops	28711606	0	O
in	28711606	0	O
the	28711606	0	O
ovarian	28711606	0	O
aromatase	28711606	0	O
(	28711606	0	B-Gene
cyp19a1	28711606	0	I-Gene
)	28711606	0	I-Gene
gene	28711606	0	O
from	28711606	0	O
an	28711606	0	O
N	28711606	0	O
-	28711606	0	O
ethyl	28711606	0	O
-	28711606	0	O
N	28711606	0	O
-	28711606	0	O
nitrosourea	28711606	0	O
-	28711606	0	O
based	28711606	0	O
gene	28711606	0	O
-	28711606	0	O
driven	28711606	0	O
mutagenesis	28711606	0	O
library	28711606	0	O
of	28711606	0	O
the	28711606	0	O
medaka	28711606	0	O
,	28711606	0	O
Oryzias	28711606	0	O
latipes	28711606	0	O
.	28711606	0	O
In	28711606	0	O
XX	28711606	0	O
mutants	28711606	0	O
,	28711606	0	O
gonads	28711606	0	O
first	28711606	0	O
differentiated	28711606	0	O
into	28711606	0	O
normal	28711606	0	O
ovaries	28711606	0	O
containing	28711606	0	O
many	28711606	0	O
ovarian	28711606	0	O
follicles	28711606	0	O
that	28711606	0	O
failed	28711606	0	O
to	28711606	0	O
accumulate	28711606	0	O
yolk	28711606	0	O
.	28711606	0	O
Subsequently	28711606	0	O
,	28711606	0	O
ovarian	28711606	0	O
tissues	28711606	0	O
underwent	28711606	0	O
extensive	28711606	0	O
degeneration	28711606	0	O
,	28711606	0	O
followed	28711606	0	O
by	28711606	0	O
the	28711606	0	O
appearance	28711606	0	O
of	28711606	0	O
testicular	28711606	0	O
tissues	28711606	0	O
on	28711606	0	O
the	28711606	0	O
dorsal	28711606	0	O
side	28711606	0	O
of	28711606	0	O
ovaries	28711606	0	O
.	28711606	0	O
In	28711606	0	O
the	28711606	0	O
newly	28711606	0	O
formed	28711606	0	O
testicular	28711606	0	O
tissue	28711606	0	O
,	28711606	0	O
strong	28711606	0	O
expression	28711606	0	O
of	28711606	0	O
gsdf	28711606	0	O
was	28711606	0	O
detected	28711606	0	O
in	28711606	0	O
sox9a2	28711606	0	O
-	28711606	0	O
positive	28711606	0	O
somatic	28711606	0	O
cells	28711606	0	O
surrounding	28711606	0	O
germline	28711606	0	O
stem	28711606	0	O
cells	28711606	0	O
suggesting	28711606	0	O
that	28711606	0	O
gsdf	28711606	0	O
plays	28711606	0	O
an	28711606	0	O
important	28711606	0	O
role	28711606	0	O
in	28711606	0	O
testicular	28711606	0	O
differentiation	28711606	0	O
during	28711606	0	O
estrogen	28711606	0	O
-	28711606	0	O
depleted	28711606	0	O
female	28711606	0	O
-	28711606	0	O
to	28711606	0	O
-	28711606	0	O
male	28711606	0	O
sex	28711606	0	O
reversal	28711606	0	O
.	28711606	0	O
We	28711606	0	O
conclude	28711606	0	O
that	28711606	0	O
endogenous	28711606	0	O
estrogens	28711606	0	O
synthesized	28711606	0	O
after	28711606	0	O
fertilization	28711606	0	O
are	28711606	0	O
not	28711606	0	O
essential	28711606	0	O
for	28711606	0	O
early	28711606	0	O
ovarian	28711606	0	O
differentiation	28711606	0	O
but	28711606	0	O
are	28711606	0	O
critical	28711606	0	O
for	28711606	0	O
the	28711606	0	O
maintenance	28711606	0	O
of	28711606	0	O
adult	28711606	0	O
ovaries	28711606	0	O
.	28711606	0	O

Refining	28717663	1	O
genotype	28717663	1	O
-	28717663	1	O
phenotype	28717663	1	O
correlation	28717663	1	O
in	28717663	1	O
Alström	28717663	1	O
syndrome	28717663	1	O
through	28717663	1	O
study	28717663	1	O
of	28717663	1	O
primary	28717663	1	O
human	28717663	1	O
fibroblasts	28717663	1	O
.	28717663	1	O
BACKGROUND	28717663	1	O
:	28717663	1	O
Alström	28717663	1	O
syndrome	28717663	1	O
(	28717663	1	O
AS	28717663	1	O
)	28717663	1	O
,	28717663	1	O
featuring	28717663	1	O
retinal	28717663	1	O
dystrophy	28717663	1	O
,	28717663	1	O
neuronal	28717663	1	O
deafness	28717663	1	O
,	28717663	1	O
cardiomyopathy	28717663	1	O
,	28717663	1	O
metabolic	28717663	1	O
syndrome	28717663	1	O
,	28717663	1	O
and	28717663	1	O
diffuse	28717663	1	O
fibrosis	28717663	1	O
,	28717663	1	O
is	28717663	1	O
caused	28717663	1	O
by	28717663	1	O
biallelic	28717663	1	O
mutations	28717663	1	O
in	28717663	1	O
the	28717663	1	O
centrosomal	28717663	1	O
protein	28717663	1	O
ALMS1	28717663	1	O
.	28717663	1	O
Genotype	28717663	1	O
-	28717663	1	O
phenotype	28717663	1	O
correlation	28717663	1	O
has	28717663	1	O
been	28717663	1	O
suggested	28717663	1	O
without	28717663	1	O
assessment	28717663	1	O
of	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
.	28717663	1	O
METHODS	28717663	1	O
:	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
(	28717663	1	O
real	28717663	1	O
-	28717663	1	O
time	28717663	1	O
PCR	28717663	1	O
and	28717663	1	O
immunocytochemistry	28717663	1	O
)	28717663	1	O
and	28717663	1	O
cilia	28717663	1	O
formation	28717663	1	O
(	28717663	1	O
immunocytochemistry	28717663	1	O
)	28717663	1	O
were	28717663	1	O
assessed	28717663	1	O
in	28717663	1	O
fibroblasts	28717663	1	O
from	28717663	1	O
deeply	28717663	1	O
phenotyped	28717663	1	O
volunteers	28717663	1	O
diagnosed	28717663	1	O
with	28717663	1	O
AS	28717663	1	O
recruited	28717663	1	O
from	28717663	1	O
a	28717663	1	O
dedicated	28717663	1	O
AS	28717663	1	O
Service	28717663	1	O
.	28717663	1	O
Exome	28717663	1	O
sequencing	28717663	1	O
was	28717663	1	O
used	28717663	1	O
in	28717663	1	O
two	28717663	1	O
participants	28717663	1	O
without	28717663	1	O
convincing	28717663	1	O
biallelic	28717663	1	O
ALMS1	28717663	1	O
mutations	28717663	1	O
,	28717663	1	O
and	28717663	1	O
BBS2	28717663	1	O
(	28717663	1	O
Bardet	28717663	1	O
-	28717663	1	O
Biedl	28717663	1	O
syndrome	28717663	1	O
2	28717663	1	O
)	28717663	1	O
protein	28717663	1	O
expression	28717663	1	O
was	28717663	1	O
assessed	28717663	1	O
in	28717663	1	O
one	28717663	1	O
patient	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
BBS2	28717663	1	O
mutations	28717663	1	O
.	28717663	1	O
Hedgehog	28717663	1	O
-	28717663	1	O
induced	28717663	1	O
GLI1	28717663	1	O
expression	28717663	1	O
and	28717663	1	O
PDGFA	28717663	1	O
signaling	28717663	1	O
was	28717663	1	O
assessed	28717663	1	O
using	28717663	1	O
quantitative	28717663	1	O
real	28717663	1	O
-	28717663	1	O
time	28717663	1	O
PCR	28717663	1	O
,	28717663	1	O
immunoblotting	28717663	1	O
,	28717663	1	O
or	28717663	1	O
immunostaining	28717663	1	O
of	28717663	1	O
fixed	28717663	1	O
cells	28717663	1	O
after	28717663	1	O
stimulation	28717663	1	O
.	28717663	1	O
RESULTS	28717663	1	O
:	28717663	1	O
In	28717663	1	O
16	28717663	1	O
of	28717663	1	O
the	28717663	1	O
patient	28717663	1	O
cell	28717663	1	O
lines	28717663	1	O
examined	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	B-Gene
protein	28717663	1	B-Protein
was	28717663	1	O
undetectable	28717663	1	B-NegReg
(	28717663	1	O
14	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
loss	28717663	1	B-NegReg
-	28717663	1	I-NegReg
of	28717663	1	I-NegReg
-	28717663	1	I-NegReg
function	28717663	1	I-NegReg
(	28717663	1	O
LoF	28717663	1	O
)	28717663	1	O
mutations	28717663	1	B-Var
)	28717663	1	I-Var
,	28717663	1	O
and	28717663	1	O
in	28717663	1	O
two	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
staining	28717663	1	O
was	28717663	1	O
equivocal	28717663	1	O
(	28717663	1	O
one	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
mutations	28717663	1	O
)	28717663	1	O
.	28717663	1	O
In	28717663	1	O
five	28717663	1	O
lines	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
was	28717663	1	O
normal	28717663	1	O
using	28717663	1	O
at	28717663	1	O
least	28717663	1	O
one	28717663	1	O
fixation	28717663	1	O
method	28717663	1	O
(	28717663	1	O
one	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
mutations	28717663	1	O
)	28717663	1	O
.	28717663	1	O
These	28717663	1	O
differences	28717663	1	O
were	28717663	1	O
not	28717663	1	O
accounted	28717663	1	O
for	28717663	1	O
by	28717663	1	O
major	28717663	1	O
differences	28717663	1	O
in	28717663	1	O
ALMS1	28717663	1	O
mRNA	28717663	1	O
expression	28717663	1	O
.	28717663	1	O
Exome	28717663	1	O
sequencing	28717663	1	O
of	28717663	1	O
two	28717663	1	O
participants	28717663	1	O
with	28717663	1	O
normal	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
identified	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
BBS2	28717663	1	O
mutations	28717663	1	O
in	28717663	1	O
one	28717663	1	O
.	28717663	1	O
No	28717663	1	O
second	28717663	1	O
,	28717663	1	O
known	28717663	1	O
ciliopathy	28717663	1	O
mutation	28717663	1	O
was	28717663	1	O
found	28717663	1	O
in	28717663	1	O
the	28717663	1	O
other	28717663	1	O
patient	28717663	1	O
,	28717663	1	O
who	28717663	1	O
had	28717663	1	O
one	28717663	1	O
LoF	28717663	1	O
ALMS1	28717663	1	O
mutation	28717663	1	O
.	28717663	1	O
Phenotypes	28717663	1	O
were	28717663	1	O
milder	28717663	1	O
or	28717663	1	O
atypical	28717663	1	O
in	28717663	1	O
participants	28717663	1	O
with	28717663	1	O
preserved	28717663	1	O
ALMS1	28717663	1	O
immunostaining	28717663	1	O
,	28717663	1	O
even	28717663	1	O
when	28717663	1	O
two	28717663	1	O
with	28717663	1	O
likely	28717663	1	O
alternative	28717663	1	O
genetic	28717663	1	O
diagnoses	28717663	1	O
were	28717663	1	O
excluded	28717663	1	O
.	28717663	1	O
All	28717663	1	O
cells	28717663	1	O
studied	28717663	1	O
developed	28717663	1	O
normal	28717663	1	O
cilia	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
and	28717663	1	O
BBS2	28717663	1	O
mutant	28717663	1	O
cells	28717663	1	O
showed	28717663	1	O
normal	28717663	1	O
Hedgehog	28717663	1	O
-	28717663	1	O
induced	28717663	1	O
upregulation	28717663	1	O
of	28717663	1	O
GLI1	28717663	1	O
expression	28717663	1	O
,	28717663	1	O
and	28717663	1	O
PDGFA	28717663	1	O
signaling	28717663	1	O
was	28717663	1	O
normal	28717663	1	O
in	28717663	1	O
ALMS1	28717663	1	O
-	28717663	1	O
deficient	28717663	1	O
cells	28717663	1	O
.	28717663	1	O
CONCLUSION	28717663	1	O
:	28717663	1	O
Milder	28717663	1	O
or	28717663	1	O
atypical	28717663	1	O
presentations	28717663	1	O
of	28717663	1	O
AS	28717663	1	O
should	28717663	1	O
prompt	28717663	1	O
genetic	28717663	1	O
evaluation	28717663	1	O
for	28717663	1	O
alternative	28717663	1	O
,	28717663	1	O
clinically	28717663	1	O
overlapping	28717663	1	O
ciliopathies	28717663	1	O
.	28717663	1	O
A	28717663	1	O
subgroup	28717663	1	O
of	28717663	1	O
patients	28717663	1	O
with	28717663	1	O
bona	28717663	1	O
fide	28717663	1	O
ALMS1	28717663	1	O
defects	28717663	1	O
have	28717663	1	O
milder	28717663	1	O
phenotypes	28717663	1	O
due	28717663	1	O
to	28717663	1	O
residual	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
,	28717663	1	O
which	28717663	1	O
may	28717663	1	O
be	28717663	1	O
more	28717663	1	O
important	28717663	1	O
than	28717663	1	O
mutation	28717663	1	O
site	28717663	1	O
.	28717663	1	O

Small	28720827	0	O
chaperons	28720827	0	O
and	28720827	0	O
autophagy	28720827	0	O
protected	28720827	0	O
neurons	28720827	0	O
from	28720827	0	O
necrotic	28720827	0	O
cell	28720827	0	O
death	28720827	0	O
.	28720827	0	O
Neuronal	28720827	0	O
necrosis	28720827	0	O
occurs	28720827	0	O
during	28720827	0	O
early	28720827	0	O
phase	28720827	0	O
of	28720827	0	O
ischemic	28720827	0	O
insult	28720827	0	O
.	28720827	0	O
However	28720827	0	O
,	28720827	0	O
our	28720827	0	O
knowledge	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
is	28720827	0	O
still	28720827	0	O
inadequate	28720827	0	O
.	28720827	0	O
To	28720827	0	O
study	28720827	0	O
the	28720827	0	O
mechanism	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
,	28720827	0	O
we	28720827	0	O
previously	28720827	0	O
established	28720827	0	O
a	28720827	0	O
Drosophila	28720827	0	O
genetic	28720827	0	O
model	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
by	28720827	0	O
calcium	28720827	0	O
overloading	28720827	0	O
through	28720827	0	O
expression	28720827	0	O
of	28720827	0	O
a	28720827	0	O
constitutively	28720827	0	O
opened	28720827	0	O
cation	28720827	0	O
channel	28720827	0	O
mutant	28720827	0	O
.	28720827	0	O
Here	28720827	0	O
,	28720827	0	O
we	28720827	0	O
performed	28720827	0	O
further	28720827	0	O
genetic	28720827	0	O
screens	28720827	0	O
and	28720827	0	O
identified	28720827	0	O
a	28720827	0	O
suppressor	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
,	28720827	0	O
CG17259	28720827	0	O
,	28720827	0	O
which	28720827	0	O
encodes	28720827	0	O
a	28720827	0	O
seryl	28720827	0	O
-	28720827	0	O
tRNA	28720827	0	O
synthetase	28720827	0	O
.	28720827	0	O
We	28720827	0	O
found	28720827	0	O
that	28720827	0	O
loss	28720827	0	B-Var
-	28720827	0	I-Var
of	28720827	0	I-Var
-	28720827	0	I-Var
function	28720827	0	I-Var
(	28720827	0	O
LOF	28720827	0	O
)	28720827	0	O
CG17259	28720827	0	B-Gene
activated	28720827	0	B-PosReg
eIF2α	28720827	0	B-Protein
phosphorylation	28720827	0	B-CPA
and	28720827	0	O
subsequent	28720827	0	O
up	28720827	0	B-PosReg
-	28720827	0	I-PosReg
regulation	28720827	0	I-PosReg
of	28720827	0	O
chaperons	28720827	0	B-CPA
(	28720827	0	B-Protein
Hsp26	28720827	0	I-Protein
and	28720827	0	O
Hsp27	28720827	0	B-Protein
)	28720827	0	I-Protein
and	28720827	0	O
autophagy	28720827	0	B-CPA
.	28720827	0	O
Genetically	28720827	0	O
,	28720827	0	O
down	28720827	0	B-NegReg
-	28720827	0	I-NegReg
regulation	28720827	0	I-NegReg
of	28720827	0	O
eIF2α	28720827	0	B-Protein
phosphorylation	28720827	0	B-CPA
,	28720827	0	O
Hsp26	28720827	0	B-Protein
/	28720827	0	I-Protein
Hsp27	28720827	0	I-Protein
or	28720827	0	O
autophagy	28720827	0	B-CPA
reduced	28720827	0	B-NegReg
the	28720827	0	O
protective	28720827	0	B-CPA
effect	28720827	0	I-CPA
of	28720827	0	O
LOF	28720827	0	B-Var
CG17259	28720827	0	B-Gene
,	28720827	0	O
indicating	28720827	0	O
they	28720827	0	O
function	28720827	0	O
downstream	28720827	0	O
of	28720827	0	O
CG17259	28720827	0	O
.	28720827	0	O
The	28720827	0	O
protective	28720827	0	O
effect	28720827	0	O
of	28720827	0	O
these	28720827	0	O
protein	28720827	0	O
degradation	28720827	0	O
pathways	28720827	0	O
indicated	28720827	0	O
activation	28720827	0	O
of	28720827	0	O
a	28720827	0	O
toxic	28720827	0	O
protein	28720827	0	O
during	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
.	28720827	0	O
Our	28720827	0	O
data	28720827	0	O
indicated	28720827	0	O
that	28720827	0	O
p53	28720827	0	O
was	28720827	0	O
likely	28720827	0	O
one	28720827	0	O
such	28720827	0	O
protein	28720827	0	O
,	28720827	0	O
because	28720827	0	O
p53	28720827	0	O
was	28720827	0	O
accumulated	28720827	0	O
in	28720827	0	O
the	28720827	0	O
necrotic	28720827	0	O
neurons	28720827	0	O
and	28720827	0	O
down	28720827	0	O
-	28720827	0	O
regulation	28720827	0	O
of	28720827	0	O
p53	28720827	0	O
rescued	28720827	0	O
necrosis	28720827	0	O
.	28720827	0	O
In	28720827	0	O
the	28720827	0	O
SH	28720827	0	O
-	28720827	0	O
SY5Y	28720827	0	O
human	28720827	0	O
cells	28720827	0	O
,	28720827	0	O
tunicamycin	28720827	0	O
(	28720827	0	O
TM	28720827	0	O
)	28720827	0	O
,	28720827	0	O
a	28720827	0	O
PERK	28720827	0	O
activator	28720827	0	O
,	28720827	0	O
promoted	28720827	0	O
transcription	28720827	0	O
of	28720827	0	O
hsp27	28720827	0	O
;	28720827	0	O
and	28720827	0	O
necrosis	28720827	0	O
induced	28720827	0	O
by	28720827	0	O
glutamate	28720827	0	O
could	28720827	0	O
be	28720827	0	O
rescued	28720827	0	O
by	28720827	0	O
TM	28720827	0	O
,	28720827	0	O
associated	28720827	0	O
with	28720827	0	O
reduced	28720827	0	O
p53	28720827	0	O
accumulation	28720827	0	O
.	28720827	0	O
In	28720827	0	O
an	28720827	0	O
ischemic	28720827	0	O
stroke	28720827	0	O
model	28720827	0	O
in	28720827	0	O
rats	28720827	0	O
,	28720827	0	O
p53	28720827	0	O
protein	28720827	0	O
was	28720827	0	O
also	28720827	0	O
increased	28720827	0	O
,	28720827	0	O
and	28720827	0	O
TM	28720827	0	O
treatment	28720827	0	O
could	28720827	0	O
reduce	28720827	0	O
the	28720827	0	O
p53	28720827	0	O
accumulation	28720827	0	O
and	28720827	0	O
brain	28720827	0	O
damage	28720827	0	O
.	28720827	0	O

In	28723893	0	O
vivo	28723893	0	O
CRISPR	28723893	0	O
screening	28723893	0	O
identifies	28723893	0	O
Ptpn2	28723893	0	O
as	28723893	0	O
a	28723893	0	O
cancer	28723893	0	O
immunotherapy	28723893	0	O
target	28723893	0	O
.	28723893	0	O
Immunotherapy	28723893	0	O
with	28723893	0	O
PD-1	28723893	0	O
checkpoint	28723893	0	O
blockade	28723893	0	O
is	28723893	0	O
effective	28723893	0	O
in	28723893	0	O
only	28723893	0	O
a	28723893	0	O
minority	28723893	0	O
of	28723893	0	O
patients	28723893	0	O
with	28723893	0	O
cancer	28723893	0	O
,	28723893	0	O
suggesting	28723893	0	O
that	28723893	0	O
additional	28723893	0	O
treatment	28723893	0	O
strategies	28723893	0	O
are	28723893	0	O
needed	28723893	0	O
.	28723893	0	O
Here	28723893	0	O
we	28723893	0	O
use	28723893	0	O
a	28723893	0	O
pooled	28723893	0	O
in	28723893	0	O
vivo	28723893	0	O
genetic	28723893	0	O
screening	28723893	0	O
approach	28723893	0	O
using	28723893	0	O
CRISPR	28723893	0	O
-	28723893	0	O
Cas9	28723893	0	O
genome	28723893	0	O
editing	28723893	0	O
in	28723893	0	O
transplantable	28723893	0	O
tumours	28723893	0	O
in	28723893	0	O
mice	28723893	0	O
treated	28723893	0	O
with	28723893	0	O
immunotherapy	28723893	0	O
to	28723893	0	O
discover	28723893	0	O
previously	28723893	0	O
undescribed	28723893	0	O
immunotherapy	28723893	0	O
targets	28723893	0	O
.	28723893	0	O
We	28723893	0	O
tested	28723893	0	O
2	28723893	0	O
,	28723893	0	O
368	28723893	0	O
genes	28723893	0	O
expressed	28723893	0	O
by	28723893	0	O
melanoma	28723893	0	O
cells	28723893	0	O
to	28723893	0	O
identify	28723893	0	O
those	28723893	0	O
that	28723893	0	O
synergize	28723893	0	O
with	28723893	0	O
or	28723893	0	O
cause	28723893	0	O
resistance	28723893	0	O
to	28723893	0	O
checkpoint	28723893	0	O
blockade	28723893	0	O
.	28723893	0	O
We	28723893	0	O
recovered	28723893	0	O
the	28723893	0	O
known	28723893	0	O
immune	28723893	0	O
evasion	28723893	0	O
molecules	28723893	0	O
PD	28723893	0	O
-	28723893	0	O
L1	28723893	0	O
and	28723893	0	O
CD47	28723893	0	O
,	28723893	0	O
and	28723893	0	O
confirmed	28723893	0	O
that	28723893	0	O
defects	28723893	0	O
in	28723893	0	O
interferon	28723893	0	O
-	28723893	0	O
γ	28723893	0	O
signalling	28723893	0	O
caused	28723893	0	O
resistance	28723893	0	O
to	28723893	0	O
immunotherapy	28723893	0	O
.	28723893	0	O
Tumours	28723893	0	O
were	28723893	0	O
sensitized	28723893	0	O
to	28723893	0	O
immunotherapy	28723893	0	O
by	28723893	0	O
deletion	28723893	0	O
of	28723893	0	O
genes	28723893	0	O
involved	28723893	0	O
in	28723893	0	O
several	28723893	0	O
diverse	28723893	0	O
pathways	28723893	0	O
,	28723893	0	O
including	28723893	0	O
NF	28723893	0	O
-	28723893	0	O
κB	28723893	0	O
signalling	28723893	0	O
,	28723893	0	O
antigen	28723893	0	O
presentation	28723893	0	O
and	28723893	0	O
the	28723893	0	O
unfolded	28723893	0	O
protein	28723893	0	O
response	28723893	0	O
.	28723893	0	O
In	28723893	0	O
addition	28723893	0	O
,	28723893	0	O
deletion	28723893	0	B-Var
of	28723893	0	O
the	28723893	0	O
protein	28723893	0	O
tyrosine	28723893	0	O
phosphatase	28723893	0	O
PTPN2	28723893	0	B-Gene
in	28723893	0	O
tumour	28723893	0	O
cells	28723893	0	O
increased	28723893	0	B-PosReg
the	28723893	0	O
efficacy	28723893	0	B-CPA
of	28723893	0	I-CPA
immunotherapy	28723893	0	I-CPA
by	28723893	0	O
enhancing	28723893	0	B-PosReg
interferon	28723893	0	B-MPA
-	28723893	0	I-MPA
γ	28723893	0	I-MPA
-	28723893	0	I-MPA
mediated	28723893	0	I-MPA
effects	28723893	0	I-MPA
on	28723893	0	I-MPA
antigen	28723893	0	I-MPA
presentation	28723893	0	I-MPA
and	28723893	0	O
growth	28723893	0	B-CPA
suppression	28723893	0	I-CPA
.	28723893	0	O
In	28723893	0	O
vivo	28723893	0	O
genetic	28723893	0	O
screens	28723893	0	O
in	28723893	0	O
tumour	28723893	0	O
models	28723893	0	O
can	28723893	0	O
identify	28723893	0	O
new	28723893	0	O
immunotherapy	28723893	0	O
targets	28723893	0	O
in	28723893	0	O
unanticipated	28723893	0	O
pathways	28723893	0	O
.	28723893	0	O

A	28726812	4	O
patient	28726812	4	O
with	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
gain	28726812	4	O
-	28726812	4	O
of	28726812	4	O
-	28726812	4	O
function	28726812	4	O
PDGFRB	28726812	4	O
p.N666H	28726812	4	O
mutation	28726812	4	O
and	28726812	4	O
marked	28726812	4	O
clinical	28726812	4	O
response	28726812	4	O
to	28726812	4	O
imatinib	28726812	4	O
.	28726812	4	O
PurposeHeterozygous	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
activating	28726812	4	O
mutations	28726812	4	B-Var
in	28726812	4	O
PDGFRB	28726812	4	B-Gene
cause	28726812	4	B-Reg
Kosaki	28726812	4	B-Disease
and	28726812	4	I-Disease
Penttinen	28726812	4	I-Disease
syndromes	28726812	4	I-Disease
and	28726812	4	O
myofibromatosis	28726812	4	B-Disease
.	28726812	4	O
We	28726812	4	O
describe	28726812	4	O
a	28726812	4	O
10	28726812	4	O
-	28726812	4	O
year	28726812	4	O
-	28726812	4	O
old	28726812	4	O
child	28726812	4	O
with	28726812	4	O
a	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
PDGFRB	28726812	4	B-Gene
p.N666H	28726812	4	B-Var
mutation	28726812	4	O
who	28726812	4	O
responded	28726812	4	B-MPA
to	28726812	4	I-MPA
the	28726812	4	I-MPA
tyrosine	28726812	4	I-MPA
kinase	28726812	4	I-MPA
inhibitor	28726812	4	I-MPA
imatinib	28726812	4	I-MPA
by	28726812	4	O
inhibition	28726812	4	B-NegReg
of	28726812	4	O
PDGFRB	28726812	4	B-Gene
.	28726812	4	I-Gene
MethodsThe	28726812	4	I-Gene
impact	28726812	4	O
of	28726812	4	O
p.N666H	28726812	4	O
on	28726812	4	O
PDGFRB	28726812	4	O
function	28726812	4	O
and	28726812	4	O
sensitivity	28726812	4	O
to	28726812	4	O
imatinib	28726812	4	O
was	28726812	4	O
studied	28726812	4	O
in	28726812	4	O
cell	28726812	4	O
culture	28726812	4	O
.	28726812	4	O
ResultsCells	28726812	4	O
expressing	28726812	4	O
the	28726812	4	O
p.N666H	28726812	4	O
mutation	28726812	4	O
showed	28726812	4	O
constitutive	28726812	4	O
PDGFRB	28726812	4	O
tyrosine	28726812	4	O
phosphorylation	28726812	4	O
.	28726812	4	O
PDGF	28726812	4	O
-	28726812	4	O
independent	28726812	4	O
proliferation	28726812	4	O
was	28726812	4	O
abolished	28726812	4	O
by	28726812	4	O
imatinib	28726812	4	O
at	28726812	4	O
1	28726812	4	O
μM	28726812	4	O
concentration	28726812	4	O
.	28726812	4	O
Patient	28726812	4	O
fibroblasts	28726812	4	O
showed	28726812	4	O
constitutive	28726812	4	O
receptor	28726812	4	O
tyrosine	28726812	4	O
phosphorylation	28726812	4	O
that	28726812	4	O
was	28726812	4	O
also	28726812	4	O
abrogated	28726812	4	O
by	28726812	4	O
imatinib	28726812	4	O
with	28726812	4	O
reduced	28726812	4	O
proliferation	28726812	4	O
of	28726812	4	O
treated	28726812	4	O
cells	28726812	4	O
.	28726812	4	O
This	28726812	4	O
led	28726812	4	O
to	28726812	4	O
patient	28726812	4	O
treatment	28726812	4	O
with	28726812	4	O
imatinib	28726812	4	O
at	28726812	4	O
400	28726812	4	O
mg	28726812	4	O
daily	28726812	4	O
(	28726812	4	O
340	28726812	4	O
mg	28726812	4	O
/	28726812	4	O
m	28726812	4	O
(	28726812	4	O
2	28726812	4	O
)	28726812	4	O
)	28726812	4	O
for	28726812	4	O
a	28726812	4	O
year	28726812	4	O
with	28726812	4	O
objective	28726812	4	O
improvement	28726812	4	O
of	28726812	4	O
debilitating	28726812	4	O
hand	28726812	4	O
and	28726812	4	O
foot	28726812	4	O
contractures	28726812	4	O
,	28726812	4	O
reduced	28726812	4	O
facial	28726812	4	O
coarseness	28726812	4	O
,	28726812	4	O
and	28726812	4	O
significant	28726812	4	O
improvement	28726812	4	O
in	28726812	4	O
quality	28726812	4	O
of	28726812	4	O
life	28726812	4	O
.	28726812	4	O
New	28726812	4	O
small	28726812	4	O
subcutaneous	28726812	4	O
nodules	28726812	4	O
developed	28726812	4	O
,	28726812	4	O
but	28726812	4	O
remained	28726812	4	O
stable	28726812	4	O
.	28726812	4	O
Transient	28726812	4	O
leukopenia	28726812	4	O
,	28726812	4	O
neutropenia	28726812	4	O
,	28726812	4	O
and	28726812	4	O
fatigue	28726812	4	O
resolved	28726812	4	O
without	28726812	4	O
intervention	28726812	4	O
;	28726812	4	O
however	28726812	4	O
,	28726812	4	O
mildly	28726812	4	O
decreased	28726812	4	O
growth	28726812	4	O
velocity	28726812	4	O
resulted	28726812	4	O
in	28726812	4	O
reducing	28726812	4	O
imatinib	28726812	4	O
dose	28726812	4	O
to	28726812	4	O
200	28726812	4	O
mg	28726812	4	O
daily	28726812	4	O
(	28726812	4	O
170	28726812	4	O
mg	28726812	4	O
/	28726812	4	O
m	28726812	4	O
(	28726812	4	O
2	28726812	4	O
)	28726812	4	O
)	28726812	4	O
.	28726812	4	O
The	28726812	4	O
patient	28726812	4	O
continues	28726812	4	O
treatment	28726812	4	O
with	28726812	4	O
ongoing	28726812	4	O
clinical	28726812	4	O
response	28726812	4	O
.	28726812	4	O
ConclusionTo	28726812	4	O
our	28726812	4	O
knowledge	28726812	4	O
,	28726812	4	O
this	28726812	4	O
is	28726812	4	O
one	28726812	4	O
of	28726812	4	O
the	28726812	4	O
first	28726812	4	O
personalized	28726812	4	O
treatments	28726812	4	O
of	28726812	4	O
a	28726812	4	O
congenital	28726812	4	O
disorder	28726812	4	O
caused	28726812	4	O
by	28726812	4	O
a	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
PDGF	28726812	4	O
receptor	28726812	4	O
mutation	28726812	4	O
with	28726812	4	O
a	28726812	4	O
PDGFRB	28726812	4	O
inhibitor	28726812	4	O
.	28726812	4	O
GENETICS	28726812	4	O
in	28726812	4	O
MEDICINE	28726812	4	O
advance	28726812	4	O
online	28726812	4	O
publication	28726812	4	O
,	28726812	4	O
20	28726812	4	O
July	28726812	4	O
2017	28726812	4	O
;	28726812	4	O
doi	28726812	4	O
:	28726812	4	O
10.1038	28726812	4	O
/	28726812	4	O
gim.2017	28726812	4	O
.104	28726812	4	O
.	28726812	4	O

Genetic	28728825	3	O
Diseases	28728825	3	O
of	28728825	3	O
PIEZO1	28728825	3	O
and	28728825	3	O
PIEZO2	28728825	3	O
Dysfunction	28728825	3	O
.	28728825	3	O
Mutations	28728825	3	O
in	28728825	3	O
the	28728825	3	O
genes	28728825	3	O
encoding	28728825	3	O
the	28728825	3	O
mechanosensitive	28728825	3	O
cation	28728825	3	O
channels	28728825	3	O
PIEZO1	28728825	3	O
and	28728825	3	O
PIEZO2	28728825	3	O
are	28728825	3	O
responsible	28728825	3	O
for	28728825	3	O
multiple	28728825	3	O
hereditary	28728825	3	O
human	28728825	3	O
diseases	28728825	3	O
.	28728825	3	O
Loss	28728825	3	B-NegReg
-	28728825	3	I-NegReg
of	28728825	3	I-NegReg
-	28728825	3	I-NegReg
function	28728825	3	I-NegReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO1	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
autosomal	28728825	3	B-Disease
recessive	28728825	3	I-Disease
congenital	28728825	3	I-Disease
lymphatic	28728825	3	I-Disease
dysplasia	28728825	3	I-Disease
.	28728825	3	O
Gain	28728825	3	B-PosReg
-	28728825	3	I-PosReg
of	28728825	3	I-PosReg
-	28728825	3	I-PosReg
function	28728825	3	I-PosReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO1	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
the	28728825	3	O
autosomal	28728825	3	B-Disease
dominant	28728825	3	I-Disease
hemolytic	28728825	3	I-Disease
anemia	28728825	3	I-Disease
,	28728825	3	O
hereditary	28728825	3	B-Disease
xerocytosis	28728825	3	I-Disease
(	28728825	3	O
also	28728825	3	O
known	28728825	3	O
as	28728825	3	O
dehydrated	28728825	3	B-Disease
stomatocytosis	28728825	3	I-Disease
)	28728825	3	I-Disease
.	28728825	3	O
Loss	28728825	3	B-NegReg
-	28728825	3	I-NegReg
of	28728825	3	I-NegReg
-	28728825	3	I-NegReg
function	28728825	3	I-NegReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO2	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
an	28728825	3	O
autosomal	28728825	3	B-Disease
recessive	28728825	3	I-Disease
syndrome	28728825	3	I-Disease
of	28728825	3	I-Disease
muscular	28728825	3	I-Disease
atrophy	28728825	3	I-Disease
with	28728825	3	O
perinatal	28728825	3	O
respiratory	28728825	3	O
distress	28728825	3	O
,	28728825	3	O
arthrogryposis	28728825	3	B-Disease
,	28728825	3	O
and	28728825	3	O
scoliosis	28728825	3	B-Disease
.	28728825	3	O
Gain	28728825	3	B-PosReg
-	28728825	3	I-PosReg
of	28728825	3	I-PosReg
-	28728825	3	I-PosReg
function	28728825	3	I-PosReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO2	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
three	28728825	3	O
clinical	28728825	3	O
types	28728825	3	O
of	28728825	3	O
autosomal	28728825	3	B-Disease
dominant	28728825	3	I-Disease
distal	28728825	3	I-Disease
arthrogryposis	28728825	3	I-Disease
.	28728825	3	O
This	28728825	3	O
chapter	28728825	3	O
will	28728825	3	O
review	28728825	3	O
the	28728825	3	O
hereditary	28728825	3	O
diseases	28728825	3	O
caused	28728825	3	O
by	28728825	3	O
mutations	28728825	3	O
in	28728825	3	O
the	28728825	3	O
PIEZO	28728825	3	O
genes	28728825	3	O
and	28728825	3	O
will	28728825	3	O
discuss	28728825	3	O
additional	28728825	3	O
physiological	28728825	3	O
systems	28728825	3	O
in	28728825	3	O
which	28728825	3	O
PIEZO	28728825	3	O
channel	28728825	3	O
dysfunction	28728825	3	O
may	28728825	3	O
contribute	28728825	3	O
to	28728825	3	O
human	28728825	3	O
disease	28728825	3	O
pathophysiology	28728825	3	O
.	28728825	3	O

Differential	28734073	2	O
calcium	28734073	2	O
sensitivity	28734073	2	O
in	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
mixed	28734073	2	O
syndrome	28734073	2	O
mutants	28734073	2	O
.	28734073	2	O
KEY	28734073	2	O
POINTS	28734073	2	O
:	28734073	2	O
SCN5a	28734073	2	B-Gene
mutations	28734073	2	B-Var
may	28734073	2	O
express	28734073	2	O
gain	28734073	2	B-PosReg
-	28734073	2	I-PosReg
of	28734073	2	I-PosReg
-	28734073	2	I-PosReg
function	28734073	2	I-PosReg
(	28734073	2	B-Disease
Long	28734073	2	I-Disease
QT	28734073	2	I-Disease
Syndrome-3	28734073	2	I-Disease
)	28734073	2	I-Disease
,	28734073	2	O
loss	28734073	2	B-NegReg
-	28734073	2	I-NegReg
of	28734073	2	I-NegReg
-	28734073	2	I-NegReg
function	28734073	2	I-NegReg
(	28734073	2	B-Disease
Brugada	28734073	2	I-Disease
Syndrome	28734073	2	I-Disease
1	28734073	2	I-Disease
)	28734073	2	I-Disease
or	28734073	2	O
both	28734073	2	O
(	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
)	28734073	2	O
,	28734073	2	O
depending	28734073	2	O
on	28734073	2	O
the	28734073	2	O
mutation	28734073	2	O
and	28734073	2	O
environmental	28734073	2	O
triggers	28734073	2	O
.	28734073	2	O
One	28734073	2	O
such	28734073	2	O
trigger	28734073	2	O
may	28734073	2	O
be	28734073	2	O
an	28734073	2	O
increase	28734073	2	O
in	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
,	28734073	2	O
accompanying	28734073	2	O
exercise	28734073	2	O
.	28734073	2	O
Many	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
mutants	28734073	2	O
,	28734073	2	O
including	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
E1784K	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
are	28734073	2	O
found	28734073	2	O
in	28734073	2	O
calcium	28734073	2	O
-	28734073	2	O
sensitive	28734073	2	O
regions	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
attenuates	28734073	2	O
gain	28734073	2	O
-	28734073	2	O
of	28734073	2	O
-	28734073	2	O
function	28734073	2	O
properties	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
not	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
By	28734073	2	O
contrast	28734073	2	O
,	28734073	2	O
elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
further	28734073	2	O
exacerbates	28734073	2	O
gain	28734073	2	O
-	28734073	2	O
of	28734073	2	O
-	28734073	2	O
function	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
by	28734073	2	O
destabilizing	28734073	2	O
slow	28734073	2	O
inactivation	28734073	2	O
.	28734073	2	O
Action	28734073	2	O
potential	28734073	2	O
modelling	28734073	2	O
,	28734073	2	O
using	28734073	2	O
a	28734073	2	O
modified	28734073	2	O
O	28734073	2	O
'	28734073	2	O
Hara	28734073	2	O
Rudy	28734073	2	O
model	28734073	2	O
,	28734073	2	O
suggests	28734073	2	O
that	28734073	2	O
elevated	28734073	2	O
heart	28734073	2	O
rate	28734073	2	O
rescues	28734073	2	O
action	28734073	2	O
potential	28734073	2	O
duration	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
not	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
Action	28734073	2	O
potential	28734073	2	O
simulations	28734073	2	O
suggest	28734073	2	O
that	28734073	2	O
E1784K	28734073	2	O
carriers	28734073	2	O
have	28734073	2	O
an	28734073	2	O
increased	28734073	2	O
intracellular	28734073	2	O
sodium	28734073	2	O
-	28734073	2	O
to	28734073	2	O
-	28734073	2	O
calcium	28734073	2	O
ratio	28734073	2	O
under	28734073	2	O
bradycardia	28734073	2	O
and	28734073	2	O
tachycardia	28734073	2	O
conditions	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
,	28734073	2	O
which	28734073	2	O
is	28734073	2	O
common	28734073	2	O
during	28734073	2	O
high	28734073	2	O
heart	28734073	2	O
rates	28734073	2	O
,	28734073	2	O
ameliorates	28734073	2	O
or	28734073	2	O
exacerbates	28734073	2	O
the	28734073	2	O
mixed	28734073	2	O
syndrome	28734073	2	O
phenotype	28734073	2	O
depending	28734073	2	O
on	28734073	2	O
the	28734073	2	O
genetic	28734073	2	O
signature	28734073	2	O
.	28734073	2	O
ABSTRACT	28734073	2	O
:	28734073	2	O
Inherited	28734073	2	O
arrhythmias	28734073	2	O
may	28734073	2	O
arise	28734073	2	O
from	28734073	2	O
mutations	28734073	2	O
in	28734073	2	O
the	28734073	2	O
gene	28734073	2	O
for	28734073	2	O
SCN5a	28734073	2	O
,	28734073	2	O
which	28734073	2	O
encodes	28734073	2	O
the	28734073	2	O
cardiac	28734073	2	O
voltage	28734073	2	O
-	28734073	2	O
gated	28734073	2	O
sodium	28734073	2	O
channel	28734073	2	O
,	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
.	28734073	2	O
Mutants	28734073	2	O
in	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
result	28734073	2	O
in	28734073	2	O
Brugada	28734073	2	O
Syndrome	28734073	2	O
(	28734073	2	O
BrS1	28734073	2	O
)	28734073	2	O
,	28734073	2	O
Long	28734073	2	O
-	28734073	2	O
QT	28734073	2	O
Syndrome	28734073	2	O
(	28734073	2	O
LQT3	28734073	2	O
)	28734073	2	O
or	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
(	28734073	2	O
an	28734073	2	O
overlap	28734073	2	O
of	28734073	2	O
BrS1	28734073	2	O
/	28734073	2	O
LQT3	28734073	2	O
)	28734073	2	O
.	28734073	2	O
Exercise	28734073	2	O
is	28734073	2	O
a	28734073	2	O
potential	28734073	2	O
arrhythmogenic	28734073	2	O
trigger	28734073	2	O
in	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
.	28734073	2	O
We	28734073	2	O
aimed	28734073	2	O
to	28734073	2	O
determine	28734073	2	O
the	28734073	2	O
effects	28734073	2	O
of	28734073	2	O
elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
,	28734073	2	O
which	28734073	2	O
is	28734073	2	O
common	28734073	2	O
during	28734073	2	O
exercise	28734073	2	O
,	28734073	2	O
in	28734073	2	O
mixed	28734073	2	O
syndrome	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
mutants	28734073	2	O
.	28734073	2	O
We	28734073	2	O
used	28734073	2	O
whole	28734073	2	O
-	28734073	2	O
cell	28734073	2	O
patch	28734073	2	O
clamp	28734073	2	O
to	28734073	2	O
assess	28734073	2	O
the	28734073	2	O
biophysical	28734073	2	O
properties	28734073	2	O
of	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
wild	28734073	2	O
-	28734073	2	O
type	28734073	2	O
(	28734073	2	O
WT	28734073	2	O
)	28734073	2	O
,	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
E1784K	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
mutants	28734073	2	O
in	28734073	2	O
human	28734073	2	O
embryonic	28734073	2	O
kidney	28734073	2	O
293	28734073	2	O
cells	28734073	2	O
transiently	28734073	2	O
transfected	28734073	2	O
with	28734073	2	O
the	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
α	28734073	2	O
subunit	28734073	2	O
(	28734073	2	O
WT	28734073	2	O
or	28734073	2	O
mutants	28734073	2	O
)	28734073	2	O
,	28734073	2	O
β1	28734073	2	O
subunit	28734073	2	O
and	28734073	2	O
enhanced	28734073	2	O
green	28734073	2	O
fluorescent	28734073	2	O
protein	28734073	2	O
.	28734073	2	O
Voltage	28734073	2	O
-	28734073	2	O
dependence	28734073	2	O
and	28734073	2	O
kinetics	28734073	2	O
were	28734073	2	O
measured	28734073	2	O
at	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
levels	28734073	2	O
of	28734073	2	O
approximately	28734073	2	O
0	28734073	2	O
,	28734073	2	O
500	28734073	2	O
and	28734073	2	O
2500	28734073	2	O
nm	28734073	2	O
.	28734073	2	O
In	28734073	2	O
silico	28734073	2	O
,	28734073	2	O
action	28734073	2	O
potential	28734073	2	O
(	28734073	2	O
AP	28734073	2	O
)	28734073	2	O
model	28734073	2	O
simulations	28734073	2	O
were	28734073	2	O
performed	28734073	2	O
using	28734073	2	O
a	28734073	2	O
modified	28734073	2	O
O	28734073	2	O
'	28734073	2	O
Hara	28734073	2	O
Rudy	28734073	2	O
model	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
attenuates	28734073	2	O
the	28734073	2	O
late	28734073	2	O
sodium	28734073	2	O
current	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
not	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
restores	28734073	2	O
steady	28734073	2	O
-	28734073	2	O
state	28734073	2	O
slow	28734073	2	O
inactivation	28734073	2	O
(	28734073	2	O
SSSI	28734073	2	O
)	28734073	2	O
to	28734073	2	O
the	28734073	2	O
WT	28734073	2	O
-	28734073	2	O
form	28734073	2	O
in	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
depolarized	28734073	2	O
SSSI	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
Our	28734073	2	O
AP	28734073	2	O
simulations	28734073	2	O
showed	28734073	2	O
a	28734073	2	O
frequency	28734073	2	O
-	28734073	2	O
dependent	28734073	2	O
reduction	28734073	2	O
of	28734073	2	O
AP	28734073	2	O
duration	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
carriers	28734073	2	O
.	28734073	2	O
In	28734073	2	O
E1784K	28734073	2	O
,	28734073	2	O
AP	28734073	2	O
duration	28734073	2	O
is	28734073	2	O
relatively	28734073	2	O
prolonged	28734073	2	O
at	28734073	2	O
both	28734073	2	O
low	28734073	2	O
and	28734073	2	O
high	28734073	2	O
heart	28734073	2	O
rates	28734073	2	O
,	28734073	2	O
resulting	28734073	2	O
in	28734073	2	O
a	28734073	2	O
sodium	28734073	2	O
overload	28734073	2	O
.	28734073	2	O
Cellular	28734073	2	O
perturbations	28734073	2	O
during	28734073	2	O
exercise	28734073	2	O
may	28734073	2	O
affect	28734073	2	O
BrS1	28734073	2	O
/	28734073	2	O
LQT3	28734073	2	O
patients	28734073	2	O
differently	28734073	2	O
depending	28734073	2	O
on	28734073	2	O
their	28734073	2	O
individual	28734073	2	O
genetic	28734073	2	O
signature	28734073	2	O
.	28734073	2	O
Thus	28734073	2	O
,	28734073	2	O
exercise	28734073	2	O
may	28734073	2	O
be	28734073	2	O
therapeutic	28734073	2	O
or	28734073	2	O
may	28734073	2	O
be	28734073	2	O
an	28734073	2	O
arrhythmogenic	28734073	2	O
trigger	28734073	2	O
in	28734073	2	O
some	28734073	2	O
SCN5a	28734073	2	O
patients	28734073	2	O
.	28734073	2	O

D242N	28739325	3	O
,	28739325	3	O
a	28739325	3	O
KV7.1	28739325	3	O
LQTS	28739325	3	O
mutation	28739325	3	O
uncovers	28739325	3	O
a	28739325	3	O
key	28739325	3	O
residue	28739325	3	O
for	28739325	3	O
IKs	28739325	3	O
voltage	28739325	3	O
dependence	28739325	3	O
.	28739325	3	O
KV7.1	28739325	3	O
and	28739325	3	O
KCNE1	28739325	3	O
co	28739325	3	O
-	28739325	3	O
assemble	28739325	3	O
to	28739325	3	O
give	28739325	3	O
rise	28739325	3	O
to	28739325	3	O
the	28739325	3	O
IKs	28739325	3	O
current	28739325	3	O
,	28739325	3	O
one	28739325	3	O
of	28739325	3	O
the	28739325	3	O
most	28739325	3	O
important	28739325	3	O
repolarizing	28739325	3	O
currents	28739325	3	O
of	28739325	3	O
the	28739325	3	O
cardiac	28739325	3	O
action	28739325	3	O
potential	28739325	3	O
.	28739325	3	O
Its	28739325	3	O
relevance	28739325	3	O
is	28739325	3	O
underscored	28739325	3	O
by	28739325	3	O
the	28739325	3	O
identification	28739325	3	O
of	28739325	3	O
>	28739325	3	O
500	28739325	3	O
mutations	28739325	3	B-Var
in	28739325	3	O
KV7.1	28739325	3	B-Gene
and	28739325	3	O
,	28739325	3	O
at	28739325	3	O
least	28739325	3	O
,	28739325	3	O
36	28739325	3	O
in	28739325	3	O
KCNE1	28739325	3	B-Gene
,	28739325	3	O
that	28739325	3	O
cause	28739325	3	B-Reg
Long	28739325	3	B-Disease
QT	28739325	3	I-Disease
Syndrome	28739325	3	I-Disease
(	28739325	3	O
LQTS	28739325	3	O
)	28739325	3	O
.	28739325	3	O
The	28739325	3	O
aim	28739325	3	O
of	28739325	3	O
this	28739325	3	O
study	28739325	3	O
was	28739325	3	O
to	28739325	3	O
characterize	28739325	3	O
the	28739325	3	O
biophysical	28739325	3	O
and	28739325	3	O
cellular	28739325	3	O
consequences	28739325	3	O
of	28739325	3	O
the	28739325	3	O
D242N	28739325	3	B-Var
KV7.1	28739325	3	B-Gene
mutation	28739325	3	O
associated	28739325	3	B-Reg
with	28739325	3	O
the	28739325	3	O
LQTS	28739325	3	B-Disease
.	28739325	3	O
The	28739325	3	O
mutation	28739325	3	B-Var
is	28739325	3	O
located	28739325	3	O
in	28739325	3	O
the	28739325	3	O
S4	28739325	3	O
transmembrane	28739325	3	O
segment	28739325	3	O
,	28739325	3	O
within	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
sensor	28739325	3	O
of	28739325	3	O
the	28739325	3	O
KV7.1	28739325	3	O
channel	28739325	3	O
,	28739325	3	O
disrupting	28739325	3	B-NegReg
the	28739325	3	O
conserved	28739325	3	B-MPA
charge	28739325	3	I-MPA
balance	28739325	3	I-MPA
of	28739325	3	I-MPA
this	28739325	3	I-MPA
region	28739325	3	I-MPA
.	28739325	3	O
Perforated	28739325	3	O
patch	28739325	3	O
-	28739325	3	O
clamp	28739325	3	O
experiments	28739325	3	O
show	28739325	3	O
that	28739325	3	O
,	28739325	3	O
unexpectedly	28739325	3	O
,	28739325	3	O
the	28739325	3	O
mutation	28739325	3	B-Var
did	28739325	3	O
not	28739325	3	O
disrupt	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
-	28739325	3	O
dependent	28739325	3	O
activation	28739325	3	O
but	28739325	3	O
it	28739325	3	O
removed	28739325	3	B-NegReg
the	28739325	3	O
inactivation	28739325	3	B-MPA
and	28739325	3	O
slowed	28739325	3	B-NegReg
the	28739325	3	O
activation	28739325	3	B-MPA
kinetics	28739325	3	I-MPA
of	28739325	3	O
D242N	28739325	3	B-MPA
KV7.1	28739325	3	I-MPA
channels	28739325	3	I-MPA
.	28739325	3	O
Biotinylation	28739325	3	O
of	28739325	3	O
cell	28739325	3	O
-	28739325	3	O
surface	28739325	3	O
protein	28739325	3	O
and	28739325	3	O
co	28739325	3	O
-	28739325	3	O
immunoprecipitation	28739325	3	O
experiments	28739325	3	O
revealed	28739325	3	O
that	28739325	3	O
neither	28739325	3	O
plasma	28739325	3	O
membrane	28739325	3	O
targeting	28739325	3	O
nor	28739325	3	O
co	28739325	3	O
-	28739325	3	O
assembly	28739325	3	O
between	28739325	3	O
KV7.1	28739325	3	O
and	28739325	3	O
KCNE1	28739325	3	O
was	28739325	3	O
altered	28739325	3	O
by	28739325	3	O
the	28739325	3	O
mutation	28739325	3	O
.	28739325	3	O
However	28739325	3	O
,	28739325	3	O
the	28739325	3	O
association	28739325	3	O
of	28739325	3	O
D242N	28739325	3	O
KV7.1	28739325	3	O
with	28739325	3	O
KCNE1	28739325	3	O
strongly	28739325	3	O
shifted	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
dependence	28739325	3	O
of	28739325	3	O
activation	28739325	3	O
to	28739325	3	O
more	28739325	3	O
depolarized	28739325	3	O
potentials	28739325	3	O
(	28739325	3	O
50	28739325	3	O
mV	28739325	3	O
)	28739325	3	O
,	28739325	3	O
hindering	28739325	3	O
IKs	28739325	3	O
current	28739325	3	O
at	28739325	3	O
physiologically	28739325	3	O
relevant	28739325	3	O
membrane	28739325	3	O
potentials	28739325	3	O
.	28739325	3	O
Both	28739325	3	O
functional	28739325	3	O
and	28739325	3	O
computational	28739325	3	O
analysis	28739325	3	O
suggest	28739325	3	O
that	28739325	3	O
the	28739325	3	O
clinical	28739325	3	O
phenotype	28739325	3	O
of	28739325	3	O
the	28739325	3	O
LQTS	28739325	3	O
patients	28739325	3	O
carrying	28739325	3	O
the	28739325	3	O
D242N	28739325	3	B-Var
mutation	28739325	3	O
is	28739325	3	O
due	28739325	3	O
to	28739325	3	O
impaired	28739325	3	B-NegReg
action	28739325	3	B-MPA
potential	28739325	3	I-MPA
adaptation	28739325	3	I-MPA
to	28739325	3	I-MPA
exercise	28739325	3	I-MPA
and	28739325	3	O
,	28739325	3	O
in	28739325	3	O
particular	28739325	3	O
,	28739325	3	O
to	28739325	3	O
increase	28739325	3	B-PosReg
in	28739325	3	O
heart	28739325	3	B-MPA
rate	28739325	3	I-MPA
.	28739325	3	O
Moreover	28739325	3	O
,	28739325	3	O
our	28739325	3	O
data	28739325	3	O
identify	28739325	3	O
D242	28739325	3	O
aminoacidic	28739325	3	O
position	28739325	3	O
as	28739325	3	O
a	28739325	3	O
potential	28739325	3	O
residue	28739325	3	O
involved	28739325	3	O
in	28739325	3	O
the	28739325	3	O
KCNE1	28739325	3	O
-	28739325	3	O
mediated	28739325	3	O
regulation	28739325	3	O
of	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
dependence	28739325	3	O
of	28739325	3	O
activation	28739325	3	O
of	28739325	3	O
the	28739325	3	O
KV7.1	28739325	3	O
channel	28739325	3	O
.	28739325	3	O

A	28739660	0	O
Gene	28739660	0	O
Implicated	28739660	0	O
in	28739660	0	O
Activation	28739660	0	O
of	28739660	0	O
Retinoic	28739660	0	O
Acid	28739660	0	O
Receptor	28739660	0	O
Targets	28739660	0	O
is	28739660	0	O
a	28739660	0	O
Novel	28739660	0	O
Renal	28739660	0	O
Agenesis	28739660	0	O
Gene	28739660	0	O
in	28739660	0	O
Humans	28739660	0	O
.	28739660	0	O
Renal	28739660	0	B-Disease
agenesis	28739660	0	I-Disease
(	28739660	0	O
RA	28739660	0	O
)	28739660	0	O
is	28739660	0	O
one	28739660	0	O
of	28739660	0	O
the	28739660	0	O
more	28739660	0	O
extreme	28739660	0	O
examples	28739660	0	O
of	28739660	0	O
congenital	28739660	0	O
anomalies	28739660	0	O
of	28739660	0	O
the	28739660	0	O
kidney	28739660	0	O
and	28739660	0	O
urinary	28739660	0	O
tract	28739660	0	O
(	28739660	0	O
CAKUT	28739660	0	O
)	28739660	0	O
.	28739660	0	O
Bilateral	28739660	0	O
renal	28739660	0	O
agenesis	28739660	0	O
is	28739660	0	O
almost	28739660	0	O
invariably	28739660	0	O
fatal	28739660	0	O
at	28739660	0	O
birth	28739660	0	O
,	28739660	0	O
and	28739660	0	O
unilateral	28739660	0	O
renal	28739660	0	O
agenesis	28739660	0	O
can	28739660	0	O
lead	28739660	0	O
to	28739660	0	O
future	28739660	0	O
health	28739660	0	O
issues	28739660	0	O
including	28739660	0	O
end	28739660	0	O
stage	28739660	0	O
renal	28739660	0	O
disease	28739660	0	O
.	28739660	0	O
Genetic	28739660	0	O
investigations	28739660	0	O
have	28739660	0	O
identified	28739660	0	O
several	28739660	0	O
gene	28739660	0	O
variants	28739660	0	B-Var
which	28739660	0	O
cause	28739660	0	B-Reg
RA	28739660	0	B-Disease
,	28739660	0	O
including	28739660	0	O
EYA1	28739660	0	O
,	28739660	0	O
LHX1	28739660	0	O
,	28739660	0	O
and	28739660	0	O
WT1	28739660	0	O
However	28739660	0	O
,	28739660	0	O
whereas	28739660	0	O
compound	28739660	0	O
null	28739660	0	O
mutations	28739660	0	O
of	28739660	0	O
genes	28739660	0	O
encoding	28739660	0	O
α	28739660	0	O
and	28739660	0	O
γ	28739660	0	O
retinoic	28739660	0	O
acid	28739660	0	O
receptors	28739660	0	O
(	28739660	0	O
RARs	28739660	0	O
)	28739660	0	O
cause	28739660	0	O
RA	28739660	0	O
in	28739660	0	O
mice	28739660	0	O
,	28739660	0	O
to	28739660	0	O
date	28739660	0	O
there	28739660	0	O
have	28739660	0	O
been	28739660	0	O
no	28739660	0	O
reports	28739660	0	O
of	28739660	0	O
variants	28739660	0	O
in	28739660	0	O
RAR	28739660	0	O
genes	28739660	0	O
causing	28739660	0	O
RA	28739660	0	O
in	28739660	0	O
humans	28739660	0	O
.	28739660	0	O
In	28739660	0	O
this	28739660	0	O
study	28739660	0	O
,	28739660	0	O
we	28739660	0	O
carried	28739660	0	O
out	28739660	0	O
whole	28739660	0	O
exome	28739660	0	O
sequence	28739660	0	O
analysis	28739660	0	O
of	28739660	0	O
two	28739660	0	O
families	28739660	0	O
showing	28739660	0	O
inheritance	28739660	0	O
of	28739660	0	O
an	28739660	0	O
RA	28739660	0	O
phenotype	28739660	0	O
,	28739660	0	O
and	28739660	0	O
in	28739660	0	O
both	28739660	0	O
identified	28739660	0	O
a	28739660	0	O
single	28739660	0	O
candidate	28739660	0	O
gene	28739660	0	O
,	28739660	0	O
GREB1L	28739660	0	O
Analysis	28739660	0	O
of	28739660	0	O
a	28739660	0	O
zebrafish	28739660	0	O
greb1l	28739660	0	O
loss	28739660	0	B-NegReg
-	28739660	0	I-NegReg
of	28739660	0	I-NegReg
-	28739660	0	I-NegReg
function	28739660	0	I-NegReg
mutant	28739660	0	B-Var
revealed	28739660	0	O
defects	28739660	0	O
in	28739660	0	O
the	28739660	0	O
pronephric	28739660	0	B-MPA
kidney	28739660	0	I-MPA
just	28739660	0	I-MPA
prior	28739660	0	I-MPA
to	28739660	0	I-MPA
death	28739660	0	I-MPA
,	28739660	0	O
and	28739660	0	O
F0	28739660	0	O
CRISPR	28739660	0	O
/	28739660	0	O
Cas9	28739660	0	O
mutagenesis	28739660	0	B-Var
of	28739660	0	O
Greb1l	28739660	0	O
in	28739660	0	O
the	28739660	0	O
mouse	28739660	0	O
revealed	28739660	0	B-Reg
kidney	28739660	0	B-MPA
agenesis	28739660	0	I-MPA
phenotypes	28739660	0	I-MPA
,	28739660	0	O
implicating	28739660	0	O
Greb1l	28739660	0	O
in	28739660	0	O
this	28739660	0	O
disorder	28739660	0	O
.	28739660	0	O
GREB1L	28739660	0	O
resides	28739660	0	O
in	28739660	0	O
a	28739660	0	O
chromatin	28739660	0	O
complex	28739660	0	O
with	28739660	0	O
RAR	28739660	0	O
members	28739660	0	O
,	28739660	0	O
and	28739660	0	O
our	28739660	0	O
data	28739660	0	O
implicate	28739660	0	O
GREB1L	28739660	0	O
as	28739660	0	O
a	28739660	0	O
coactivator	28739660	0	O
for	28739660	0	O
RARs	28739660	0	O
.	28739660	0	O
This	28739660	0	O
study	28739660	0	O
is	28739660	0	O
the	28739660	0	O
first	28739660	0	O
to	28739660	0	O
associate	28739660	0	O
a	28739660	0	O
component	28739660	0	O
of	28739660	0	O
the	28739660	0	O
RAR	28739660	0	O
pathway	28739660	0	O
with	28739660	0	O
renal	28739660	0	O
agenesis	28739660	0	O
in	28739660	0	O
humans	28739660	0	O
.	28739660	0	O

Equivalent	28741757	4	O
missense	28741757	4	B-Var
variant	28741757	4	I-Var
in	28741757	4	O
the	28741757	4	O
FOXP2	28741757	4	B-Gene
and	28741757	4	O
FOXP1	28741757	4	B-Gene
transcription	28741757	4	O
factors	28741757	4	O
causes	28741757	4	B-Reg
distinct	28741757	4	O
neurodevelopmental	28741757	4	B-Disease
disorders	28741757	4	I-Disease
.	28741757	4	O
The	28741757	4	O
closely	28741757	4	O
related	28741757	4	O
paralogues	28741757	4	O
FOXP2	28741757	4	O
and	28741757	4	O
FOXP1	28741757	4	O
encode	28741757	4	O
transcription	28741757	4	O
factors	28741757	4	O
with	28741757	4	O
shared	28741757	4	O
functions	28741757	4	O
in	28741757	4	O
the	28741757	4	O
development	28741757	4	O
of	28741757	4	O
many	28741757	4	O
tissues	28741757	4	O
,	28741757	4	O
including	28741757	4	O
the	28741757	4	O
brain	28741757	4	O
.	28741757	4	O
However	28741757	4	O
,	28741757	4	O
while	28741757	4	O
mutations	28741757	4	B-Var
in	28741757	4	O
FOXP2	28741757	4	B-Gene
lead	28741757	4	B-Reg
to	28741757	4	I-Reg
a	28741757	4	O
speech	28741757	4	O
/	28741757	4	O
language	28741757	4	O
disorder	28741757	4	O
characterized	28741757	4	O
by	28741757	4	O
childhood	28741757	4	B-Disease
apraxia	28741757	4	I-Disease
of	28741757	4	I-Disease
speech	28741757	4	I-Disease
(	28741757	4	O
CAS	28741757	4	O
)	28741757	4	O
,	28741757	4	O
the	28741757	4	O
clinical	28741757	4	O
profile	28741757	4	O
of	28741757	4	O
FOXP1	28741757	4	B-Gene
variants	28741757	4	B-Var
includes	28741757	4	B-Reg
a	28741757	4	O
broader	28741757	4	O
neurodevelopmental	28741757	4	O
phenotype	28741757	4	O
with	28741757	4	O
global	28741757	4	B-Disease
developmental	28741757	4	I-Disease
delay	28741757	4	I-Disease
,	28741757	4	O
intellectual	28741757	4	B-Disease
disability	28741757	4	I-Disease
,	28741757	4	O
and	28741757	4	O
speech	28741757	4	B-Disease
/	28741757	4	I-Disease
language	28741757	4	I-Disease
impairment	28741757	4	I-Disease
.	28741757	4	O
Using	28741757	4	O
clinical	28741757	4	O
whole	28741757	4	O
-	28741757	4	O
exome	28741757	4	O
sequencing	28741757	4	O
,	28741757	4	O
we	28741757	4	O
report	28741757	4	O
an	28741757	4	O
identical	28741757	4	O
de	28741757	4	O
novo	28741757	4	O
missense	28741757	4	O
FOXP1	28741757	4	O
variant	28741757	4	O
identified	28741757	4	O
in	28741757	4	O
three	28741757	4	O
unrelated	28741757	4	O
patients	28741757	4	O
.	28741757	4	O
The	28741757	4	O
variant	28741757	4	O
,	28741757	4	O
p.R514H	28741757	4	O
,	28741757	4	O
is	28741757	4	O
located	28741757	4	O
in	28741757	4	O
the	28741757	4	O
forkhead	28741757	4	O
-	28741757	4	O
box	28741757	4	O
DNA	28741757	4	O
-	28741757	4	O
binding	28741757	4	O
domain	28741757	4	O
and	28741757	4	O
is	28741757	4	O
equivalent	28741757	4	O
to	28741757	4	O
the	28741757	4	O
well	28741757	4	O
-	28741757	4	O
studied	28741757	4	O
p.R553H	28741757	4	O
FOXP2	28741757	4	O
variant	28741757	4	O
that	28741757	4	O
cosegregates	28741757	4	O
with	28741757	4	O
CAS	28741757	4	O
in	28741757	4	O
a	28741757	4	O
large	28741757	4	O
UK	28741757	4	O
family	28741757	4	O
.	28741757	4	O
We	28741757	4	O
present	28741757	4	O
here	28741757	4	O
for	28741757	4	O
the	28741757	4	O
first	28741757	4	O
time	28741757	4	O
a	28741757	4	O
direct	28741757	4	O
comparison	28741757	4	O
of	28741757	4	O
the	28741757	4	O
molecular	28741757	4	O
and	28741757	4	O
clinical	28741757	4	O
consequences	28741757	4	O
of	28741757	4	O
the	28741757	4	O
same	28741757	4	O
mutation	28741757	4	O
affecting	28741757	4	O
the	28741757	4	O
equivalent	28741757	4	O
residue	28741757	4	O
in	28741757	4	O
FOXP1	28741757	4	O
and	28741757	4	O
FOXP2	28741757	4	O
.	28741757	4	O
Detailed	28741757	4	O
functional	28741757	4	O
characterization	28741757	4	O
of	28741757	4	O
the	28741757	4	O
two	28741757	4	O
variants	28741757	4	O
in	28741757	4	O
cell	28741757	4	O
model	28741757	4	O
systems	28741757	4	O
revealed	28741757	4	O
very	28741757	4	O
similar	28741757	4	O
molecular	28741757	4	O
consequences	28741757	4	O
,	28741757	4	O
including	28741757	4	O
aberrant	28741757	4	O
subcellular	28741757	4	O
localization	28741757	4	O
,	28741757	4	O
disruption	28741757	4	O
of	28741757	4	O
transcription	28741757	4	O
factor	28741757	4	O
activity	28741757	4	O
,	28741757	4	O
and	28741757	4	O
deleterious	28741757	4	O
effects	28741757	4	O
on	28741757	4	O
protein	28741757	4	O
interactions	28741757	4	O
.	28741757	4	O
Nonetheless	28741757	4	O
,	28741757	4	O
clinical	28741757	4	O
manifestations	28741757	4	O
were	28741757	4	O
broader	28741757	4	O
and	28741757	4	O
more	28741757	4	O
severe	28741757	4	O
in	28741757	4	O
the	28741757	4	O
three	28741757	4	O
cases	28741757	4	O
carrying	28741757	4	O
the	28741757	4	O
p.R514H	28741757	4	O
FOXP1	28741757	4	O
variant	28741757	4	O
than	28741757	4	O
in	28741757	4	O
individuals	28741757	4	O
with	28741757	4	O
the	28741757	4	O
p.R553H	28741757	4	O
variant	28741757	4	O
related	28741757	4	O
to	28741757	4	O
CAS	28741757	4	O
,	28741757	4	O
highlighting	28741757	4	O
divergent	28741757	4	O
roles	28741757	4	O
of	28741757	4	O
FOXP2	28741757	4	O
and	28741757	4	O
FOXP1	28741757	4	O
in	28741757	4	O
neurodevelopment	28741757	4	O
.	28741757	4	O

Novel	28742244	0	O
PRPS1	28742244	0	O
gain	28742244	0	O
-	28742244	0	O
of	28742244	0	O
-	28742244	0	O
function	28742244	0	O
mutation	28742244	0	O
in	28742244	0	O
a	28742244	0	O
patient	28742244	0	O
with	28742244	0	O
congenital	28742244	0	O
hyperuricemia	28742244	0	O
and	28742244	0	O
facial	28742244	0	O
anomalies	28742244	0	O
.	28742244	0	O
Phosphoribosylpyrophosphate	28742244	0	O
synthetase	28742244	0	O
(	28742244	0	O
PRPPS	28742244	0	O
)	28742244	0	O
superactivity	28742244	0	O
(	28742244	0	O
OMIM	28742244	0	O
300661	28742244	0	O
)	28742244	0	O
is	28742244	0	O
a	28742244	0	O
rare	28742244	0	O
inborn	28742244	0	O
error	28742244	0	O
of	28742244	0	O
purine	28742244	0	O
metabolism	28742244	0	O
that	28742244	0	O
is	28742244	0	O
caused	28742244	0	O
by	28742244	0	O
gain	28742244	0	O
-	28742244	0	O
of	28742244	0	O
-	28742244	0	O
function	28742244	0	O
mutations	28742244	0	O
in	28742244	0	O
the	28742244	0	O
X	28742244	0	O
-	28742244	0	O
chromosomal	28742244	0	O
gene	28742244	0	O
PRPS1	28742244	0	O
(	28742244	0	O
Xq22.3	28742244	0	O
)	28742244	0	O
.	28742244	0	O
Clinical	28742244	0	O
characteristics	28742244	0	O
include	28742244	0	O
congenital	28742244	0	O
hyperuricemia	28742244	0	O
and	28742244	0	O
hyperuricosuria	28742244	0	O
,	28742244	0	O
gouty	28742244	0	O
arthritis	28742244	0	O
,	28742244	0	O
urolithiasis	28742244	0	O
,	28742244	0	O
developmental	28742244	0	O
delay	28742244	0	O
,	28742244	0	O
hypotonia	28742244	0	O
,	28742244	0	O
recurrent	28742244	0	O
infections	28742244	0	O
,	28742244	0	O
short	28742244	0	O
stature	28742244	0	O
,	28742244	0	O
and	28742244	0	O
hearing	28742244	0	O
loss	28742244	0	O
.	28742244	0	O
Only	28742244	0	O
eight	28742244	0	O
families	28742244	0	O
with	28742244	0	O
PRPPS	28742244	0	O
superactivity	28742244	0	O
and	28742244	0	O
PRPS1	28742244	0	O
gain	28742244	0	O
-	28742244	0	O
of	28742244	0	O
-	28742244	0	O
function	28742244	0	O
mutations	28742244	0	O
have	28742244	0	O
been	28742244	0	O
reported	28742244	0	O
to	28742244	0	O
date	28742244	0	O
.	28742244	0	O
We	28742244	0	O
report	28742244	0	O
on	28742244	0	O
a	28742244	0	O
7	28742244	0	O
-	28742244	0	O
year	28742244	0	O
-	28742244	0	O
old	28742244	0	O
boy	28742244	0	O
with	28742244	0	O
congenital	28742244	0	O
hyperuricemia	28742244	0	O
,	28742244	0	O
urolithiasis	28742244	0	O
,	28742244	0	O
developmental	28742244	0	O
delay	28742244	0	O
,	28742244	0	O
short	28742244	0	O
stature	28742244	0	O
,	28742244	0	O
hypospadias	28742244	0	O
,	28742244	0	O
and	28742244	0	O
facial	28742244	0	O
dysmorphisms	28742244	0	O
.	28742244	0	O
His	28742244	0	O
mother	28742244	0	O
also	28742244	0	O
suffered	28742244	0	O
from	28742244	0	O
hyperuricemia	28742244	0	O
that	28742244	0	O
was	28742244	0	O
diagnosed	28742244	0	O
at	28742244	0	O
age	28742244	0	O
13	28742244	0	O
years	28742244	0	O
.	28742244	0	O
A	28742244	0	O
novel	28742244	0	O
PRPS1	28742244	0	O
missense	28742244	0	O
mutation	28742244	0	O
(	28742244	0	O
c.573G	28742244	0	O
>	28742244	0	O
C	28742244	0	O
,	28742244	0	O
p	28742244	0	O
.	28742244	0	O
[	28742244	0	O
Leu191Phe	28742244	0	O
]	28742244	0	O
)	28742244	0	O
was	28742244	0	O
detected	28742244	0	O
in	28742244	0	O
the	28742244	0	O
proband	28742244	0	O
and	28742244	0	O
his	28742244	0	O
mother	28742244	0	O
.	28742244	0	O
Enzyme	28742244	0	O
activity	28742244	0	O
analysis	28742244	0	O
confirmed	28742244	0	O
superactivity	28742244	0	O
of	28742244	0	O
PRPP	28742244	0	O
synthetase	28742244	0	O
.	28742244	0	O
Analysis	28742244	0	O
of	28742244	0	O
the	28742244	0	O
crystal	28742244	0	O
structure	28742244	0	O
of	28742244	0	O
human	28742244	0	O
PRPPS	28742244	0	O
suggests	28742244	0	O
that	28742244	0	O
the	28742244	0	O
Leu191Phe	28742244	0	B-Gene
mutation	28742244	0	B-Var
affects	28742244	0	B-Reg
the	28742244	0	O
architecture	28742244	0	B-MPA
of	28742244	0	O
both	28742244	0	O
allosteric	28742244	0	O
sites	28742244	0	O
,	28742244	0	O
thereby	28742244	0	O
preventing	28742244	0	B-NegReg
the	28742244	0	O
allosteric	28742244	0	B-MPA
inhibition	28742244	0	I-MPA
of	28742244	0	O
the	28742244	0	O
enzyme	28742244	0	B-Enzyme
.	28742244	0	O
The	28742244	0	O
family	28742244	0	O
reported	28742244	0	O
here	28742244	0	O
broadens	28742244	0	O
the	28742244	0	O
clinical	28742244	0	O
spectrum	28742244	0	O
of	28742244	0	O
PRPPS	28742244	0	O
superactivity	28742244	0	O
and	28742244	0	O
indicates	28742244	0	O
that	28742244	0	O
this	28742244	0	O
rare	28742244	0	O
metabolic	28742244	0	O
disorder	28742244	0	O
might	28742244	0	O
be	28742244	0	O
associated	28742244	0	O
with	28742244	0	O
a	28742244	0	O
recognizable	28742244	0	O
facial	28742244	0	O
gestalt	28742244	0	O
.	28742244	0	O

Naturally	28743761	0	B-Var
-	28743761	0	I-Var
Segregating	28743761	0	I-Var
Variation	28743761	0	I-Var
at	28743761	0	O
Ugt86Dd	28743761	0	B-Gene
Contributes	28743761	0	B-PosReg
to	28743761	0	O
Nicotine	28743761	0	B-MPA
Resistance	28743761	0	I-MPA
in	28743761	0	I-MPA
Drosophila	28743761	0	I-MPA
melanogaster	28743761	0	I-MPA
.	28743761	0	O
Identifying	28743761	0	O
the	28743761	0	O
sequence	28743761	0	O
polymorphisms	28743761	0	O
underlying	28743761	0	O
complex	28743761	0	O
trait	28743761	0	O
variation	28743761	0	O
is	28743761	0	O
a	28743761	0	O
key	28743761	0	O
goal	28743761	0	O
of	28743761	0	O
genetics	28743761	0	O
research	28743761	0	O
,	28743761	0	O
since	28743761	0	O
knowing	28743761	0	O
the	28743761	0	O
precise	28743761	0	O
causative	28743761	0	O
molecular	28743761	0	O
events	28743761	0	O
allows	28743761	0	O
insight	28743761	0	O
into	28743761	0	O
the	28743761	0	O
pathways	28743761	0	O
governing	28743761	0	O
trait	28743761	0	O
variation	28743761	0	O
.	28743761	0	O
Genetic	28743761	0	O
analysis	28743761	0	O
of	28743761	0	O
complex	28743761	0	O
traits	28743761	0	O
in	28743761	0	O
model	28743761	0	O
systems	28743761	0	O
regularly	28743761	0	O
starts	28743761	0	O
by	28743761	0	O
constructing	28743761	0	O
QTL	28743761	0	O
maps	28743761	0	O
,	28743761	0	O
but	28743761	0	O
generally	28743761	0	O
fails	28743761	0	O
to	28743761	0	O
identify	28743761	0	O
causative	28743761	0	O
sequence	28743761	0	O
polymorphisms	28743761	0	O
.	28743761	0	O
Previously	28743761	0	O
we	28743761	0	O
mapped	28743761	0	O
a	28743761	0	O
series	28743761	0	O
of	28743761	0	O
QTL	28743761	0	O
contributing	28743761	0	O
to	28743761	0	O
resistance	28743761	0	O
to	28743761	0	O
nicotine	28743761	0	O
in	28743761	0	O
a	28743761	0	O
Drosophila	28743761	0	O
melanogaster	28743761	0	O
multiparental	28743761	0	O
mapping	28743761	0	O
resource	28743761	0	O
,	28743761	0	O
and	28743761	0	O
here	28743761	0	O
use	28743761	0	O
a	28743761	0	O
battery	28743761	0	O
of	28743761	0	O
functional	28743761	0	O
tests	28743761	0	O
to	28743761	0	O
resolve	28743761	0	O
QTL	28743761	0	O
to	28743761	0	O
the	28743761	0	O
molecular	28743761	0	O
level	28743761	0	O
.	28743761	0	O
One	28743761	0	O
large	28743761	0	O
-	28743761	0	O
effect	28743761	0	O
QTL	28743761	0	O
resided	28743761	0	O
over	28743761	0	O
a	28743761	0	O
cluster	28743761	0	O
of	28743761	0	O
UDP	28743761	0	O
-	28743761	0	O
glucuronosyltransferases	28743761	0	O
,	28743761	0	O
and	28743761	0	O
quantitative	28743761	0	O
complementation	28743761	0	O
tests	28743761	0	O
using	28743761	0	O
deficiencies	28743761	0	O
eliminating	28743761	0	O
subsets	28743761	0	O
of	28743761	0	O
these	28743761	0	O
detoxification	28743761	0	O
genes	28743761	0	O
revealed	28743761	0	O
allelic	28743761	0	O
variation	28743761	0	O
impacting	28743761	0	O
resistance	28743761	0	O
.	28743761	0	O
RNAseq	28743761	0	O
showed	28743761	0	O
that	28743761	0	O
Ugt86Dd	28743761	0	O
had	28743761	0	O
significantly	28743761	0	O
higher	28743761	0	O
expression	28743761	0	O
in	28743761	0	O
genotypes	28743761	0	O
that	28743761	0	O
are	28743761	0	O
more	28743761	0	O
resistant	28743761	0	O
to	28743761	0	O
nicotine	28743761	0	O
,	28743761	0	O
and	28743761	0	O
anterior	28743761	0	O
midgut	28743761	0	O
-	28743761	0	O
specific	28743761	0	O
RNAi	28743761	0	O
of	28743761	0	O
this	28743761	0	O
gene	28743761	0	O
reduced	28743761	0	O
resistance	28743761	0	O
.	28743761	0	O
We	28743761	0	O
discovered	28743761	0	O
a	28743761	0	O
segregating	28743761	0	O
22	28743761	0	O
-	28743761	0	O
bp	28743761	0	O
frameshift	28743761	0	B-Var
deletion	28743761	0	I-Var
in	28743761	0	O
Ugt86Dd	28743761	0	B-Gene
,	28743761	0	O
and	28743761	0	O
accounting	28743761	0	O
for	28743761	0	O
the	28743761	0	O
InDel	28743761	0	O
during	28743761	0	O
mapping	28743761	0	O
largely	28743761	0	O
eliminates	28743761	0	B-NegReg
the	28743761	0	O
QTL	28743761	0	B-MPA
,	28743761	0	O
implying	28743761	0	O
the	28743761	0	O
event	28743761	0	O
explains	28743761	0	O
the	28743761	0	O
bulk	28743761	0	O
of	28743761	0	O
the	28743761	0	O
effect	28743761	0	O
of	28743761	0	O
the	28743761	0	O
mapped	28743761	0	O
locus	28743761	0	O
.	28743761	0	O
CRISPR	28743761	0	O
/	28743761	0	O
Cas9	28743761	0	O
editing	28743761	0	O
a	28743761	0	O
relatively	28743761	0	O
resistant	28743761	0	O
genotype	28743761	0	O
to	28743761	0	O
generate	28743761	0	O
lesions	28743761	0	B-Var
in	28743761	0	O
Ugt86Dd	28743761	0	B-Gene
that	28743761	0	O
recapitulate	28743761	0	O
the	28743761	0	O
naturally	28743761	0	O
-	28743761	0	O
occurring	28743761	0	O
putative	28743761	0	O
loss	28743761	0	B-NegReg
-	28743761	0	I-NegReg
of	28743761	0	I-NegReg
-	28743761	0	I-NegReg
function	28743761	0	I-NegReg
allele	28743761	0	O
leads	28743761	0	O
to	28743761	0	O
a	28743761	0	O
large	28743761	0	O
reduction	28743761	0	B-NegReg
in	28743761	0	O
resistance	28743761	0	B-MPA
.	28743761	0	O
Despite	28743761	0	O
this	28743761	0	O
major	28743761	0	O
effect	28743761	0	O
of	28743761	0	O
the	28743761	0	O
deletion	28743761	0	O
,	28743761	0	O
the	28743761	0	O
allele	28743761	0	O
appears	28743761	0	O
to	28743761	0	O
be	28743761	0	O
very	28743761	0	O
rare	28743761	0	O
in	28743761	0	O
wild	28743761	0	O
-	28743761	0	O
caught	28743761	0	O
populations	28743761	0	O
,	28743761	0	O
and	28743761	0	O
likely	28743761	0	O
explains	28743761	0	O
only	28743761	0	O
a	28743761	0	O
small	28743761	0	O
fraction	28743761	0	O
of	28743761	0	O
the	28743761	0	O
natural	28743761	0	O
variation	28743761	0	O
for	28743761	0	O
the	28743761	0	O
trait	28743761	0	O
.	28743761	0	O
Nonetheless	28743761	0	O
,	28743761	0	O
this	28743761	0	O
putatively	28743761	0	O
causative	28743761	0	O
coding	28743761	0	O
InDel	28743761	0	O
can	28743761	0	O
be	28743761	0	O
a	28743761	0	O
launchpad	28743761	0	O
for	28743761	0	O
future	28743761	0	O
mechanistic	28743761	0	O
exploration	28743761	0	O
of	28743761	0	O
xenobiotic	28743761	0	O
detoxification	28743761	0	O
.	28743761	0	O

Sequence	28747428	0	B-Var
exchange	28747428	0	I-Var
between	28747428	0	O
R	28747428	0	B-Gene
genes	28747428	0	O
converts	28747428	0	B-Reg
virus	28747428	0	O
resistance	28747428	0	O
into	28747428	0	O
nematode	28747428	0	B-MPA
resistance	28747428	0	I-MPA
,	28747428	0	O
and	28747428	0	O
vice	28747428	0	O
versa	28747428	0	O
.	28747428	0	O
Plants	28747428	0	O
have	28747428	0	O
evolved	28747428	0	O
a	28747428	0	O
limited	28747428	0	O
repertoire	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
disease	28747428	0	O
resistance	28747428	0	O
(	28747428	0	O
R	28747428	0	O
)	28747428	0	O
genes	28747428	0	O
to	28747428	0	O
protect	28747428	0	O
themselves	28747428	0	O
against	28747428	0	O
a	28747428	0	O
myriad	28747428	0	O
of	28747428	0	O
pathogens	28747428	0	O
.	28747428	0	O
This	28747428	0	O
limitation	28747428	0	O
is	28747428	0	O
thought	28747428	0	O
to	28747428	0	O
be	28747428	0	O
counterbalanced	28747428	0	O
by	28747428	0	O
the	28747428	0	O
rapid	28747428	0	O
evolution	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
proteins	28747428	0	O
,	28747428	0	O
as	28747428	0	O
only	28747428	0	O
few	28747428	0	O
sequence	28747428	0	O
changes	28747428	0	B-Var
have	28747428	0	O
been	28747428	0	O
shown	28747428	0	O
to	28747428	0	O
be	28747428	0	O
sufficient	28747428	0	O
to	28747428	0	O
alter	28747428	0	B-Reg
resistance	28747428	0	B-MPA
specificities	28747428	0	I-MPA
towards	28747428	0	I-MPA
novel	28747428	0	I-MPA
strains	28747428	0	I-MPA
of	28747428	0	I-MPA
a	28747428	0	I-MPA
pathogen	28747428	0	I-MPA
.	28747428	0	O
However	28747428	0	O
,	28747428	0	O
little	28747428	0	O
is	28747428	0	O
known	28747428	0	O
about	28747428	0	O
the	28747428	0	O
flexibility	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
genes	28747428	0	O
to	28747428	0	O
switch	28747428	0	O
resistance	28747428	0	O
specificities	28747428	0	O
between	28747428	0	O
phylogenetically	28747428	0	O
unrelated	28747428	0	O
pathogens	28747428	0	O
.	28747428	0	O
To	28747428	0	O
investigate	28747428	0	O
this	28747428	0	O
,	28747428	0	O
we	28747428	0	O
created	28747428	0	O
domain	28747428	0	O
swaps	28747428	0	O
between	28747428	0	O
the	28747428	0	O
close	28747428	0	O
homologs	28747428	0	O
Gpa2	28747428	0	O
and	28747428	0	O
Rx1	28747428	0	O
,	28747428	0	O
which	28747428	0	O
confer	28747428	0	O
resistance	28747428	0	O
in	28747428	0	O
potato	28747428	0	O
to	28747428	0	O
the	28747428	0	O
cyst	28747428	0	O
nematode	28747428	0	O
Globodera	28747428	0	O
pallida	28747428	0	O
and	28747428	0	O
Potato	28747428	0	O
virus	28747428	0	O
X	28747428	0	O
(	28747428	0	O
PVX	28747428	0	O
)	28747428	0	O
,	28747428	0	O
respectively	28747428	0	O
.	28747428	0	O
The	28747428	0	O
genetic	28747428	0	O
fusion	28747428	0	O
of	28747428	0	O
the	28747428	0	O
CC	28747428	0	O
-	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
ARC	28747428	0	O
of	28747428	0	O
Gpa2	28747428	0	O
with	28747428	0	O
the	28747428	0	O
LRR	28747428	0	O
of	28747428	0	O
Rx1	28747428	0	O
(	28747428	0	O
Gpa2CN	28747428	0	O
/	28747428	0	O
Rx1L	28747428	0	O
)	28747428	0	O
resulted	28747428	0	O
in	28747428	0	O
autoactivity	28747428	0	O
,	28747428	0	O
but	28747428	0	O
lowering	28747428	0	O
the	28747428	0	O
protein	28747428	0	O
levels	28747428	0	O
restored	28747428	0	O
its	28747428	0	O
specific	28747428	0	O
activation	28747428	0	O
response	28747428	0	O
including	28747428	0	O
extreme	28747428	0	O
resistance	28747428	0	O
to	28747428	0	O
PVX	28747428	0	O
in	28747428	0	O
potato	28747428	0	O
shoots	28747428	0	O
.	28747428	0	O
The	28747428	0	O
reciprocal	28747428	0	O
construct	28747428	0	O
(	28747428	0	O
Rx1CN	28747428	0	O
/	28747428	0	O
Gpa2L	28747428	0	O
)	28747428	0	O
showed	28747428	0	O
a	28747428	0	O
loss	28747428	0	O
-	28747428	0	O
of	28747428	0	O
-	28747428	0	O
function	28747428	0	O
phenotype	28747428	0	O
,	28747428	0	O
but	28747428	0	O
exchange	28747428	0	B-Var
of	28747428	0	O
the	28747428	0	O
first	28747428	0	O
3	28747428	0	O
LRR	28747428	0	O
repeats	28747428	0	O
of	28747428	0	O
Rx1	28747428	0	B-Gene
was	28747428	0	O
sufficient	28747428	0	O
to	28747428	0	O
regain	28747428	0	B-PosReg
a	28747428	0	O
wild	28747428	0	B-MPA
type	28747428	0	I-MPA
resistance	28747428	0	I-MPA
response	28747428	0	I-MPA
to	28747428	0	I-MPA
G.	28747428	0	I-MPA
pallida	28747428	0	I-MPA
in	28747428	0	I-MPA
the	28747428	0	I-MPA
roots	28747428	0	I-MPA
.	28747428	0	O
These	28747428	0	O
data	28747428	0	O
demonstrate	28747428	0	O
that	28747428	0	O
exchanging	28747428	0	B-Var
the	28747428	0	O
recognition	28747428	0	O
moiety	28747428	0	O
in	28747428	0	O
the	28747428	0	O
LRR	28747428	0	O
is	28747428	0	O
sufficient	28747428	0	O
to	28747428	0	O
convert	28747428	0	B-Reg
extreme	28747428	0	O
virus	28747428	0	O
resistance	28747428	0	O
in	28747428	0	O
the	28747428	0	O
leaves	28747428	0	O
into	28747428	0	O
mild	28747428	0	B-MPA
nematode	28747428	0	I-MPA
resistance	28747428	0	I-MPA
in	28747428	0	I-MPA
the	28747428	0	I-MPA
roots	28747428	0	I-MPA
,	28747428	0	O
and	28747428	0	O
vice	28747428	0	O
versa	28747428	0	O
.	28747428	0	O
In	28747428	0	O
addition	28747428	0	O
,	28747428	0	O
we	28747428	0	O
show	28747428	0	O
that	28747428	0	O
the	28747428	0	O
CC	28747428	0	O
-	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
ARC	28747428	0	O
can	28747428	0	O
operate	28747428	0	O
independently	28747428	0	O
of	28747428	0	O
the	28747428	0	O
recognition	28747428	0	O
specificities	28747428	0	O
defined	28747428	0	O
by	28747428	0	O
the	28747428	0	O
LRR	28747428	0	O
domain	28747428	0	O
,	28747428	0	O
either	28747428	0	O
above	28747428	0	O
or	28747428	0	O
belowground	28747428	0	O
.	28747428	0	O
These	28747428	0	O
data	28747428	0	O
show	28747428	0	O
the	28747428	0	O
versatility	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
genes	28747428	0	O
to	28747428	0	O
generate	28747428	0	O
resistances	28747428	0	O
to	28747428	0	O
unrelated	28747428	0	O
pathogens	28747428	0	O
with	28747428	0	O
completely	28747428	0	O
different	28747428	0	O
lifestyles	28747428	0	O
and	28747428	0	O
routes	28747428	0	O
of	28747428	0	O
invasion	28747428	0	O
.	28747428	0	O

Lethal	28747464	1	O
digenic	28747464	1	O
mutations	28747464	1	B-Var
in	28747464	1	O
the	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
channels	28747464	1	O
Kir4.1	28747464	1	O
(	28747464	1	B-Gene
KCNJ10	28747464	1	I-Gene
)	28747464	1	I-Gene
and	28747464	1	O
SLACK	28747464	1	O
(	28747464	1	B-Gene
KCNT1	28747464	1	I-Gene
)	28747464	1	I-Gene
associated	28747464	1	B-Reg
with	28747464	1	O
severe	28747464	1	O
-	28747464	1	O
disabling	28747464	1	O
seizures	28747464	1	B-Disease
and	28747464	1	O
neurodevelopmental	28747464	1	B-Disease
delay	28747464	1	I-Disease
.	28747464	1	O
A	28747464	1	O
2	28747464	1	O
-	28747464	1	O
year	28747464	1	O
-	28747464	1	O
old	28747464	1	O
boy	28747464	1	O
presented	28747464	1	O
profound	28747464	1	O
developmental	28747464	1	O
delay	28747464	1	O
,	28747464	1	O
failure	28747464	1	O
to	28747464	1	O
thrive	28747464	1	O
,	28747464	1	O
ataxia	28747464	1	O
,	28747464	1	O
hypotonia	28747464	1	O
and	28747464	1	O
tonic	28747464	1	O
-	28747464	1	O
clonic	28747464	1	O
seizures	28747464	1	O
that	28747464	1	O
caused	28747464	1	O
the	28747464	1	O
death	28747464	1	O
of	28747464	1	O
the	28747464	1	O
patient	28747464	1	O
.	28747464	1	O
Targeted	28747464	1	O
and	28747464	1	O
whole	28747464	1	O
-	28747464	1	O
exome	28747464	1	O
sequencing	28747464	1	O
revealed	28747464	1	O
two	28747464	1	O
heterozygous	28747464	1	O
missense	28747464	1	O
variants	28747464	1	O
:	28747464	1	O
a	28747464	1	O
novel	28747464	1	O
mutation	28747464	1	O
in	28747464	1	O
KCNJ10	28747464	1	O
gene	28747464	1	O
that	28747464	1	O
encodes	28747464	1	O
for	28747464	1	O
the	28747464	1	O
inwardly	28747464	1	O
-	28747464	1	O
rectifying	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
channel	28747464	1	O
Kir4.1	28747464	1	O
and	28747464	1	O
another	28747464	1	O
previously	28747464	1	O
characterized	28747464	1	O
mutation	28747464	1	O
in	28747464	1	O
KCNT1	28747464	1	O
that	28747464	1	O
encodes	28747464	1	O
for	28747464	1	O
the	28747464	1	O
Na	28747464	1	O
(	28747464	1	O
)	28747464	1	O
-	28747464	1	O
activated	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
channel	28747464	1	O
known	28747464	1	O
as	28747464	1	O
Slo2.2	28747464	1	O
or	28747464	1	O
SLACK	28747464	1	O
.	28747464	1	O
The	28747464	1	O
objectives	28747464	1	O
of	28747464	1	O
this	28747464	1	O
study	28747464	1	O
were	28747464	1	O
to	28747464	1	O
perform	28747464	1	O
the	28747464	1	O
clinical	28747464	1	O
and	28747464	1	O
genetic	28747464	1	O
characterization	28747464	1	O
of	28747464	1	O
the	28747464	1	O
proband	28747464	1	O
and	28747464	1	O
his	28747464	1	O
family	28747464	1	O
and	28747464	1	O
to	28747464	1	O
examine	28747464	1	O
the	28747464	1	O
functional	28747464	1	O
consequence	28747464	1	O
of	28747464	1	O
the	28747464	1	O
Kir4.1	28747464	1	O
mutation	28747464	1	O
.	28747464	1	O
The	28747464	1	O
mutant	28747464	1	O
and	28747464	1	O
wild	28747464	1	O
-	28747464	1	O
type	28747464	1	O
KCNJ10	28747464	1	O
constructs	28747464	1	O
were	28747464	1	O
generated	28747464	1	O
and	28747464	1	O
heterologously	28747464	1	O
expressed	28747464	1	O
in	28747464	1	O
Xenopus	28747464	1	O
laevis	28747464	1	O
oocytes	28747464	1	O
,	28747464	1	O
and	28747464	1	O
whole	28747464	1	O
-	28747464	1	O
cell	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
currents	28747464	1	O
were	28747464	1	O
measured	28747464	1	O
using	28747464	1	O
the	28747464	1	O
two	28747464	1	O
-	28747464	1	O
electrode	28747464	1	O
voltage	28747464	1	O
-	28747464	1	O
clamp	28747464	1	O
technique	28747464	1	O
.	28747464	1	O
The	28747464	1	O
KCNJ10	28747464	1	B-Gene
mutation	28747464	1	B-Var
c.652C	28747464	1	O
>	28747464	1	O
T	28747464	1	O
resulted	28747464	1	B-Reg
in	28747464	1	I-Reg
a	28747464	1	O
p.L218F	28747464	1	O
substitution	28747464	1	B-Var
at	28747464	1	O
a	28747464	1	O
highly	28747464	1	O
conserved	28747464	1	O
residue	28747464	1	O
site	28747464	1	O
.	28747464	1	O
Wild	28747464	1	O
-	28747464	1	O
type	28747464	1	O
KCNJ10	28747464	1	O
expression	28747464	1	O
yielded	28747464	1	O
robust	28747464	1	O
Kir	28747464	1	O
currents	28747464	1	O
,	28747464	1	O
while	28747464	1	O
currents	28747464	1	O
from	28747464	1	O
oocytes	28747464	1	O
expressing	28747464	1	O
the	28747464	1	O
mutation	28747464	1	O
were	28747464	1	O
reduced	28747464	1	O
.	28747464	1	O
Western	28747464	1	O
Blot	28747464	1	O
analysis	28747464	1	O
revealed	28747464	1	O
reduced	28747464	1	B-NegReg
protein	28747464	1	B-MPA
expression	28747464	1	I-MPA
by	28747464	1	O
the	28747464	1	O
mutation	28747464	1	B-Var
.	28747464	1	O
Kir5.1	28747464	1	O
subunits	28747464	1	O
display	28747464	1	O
selective	28747464	1	O
heteromultimerization	28747464	1	O
with	28747464	1	O
Kir4.1	28747464	1	O
constituting	28747464	1	O
channels	28747464	1	O
with	28747464	1	O
unique	28747464	1	O
kinetics	28747464	1	O
.	28747464	1	O
The	28747464	1	O
effect	28747464	1	O
of	28747464	1	O
the	28747464	1	O
mutation	28747464	1	O
on	28747464	1	O
Kir4.1	28747464	1	O
/	28747464	1	O
5.1	28747464	1	O
channel	28747464	1	O
activity	28747464	1	O
was	28747464	1	O
twofold	28747464	1	O
:	28747464	1	O
a	28747464	1	O
reduction	28747464	1	O
in	28747464	1	O
current	28747464	1	O
amplitudes	28747464	1	O
and	28747464	1	O
an	28747464	1	O
increase	28747464	1	O
in	28747464	1	O
the	28747464	1	O
pH	28747464	1	O
-	28747464	1	O
dependent	28747464	1	O
inhibition	28747464	1	O
.	28747464	1	O
We	28747464	1	O
thus	28747464	1	O
report	28747464	1	O
a	28747464	1	O
novel	28747464	1	O
loss	28747464	1	B-NegReg
-	28747464	1	I-NegReg
of	28747464	1	I-NegReg
-	28747464	1	I-NegReg
function	28747464	1	I-NegReg
mutation	28747464	1	B-Var
in	28747464	1	O
Kir4.1	28747464	1	O
found	28747464	1	O
in	28747464	1	O
a	28747464	1	O
patient	28747464	1	O
with	28747464	1	O
a	28747464	1	O
co	28747464	1	O
-	28747464	1	O
exiting	28747464	1	O
mutation	28747464	1	B-Var
in	28747464	1	O
SLACK	28747464	1	O
channels	28747464	1	O
that	28747464	1	O
results	28747464	1	B-Reg
in	28747464	1	I-Reg
a	28747464	1	O
fatal	28747464	1	B-Disease
disease	28747464	1	I-Disease
.	28747464	1	O

Allelic	28749435	4	O
Complexity	28749435	4	O
in	28749435	4	O
Long	28749435	4	O
QT	28749435	4	O
Syndrome	28749435	4	O
:	28749435	4	O
A	28749435	4	O
Family	28749435	4	O
-	28749435	4	O
Case	28749435	4	O
Study	28749435	4	O
.	28749435	4	O
Congenital	28749435	4	O
long	28749435	4	B-Disease
QT	28749435	4	I-Disease
syndrome	28749435	4	I-Disease
(	28749435	4	O
LQTS	28749435	4	O
)	28749435	4	O
is	28749435	4	O
associated	28749435	4	O
with	28749435	4	O
high	28749435	4	O
genetic	28749435	4	O
and	28749435	4	O
allelic	28749435	4	O
heterogeneity	28749435	4	O
.	28749435	4	O
In	28749435	4	O
some	28749435	4	O
cases	28749435	4	O
,	28749435	4	O
more	28749435	4	O
than	28749435	4	O
one	28749435	4	O
genetic	28749435	4	O
variant	28749435	4	O
is	28749435	4	O
identified	28749435	4	O
in	28749435	4	O
the	28749435	4	O
same	28749435	4	O
(	28749435	4	O
compound	28749435	4	O
heterozygosity	28749435	4	O
)	28749435	4	O
or	28749435	4	O
different	28749435	4	O
(	28749435	4	O
digenic	28749435	4	O
heterozygosity	28749435	4	O
)	28749435	4	O
genes	28749435	4	O
,	28749435	4	O
and	28749435	4	O
subjects	28749435	4	O
with	28749435	4	O
multiple	28749435	4	O
pathogenic	28749435	4	O
mutations	28749435	4	O
may	28749435	4	O
have	28749435	4	O
a	28749435	4	O
more	28749435	4	O
severe	28749435	4	O
disease	28749435	4	O
.	28749435	4	O
Standard	28749435	4	O
-	28749435	4	O
of	28749435	4	O
-	28749435	4	O
care	28749435	4	O
clinical	28749435	4	O
genetic	28749435	4	O
testing	28749435	4	O
for	28749435	4	O
this	28749435	4	O
and	28749435	4	O
other	28749435	4	O
arrhythmia	28749435	4	O
susceptibility	28749435	4	O
syndromes	28749435	4	O
improves	28749435	4	O
the	28749435	4	O
identification	28749435	4	O
of	28749435	4	O
complex	28749435	4	O
genotypes	28749435	4	O
.	28749435	4	O
Therefore	28749435	4	O
,	28749435	4	O
it	28749435	4	O
is	28749435	4	O
important	28749435	4	O
to	28749435	4	O
distinguish	28749435	4	O
between	28749435	4	O
pathogenic	28749435	4	O
mutations	28749435	4	O
and	28749435	4	O
benign	28749435	4	O
rare	28749435	4	O
variants	28749435	4	O
.	28749435	4	O
We	28749435	4	O
identified	28749435	4	O
four	28749435	4	O
genetic	28749435	4	O
variants	28749435	4	O
(	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.C108Y	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
,	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
)	28749435	4	O
in	28749435	4	O
an	28749435	4	O
LQTS	28749435	4	O
family	28749435	4	O
.	28749435	4	O
On	28749435	4	O
the	28749435	4	O
basis	28749435	4	O
of	28749435	4	O
in	28749435	4	O
silico	28749435	4	O
analysis	28749435	4	O
,	28749435	4	O
clinical	28749435	4	O
data	28749435	4	O
from	28749435	4	O
our	28749435	4	O
family	28749435	4	O
,	28749435	4	O
and	28749435	4	O
the	28749435	4	O
evidence	28749435	4	O
from	28749435	4	O
previous	28749435	4	O
studies	28749435	4	O
,	28749435	4	O
we	28749435	4	O
analyzed	28749435	4	O
two	28749435	4	O
mutated	28749435	4	O
channels	28749435	4	O
,	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
and	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.C108Y	28749435	4	O
,	28749435	4	O
using	28749435	4	O
the	28749435	4	O
whole	28749435	4	O
-	28749435	4	O
cell	28749435	4	O
patch	28749435	4	O
clamp	28749435	4	O
technique	28749435	4	O
.	28749435	4	O
We	28749435	4	O
found	28749435	4	O
that	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
was	28749435	4	O
not	28749435	4	O
associated	28749435	4	O
with	28749435	4	O
a	28749435	4	O
severe	28749435	4	O
functional	28749435	4	O
impairment	28749435	4	O
,	28749435	4	O
whereas	28749435	4	O
KCNH2	28749435	4	B-Var
-	28749435	4	I-Var
p.C108Y	28749435	4	I-Var
,	28749435	4	O
a	28749435	4	O
novel	28749435	4	O
variant	28749435	4	O
,	28749435	4	O
encoded	28749435	4	B-Reg
a	28749435	4	O
non	28749435	4	B-Pathway
-	28749435	4	I-Pathway
functional	28749435	4	I-Pathway
channel	28749435	4	I-Pathway
that	28749435	4	O
exerts	28749435	4	O
dominant	28749435	4	B-NegReg
-	28749435	4	I-NegReg
negative	28749435	4	I-NegReg
effects	28749435	4	B-MPA
on	28749435	4	O
the	28749435	4	O
wild	28749435	4	O
-	28749435	4	O
type	28749435	4	O
.	28749435	4	O
Notably	28749435	4	O
,	28749435	4	O
the	28749435	4	O
common	28749435	4	O
variants	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
were	28749435	4	O
previously	28749435	4	O
reported	28749435	4	O
to	28749435	4	O
produce	28749435	4	O
more	28749435	4	O
severe	28749435	4	O
phenotypes	28749435	4	O
when	28749435	4	O
combined	28749435	4	O
with	28749435	4	O
disease	28749435	4	O
-	28749435	4	O
causing	28749435	4	O
alleles	28749435	4	O
.	28749435	4	O
Our	28749435	4	O
results	28749435	4	O
indicate	28749435	4	O
that	28749435	4	O
the	28749435	4	O
novel	28749435	4	O
KCNH2	28749435	4	B-Var
-	28749435	4	I-Var
C108Y	28749435	4	I-Var
variant	28749435	4	O
can	28749435	4	O
be	28749435	4	O
a	28749435	4	O
pathogenic	28749435	4	B-Reg
LQTS	28749435	4	B-Disease
mutation	28749435	4	O
,	28749435	4	O
whereas	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
,	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
could	28749435	4	O
be	28749435	4	O
LQTS	28749435	4	O
modifiers	28749435	4	O
.	28749435	4	O

POSITIVE	28751317	0	O
REGULATOR	28751317	0	O
OF	28751317	0	O
IRON	28751317	0	O
HOMEOSTASIS	28751317	0	O
1	28751317	0	O
(	28751317	0	O
OsPRI1	28751317	0	O
)	28751317	0	O
positively	28751317	0	O
regulates	28751317	0	O
iron	28751317	0	O
homeostasis	28751317	0	O
in	28751317	0	O
rice	28751317	0	O
.	28751317	0	O
OsHRZ1	28751317	0	O
is	28751317	0	O
a	28751317	0	O
potential	28751317	0	O
iron	28751317	0	O
-	28751317	0	O
binding	28751317	0	O
sensor	28751317	0	O
.	28751317	0	O
However	28751317	0	O
,	28751317	0	O
it	28751317	0	O
is	28751317	0	O
unclear	28751317	0	O
how	28751317	0	O
OsHRZ1	28751317	0	O
transmits	28751317	0	O
signals	28751317	0	O
.	28751317	0	O
In	28751317	0	O
this	28751317	0	O
study	28751317	0	O
,	28751317	0	O
we	28751317	0	O
reveal	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
interacts	28751317	0	O
with	28751317	0	O
OsHRZ1	28751317	0	O
.	28751317	0	O
A	28751317	0	O
loss	28751317	0	B-NegReg
-	28751317	0	I-NegReg
of	28751317	0	I-NegReg
-	28751317	0	I-NegReg
function	28751317	0	I-NegReg
mutation	28751317	0	B-Var
to	28751317	0	O
OsPRI1	28751317	0	B-Gene
increased	28751317	0	B-PosReg
the	28751317	0	O
sensitivity	28751317	0	B-MPA
of	28751317	0	I-MPA
plants	28751317	0	I-MPA
to	28751317	0	I-MPA
Fe	28751317	0	I-MPA
-	28751317	0	I-MPA
deficient	28751317	0	I-MPA
conditions	28751317	0	I-MPA
and	28751317	0	O
downregulated	28751317	0	B-NegReg
the	28751317	0	O
expression	28751317	0	B-MPA
of	28751317	0	I-MPA
Fe	28751317	0	I-MPA
-	28751317	0	I-MPA
deficiency	28751317	0	I-MPA
-	28751317	0	I-MPA
responsive	28751317	0	I-MPA
genes	28751317	0	I-MPA
.	28751317	0	O
Yeast	28751317	0	O
one	28751317	0	O
-	28751317	0	O
hybrid	28751317	0	O
and	28751317	0	O
electrophoretic	28751317	0	O
mobility	28751317	0	O
shift	28751317	0	O
assay	28751317	0	O
results	28751317	0	O
suggested	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
binds	28751317	0	O
to	28751317	0	O
the	28751317	0	O
OsIRO2	28751317	0	O
and	28751317	0	O
OsIRO3	28751317	0	O
promoters	28751317	0	O
.	28751317	0	O
In	28751317	0	O
vitro	28751317	0	O
ubiquitination	28751317	0	O
experiments	28751317	0	O
indicated	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
is	28751317	0	O
ubiquitinated	28751317	0	O
by	28751317	0	O
OsHRZ1	28751317	0	O
.	28751317	0	O
Cell	28751317	0	O
-	28751317	0	O
free	28751317	0	O
degradation	28751317	0	O
assays	28751317	0	O
revealed	28751317	0	O
that	28751317	0	O
the	28751317	0	O
stability	28751317	0	B-MPA
of	28751317	0	O
OsPRI1	28751317	0	O
decreased	28751317	0	O
in	28751317	0	O
wild	28751317	0	O
type	28751317	0	O
roots	28751317	0	O
,	28751317	0	O
but	28751317	0	O
increased	28751317	0	B-PosReg
in	28751317	0	O
the	28751317	0	O
hrz1-2	28751317	0	B-Gene
mutant	28751317	0	B-Var
,	28751317	0	O
suggesting	28751317	0	O
OsHRZ1	28751317	0	O
is	28751317	0	O
responsible	28751317	0	O
for	28751317	0	O
the	28751317	0	O
instability	28751317	0	O
of	28751317	0	O
OsPRI1	28751317	0	O
.	28751317	0	O
The	28751317	0	O
hrz1-2	28751317	0	O
seedlings	28751317	0	O
were	28751317	0	O
insensitive	28751317	0	O
to	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficient	28751317	0	O
conditions	28751317	0	O
.	28751317	0	O
When	28751317	0	O
the	28751317	0	O
pri1-1	28751317	0	B-Gene
mutation	28751317	0	B-Var
was	28751317	0	O
introduced	28751317	0	B-Interaction
into	28751317	0	O
hrz1-2	28751317	0	B-Gene
mutants	28751317	0	B-Var
,	28751317	0	O
the	28751317	0	O
pri1hrz1	28751317	0	O
double	28751317	0	O
mutant	28751317	0	O
was	28751317	0	O
more	28751317	0	B-PosReg
sensitive	28751317	0	B-MPA
to	28751317	0	I-MPA
Fe	28751317	0	I-MPA
deficiency	28751317	0	I-MPA
than	28751317	0	O
the	28751317	0	O
hrz1-2	28751317	0	O
mutant	28751317	0	O
.	28751317	0	O
Additionally	28751317	0	O
,	28751317	0	O
the	28751317	0	O
expression	28751317	0	O
levels	28751317	0	O
of	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficiency	28751317	0	O
-	28751317	0	O
responsive	28751317	0	O
genes	28751317	0	O
were	28751317	0	O
lower	28751317	0	O
in	28751317	0	O
the	28751317	0	O
hrz1pri1	28751317	0	O
double	28751317	0	O
mutant	28751317	0	O
than	28751317	0	O
in	28751317	0	O
the	28751317	0	O
hrz1-2	28751317	0	O
mutant	28751317	0	O
.	28751317	0	O
Collectively	28751317	0	O
,	28751317	0	O
these	28751317	0	O
results	28751317	0	O
imply	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
,	28751317	0	O
which	28751317	0	O
is	28751317	0	O
ubiquitinated	28751317	0	O
by	28751317	0	O
OsHRZ1	28751317	0	O
,	28751317	0	O
mediates	28751317	0	O
rice	28751317	0	O
responses	28751317	0	O
to	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficiency	28751317	0	O
by	28751317	0	O
positively	28751317	0	O
regulating	28751317	0	O
OsIRO2	28751317	0	O
and	28751317	0	O
OsIRO3	28751317	0	O
expression	28751317	0	O
as	28751317	0	O
part	28751317	0	O
of	28751317	0	O
the	28751317	0	O
OsHRZ1	28751317	0	O
-	28751317	0	O
OsPRI1	28751317	0	O
-	28751317	0	O
OsIRO2	28751317	0	O
/	28751317	0	O
3	28751317	0	O
signal	28751317	0	O
transduction	28751317	0	O
cascade	28751317	0	O
.	28751317	0	O

Loss	28751559	1	B-NegReg
-	28751559	1	I-NegReg
of	28751559	1	I-NegReg
-	28751559	1	I-NegReg
function	28751559	1	I-NegReg
but	28751559	1	O
not	28751559	1	O
dominant	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
intragenic	28751559	1	O
IKZF1	28751559	1	B-Gene
deletions	28751559	1	B-Var
are	28751559	1	O
associated	28751559	1	O
with	28751559	1	O
an	28751559	1	O
adverse	28751559	1	O
prognosis	28751559	1	O
in	28751559	1	O
adult	28751559	1	O
BCR	28751559	1	O
-	28751559	1	O
ABL	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
acute	28751559	1	B-Disease
lymphoblastic	28751559	1	I-Disease
leukemia	28751559	1	I-Disease
.	28751559	1	O
Genetic	28751559	1	O
alterations	28751559	1	O
of	28751559	1	O
the	28751559	1	O
transcription	28751559	1	O
factor	28751559	1	O
IKZF1	28751559	1	O
(	28751559	1	O
"	28751559	1	O
IKAROS	28751559	1	O
"	28751559	1	O
)	28751559	1	O
are	28751559	1	O
detected	28751559	1	O
in	28751559	1	O
around	28751559	1	O
15	28751559	1	O
-	28751559	1	O
30%	28751559	1	O
of	28751559	1	O
cases	28751559	1	O
of	28751559	1	O
BCR	28751559	1	O
-	28751559	1	O
ABL	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
B	28751559	1	O
-	28751559	1	O
cell	28751559	1	O
precursor	28751559	1	O
acute	28751559	1	O
lymphoblastic	28751559	1	O
leukemia	28751559	1	O
(	28751559	1	O
ALL	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Different	28751559	1	O
types	28751559	1	O
of	28751559	1	O
intragenic	28751559	1	O
deletions	28751559	1	B-Var
have	28751559	1	O
been	28751559	1	O
observed	28751559	1	O
,	28751559	1	O
resulting	28751559	1	O
in	28751559	1	O
a	28751559	1	O
functionally	28751559	1	B-MPA
inactivated	28751559	1	I-MPA
allele	28751559	1	I-MPA
(	28751559	1	B-NegReg
"	28751559	1	I-NegReg
loss	28751559	1	I-NegReg
-	28751559	1	I-NegReg
of	28751559	1	I-NegReg
-	28751559	1	I-NegReg
function	28751559	1	I-NegReg
"	28751559	1	I-NegReg
)	28751559	1	I-NegReg
or	28751559	1	O
in	28751559	1	O
"	28751559	1	B-NegReg
dominant	28751559	1	I-NegReg
-	28751559	1	I-NegReg
negative	28751559	1	I-NegReg
"	28751559	1	I-NegReg
isoforms	28751559	1	B-MPA
.	28751559	1	O
The	28751559	1	O
prognostic	28751559	1	O
impact	28751559	1	O
of	28751559	1	O
these	28751559	1	O
alterations	28751559	1	O
especially	28751559	1	O
in	28751559	1	O
adult	28751559	1	O
acute	28751559	1	O
lymphoblastic	28751559	1	O
leukemia	28751559	1	O
is	28751559	1	O
not	28751559	1	O
well	28751559	1	O
defined	28751559	1	O
.	28751559	1	O
We	28751559	1	O
analyzed	28751559	1	O
482	28751559	1	O
well	28751559	1	O
-	28751559	1	O
characterized	28751559	1	O
cases	28751559	1	O
of	28751559	1	O
adult	28751559	1	O
BCR	28751559	1	O
-	28751559	1	O
ABL	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
B	28751559	1	O
-	28751559	1	O
precursor	28751559	1	O
acute	28751559	1	O
lymphoblastic	28751559	1	O
leukemia	28751559	1	O
uniformly	28751559	1	O
treated	28751559	1	O
in	28751559	1	O
the	28751559	1	O
framework	28751559	1	O
of	28751559	1	O
the	28751559	1	O
GMALL	28751559	1	O
studies	28751559	1	O
and	28751559	1	O
detected	28751559	1	O
IKZF1	28751559	1	O
alterations	28751559	1	O
in	28751559	1	O
128	28751559	1	O
cases	28751559	1	O
(	28751559	1	O
27%	28751559	1	O
)	28751559	1	O
.	28751559	1	O
In	28751559	1	O
20%	28751559	1	O
,	28751559	1	O
the	28751559	1	O
IKZF1	28751559	1	O
alteration	28751559	1	O
was	28751559	1	O
present	28751559	1	O
in	28751559	1	O
a	28751559	1	O
large	28751559	1	O
fraction	28751559	1	O
of	28751559	1	O
leukemic	28751559	1	O
cells	28751559	1	O
(	28751559	1	O
"	28751559	1	O
high	28751559	1	O
deletion	28751559	1	O
load	28751559	1	O
"	28751559	1	O
)	28751559	1	O
while	28751559	1	O
in	28751559	1	O
7%	28751559	1	O
it	28751559	1	O
was	28751559	1	O
detected	28751559	1	O
only	28751559	1	O
in	28751559	1	O
small	28751559	1	O
subclones	28751559	1	O
(	28751559	1	O
"	28751559	1	O
low	28751559	1	O
deletion	28751559	1	O
load	28751559	1	O
"	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Some	28751559	1	O
patients	28751559	1	O
showed	28751559	1	O
more	28751559	1	O
than	28751559	1	O
one	28751559	1	O
IKZF1	28751559	1	O
alteration	28751559	1	O
(	28751559	1	O
8%	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Patients	28751559	1	O
exhibiting	28751559	1	O
a	28751559	1	O
loss	28751559	1	O
-	28751559	1	O
of	28751559	1	O
-	28751559	1	O
function	28751559	1	O
isoform	28751559	1	O
with	28751559	1	O
high	28751559	1	B-Var
deletion	28751559	1	I-Var
load	28751559	1	I-Var
had	28751559	1	O
a	28751559	1	O
shorter	28751559	1	B-NegReg
overall	28751559	1	B-MPA
survival	28751559	1	I-MPA
(	28751559	1	O
OS	28751559	1	O
at	28751559	1	O
5	28751559	1	O
years	28751559	1	O
28%	28751559	1	O
vs.59	28751559	1	O
,	28751559	1	O
p	28751559	1	O
<	28751559	1	O
0.0001	28751559	1	O
)	28751559	1	O
,	28751559	1	O
also	28751559	1	O
significant	28751559	1	O
in	28751559	1	O
a	28751559	1	O
subgroup	28751559	1	O
analysis	28751559	1	O
of	28751559	1	O
standard	28751559	1	O
risk	28751559	1	O
patients	28751559	1	O
according	28751559	1	O
to	28751559	1	O
GMALL	28751559	1	O
classification	28751559	1	O
(	28751559	1	O
OS	28751559	1	O
at	28751559	1	O
5	28751559	1	O
years	28751559	1	O
37%	28751559	1	O
vs.68	28751559	1	O
,	28751559	1	O
p	28751559	1	O
=	28751559	1	O
0.0002	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Low	28751559	1	O
deletion	28751559	1	O
load	28751559	1	O
or	28751559	1	O
dominant	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
IKZF1	28751559	1	O
alterations	28751559	1	O
had	28751559	1	O
no	28751559	1	O
prognostic	28751559	1	O
impact	28751559	1	O
.	28751559	1	O
The	28751559	1	O
results	28751559	1	O
thus	28751559	1	O
suggest	28751559	1	O
that	28751559	1	O
there	28751559	1	O
is	28751559	1	O
a	28751559	1	O
clear	28751559	1	O
distinction	28751559	1	O
between	28751559	1	O
loss	28751559	1	O
-	28751559	1	O
of	28751559	1	O
-	28751559	1	O
function	28751559	1	O
and	28751559	1	O
dominant	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
IKZF1	28751559	1	O
deletions	28751559	1	O
.	28751559	1	O
Affected	28751559	1	O
patients	28751559	1	O
should	28751559	1	O
thus	28751559	1	O
be	28751559	1	O
monitored	28751559	1	O
for	28751559	1	O
minimal	28751559	1	O
residual	28751559	1	O
disease	28751559	1	O
carefully	28751559	1	O
to	28751559	1	O
detect	28751559	1	O
incipient	28751559	1	O
relapses	28751559	1	O
at	28751559	1	O
an	28751559	1	O
early	28751559	1	O
stage	28751559	1	O
and	28751559	1	O
they	28751559	1	O
are	28751559	1	O
potential	28751559	1	O
candidates	28751559	1	O
for	28751559	1	O
alternative	28751559	1	O
or	28751559	1	O
intensified	28751559	1	O
treatment	28751559	1	O
regimes	28751559	1	O
.	28751559	1	O
Registered	28751559	1	O
at	28751559	1	O
http	28751559	1	O
:	28751559	1	O
/	28751559	1	O
/	28751559	1	O
www	28751559	1	O
.	28751559	1	O
clinicaltrials	28751559	1	O
.	28751559	1	O
gov	28751559	1	O
:	28751559	1	O
NCT00199056	28751559	1	O
,	28751559	1	O
NCT00198991	28751559	1	O
.	28751559	1	O

Stress	28754659	0	O
-	28754659	0	O
Induced	28754659	0	O
Sleep	28754659	0	O
After	28754659	0	O
Exposure	28754659	0	O
to	28754659	0	O
Ultraviolet	28754659	0	O
Light	28754659	0	O
Is	28754659	0	O
Promoted	28754659	0	O
by	28754659	0	O
p53	28754659	0	O
in	28754659	0	O
Caenorhabditis	28754659	0	O
elegans	28754659	0	O
.	28754659	0	O
Stress	28754659	0	O
-	28754659	0	O
induced	28754659	0	O
sleep	28754659	0	O
(	28754659	0	O
SIS	28754659	0	O
)	28754659	0	O
in	28754659	0	O
C.	28754659	0	O
elegans	28754659	0	O
is	28754659	0	O
important	28754659	0	O
for	28754659	0	O
restoration	28754659	0	O
of	28754659	0	O
cellular	28754659	0	O
homeostasis	28754659	0	O
and	28754659	0	O
is	28754659	0	O
a	28754659	0	O
useful	28754659	0	O
model	28754659	0	O
to	28754659	0	O
study	28754659	0	O
the	28754659	0	O
function	28754659	0	O
and	28754659	0	O
regulation	28754659	0	O
of	28754659	0	O
sleep	28754659	0	O
.	28754659	0	O
SIS	28754659	0	O
is	28754659	0	O
triggered	28754659	0	O
when	28754659	0	O
epidermal	28754659	0	O
growth	28754659	0	O
factor	28754659	0	O
(	28754659	0	O
EGF	28754659	0	O
)	28754659	0	O
activates	28754659	0	O
the	28754659	0	O
ALA	28754659	0	O
neuron	28754659	0	O
,	28754659	0	O
which	28754659	0	O
then	28754659	0	O
releases	28754659	0	O
neuropeptides	28754659	0	O
to	28754659	0	O
promote	28754659	0	O
sleep	28754659	0	O
.	28754659	0	O
To	28754659	0	O
further	28754659	0	O
understand	28754659	0	O
this	28754659	0	O
behavior	28754659	0	O
,	28754659	0	O
we	28754659	0	O
established	28754659	0	O
a	28754659	0	O
new	28754659	0	O
model	28754659	0	O
of	28754659	0	O
stress	28754659	0	O
-	28754659	0	O
induced	28754659	0	O
sleep	28754659	0	O
using	28754659	0	O
irradiation	28754659	0	O
by	28754659	0	O
ultraviolet	28754659	0	O
C	28754659	0	O
(	28754659	0	O
UVC	28754659	0	O
)	28754659	0	O
light	28754659	0	O
.	28754659	0	O
While	28754659	0	O
UVC	28754659	0	O
irradiation	28754659	0	O
requires	28754659	0	O
ALA	28754659	0	O
signaling	28754659	0	O
and	28754659	0	O
leads	28754659	0	O
to	28754659	0	O
a	28754659	0	O
sleep	28754659	0	O
state	28754659	0	O
similar	28754659	0	O
to	28754659	0	O
that	28754659	0	O
induced	28754659	0	O
by	28754659	0	O
heat	28754659	0	O
and	28754659	0	O
other	28754659	0	O
stressors	28754659	0	O
,	28754659	0	O
it	28754659	0	O
does	28754659	0	O
not	28754659	0	O
induce	28754659	0	O
the	28754659	0	O
proteostatic	28754659	0	O
stress	28754659	0	O
seen	28754659	0	O
with	28754659	0	O
heat	28754659	0	O
exposure	28754659	0	O
.	28754659	0	O
Based	28754659	0	O
on	28754659	0	O
the	28754659	0	O
known	28754659	0	O
genotoxic	28754659	0	O
effects	28754659	0	O
of	28754659	0	O
UVC	28754659	0	O
irradiation	28754659	0	O
,	28754659	0	O
we	28754659	0	O
tested	28754659	0	O
two	28754659	0	O
genes	28754659	0	O
-	28754659	0	O
atl-1	28754659	0	O
and	28754659	0	O
cep-1	28754659	0	O
-	28754659	0	O
which	28754659	0	O
encode	28754659	0	O
proteins	28754659	0	O
that	28754659	0	O
act	28754659	0	O
in	28754659	0	O
the	28754659	0	O
DNA	28754659	0	O
damage	28754659	0	O
response	28754659	0	O
pathway	28754659	0	O
.	28754659	0	O
Loss	28754659	0	O
of	28754659	0	O
function	28754659	0	O
mutants	28754659	0	O
of	28754659	0	O
atl-1	28754659	0	O
had	28754659	0	O
no	28754659	0	O
defect	28754659	0	O
in	28754659	0	O
UVC	28754659	0	O
induced	28754659	0	O
SIS	28754659	0	O
but	28754659	0	O
a	28754659	0	O
partial	28754659	0	O
loss	28754659	0	B-NegReg
of	28754659	0	I-NegReg
function	28754659	0	I-NegReg
mutant	28754659	0	B-Var
of	28754659	0	O
cep-1	28754659	0	B-Gene
,	28754659	0	O
gk138	28754659	0	O
,	28754659	0	O
had	28754659	0	O
decreased	28754659	0	B-NegReg
movement	28754659	0	B-MPA
quiescence	28754659	0	I-MPA
following	28754659	0	O
UVC	28754659	0	O
irradiation	28754659	0	O
.	28754659	0	O
Germline	28754659	0	O
ablation	28754659	0	O
experiments	28754659	0	O
and	28754659	0	O
tissue	28754659	0	O
-	28754659	0	O
specific	28754659	0	O
RNA	28754659	0	O
interference	28754659	0	O
experiments	28754659	0	O
showed	28754659	0	O
that	28754659	0	O
cep-1	28754659	0	O
is	28754659	0	O
required	28754659	0	O
somatically	28754659	0	O
in	28754659	0	O
neurons	28754659	0	O
for	28754659	0	O
its	28754659	0	O
effect	28754659	0	O
on	28754659	0	O
SIS	28754659	0	O
.	28754659	0	O
The	28754659	0	O
cep-1	28754659	0	B-Gene
(	28754659	0	I-Gene
gk138	28754659	0	I-Gene
)	28754659	0	I-Gene
mutant	28754659	0	B-Var
suppressed	28754659	0	B-NegReg
body	28754659	0	B-MPA
movement	28754659	0	I-MPA
quiescence	28754659	0	I-MPA
controlled	28754659	0	I-MPA
by	28754659	0	I-MPA
EGF	28754659	0	I-MPA
,	28754659	0	O
indicating	28754659	0	O
that	28754659	0	O
CEP-1	28754659	0	O
acts	28754659	0	O
downstream	28754659	0	O
or	28754659	0	O
in	28754659	0	O
parallel	28754659	0	O
to	28754659	0	O
ALA	28754659	0	O
activation	28754659	0	O
to	28754659	0	O
promote	28754659	0	O
quiescence	28754659	0	O
in	28754659	0	O
response	28754659	0	O
to	28754659	0	O
ultraviolet	28754659	0	O
light	28754659	0	O
.	28754659	0	O

PCSK9	28758421	0	B-Gene
deficiency	28758421	0	B-Var
results	28758421	0	O
in	28758421	0	O
increased	28758421	0	B-PosReg
ectopic	28758421	0	B-MPA
fat	28758421	0	I-MPA
accumulation	28758421	0	I-MPA
in	28758421	0	O
experimental	28758421	0	O
models	28758421	0	O
and	28758421	0	O
in	28758421	0	O
humans	28758421	0	O
.	28758421	0	O
Background	28758421	0	O
Proprotein	28758421	0	O
convertase	28758421	0	O
subtilisin	28758421	0	O
kexin	28758421	0	O
type	28758421	0	O
9	28758421	0	O
(	28758421	0	O
PCSK9	28758421	0	O
)	28758421	0	O
regulates	28758421	0	O
low	28758421	0	O
-	28758421	0	O
density	28758421	0	O
lipoprotein	28758421	0	O
and	28758421	0	O
very	28758421	0	O
low	28758421	0	O
-	28758421	0	O
density	28758421	0	O
lipoprotein	28758421	0	O
receptor	28758421	0	O
expression	28758421	0	O
in	28758421	0	O
several	28758421	0	O
tissues	28758421	0	O
.	28758421	0	O
Here	28758421	0	O
we	28758421	0	O
evaluated	28758421	0	O
whether	28758421	0	O
PCSK9	28758421	0	O
may	28758421	0	O
modulate	28758421	0	O
the	28758421	0	O
handling	28758421	0	O
of	28758421	0	O
triglycerides	28758421	0	O
in	28758421	0	O
the	28758421	0	O
liver	28758421	0	O
and	28758421	0	O
peripheral	28758421	0	O
tissues	28758421	0	O
.	28758421	0	O
Methods	28758421	0	O
Subjects	28758421	0	O
from	28758421	0	O
the	28758421	0	O
PLIC	28758421	0	O
cohort	28758421	0	O
were	28758421	0	O
genotyped	28758421	0	O
for	28758421	0	O
the	28758421	0	O
loss	28758421	0	O
-	28758421	0	O
of	28758421	0	O
-	28758421	0	O
function	28758421	0	O
PCSK9	28758421	0	O
R46L	28758421	0	O
variant	28758421	0	O
and	28758421	0	O
characterized	28758421	0	O
for	28758421	0	O
clinical	28758421	0	O
and	28758421	0	O
biochemical	28758421	0	O
parameters	28758421	0	O
,	28758421	0	O
total	28758421	0	O
and	28758421	0	O
android	28758421	0	O
fat	28758421	0	O
mass	28758421	0	O
,	28758421	0	O
hepatic	28758421	0	O
steatosis	28758421	0	O
and	28758421	0	O
epicardial	28758421	0	O
fat	28758421	0	O
thickness	28758421	0	O
.	28758421	0	O
Visceral	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
and	28758421	0	O
subcutaneous	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
in	28758421	0	O
PCSK9	28758421	0	O
KO	28758421	0	O
and	28758421	0	O
wild	28758421	0	O
type	28758421	0	O
mice	28758421	0	O
were	28758421	0	O
quantified	28758421	0	O
by	28758421	0	O
nuclear	28758421	0	O
magnetic	28758421	0	O
resonance	28758421	0	O
imaging	28758421	0	O
.	28758421	0	O
Results	28758421	0	O
Carriers	28758421	0	O
of	28758421	0	O
the	28758421	0	O
R46L	28758421	0	O
variant	28758421	0	O
(	28758421	0	O
n	28758421	0	O
=	28758421	0	O
13	28758421	0	O
)	28758421	0	O
had	28758421	0	O
lower	28758421	0	O
low	28758421	0	O
-	28758421	0	O
density	28758421	0	O
lipoprotein	28758421	0	O
cholesterol	28758421	0	O
levels	28758421	0	O
,	28758421	0	O
higher	28758421	0	O
body	28758421	0	O
mass	28758421	0	O
index	28758421	0	O
and	28758421	0	O
increased	28758421	0	O
percentage	28758421	0	O
of	28758421	0	O
total	28758421	0	O
and	28758421	0	O
android	28758421	0	O
fat	28758421	0	O
masses	28758421	0	O
compared	28758421	0	O
with	28758421	0	O
non	28758421	0	O
-	28758421	0	O
carriers	28758421	0	O
(	28758421	0	O
n	28758421	0	O
=	28758421	0	O
521	28758421	0	O
)	28758421	0	O
.	28758421	0	O
R46L	28758421	0	B-Gene
variant	28758421	0	B-Var
associated	28758421	0	O
with	28758421	0	O
a	28758421	0	O
two	28758421	0	O
-	28758421	0	O
fold	28758421	0	O
increase	28758421	0	B-PosReg
prevalence	28758421	0	O
of	28758421	0	O
hepatic	28758421	0	B-MPA
steatosis	28758421	0	I-MPA
and	28758421	0	I-MPA
higher	28758421	0	I-MPA
epicardial	28758421	0	I-MPA
fat	28758421	0	I-MPA
thickness	28758421	0	I-MPA
.	28758421	0	O
These	28758421	0	O
observations	28758421	0	O
were	28758421	0	O
replicated	28758421	0	O
in	28758421	0	O
PCSK9	28758421	0	O
KO	28758421	0	O
mice	28758421	0	O
,	28758421	0	O
which	28758421	0	O
showed	28758421	0	O
increased	28758421	0	O
visceral	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
(	28758421	0	O
but	28758421	0	O
not	28758421	0	O
subcutaneous	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
)	28758421	0	O
when	28758421	0	O
fed	28758421	0	O
chow	28758421	0	O
or	28758421	0	O
high	28758421	0	O
-	28758421	0	O
fat	28758421	0	O
diet	28758421	0	O
for	28758421	0	O
20	28758421	0	O
weeks	28758421	0	O
,	28758421	0	O
compared	28758421	0	O
with	28758421	0	O
wild	28758421	0	O
type	28758421	0	O
mice	28758421	0	O
.	28758421	0	O
Conclusions	28758421	0	O
These	28758421	0	O
data	28758421	0	O
suggest	28758421	0	O
that	28758421	0	O
genetically	28758421	0	O
determined	28758421	0	O
PCSK9	28758421	0	B-Gene
deficiency	28758421	0	B-Var
might	28758421	0	O
be	28758421	0	O
associated	28758421	0	B-Reg
with	28758421	0	O
ectopic	28758421	0	B-MPA
fat	28758421	0	I-MPA
accumulation	28758421	0	I-MPA
.	28758421	0	O

A	28783725	2	O
Braf	28783725	2	B-Gene
kinase	28783725	2	O
-	28783725	2	O
inactive	28783725	2	O
mutant	28783725	2	B-Var
induces	28783725	2	B-Reg
lung	28783725	2	B-Disease
adenocarcinoma	28783725	2	I-Disease
.	28783725	2	O
The	28783725	2	O
initiating	28783725	2	O
oncogenic	28783725	2	O
event	28783725	2	O
in	28783725	2	O
almost	28783725	2	O
half	28783725	2	O
of	28783725	2	O
human	28783725	2	O
lung	28783725	2	O
adenocarcinomas	28783725	2	O
is	28783725	2	O
still	28783725	2	O
unknown	28783725	2	O
,	28783725	2	O
a	28783725	2	O
fact	28783725	2	O
that	28783725	2	O
complicates	28783725	2	O
the	28783725	2	O
development	28783725	2	O
of	28783725	2	O
selective	28783725	2	O
targeted	28783725	2	O
therapies	28783725	2	O
.	28783725	2	O
Yet	28783725	2	O
these	28783725	2	O
tumours	28783725	2	O
harbour	28783725	2	O
a	28783725	2	O
number	28783725	2	O
of	28783725	2	O
alterations	28783725	2	O
without	28783725	2	O
obvious	28783725	2	O
oncogenic	28783725	2	O
function	28783725	2	O
including	28783725	2	O
BRAF	28783725	2	O
-	28783725	2	O
inactivating	28783725	2	O
mutations	28783725	2	O
.	28783725	2	O
Inactivating	28783725	2	O
BRAF	28783725	2	O
mutants	28783725	2	O
in	28783725	2	O
lung	28783725	2	O
predominate	28783725	2	O
over	28783725	2	O
the	28783725	2	O
activating	28783725	2	O
V600E	28783725	2	O
mutant	28783725	2	O
that	28783725	2	O
is	28783725	2	O
frequently	28783725	2	O
observed	28783725	2	O
in	28783725	2	O
other	28783725	2	O
tumour	28783725	2	O
types	28783725	2	O
.	28783725	2	O
Here	28783725	2	O
we	28783725	2	O
demonstrate	28783725	2	O
that	28783725	2	O
the	28783725	2	O
expression	28783725	2	O
of	28783725	2	O
an	28783725	2	O
endogenous	28783725	2	O
Braf	28783725	2	O
(	28783725	2	O
D631A	28783725	2	O
)	28783725	2	O
kinase	28783725	2	O
-	28783725	2	O
inactive	28783725	2	O
isoform	28783725	2	O
in	28783725	2	O
mice	28783725	2	O
(	28783725	2	O
corresponding	28783725	2	O
to	28783725	2	O
the	28783725	2	O
human	28783725	2	O
BRAF	28783725	2	O
(	28783725	2	O
D594A	28783725	2	O
)	28783725	2	O
mutation	28783725	2	O
)	28783725	2	O
triggers	28783725	2	O
lung	28783725	2	O
adenocarcinoma	28783725	2	O
in	28783725	2	O
vivo	28783725	2	O
,	28783725	2	O
indicating	28783725	2	O
that	28783725	2	O
BRAF	28783725	2	O
-	28783725	2	O
inactivating	28783725	2	O
mutations	28783725	2	O
are	28783725	2	O
initiating	28783725	2	O
events	28783725	2	O
in	28783725	2	O
lung	28783725	2	O
oncogenesis	28783725	2	O
.	28783725	2	O
Moreover	28783725	2	O
,	28783725	2	O
inactivating	28783725	2	O
BRAF	28783725	2	O
mutations	28783725	2	O
have	28783725	2	O
also	28783725	2	O
been	28783725	2	O
identified	28783725	2	O
in	28783725	2	O
a	28783725	2	O
subset	28783725	2	O
of	28783725	2	O
KRAS	28783725	2	O
-	28783725	2	O
driven	28783725	2	O
human	28783725	2	O
lung	28783725	2	O
tumours	28783725	2	O
.	28783725	2	O
Co	28783725	2	O
-	28783725	2	O
expression	28783725	2	O
of	28783725	2	O
Kras	28783725	2	B-Var
(	28783725	2	I-Var
G12V	28783725	2	I-Var
)	28783725	2	I-Var
and	28783725	2	O
Braf	28783725	2	B-Var
(	28783725	2	I-Var
D631A	28783725	2	I-Var
)	28783725	2	I-Var
in	28783725	2	O
mouse	28783725	2	O
lung	28783725	2	O
cells	28783725	2	O
markedly	28783725	2	O
enhances	28783725	2	B-PosReg
tumour	28783725	2	B-MPA
initiation	28783725	2	I-MPA
,	28783725	2	O
a	28783725	2	O
phenomenon	28783725	2	O
mediated	28783725	2	O
by	28783725	2	O
Craf	28783725	2	O
kinase	28783725	2	O
activity	28783725	2	O
,	28783725	2	O
and	28783725	2	O
effectively	28783725	2	O
accelerates	28783725	2	O
tumour	28783725	2	O
progression	28783725	2	O
when	28783725	2	O
activated	28783725	2	O
in	28783725	2	O
advanced	28783725	2	O
lung	28783725	2	O
adenocarcinomas	28783725	2	O
.	28783725	2	O
We	28783725	2	O
also	28783725	2	O
report	28783725	2	O
a	28783725	2	O
key	28783725	2	O
role	28783725	2	O
for	28783725	2	O
the	28783725	2	O
wild	28783725	2	O
-	28783725	2	O
type	28783725	2	O
Braf	28783725	2	O
kinase	28783725	2	O
in	28783725	2	O
sustaining	28783725	2	O
Kras	28783725	2	O
(	28783725	2	O
G12V	28783725	2	O
)	28783725	2	O
/	28783725	2	O
Braf	28783725	2	O
(	28783725	2	O
D631A	28783725	2	O
)	28783725	2	O
-	28783725	2	O
driven	28783725	2	O
tumours	28783725	2	O
.	28783725	2	O
Ablation	28783725	2	O
of	28783725	2	O
the	28783725	2	O
wild	28783725	2	O
-	28783725	2	O
type	28783725	2	O
Braf	28783725	2	O
allele	28783725	2	O
prevents	28783725	2	O
the	28783725	2	O
development	28783725	2	O
of	28783725	2	O
lung	28783725	2	O
adenocarcinoma	28783725	2	O
by	28783725	2	O
inducing	28783725	2	O
a	28783725	2	O
further	28783725	2	O
increase	28783725	2	O
in	28783725	2	O
MAPK	28783725	2	O
signalling	28783725	2	O
that	28783725	2	O
results	28783725	2	O
in	28783725	2	O
oncogenic	28783725	2	O
toxicity	28783725	2	O
;	28783725	2	O
this	28783725	2	O
effect	28783725	2	O
can	28783725	2	O
be	28783725	2	O
abolished	28783725	2	O
by	28783725	2	O
pharmacological	28783725	2	O
inhibition	28783725	2	O
of	28783725	2	O
Mek	28783725	2	O
to	28783725	2	O
restore	28783725	2	O
tumour	28783725	2	O
growth	28783725	2	O
.	28783725	2	O
However	28783725	2	O
,	28783725	2	O
the	28783725	2	O
loss	28783725	2	B-Var
of	28783725	2	O
wild	28783725	2	O
-	28783725	2	O
type	28783725	2	O
Braf	28783725	2	B-Gene
also	28783725	2	O
induces	28783725	2	B-Reg
transdifferentiation	28783725	2	B-CPA
of	28783725	2	O
club	28783725	2	O
cells	28783725	2	O
,	28783725	2	O
which	28783725	2	O
leads	28783725	2	B-Reg
to	28783725	2	I-Reg
the	28783725	2	O
rapid	28783725	2	B-MPA
development	28783725	2	I-MPA
of	28783725	2	I-MPA
lethal	28783725	2	I-MPA
intrabronchiolar	28783725	2	I-MPA
lesions	28783725	2	I-MPA
.	28783725	2	O
These	28783725	2	O
observations	28783725	2	O
indicate	28783725	2	O
that	28783725	2	O
the	28783725	2	O
signal	28783725	2	O
intensity	28783725	2	O
of	28783725	2	O
the	28783725	2	O
MAPK	28783725	2	O
pathway	28783725	2	O
is	28783725	2	O
a	28783725	2	O
critical	28783725	2	O
determinant	28783725	2	O
not	28783725	2	O
only	28783725	2	O
in	28783725	2	O
tumour	28783725	2	O
development	28783725	2	O
,	28783725	2	O
but	28783725	2	O
also	28783725	2	O
in	28783725	2	O
dictating	28783725	2	O
the	28783725	2	O
nature	28783725	2	O
of	28783725	2	O
the	28783725	2	O
cancer	28783725	2	O
-	28783725	2	O
initiating	28783725	2	O
cell	28783725	2	O
and	28783725	2	O
ultimately	28783725	2	O
the	28783725	2	O
resulting	28783725	2	O
tumour	28783725	2	O
phenotype	28783725	2	O
.	28783725	2	O

Enpp1	28798354	4	O
is	28798354	4	O
an	28798354	4	O
anti	28798354	4	O
-	28798354	4	O
aging	28798354	4	O
factor	28798354	4	O
that	28798354	4	O
regulates	28798354	4	O
Klotho	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
.	28798354	4	O
Control	28798354	4	O
of	28798354	4	O
phosphate	28798354	4	O
metabolism	28798354	4	O
is	28798354	4	O
crucial	28798354	4	O
to	28798354	4	O
regulate	28798354	4	O
aging	28798354	4	O
in	28798354	4	O
mammals	28798354	4	O
.	28798354	4	O
Klotho	28798354	4	O
is	28798354	4	O
a	28798354	4	O
well	28798354	4	O
-	28798354	4	O
known	28798354	4	O
anti	28798354	4	O
-	28798354	4	O
aging	28798354	4	O
factor	28798354	4	O
that	28798354	4	O
regulates	28798354	4	O
phosphate	28798354	4	O
metabolism	28798354	4	O
:	28798354	4	O
mice	28798354	4	O
mutant	28798354	4	O
or	28798354	4	O
deficient	28798354	4	O
in	28798354	4	O
Klotho	28798354	4	O
exhibit	28798354	4	O
phenotypes	28798354	4	O
resembling	28798354	4	O
human	28798354	4	O
aging	28798354	4	O
.	28798354	4	O
Here	28798354	4	O
we	28798354	4	O
show	28798354	4	O
that	28798354	4	O
ectonucleotide	28798354	4	O
pyrophosphatase	28798354	4	O
/	28798354	4	O
phosphodiesterase	28798354	4	O
1	28798354	4	O
(	28798354	4	O
Enpp1	28798354	4	O
)	28798354	4	O
is	28798354	4	O
required	28798354	4	O
for	28798354	4	O
Klotho	28798354	4	O
expression	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
.	28798354	4	O
Loss	28798354	4	B-Var
-	28798354	4	I-Var
of	28798354	4	I-Var
-	28798354	4	I-Var
function	28798354	4	I-Var
Enpp1	28798354	4	B-Gene
(	28798354	4	O
ttw	28798354	4	O
/	28798354	4	O
ttw	28798354	4	O
)	28798354	4	O
mice	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
exhibited	28798354	4	B-Reg
phenotypes	28798354	4	O
resembling	28798354	4	O
human	28798354	4	O
aging	28798354	4	O
and	28798354	4	O
Klotho	28798354	4	O
mutants	28798354	4	O
,	28798354	4	O
such	28798354	4	O
as	28798354	4	O
short	28798354	4	O
life	28798354	4	O
span	28798354	4	O
,	28798354	4	O
arteriosclerosis	28798354	4	B-Disease
and	28798354	4	O
osteoporosis	28798354	4	B-Disease
,	28798354	4	O
with	28798354	4	O
elevated	28798354	4	B-PosReg
serum	28798354	4	B-MPA
1	28798354	4	I-MPA
,	28798354	4	I-MPA
25	28798354	4	I-MPA
(	28798354	4	I-MPA
OH	28798354	4	I-MPA
)	28798354	4	I-MPA
2	28798354	4	I-MPA
D3	28798354	4	I-MPA
levels	28798354	4	I-MPA
.	28798354	4	O
Enpp1	28798354	4	O
(	28798354	4	O
ttw	28798354	4	O
/	28798354	4	O
ttw	28798354	4	O
)	28798354	4	O
mice	28798354	4	O
also	28798354	4	O
exhibited	28798354	4	O
significantly	28798354	4	O
reduced	28798354	4	O
renal	28798354	4	O
Klotho	28798354	4	O
expression	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
,	28798354	4	O
and	28798354	4	O
aging	28798354	4	O
phenotypes	28798354	4	O
in	28798354	4	O
these	28798354	4	O
mice	28798354	4	O
were	28798354	4	O
rescued	28798354	4	O
by	28798354	4	O
Klotho	28798354	4	O
overexpression	28798354	4	O
,	28798354	4	O
a	28798354	4	O
low	28798354	4	O
vitamin	28798354	4	O
D	28798354	4	O
diet	28798354	4	O
or	28798354	4	O
vitamin	28798354	4	O
D	28798354	4	O
receptor	28798354	4	O
knockout	28798354	4	O
.	28798354	4	O
These	28798354	4	O
findings	28798354	4	O
indicate	28798354	4	O
that	28798354	4	O
Enpp1	28798354	4	O
plays	28798354	4	O
a	28798354	4	O
crucial	28798354	4	O
role	28798354	4	O
in	28798354	4	O
regulating	28798354	4	O
aging	28798354	4	O
via	28798354	4	O
Klotho	28798354	4	O
expression	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
.	28798354	4	O

Characterization	28800850	0	O
of	28800850	0	O
the	28800850	0	O
autophagy	28800850	0	O
-	28800850	0	O
related	28800850	0	O
gene	28800850	0	O
BmATG8	28800850	0	O
in	28800850	0	O
Bipolaris	28800850	0	O
maydis	28800850	0	O
.	28800850	0	O
Autophagy	28800850	0	O
is	28800850	0	O
involved	28800850	0	O
in	28800850	0	O
cellular	28800850	0	O
development	28800850	0	O
and	28800850	0	O
the	28800850	0	O
maintenance	28800850	0	O
of	28800850	0	O
viability	28800850	0	O
under	28800850	0	O
nutrient	28800850	0	O
deprivation	28800850	0	O
in	28800850	0	O
a	28800850	0	O
wide	28800850	0	O
range	28800850	0	O
of	28800850	0	O
eukaryotes	28800850	0	O
.	28800850	0	O
A	28800850	0	O
filamentous	28800850	0	O
ascomycete	28800850	0	O
Bipolaris	28800850	0	O
maydis	28800850	0	O
,	28800850	0	O
responsible	28800850	0	O
for	28800850	0	O
southern	28800850	0	O
corn	28800850	0	O
leaf	28800850	0	O
blight	28800850	0	O
,	28800850	0	O
is	28800850	0	O
also	28800850	0	O
studied	28800850	0	O
as	28800850	0	O
a	28800850	0	O
model	28800850	0	O
fungus	28800850	0	O
for	28800850	0	O
sexual	28800850	0	O
reproduction	28800850	0	O
in	28800850	0	O
filamentous	28800850	0	O
ascomycetes	28800850	0	O
that	28800850	0	O
form	28800850	0	O
filiform	28800850	0	O
ascospores	28800850	0	O
.	28800850	0	O
In	28800850	0	O
order	28800850	0	O
to	28800850	0	O
clarify	28800850	0	O
the	28800850	0	O
roles	28800850	0	O
of	28800850	0	O
autophagy	28800850	0	O
in	28800850	0	O
various	28800850	0	O
stages	28800850	0	O
of	28800850	0	O
the	28800850	0	O
life	28800850	0	O
cycle	28800850	0	O
of	28800850	0	O
B.	28800850	0	O
maydis	28800850	0	O
,	28800850	0	O
we	28800850	0	O
constructed	28800850	0	O
null	28800850	0	O
mutants	28800850	0	O
of	28800850	0	O
BmATG8	28800850	0	O
,	28800850	0	O
an	28800850	0	O
orthologue	28800850	0	O
of	28800850	0	O
the	28800850	0	O
Saccharomyces	28800850	0	O
cerevisiae	28800850	0	O
autophagy	28800850	0	O
gene	28800850	0	O
ATG8	28800850	0	O
in	28800850	0	O
B.	28800850	0	O
maydis	28800850	0	O
.	28800850	0	O
Deletion	28800850	0	B-Var
of	28800850	0	O
BmATG8	28800850	0	B-Gene
impaired	28800850	0	B-NegReg
localization	28800850	0	B-MPA
of	28800850	0	O
cytosolic	28800850	0	O
components	28800850	0	O
to	28800850	0	O
the	28800850	0	O
vacuole	28800850	0	O
under	28800850	0	O
nitrogen	28800850	0	O
starvation	28800850	0	O
,	28800850	0	O
suggesting	28800850	0	O
that	28800850	0	O
autophagy	28800850	0	B-CPA
was	28800850	0	O
deficient	28800850	0	B-NegReg
in	28800850	0	O
the	28800850	0	O
null	28800850	0	O
mutants	28800850	0	O
.	28800850	0	O
Additionally	28800850	0	O
,	28800850	0	O
fluorescent	28800850	0	O
microscopic	28800850	0	O
observations	28800850	0	O
on	28800850	0	O
a	28800850	0	O
eGFP	28800850	0	O
-	28800850	0	O
fused	28800850	0	O
BmATG8	28800850	0	O
expressing	28800850	0	O
strain	28800850	0	O
showed	28800850	0	O
that	28800850	0	O
BmATG8	28800850	0	O
is	28800850	0	O
associated	28800850	0	O
with	28800850	0	O
autophagy	28800850	0	O
-	28800850	0	O
related	28800850	0	O
structures	28800850	0	O
.	28800850	0	O
In	28800850	0	O
vegetative	28800850	0	O
growth	28800850	0	O
,	28800850	0	O
ΔBmATG8	28800850	0	B-Gene
strains	28800850	0	O
showed	28800850	0	O
a	28800850	0	O
reduction	28800850	0	B-NegReg
in	28800850	0	O
conidiation	28800850	0	B-CPA
and	28800850	0	I-CPA
aerial	28800850	0	I-CPA
mycelial	28800850	0	I-CPA
growth	28800850	0	I-CPA
.	28800850	0	O
Interestingly	28800850	0	O
,	28800850	0	O
the	28800850	0	O
mutant	28800850	0	O
conidia	28800850	0	O
indicated	28800850	0	O
loss	28800850	0	O
of	28800850	0	O
the	28800850	0	O
germination	28800850	0	O
rate	28800850	0	O
under	28800850	0	O
starvation	28800850	0	O
conditions	28800850	0	O
and	28800850	0	O
affected	28800850	0	O
longevity	28800850	0	O
.	28800850	0	O
However	28800850	0	O
,	28800850	0	O
germinated	28800850	0	O
mutant	28800850	0	O
conidia	28800850	0	O
were	28800850	0	O
still	28800850	0	O
capable	28800850	0	O
of	28800850	0	O
infecting	28800850	0	O
the	28800850	0	O
host	28800850	0	O
plant	28800850	0	O
via	28800850	0	O
appressoria	28800850	0	O
.	28800850	0	O
In	28800850	0	O
sexual	28800850	0	O
reproduction	28800850	0	O
,	28800850	0	O
ascospores	28800850	0	O
with	28800850	0	O
ΔBmATG8	28800850	0	O
genetic	28800850	0	O
background	28800850	0	O
were	28800850	0	O
aborted	28800850	0	O
.	28800850	0	O
Our	28800850	0	O
results	28800850	0	O
revealed	28800850	0	O
that	28800850	0	O
autophagy	28800850	0	O
plays	28800850	0	O
a	28800850	0	O
crucial	28800850	0	O
role	28800850	0	O
in	28800850	0	O
the	28800850	0	O
function	28800850	0	O
of	28800850	0	O
conidia	28800850	0	O
,	28800850	0	O
not	28800850	0	O
in	28800850	0	O
host	28800850	0	O
infection	28800850	0	O
via	28800850	0	O
appressoria	28800850	0	O
in	28800850	0	O
B.	28800850	0	O
maydis	28800850	0	O
.	28800850	0	O
In	28800850	0	O
addition	28800850	0	O
,	28800850	0	O
conservation	28800850	0	O
of	28800850	0	O
the	28800850	0	O
importance	28800850	0	O
of	28800850	0	O
autophagy	28800850	0	O
in	28800850	0	O
ascospore	28800850	0	O
development	28800850	0	O
is	28800850	0	O
suggested	28800850	0	O
among	28800850	0	O
ascomycetes	28800850	0	O
including	28800850	0	O
species	28800850	0	O
that	28800850	0	O
form	28800850	0	O
bitunicate	28800850	0	O
ascus	28800850	0	O
.	28800850	0	O

Impairment	28807867	4	O
of	28807867	4	O
different	28807867	4	O
protein	28807867	4	O
domains	28807867	4	O
causes	28807867	4	O
variable	28807867	4	O
clinical	28807867	4	O
presentation	28807867	4	O
within	28807867	4	O
Pitt	28807867	4	O
-	28807867	4	O
Hopkins	28807867	4	O
syndrome	28807867	4	O
and	28807867	4	O
suggests	28807867	4	O
intragenic	28807867	4	O
molecular	28807867	4	O
syndromology	28807867	4	O
of	28807867	4	O
TCF4	28807867	4	O
.	28807867	4	O
Pitt	28807867	4	B-Disease
-	28807867	4	I-Disease
Hopkins	28807867	4	I-Disease
syndrome	28807867	4	I-Disease
is	28807867	4	O
a	28807867	4	O
neurodevelopmental	28807867	4	O
disorder	28807867	4	O
characterized	28807867	4	O
by	28807867	4	O
severe	28807867	4	O
intellectual	28807867	4	O
disability	28807867	4	O
and	28807867	4	O
a	28807867	4	O
distinctive	28807867	4	O
facial	28807867	4	O
gestalt	28807867	4	O
.	28807867	4	O
It	28807867	4	O
is	28807867	4	O
caused	28807867	4	B-Reg
by	28807867	4	I-Reg
haploinsufficiency	28807867	4	B-Var
of	28807867	4	O
the	28807867	4	O
TCF4	28807867	4	B-Gene
gene	28807867	4	O
.	28807867	4	O
The	28807867	4	O
TCF4	28807867	4	O
protein	28807867	4	O
has	28807867	4	O
different	28807867	4	O
functional	28807867	4	O
domains	28807867	4	O
,	28807867	4	O
with	28807867	4	O
the	28807867	4	O
NLS	28807867	4	O
(	28807867	4	O
nuclear	28807867	4	O
localization	28807867	4	O
signal	28807867	4	O
)	28807867	4	O
domain	28807867	4	O
coded	28807867	4	O
by	28807867	4	O
exons	28807867	4	O
7	28807867	4	O
-	28807867	4	O
8	28807867	4	O
and	28807867	4	O
the	28807867	4	O
bHLH	28807867	4	O
(	28807867	4	O
basic	28807867	4	O
Helix	28807867	4	O
-	28807867	4	O
Loop	28807867	4	O
-	28807867	4	O
Helix	28807867	4	O
)	28807867	4	O
domain	28807867	4	O
coded	28807867	4	O
by	28807867	4	O
exon	28807867	4	O
18	28807867	4	O
.	28807867	4	O
Several	28807867	4	O
alternatively	28807867	4	O
spliced	28807867	4	O
TCF4	28807867	4	O
variants	28807867	4	O
have	28807867	4	O
been	28807867	4	O
described	28807867	4	O
,	28807867	4	O
allowing	28807867	4	O
for	28807867	4	O
translation	28807867	4	O
of	28807867	4	O
variable	28807867	4	O
protein	28807867	4	O
isoforms	28807867	4	O
.	28807867	4	O
Typical	28807867	4	O
PTHS	28807867	4	O
patients	28807867	4	O
have	28807867	4	O
impairment	28807867	4	O
of	28807867	4	O
at	28807867	4	O
least	28807867	4	O
the	28807867	4	O
bHLH	28807867	4	O
domain	28807867	4	O
.	28807867	4	O
To	28807867	4	O
which	28807867	4	O
extent	28807867	4	O
impairment	28807867	4	O
of	28807867	4	O
the	28807867	4	O
remaining	28807867	4	O
domains	28807867	4	O
contributes	28807867	4	O
to	28807867	4	O
the	28807867	4	O
final	28807867	4	O
phenotype	28807867	4	O
is	28807867	4	O
not	28807867	4	O
clear	28807867	4	O
.	28807867	4	O
There	28807867	4	O
is	28807867	4	O
recent	28807867	4	O
evidence	28807867	4	O
that	28807867	4	O
certain	28807867	4	O
loss	28807867	4	O
-	28807867	4	O
of	28807867	4	O
-	28807867	4	O
function	28807867	4	O
variants	28807867	4	B-Var
disrupting	28807867	4	B-NegReg
TCF4	28807867	4	B-Gene
are	28807867	4	O
associated	28807867	4	O
with	28807867	4	O
mild	28807867	4	B-Disease
ID	28807867	4	I-Disease
,	28807867	4	O
but	28807867	4	O
not	28807867	4	O
with	28807867	4	O
typical	28807867	4	O
PTHS	28807867	4	O
.	28807867	4	O
We	28807867	4	O
describe	28807867	4	O
a	28807867	4	O
frameshift	28807867	4	B-Reg
-	28807867	4	I-Reg
causing	28807867	4	I-Reg
partial	28807867	4	B-Var
gene	28807867	4	I-Var
deletion	28807867	4	I-Var
encompassing	28807867	4	O
exons	28807867	4	O
4	28807867	4	O
-	28807867	4	O
6	28807867	4	O
of	28807867	4	O
TCF4	28807867	4	B-Gene
in	28807867	4	O
an	28807867	4	O
adult	28807867	4	O
patient	28807867	4	O
with	28807867	4	B-Reg
mild	28807867	4	B-Disease
ID	28807867	4	I-Disease
and	28807867	4	O
nonspecific	28807867	4	O
facial	28807867	4	O
dysmorphisms	28807867	4	O
but	28807867	4	O
without	28807867	4	O
the	28807867	4	O
typical	28807867	4	O
features	28807867	4	O
of	28807867	4	O
PTHS	28807867	4	O
,	28807867	4	O
and	28807867	4	O
a	28807867	4	O
c.520C	28807867	4	B-Var
>	28807867	4	I-Var
T	28807867	4	I-Var
nonsense	28807867	4	O
variant	28807867	4	O
within	28807867	4	O
exon	28807867	4	O
8	28807867	4	O
in	28807867	4	O
a	28807867	4	O
child	28807867	4	O
presenting	28807867	4	O
with	28807867	4	B-Reg
a	28807867	4	O
severe	28807867	4	O
phenotype	28807867	4	O
largely	28807867	4	O
mimicking	28807867	4	O
PTHS	28807867	4	B-Disease
,	28807867	4	O
but	28807867	4	O
lacking	28807867	4	O
the	28807867	4	O
typical	28807867	4	O
facial	28807867	4	O
dysmorphism	28807867	4	O
.	28807867	4	O
Investigation	28807867	4	O
on	28807867	4	O
mRNA	28807867	4	O
,	28807867	4	O
along	28807867	4	O
with	28807867	4	O
literature	28807867	4	O
review	28807867	4	O
,	28807867	4	O
led	28807867	4	O
us	28807867	4	O
to	28807867	4	O
suggest	28807867	4	O
a	28807867	4	O
preliminary	28807867	4	O
phenotypic	28807867	4	O
map	28807867	4	O
of	28807867	4	O
loss	28807867	4	O
-	28807867	4	O
of	28807867	4	O
-	28807867	4	O
function	28807867	4	O
variants	28807867	4	O
affecting	28807867	4	O
TCF4	28807867	4	O
.	28807867	4	O
An	28807867	4	O
intragenic	28807867	4	O
phenotypic	28807867	4	O
map	28807867	4	O
of	28807867	4	O
loss	28807867	4	O
-	28807867	4	O
of	28807867	4	O
-	28807867	4	O
function	28807867	4	O
variants	28807867	4	O
in	28807867	4	O
TCF4	28807867	4	O
is	28807867	4	O
suggested	28807867	4	O
here	28807867	4	O
for	28807867	4	O
the	28807867	4	O
first	28807867	4	O
time	28807867	4	O
:	28807867	4	O
variants	28807867	4	O
within	28807867	4	O
exons	28807867	4	O
1	28807867	4	O
-	28807867	4	O
4	28807867	4	O
and	28807867	4	O
exons	28807867	4	O
4	28807867	4	O
-	28807867	4	O
6	28807867	4	O
give	28807867	4	O
rise	28807867	4	O
to	28807867	4	O
a	28807867	4	O
recurrent	28807867	4	O
phenotype	28807867	4	O
with	28807867	4	O
mild	28807867	4	O
ID	28807867	4	O
not	28807867	4	O
in	28807867	4	O
the	28807867	4	O
spectrum	28807867	4	O
of	28807867	4	O
Pitt	28807867	4	O
-	28807867	4	O
Hopkins	28807867	4	O
syndrome	28807867	4	O
(	28807867	4	O
biallelic	28807867	4	O
preservation	28807867	4	O
of	28807867	4	O
both	28807867	4	O
the	28807867	4	O
NLS	28807867	4	O
and	28807867	4	O
bHLH	28807867	4	O
domains	28807867	4	O
)	28807867	4	O
;	28807867	4	O
variants	28807867	4	O
within	28807867	4	O
exons	28807867	4	O
7	28807867	4	O
-	28807867	4	O
8	28807867	4	O
cause	28807867	4	O
a	28807867	4	O
severe	28807867	4	O
phenotype	28807867	4	O
resembling	28807867	4	O
PTHS	28807867	4	O
but	28807867	4	O
in	28807867	4	O
absence	28807867	4	O
of	28807867	4	O
the	28807867	4	O
typical	28807867	4	O
facial	28807867	4	O
dysmorphism	28807867	4	O
(	28807867	4	O
impairment	28807867	4	O
limited	28807867	4	O
to	28807867	4	O
the	28807867	4	O
NLS	28807867	4	O
domain	28807867	4	O
)	28807867	4	O
;	28807867	4	O
variants	28807867	4	O
within	28807867	4	O
exons	28807867	4	O
9	28807867	4	O
-	28807867	4	O
19	28807867	4	O
cause	28807867	4	O
typical	28807867	4	O
Pitt	28807867	4	O
-	28807867	4	O
Hopkins	28807867	4	O
syndrome	28807867	4	O
(	28807867	4	O
impairment	28807867	4	O
of	28807867	4	O
at	28807867	4	O
least	28807867	4	O
the	28807867	4	O
bHLH	28807867	4	O
domain	28807867	4	O
)	28807867	4	O
.	28807867	4	O
Understanding	28807867	4	O
the	28807867	4	O
TCF4	28807867	4	O
molecular	28807867	4	O
syndromology	28807867	4	O
can	28807867	4	O
allow	28807867	4	O
for	28807867	4	O
proper	28807867	4	O
nosology	28807867	4	O
in	28807867	4	O
the	28807867	4	O
current	28807867	4	O
era	28807867	4	O
of	28807867	4	O
whole	28807867	4	O
genomic	28807867	4	O
investigations	28807867	4	O
.	28807867	4	O

ARHGAP29	28817352	1	O
Mutation	28817352	1	O
Is	28817352	1	O
Associated	28817352	1	O
with	28817352	1	O
Abnormal	28817352	1	O
Oral	28817352	1	O
Epithelial	28817352	1	O
Adhesions	28817352	1	O
.	28817352	1	O
Nonsyndromic	28817352	1	O
cleft	28817352	1	O
lip	28817352	1	O
and	28817352	1	O
/	28817352	1	O
or	28817352	1	O
palate	28817352	1	O
(	28817352	1	O
NSCL	28817352	1	O
/	28817352	1	O
P	28817352	1	O
)	28817352	1	O
is	28817352	1	O
a	28817352	1	O
prevalent	28817352	1	O
birth	28817352	1	O
defect	28817352	1	O
of	28817352	1	O
complex	28817352	1	O
etiology	28817352	1	O
.	28817352	1	O
Previous	28817352	1	O
studies	28817352	1	O
identified	28817352	1	O
mutations	28817352	1	B-Var
in	28817352	1	O
ARHGAP29	28817352	1	B-Gene
associated	28817352	1	B-Reg
with	28817352	1	O
an	28817352	1	O
increased	28817352	1	O
risk	28817352	1	O
for	28817352	1	O
NSCL	28817352	1	B-Disease
/	28817352	1	I-Disease
P.	28817352	1	I-Disease
To	28817352	1	O
investigate	28817352	1	O
the	28817352	1	O
effects	28817352	1	O
of	28817352	1	O
ARHGAP29	28817352	1	O
in	28817352	1	O
vivo	28817352	1	O
,	28817352	1	O
we	28817352	1	O
generated	28817352	1	O
a	28817352	1	O
novel	28817352	1	O
murine	28817352	1	O
allele	28817352	1	O
by	28817352	1	O
inserting	28817352	1	O
a	28817352	1	O
point	28817352	1	O
mutation	28817352	1	O
identified	28817352	1	O
in	28817352	1	O
a	28817352	1	O
patient	28817352	1	O
with	28817352	1	O
NSCL	28817352	1	O
/	28817352	1	O
P.	28817352	1	O
This	28817352	1	O
single	28817352	1	B-Var
-	28817352	1	I-Var
nucleotide	28817352	1	I-Var
variation	28817352	1	I-Var
of	28817352	1	O
ARHGAP29	28817352	1	B-Gene
translates	28817352	1	O
to	28817352	1	O
an	28817352	1	O
early	28817352	1	O
nonsense	28817352	1	O
mutation	28817352	1	O
(	28817352	1	B-Var
K326X	28817352	1	I-Var
)	28817352	1	I-Var
,	28817352	1	O
presumably	28817352	1	O
resulting	28817352	1	O
in	28817352	1	O
loss	28817352	1	B-NegReg
-	28817352	1	I-NegReg
of	28817352	1	I-NegReg
-	28817352	1	I-NegReg
function	28817352	1	I-NegReg
(	28817352	1	O
LoF	28817352	1	O
)	28817352	1	O
.	28817352	1	O
Embryos	28817352	1	O
from	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
intercrosses	28817352	1	O
were	28817352	1	O
harvested	28817352	1	O
at	28817352	1	O
various	28817352	1	O
time	28817352	1	O
points	28817352	1	O
.	28817352	1	O
No	28817352	1	O
homozygous	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
)	28817352	1	O
animals	28817352	1	O
were	28817352	1	O
found	28817352	1	O
in	28817352	1	O
the	28817352	1	O
45	28817352	1	O
analyzed	28817352	1	O
litters	28817352	1	O
,	28817352	1	O
assessed	28817352	1	O
as	28817352	1	O
early	28817352	1	O
as	28817352	1	O
embryonic	28817352	1	O
day	28817352	1	O
8.5	28817352	1	O
(	28817352	1	O
e8.5	28817352	1	O
)	28817352	1	O
.	28817352	1	O
Coronal	28817352	1	O
sectioning	28817352	1	O
of	28817352	1	O
e13.5	28817352	1	O
and	28817352	1	O
e14.5	28817352	1	O
heads	28817352	1	O
revealed	28817352	1	O
that	28817352	1	O
59%	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
mice	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
37	28817352	1	O
)	28817352	1	O
exhibited	28817352	1	O
improper	28817352	1	O
epithelial	28817352	1	O
contact	28817352	1	O
between	28817352	1	O
developing	28817352	1	O
oral	28817352	1	O
structures	28817352	1	O
,	28817352	1	O
while	28817352	1	O
none	28817352	1	O
were	28817352	1	O
observed	28817352	1	O
in	28817352	1	O
wild	28817352	1	O
types	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
10	28817352	1	O
)	28817352	1	O
.	28817352	1	O
In	28817352	1	O
addition	28817352	1	O
,	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
embryos	28817352	1	O
exhibited	28817352	1	O
a	28817352	1	O
significantly	28817352	1	O
higher	28817352	1	O
percentage	28817352	1	O
of	28817352	1	O
maxillary	28817352	1	O
epithelium	28817352	1	O
in	28817352	1	O
contact	28817352	1	O
with	28817352	1	O
mandibular	28817352	1	O
epithelium	28817352	1	O
.	28817352	1	O
Immunofluorescent	28817352	1	O
analyses	28817352	1	O
of	28817352	1	O
the	28817352	1	O
periderm	28817352	1	O
and	28817352	1	O
oral	28817352	1	O
adhesions	28817352	1	O
revealed	28817352	1	O
the	28817352	1	O
presence	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	O
in	28817352	1	O
periderm	28817352	1	O
cells	28817352	1	O
.	28817352	1	O
These	28817352	1	O
cells	28817352	1	O
were	28817352	1	O
p63	28817352	1	O
negative	28817352	1	O
,	28817352	1	O
keratin	28817352	1	O
17	28817352	1	O
positive	28817352	1	O
,	28817352	1	O
and	28817352	1	O
keratin	28817352	1	O
6	28817352	1	O
positive	28817352	1	O
and	28817352	1	O
present	28817352	1	O
at	28817352	1	O
sites	28817352	1	O
of	28817352	1	O
adhesion	28817352	1	O
,	28817352	1	O
although	28817352	1	O
occasionally	28817352	1	O
disorganized	28817352	1	O
.	28817352	1	O
Oral	28817352	1	O
adhesions	28817352	1	O
did	28817352	1	O
not	28817352	1	O
appear	28817352	1	O
to	28817352	1	O
impair	28817352	1	O
palatogenesis	28817352	1	O
,	28817352	1	O
as	28817352	1	O
all	28817352	1	O
analyzed	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
embryos	28817352	1	O
showed	28817352	1	O
confluent	28817352	1	O
palatal	28817352	1	O
mesenchyme	28817352	1	O
and	28817352	1	O
epithelium	28817352	1	O
at	28817352	1	O
e18.5	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
16	28817352	1	O
)	28817352	1	O
,	28817352	1	O
and	28817352	1	O
no	28817352	1	O
mice	28817352	1	O
were	28817352	1	O
found	28817352	1	O
with	28817352	1	O
a	28817352	1	O
cleft	28817352	1	O
at	28817352	1	O
birth	28817352	1	O
.	28817352	1	O
Collectively	28817352	1	O
,	28817352	1	O
our	28817352	1	O
data	28817352	1	O
demonstrate	28817352	1	O
that	28817352	1	O
ARHGAP29	28817352	1	O
is	28817352	1	O
required	28817352	1	O
for	28817352	1	O
embryonic	28817352	1	O
survival	28817352	1	O
and	28817352	1	O
that	28817352	1	O
heterozygosity	28817352	1	O
for	28817352	1	O
LoF	28817352	1	B-NegReg
variants	28817352	1	B-Var
of	28817352	1	O
Arhgap29	28817352	1	B-Gene
increases	28817352	1	B-PosReg
the	28817352	1	O
incidence	28817352	1	B-CPA
and	28817352	1	I-CPA
length	28817352	1	I-CPA
of	28817352	1	I-CPA
oral	28817352	1	I-CPA
adhesions	28817352	1	I-CPA
at	28817352	1	I-CPA
a	28817352	1	I-CPA
critical	28817352	1	I-CPA
time	28817352	1	I-CPA
point	28817352	1	I-CPA
during	28817352	1	I-CPA
orofacial	28817352	1	I-CPA
development	28817352	1	I-CPA
.	28817352	1	O
In	28817352	1	O
conclusion	28817352	1	O
,	28817352	1	O
we	28817352	1	O
validate	28817352	1	O
the	28817352	1	O
LoF	28817352	1	B-NegReg
nature	28817352	1	O
of	28817352	1	O
the	28817352	1	O
human	28817352	1	O
K326X	28817352	1	B-Var
mutation	28817352	1	I-Var
in	28817352	1	O
vivo	28817352	1	O
and	28817352	1	O
reveal	28817352	1	O
a	28817352	1	O
previously	28817352	1	O
unknown	28817352	1	O
effect	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	B-Gene
in	28817352	1	O
murine	28817352	1	O
craniofacial	28817352	1	B-CPA
development	28817352	1	I-CPA
.	28817352	1	O

Deciphering	28826751	4	O
the	28826751	4	O
molecular	28826751	4	O
basis	28826751	4	O
of	28826751	4	O
ferroportin	28826751	4	O
resistance	28826751	4	O
to	28826751	4	O
hepcidin	28826751	4	O
:	28826751	4	O
Structure	28826751	4	O
/	28826751	4	O
function	28826751	4	O
analysis	28826751	4	O
of	28826751	4	O
rare	28826751	4	O
SLC40A1	28826751	4	B-Gene
missense	28826751	4	B-Var
mutations	28826751	4	I-Var
found	28826751	4	B-Reg
in	28826751	4	O
suspected	28826751	4	O
hemochromatosis	28826751	4	B-Disease
type	28826751	4	I-Disease
4	28826751	4	I-Disease
patients	28826751	4	O
.	28826751	4	O
Genetic	28826751	4	O
medicine	28826751	4	O
applied	28826751	4	O
to	28826751	4	O
the	28826751	4	O
study	28826751	4	O
of	28826751	4	O
hemochromatosis	28826751	4	O
has	28826751	4	O
identified	28826751	4	O
the	28826751	4	O
systemic	28826751	4	O
loop	28826751	4	O
controlling	28826751	4	O
iron	28826751	4	O
homeostasis	28826751	4	O
,	28826751	4	O
centered	28826751	4	O
on	28826751	4	O
hepcidin	28826751	4	O
-	28826751	4	O
ferroportin	28826751	4	O
interaction	28826751	4	O
.	28826751	4	O
Current	28826751	4	O
challenges	28826751	4	O
are	28826751	4	O
to	28826751	4	O
dissect	28826751	4	O
the	28826751	4	O
molecular	28826751	4	O
pathways	28826751	4	O
underlying	28826751	4	O
liver	28826751	4	O
hepcidin	28826751	4	O
synthesis	28826751	4	O
in	28826751	4	O
response	28826751	4	O
to	28826751	4	O
circulatory	28826751	4	O
iron	28826751	4	O
,	28826751	4	O
HFE	28826751	4	O
,	28826751	4	O
TFR2	28826751	4	O
,	28826751	4	O
HJV	28826751	4	O
,	28826751	4	O
TMPRSS6	28826751	4	O
and	28826751	4	O
BMP6	28826751	4	O
functions	28826751	4	O
,	28826751	4	O
and	28826751	4	O
to	28826751	4	O
define	28826751	4	O
the	28826751	4	O
major	28826751	4	O
structural	28826751	4	O
elements	28826751	4	O
of	28826751	4	O
hepcidin	28826751	4	O
-	28826751	4	O
ferroportin	28826751	4	O
interaction	28826751	4	O
.	28826751	4	O
We	28826751	4	O
built	28826751	4	O
a	28826751	4	O
first	28826751	4	O
3	28826751	4	O
D	28826751	4	O
model	28826751	4	O
of	28826751	4	O
human	28826751	4	O
ferroportin	28826751	4	O
structure	28826751	4	O
,	28826751	4	O
using	28826751	4	O
the	28826751	4	O
crystal	28826751	4	O
structure	28826751	4	O
of	28826751	4	O
EmrD	28826751	4	O
,	28826751	4	O
a	28826751	4	O
bacterial	28826751	4	O
drug	28826751	4	O
efflux	28826751	4	O
transporter	28826751	4	O
of	28826751	4	O
the	28826751	4	O
Major	28826751	4	O
Facilitator	28826751	4	O
Superfamily	28826751	4	O
,	28826751	4	O
as	28826751	4	O
template	28826751	4	O
.	28826751	4	O
The	28826751	4	O
model	28826751	4	O
enabled	28826751	4	O
study	28826751	4	O
of	28826751	4	O
disease	28826751	4	O
-	28826751	4	O
associated	28826751	4	O
mutations	28826751	4	O
,	28826751	4	O
and	28826751	4	O
guided	28826751	4	O
mutagenesis	28826751	4	O
experiments	28826751	4	O
to	28826751	4	O
determine	28826751	4	O
the	28826751	4	O
role	28826751	4	O
of	28826751	4	O
conserved	28826751	4	O
residues	28826751	4	O
in	28826751	4	O
protein	28826751	4	O
stability	28826751	4	O
and	28826751	4	O
iron	28826751	4	O
transport	28826751	4	O
.	28826751	4	O
Results	28826751	4	O
revealed	28826751	4	O
novel	28826751	4	O
amino	28826751	4	O
acids	28826751	4	O
that	28826751	4	O
are	28826751	4	O
critical	28826751	4	O
for	28826751	4	O
the	28826751	4	O
iron	28826751	4	O
export	28826751	4	O
function	28826751	4	O
and	28826751	4	O
the	28826751	4	O
hepcidin	28826751	4	O
-	28826751	4	O
mediated	28826751	4	O
inhibition	28826751	4	O
mechanism	28826751	4	O
:	28826751	4	O
for	28826751	4	O
example	28826751	4	O
,	28826751	4	O
tryptophan	28826751	4	O
42	28826751	4	O
,	28826751	4	O
localized	28826751	4	O
in	28826751	4	O
the	28826751	4	O
extracellular	28826751	4	O
end	28826751	4	O
of	28826751	4	O
the	28826751	4	O
ferroportin	28826751	4	O
pore	28826751	4	O
and	28826751	4	O
involved	28826751	4	O
in	28826751	4	O
both	28826751	4	O
biological	28826751	4	O
functions	28826751	4	O
.	28826751	4	O
Here	28826751	4	O
,	28826751	4	O
we	28826751	4	O
propose	28826751	4	O
a	28826751	4	O
strategy	28826751	4	O
that	28826751	4	O
is	28826751	4	O
not	28826751	4	O
limited	28826751	4	O
to	28826751	4	O
structure	28826751	4	O
analysis	28826751	4	O
,	28826751	4	O
but	28826751	4	O
integrates	28826751	4	O
information	28826751	4	O
from	28826751	4	O
different	28826751	4	O
sources	28826751	4	O
,	28826751	4	O
including	28826751	4	O
human	28826751	4	O
disease	28826751	4	O
-	28826751	4	O
associated	28826751	4	O
mutations	28826751	4	O
and	28826751	4	O
functional	28826751	4	O
in	28826751	4	O
vitro	28826751	4	O
assays	28826751	4	O
.	28826751	4	O
The	28826751	4	O
first	28826751	4	O
major	28826751	4	O
hypothesis	28826751	4	O
of	28826751	4	O
this	28826751	4	O
PhD	28826751	4	O
thesis	28826751	4	O
is	28826751	4	O
that	28826751	4	O
ferroportin	28826751	4	O
resistance	28826751	4	O
to	28826751	4	O
hepcidin	28826751	4	O
relies	28826751	4	O
on	28826751	4	O
different	28826751	4	O
molecular	28826751	4	O
mechanisms	28826751	4	O
that	28826751	4	O
are	28826751	4	O
critical	28826751	4	O
for	28826751	4	O
ferroportin	28826751	4	O
endocytosis	28826751	4	O
,	28826751	4	O
and	28826751	4	O
include	28826751	4	O
at	28826751	4	O
least	28826751	4	O
three	28826751	4	O
fundamental	28826751	4	O
steps	28826751	4	O
:	28826751	4	O
(	28826751	4	O
i	28826751	4	O
)	28826751	4	O
hepcidin	28826751	4	O
binding	28826751	4	O
to	28826751	4	O
ferroportin	28826751	4	O
,	28826751	4	O
(	28826751	4	O
ii	28826751	4	O
)	28826751	4	O
structural	28826751	4	O
reorganization	28826751	4	O
of	28826751	4	O
the	28826751	4	O
N	28826751	4	O
-	28826751	4	O
and	28826751	4	O
C	28826751	4	O
-	28826751	4	O
ter	28826751	4	O
ferroportin	28826751	4	O
lobes	28826751	4	O
,	28826751	4	O
and	28826751	4	O
(	28826751	4	O
iii	28826751	4	O
)	28826751	4	O
ferroportin	28826751	4	O
ubiquitination	28826751	4	O
.	28826751	4	O

Loss	28833578	1	O
-	28833578	1	O
of	28833578	1	O
-	28833578	1	O
function	28833578	1	O
mutations	28833578	1	O
in	28833578	1	O
filaggrin	28833578	1	O
gene	28833578	1	O
and	28833578	1	O
malignant	28833578	1	O
melanoma	28833578	1	O
:	28833578	1	O
a	28833578	1	O
case	28833578	1	O
control	28833578	1	O
study	28833578	1	O
.	28833578	1	O
BACKGROUND	28833578	1	O
:	28833578	1	O
Loss	28833578	1	B-NegReg
-	28833578	1	I-NegReg
of	28833578	1	I-NegReg
-	28833578	1	I-NegReg
function	28833578	1	I-NegReg
mutations	28833578	1	B-Var
in	28833578	1	O
filaggrin	28833578	1	O
gene	28833578	1	O
(	28833578	1	B-Gene
FLG	28833578	1	I-Gene
)	28833578	1	I-Gene
have	28833578	1	O
been	28833578	1	O
suggested	28833578	1	O
to	28833578	1	O
increase	28833578	1	O
the	28833578	1	O
susceptibility	28833578	1	O
of	28833578	1	O
skin	28833578	1	B-Disease
malignancies	28833578	1	I-Disease
due	28833578	1	O
to	28833578	1	O
reduced	28833578	1	B-NegReg
levels	28833578	1	B-MPA
of	28833578	1	I-MPA
epidermal	28833578	1	I-MPA
filaggrin	28833578	1	I-MPA
and	28833578	1	O
its	28833578	1	O
degradation	28833578	1	B-MPA
products	28833578	1	I-MPA
,	28833578	1	O
urocanic	28833578	1	B-MPA
acid	28833578	1	I-MPA
,	28833578	1	O
which	28833578	1	O
may	28833578	1	O
be	28833578	1	O
protective	28833578	1	O
against	28833578	1	O
ultraviolet	28833578	1	O
irradiation	28833578	1	O
.	28833578	1	O
OBJECTIVE	28833578	1	O
:	28833578	1	O
We	28833578	1	O
aimed	28833578	1	O
to	28833578	1	O
investigate	28833578	1	O
the	28833578	1	O
association	28833578	1	O
between	28833578	1	O
FLG	28833578	1	O
mutation	28833578	1	O
status	28833578	1	O
and	28833578	1	O
the	28833578	1	O
occurrence	28833578	1	O
of	28833578	1	O
malignant	28833578	1	O
melanoma	28833578	1	O
(	28833578	1	O
MM	28833578	1	O
)	28833578	1	O
in	28833578	1	O
Danish	28833578	1	O
adults	28833578	1	O
.	28833578	1	O
METHODS	28833578	1	O
:	28833578	1	O
The	28833578	1	O
prevalence	28833578	1	O
of	28833578	1	O
FLG	28833578	1	O
mutations	28833578	1	O
in	28833578	1	O
a	28833578	1	O
sample	28833578	1	O
of	28833578	1	O
MM	28833578	1	O
biopsies	28833578	1	O
was	28833578	1	O
compared	28833578	1	O
with	28833578	1	O
a	28833578	1	O
FLG	28833578	1	O
genotyped	28833578	1	O
cohort	28833578	1	O
from	28833578	1	O
two	28833578	1	O
general	28833578	1	O
population	28833578	1	O
studies	28833578	1	O
.	28833578	1	O
Pearson	28833578	1	O
'	28833578	1	O
s	28833578	1	O
chi	28833578	1	O
-	28833578	1	O
square	28833578	1	O
and	28833578	1	O
Fisher	28833578	1	O
'	28833578	1	O
s	28833578	1	O
exact	28833578	1	O
tests	28833578	1	O
were	28833578	1	O
used	28833578	1	O
to	28833578	1	O
compare	28833578	1	O
the	28833578	1	O
two	28833578	1	O
groups	28833578	1	O
.	28833578	1	O
RESULTS	28833578	1	O
:	28833578	1	O
A	28833578	1	O
total	28833578	1	O
of	28833578	1	O
867	28833578	1	O
MM	28833578	1	O
biopsies	28833578	1	O
and	28833578	1	O
9965	28833578	1	O
general	28833578	1	O
population	28833578	1	O
controls	28833578	1	O
were	28833578	1	O
genotyped	28833578	1	O
,	28833578	1	O
respectively	28833578	1	O
.	28833578	1	O
In	28833578	1	O
the	28833578	1	O
MM	28833578	1	O
sample	28833578	1	O
2	28833578	1	O
(	28833578	1	O
0.23%	28833578	1	O
)	28833578	1	O
individuals	28833578	1	O
were	28833578	1	O
homozygous	28833578	1	O
and	28833578	1	O
80	28833578	1	O
(	28833578	1	O
9.4%	28833578	1	O
)	28833578	1	O
heterozygous	28833578	1	O
mutation	28833578	1	O
carriers	28833578	1	O
.	28833578	1	O
In	28833578	1	O
the	28833578	1	O
general	28833578	1	O
population	28833578	1	O
controls	28833578	1	O
the	28833578	1	O
prevalence	28833578	1	O
of	28833578	1	O
FLG	28833578	1	O
mutations	28833578	1	O
was	28833578	1	O
18	28833578	1	O
(	28833578	1	O
0.18%	28833578	1	O
)	28833578	1	O
and	28833578	1	O
835	28833578	1	O
(	28833578	1	O
8.4%	28833578	1	O
)	28833578	1	O
for	28833578	1	O
homozygous	28833578	1	O
and	28833578	1	O
heterozygous	28833578	1	O
mutations	28833578	1	O
,	28833578	1	O
respectively	28833578	1	O
.	28833578	1	O
Fisher	28833578	1	O
'	28833578	1	O
s	28833578	1	O
exact	28833578	1	O
test	28833578	1	O
and	28833578	1	O
Pearson	28833578	1	O
'	28833578	1	O
s	28833578	1	O
chi	28833578	1	O
square	28833578	1	O
test	28833578	1	O
yielded	28833578	1	O
non	28833578	1	O
-	28833578	1	O
significant	28833578	1	O
p	28833578	1	O
-	28833578	1	O
values	28833578	1	O
when	28833578	1	O
the	28833578	1	O
groups	28833578	1	O
were	28833578	1	O
compared	28833578	1	O
.	28833578	1	O
CONCLUSION	28833578	1	O
:	28833578	1	O
FLG	28833578	1	O
mutation	28833578	1	O
was	28833578	1	O
not	28833578	1	O
associated	28833578	1	O
with	28833578	1	O
MM	28833578	1	O
in	28833578	1	O
the	28833578	1	O
studied	28833578	1	O
populations	28833578	1	O
.	28833578	1	O
This	28833578	1	O
finding	28833578	1	O
indicates	28833578	1	O
that	28833578	1	O
epidermal	28833578	1	O
deficiency	28833578	1	O
of	28833578	1	O
filaggrin	28833578	1	O
and	28833578	1	O
its	28833578	1	O
degradation	28833578	1	O
products	28833578	1	O
do	28833578	1	O
not	28833578	1	O
influence	28833578	1	O
the	28833578	1	O
risk	28833578	1	O
of	28833578	1	O
MM	28833578	1	O
significantly	28833578	1	O
.	28833578	1	O
This	28833578	1	O
article	28833578	1	O
is	28833578	1	O
protected	28833578	1	O
by	28833578	1	O
copyright	28833578	1	O
.	28833578	1	O
All	28833578	1	O
rights	28833578	1	O
reserved	28833578	1	O
.	28833578	1	O

A	28834165	2	O
gain	28834165	2	B-PosReg
-	28834165	2	I-PosReg
of	28834165	2	I-PosReg
-	28834165	2	I-PosReg
function	28834165	2	I-PosReg
mutation	28834165	2	B-Var
in	28834165	2	O
TNFRSF13B	28834165	2	B-Gene
is	28834165	2	O
a	28834165	2	O
candidate	28834165	2	O
for	28834165	2	O
predisposition	28834165	2	O
to	28834165	2	O
familial	28834165	2	B-Disease
or	28834165	2	I-Disease
sporadic	28834165	2	I-Disease
immune	28834165	2	I-Disease
thrombocytopenia	28834165	2	I-Disease
.	28834165	2	O
BACKGROUND	28834165	2	O
:	28834165	2	O
Most	28834165	2	O
immune	28834165	2	B-Disease
thrombocytopenia	28834165	2	I-Disease
(	28834165	2	O
ITP	28834165	2	O
)	28834165	2	O
is	28834165	2	O
sporadic	28834165	2	O
but	28834165	2	O
a	28834165	2	O
positive	28834165	2	O
family	28834165	2	O
history	28834165	2	O
of	28834165	2	O
ITP	28834165	2	O
in	28834165	2	O
some	28834165	2	O
patients	28834165	2	O
suggests	28834165	2	O
that	28834165	2	O
hereditary	28834165	2	O
forms	28834165	2	O
exist	28834165	2	O
.	28834165	2	O
Due	28834165	2	O
to	28834165	2	O
the	28834165	2	O
rarity	28834165	2	O
of	28834165	2	O
familial	28834165	2	O
ITP	28834165	2	O
families	28834165	2	O
available	28834165	2	O
for	28834165	2	O
study	28834165	2	O
and	28834165	2	O
the	28834165	2	O
heterogeneity	28834165	2	O
of	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
,	28834165	2	O
family	28834165	2	O
linkage	28834165	2	O
analysis	28834165	2	O
or	28834165	2	O
genome	28834165	2	O
wide	28834165	2	O
association	28834165	2	O
studies	28834165	2	O
are	28834165	2	O
limited	28834165	2	O
.	28834165	2	O
OBJECTIVES	28834165	2	O
:	28834165	2	O
Based	28834165	2	O
on	28834165	2	O
one	28834165	2	O
ITP	28834165	2	O
pedigree	28834165	2	O
,	28834165	2	O
we	28834165	2	O
try	28834165	2	O
to	28834165	2	O
identify	28834165	2	O
the	28834165	2	O
predisposing	28834165	2	O
gene	28834165	2	O
in	28834165	2	O
familial	28834165	2	O
or	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
and	28834165	2	O
reveal	28834165	2	O
the	28834165	2	O
way	28834165	2	O
in	28834165	2	O
which	28834165	2	O
it	28834165	2	O
causes	28834165	2	O
thrombocytopenia	28834165	2	O
.	28834165	2	O
METHODS	28834165	2	O
:	28834165	2	O
Gene	28834165	2	O
expression	28834165	2	O
profiling	28834165	2	O
analysis	28834165	2	O
and	28834165	2	O
whole	28834165	2	O
-	28834165	2	O
exome	28834165	2	O
sequencing	28834165	2	O
was	28834165	2	O
performed	28834165	2	O
on	28834165	2	O
samples	28834165	2	O
from	28834165	2	O
familial	28834165	2	O
ITP	28834165	2	O
members	28834165	2	O
,	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
cases	28834165	2	O
and	28834165	2	O
healthy	28834165	2	O
individuals	28834165	2	O
.	28834165	2	O
We	28834165	2	O
also	28834165	2	O
evaluated	28834165	2	O
the	28834165	2	O
influence	28834165	2	O
of	28834165	2	O
potential	28834165	2	O
pathogenic	28834165	2	O
mutation	28834165	2	O
on	28834165	2	O
immune	28834165	2	O
function	28834165	2	O
and	28834165	2	O
megakaryocyte	28834165	2	O
apoptosis	28834165	2	O
.	28834165	2	O
RESULTS	28834165	2	O
:	28834165	2	O
Whole	28834165	2	O
-	28834165	2	O
exome	28834165	2	O
sequencing	28834165	2	O
identified	28834165	2	O
a	28834165	2	O
potential	28834165	2	O
pathologic	28834165	2	B-Reg
p.G76S	28834165	2	B-Var
heterozygous	28834165	2	O
mutation	28834165	2	O
on	28834165	2	O
the	28834165	2	O
TNFRSF13B	28834165	2	B-Gene
gene	28834165	2	O
in	28834165	2	O
familial	28834165	2	B-Disease
ITP	28834165	2	I-Disease
patients	28834165	2	O
.	28834165	2	O
ITP	28834165	2	O
patients	28834165	2	O
harboring	28834165	2	O
G76S	28834165	2	B-Var
mutation	28834165	2	O
displayed	28834165	2	O
upregulated	28834165	2	B-PosReg
"	28834165	2	B-MPA
cytokine	28834165	2	I-MPA
-	28834165	2	I-MPA
cytokine	28834165	2	I-MPA
receptor	28834165	2	I-MPA
interaction	28834165	2	I-MPA
"	28834165	2	I-MPA
signal	28834165	2	I-MPA
,	28834165	2	O
increased	28834165	2	B-PosReg
serum	28834165	2	B-MPA
TNFα	28834165	2	I-MPA
,	28834165	2	O
IL-17	28834165	2	I-MPA
α	28834165	2	I-MPA
,	28834165	2	O
IFNγ	28834165	2	I-MPA
and	28834165	2	I-MPA
BAFF	28834165	2	I-MPA
levels	28834165	2	I-MPA
,	28834165	2	O
and	28834165	2	O
enhanced	28834165	2	B-PosReg
binding	28834165	2	B-Interaction
capacity	28834165	2	I-Interaction
of	28834165	2	I-Interaction
APRIL	28834165	2	I-Interaction
ligand	28834165	2	I-Interaction
to	28834165	2	I-Interaction
B	28834165	2	I-Interaction
cells	28834165	2	I-Interaction
.	28834165	2	O
Additionally	28834165	2	O
,	28834165	2	O
EBV	28834165	2	O
-	28834165	2	O
transformed	28834165	2	O
B	28834165	2	O
cells	28834165	2	O
with	28834165	2	O
the	28834165	2	O
G76S	28834165	2	B-Var
mutation	28834165	2	O
could	28834165	2	O
induce	28834165	2	B-PosReg
human	28834165	2	B-CPA
megakaryocyte	28834165	2	I-CPA
line	28834165	2	I-CPA
(	28834165	2	I-CPA
Meg-01	28834165	2	I-CPA
)	28834165	2	I-CPA
apoptosis	28834165	2	I-CPA
significantly	28834165	2	O
.	28834165	2	O
CONCLUSION	28834165	2	O
:	28834165	2	O
p.G76S	28834165	2	B-Var
mutation	28834165	2	O
on	28834165	2	O
TNFRSF13B	28834165	2	B-Gene
gene	28834165	2	O
is	28834165	2	O
responsible	28834165	2	B-Reg
for	28834165	2	O
ITP	28834165	2	B-Disease
,	28834165	2	O
and	28834165	2	O
is	28834165	2	O
a	28834165	2	O
genetic	28834165	2	O
predisposing	28834165	2	O
factor	28834165	2	O
for	28834165	2	O
familial	28834165	2	O
or	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
.	28834165	2	O
This	28834165	2	O
article	28834165	2	O
is	28834165	2	O
protected	28834165	2	O
by	28834165	2	O
copyright	28834165	2	O
.	28834165	2	O
All	28834165	2	O
rights	28834165	2	O
reserved	28834165	2	O
.	28834165	2	O

A	28836768	0	O
single	28836768	0	O
active	28836768	0	O
site	28836768	0	O
mutation	28836768	0	O
in	28836768	0	O
the	28836768	0	O
pikromycin	28836768	0	O
thioesterase	28836768	0	O
generates	28836768	0	O
a	28836768	0	O
more	28836768	0	O
effective	28836768	0	O
macrocyclization	28836768	0	O
catalyst	28836768	0	O
.	28836768	0	O
Macrolactonization	28836768	0	O
of	28836768	0	O
natural	28836768	0	O
product	28836768	0	O
analogs	28836768	0	O
presents	28836768	0	O
a	28836768	0	O
significant	28836768	0	O
challenge	28836768	0	O
to	28836768	0	O
both	28836768	0	O
biosynthetic	28836768	0	O
assembly	28836768	0	O
and	28836768	0	O
synthetic	28836768	0	O
chemistry	28836768	0	O
.	28836768	0	O
In	28836768	0	O
the	28836768	0	O
preceding	28836768	0	O
paper	28836768	0	O
,	28836768	0	O
we	28836768	0	O
identified	28836768	0	O
a	28836768	0	O
thioesterase	28836768	0	O
(	28836768	0	O
TE	28836768	0	O
)	28836768	0	O
domain	28836768	0	O
catalytic	28836768	0	O
bottleneck	28836768	0	O
in	28836768	0	O
the	28836768	0	O
processing	28836768	0	O
of	28836768	0	O
un	28836768	0	O
-	28836768	0	O
natural	28836768	0	O
substrates	28836768	0	O
in	28836768	0	O
the	28836768	0	O
pikromycin	28836768	0	O
(	28836768	0	O
Pik	28836768	0	O
)	28836768	0	O
system	28836768	0	O
,	28836768	0	O
preventing	28836768	0	O
the	28836768	0	O
formation	28836768	0	O
of	28836768	0	O
epimerized	28836768	0	O
macrolactones	28836768	0	O
.	28836768	0	O
Here	28836768	0	O
,	28836768	0	O
we	28836768	0	O
perform	28836768	0	O
molecular	28836768	0	O
dynamics	28836768	0	O
(	28836768	0	O
MD	28836768	0	O
)	28836768	0	O
simulations	28836768	0	O
showing	28836768	0	O
the	28836768	0	O
epimerized	28836768	0	O
hexaketide	28836768	0	O
was	28836768	0	O
accommodated	28836768	0	O
within	28836768	0	O
the	28836768	0	O
Pik	28836768	0	O
TE	28836768	0	O
active	28836768	0	O
site	28836768	0	O
;	28836768	0	O
however	28836768	0	O
,	28836768	0	O
intrinsic	28836768	0	O
conformational	28836768	0	O
preferences	28836768	0	O
of	28836768	0	O
the	28836768	0	O
substrate	28836768	0	O
resulted	28836768	0	O
in	28836768	0	O
predominately	28836768	0	O
unproductive	28836768	0	O
conformations	28836768	0	O
,	28836768	0	O
in	28836768	0	O
agreement	28836768	0	O
with	28836768	0	O
the	28836768	0	O
observed	28836768	0	O
hydrolysis	28836768	0	O
.	28836768	0	O
Accordingly	28836768	0	O
,	28836768	0	O
we	28836768	0	O
engineered	28836768	0	O
the	28836768	0	O
stereospecific	28836768	0	O
Pik	28836768	0	O
TE	28836768	0	O
to	28836768	0	O
yield	28836768	0	O
a	28836768	0	O
variant	28836768	0	O
(	28836768	0	O
TES148C	28836768	0	O
)	28836768	0	O
with	28836768	0	O
improved	28836768	0	O
reaction	28836768	0	O
kinetics	28836768	0	O
and	28836768	0	O
gain	28836768	0	O
-	28836768	0	O
of	28836768	0	O
-	28836768	0	O
function	28836768	0	O
processing	28836768	0	O
of	28836768	0	O
an	28836768	0	O
unnatural	28836768	0	O
,	28836768	0	O
epimerized	28836768	0	O
hexaketide	28836768	0	O
.	28836768	0	O
Quantum	28836768	0	O
mechanical	28836768	0	O
(	28836768	0	O
QM	28836768	0	O
)	28836768	0	O
comparison	28836768	0	O
of	28836768	0	O
model	28836768	0	O
TES148C	28836768	0	O
and	28836768	0	O
TEWT	28836768	0	O
reaction	28836768	0	O
coordinate	28836768	0	O
diagrams	28836768	0	O
revealed	28836768	0	O
a	28836768	0	O
change	28836768	0	O
in	28836768	0	O
mechanism	28836768	0	O
from	28836768	0	O
a	28836768	0	O
stepwise	28836768	0	O
addition	28836768	0	O
-	28836768	0	O
elimination	28836768	0	O
(	28836768	0	O
TEWT	28836768	0	O
)	28836768	0	O
to	28836768	0	O
a	28836768	0	O
lower	28836768	0	O
energy	28836768	0	O
concerted	28836768	0	O
acyl	28836768	0	O
substitution	28836768	0	O
(	28836768	0	O
TES148C	28836768	0	O
)	28836768	0	O
,	28836768	0	O
accounting	28836768	0	O
for	28836768	0	O
the	28836768	0	O
gain	28836768	0	O
-	28836768	0	O
of	28836768	0	O
-	28836768	0	O
function	28836768	0	O
and	28836768	0	O
improved	28836768	0	O
reaction	28836768	0	O
kinetics	28836768	0	O
.	28836768	0	O
Finally	28836768	0	O
,	28836768	0	O
we	28836768	0	O
introduced	28836768	0	O
the	28836768	0	O
S148C	28836768	0	B-Var
mutation	28836768	0	O
into	28836768	0	O
a	28836768	0	O
polyketide	28836768	0	O
synthase	28836768	0	O
module	28836768	0	O
(	28836768	0	O
PikAIII	28836768	0	O
-	28836768	0	O
TE	28836768	0	O
)	28836768	0	O
to	28836768	0	O
impart	28836768	0	O
increased	28836768	0	B-PosReg
substrate	28836768	0	B-MPA
flexibility	28836768	0	I-MPA
,	28836768	0	O
enabling	28836768	0	B-PosReg
the	28836768	0	O
production	28836768	0	B-MPA
of	28836768	0	I-MPA
diastereomeric	28836768	0	I-MPA
macrolactones	28836768	0	I-MPA
.	28836768	0	O

A	28838926	0	O
comprehensive	28838926	0	O
functional	28838926	0	O
assessment	28838926	0	O
of	28838926	0	O
carboxylesterase	28838926	0	O
1	28838926	0	O
nonsynonymous	28838926	0	O
polymorphisms	28838926	0	O
.	28838926	0	O
Carboxylesterase	28838926	0	O
1	28838926	0	O
(	28838926	0	O
CES1	28838926	0	O
)	28838926	0	O
is	28838926	0	O
the	28838926	0	O
predominant	28838926	0	O
human	28838926	0	O
hepatic	28838926	0	O
hydrolase	28838926	0	O
responsible	28838926	0	O
for	28838926	0	O
the	28838926	0	O
metabolism	28838926	0	O
of	28838926	0	O
many	28838926	0	O
clinically	28838926	0	O
important	28838926	0	O
medications	28838926	0	O
.	28838926	0	O
CES1	28838926	0	O
expression	28838926	0	O
and	28838926	0	O
activity	28838926	0	O
vary	28838926	0	O
markedly	28838926	0	O
among	28838926	0	O
individuals	28838926	0	O
;	28838926	0	O
and	28838926	0	O
genetic	28838926	0	O
variation	28838926	0	O
is	28838926	0	O
a	28838926	0	O
major	28838926	0	O
contributing	28838926	0	O
factor	28838926	0	O
to	28838926	0	O
CES1	28838926	0	O
interindividual	28838926	0	O
variability	28838926	0	O
.	28838926	0	O
In	28838926	0	O
the	28838926	0	O
present	28838926	0	O
study	28838926	0	O
,	28838926	0	O
we	28838926	0	O
comprehensively	28838926	0	O
examined	28838926	0	O
the	28838926	0	O
functions	28838926	0	O
of	28838926	0	O
CES1	28838926	0	O
nonsynonymous	28838926	0	O
single	28838926	0	O
nucleotide	28838926	0	O
polymorphisms	28838926	0	O
(	28838926	0	O
nsSNPs	28838926	0	O
)	28838926	0	O
and	28838926	0	O
haplotypes	28838926	0	O
using	28838926	0	O
transfected	28838926	0	O
cell	28838926	0	O
lines	28838926	0	O
and	28838926	0	O
individual	28838926	0	O
human	28838926	0	O
liver	28838926	0	O
tissues	28838926	0	O
.	28838926	0	O
The	28838926	0	O
20	28838926	0	O
candidate	28838926	0	O
variants	28838926	0	O
include	28838926	0	O
CES1	28838926	0	O
nsSNPs	28838926	0	O
with	28838926	0	O
a	28838926	0	O
minor	28838926	0	O
allele	28838926	0	O
frequency	28838926	0	O
(	28838926	0	O
MAF	28838926	0	O
)	28838926	0	O
>	28838926	0	O
0.5%	28838926	0	O
in	28838926	0	O
a	28838926	0	O
given	28838926	0	O
population	28838926	0	O
or	28838926	0	O
located	28838926	0	O
in	28838926	0	O
close	28838926	0	O
proximity	28838926	0	O
to	28838926	0	O
the	28838926	0	O
CES1	28838926	0	O
active	28838926	0	O
site	28838926	0	O
.	28838926	0	O
Five	28838926	0	O
nsSNPs	28838926	0	O
including	28838926	0	O
L40Ter	28838926	0	O
(	28838926	0	B-Var
rs151291296	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
G142E	28838926	0	O
(	28838926	0	B-Var
rs121912777	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
G147C	28838926	0	O
(	28838926	0	B-Var
rs146456965	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
Y170D	28838926	0	O
(	28838926	0	B-Var
rs148947808	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
and	28838926	0	O
R171C	28838926	0	O
(	28838926	0	B-Var
rs201065375	28838926	0	I-Var
)	28838926	0	I-Var
were	28838926	0	O
found	28838926	0	O
to	28838926	0	O
be	28838926	0	O
loss	28838926	0	B-NegReg
-	28838926	0	I-NegReg
of	28838926	0	I-NegReg
-	28838926	0	I-NegReg
function	28838926	0	I-NegReg
variants	28838926	0	O
for	28838926	0	O
metabolizing	28838926	0	B-MPA
the	28838926	0	O
CES1	28838926	0	B-Enzyme
substrates	28838926	0	O
clopidogrel	28838926	0	O
,	28838926	0	O
enalapril	28838926	0	O
,	28838926	0	O
and	28838926	0	O
sacubitril	28838926	0	O
.	28838926	0	O
Additionally	28838926	0	O
,	28838926	0	O
the	28838926	0	O
A158V	28838926	0	O
(	28838926	0	B-Var
rs202121317	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
R199H	28838926	0	O
(	28838926	0	B-Var
rs2307243	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
E220G	28838926	0	O
(	28838926	0	B-Var
rs200707504	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
and	28838926	0	O
T290M	28838926	0	O
(	28838926	0	B-Var
rs202001817	28838926	0	I-Var
)	28838926	0	I-Var
decreased	28838926	0	B-NegReg
CES1	28838926	0	B-Enzyme
activity	28838926	0	B-MPA
to	28838926	0	O
a	28838926	0	O
lesser	28838926	0	O
extent	28838926	0	O
in	28838926	0	O
a	28838926	0	O
substrate	28838926	0	O
-	28838926	0	O
dependent	28838926	0	O
manner	28838926	0	O
.	28838926	0	O
Several	28838926	0	O
nsSNPs	28838926	0	O
including	28838926	0	O
the	28838926	0	O
L40Ter	28838926	0	O
(	28838926	0	B-Var
rs151291296	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
G147C	28838926	0	O
(	28838926	0	B-Var
rs146456965	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
Y170D	28838926	0	O
(	28838926	0	B-Var
rs148947808	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
and	28838926	0	O
R171C	28838926	0	O
(	28838926	0	B-Var
rs201065375	28838926	0	I-Var
)	28838926	0	I-Var
significantly	28838926	0	O
reduced	28838926	0	B-NegReg
CES1	28838926	0	B-Protein
protein	28838926	0	I-Protein
and	28838926	0	O
/	28838926	0	O
or	28838926	0	O
mRNA	28838926	0	B-MPA
expressions	28838926	0	I-MPA
in	28838926	0	O
the	28838926	0	O
transfected	28838926	0	O
cells	28838926	0	O
.	28838926	0	O
Functions	28838926	0	O
of	28838926	0	O
the	28838926	0	O
common	28838926	0	O
nonsynonymous	28838926	0	O
haplotypes	28838926	0	O
D203E	28838926	0	O
-	28838926	0	O
A269S	28838926	0	O
and	28838926	0	O
S75N	28838926	0	O
-	28838926	0	O
D203E	28838926	0	O
-	28838926	0	O
A269S	28838926	0	O
were	28838926	0	O
evaluated	28838926	0	O
using	28838926	0	O
cells	28838926	0	O
stably	28838926	0	O
expressing	28838926	0	O
the	28838926	0	O
haplotypes	28838926	0	O
and	28838926	0	O
a	28838926	0	O
large	28838926	0	O
set	28838926	0	O
of	28838926	0	O
human	28838926	0	O
livers	28838926	0	O
.	28838926	0	O
Neither	28838926	0	O
CES1	28838926	0	O
expression	28838926	0	O
nor	28838926	0	O
activity	28838926	0	O
were	28838926	0	O
affected	28838926	0	O
by	28838926	0	O
the	28838926	0	O
two	28838926	0	O
haplotypes	28838926	0	O
.	28838926	0	O
In	28838926	0	O
sum	28838926	0	O
,	28838926	0	O
the	28838926	0	O
study	28838926	0	O
revealed	28838926	0	O
several	28838926	0	O
functional	28838926	0	O
nsSNPs	28838926	0	O
with	28838926	0	O
impaired	28838926	0	O
activity	28838926	0	O
on	28838926	0	O
the	28838926	0	O
metabolism	28838926	0	O
of	28838926	0	O
CES1	28838926	0	O
substrate	28838926	0	O
drugs	28838926	0	O
.	28838926	0	O
Clinical	28838926	0	O
investigations	28838926	0	O
are	28838926	0	O
warranted	28838926	0	O
to	28838926	0	O
determine	28838926	0	O
whether	28838926	0	O
these	28838926	0	O
nsSNPs	28838926	0	O
can	28838926	0	O
serve	28838926	0	O
as	28838926	0	O
biomarkers	28838926	0	O
for	28838926	0	O
the	28838926	0	O
prediction	28838926	0	O
of	28838926	0	O
therapeutic	28838926	0	O
outcomes	28838926	0	O
of	28838926	0	O
drugs	28838926	0	O
metabolized	28838926	0	O
by	28838926	0	O
CES1	28838926	0	O
.	28838926	0	O

Progranulin	28845019	0	B-Protein
haploinsufficiency	28845019	0	B-Var
reduces	28845019	0	B-NegReg
amyloid	28845019	0	B-MPA
beta	28845019	0	I-MPA
deposition	28845019	0	I-MPA
in	28845019	0	O
Alzheimer	28845019	0	B-Disease
'	28845019	0	I-Disease
s	28845019	0	I-Disease
disease	28845019	0	I-Disease
model	28845019	0	O
mice	28845019	0	O
.	28845019	0	O
Granulin	28845019	0	O
(	28845019	0	O
Grn	28845019	0	O
)	28845019	0	O
mutations	28845019	0	O
were	28845019	0	O
identified	28845019	0	O
in	28845019	0	O
familial	28845019	0	O
frontotemporal	28845019	0	B-Disease
lobar	28845019	0	I-Disease
degeneration	28845019	0	I-Disease
(	28845019	0	O
FTLD	28845019	0	O
)	28845019	0	O
patients	28845019	0	O
with	28845019	0	O
TAR	28845019	0	O
DNA	28845019	0	O
-	28845019	0	O
binding	28845019	0	O
protein	28845019	0	O
of	28845019	0	O
43	28845019	0	O
kd	28845019	0	O
(	28845019	0	O
TDP-43	28845019	0	O
)	28845019	0	O
pathology	28845019	0	O
.	28845019	0	O
Grn	28845019	0	B-Protein
transcript	28845019	0	O
haploinsufficiency	28845019	0	B-Var
is	28845019	0	O
proposed	28845019	0	O
as	28845019	0	O
a	28845019	0	O
disease	28845019	0	O
mechanism	28845019	0	O
that	28845019	0	O
leads	28845019	0	O
to	28845019	0	O
the	28845019	0	O
loss	28845019	0	B-NegReg
of	28845019	0	I-NegReg
functional	28845019	0	I-NegReg
progranulin	28845019	0	O
(	28845019	0	B-Protein
PGRN	28845019	0	I-Protein
)	28845019	0	I-Protein
protein	28845019	0	O
.	28845019	0	O
Thus	28845019	0	O
,	28845019	0	O
these	28845019	0	O
mutations	28845019	0	B-Var
are	28845019	0	O
strongly	28845019	0	O
involved	28845019	0	B-Reg
in	28845019	0	O
FTLD	28845019	0	B-Disease
pathogenesis	28845019	0	O
.	28845019	0	O
Moreover	28845019	0	O
,	28845019	0	O
recent	28845019	0	O
findings	28845019	0	O
indicate	28845019	0	O
that	28845019	0	O
Grn	28845019	0	B-Protein
mutations	28845019	0	B-Var
are	28845019	0	O
associated	28845019	0	B-Reg
with	28845019	0	O
other	28845019	0	O
neurodegenerative	28845019	0	O
disorders	28845019	0	O
with	28845019	0	O
tau	28845019	0	O
pathology	28845019	0	O
,	28845019	0	O
including	28845019	0	O
Alzheimer	28845019	0	B-Disease
'	28845019	0	I-Disease
s	28845019	0	I-Disease
disease	28845019	0	I-Disease
.	28845019	0	O
To	28845019	0	O
investigate	28845019	0	O
the	28845019	0	O
influence	28845019	0	O
of	28845019	0	O
PGRN	28845019	0	O
on	28845019	0	O
amyloid	28845019	0	O
beta	28845019	0	O
(	28845019	0	O
Aβ	28845019	0	O
)	28845019	0	O
accumulation	28845019	0	O
,	28845019	0	O
amyloid	28845019	0	O
precursor	28845019	0	O
protein	28845019	0	O
(	28845019	0	O
APP	28845019	0	O
)	28845019	0	O
transgenic	28845019	0	O
mice	28845019	0	O
were	28845019	0	O
interbred	28845019	0	O
with	28845019	0	O
Grn	28845019	0	O
-	28845019	0	O
deficient	28845019	0	O
mice	28845019	0	O
,	28845019	0	O
producing	28845019	0	O
APP	28845019	0	O
transgenic	28845019	0	O
mice	28845019	0	O
harboring	28845019	0	O
the	28845019	0	O
Grn	28845019	0	O
hemizygote	28845019	0	O
(	28845019	0	O
APP	28845019	0	O
/	28845019	0	O
Grn	28845019	0	O
/	28845019	0	O
-	28845019	0	O
)	28845019	0	O
.	28845019	0	O
Brains	28845019	0	O
were	28845019	0	O
collected	28845019	0	O
from	28845019	0	O
16	28845019	0	O
-	28845019	0	O
18	28845019	0	O
-	28845019	0	O
month	28845019	0	O
-	28845019	0	O
old	28845019	0	O
APP	28845019	0	O
and	28845019	0	O
APP	28845019	0	O
/	28845019	0	O
Grn	28845019	0	O
/	28845019	0	O
-	28845019	0	O
mice	28845019	0	O
and	28845019	0	O
sequential	28845019	0	O
extraction	28845019	0	O
of	28845019	0	O
proteins	28845019	0	O
,	28845019	0	O
immunoblotting	28845019	0	O
and	28845019	0	O
immunohistochemical	28845019	0	O
analysis	28845019	0	O
were	28845019	0	O
performed	28845019	0	O
.	28845019	0	O
Immunohistochemical	28845019	0	O
analysis	28845019	0	O
showed	28845019	0	O
that	28845019	0	O
the	28845019	0	O
number	28845019	0	O
and	28845019	0	O
area	28845019	0	O
of	28845019	0	O
Aβ	28845019	0	O
plaque	28845019	0	O
was	28845019	0	O
significantly	28845019	0	O
decreased	28845019	0	O
in	28845019	0	O
APP	28845019	0	O
/	28845019	0	O
Grn	28845019	0	O
/	28845019	0	O
-	28845019	0	O
mice	28845019	0	O
as	28845019	0	O
compared	28845019	0	O
to	28845019	0	O
APP	28845019	0	O
mice	28845019	0	O
.	28845019	0	O
Immunoblotting	28845019	0	O
analysis	28845019	0	O
revealed	28845019	0	O
that	28845019	0	O
Aβ	28845019	0	O
was	28845019	0	O
reduced	28845019	0	O
in	28845019	0	O
the	28845019	0	O
sarkosyl	28845019	0	O
-	28845019	0	O
insoluble	28845019	0	O
fraction	28845019	0	O
of	28845019	0	O
16	28845019	0	O
-	28845019	0	O
18	28845019	0	O
-	28845019	0	O
month	28845019	0	O
-	28845019	0	O
old	28845019	0	O
APP	28845019	0	O
/	28845019	0	O
Grn	28845019	0	O
/	28845019	0	O
-	28845019	0	O
mice	28845019	0	O
as	28845019	0	O
compared	28845019	0	O
with	28845019	0	O
that	28845019	0	O
of	28845019	0	O
APP	28845019	0	O
transgenic	28845019	0	O
mice	28845019	0	O
.	28845019	0	O
Our	28845019	0	O
data	28845019	0	O
suggest	28845019	0	O
that	28845019	0	O
PGRN	28845019	0	B-Protein
haploinsufficiency	28845019	0	B-Var
may	28845019	0	O
decrease	28845019	0	B-NegReg
accumulation	28845019	0	B-MPA
of	28845019	0	I-MPA
Aβ	28845019	0	I-MPA
.	28845019	0	O

Identification	28860350	4	O
of	28860350	4	O
distinct	28860350	4	O
mutational	28860350	4	O
patterns	28860350	4	O
and	28860350	4	O
new	28860350	4	O
driver	28860350	4	O
genes	28860350	4	O
in	28860350	4	O
oesophageal	28860350	4	O
squamous	28860350	4	O
cell	28860350	4	O
carcinomas	28860350	4	O
and	28860350	4	O
adenocarcinomas	28860350	4	O
.	28860350	4	O
OBJECTIVES	28860350	4	O
:	28860350	4	O
Oesophageal	28860350	4	B-Disease
squamous	28860350	4	I-Disease
cell	28860350	4	I-Disease
carcinoma	28860350	4	I-Disease
(	28860350	4	O
OSCC	28860350	4	O
)	28860350	4	O
and	28860350	4	O
adenocarcinoma	28860350	4	O
(	28860350	4	O
OAC	28860350	4	O
)	28860350	4	O
are	28860350	4	O
distinct	28860350	4	O
cancers	28860350	4	O
in	28860350	4	O
terms	28860350	4	O
of	28860350	4	O
a	28860350	4	O
number	28860350	4	O
of	28860350	4	O
clinical	28860350	4	O
and	28860350	4	O
epidemiological	28860350	4	O
characteristics	28860350	4	O
,	28860350	4	O
complicating	28860350	4	O
the	28860350	4	O
design	28860350	4	O
of	28860350	4	O
clinical	28860350	4	O
trials	28860350	4	O
and	28860350	4	O
biomarker	28860350	4	O
developments	28860350	4	O
.	28860350	4	O
We	28860350	4	O
analysed	28860350	4	O
1048	28860350	4	O
oesophageal	28860350	4	O
tumour	28860350	4	O
-	28860350	4	O
germline	28860350	4	O
pairs	28860350	4	O
from	28860350	4	O
both	28860350	4	O
subtypes	28860350	4	O
,	28860350	4	O
to	28860350	4	O
characterise	28860350	4	O
their	28860350	4	O
genomic	28860350	4	O
features	28860350	4	O
,	28860350	4	O
and	28860350	4	O
biological	28860350	4	O
and	28860350	4	O
clinical	28860350	4	O
significance	28860350	4	O
.	28860350	4	O
DESIGN	28860350	4	O
:	28860350	4	O
Previously	28860350	4	O
exome	28860350	4	O
-	28860350	4	O
sequenced	28860350	4	O
samples	28860350	4	O
were	28860350	4	O
re	28860350	4	O
-	28860350	4	O
analysed	28860350	4	O
to	28860350	4	O
identify	28860350	4	O
significantly	28860350	4	O
mutated	28860350	4	O
genes	28860350	4	O
(	28860350	4	O
SMGs	28860350	4	O
)	28860350	4	O
and	28860350	4	O
mutational	28860350	4	O
signatures	28860350	4	O
.	28860350	4	O
The	28860350	4	O
biological	28860350	4	O
functions	28860350	4	O
of	28860350	4	O
novel	28860350	4	O
SMGs	28860350	4	O
were	28860350	4	O
investigated	28860350	4	O
using	28860350	4	O
cell	28860350	4	O
line	28860350	4	O
and	28860350	4	O
xenograft	28860350	4	O
models	28860350	4	O
.	28860350	4	O
We	28860350	4	O
further	28860350	4	O
performed	28860350	4	O
whole	28860350	4	O
-	28860350	4	O
genome	28860350	4	O
bisulfite	28860350	4	O
sequencing	28860350	4	O
and	28860350	4	O
chromatin	28860350	4	O
immunoprecipitation	28860350	4	O
(	28860350	4	O
ChIP	28860350	4	O
)	28860350	4	O
-	28860350	4	O
seq	28860350	4	O
to	28860350	4	O
characterise	28860350	4	O
epigenetic	28860350	4	O
alterations	28860350	4	O
.	28860350	4	O
RESULTS	28860350	4	O
:	28860350	4	O
OSCC	28860350	4	O
and	28860350	4	O
OAC	28860350	4	O
displayed	28860350	4	O
nearly	28860350	4	O
mutually	28860350	4	O
exclusive	28860350	4	O
sets	28860350	4	O
of	28860350	4	O
driver	28860350	4	O
genes	28860350	4	O
,	28860350	4	O
indicating	28860350	4	O
that	28860350	4	O
they	28860350	4	O
follow	28860350	4	O
independent	28860350	4	O
developmental	28860350	4	O
paths	28860350	4	O
.	28860350	4	O
The	28860350	4	O
combined	28860350	4	O
sample	28860350	4	O
size	28860350	4	O
allowed	28860350	4	O
the	28860350	4	O
statistical	28860350	4	O
identification	28860350	4	O
of	28860350	4	O
a	28860350	4	O
number	28860350	4	O
of	28860350	4	O
novel	28860350	4	O
subtype	28860350	4	O
-	28860350	4	O
specific	28860350	4	O
SMGs	28860350	4	O
,	28860350	4	O
mutational	28860350	4	O
signatures	28860350	4	O
and	28860350	4	O
prognostic	28860350	4	O
biomarkers	28860350	4	O
.	28860350	4	O
Particularly	28860350	4	O
,	28860350	4	O
we	28860350	4	O
identified	28860350	4	O
a	28860350	4	O
novel	28860350	4	O
mutational	28860350	4	O
signature	28860350	4	O
similar	28860350	4	O
to	28860350	4	O
Catalogue	28860350	4	O
Of	28860350	4	O
Somatic	28860350	4	O
Mutations	28860350	4	O
In	28860350	4	O
Cancer	28860350	4	O
(	28860350	4	O
COSMIC	28860350	4	O
)	28860350	4	O
signature	28860350	4	O
16	28860350	4	O
,	28860350	4	O
which	28860350	4	O
has	28860350	4	O
prognostic	28860350	4	O
value	28860350	4	O
in	28860350	4	O
OSCC	28860350	4	O
.	28860350	4	O
Two	28860350	4	O
newly	28860350	4	O
discovered	28860350	4	O
SMGs	28860350	4	O
,	28860350	4	O
CUL3	28860350	4	O
and	28860350	4	O
ZFP36L2	28860350	4	O
,	28860350	4	O
were	28860350	4	O
validated	28860350	4	O
as	28860350	4	O
important	28860350	4	O
tumour	28860350	4	O
-	28860350	4	O
suppressors	28860350	4	O
specific	28860350	4	O
to	28860350	4	O
the	28860350	4	O
OSCC	28860350	4	O
subtype	28860350	4	O
.	28860350	4	O
We	28860350	4	O
further	28860350	4	O
identified	28860350	4	O
their	28860350	4	O
additional	28860350	4	O
loss	28860350	4	O
-	28860350	4	O
of	28860350	4	O
-	28860350	4	O
function	28860350	4	O
mechanisms	28860350	4	O
.	28860350	4	O
CUL3	28860350	4	B-Gene
was	28860350	4	O
homozygously	28860350	4	O
deleted	28860350	4	B-Var
specifically	28860350	4	O
in	28860350	4	B-Reg
OSCC	28860350	4	B-Disease
and	28860350	4	O
other	28860350	4	O
squamous	28860350	4	B-Disease
cell	28860350	4	I-Disease
cancers	28860350	4	I-Disease
(	28860350	4	O
SCCs	28860350	4	O
)	28860350	4	O
.	28860350	4	O
Notably	28860350	4	O
,	28860350	4	O
ZFP36L2	28860350	4	O
is	28860350	4	O
associated	28860350	4	O
with	28860350	4	O
super	28860350	4	O
-	28860350	4	O
enhancer	28860350	4	O
in	28860350	4	O
healthy	28860350	4	O
oesophageal	28860350	4	O
mucosa	28860350	4	O
;	28860350	4	O
DNA	28860350	4	O
hypermethylation	28860350	4	O
in	28860350	4	O
its	28860350	4	O
super	28860350	4	O
-	28860350	4	O
enhancer	28860350	4	O
reduced	28860350	4	O
active	28860350	4	O
histone	28860350	4	O
markers	28860350	4	O
in	28860350	4	O
squamous	28860350	4	O
cancer	28860350	4	O
cells	28860350	4	O
,	28860350	4	O
suggesting	28860350	4	O
an	28860350	4	O
epigenetic	28860350	4	O
inactivation	28860350	4	O
of	28860350	4	O
a	28860350	4	O
super	28860350	4	O
-	28860350	4	O
enhancer	28860350	4	O
-	28860350	4	O
associated	28860350	4	O
SCC	28860350	4	O
suppressor	28860350	4	O
.	28860350	4	O
CONCLUSIONS	28860350	4	O
:	28860350	4	O
These	28860350	4	O
data	28860350	4	O
comprehensively	28860350	4	O
contrast	28860350	4	O
differences	28860350	4	O
between	28860350	4	O
OSCC	28860350	4	O
and	28860350	4	O
OAC	28860350	4	O
at	28860350	4	O
both	28860350	4	O
genomic	28860350	4	O
and	28860350	4	O
epigenomic	28860350	4	O
levels	28860350	4	O
,	28860350	4	O
and	28860350	4	O
reveal	28860350	4	O
novel	28860350	4	O
molecular	28860350	4	O
features	28860350	4	O
for	28860350	4	O
further	28860350	4	O
delineating	28860350	4	O
the	28860350	4	O
pathophysiological	28860350	4	O
mechanisms	28860350	4	O
and	28860350	4	O
treatment	28860350	4	O
strategies	28860350	4	O
for	28860350	4	O
these	28860350	4	O
cancers	28860350	4	O
.	28860350	4	O

Gait	28867506	0	O
disturbance	28867506	0	O
and	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
pain	28867506	0	O
in	28867506	0	O
a	28867506	0	O
patient	28867506	0	O
with	28867506	0	O
PIK3CA	28867506	0	O
-	28867506	0	O
related	28867506	0	O
disorder	28867506	0	O
.	28867506	0	O
Post	28867506	0	O
-	28867506	0	O
zygotic	28867506	0	O
activating	28867506	0	O
mutations	28867506	0	O
in	28867506	0	O
PIK3CA	28867506	0	O
and	28867506	0	O
other	28867506	0	O
genes	28867506	0	O
encoding	28867506	0	O
members	28867506	0	O
of	28867506	0	O
PI3K	28867506	0	O
-	28867506	0	O
AKT	28867506	0	O
-	28867506	0	O
mTOR	28867506	0	O
pathway	28867506	0	O
have	28867506	0	O
been	28867506	0	O
found	28867506	0	O
in	28867506	0	O
various	28867506	0	O
overgrowth	28867506	0	O
syndromes	28867506	0	O
that	28867506	0	O
have	28867506	0	O
been	28867506	0	O
grouped	28867506	0	O
together	28867506	0	O
as	28867506	0	O
PIK3CA	28867506	0	O
-	28867506	0	O
related	28867506	0	O
overgrowth	28867506	0	O
spectrum	28867506	0	O
(	28867506	0	O
PROS	28867506	0	O
)	28867506	0	O
.	28867506	0	O
We	28867506	0	O
report	28867506	0	O
a	28867506	0	O
female	28867506	0	O
patient	28867506	0	O
with	28867506	0	O
gait	28867506	0	O
disturbance	28867506	0	O
,	28867506	0	O
leg	28867506	0	O
pain	28867506	0	O
,	28867506	0	O
isolated	28867506	0	O
macrodactyly	28867506	0	O
of	28867506	0	O
the	28867506	0	O
foot	28867506	0	O
,	28867506	0	O
and	28867506	0	O
mild	28867506	0	O
intellectual	28867506	0	O
disability	28867506	0	O
.	28867506	0	O
Imaging	28867506	0	O
of	28867506	0	O
the	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
showed	28867506	0	O
a	28867506	0	O
lipoblastoma	28867506	0	O
of	28867506	0	O
the	28867506	0	O
right	28867506	0	O
thigh	28867506	0	O
.	28867506	0	O
A	28867506	0	O
mosaic	28867506	0	O
gain	28867506	0	B-PosReg
-	28867506	0	I-PosReg
of	28867506	0	I-PosReg
-	28867506	0	I-PosReg
function	28867506	0	I-PosReg
mutation	28867506	0	O
in	28867506	0	O
the	28867506	0	O
catalytic	28867506	0	O
domain	28867506	0	O
of	28867506	0	O
PIK3CA	28867506	0	B-Gene
(	28867506	0	B-Var
c.3140	28867506	0	I-Var
A	28867506	0	I-Var
>	28867506	0	I-Var
G	28867506	0	I-Var
;	28867506	0	I-Var
p.His1047Arg	28867506	0	B-Var
)	28867506	0	I-Var
was	28867506	0	O
detected	28867506	0	O
in	28867506	0	O
the	28867506	0	O
adipose	28867506	0	O
tissue	28867506	0	O
and	28867506	0	O
in	28867506	0	O
skin	28867506	0	O
cultured	28867506	0	O
fibroblasts	28867506	0	O
from	28867506	0	O
the	28867506	0	O
macrodactyly	28867506	0	O
but	28867506	0	O
not	28867506	0	O
in	28867506	0	O
blood	28867506	0	O
.	28867506	0	O
The	28867506	0	O
leg	28867506	0	O
pain	28867506	0	O
and	28867506	0	O
the	28867506	0	O
severe	28867506	0	O
walking	28867506	0	O
disturbance	28867506	0	O
improved	28867506	0	O
slightly	28867506	0	O
over	28867506	0	O
time	28867506	0	O
and	28867506	0	O
serial	28867506	0	O
MRI	28867506	0	O
of	28867506	0	O
the	28867506	0	O
lower	28867506	0	O
limbs	28867506	0	O
suggested	28867506	0	O
that	28867506	0	O
the	28867506	0	O
size	28867506	0	O
of	28867506	0	O
the	28867506	0	O
lipoblastoma	28867506	0	O
relative	28867506	0	O
to	28867506	0	O
the	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
muscles	28867506	0	O
or	28867506	0	O
to	28867506	0	O
the	28867506	0	O
whole	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
was	28867506	0	O
unchanged	28867506	0	O
as	28867506	0	O
consequence	28867506	0	O
of	28867506	0	O
limb	28867506	0	O
growth	28867506	0	O
.	28867506	0	O
This	28867506	0	O
case	28867506	0	O
report	28867506	0	O
illustrates	28867506	0	O
that	28867506	0	O
pain	28867506	0	O
and	28867506	0	O
gait	28867506	0	O
disturbance	28867506	0	O
can	28867506	0	O
be	28867506	0	O
features	28867506	0	O
of	28867506	0	O
PROS	28867506	0	O
and	28867506	0	O
highlights	28867506	0	O
the	28867506	0	O
need	28867506	0	O
of	28867506	0	O
better	28867506	0	O
knowledge	28867506	0	O
about	28867506	0	O
the	28867506	0	O
natural	28867506	0	O
history	28867506	0	O
of	28867506	0	O
the	28867506	0	O
disease	28867506	0	O
.	28867506	0	O

Loss	28886269	1	O
-	28886269	1	O
of	28886269	1	O
-	28886269	1	O
Function	28886269	1	O
GRHL3	28886269	1	O
Variants	28886269	1	O
Detected	28886269	1	O
in	28886269	1	O
African	28886269	1	O
Patients	28886269	1	O
with	28886269	1	O
Isolated	28886269	1	O
Cleft	28886269	1	O
Palate	28886269	1	O
.	28886269	1	O
In	28886269	1	O
contrast	28886269	1	O
to	28886269	1	O
the	28886269	1	O
progress	28886269	1	O
that	28886269	1	O
has	28886269	1	O
been	28886269	1	O
made	28886269	1	O
toward	28886269	1	O
understanding	28886269	1	O
the	28886269	1	O
genetic	28886269	1	O
etiology	28886269	1	O
of	28886269	1	O
cleft	28886269	1	O
lip	28886269	1	O
with	28886269	1	O
or	28886269	1	O
without	28886269	1	O
cleft	28886269	1	O
palate	28886269	1	O
,	28886269	1	O
relatively	28886269	1	O
little	28886269	1	O
is	28886269	1	O
known	28886269	1	O
about	28886269	1	O
the	28886269	1	O
genetic	28886269	1	O
etiology	28886269	1	O
for	28886269	1	O
cleft	28886269	1	B-Disease
palate	28886269	1	I-Disease
only	28886269	1	I-Disease
(	28886269	1	O
CPO	28886269	1	O
)	28886269	1	O
.	28886269	1	O
A	28886269	1	O
common	28886269	1	O
coding	28886269	1	O
variant	28886269	1	O
of	28886269	1	O
grainyhead	28886269	1	O
like	28886269	1	O
transcription	28886269	1	O
factor	28886269	1	O
3	28886269	1	O
(	28886269	1	O
GRHL3	28886269	1	O
)	28886269	1	O
was	28886269	1	O
recently	28886269	1	O
shown	28886269	1	O
to	28886269	1	O
be	28886269	1	O
associated	28886269	1	O
with	28886269	1	O
risk	28886269	1	O
for	28886269	1	O
CPO	28886269	1	O
in	28886269	1	O
Europeans	28886269	1	O
.	28886269	1	O
Mutations	28886269	1	O
in	28886269	1	O
this	28886269	1	O
gene	28886269	1	O
were	28886269	1	O
also	28886269	1	O
reported	28886269	1	O
in	28886269	1	O
families	28886269	1	O
with	28886269	1	O
Van	28886269	1	O
der	28886269	1	O
Woude	28886269	1	O
syndrome	28886269	1	O
.	28886269	1	O
To	28886269	1	O
identify	28886269	1	O
rare	28886269	1	O
mutations	28886269	1	O
in	28886269	1	O
GRHL3	28886269	1	O
that	28886269	1	O
might	28886269	1	O
explain	28886269	1	O
the	28886269	1	O
missing	28886269	1	O
heritability	28886269	1	O
for	28886269	1	O
CPO	28886269	1	O
,	28886269	1	O
we	28886269	1	O
sequenced	28886269	1	O
GRHL3	28886269	1	O
in	28886269	1	O
cases	28886269	1	O
of	28886269	1	O
CPO	28886269	1	O
from	28886269	1	O
Africa	28886269	1	O
.	28886269	1	O
We	28886269	1	O
recruited	28886269	1	O
participants	28886269	1	O
from	28886269	1	O
Ghana	28886269	1	O
,	28886269	1	O
Ethiopia	28886269	1	O
,	28886269	1	O
and	28886269	1	O
Nigeria	28886269	1	O
.	28886269	1	O
This	28886269	1	O
cohort	28886269	1	O
included	28886269	1	O
case	28886269	1	O
-	28886269	1	O
parent	28886269	1	O
trios	28886269	1	O
,	28886269	1	O
cases	28886269	1	O
and	28886269	1	O
other	28886269	1	O
family	28886269	1	O
members	28886269	1	O
,	28886269	1	O
as	28886269	1	O
well	28886269	1	O
as	28886269	1	O
controls	28886269	1	O
.	28886269	1	O
We	28886269	1	O
sequenced	28886269	1	O
exons	28886269	1	O
of	28886269	1	O
this	28886269	1	O
gene	28886269	1	O
in	28886269	1	O
DNA	28886269	1	O
from	28886269	1	O
a	28886269	1	O
total	28886269	1	O
of	28886269	1	O
134	28886269	1	O
nonsyndromic	28886269	1	O
cases	28886269	1	O
.	28886269	1	O
When	28886269	1	O
possible	28886269	1	O
,	28886269	1	O
we	28886269	1	O
sequenced	28886269	1	O
them	28886269	1	O
in	28886269	1	O
parents	28886269	1	O
to	28886269	1	O
identify	28886269	1	O
de	28886269	1	O
novo	28886269	1	O
mutations	28886269	1	O
.	28886269	1	O
Five	28886269	1	O
novel	28886269	1	O
mutations	28886269	1	O
were	28886269	1	O
identified	28886269	1	O
:	28886269	1	O
2	28886269	1	O
missense	28886269	1	O
(	28886269	1	O
c.497C	28886269	1	O
>	28886269	1	O
A	28886269	1	O
;	28886269	1	O
p.Pro166His	28886269	1	O
and	28886269	1	O
c.1229A	28886269	1	O
>	28886269	1	O
G	28886269	1	O
;	28886269	1	O
p.Asp410Gly	28886269	1	O
)	28886269	1	O
,	28886269	1	O
1	28886269	1	O
splice	28886269	1	O
site	28886269	1	O
(	28886269	1	O
c.1282A	28886269	1	O
>	28886269	1	O
C	28886269	1	O
p.Ser428Arg	28886269	1	O
)	28886269	1	O
,	28886269	1	O
1	28886269	1	O
frameshift	28886269	1	O
(	28886269	1	O
c.470delC	28886269	1	O
;	28886269	1	O
p.Gly158Alafster55	28886269	1	O
)	28886269	1	O
,	28886269	1	O
and	28886269	1	O
1	28886269	1	O
nonsense	28886269	1	O
(	28886269	1	O
c.1677C	28886269	1	O
>	28886269	1	O
A	28886269	1	O
;	28886269	1	O
p.Tyr559Ter	28886269	1	O
)	28886269	1	O
.	28886269	1	O
These	28886269	1	O
mutations	28886269	1	O
were	28886269	1	O
absent	28886269	1	O
from	28886269	1	O
270	28886269	1	O
sequenced	28886269	1	O
controls	28886269	1	O
and	28886269	1	O
from	28886269	1	O
all	28886269	1	O
public	28886269	1	O
exome	28886269	1	O
and	28886269	1	O
whole	28886269	1	O
genome	28886269	1	O
databases	28886269	1	O
,	28886269	1	O
including	28886269	1	O
the	28886269	1	O
1000	28886269	1	O
Genomes	28886269	1	O
database	28886269	1	O
(	28886269	1	O
which	28886269	1	O
includes	28886269	1	O
data	28886269	1	O
from	28886269	1	O
Africa	28886269	1	O
)	28886269	1	O
.	28886269	1	O
However	28886269	1	O
,	28886269	1	O
4	28886269	1	O
of	28886269	1	O
the	28886269	1	O
5	28886269	1	O
mutations	28886269	1	O
were	28886269	1	O
present	28886269	1	O
in	28886269	1	O
unaffected	28886269	1	O
mothers	28886269	1	O
,	28886269	1	O
indicating	28886269	1	O
that	28886269	1	O
their	28886269	1	O
penetrance	28886269	1	O
is	28886269	1	O
incomplete	28886269	1	O
.	28886269	1	O
Interestingly	28886269	1	O
,	28886269	1	O
1	28886269	1	O
mutation	28886269	1	B-Var
damaged	28886269	1	B-NegReg
a	28886269	1	O
predicted	28886269	1	O
sumoylation	28886269	1	B-MPA
site	28886269	1	I-MPA
,	28886269	1	O
and	28886269	1	O
another	28886269	1	O
disrupted	28886269	1	B-NegReg
a	28886269	1	O
predicted	28886269	1	O
CK1	28886269	1	B-MPA
phosphorylation	28886269	1	I-MPA
site	28886269	1	O
.	28886269	1	O
Overexpression	28886269	1	O
assays	28886269	1	O
in	28886269	1	O
zebrafish	28886269	1	O
and	28886269	1	O
reporter	28886269	1	O
assays	28886269	1	O
in	28886269	1	O
vitro	28886269	1	O
indicated	28886269	1	O
that	28886269	1	O
4	28886269	1	O
variants	28886269	1	O
were	28886269	1	O
functionally	28886269	1	O
null	28886269	1	O
or	28886269	1	O
hypomorphic	28886269	1	O
,	28886269	1	O
while	28886269	1	O
1	28886269	1	O
was	28886269	1	O
dominant	28886269	1	O
negative	28886269	1	O
.	28886269	1	O
This	28886269	1	O
study	28886269	1	O
provides	28886269	1	O
evidence	28886269	1	O
that	28886269	1	O
,	28886269	1	O
as	28886269	1	O
in	28886269	1	O
Caucasian	28886269	1	O
populations	28886269	1	O
,	28886269	1	O
mutations	28886269	1	B-Var
in	28886269	1	O
GRHL3	28886269	1	B-Gene
contribute	28886269	1	O
to	28886269	1	O
the	28886269	1	O
risk	28886269	1	B-Reg
of	28886269	1	O
nonsyndromic	28886269	1	O
CPO	28886269	1	B-Disease
in	28886269	1	O
the	28886269	1	O
African	28886269	1	O
population	28886269	1	O
.	28886269	1	O

The	28887372	2	O
apolipoprotein	28887372	2	B-Protein
C	28887372	2	I-Protein
-	28887372	2	I-Protein
III	28887372	2	I-Protein
(	28887372	2	B-Var
Gln38Lys	28887372	2	I-Var
)	28887372	2	I-Var
variant	28887372	2	O
associated	28887372	2	O
with	28887372	2	O
human	28887372	2	B-Disease
hypertriglyceridemia	28887372	2	I-Disease
is	28887372	2	O
a	28887372	2	O
gain	28887372	2	B-PosReg
-	28887372	2	I-PosReg
of	28887372	2	I-PosReg
-	28887372	2	I-PosReg
function	28887372	2	I-PosReg
mutation	28887372	2	O
.	28887372	2	O
Recent	28887372	2	O
cell	28887372	2	O
culture	28887372	2	O
and	28887372	2	O
animal	28887372	2	O
studies	28887372	2	O
have	28887372	2	O
suggested	28887372	2	O
that	28887372	2	O
expression	28887372	2	O
of	28887372	2	O
human	28887372	2	O
apo	28887372	2	O
C	28887372	2	O
-	28887372	2	O
III	28887372	2	O
in	28887372	2	O
the	28887372	2	O
liver	28887372	2	O
has	28887372	2	O
a	28887372	2	O
profound	28887372	2	O
impact	28887372	2	O
on	28887372	2	O
the	28887372	2	O
triacylglycerol	28887372	2	O
(	28887372	2	O
TAG	28887372	2	O
)	28887372	2	O
-	28887372	2	O
rich	28887372	2	O
VLDL1	28887372	2	O
production	28887372	2	O
under	28887372	2	O
lipid	28887372	2	O
-	28887372	2	O
rich	28887372	2	O
conditions	28887372	2	O
.	28887372	2	O
The	28887372	2	O
apoC	28887372	2	O
-	28887372	2	O
III	28887372	2	O
Gln38Lys	28887372	2	O
variant	28887372	2	O
was	28887372	2	O
identified	28887372	2	O
in	28887372	2	O
subjects	28887372	2	O
of	28887372	2	O
Mexican	28887372	2	O
origin	28887372	2	O
with	28887372	2	O
moderate	28887372	2	O
hypertriglyceridemia	28887372	2	O
.	28887372	2	O
We	28887372	2	O
postulated	28887372	2	O
that	28887372	2	O
Gln38Lys	28887372	2	O
(	28887372	2	O
C3QK	28887372	2	O
)	28887372	2	O
,	28887372	2	O
being	28887372	2	O
a	28887372	2	O
gain	28887372	2	O
-	28887372	2	O
of	28887372	2	O
-	28887372	2	O
function	28887372	2	O
mutation	28887372	2	O
,	28887372	2	O
promotes	28887372	2	O
hepatic	28887372	2	O
VLDL1	28887372	2	O
assembly	28887372	2	O
/	28887372	2	O
secretion	28887372	2	O
.	28887372	2	O
To	28887372	2	O
test	28887372	2	O
this	28887372	2	O
hypothesis	28887372	2	O
,	28887372	2	O
we	28887372	2	O
expressed	28887372	2	O
C3QK	28887372	2	O
in	28887372	2	O
McA	28887372	2	O
-	28887372	2	O
RH7777	28887372	2	O
cells	28887372	2	O
and	28887372	2	O
apoc3	28887372	2	O
-	28887372	2	O
null	28887372	2	O
mice	28887372	2	O
to	28887372	2	O
contrast	28887372	2	O
its	28887372	2	O
effect	28887372	2	O
with	28887372	2	O
WT	28887372	2	O
apoC	28887372	2	O
-	28887372	2	O
III	28887372	2	O
(	28887372	2	O
C3WT	28887372	2	O
)	28887372	2	O
.	28887372	2	O
In	28887372	2	O
both	28887372	2	O
model	28887372	2	O
systems	28887372	2	O
,	28887372	2	O
C3QK	28887372	2	O
expression	28887372	2	O
increased	28887372	2	O
the	28887372	2	O
secretion	28887372	2	O
of	28887372	2	O
VLDL1	28887372	2	O
-	28887372	2	O
TAG	28887372	2	O
(	28887372	2	O
by	28887372	2	O
230%	28887372	2	O
)	28887372	2	O
under	28887372	2	O
lipid	28887372	2	O
-	28887372	2	O
rich	28887372	2	O
conditions	28887372	2	O
.	28887372	2	O
Metabolic	28887372	2	O
labeling	28887372	2	O
experiments	28887372	2	O
with	28887372	2	O
C3QK	28887372	2	O
cells	28887372	2	O
showed	28887372	2	O
an	28887372	2	O
increase	28887372	2	O
in	28887372	2	O
de	28887372	2	B-MPA
novo	28887372	2	I-MPA
lipogenesis	28887372	2	I-MPA
(	28887372	2	O
DNL	28887372	2	O
)	28887372	2	O
.	28887372	2	O
Fasting	28887372	2	O
plasma	28887372	2	O
concentration	28887372	2	O
of	28887372	2	O
TAG	28887372	2	O
,	28887372	2	O
cholesterol	28887372	2	O
,	28887372	2	O
cholesteryl	28887372	2	O
ester	28887372	2	O
,	28887372	2	O
and	28887372	2	O
FA	28887372	2	O
were	28887372	2	O
increased	28887372	2	O
in	28887372	2	O
C3QK	28887372	2	O
mice	28887372	2	O
as	28887372	2	O
compared	28887372	2	O
with	28887372	2	O
C3WT	28887372	2	O
mice	28887372	2	O
.	28887372	2	O
Liver	28887372	2	O
of	28887372	2	O
C3QK	28887372	2	B-Var
mice	28887372	2	O
also	28887372	2	O
displayed	28887372	2	O
an	28887372	2	O
increase	28887372	2	B-PosReg
in	28887372	2	O
DNL	28887372	2	B-MPA
and	28887372	2	O
expression	28887372	2	B-MPA
of	28887372	2	O
lipogenic	28887372	2	B-Gene
genes	28887372	2	I-Gene
as	28887372	2	O
compared	28887372	2	O
with	28887372	2	O
that	28887372	2	O
in	28887372	2	O
C3WT	28887372	2	O
mice	28887372	2	O
.	28887372	2	O
These	28887372	2	O
results	28887372	2	O
suggest	28887372	2	O
that	28887372	2	O
C3QK	28887372	2	B-Var
variant	28887372	2	O
is	28887372	2	O
a	28887372	2	O
gain	28887372	2	O
-	28887372	2	O
of	28887372	2	O
-	28887372	2	O
function	28887372	2	O
mutation	28887372	2	O
that	28887372	2	O
can	28887372	2	O
stimulate	28887372	2	B-PosReg
VLDL1	28887372	2	B-MPA
production	28887372	2	I-MPA
,	28887372	2	O
through	28887372	2	O
enhanced	28887372	2	B-PosReg
DNL	28887372	2	B-MPA
.	28887372	2	O

The	28889099	1	O
Impact	28889099	1	O
of	28889099	1	O
Heterozygous	28889099	1	O
KCNK3	28889099	1	O
Mutations	28889099	1	O
Associated	28889099	1	O
With	28889099	1	O
Pulmonary	28889099	1	O
Arterial	28889099	1	O
Hypertension	28889099	1	O
on	28889099	1	O
Channel	28889099	1	O
Function	28889099	1	O
and	28889099	1	O
Pharmacological	28889099	1	O
Recovery	28889099	1	O
.	28889099	1	O
BACKGROUND	28889099	1	O
:	28889099	1	O
Heterozygous	28889099	1	O
loss	28889099	1	O
of	28889099	1	O
function	28889099	1	O
mutations	28889099	1	B-Var
in	28889099	1	O
the	28889099	1	O
KCNK3	28889099	1	B-Gene
gene	28889099	1	O
cause	28889099	1	B-Reg
hereditary	28889099	1	O
pulmonary	28889099	1	B-Disease
arterial	28889099	1	I-Disease
hypertension	28889099	1	I-Disease
(	28889099	1	O
PAH	28889099	1	O
)	28889099	1	O
.	28889099	1	O
KCNK3	28889099	1	O
encodes	28889099	1	O
an	28889099	1	O
acid	28889099	1	O
-	28889099	1	O
sensitive	28889099	1	O
potassium	28889099	1	O
channel	28889099	1	O
,	28889099	1	O
which	28889099	1	O
contributes	28889099	1	O
to	28889099	1	O
the	28889099	1	O
resting	28889099	1	O
potential	28889099	1	O
of	28889099	1	O
human	28889099	1	O
pulmonary	28889099	1	O
artery	28889099	1	O
smooth	28889099	1	O
muscle	28889099	1	O
cells	28889099	1	O
.	28889099	1	O
KCNK3	28889099	1	O
is	28889099	1	O
widely	28889099	1	O
expressed	28889099	1	O
in	28889099	1	O
the	28889099	1	O
body	28889099	1	O
,	28889099	1	O
and	28889099	1	O
dimerizes	28889099	1	O
with	28889099	1	O
other	28889099	1	O
KCNK3	28889099	1	O
subunits	28889099	1	O
,	28889099	1	O
or	28889099	1	O
the	28889099	1	O
closely	28889099	1	O
related	28889099	1	O
,	28889099	1	O
acid	28889099	1	O
-	28889099	1	O
sensitive	28889099	1	O
KCNK9	28889099	1	O
channel	28889099	1	O
.	28889099	1	O
METHODS	28889099	1	O
AND	28889099	1	O
RESULTS	28889099	1	O
:	28889099	1	O
We	28889099	1	O
engineered	28889099	1	O
homomeric	28889099	1	O
and	28889099	1	O
heterodimeric	28889099	1	O
mutant	28889099	1	O
and	28889099	1	O
nonmutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
associated	28889099	1	O
with	28889099	1	O
PAH	28889099	1	O
.	28889099	1	O
Using	28889099	1	O
whole	28889099	1	O
-	28889099	1	O
cell	28889099	1	O
patch	28889099	1	O
-	28889099	1	O
clamp	28889099	1	O
electrophysiology	28889099	1	O
in	28889099	1	O
human	28889099	1	O
pulmonary	28889099	1	O
artery	28889099	1	O
smooth	28889099	1	O
muscle	28889099	1	O
and	28889099	1	O
COS7	28889099	1	O
cell	28889099	1	O
lines	28889099	1	O
,	28889099	1	O
we	28889099	1	O
determined	28889099	1	O
that	28889099	1	O
homomeric	28889099	1	O
and	28889099	1	O
heterodimeric	28889099	1	O
mutant	28889099	1	O
channels	28889099	1	O
in	28889099	1	O
heterozygous	28889099	1	O
KCNK3	28889099	1	O
conditions	28889099	1	O
lead	28889099	1	O
to	28889099	1	O
mutation	28889099	1	O
-	28889099	1	O
specific	28889099	1	O
severity	28889099	1	O
of	28889099	1	O
channel	28889099	1	O
dysfunction	28889099	1	O
.	28889099	1	O
Both	28889099	1	O
wildtype	28889099	1	O
and	28889099	1	O
mutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
were	28889099	1	O
activated	28889099	1	O
by	28889099	1	O
ONO	28889099	1	O
-	28889099	1	O
RS-082	28889099	1	O
(	28889099	1	O
10	28889099	1	O
μmol	28889099	1	O
/	28889099	1	O
L	28889099	1	O
)	28889099	1	O
,	28889099	1	O
causing	28889099	1	O
cell	28889099	1	O
hyperpolarization	28889099	1	O
.	28889099	1	O
We	28889099	1	O
observed	28889099	1	O
robust	28889099	1	O
gene	28889099	1	O
expression	28889099	1	O
of	28889099	1	O
KCNK3	28889099	1	O
in	28889099	1	O
healthy	28889099	1	O
and	28889099	1	O
familial	28889099	1	O
PAH	28889099	1	O
patient	28889099	1	O
lungs	28889099	1	O
,	28889099	1	O
but	28889099	1	O
no	28889099	1	O
quantifiable	28889099	1	O
expression	28889099	1	O
of	28889099	1	O
KCNK9	28889099	1	O
,	28889099	1	O
and	28889099	1	O
demonstrated	28889099	1	O
in	28889099	1	O
functional	28889099	1	O
studies	28889099	1	O
that	28889099	1	O
KCNK9	28889099	1	O
minimizes	28889099	1	O
the	28889099	1	O
impact	28889099	1	O
of	28889099	1	O
select	28889099	1	O
KCNK3	28889099	1	O
mutations	28889099	1	O
when	28889099	1	O
the	28889099	1	O
2	28889099	1	O
channel	28889099	1	O
subunits	28889099	1	O
co	28889099	1	O
-	28889099	1	O
assemble	28889099	1	O
.	28889099	1	O
CONCLUSIONS	28889099	1	O
:	28889099	1	O
Heterozygous	28889099	1	O
KCNK3	28889099	1	B-Gene
mutations	28889099	1	B-Var
in	28889099	1	O
PAH	28889099	1	O
lead	28889099	1	O
to	28889099	1	O
variable	28889099	1	O
loss	28889099	1	B-NegReg
of	28889099	1	O
channel	28889099	1	B-MPA
function	28889099	1	I-MPA
via	28889099	1	O
distinct	28889099	1	O
mechanisms	28889099	1	O
.	28889099	1	O
Homomeric	28889099	1	O
and	28889099	1	O
heterodimeric	28889099	1	O
mutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
represent	28889099	1	O
novel	28889099	1	O
therapeutic	28889099	1	O
substrates	28889099	1	O
in	28889099	1	O
PAH	28889099	1	O
.	28889099	1	O
Pharmacological	28889099	1	O
and	28889099	1	O
pH	28889099	1	O
-	28889099	1	O
dependent	28889099	1	O
activation	28889099	1	O
of	28889099	1	O
wildtype	28889099	1	O
and	28889099	1	O
mutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
in	28889099	1	O
pulmonary	28889099	1	O
artery	28889099	1	O
smooth	28889099	1	O
muscle	28889099	1	O
cells	28889099	1	O
leads	28889099	1	O
to	28889099	1	O
membrane	28889099	1	O
hyperpolarization	28889099	1	O
.	28889099	1	O
Co	28889099	1	O
-	28889099	1	O
assembly	28889099	1	O
of	28889099	1	O
KCNK3	28889099	1	O
with	28889099	1	O
KCNK9	28889099	1	O
subunits	28889099	1	O
may	28889099	1	O
provide	28889099	1	O
protection	28889099	1	O
against	28889099	1	O
KCNK3	28889099	1	O
loss	28889099	1	O
of	28889099	1	O
function	28889099	1	O
in	28889099	1	O
tissues	28889099	1	O
where	28889099	1	O
both	28889099	1	O
KCNK9	28889099	1	O
and	28889099	1	O
KCNK3	28889099	1	O
are	28889099	1	O
expressed	28889099	1	O
,	28889099	1	O
contributing	28889099	1	O
to	28889099	1	O
the	28889099	1	O
lung	28889099	1	O
-	28889099	1	O
specific	28889099	1	O
phenotype	28889099	1	O
observed	28889099	1	O
clinically	28889099	1	O
in	28889099	1	O
patients	28889099	1	O
with	28889099	1	O
PAH	28889099	1	O
because	28889099	1	O
of	28889099	1	O
KCNK3	28889099	1	O
mutations	28889099	1	O
.	28889099	1	O

Modifiers	28890134	1	O
of	28890134	1	O
GRN	28890134	1	O
-	28890134	1	O
Associated	28890134	1	O
Frontotemporal	28890134	1	O
Lobar	28890134	1	O
Degeneration	28890134	1	O
.	28890134	1	O
Heterozygous	28890134	1	O
loss	28890134	1	B-NegReg
-	28890134	1	I-NegReg
of	28890134	1	I-NegReg
-	28890134	1	I-NegReg
function	28890134	1	I-NegReg
(	28890134	1	O
LOF	28890134	1	O
)	28890134	1	O
mutations	28890134	1	B-Var
in	28890134	1	O
the	28890134	1	O
human	28890134	1	B-Gene
progranulin	28890134	1	I-Gene
gene	28890134	1	I-Gene
(	28890134	1	B-Gene
GRN	28890134	1	I-Gene
)	28890134	1	I-Gene
cause	28890134	1	B-Reg
frontotemporal	28890134	1	B-Disease
lobar	28890134	1	I-Disease
degeneration	28890134	1	I-Disease
(	28890134	1	O
FTLD	28890134	1	O
)	28890134	1	O
by	28890134	1	O
a	28890134	1	O
mechanism	28890134	1	O
of	28890134	1	O
haploinsufficiency	28890134	1	B-MPA
.	28890134	1	O
Patients	28890134	1	O
present	28890134	1	O
most	28890134	1	O
frequently	28890134	1	O
with	28890134	1	O
frontotemporal	28890134	1	O
dementia	28890134	1	O
,	28890134	1	O
which	28890134	1	O
is	28890134	1	O
the	28890134	1	O
second	28890134	1	O
most	28890134	1	O
common	28890134	1	O
neurodegenerative	28890134	1	O
dementia	28890134	1	O
at	28890134	1	O
young	28890134	1	O
age	28890134	1	O
.	28890134	1	O
Currently	28890134	1	O
,	28890134	1	O
no	28890134	1	O
disease	28890134	1	O
-	28890134	1	O
modifying	28890134	1	O
therapies	28890134	1	O
are	28890134	1	O
available	28890134	1	O
for	28890134	1	O
these	28890134	1	O
patients	28890134	1	O
.	28890134	1	O
Stimulating	28890134	1	O
GRN	28890134	1	O
protein	28890134	1	O
expression	28890134	1	O
or	28890134	1	O
inhibiting	28890134	1	O
its	28890134	1	O
breakdown	28890134	1	O
is	28890134	1	O
an	28890134	1	O
obvious	28890134	1	O
therapeutic	28890134	1	O
strategy	28890134	1	O
,	28890134	1	O
and	28890134	1	O
is	28890134	1	O
indeed	28890134	1	O
the	28890134	1	O
focus	28890134	1	O
of	28890134	1	O
current	28890134	1	O
preclinical	28890134	1	O
research	28890134	1	O
and	28890134	1	O
clinical	28890134	1	O
trials	28890134	1	O
.	28890134	1	O
Multiple	28890134	1	O
studies	28890134	1	O
have	28890134	1	O
demonstrated	28890134	1	O
the	28890134	1	O
heterogeneity	28890134	1	O
in	28890134	1	O
clinical	28890134	1	O
presentation	28890134	1	O
and	28890134	1	O
wide	28890134	1	O
variability	28890134	1	O
in	28890134	1	O
age	28890134	1	O
of	28890134	1	O
onset	28890134	1	O
in	28890134	1	O
patients	28890134	1	O
carrying	28890134	1	O
a	28890134	1	O
GRN	28890134	1	O
LOF	28890134	1	O
mutation	28890134	1	O
.	28890134	1	O
Recently	28890134	1	O
,	28890134	1	O
this	28890134	1	O
heterogeneity	28890134	1	O
became	28890134	1	O
an	28890134	1	O
opportunity	28890134	1	O
to	28890134	1	O
identify	28890134	1	O
disease	28890134	1	O
modifiers	28890134	1	O
,	28890134	1	O
considering	28890134	1	O
that	28890134	1	O
these	28890134	1	O
might	28890134	1	O
constitute	28890134	1	O
suitable	28890134	1	O
targets	28890134	1	O
for	28890134	1	O
developing	28890134	1	O
disease	28890134	1	O
-	28890134	1	O
modifying	28890134	1	O
or	28890134	1	O
disease	28890134	1	O
-	28890134	1	O
delaying	28890134	1	O
therapies	28890134	1	O
.	28890134	1	O

De	28905509	1	O
novo	28905509	1	O
SETD5	28905509	1	B-Gene
loss	28905509	1	B-NegReg
-	28905509	1	I-NegReg
of	28905509	1	I-NegReg
-	28905509	1	I-NegReg
function	28905509	1	I-NegReg
variant	28905509	1	B-Var
as	28905509	1	O
a	28905509	1	O
cause	28905509	1	O
for	28905509	1	O
intellectual	28905509	1	B-Disease
disability	28905509	1	I-Disease
in	28905509	1	O
a	28905509	1	O
10	28905509	1	O
-	28905509	1	O
year	28905509	1	O
old	28905509	1	O
boy	28905509	1	O
with	28905509	1	O
an	28905509	1	O
aberrant	28905509	1	O
blind	28905509	1	O
ending	28905509	1	O
bronchus	28905509	1	O
.	28905509	1	O
Although	28905509	1	O
rare	28905509	1	O
,	28905509	1	O
3	28905509	1	O
p	28905509	1	O
microdeletion	28905509	1	O
cases	28905509	1	O
have	28905509	1	O
been	28905509	1	O
well	28905509	1	O
described	28905509	1	O
in	28905509	1	O
the	28905509	1	O
clinical	28905509	1	O
literature	28905509	1	O
.	28905509	1	O
The	28905509	1	O
clinical	28905509	1	O
phenotype	28905509	1	O
includes	28905509	1	O
;	28905509	1	O
intellectual	28905509	1	O
disability	28905509	1	O
(	28905509	1	O
ID	28905509	1	O
)	28905509	1	O
,	28905509	1	O
growth	28905509	1	O
retardation	28905509	1	O
,	28905509	1	O
facial	28905509	1	O
dysmorphism	28905509	1	O
,	28905509	1	O
and	28905509	1	O
cardiac	28905509	1	O
malformations	28905509	1	O
.	28905509	1	O
Advances	28905509	1	O
in	28905509	1	O
chromosome	28905509	1	O
microarray	28905509	1	O
(	28905509	1	O
CMA	28905509	1	O
)	28905509	1	O
testing	28905509	1	O
narrowed	28905509	1	O
the	28905509	1	O
3	28905509	1	O
p25	28905509	1	O
critical	28905509	1	O
region	28905509	1	O
to	28905509	1	O
a	28905509	1	O
124	28905509	1	O
kb	28905509	1	O
region	28905509	1	O
,	28905509	1	O
and	28905509	1	O
recent	28905509	1	O
Whole	28905509	1	O
Exome	28905509	1	O
Sequencing	28905509	1	O
(	28905509	1	O
WES	28905509	1	O
)	28905509	1	O
studies	28905509	1	O
have	28905509	1	O
suggested	28905509	1	O
that	28905509	1	O
the	28905509	1	O
SETD5	28905509	1	O
gene	28905509	1	O
contributes	28905509	1	O
significantly	28905509	1	O
to	28905509	1	O
the	28905509	1	O
3	28905509	1	O
p25	28905509	1	O
phenotype	28905509	1	O
.	28905509	1	O
Loss	28905509	1	B-NegReg
-	28905509	1	I-NegReg
of	28905509	1	I-NegReg
-	28905509	1	I-NegReg
Function	28905509	1	I-NegReg
(	28905509	1	O
LoF	28905509	1	O
)	28905509	1	O
variants	28905509	1	B-Var
in	28905509	1	O
SETD5	28905509	1	B-Gene
are	28905509	1	O
now	28905509	1	O
considered	28905509	1	O
a	28905509	1	O
likely	28905509	1	O
cause	28905509	1	O
of	28905509	1	O
ID	28905509	1	B-Disease
.	28905509	1	O
We	28905509	1	O
report	28905509	1	O
here	28905509	1	O
a	28905509	1	O
patient	28905509	1	O
with	28905509	1	O
a	28905509	1	O
frameshift	28905509	1	O
LoF	28905509	1	O
variant	28905509	1	O
in	28905509	1	O
exon	28905509	1	O
12	28905509	1	O
of	28905509	1	O
SETD5	28905509	1	O
.	28905509	1	O
This	28905509	1	O
patient	28905509	1	O
has	28905509	1	O
features	28905509	1	O
overlapping	28905509	1	O
with	28905509	1	O
other	28905509	1	O
patients	28905509	1	O
described	28905509	1	O
with	28905509	1	O
LoF	28905509	1	O
SETD5	28905509	1	O
variants	28905509	1	O
to	28905509	1	O
include	28905509	1	O
;	28905509	1	O
similar	28905509	1	O
facial	28905509	1	O
morphology	28905509	1	O
,	28905509	1	O
feeding	28905509	1	O
difficulties	28905509	1	O
,	28905509	1	O
ID	28905509	1	O
,	28905509	1	O
behavioral	28905509	1	O
abnormalities	28905509	1	O
and	28905509	1	O
leg	28905509	1	O
length	28905509	1	O
discrepancy	28905509	1	O
.	28905509	1	O
In	28905509	1	O
addition	28905509	1	O
,	28905509	1	O
he	28905509	1	O
presents	28905509	1	O
with	28905509	1	O
an	28905509	1	O
aberrant	28905509	1	O
blind	28905509	1	O
ending	28905509	1	O
bronchus	28905509	1	O
.	28905509	1	O
This	28905509	1	O
report	28905509	1	O
adds	28905509	1	O
to	28905509	1	O
publications	28905509	1	O
describing	28905509	1	O
intragenic	28905509	1	O
mutations	28905509	1	O
in	28905509	1	O
SETD5	28905509	1	O
and	28905509	1	O
supports	28905509	1	O
the	28905509	1	O
assertion	28905509	1	O
that	28905509	1	O
de	28905509	1	O
novo	28905509	1	O
LoF	28905509	1	O
mutations	28905509	1	O
in	28905509	1	O
SETD5	28905509	1	O
present	28905509	1	O
with	28905509	1	O
an	28905509	1	O
overlapping	28905509	1	O
but	28905509	1	O
distinct	28905509	1	O
phenotype	28905509	1	O
in	28905509	1	O
comparison	28905509	1	O
with	28905509	1	O
3	28905509	1	O
p25	28905509	1	O
microdeletion	28905509	1	O
syndromes	28905509	1	O
.	28905509	1	O

Signal	28914637	2	O
transducer	28914637	2	O
and	28914637	2	O
activator	28914637	2	O
of	28914637	2	O
transcription	28914637	2	O
gain	28914637	2	O
-	28914637	2	O
of	28914637	2	O
-	28914637	2	O
function	28914637	2	O
primary	28914637	2	O
immunodeficiency	28914637	2	O
/	28914637	2	O
immunodysregulation	28914637	2	O
disorders	28914637	2	O
.	28914637	2	O
PURPOSE	28914637	2	O
OF	28914637	2	O
REVIEW	28914637	2	O
:	28914637	2	O
To	28914637	2	O
describe	28914637	2	O
primary	28914637	2	B-Disease
immunodeficiencies	28914637	2	I-Disease
caused	28914637	2	O
by	28914637	2	O
gain	28914637	2	B-PosReg
-	28914637	2	I-PosReg
of	28914637	2	I-PosReg
-	28914637	2	I-PosReg
function	28914637	2	I-PosReg
(	28914637	2	O
GOF	28914637	2	O
)	28914637	2	O
mutations	28914637	2	B-Var
of	28914637	2	O
signal	28914637	2	O
transducer	28914637	2	O
and	28914637	2	O
activator	28914637	2	O
of	28914637	2	O
transcription	28914637	2	O
(	28914637	2	B-Gene
STAT	28914637	2	I-Gene
)	28914637	2	I-Gene
genes	28914637	2	O
,	28914637	2	O
a	28914637	2	O
group	28914637	2	O
of	28914637	2	O
genetically	28914637	2	O
determined	28914637	2	O
disorders	28914637	2	O
characterized	28914637	2	O
by	28914637	2	O
susceptibility	28914637	2	O
to	28914637	2	O
infections	28914637	2	O
and	28914637	2	O
,	28914637	2	O
in	28914637	2	O
many	28914637	2	O
cases	28914637	2	O
,	28914637	2	O
autoimmune	28914637	2	O
manifestations	28914637	2	O
.	28914637	2	O
RECENT	28914637	2	O
FINDINGS	28914637	2	O
:	28914637	2	O
GOF	28914637	2	O
mutations	28914637	2	B-Var
affecting	28914637	2	O
STAT1	28914637	2	B-Gene
result	28914637	2	O
in	28914637	2	O
increased	28914637	2	B-PosReg
STAT	28914637	2	B-MPA
tyrosine	28914637	2	I-MPA
phosphorylation	28914637	2	I-MPA
and	28914637	2	O
secondarily	28914637	2	O
increased	28914637	2	B-PosReg
response	28914637	2	B-MPA
to	28914637	2	I-MPA
STAT1	28914637	2	I-MPA
-	28914637	2	I-MPA
signaling	28914637	2	I-MPA
cytokines	28914637	2	I-MPA
,	28914637	2	O
such	28914637	2	O
as	28914637	2	O
interferons	28914637	2	O
.	28914637	2	O
In	28914637	2	O
contrast	28914637	2	O
,	28914637	2	O
STAT3	28914637	2	O
hyperactivity	28914637	2	O
is	28914637	2	O
not	28914637	2	O
usually	28914637	2	O
related	28914637	2	O
to	28914637	2	O
hyperphosphorylation	28914637	2	O
but	28914637	2	O
rather	28914637	2	O
to	28914637	2	O
increased	28914637	2	O
STAT3	28914637	2	O
-	28914637	2	O
mediated	28914637	2	O
transcriptional	28914637	2	O
activity	28914637	2	O
.	28914637	2	O
In	28914637	2	O
both	28914637	2	O
cases	28914637	2	O
,	28914637	2	O
heterozygous	28914637	2	O
STAT1	28914637	2	O
and	28914637	2	O
STAT3	28914637	2	O
GOF	28914637	2	O
mutations	28914637	2	O
trigger	28914637	2	O
a	28914637	2	O
distinct	28914637	2	O
set	28914637	2	O
of	28914637	2	O
genes	28914637	2	O
in	28914637	2	O
target	28914637	2	O
cells	28914637	2	O
that	28914637	2	O
lead	28914637	2	O
to	28914637	2	O
abnormal	28914637	2	O
functioning	28914637	2	O
of	28914637	2	O
antimicrobial	28914637	2	O
response	28914637	2	O
and	28914637	2	O
/	28914637	2	O
or	28914637	2	O
autoimmunity	28914637	2	O
and	28914637	2	O
result	28914637	2	O
in	28914637	2	O
autosomal	28914637	2	O
dominant	28914637	2	O
diseases	28914637	2	O
.	28914637	2	O
SUMMARY	28914637	2	O
:	28914637	2	O
Clinical	28914637	2	O
manifestations	28914637	2	O
of	28914637	2	O
patients	28914637	2	O
with	28914637	2	O
STAT1	28914637	2	O
GOF	28914637	2	O
are	28914637	2	O
characterized	28914637	2	O
by	28914637	2	O
mucocutaneous	28914637	2	O
candidiasis	28914637	2	O
and	28914637	2	O
recurrent	28914637	2	O
lower	28914637	2	O
tract	28914637	2	O
respiratory	28914637	2	O
infections	28914637	2	O
.	28914637	2	O
In	28914637	2	O
addition	28914637	2	O
,	28914637	2	O
many	28914637	2	O
patients	28914637	2	O
have	28914637	2	O
thyroiditis	28914637	2	O
,	28914637	2	O
type	28914637	2	O
1	28914637	2	O
diabetes	28914637	2	O
mellitus	28914637	2	O
,	28914637	2	O
autoimmune	28914637	2	O
cytopenias	28914637	2	O
,	28914637	2	O
cancer	28914637	2	O
or	28914637	2	O
aneurysms	28914637	2	O
.	28914637	2	O
Patients	28914637	2	O
with	28914637	2	O
germline	28914637	2	O
STAT3	28914637	2	O
GOF	28914637	2	O
mutations	28914637	2	O
have	28914637	2	O
an	28914637	2	O
increased	28914637	2	O
frequency	28914637	2	O
of	28914637	2	O
early	28914637	2	O
-	28914637	2	O
onset	28914637	2	O
multiorgan	28914637	2	O
autoimmunity	28914637	2	O
(	28914637	2	O
i	28914637	2	O
.	28914637	2	O
e	28914637	2	O
.	28914637	2	O
autoimmune	28914637	2	O
enteropathy	28914637	2	O
,	28914637	2	O
type	28914637	2	O
1	28914637	2	O
diabetes	28914637	2	O
mellitus	28914637	2	O
,	28914637	2	O
autoimmune	28914637	2	O
interstitial	28914637	2	O
lung	28914637	2	O
disease	28914637	2	O
and	28914637	2	O
autoimmune	28914637	2	O
cytopenias	28914637	2	O
)	28914637	2	O
,	28914637	2	O
lymphoproliferation	28914637	2	O
,	28914637	2	O
short	28914637	2	O
stature	28914637	2	O
and	28914637	2	O
,	28914637	2	O
less	28914637	2	O
frequently	28914637	2	O
,	28914637	2	O
severe	28914637	2	O
recurrent	28914637	2	O
infections	28914637	2	O
.	28914637	2	O
Treatment	28914637	2	O
options	28914637	2	O
range	28914637	2	O
from	28914637	2	O
antimicrobial	28914637	2	O
therapy	28914637	2	O
,	28914637	2	O
intravenous	28914637	2	O
or	28914637	2	O
subcutaneous	28914637	2	O
immunoglobulin	28914637	2	O
and	28914637	2	O
immunosuppressive	28914637	2	O
drugs	28914637	2	O
.	28914637	2	O
Some	28914637	2	O
patients	28914637	2	O
with	28914637	2	O
STAT1	28914637	2	O
GOF	28914637	2	O
disorder	28914637	2	O
have	28914637	2	O
undergone	28914637	2	O
hematopoietic	28914637	2	O
stem	28914637	2	O
cell	28914637	2	O
transplantation	28914637	2	O
,	28914637	2	O
although	28914637	2	O
these	28914637	2	O
have	28914637	2	O
been	28914637	2	O
difficult	28914637	2	O
because	28914637	2	O
of	28914637	2	O
the	28914637	2	O
underlying	28914637	2	O
proinflammatory	28914637	2	O
milieu	28914637	2	O
from	28914637	2	O
the	28914637	2	O
mutation	28914637	2	O
.	28914637	2	O

GNPTAB	28918368	0	O
missense	28918368	0	O
mutations	28918368	0	O
cause	28918368	0	O
loss	28918368	0	O
of	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
activity	28918368	0	O
in	28918368	0	O
mucolipidosis	28918368	0	O
type	28918368	0	O
II	28918368	0	O
through	28918368	0	O
distinct	28918368	0	O
mechanisms	28918368	0	O
.	28918368	0	O
Mucolipidoses	28918368	0	O
(	28918368	0	O
ML	28918368	0	O
)	28918368	0	O
II	28918368	0	O
and	28918368	0	O
III	28918368	0	O
alpha	28918368	0	O
/	28918368	0	O
beta	28918368	0	O
are	28918368	0	O
lysosomal	28918368	0	O
storage	28918368	0	O
diseases	28918368	0	O
caused	28918368	0	O
by	28918368	0	O
pathogenic	28918368	0	O
mutations	28918368	0	O
in	28918368	0	O
GNPTAB	28918368	0	O
encoding	28918368	0	O
the	28918368	0	O
α	28918368	0	O
β	28918368	0	O
-	28918368	0	O
subunit	28918368	0	O
precursor	28918368	0	O
of	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
.	28918368	0	O
To	28918368	0	O
determine	28918368	0	O
genotype	28918368	0	O
-	28918368	0	O
phenotype	28918368	0	O
correlation	28918368	0	O
and	28918368	0	O
functional	28918368	0	O
analysis	28918368	0	O
of	28918368	0	O
mutant	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
,	28918368	0	O
13	28918368	0	O
Brazilian	28918368	0	O
patients	28918368	0	O
clinically	28918368	0	O
and	28918368	0	O
biochemical	28918368	0	O
diagnosed	28918368	0	O
for	28918368	0	O
MLII	28918368	0	O
or	28918368	0	O
III	28918368	0	O
alpha	28918368	0	O
/	28918368	0	O
beta	28918368	0	O
were	28918368	0	O
studied	28918368	0	O
.	28918368	0	O
By	28918368	0	O
sequencing	28918368	0	O
of	28918368	0	O
genomic	28918368	0	O
GNPTAB	28918368	0	B-Gene
of	28918368	0	O
the	28918368	0	O
MLII	28918368	0	O
and	28918368	0	O
MLIII	28918368	0	O
alpha	28918368	0	O
/	28918368	0	O
beta	28918368	0	O
patients	28918368	0	O
we	28918368	0	O
identified	28918368	0	O
six	28918368	0	O
novel	28918368	0	O
mutations	28918368	0	O
:	28918368	0	O
p.D76G	28918368	0	B-Var
,	28918368	0	O
p.S385L	28918368	0	B-Var
,	28918368	0	O
p.Q278Kfs	28918368	0	B-Var
3	28918368	0	I-Var
,	28918368	0	O
p.H588Qfs	28918368	0	B-Var
27	28918368	0	I-Var
,	28918368	0	O
p.N642Lfs	28918368	0	B-Var
10	28918368	0	I-Var
and	28918368	0	O
p.Y1111	28918368	0	B-Var
.	28918368	0	O
Expression	28918368	0	O
analysis	28918368	0	O
by	28918368	0	O
western	28918368	0	O
blotting	28918368	0	O
and	28918368	0	O
immunofluorescence	28918368	0	O
microscopy	28918368	0	O
revealed	28918368	0	O
that	28918368	0	O
the	28918368	0	O
mutant	28918368	0	O
α	28918368	0	O
β	28918368	0	O
-	28918368	0	O
subunit	28918368	0	O
precursor	28918368	0	O
p.D76G	28918368	0	B-Var
is	28918368	0	O
retained	28918368	0	O
in	28918368	0	O
the	28918368	0	O
endoplasmic	28918368	0	O
reticulum	28918368	0	O
whereas	28918368	0	O
the	28918368	0	O
mutant	28918368	0	O
p.S385L	28918368	0	B-Var
is	28918368	0	O
correctly	28918368	0	O
transported	28918368	0	O
to	28918368	0	O
the	28918368	0	O
cis	28918368	0	O
-	28918368	0	O
Golgi	28918368	0	O
apparatus	28918368	0	O
and	28918368	0	O
proteolytically	28918368	0	O
processed	28918368	0	O
.	28918368	0	O
Both	28918368	0	O
mutations	28918368	0	O
lead	28918368	0	O
to	28918368	0	O
complete	28918368	0	O
loss	28918368	0	B-NegReg
of	28918368	0	O
GlcNAc-1	28918368	0	B-Enzyme
-	28918368	0	I-Enzyme
phosphotransferase	28918368	0	I-Enzyme
activity	28918368	0	B-MPA
,	28918368	0	O
consistent	28918368	0	O
with	28918368	0	O
the	28918368	0	O
severe	28918368	0	O
clinical	28918368	0	O
MLII	28918368	0	O
phenotype	28918368	0	O
of	28918368	0	O
the	28918368	0	O
patients	28918368	0	O
.	28918368	0	O
Our	28918368	0	O
study	28918368	0	O
expands	28918368	0	O
the	28918368	0	O
genotypic	28918368	0	O
spectrum	28918368	0	O
of	28918368	0	O
MLII	28918368	0	O
and	28918368	0	O
provides	28918368	0	O
novel	28918368	0	O
insights	28918368	0	O
into	28918368	0	O
structural	28918368	0	O
requirements	28918368	0	O
to	28918368	0	O
ensure	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
activity	28918368	0	O
.	28918368	0	O

Altered	28921675	2	O
Cav1.2	28921675	2	O
function	28921675	2	O
in	28921675	2	O
the	28921675	2	O
Timothy	28921675	2	O
syndrome	28921675	2	O
mouse	28921675	2	O
model	28921675	2	O
produces	28921675	2	O
ascending	28921675	2	O
serotonergic	28921675	2	O
abnormalities	28921675	2	O
.	28921675	2	O
Polymorphism	28921675	2	O
in	28921675	2	O
the	28921675	2	O
gene	28921675	2	O
CACNA1C	28921675	2	O
,	28921675	2	O
encoding	28921675	2	O
the	28921675	2	O
pore	28921675	2	O
-	28921675	2	O
forming	28921675	2	O
subunit	28921675	2	O
of	28921675	2	O
Cav1.2	28921675	2	O
L	28921675	2	O
-	28921675	2	O
type	28921675	2	O
calcium	28921675	2	O
channels	28921675	2	O
,	28921675	2	O
has	28921675	2	O
one	28921675	2	O
of	28921675	2	O
the	28921675	2	O
strongest	28921675	2	O
genetic	28921675	2	O
linkages	28921675	2	O
to	28921675	2	O
schizophrenia	28921675	2	O
,	28921675	2	O
bipolar	28921675	2	O
disorder	28921675	2	O
and	28921675	2	O
major	28921675	2	O
depressive	28921675	2	O
disorder	28921675	2	O
:	28921675	2	O
psychopathologies	28921675	2	O
in	28921675	2	O
which	28921675	2	O
serotonin	28921675	2	O
signaling	28921675	2	O
has	28921675	2	O
been	28921675	2	O
implicated	28921675	2	O
.	28921675	2	O
Additionally	28921675	2	O
,	28921675	2	O
a	28921675	2	O
gain	28921675	2	B-PosReg
-	28921675	2	I-PosReg
of	28921675	2	I-PosReg
-	28921675	2	I-PosReg
function	28921675	2	I-PosReg
mutation	28921675	2	B-Var
in	28921675	2	O
CACNA1C	28921675	2	B-Gene
is	28921675	2	O
responsible	28921675	2	O
for	28921675	2	O
the	28921675	2	O
neurodevelopmental	28921675	2	O
disorder	28921675	2	O
Timothy	28921675	2	B-Disease
syndrome	28921675	2	I-Disease
that	28921675	2	O
presents	28921675	2	O
with	28921675	2	O
prominent	28921675	2	O
behavioral	28921675	2	O
features	28921675	2	O
on	28921675	2	O
the	28921675	2	O
autism	28921675	2	O
spectrum	28921675	2	O
.	28921675	2	O
Given	28921675	2	O
an	28921675	2	O
emerging	28921675	2	O
role	28921675	2	O
for	28921675	2	O
serotonin	28921675	2	O
in	28921675	2	O
the	28921675	2	O
etiology	28921675	2	O
of	28921675	2	O
autism	28921675	2	O
spectrum	28921675	2	O
disorders	28921675	2	O
(	28921675	2	O
ASD	28921675	2	O
)	28921675	2	O
,	28921675	2	O
we	28921675	2	O
investigate	28921675	2	O
the	28921675	2	O
relationship	28921675	2	O
between	28921675	2	O
Cav1.2	28921675	2	O
and	28921675	2	O
the	28921675	2	O
ascending	28921675	2	O
serotonin	28921675	2	O
system	28921675	2	O
in	28921675	2	O
the	28921675	2	O
Timothy	28921675	2	O
syndrome	28921675	2	O
type	28921675	2	O
2	28921675	2	O
(	28921675	2	O
TS2	28921675	2	O
-	28921675	2	O
neo	28921675	2	O
)	28921675	2	O
mouse	28921675	2	O
,	28921675	2	O
which	28921675	2	O
displays	28921675	2	O
behavioral	28921675	2	O
features	28921675	2	O
consistent	28921675	2	O
with	28921675	2	O
the	28921675	2	O
core	28921675	2	O
triad	28921675	2	O
of	28921675	2	O
ASD	28921675	2	O
.	28921675	2	O
We	28921675	2	O
find	28921675	2	O
that	28921675	2	O
TS2	28921675	2	O
-	28921675	2	O
neo	28921675	2	O
mice	28921675	2	O
exhibit	28921675	2	O
enhanced	28921675	2	O
serotonin	28921675	2	O
tissue	28921675	2	O
content	28921675	2	O
and	28921675	2	O
axon	28921675	2	O
innervation	28921675	2	O
of	28921675	2	O
the	28921675	2	O
dorsal	28921675	2	O
striatum	28921675	2	O
,	28921675	2	O
as	28921675	2	O
well	28921675	2	O
as	28921675	2	O
decreased	28921675	2	O
serotonin	28921675	2	O
turnover	28921675	2	O
in	28921675	2	O
the	28921675	2	O
amygdala	28921675	2	O
.	28921675	2	O
These	28921675	2	O
regionally	28921675	2	O
specific	28921675	2	O
alterations	28921675	2	O
are	28921675	2	O
accompanied	28921675	2	O
by	28921675	2	O
an	28921675	2	O
enhanced	28921675	2	O
active	28921675	2	O
coping	28921675	2	O
response	28921675	2	O
during	28921675	2	O
acute	28921675	2	O
stress	28921675	2	O
(	28921675	2	O
forced	28921675	2	O
swim	28921675	2	O
)	28921675	2	O
,	28921675	2	O
serotonin	28921675	2	O
neuron	28921675	2	O
Fos	28921675	2	O
activity	28921675	2	O
in	28921675	2	O
the	28921675	2	O
caudal	28921675	2	O
dorsal	28921675	2	O
raphe	28921675	2	O
,	28921675	2	O
and	28921675	2	O
serotonin	28921675	2	O
type	28921675	2	O
1	28921675	2	O
A	28921675	2	O
receptor	28921675	2	O
-	28921675	2	O
dependent	28921675	2	O
feedback	28921675	2	O
inhibition	28921675	2	O
of	28921675	2	O
the	28921675	2	O
rostral	28921675	2	O
dorsal	28921675	2	O
raphe	28921675	2	O
nuclei	28921675	2	O
.	28921675	2	O
Collectively	28921675	2	O
,	28921675	2	O
these	28921675	2	O
results	28921675	2	O
suggest	28921675	2	O
that	28921675	2	O
the	28921675	2	O
global	28921675	2	O
gain	28921675	2	O
-	28921675	2	O
of	28921675	2	O
-	28921675	2	O
function	28921675	2	O
Cav1.2	28921675	2	O
mutation	28921675	2	O
associated	28921675	2	O
with	28921675	2	O
Timothy	28921675	2	O
syndrome	28921675	2	O
has	28921675	2	O
pleiotropic	28921675	2	O
effects	28921675	2	O
on	28921675	2	O
the	28921675	2	O
ascending	28921675	2	O
serotonin	28921675	2	O
system	28921675	2	O
including	28921675	2	O
neuroanatomical	28921675	2	O
changes	28921675	2	O
,	28921675	2	O
regional	28921675	2	O
differences	28921675	2	O
in	28921675	2	O
forebrain	28921675	2	O
serotonin	28921675	2	O
metabolism	28921675	2	O
and	28921675	2	O
feedback	28921675	2	O
regulatory	28921675	2	O
control	28921675	2	O
mechanisms	28921675	2	O
within	28921675	2	O
the	28921675	2	O
dorsal	28921675	2	O
raphe	28921675	2	O
.	28921675	2	O
Altered	28921675	2	O
activity	28921675	2	O
of	28921675	2	O
the	28921675	2	O
ascending	28921675	2	O
serotonin	28921675	2	O
system	28921675	2	O
continues	28921675	2	O
to	28921675	2	O
emerge	28921675	2	O
as	28921675	2	O
a	28921675	2	O
common	28921675	2	O
neural	28921675	2	O
signature	28921675	2	O
across	28921675	2	O
several	28921675	2	O
ASD	28921675	2	O
mouse	28921675	2	O
models	28921675	2	O
,	28921675	2	O
and	28921675	2	O
the	28921675	2	O
capacity	28921675	2	O
for	28921675	2	O
Cav1.2	28921675	2	O
L	28921675	2	O
-	28921675	2	O
type	28921675	2	O
calcium	28921675	2	O
channels	28921675	2	O
to	28921675	2	O
impact	28921675	2	O
both	28921675	2	O
serotonin	28921675	2	O
structure	28921675	2	O
and	28921675	2	O
function	28921675	2	O
has	28921675	2	O
important	28921675	2	O
implications	28921675	2	O
for	28921675	2	O
several	28921675	2	O
neuropsychiatric	28921675	2	O
conditions	28921675	2	O
.	28921675	2	O

Localization	28924058	0	O
of	28924058	0	O
Cdc7	28924058	0	O
Protein	28924058	0	O
Kinase	28924058	0	O
During	28924058	0	O
DNA	28924058	0	O
Replication	28924058	0	O
in	28924058	0	O
Saccharomyces	28924058	0	O
cerevisiae	28924058	0	O
.	28924058	0	O
DDK	28924058	0	O
,	28924058	0	O
a	28924058	0	O
conserved	28924058	0	O
serine	28924058	0	O
-	28924058	0	O
threonine	28924058	0	O
protein	28924058	0	O
kinase	28924058	0	O
composed	28924058	0	O
of	28924058	0	O
a	28924058	0	O
regulatory	28924058	0	O
subunit	28924058	0	O
,	28924058	0	O
Dbf4	28924058	0	O
,	28924058	0	O
and	28924058	0	O
a	28924058	0	O
catalytic	28924058	0	O
subunit	28924058	0	O
,	28924058	0	O
Cdc7	28924058	0	O
,	28924058	0	O
is	28924058	0	O
essential	28924058	0	O
for	28924058	0	O
DNA	28924058	0	O
replication	28924058	0	O
initiation	28924058	0	O
during	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
of	28924058	0	O
the	28924058	0	O
cell	28924058	0	O
cycle	28924058	0	O
through	28924058	0	O
MCM2-7	28924058	0	O
helicase	28924058	0	O
phosphorylation	28924058	0	O
.	28924058	0	O
The	28924058	0	O
biological	28924058	0	O
significance	28924058	0	O
of	28924058	0	O
DDK	28924058	0	O
is	28924058	0	O
well	28924058	0	O
characterized	28924058	0	O
,	28924058	0	O
but	28924058	0	O
the	28924058	0	O
full	28924058	0	O
mechanism	28924058	0	O
of	28924058	0	O
how	28924058	0	O
DDK	28924058	0	O
associates	28924058	0	O
with	28924058	0	O
substrates	28924058	0	O
remains	28924058	0	O
unclear	28924058	0	O
.	28924058	0	O
Cdc7	28924058	0	O
is	28924058	0	O
bound	28924058	0	O
to	28924058	0	O
chromatin	28924058	0	O
in	28924058	0	O
the	28924058	0	O
Saccharomyces	28924058	0	O
cerevisiae	28924058	0	O
genome	28924058	0	O
throughout	28924058	0	O
the	28924058	0	O
cell	28924058	0	O
cycle	28924058	0	O
,	28924058	0	O
but	28924058	0	O
there	28924058	0	O
is	28924058	0	O
little	28924058	0	O
empirical	28924058	0	O
evidence	28924058	0	O
as	28924058	0	O
to	28924058	0	O
specific	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
locations	28924058	0	O
.	28924058	0	O
Using	28924058	0	O
biochemical	28924058	0	O
and	28924058	0	O
genetic	28924058	0	O
techniques	28924058	0	O
,	28924058	0	O
this	28924058	0	O
study	28924058	0	O
investigated	28924058	0	O
the	28924058	0	O
specific	28924058	0	O
localization	28924058	0	O
of	28924058	0	O
Cdc7	28924058	0	O
on	28924058	0	O
chromatin	28924058	0	O
.	28924058	0	O
The	28924058	0	O
Calling	28924058	0	O
Cards	28924058	0	O
method	28924058	0	O
,	28924058	0	O
using	28924058	0	O
Ty5	28924058	0	O
retrotransposons	28924058	0	O
as	28924058	0	O
a	28924058	0	O
marker	28924058	0	O
for	28924058	0	O
DNA	28924058	0	O
-	28924058	0	O
protein	28924058	0	O
binding	28924058	0	O
,	28924058	0	O
suggests	28924058	0	O
Cdc7	28924058	0	O
kinase	28924058	0	O
is	28924058	0	O
preferentially	28924058	0	O
bound	28924058	0	O
to	28924058	0	O
genomic	28924058	0	O
DNA	28924058	0	O
known	28924058	0	O
to	28924058	0	O
replicate	28924058	0	O
early	28924058	0	O
in	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
,	28924058	0	O
including	28924058	0	O
centromeres	28924058	0	O
and	28924058	0	O
origins	28924058	0	O
of	28924058	0	O
replication	28924058	0	O
.	28924058	0	O
We	28924058	0	O
also	28924058	0	O
discovered	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
throughout	28924058	0	O
the	28924058	0	O
genome	28924058	0	O
,	28924058	0	O
which	28924058	0	O
may	28924058	0	O
be	28924058	0	O
necessary	28924058	0	O
to	28924058	0	O
initiate	28924058	0	O
other	28924058	0	O
cellular	28924058	0	O
processes	28924058	0	O
,	28924058	0	O
including	28924058	0	O
meiotic	28924058	0	O
recombination	28924058	0	O
and	28924058	0	O
translesion	28924058	0	O
synthesis	28924058	0	O
.	28924058	0	O
A	28924058	0	O
kinase	28924058	0	O
dead	28924058	0	O
Cdc7	28924058	0	B-Gene
point	28924058	0	B-Var
mutation	28924058	0	I-Var
increases	28924058	0	B-PosReg
the	28924058	0	O
Ty5	28924058	0	B-MPA
retrotransposon	28924058	0	I-MPA
integration	28924058	0	I-MPA
efficiency	28924058	0	I-MPA
and	28924058	0	O
a	28924058	0	O
55	28924058	0	B-MPA
-	28924058	0	I-MPA
amino	28924058	0	I-MPA
acid	28924058	0	I-MPA
C	28924058	0	I-MPA
-	28924058	0	I-MPA
terminal	28924058	0	I-MPA
truncation	28924058	0	I-MPA
of	28924058	0	O
Cdc7	28924058	0	B-Gene
,	28924058	0	O
unable	28924058	0	B-NegReg
to	28924058	0	O
bind	28924058	0	B-Interaction
Dbf4	28924058	0	B-Gene
,	28924058	0	O
reduces	28924058	0	B-NegReg
Cdc7	28924058	0	B-Gene
binding	28924058	0	B-Interaction
suggesting	28924058	0	O
a	28924058	0	O
requirement	28924058	0	O
for	28924058	0	O
Dbf4	28924058	0	O
to	28924058	0	O
stabilize	28924058	0	O
Cdc7	28924058	0	O
on	28924058	0	O
chromatin	28924058	0	O
during	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
.	28924058	0	O
Chromatin	28924058	0	O
immunoprecipitation	28924058	0	O
demonstrates	28924058	0	O
that	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
near	28924058	0	O
specific	28924058	0	O
origins	28924058	0	O
changes	28924058	0	O
during	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
.	28924058	0	O
Our	28924058	0	O
results	28924058	0	O
suggest	28924058	0	O
a	28924058	0	O
model	28924058	0	O
where	28924058	0	O
Cdc7	28924058	0	O
is	28924058	0	O
loosely	28924058	0	O
bound	28924058	0	O
to	28924058	0	O
chromatin	28924058	0	O
during	28924058	0	O
G1	28924058	0	O
At	28924058	0	O
the	28924058	0	O
G1	28924058	0	O
/	28924058	0	O
S	28924058	0	O
transition	28924058	0	O
,	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
to	28924058	0	O
chromatin	28924058	0	O
is	28924058	0	O
increased	28924058	0	O
and	28924058	0	O
stabilized	28924058	0	O
,	28924058	0	O
preferentially	28924058	0	O
at	28924058	0	O
sites	28924058	0	O
that	28924058	0	O
may	28924058	0	O
become	28924058	0	O
origins	28924058	0	O
,	28924058	0	O
in	28924058	0	O
order	28924058	0	O
to	28924058	0	O
carry	28924058	0	O
out	28924058	0	O
a	28924058	0	O
variety	28924058	0	O
of	28924058	0	O
cellular	28924058	0	O
processes	28924058	0	O
.	28924058	0	O

Gain	28929581	2	B-PosReg
-	28929581	2	I-PosReg
of	28929581	2	I-PosReg
-	28929581	2	I-PosReg
function	28929581	2	I-PosReg
mutation	28929581	2	B-Var
in	28929581	2	O
PTPN11	28929581	2	B-Gene
in	28929581	2	O
histiocytic	28929581	2	B-Disease
sarcomas	28929581	2	I-Disease
of	28929581	2	O
Bernese	28929581	2	O
Mountain	28929581	2	O
Dogs	28929581	2	O
.	28929581	2	O
Histiocytic	28929581	2	O
sarcoma	28929581	2	O
(	28929581	2	O
HS	28929581	2	O
)	28929581	2	O
is	28929581	2	O
an	28929581	2	O
aggressive	28929581	2	O
malignant	28929581	2	O
neoplasm	28929581	2	O
of	28929581	2	O
dendritic	28929581	2	O
cell	28929581	2	O
origin	28929581	2	O
that	28929581	2	O
is	28929581	2	O
common	28929581	2	O
in	28929581	2	O
certain	28929581	2	O
breeds	28929581	2	O
of	28929581	2	O
dogs	28929581	2	O
.	28929581	2	O
High	28929581	2	O
prevalence	28929581	2	O
of	28929581	2	O
fatal	28929581	2	O
,	28929581	2	O
disseminated	28929581	2	O
HS	28929581	2	O
has	28929581	2	O
been	28929581	2	O
described	28929581	2	O
in	28929581	2	O
Bernese	28929581	2	O
Mountain	28929581	2	O
Dogs	28929581	2	O
(	28929581	2	O
BMDs	28929581	2	O
)	28929581	2	O
.	28929581	2	O
Support	28929581	2	O
for	28929581	2	O
genetic	28929581	2	O
predisposition	28929581	2	O
to	28929581	2	O
develop	28929581	2	O
HS	28929581	2	O
has	28929581	2	O
been	28929581	2	O
presented	28929581	2	O
in	28929581	2	O
several	28929581	2	O
studies	28929581	2	O
,	28929581	2	O
but	28929581	2	O
to	28929581	2	O
date	28929581	2	O
,	28929581	2	O
causative	28929581	2	O
genetic	28929581	2	O
events	28929581	2	O
have	28929581	2	O
not	28929581	2	O
been	28929581	2	O
reported	28929581	2	O
.	28929581	2	O
In	28929581	2	O
addition	28929581	2	O
,	28929581	2	O
no	28929581	2	O
driver	28929581	2	O
mutations	28929581	2	O
have	28929581	2	O
been	28929581	2	O
identified	28929581	2	O
in	28929581	2	O
tumours	28929581	2	O
.	28929581	2	O
Recently	28929581	2	O
,	28929581	2	O
E76K	28929581	2	B-Var
gain	28929581	2	B-PosReg
-	28929581	2	I-PosReg
of	28929581	2	I-PosReg
-	28929581	2	I-PosReg
function	28929581	2	I-PosReg
mutation	28929581	2	O
in	28929581	2	O
SHP2	28929581	2	O
encoded	28929581	2	O
by	28929581	2	O
the	28929581	2	O
PTPN11	28929581	2	B-Gene
gene	28929581	2	O
has	28929581	2	O
been	28929581	2	O
described	28929581	2	O
in	28929581	2	O
human	28929581	2	O
histiocytic	28929581	2	B-Disease
malignancies	28929581	2	I-Disease
.	28929581	2	O
In	28929581	2	O
our	28929581	2	O
study	28929581	2	O
,	28929581	2	O
we	28929581	2	O
identified	28929581	2	O
the	28929581	2	O
PTPN11E76K	28929581	2	O
in	28929581	2	O
HS	28929581	2	O
of	28929581	2	O
BMDs	28929581	2	O
.	28929581	2	O
Amplification	28929581	2	O
of	28929581	2	O
exon	28929581	2	O
3	28929581	2	O
of	28929581	2	O
the	28929581	2	O
PTPN11	28929581	2	O
gene	28929581	2	O
followed	28929581	2	O
by	28929581	2	O
Sanger	28929581	2	O
sequencing	28929581	2	O
was	28929581	2	O
used	28929581	2	O
to	28929581	2	O
detect	28929581	2	O
the	28929581	2	O
mutation	28929581	2	O
and	28929581	2	O
estimate	28929581	2	O
the	28929581	2	O
prevalence	28929581	2	O
in	28929581	2	O
HS	28929581	2	O
from	28929581	2	O
30	28929581	2	O
BMDs	28929581	2	O
,	28929581	2	O
13	28929581	2	O
Golden	28929581	2	O
Retrievers	28929581	2	O
and	28929581	2	O
10	28929581	2	O
other	28929581	2	O
dog	28929581	2	O
breeds	28929581	2	O
.	28929581	2	O
The	28929581	2	O
overall	28929581	2	O
prevalence	28929581	2	O
of	28929581	2	O
PTPN11E76K	28929581	2	O
in	28929581	2	O
HS	28929581	2	O
of	28929581	2	O
BMDs	28929581	2	O
was	28929581	2	O
36.67%	28929581	2	O
compared	28929581	2	O
with	28929581	2	O
8.69%	28929581	2	O
in	28929581	2	O
other	28929581	2	O
breeds	28929581	2	O
.	28929581	2	O
No	28929581	2	O
mutation	28929581	2	O
was	28929581	2	O
identified	28929581	2	O
in	28929581	2	O
normal	28929581	2	O
tissues	28929581	2	O
from	28929581	2	O
10	28929581	2	O
BMDs	28929581	2	O
with	28929581	2	O
HS	28929581	2	O
that	28929581	2	O
carried	28929581	2	O
the	28929581	2	O
mutation	28929581	2	O
and	28929581	2	O
12	28929581	2	O
control	28929581	2	O
dogs	28929581	2	O
with	28929581	2	O
no	28929581	2	O
neoplastic	28929581	2	O
disease	28929581	2	O
,	28929581	2	O
including	28929581	2	O
6	28929581	2	O
BMDs	28929581	2	O
.	28929581	2	O
Increased	28929581	2	O
immunoreactivity	28929581	2	O
for	28929581	2	O
AKT	28929581	2	O
,	28929581	2	O
phosphorylated	28929581	2	O
ERK1	28929581	2	O
/	28929581	2	O
2	28929581	2	O
and	28929581	2	O
phosphorylated	28929581	2	O
AKT	28929581	2	O
in	28929581	2	O
a	28929581	2	O
small	28929581	2	O
subset	28929581	2	O
of	28929581	2	O
BMDs	28929581	2	O
with	28929581	2	O
PTPN11E76K	28929581	2	O
suggests	28929581	2	O
that	28929581	2	O
a	28929581	2	O
gain	28929581	2	O
-	28929581	2	O
of	28929581	2	O
-	28929581	2	O
function	28929581	2	O
might	28929581	2	O
be	28929581	2	O
mediated	28929581	2	O
by	28929581	2	O
the	28929581	2	O
ERK	28929581	2	O
and	28929581	2	O
AKT	28929581	2	O
pathways	28929581	2	O
.	28929581	2	O
These	28929581	2	O
data	28929581	2	O
suggest	28929581	2	O
PTPN11E76K	28929581	2	O
as	28929581	2	O
an	28929581	2	O
important	28929581	2	O
driver	28929581	2	O
mutation	28929581	2	O
of	28929581	2	O
HS	28929581	2	O
in	28929581	2	O
BMDs	28929581	2	O
.	28929581	2	O
This	28929581	2	O
information	28929581	2	O
may	28929581	2	O
not	28929581	2	O
only	28929581	2	O
aid	28929581	2	O
in	28929581	2	O
unravelling	28929581	2	O
the	28929581	2	O
tumourigenic	28929581	2	O
events	28929581	2	O
associated	28929581	2	O
with	28929581	2	O
HS	28929581	2	O
in	28929581	2	O
BMDs	28929581	2	O
,	28929581	2	O
but	28929581	2	O
also	28929581	2	O
help	28929581	2	O
in	28929581	2	O
identifying	28929581	2	O
more	28929581	2	O
promising	28929581	2	O
therapeutic	28929581	2	O
strategies	28929581	2	O
.	28929581	2	O

Homozygous	28934391	1	O
KIDINS220	28934391	1	B-Gene
loss	28934391	1	B-NegReg
-	28934391	1	I-NegReg
of	28934391	1	I-NegReg
-	28934391	1	I-NegReg
function	28934391	1	I-NegReg
variants	28934391	1	B-Var
in	28934391	1	O
fetuses	28934391	1	O
with	28934391	1	O
cerebral	28934391	1	B-CPA
ventriculomegaly	28934391	1	I-CPA
and	28934391	1	O
limb	28934391	1	B-CPA
contractures	28934391	1	I-CPA
.	28934391	1	O
Heterozygous	28934391	1	B-Var
mutations	28934391	1	I-Var
in	28934391	1	O
KIDINS220	28934391	1	B-Gene
were	28934391	1	O
recently	28934391	1	O
suggested	28934391	1	O
a	28934391	1	O
cause	28934391	1	B-Reg
of	28934391	1	O
spastic	28934391	1	B-Disease
paraplegia	28934391	1	I-Disease
,	28934391	1	O
intellectual	28934391	1	B-Disease
disability	28934391	1	I-Disease
,	28934391	1	O
nystagmus	28934391	1	B-Disease
and	28934391	1	O
obesity	28934391	1	B-Disease
.	28934391	1	O
All	28934391	1	O
patients	28934391	1	O
carried	28934391	1	O
terminal	28934391	1	O
nonsense	28934391	1	O
de	28934391	1	O
novo	28934391	1	O
mutations	28934391	1	O
that	28934391	1	O
seemed	28934391	1	O
to	28934391	1	O
escape	28934391	1	O
nonsense	28934391	1	O
-	28934391	1	O
mediated	28934391	1	O
mRNA	28934391	1	O
decay	28934391	1	O
.	28934391	1	O
The	28934391	1	O
mechanism	28934391	1	O
for	28934391	1	O
pathogenicity	28934391	1	O
is	28934391	1	O
yet	28934391	1	O
unexplained	28934391	1	O
,	28934391	1	O
as	28934391	1	O
it	28934391	1	O
seems	28934391	1	O
that	28934391	1	O
heterozygous	28934391	1	O
loss	28934391	1	O
-	28934391	1	O
of	28934391	1	O
-	28934391	1	O
function	28934391	1	O
variants	28934391	1	O
of	28934391	1	O
KIDINS220	28934391	1	O
are	28934391	1	O
generally	28934391	1	O
well	28934391	1	O
tolerated	28934391	1	O
.	28934391	1	O
We	28934391	1	O
present	28934391	1	O
a	28934391	1	O
consanguineous	28934391	1	O
couple	28934391	1	O
who	28934391	1	O
experienced	28934391	1	O
four	28934391	1	O
pregnancy	28934391	1	O
terminations	28934391	1	O
due	28934391	1	O
to	28934391	1	O
repeated	28934391	1	O
findings	28934391	1	O
in	28934391	1	O
the	28934391	1	O
fetuses	28934391	1	O
comprising	28934391	1	O
enlarged	28934391	1	O
cerebral	28934391	1	O
ventricles	28934391	1	O
and	28934391	1	O
limb	28934391	1	O
contractures	28934391	1	O
.	28934391	1	O
Exome	28934391	1	O
sequencing	28934391	1	O
in	28934391	1	O
two	28934391	1	O
of	28934391	1	O
the	28934391	1	O
aborted	28934391	1	O
fetuses	28934391	1	O
revealed	28934391	1	O
a	28934391	1	O
shared	28934391	1	O
homozygous	28934391	1	O
frameshift	28934391	1	O
variant	28934391	1	O
in	28934391	1	O
exon	28934391	1	O
24	28934391	1	O
in	28934391	1	O
KIDINS220	28934391	1	O
.	28934391	1	O
Sanger	28934391	1	O
sequencing	28934391	1	O
of	28934391	1	O
the	28934391	1	O
variant	28934391	1	O
in	28934391	1	O
available	28934391	1	O
family	28934391	1	O
members	28934391	1	O
showed	28934391	1	O
complete	28934391	1	O
segregation	28934391	1	O
with	28934391	1	O
the	28934391	1	O
affection	28934391	1	O
status	28934391	1	O
,	28934391	1	O
resulting	28934391	1	O
in	28934391	1	O
a	28934391	1	O
LOD	28934391	1	O
score	28934391	1	O
of	28934391	1	O
2.5	28934391	1	O
under	28934391	1	O
an	28934391	1	O
autozygous	28934391	1	O
inheritance	28934391	1	O
model	28934391	1	O
.	28934391	1	O
mRNA	28934391	1	O
studies	28934391	1	O
revealed	28934391	1	O
destruction	28934391	1	O
of	28934391	1	O
the	28934391	1	O
original	28934391	1	O
splice	28934391	1	O
site	28934391	1	O
,	28934391	1	O
resulting	28934391	1	O
in	28934391	1	O
an	28934391	1	O
out	28934391	1	O
-	28934391	1	O
of	28934391	1	O
-	28934391	1	O
frame	28934391	1	O
transcript	28934391	1	O
and	28934391	1	O
introduction	28934391	1	O
of	28934391	1	O
a	28934391	1	O
premature	28934391	1	O
termination	28934391	1	O
codon	28934391	1	O
in	28934391	1	O
exon	28934391	1	O
25	28934391	1	O
.	28934391	1	O
Premature	28934391	1	O
termination	28934391	1	O
codons	28934391	1	O
in	28934391	1	O
this	28934391	1	O
position	28934391	1	O
are	28934391	1	O
likely	28934391	1	O
to	28934391	1	O
cause	28934391	1	O
activation	28934391	1	O
of	28934391	1	O
nonsense	28934391	1	O
-	28934391	1	O
mediated	28934391	1	O
mRNA	28934391	1	O
decay	28934391	1	O
and	28934391	1	O
result	28934391	1	O
in	28934391	1	O
complete	28934391	1	O
absence	28934391	1	O
of	28934391	1	O
KIDINS220	28934391	1	O
protein	28934391	1	O
in	28934391	1	O
individuals	28934391	1	O
homozygous	28934391	1	O
for	28934391	1	O
the	28934391	1	O
variant	28934391	1	O
.	28934391	1	O
The	28934391	1	O
phenotype	28934391	1	O
of	28934391	1	O
the	28934391	1	O
presented	28934391	1	O
fetuses	28934391	1	O
overlaps	28934391	1	O
with	28934391	1	O
findings	28934391	1	O
in	28934391	1	O
functional	28934391	1	O
studies	28934391	1	O
of	28934391	1	O
knockout	28934391	1	O
Kidins220	28934391	1	O
mice	28934391	1	O
embryos	28934391	1	O
that	28934391	1	O
are	28934391	1	O
non	28934391	1	O
-	28934391	1	O
viable	28934391	1	O
with	28934391	1	O
enlarged	28934391	1	O
cerebral	28934391	1	O
ventricles	28934391	1	O
.	28934391	1	O
The	28934391	1	O
human	28934391	1	O
fetuses	28934391	1	O
also	28934391	1	O
exhibit	28934391	1	O
several	28934391	1	O
similarities	28934391	1	O
to	28934391	1	O
the	28934391	1	O
milder	28934391	1	O
phenotype	28934391	1	O
described	28934391	1	O
in	28934391	1	O
patients	28934391	1	O
with	28934391	1	O
heterozygous	28934391	1	O
KIDINS220	28934391	1	O
mutations	28934391	1	O
.	28934391	1	O
We	28934391	1	O
hence	28934391	1	O
propose	28934391	1	O
that	28934391	1	O
the	28934391	1	O
identified	28934391	1	O
homozygous	28934391	1	O
loss	28934391	1	O
-	28934391	1	O
of	28934391	1	O
-	28934391	1	O
function	28934391	1	O
variant	28934391	1	O
in	28934391	1	O
KIDINS220	28934391	1	O
causes	28934391	1	O
the	28934391	1	O
phenotype	28934391	1	O
in	28934391	1	O
the	28934391	1	O
presented	28934391	1	O
fetuses	28934391	1	O
,	28934391	1	O
and	28934391	1	O
that	28934391	1	O
this	28934391	1	O
represents	28934391	1	O
a	28934391	1	O
hitherto	28934391	1	O
undescribed	28934391	1	O
severe	28934391	1	O
autosomal	28934391	1	O
recessive	28934391	1	O
neurodevelopmental	28934391	1	O
disorder	28934391	1	O
.	28934391	1	O

The	28939416	0	O
GNASR201C	28939416	0	O
mutation	28939416	0	O
associated	28939416	0	O
with	28939416	0	O
clonal	28939416	0	O
hematopoiesis	28939416	0	O
supports	28939416	0	O
transplantable	28939416	0	O
hematopoietic	28939416	0	O
stem	28939416	0	O
cell	28939416	0	O
activity	28939416	0	O
.	28939416	0	O
Genome	28939416	0	O
sequencing	28939416	0	O
efforts	28939416	0	O
have	28939416	0	O
identified	28939416	0	O
virtually	28939416	0	O
all	28939416	0	O
of	28939416	0	O
the	28939416	0	O
important	28939416	0	O
mutations	28939416	0	O
in	28939416	0	O
adult	28939416	0	O
myeloid	28939416	0	O
malignancies	28939416	0	O
.	28939416	0	O
More	28939416	0	O
recently	28939416	0	O
,	28939416	0	O
population	28939416	0	O
studies	28939416	0	O
have	28939416	0	O
identified	28939416	0	O
cancer	28939416	0	O
-	28939416	0	O
associated	28939416	0	O
variants	28939416	0	O
in	28939416	0	O
the	28939416	0	O
blood	28939416	0	O
of	28939416	0	O
otherwise	28939416	0	O
healthy	28939416	0	O
individuals	28939416	0	O
as	28939416	0	O
they	28939416	0	O
age	28939416	0	O
,	28939416	0	O
a	28939416	0	O
phenomenon	28939416	0	O
termed	28939416	0	O
clonal	28939416	0	O
hematopoiesis	28939416	0	O
of	28939416	0	O
indeterminate	28939416	0	O
potential	28939416	0	O
(	28939416	0	O
CHIP	28939416	0	O
)	28939416	0	O
.	28939416	0	O
This	28939416	0	O
suggests	28939416	0	O
that	28939416	0	O
these	28939416	0	O
mutations	28939416	0	O
may	28939416	0	O
occur	28939416	0	O
in	28939416	0	O
hematopoietic	28939416	0	O
stem	28939416	0	O
cells	28939416	0	O
(	28939416	0	O
HSCs	28939416	0	O
)	28939416	0	O
long	28939416	0	O
before	28939416	0	O
any	28939416	0	O
clinical	28939416	0	O
presentation	28939416	0	O
but	28939416	0	O
are	28939416	0	O
not	28939416	0	O
necessarily	28939416	0	O
harbingers	28939416	0	O
of	28939416	0	O
transformation	28939416	0	O
because	28939416	0	O
only	28939416	0	O
a	28939416	0	O
fraction	28939416	0	O
of	28939416	0	O
individuals	28939416	0	O
with	28939416	0	O
CHIP	28939416	0	O
develop	28939416	0	O
hematopoietic	28939416	0	O
pathologies	28939416	0	O
.	28939416	0	O
Delineation	28939416	0	O
between	28939416	0	O
CHIP	28939416	0	O
variants	28939416	0	O
that	28939416	0	O
predispose	28939416	0	O
for	28939416	0	O
disease	28939416	0	O
versus	28939416	0	O
those	28939416	0	O
that	28939416	0	O
are	28939416	0	O
more	28939416	0	O
benign	28939416	0	O
could	28939416	0	O
be	28939416	0	O
used	28939416	0	O
as	28939416	0	O
a	28939416	0	O
prognostic	28939416	0	O
factor	28939416	0	O
to	28939416	0	O
identify	28939416	0	O
individuals	28939416	0	O
at	28939416	0	O
greater	28939416	0	O
risk	28939416	0	O
for	28939416	0	O
transformation	28939416	0	O
.	28939416	0	O
To	28939416	0	O
achieve	28939416	0	O
this	28939416	0	O
,	28939416	0	O
the	28939416	0	O
biological	28939416	0	O
impact	28939416	0	O
of	28939416	0	O
CHIP	28939416	0	O
variants	28939416	0	O
on	28939416	0	O
HSC	28939416	0	O
function	28939416	0	O
must	28939416	0	O
be	28939416	0	O
validated	28939416	0	O
.	28939416	0	O
One	28939416	0	O
variant	28939416	0	O
that	28939416	0	O
has	28939416	0	O
been	28939416	0	O
identified	28939416	0	O
recurrently	28939416	0	O
in	28939416	0	O
CHIP	28939416	0	B-CPA
is	28939416	0	O
a	28939416	0	O
gain	28939416	0	B-PosReg
-	28939416	0	I-PosReg
of	28939416	0	I-PosReg
-	28939416	0	I-PosReg
function	28939416	0	I-PosReg
missense	28939416	0	B-Var
mutation	28939416	0	I-Var
in	28939416	0	O
the	28939416	0	O
imprinted	28939416	0	O
gene	28939416	0	O
GNAS	28939416	0	B-Gene
(	28939416	0	O
Guanine	28939416	0	O
Nucleotide	28939416	0	O
Binding	28939416	0	O
Protein	28939416	0	O
,	28939416	0	O
Alpha	28939416	0	O
Stimulating	28939416	0	O
)	28939416	0	O
.	28939416	0	O
In	28939416	0	O
this	28939416	0	O
study	28939416	0	O
,	28939416	0	O
we	28939416	0	O
examined	28939416	0	O
the	28939416	0	O
effect	28939416	0	O
of	28939416	0	O
the	28939416	0	O
GNASR201C	28939416	0	O
variant	28939416	0	O
on	28939416	0	O
HSC	28939416	0	O
function	28939416	0	O
.	28939416	0	O
Ectopic	28939416	0	O
expression	28939416	0	O
of	28939416	0	O
GNASR201C	28939416	0	B-Var
supported	28939416	0	B-PosReg
transplantable	28939416	0	B-CPA
HSC	28939416	0	I-CPA
activity	28939416	0	I-CPA
and	28939416	0	O
improved	28939416	0	B-PosReg
lymphoid	28939416	0	B-CPA
output	28939416	0	I-CPA
in	28939416	0	O
secondary	28939416	0	O
recipients	28939416	0	O
.	28939416	0	O
Because	28939416	0	O
declining	28939416	0	O
lymphoid	28939416	0	O
output	28939416	0	O
is	28939416	0	O
a	28939416	0	O
hallmark	28939416	0	O
of	28939416	0	O
aging	28939416	0	O
,	28939416	0	O
GNASR201C	28939416	0	O
mutations	28939416	0	O
may	28939416	0	O
sustain	28939416	0	O
lymphoid	28939416	0	O
-	28939416	0	O
biased	28939416	0	O
HSCs	28939416	0	O
over	28939416	0	O
time	28939416	0	O
and	28939416	0	O
maintain	28939416	0	O
them	28939416	0	O
in	28939416	0	O
a	28939416	0	O
developmental	28939416	0	O
state	28939416	0	O
favorable	28939416	0	O
for	28939416	0	O
transformation	28939416	0	O
.	28939416	0	O

N1366S	28940424	2	O
mutation	28940424	2	O
of	28940424	2	O
human	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
sodium	28940424	2	O
channel	28940424	2	O
causes	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
.	28940424	2	O
KEY	28940424	2	O
POINTS	28940424	2	O
:	28940424	2	O
Paramyotonia	28940424	2	B-Disease
congenita	28940424	2	I-Disease
is	28940424	2	O
a	28940424	2	O
hereditary	28940424	2	O
channelopathy	28940424	2	O
caused	28940424	2	B-Reg
by	28940424	2	O
missense	28940424	2	B-Var
mutations	28940424	2	I-Var
in	28940424	2	O
the	28940424	2	O
SCN4A	28940424	2	B-Gene
gene	28940424	2	O
,	28940424	2	O
which	28940424	2	O
encodes	28940424	2	O
the	28940424	2	O
α	28940424	2	O
subunit	28940424	2	O
of	28940424	2	O
the	28940424	2	O
human	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
voltage	28940424	2	O
-	28940424	2	O
gated	28940424	2	O
sodium	28940424	2	O
channel	28940424	2	O
NaV1.4	28940424	2	O
.	28940424	2	O
Affected	28940424	2	O
individuals	28940424	2	O
suffered	28940424	2	O
from	28940424	2	O
myotonia	28940424	2	O
and	28940424	2	O
paralysis	28940424	2	O
of	28940424	2	O
muscles	28940424	2	O
,	28940424	2	O
which	28940424	2	O
were	28940424	2	O
aggravated	28940424	2	O
by	28940424	2	O
exposure	28940424	2	O
to	28940424	2	O
cold	28940424	2	O
.	28940424	2	O
We	28940424	2	O
report	28940424	2	O
a	28940424	2	O
three	28940424	2	O
-	28940424	2	O
generation	28940424	2	O
Chinese	28940424	2	O
family	28940424	2	O
with	28940424	2	O
patients	28940424	2	O
presenting	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
and	28940424	2	O
identify	28940424	2	O
a	28940424	2	O
novel	28940424	2	O
N1366S	28940424	2	O
mutation	28940424	2	O
of	28940424	2	O
NaV1.4	28940424	2	O
.	28940424	2	O
Whole	28940424	2	O
-	28940424	2	O
cell	28940424	2	O
electrophysiological	28940424	2	O
recordings	28940424	2	O
of	28940424	2	O
the	28940424	2	O
N1366S	28940424	2	O
channel	28940424	2	O
reveal	28940424	2	O
a	28940424	2	O
gain	28940424	2	O
-	28940424	2	O
of	28940424	2	O
-	28940424	2	O
function	28940424	2	O
change	28940424	2	O
of	28940424	2	O
gating	28940424	2	O
in	28940424	2	O
response	28940424	2	O
to	28940424	2	O
cold	28940424	2	O
.	28940424	2	O
Modelling	28940424	2	O
and	28940424	2	O
molecular	28940424	2	O
dynamic	28940424	2	O
simulation	28940424	2	O
data	28940424	2	O
suggest	28940424	2	O
that	28940424	2	O
an	28940424	2	O
arginine	28940424	2	O
-	28940424	2	O
to	28940424	2	O
-	28940424	2	O
serine	28940424	2	O
substitution	28940424	2	O
at	28940424	2	O
position	28940424	2	O
1366	28940424	2	O
increases	28940424	2	O
the	28940424	2	O
distance	28940424	2	O
from	28940424	2	O
N1366	28940424	2	O
to	28940424	2	O
R1454	28940424	2	O
and	28940424	2	O
disrupts	28940424	2	O
the	28940424	2	O
hydrogen	28940424	2	O
bond	28940424	2	O
formed	28940424	2	O
between	28940424	2	O
them	28940424	2	O
at	28940424	2	O
low	28940424	2	O
temperature	28940424	2	O
.	28940424	2	O
We	28940424	2	O
demonstrate	28940424	2	O
that	28940424	2	O
N1366S	28940424	2	O
is	28940424	2	O
a	28940424	2	O
disease	28940424	2	O
-	28940424	2	O
causing	28940424	2	O
mutation	28940424	2	O
and	28940424	2	O
that	28940424	2	O
the	28940424	2	O
temperature	28940424	2	O
-	28940424	2	O
sensitive	28940424	2	O
alteration	28940424	2	O
of	28940424	2	O
N1366S	28940424	2	O
channel	28940424	2	O
activity	28940424	2	O
may	28940424	2	O
be	28940424	2	O
responsible	28940424	2	O
for	28940424	2	O
the	28940424	2	O
pronounced	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
symptoms	28940424	2	O
of	28940424	2	O
these	28940424	2	O
patients	28940424	2	O
.	28940424	2	O
ABSTRACT	28940424	2	O
:	28940424	2	O
Paramyotonia	28940424	2	B-Disease
congenita	28940424	2	I-Disease
is	28940424	2	O
an	28940424	2	O
autosomal	28940424	2	O
dominant	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
channelopathy	28940424	2	O
caused	28940424	2	B-Reg
by	28940424	2	O
missense	28940424	2	B-Var
mutations	28940424	2	I-Var
in	28940424	2	O
SCN4A	28940424	2	B-Gene
,	28940424	2	O
the	28940424	2	O
gene	28940424	2	O
encoding	28940424	2	O
the	28940424	2	O
α	28940424	2	O
subunit	28940424	2	O
of	28940424	2	O
the	28940424	2	O
human	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
voltage	28940424	2	O
-	28940424	2	O
gated	28940424	2	O
sodium	28940424	2	O
channel	28940424	2	O
NaV1.4	28940424	2	O
.	28940424	2	O
We	28940424	2	O
report	28940424	2	O
a	28940424	2	O
three	28940424	2	O
-	28940424	2	O
generation	28940424	2	O
family	28940424	2	O
in	28940424	2	O
which	28940424	2	O
six	28940424	2	O
members	28940424	2	O
present	28940424	2	O
clinical	28940424	2	O
symptoms	28940424	2	O
of	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
characterized	28940424	2	O
by	28940424	2	O
a	28940424	2	O
marked	28940424	2	O
worsening	28940424	2	O
of	28940424	2	O
myotonia	28940424	2	O
by	28940424	2	O
cold	28940424	2	O
and	28940424	2	O
by	28940424	2	O
the	28940424	2	O
presence	28940424	2	O
of	28940424	2	O
clear	28940424	2	O
episodes	28940424	2	O
of	28940424	2	O
paralysis	28940424	2	O
.	28940424	2	O
We	28940424	2	O
identified	28940424	2	O
a	28940424	2	O
novel	28940424	2	O
mutation	28940424	2	O
in	28940424	2	O
SCN4A	28940424	2	O
(	28940424	2	O
Asn1366Ser	28940424	2	O
,	28940424	2	O
N1366S	28940424	2	O
)	28940424	2	O
in	28940424	2	O
all	28940424	2	O
patients	28940424	2	O
in	28940424	2	O
the	28940424	2	O
family	28940424	2	O
but	28940424	2	O
not	28940424	2	O
in	28940424	2	O
healthy	28940424	2	O
relatives	28940424	2	O
or	28940424	2	O
in	28940424	2	O
500	28940424	2	O
normal	28940424	2	O
control	28940424	2	O
subjects	28940424	2	O
.	28940424	2	O
Functional	28940424	2	O
analysis	28940424	2	O
of	28940424	2	O
the	28940424	2	O
channel	28940424	2	O
protein	28940424	2	O
expressed	28940424	2	O
in	28940424	2	O
HEK293	28940424	2	O
cells	28940424	2	O
by	28940424	2	O
whole	28940424	2	O
-	28940424	2	O
cell	28940424	2	O
patch	28940424	2	O
clamp	28940424	2	O
recording	28940424	2	O
revealed	28940424	2	O
that	28940424	2	O
the	28940424	2	O
N1366S	28940424	2	O
mutation	28940424	2	O
led	28940424	2	O
to	28940424	2	O
significant	28940424	2	O
alterations	28940424	2	O
in	28940424	2	O
the	28940424	2	O
gating	28940424	2	O
process	28940424	2	O
of	28940424	2	O
the	28940424	2	O
NaV1.4	28940424	2	O
channel	28940424	2	O
.	28940424	2	O
The	28940424	2	O
N1366S	28940424	2	B-Var
mutant	28940424	2	O
displayed	28940424	2	O
a	28940424	2	O
cold	28940424	2	O
-	28940424	2	O
induced	28940424	2	O
hyperpolarizing	28940424	2	O
shift	28940424	2	O
in	28940424	2	O
the	28940424	2	O
voltage	28940424	2	O
dependence	28940424	2	O
of	28940424	2	O
activation	28940424	2	O
and	28940424	2	O
a	28940424	2	O
depolarizing	28940424	2	O
shift	28940424	2	O
in	28940424	2	O
fast	28940424	2	O
inactivation	28940424	2	O
,	28940424	2	O
as	28940424	2	O
well	28940424	2	O
as	28940424	2	O
a	28940424	2	O
reduced	28940424	2	B-NegReg
rate	28940424	2	B-MPA
of	28940424	2	O
fast	28940424	2	B-MPA
inactivation	28940424	2	I-MPA
and	28940424	2	O
accelerated	28940424	2	B-PosReg
recovery	28940424	2	B-MPA
from	28940424	2	O
fast	28940424	2	B-MPA
inactivation	28940424	2	I-MPA
.	28940424	2	O
In	28940424	2	O
addition	28940424	2	O
,	28940424	2	O
homology	28940424	2	O
modelling	28940424	2	O
and	28940424	2	O
molecular	28940424	2	O
dynamic	28940424	2	O
simulation	28940424	2	O
of	28940424	2	O
N1366S	28940424	2	O
and	28940424	2	O
wild	28940424	2	O
-	28940424	2	O
type	28940424	2	O
NaV1.4	28940424	2	O
channels	28940424	2	O
indicated	28940424	2	O
that	28940424	2	O
the	28940424	2	O
arginine	28940424	2	O
-	28940424	2	O
to	28940424	2	O
-	28940424	2	O
serine	28940424	2	O
substitution	28940424	2	O
disrupted	28940424	2	O
the	28940424	2	O
hydrogen	28940424	2	O
bond	28940424	2	O
formed	28940424	2	O
between	28940424	2	O
N1366	28940424	2	O
and	28940424	2	O
R1454	28940424	2	O
.	28940424	2	O
Together	28940424	2	O
,	28940424	2	O
our	28940424	2	O
results	28940424	2	O
suggest	28940424	2	O
that	28940424	2	O
N1366S	28940424	2	B-Var
is	28940424	2	O
a	28940424	2	O
gain	28940424	2	B-PosReg
-	28940424	2	I-PosReg
of	28940424	2	I-PosReg
-	28940424	2	I-PosReg
function	28940424	2	I-PosReg
mutation	28940424	2	O
of	28940424	2	O
NaV1.4	28940424	2	O
at	28940424	2	O
low	28940424	2	O
temperature	28940424	2	O
and	28940424	2	O
the	28940424	2	O
mutation	28940424	2	O
may	28940424	2	O
be	28940424	2	O
responsible	28940424	2	O
for	28940424	2	O
the	28940424	2	O
clinical	28940424	2	O
symptoms	28940424	2	O
of	28940424	2	O
paramyotonia	28940424	2	B-Disease
congenita	28940424	2	I-Disease
in	28940424	2	O
the	28940424	2	O
affected	28940424	2	O
family	28940424	2	O
and	28940424	2	O
constitute	28940424	2	O
a	28940424	2	O
basis	28940424	2	O
for	28940424	2	O
studies	28940424	2	O
into	28940424	2	O
its	28940424	2	O
pathogenesis	28940424	2	O
.	28940424	2	O

Loss	28941020	1	B-NegReg
-	28941020	1	I-NegReg
of	28941020	1	I-NegReg
-	28941020	1	I-NegReg
function	28941020	1	I-NegReg
variants	28941020	1	B-Var
in	28941020	1	O
NFIA	28941020	1	B-Gene
provide	28941020	1	O
further	28941020	1	O
support	28941020	1	O
that	28941020	1	O
NFIA	28941020	1	O
is	28941020	1	O
a	28941020	1	O
critical	28941020	1	O
gene	28941020	1	O
in	28941020	1	O
1	28941020	1	B-Disease
p32	28941020	1	I-Disease
-	28941020	1	I-Disease
p31	28941020	1	I-Disease
deletion	28941020	1	I-Disease
syndrome	28941020	1	I-Disease
:	28941020	1	I-Disease
A	28941020	1	O
four	28941020	1	O
patient	28941020	1	O
series	28941020	1	O
.	28941020	1	O
The	28941020	1	O
association	28941020	1	O
between	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
contiguous	28941020	1	O
gene	28941020	1	O
deletions	28941020	1	O
and	28941020	1	O
a	28941020	1	O
distinct	28941020	1	O
phenotype	28941020	1	O
that	28941020	1	O
includes	28941020	1	O
anomalies	28941020	1	O
of	28941020	1	O
the	28941020	1	O
corpus	28941020	1	O
callosum	28941020	1	O
,	28941020	1	O
ventriculomegaly	28941020	1	O
,	28941020	1	O
developmental	28941020	1	O
delay	28941020	1	O
,	28941020	1	O
seizures	28941020	1	O
,	28941020	1	O
and	28941020	1	O
dysmorphic	28941020	1	O
features	28941020	1	O
has	28941020	1	O
been	28941020	1	O
long	28941020	1	O
recognized	28941020	1	O
and	28941020	1	O
described	28941020	1	O
.	28941020	1	O
Recently	28941020	1	O
,	28941020	1	O
the	28941020	1	O
observation	28941020	1	O
of	28941020	1	O
overlapping	28941020	1	O
phenotypes	28941020	1	O
in	28941020	1	O
patients	28941020	1	O
with	28941020	1	O
chromosome	28941020	1	O
translocations	28941020	1	O
that	28941020	1	O
disrupt	28941020	1	O
NFIA	28941020	1	O
(	28941020	1	O
Nuclear	28941020	1	O
factor	28941020	1	O
I	28941020	1	O
/	28941020	1	O
A	28941020	1	O
)	28941020	1	O
,	28941020	1	O
a	28941020	1	O
gene	28941020	1	O
within	28941020	1	O
this	28941020	1	O
deleted	28941020	1	O
region	28941020	1	O
,	28941020	1	O
and	28941020	1	O
NFIA	28941020	1	O
intragenic	28941020	1	O
deletions	28941020	1	O
has	28941020	1	O
led	28941020	1	O
to	28941020	1	O
the	28941020	1	O
hypothesis	28941020	1	O
that	28941020	1	O
NFIA	28941020	1	O
is	28941020	1	O
a	28941020	1	O
critical	28941020	1	O
gene	28941020	1	O
within	28941020	1	O
this	28941020	1	O
region	28941020	1	O
.	28941020	1	O
The	28941020	1	O
wide	28941020	1	O
application	28941020	1	O
and	28941020	1	O
increasing	28941020	1	O
accessibility	28941020	1	O
of	28941020	1	O
whole	28941020	1	O
exome	28941020	1	O
sequencing	28941020	1	O
(	28941020	1	O
WES	28941020	1	O
)	28941020	1	O
has	28941020	1	O
helped	28941020	1	O
identify	28941020	1	O
new	28941020	1	O
cases	28941020	1	O
to	28941020	1	O
support	28941020	1	O
this	28941020	1	O
hypothesis	28941020	1	O
.	28941020	1	O
Here	28941020	1	O
,	28941020	1	O
we	28941020	1	O
describe	28941020	1	O
four	28941020	1	O
patients	28941020	1	O
with	28941020	1	O
loss	28941020	1	O
-	28941020	1	O
of	28941020	1	O
-	28941020	1	O
function	28941020	1	O
variants	28941020	1	O
in	28941020	1	O
the	28941020	1	O
NFIA	28941020	1	O
gene	28941020	1	O
identified	28941020	1	O
through	28941020	1	O
WES	28941020	1	O
.	28941020	1	O
The	28941020	1	O
clinical	28941020	1	O
presentation	28941020	1	O
of	28941020	1	O
these	28941020	1	O
patients	28941020	1	O
significantly	28941020	1	O
overlaps	28941020	1	O
with	28941020	1	O
the	28941020	1	O
phenotype	28941020	1	O
described	28941020	1	O
in	28941020	1	O
previously	28941020	1	O
reported	28941020	1	O
cases	28941020	1	O
of	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
deletion	28941020	1	O
syndrome	28941020	1	O
,	28941020	1	O
NFIA	28941020	1	O
gene	28941020	1	O
disruptions	28941020	1	O
and	28941020	1	O
intragenic	28941020	1	O
NFIA	28941020	1	O
deletions	28941020	1	O
.	28941020	1	O
Our	28941020	1	O
cohort	28941020	1	O
includes	28941020	1	O
a	28941020	1	O
mother	28941020	1	O
and	28941020	1	O
daughter	28941020	1	O
as	28941020	1	O
well	28941020	1	O
as	28941020	1	O
an	28941020	1	O
unrelated	28941020	1	O
individual	28941020	1	O
who	28941020	1	O
share	28941020	1	O
the	28941020	1	O
same	28941020	1	O
nonsense	28941020	1	O
variant	28941020	1	O
(	28941020	1	O
c.205C	28941020	1	O
>	28941020	1	O
T	28941020	1	O
,	28941020	1	O
p.Arg69Ter	28941020	1	O
;	28941020	1	O
NM_001145512.1	28941020	1	O
)	28941020	1	O
.	28941020	1	O
We	28941020	1	O
also	28941020	1	O
report	28941020	1	O
a	28941020	1	O
patient	28941020	1	O
with	28941020	1	O
a	28941020	1	O
frameshift	28941020	1	O
NFIA	28941020	1	O
variant	28941020	1	O
(	28941020	1	O
c.159_160dupCC	28941020	1	O
,	28941020	1	O
p.Gln54ProfsTer49	28941020	1	O
)	28941020	1	O
.	28941020	1	O
We	28941020	1	O
have	28941020	1	O
compared	28941020	1	O
published	28941020	1	O
cases	28941020	1	O
of	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
microdeletion	28941020	1	O
syndrome	28941020	1	O
,	28941020	1	O
translocations	28941020	1	O
resulting	28941020	1	O
in	28941020	1	O
NFIA	28941020	1	O
gene	28941020	1	O
disruption	28941020	1	O
,	28941020	1	O
intragenic	28941020	1	O
deletions	28941020	1	O
,	28941020	1	O
and	28941020	1	O
loss	28941020	1	O
-	28941020	1	O
of	28941020	1	O
-	28941020	1	O
function	28941020	1	O
mutations	28941020	1	O
(	28941020	1	O
including	28941020	1	O
our	28941020	1	O
four	28941020	1	O
patients	28941020	1	O
)	28941020	1	O
to	28941020	1	O
reveal	28941020	1	O
that	28941020	1	O
abnormalities	28941020	1	O
of	28941020	1	O
the	28941020	1	O
corpus	28941020	1	O
callosum	28941020	1	O
,	28941020	1	O
ventriculomegaly	28941020	1	O
/	28941020	1	O
hydrocephalus	28941020	1	O
,	28941020	1	O
macrocephaly	28941020	1	O
,	28941020	1	O
Chiari	28941020	1	O
I	28941020	1	O
malformation	28941020	1	O
,	28941020	1	O
dysmorphic	28941020	1	O
features	28941020	1	O
,	28941020	1	O
developmental	28941020	1	O
delay	28941020	1	O
,	28941020	1	O
hypotonia	28941020	1	O
,	28941020	1	O
and	28941020	1	O
urinary	28941020	1	O
tract	28941020	1	O
defects	28941020	1	O
are	28941020	1	O
common	28941020	1	O
findings	28941020	1	O
.	28941020	1	O
The	28941020	1	O
consistent	28941020	1	O
overlap	28941020	1	O
in	28941020	1	O
clinical	28941020	1	O
presentation	28941020	1	O
provides	28941020	1	O
further	28941020	1	O
evidence	28941020	1	O
of	28941020	1	O
the	28941020	1	O
critical	28941020	1	O
role	28941020	1	O
of	28941020	1	O
NFIA	28941020	1	O
haploinsufficiency	28941020	1	O
in	28941020	1	O
the	28941020	1	O
development	28941020	1	O
of	28941020	1	O
the	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
microdeletion	28941020	1	O
syndrome	28941020	1	O
phenotype	28941020	1	O
.	28941020	1	O

Clcn7F318L	28942122	1	O
/	28942122	1	O
as	28942122	1	O
a	28942122	1	O
new	28942122	1	O
mouse	28942122	1	O
model	28942122	1	O
of	28942122	1	O
Albers	28942122	1	O
-	28942122	1	O
Schönberg	28942122	1	O
disease	28942122	1	O
.	28942122	1	O
Dominant	28942122	1	O
negative	28942122	1	B-NegReg
mutations	28942122	1	B-Var
in	28942122	1	O
CLCN7	28942122	1	B-Gene
,	28942122	1	O
which	28942122	1	O
encodes	28942122	1	O
a	28942122	1	O
homodimeric	28942122	1	O
chloride	28942122	1	O
channel	28942122	1	O
needed	28942122	1	O
for	28942122	1	O
matrix	28942122	1	O
acidification	28942122	1	O
by	28942122	1	O
osteoclasts	28942122	1	O
,	28942122	1	O
cause	28942122	1	O
Albers	28942122	1	B-Disease
-	28942122	1	I-Disease
Schönberg	28942122	1	I-Disease
disease	28942122	1	I-Disease
(	28942122	1	O
also	28942122	1	O
known	28942122	1	O
as	28942122	1	O
autosomal	28942122	1	O
dominant	28942122	1	O
osteopetrosis	28942122	1	O
type	28942122	1	O
2	28942122	1	O
)	28942122	1	O
.	28942122	1	O
More	28942122	1	O
than	28942122	1	O
25	28942122	1	O
different	28942122	1	O
CLCN7	28942122	1	O
mutations	28942122	1	O
have	28942122	1	O
been	28942122	1	O
identified	28942122	1	O
in	28942122	1	O
patients	28942122	1	O
affected	28942122	1	O
with	28942122	1	O
Albers	28942122	1	O
-	28942122	1	O
Schönberg	28942122	1	O
disease	28942122	1	O
,	28942122	1	O
but	28942122	1	O
only	28942122	1	O
one	28942122	1	O
mutation	28942122	1	O
(	28942122	1	O
Clcn7G213R	28942122	1	O
)	28942122	1	O
has	28942122	1	O
been	28942122	1	O
introduced	28942122	1	O
in	28942122	1	O
mice	28942122	1	O
to	28942122	1	O
create	28942122	1	O
an	28942122	1	O
animal	28942122	1	O
model	28942122	1	O
of	28942122	1	O
this	28942122	1	O
disease	28942122	1	O
.	28942122	1	O
Here	28942122	1	O
we	28942122	1	O
describe	28942122	1	O
a	28942122	1	O
mouse	28942122	1	O
with	28942122	1	O
a	28942122	1	O
different	28942122	1	O
osteopetrosis	28942122	1	O
-	28942122	1	O
causing	28942122	1	O
mutation	28942122	1	O
(	28942122	1	O
Clcn7F318L	28942122	1	O
)	28942122	1	O
.	28942122	1	O
Compared	28942122	1	O
to	28942122	1	O
Clcn7	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
,	28942122	1	O
12	28942122	1	O
-	28942122	1	O
week	28942122	1	O
-	28942122	1	O
old	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
have	28942122	1	O
significantly	28942122	1	O
increased	28942122	1	B-PosReg
trabecular	28942122	1	B-CPA
bone	28942122	1	I-CPA
volume	28942122	1	I-CPA
,	28942122	1	O
consistent	28942122	1	O
with	28942122	1	O
Clcn7F318L	28942122	1	B-Var
acting	28942122	1	O
as	28942122	1	O
a	28942122	1	O
dominant	28942122	1	O
negative	28942122	1	B-NegReg
mutation	28942122	1	O
.	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
F318L	28942122	1	O
and	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
G213R	28942122	1	O
mice	28942122	1	O
die	28942122	1	O
by	28942122	1	O
1	28942122	1	O
month	28942122	1	O
of	28942122	1	O
age	28942122	1	O
and	28942122	1	O
resemble	28942122	1	O
Clcn7	28942122	1	O
knockout	28942122	1	O
mice	28942122	1	O
,	28942122	1	O
which	28942122	1	O
indicate	28942122	1	O
that	28942122	1	O
p.F318L	28942122	1	B-Var
mutant	28942122	1	O
protein	28942122	1	B-Protein
is	28942122	1	O
non	28942122	1	B-MPA
-	28942122	1	I-MPA
functional	28942122	1	I-MPA
and	28942122	1	O
p.F318L	28942122	1	O
and	28942122	1	O
p.G213R	28942122	1	O
mutant	28942122	1	O
proteins	28942122	1	O
do	28942122	1	O
not	28942122	1	O
complement	28942122	1	O
one	28942122	1	O
another	28942122	1	O
.	28942122	1	O
Since	28942122	1	O
it	28942122	1	O
has	28942122	1	O
been	28942122	1	O
reported	28942122	1	O
that	28942122	1	O
treatment	28942122	1	O
with	28942122	1	O
interferon	28942122	1	O
gamma	28942122	1	O
(	28942122	1	O
IFN	28942122	1	O
-	28942122	1	O
G	28942122	1	O
)	28942122	1	O
improves	28942122	1	O
bone	28942122	1	O
properties	28942122	1	O
in	28942122	1	O
Clcn7G213R	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
,	28942122	1	O
we	28942122	1	O
treated	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
with	28942122	1	O
IFN	28942122	1	O
-	28942122	1	O
G	28942122	1	O
and	28942122	1	O
observed	28942122	1	O
a	28942122	1	O
decrease	28942122	1	O
in	28942122	1	O
osteoclast	28942122	1	O
number	28942122	1	O
and	28942122	1	O
mineral	28942122	1	O
apposition	28942122	1	O
rate	28942122	1	O
,	28942122	1	O
but	28942122	1	O
no	28942122	1	O
overall	28942122	1	O
improvement	28942122	1	O
in	28942122	1	O
bone	28942122	1	O
properties	28942122	1	O
.	28942122	1	O
Our	28942122	1	O
results	28942122	1	O
suggest	28942122	1	O
that	28942122	1	O
the	28942122	1	O
benefits	28942122	1	O
of	28942122	1	O
IFN	28942122	1	O
-	28942122	1	O
G	28942122	1	O
therapy	28942122	1	O
in	28942122	1	O
patients	28942122	1	O
with	28942122	1	O
Albers	28942122	1	O
-	28942122	1	O
Schönberg	28942122	1	O
disease	28942122	1	O
may	28942122	1	O
be	28942122	1	O
mutation	28942122	1	O
-	28942122	1	O
specific	28942122	1	O
.	28942122	1	O

Highlighting	28967976	1	O
Interleukin-36	28967976	1	O
Signalling	28967976	1	O
in	28967976	1	O
Plaque	28967976	1	O
Psoriasis	28967976	1	O
and	28967976	1	O
Pustular	28967976	1	O
Psoriasis	28967976	1	O
.	28967976	1	O
Plaque	28967976	1	O
psoriasis	28967976	1	O
and	28967976	1	O
pustular	28967976	1	O
psoriasis	28967976	1	O
are	28967976	1	O
overlapping	28967976	1	O
,	28967976	1	O
but	28967976	1	O
distinct	28967976	1	O
,	28967976	1	O
disorders	28967976	1	O
.	28967976	1	O
The	28967976	1	O
therapeutic	28967976	1	O
response	28967976	1	O
to	28967976	1	O
biologics	28967976	1	O
supports	28967976	1	O
the	28967976	1	O
pivotal	28967976	1	O
role	28967976	1	O
of	28967976	1	O
the	28967976	1	O
tumour	28967976	1	O
necrosis	28967976	1	O
alpha	28967976	1	O
(	28967976	1	O
TNF	28967976	1	O
-	28967976	1	O
?	28967976	1	O
)	28967976	1	O
/	28967976	1	O
interleukin	28967976	1	O
(	28967976	1	O
IL	28967976	1	O
)	28967976	1	O
-	28967976	1	O
23	28967976	1	O
/	28967976	1	O
IL-17	28967976	1	O
/	28967976	1	O
IL-22	28967976	1	O
axis	28967976	1	O
in	28967976	1	O
the	28967976	1	O
pathogenesis	28967976	1	O
of	28967976	1	O
these	28967976	1	O
disorders	28967976	1	O
.	28967976	1	O
Recently	28967976	1	O
,	28967976	1	O
functional	28967976	1	O
activation	28967976	1	O
of	28967976	1	O
the	28967976	1	O
IL-36	28967976	1	O
receptor	28967976	1	O
(	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
)	28967976	1	O
was	28967976	1	O
discovered	28967976	1	O
to	28967976	1	O
be	28967976	1	O
another	28967976	1	O
driving	28967976	1	O
force	28967976	1	O
in	28967976	1	O
the	28967976	1	O
pathogenesis	28967976	1	O
of	28967976	1	O
psoriasis	28967976	1	O
.	28967976	1	O
This	28967976	1	O
was	28967976	1	O
first	28967976	1	O
highlighted	28967976	1	O
by	28967976	1	O
the	28967976	1	O
discovery	28967976	1	O
that	28967976	1	O
a	28967976	1	O
loss	28967976	1	B-NegReg
-	28967976	1	I-NegReg
of	28967976	1	I-NegReg
-	28967976	1	I-NegReg
function	28967976	1	I-NegReg
mutation	28967976	1	B-Var
of	28967976	1	O
the	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
antagonist	28967976	1	O
(	28967976	1	B-Gene
IL-36	28967976	1	I-Gene
Ra	28967976	1	I-Gene
)	28967976	1	I-Gene
causes	28967976	1	O
pustular	28967976	1	B-Disease
psoriasis	28967976	1	I-Disease
.	28967976	1	O
Although	28967976	1	O
the	28967976	1	O
TNF	28967976	1	O
-	28967976	1	O
?	28967976	1	O
/	28967976	1	O
IL-23	28967976	1	O
/	28967976	1	O
IL-17	28967976	1	O
/	28967976	1	O
IL-22	28967976	1	O
axis	28967976	1	O
and	28967976	1	O
the	28967976	1	O
functional	28967976	1	O
activation	28967976	1	O
of	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
are	28967976	1	O
fundamentally	28967976	1	O
involved	28967976	1	O
in	28967976	1	O
plaque	28967976	1	O
psoriasis	28967976	1	O
and	28967976	1	O
pustular	28967976	1	O
psoriasis	28967976	1	O
,	28967976	1	O
respectively	28967976	1	O
,	28967976	1	O
the	28967976	1	O
2	28967976	1	O
pathways	28967976	1	O
are	28967976	1	O
closely	28967976	1	O
related	28967976	1	O
and	28967976	1	O
mutually	28967976	1	O
reinforced	28967976	1	O
,	28967976	1	O
resulting	28967976	1	O
in	28967976	1	O
full	28967976	1	O
-	28967976	1	O
blown	28967976	1	O
clinical	28967976	1	O
manifestations	28967976	1	O
.	28967976	1	O
This	28967976	1	O
review	28967976	1	O
summarizes	28967976	1	O
current	28967976	1	O
topics	28967976	1	O
on	28967976	1	O
how	28967976	1	O
IL-36	28967976	1	O
agonists	28967976	1	O
(	28967976	1	O
IL-36	28967976	1	O
?	28967976	1	O
,	28967976	1	O
IL-36	28967976	1	O
?	28967976	1	O
,	28967976	1	O
IL-36	28967976	1	O
?	28967976	1	O
)	28967976	1	O
signal	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
,	28967976	1	O
the	28967976	1	O
pathological	28967976	1	O
expression	28967976	1	O
of	28967976	1	O
IL-36	28967976	1	O
agonists	28967976	1	O
and	28967976	1	O
IL-36	28967976	1	O
Ra	28967976	1	O
in	28967976	1	O
plaque	28967976	1	O
and	28967976	1	O
pustular	28967976	1	O
psoriatic	28967976	1	O
lesions	28967976	1	O
,	28967976	1	O
and	28967976	1	O
the	28967976	1	O
cross	28967976	1	O
-	28967976	1	O
talk	28967976	1	O
between	28967976	1	O
the	28967976	1	O
TNF	28967976	1	O
-	28967976	1	O
?	28967976	1	O
/	28967976	1	O
IL-23	28967976	1	O
/	28967976	1	O
IL-17	28967976	1	O
/	28967976	1	O
IL-22	28967976	1	O
axis	28967976	1	O
and	28967976	1	O
the	28967976	1	O
functional	28967976	1	O
activation	28967976	1	O
of	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
in	28967976	1	O
the	28967976	1	O
epidermal	28967976	1	O
milieu	28967976	1	O
.	28967976	1	O

CCR5Δ32	28969941	0	O
(	28969941	0	O
rs333	28969941	0	O
)	28969941	0	O
polymorphism	28969941	0	O
is	28969941	0	O
associated	28969941	0	O
with	28969941	0	O
decreased	28969941	0	O
risk	28969941	0	O
of	28969941	0	O
chronic	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
periodontitis	28969941	0	O
:	28969941	0	O
A	28969941	0	O
case	28969941	0	O
-	28969941	0	O
control	28969941	0	O
analysis	28969941	0	O
based	28969941	0	O
in	28969941	0	O
disease	28969941	0	O
resistance	28969941	0	O
and	28969941	0	O
susceptibility	28969941	0	O
phenotypes	28969941	0	O
.	28969941	0	O
Chronic	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
periodontitis	28969941	0	O
are	28969941	0	O
infectious	28969941	0	O
diseases	28969941	0	O
characterized	28969941	0	O
by	28969941	0	O
the	28969941	0	O
irreversible	28969941	0	O
destruction	28969941	0	O
of	28969941	0	O
periodontal	28969941	0	O
tissues	28969941	0	O
,	28969941	0	O
which	28969941	0	O
is	28969941	0	O
mediated	28969941	0	O
by	28969941	0	O
the	28969941	0	O
host	28969941	0	O
inflammatory	28969941	0	O
immune	28969941	0	O
response	28969941	0	O
triggered	28969941	0	O
by	28969941	0	O
periodontal	28969941	0	O
infection	28969941	0	O
.	28969941	0	O
The	28969941	0	O
chemokine	28969941	0	O
receptor	28969941	0	O
CCR5	28969941	0	O
play	28969941	0	O
an	28969941	0	O
important	28969941	0	O
role	28969941	0	O
in	28969941	0	O
disease	28969941	0	O
pathogenesis	28969941	0	O
,	28969941	0	O
contributing	28969941	0	O
to	28969941	0	O
pro	28969941	0	O
-	28969941	0	O
inflammatory	28969941	0	O
response	28969941	0	O
and	28969941	0	O
osteoclastogenesis	28969941	0	O
.	28969941	0	O
CCR5Δ32	28969941	0	O
(	28969941	0	B-Var
rs333	28969941	0	I-Var
)	28969941	0	I-Var
is	28969941	0	O
a	28969941	0	O
loss	28969941	0	B-NegReg
-	28969941	0	I-NegReg
of	28969941	0	I-NegReg
-	28969941	0	I-NegReg
function	28969941	0	I-NegReg
mutation	28969941	0	O
in	28969941	0	O
the	28969941	0	O
CCR5	28969941	0	B-Gene
gene	28969941	0	O
,	28969941	0	O
which	28969941	0	O
can	28969941	0	O
potentially	28969941	0	O
modulate	28969941	0	B-Reg
the	28969941	0	O
host	28969941	0	B-CPA
response	28969941	0	I-CPA
and	28969941	0	O
,	28969941	0	O
consequently	28969941	0	O
periodontitis	28969941	0	O
outcome	28969941	0	O
.	28969941	0	O
Thus	28969941	0	O
,	28969941	0	O
we	28969941	0	O
investigated	28969941	0	O
the	28969941	0	O
effect	28969941	0	O
of	28969941	0	O
the	28969941	0	O
CCR5Δ32	28969941	0	O
mutation	28969941	0	O
over	28969941	0	O
the	28969941	0	O
risk	28969941	0	O
to	28969941	0	O
suffer	28969941	0	O
periodontitis	28969941	0	O
in	28969941	0	O
a	28969941	0	O
cohort	28969941	0	O
of	28969941	0	O
Brazilian	28969941	0	O
patients	28969941	0	O
(	28969941	0	O
total	28969941	0	O
N	28969941	0	O
=	28969941	0	O
699	28969941	0	O
)	28969941	0	O
,	28969941	0	O
representative	28969941	0	O
of	28969941	0	O
disease	28969941	0	O
susceptibility	28969941	0	O
(	28969941	0	O
chronic	28969941	0	O
periodontitis	28969941	0	O
,	28969941	0	O
N	28969941	0	O
=	28969941	0	O
197	28969941	0	O
;	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
periodontitis	28969941	0	O
,	28969941	0	O
N	28969941	0	O
=	28969941	0	O
91	28969941	0	O
)	28969941	0	O
or	28969941	0	O
resistance	28969941	0	O
(	28969941	0	O
chronic	28969941	0	O
gingivitis	28969941	0	O
,	28969941	0	O
N	28969941	0	O
=	28969941	0	O
193	28969941	0	O
)	28969941	0	O
phenotypes	28969941	0	O
,	28969941	0	O
and	28969941	0	O
healthy	28969941	0	O
subjects	28969941	0	O
(	28969941	0	O
N	28969941	0	O
=	28969941	0	O
218	28969941	0	O
)	28969941	0	O
.	28969941	0	O
Additionally	28969941	0	O
,	28969941	0	O
we	28969941	0	O
assayed	28969941	0	O
the	28969941	0	O
influence	28969941	0	O
of	28969941	0	O
CCR5Δ32	28969941	0	O
in	28969941	0	O
the	28969941	0	O
expression	28969941	0	O
of	28969941	0	O
the	28969941	0	O
biomarkers	28969941	0	O
TNFα	28969941	0	O
,	28969941	0	O
IL-1	28969941	0	O
β	28969941	0	O
,	28969941	0	O
IL-10	28969941	0	O
,	28969941	0	O
IL-6	28969941	0	O
,	28969941	0	O
IFN	28969941	0	O
-	28969941	0	O
γ	28969941	0	O
and	28969941	0	O
T	28969941	0	O
-	28969941	0	O
bet	28969941	0	O
,	28969941	0	O
and	28969941	0	O
key	28969941	0	O
periodontal	28969941	0	O
pathogens	28969941	0	O
P.	28969941	0	O
gingivalis	28969941	0	O
,	28969941	0	O
T.	28969941	0	O
forsythia	28969941	0	O
,	28969941	0	O
and	28969941	0	O
T.	28969941	0	O
denticola	28969941	0	O
.	28969941	0	O
In	28969941	0	O
the	28969941	0	O
association	28969941	0	O
analysis	28969941	0	O
of	28969941	0	O
resistant	28969941	0	O
versus	28969941	0	O
susceptible	28969941	0	O
subjects	28969941	0	O
,	28969941	0	O
CCR5Δ32	28969941	0	O
mutant	28969941	0	O
allele	28969941	0	O
-	28969941	0	O
carriers	28969941	0	O
proved	28969941	0	O
significantly	28969941	0	O
protected	28969941	0	O
against	28969941	0	O
chronic	28969941	0	O
(	28969941	0	O
OR	28969941	0	O
0.49	28969941	0	O
;	28969941	0	O
95%	28969941	0	O
CI	28969941	0	O
0.29	28969941	0	O
-	28969941	0	O
0.83	28969941	0	O
;	28969941	0	O
p	28969941	0	O
-	28969941	0	O
value	28969941	0	O
0.01	28969941	0	O
)	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
(	28969941	0	O
OR	28969941	0	O
0.46	28969941	0	O
;	28969941	0	O
95%	28969941	0	O
CI	28969941	0	O
0.22	28969941	0	O
-	28969941	0	O
0.94	28969941	0	O
;	28969941	0	O
p	28969941	0	O
-	28969941	0	O
value	28969941	0	O
0.03	28969941	0	O
)	28969941	0	O
periodontitis	28969941	0	O
.	28969941	0	O
Further	28969941	0	O
,	28969941	0	O
heterozygous	28969941	0	O
subjects	28969941	0	O
exhibited	28969941	0	O
significantly	28969941	0	O
decreased	28969941	0	B-NegReg
expression	28969941	0	B-MPA
of	28969941	0	O
TNFα	28969941	0	B-Protein
in	28969941	0	O
periodontal	28969941	0	O
tissues	28969941	0	O
,	28969941	0	O
pointing	28969941	0	O
to	28969941	0	O
a	28969941	0	O
functional	28969941	0	O
effect	28969941	0	O
of	28969941	0	O
the	28969941	0	O
mutation	28969941	0	B-Var
in	28969941	0	O
periodontal	28969941	0	O
tissues	28969941	0	O
during	28969941	0	O
the	28969941	0	O
progression	28969941	0	O
of	28969941	0	O
the	28969941	0	O
disease	28969941	0	O
.	28969941	0	O
Conversely	28969941	0	O
,	28969941	0	O
no	28969941	0	O
significant	28969941	0	O
changes	28969941	0	O
were	28969941	0	O
observed	28969941	0	O
in	28969941	0	O
the	28969941	0	O
presence	28969941	0	O
or	28969941	0	O
quantity	28969941	0	O
of	28969941	0	O
the	28969941	0	O
periodontal	28969941	0	O
pathogens	28969941	0	O
P.	28969941	0	O
gingivalis	28969941	0	O
,	28969941	0	O
T.	28969941	0	O
forsythia	28969941	0	O
,	28969941	0	O
and	28969941	0	O
T.	28969941	0	O
denticola	28969941	0	O
in	28969941	0	O
the	28969941	0	O
subgingival	28969941	0	O
biofilm	28969941	0	O
that	28969941	0	O
could	28969941	0	O
be	28969941	0	O
attributable	28969941	0	O
to	28969941	0	O
the	28969941	0	O
mutant	28969941	0	O
genotype	28969941	0	O
.	28969941	0	O

Tacrolimus	28973643	1	O
rescues	28973643	1	O
the	28973643	1	O
signaling	28973643	1	O
and	28973643	1	O
gene	28973643	1	O
expression	28973643	1	O
signature	28973643	1	O
of	28973643	1	O
endothelial	28973643	1	O
ALK1	28973643	1	O
loss	28973643	1	O
-	28973643	1	O
of	28973643	1	O
-	28973643	1	O
function	28973643	1	O
and	28973643	1	O
improves	28973643	1	O
HHT	28973643	1	O
vascular	28973643	1	O
pathology	28973643	1	O
.	28973643	1	O
Hereditary	28973643	1	B-Disease
hemorrhagic	28973643	1	I-Disease
telangiectasia	28973643	1	I-Disease
(	28973643	1	O
HHT	28973643	1	O
)	28973643	1	O
is	28973643	1	O
a	28973643	1	O
highly	28973643	1	O
debilitating	28973643	1	O
and	28973643	1	O
life	28973643	1	O
-	28973643	1	O
threatening	28973643	1	O
genetic	28973643	1	O
vascular	28973643	1	O
disorder	28973643	1	O
arising	28973643	1	O
from	28973643	1	O
endothelial	28973643	1	O
cell	28973643	1	O
(	28973643	1	O
EC	28973643	1	O
)	28973643	1	O
proliferation	28973643	1	O
and	28973643	1	O
hypervascularization	28973643	1	O
,	28973643	1	O
for	28973643	1	O
which	28973643	1	O
no	28973643	1	O
cure	28973643	1	O
exists	28973643	1	O
.	28973643	1	O
Because	28973643	1	O
HHT	28973643	1	B-Disease
is	28973643	1	O
caused	28973643	1	O
by	28973643	1	O
loss	28973643	1	B-NegReg
-	28973643	1	I-NegReg
of	28973643	1	I-NegReg
-	28973643	1	I-NegReg
function	28973643	1	I-NegReg
mutations	28973643	1	B-Var
in	28973643	1	O
bone	28973643	1	O
morphogenetic	28973643	1	O
protein	28973643	1	O
9	28973643	1	O
(	28973643	1	B-MPA
BMP9	28973643	1	I-MPA
)	28973643	1	I-MPA
-	28973643	1	I-MPA
ALK1	28973643	1	I-MPA
-	28973643	1	I-MPA
Smad1	28973643	1	I-MPA
/	28973643	1	I-MPA
5	28973643	1	I-MPA
/	28973643	1	I-MPA
8	28973643	1	I-MPA
signaling	28973643	1	I-MPA
,	28973643	1	O
interventions	28973643	1	O
aimed	28973643	1	O
at	28973643	1	O
activating	28973643	1	O
this	28973643	1	O
pathway	28973643	1	O
are	28973643	1	O
of	28973643	1	O
therapeutic	28973643	1	O
value	28973643	1	O
.	28973643	1	O
We	28973643	1	O
interrogated	28973643	1	O
the	28973643	1	O
whole	28973643	1	O
-	28973643	1	O
transcriptome	28973643	1	O
in	28973643	1	O
human	28973643	1	O
umbilical	28973643	1	O
vein	28973643	1	O
ECs	28973643	1	O
(	28973643	1	O
HUVECs	28973643	1	O
)	28973643	1	O
and	28973643	1	O
found	28973643	1	O
that	28973643	1	O
ALK1	28973643	1	O
signaling	28973643	1	O
inhibition	28973643	1	O
was	28973643	1	O
associated	28973643	1	O
with	28973643	1	O
a	28973643	1	O
specific	28973643	1	O
pro	28973643	1	O
-	28973643	1	O
angiogenic	28973643	1	O
gene	28973643	1	O
expression	28973643	1	O
signature	28973643	1	O
,	28973643	1	O
which	28973643	1	O
included	28973643	1	O
a	28973643	1	O
significant	28973643	1	O
elevation	28973643	1	O
of	28973643	1	O
DLL4	28973643	1	O
expression	28973643	1	O
.	28973643	1	O
By	28973643	1	O
screening	28973643	1	O
the	28973643	1	O
NIH	28973643	1	O
clinical	28973643	1	O
collections	28973643	1	O
of	28973643	1	O
FDA	28973643	1	O
-	28973643	1	O
approved	28973643	1	O
drugs	28973643	1	O
,	28973643	1	O
we	28973643	1	O
identified	28973643	1	O
tacrolimus	28973643	1	O
(	28973643	1	O
FK-506	28973643	1	O
)	28973643	1	O
as	28973643	1	O
the	28973643	1	O
most	28973643	1	O
potent	28973643	1	O
activator	28973643	1	O
of	28973643	1	O
ALK1	28973643	1	O
signaling	28973643	1	O
in	28973643	1	O
BMP9	28973643	1	O
-	28973643	1	O
challenged	28973643	1	O
C2C12	28973643	1	O
reporter	28973643	1	O
cells	28973643	1	O
.	28973643	1	O
In	28973643	1	O
HUVECs	28973643	1	O
,	28973643	1	O
tacrolimus	28973643	1	O
activated	28973643	1	O
Smad1	28973643	1	O
/	28973643	1	O
5	28973643	1	O
/	28973643	1	O
8	28973643	1	O
and	28973643	1	O
opposed	28973643	1	O
the	28973643	1	O
pro	28973643	1	O
-	28973643	1	O
angiogenic	28973643	1	O
gene	28973643	1	O
expression	28973643	1	O
signature	28973643	1	O
associated	28973643	1	O
with	28973643	1	O
ALK1	28973643	1	O
loss	28973643	1	O
-	28973643	1	O
of	28973643	1	O
-	28973643	1	O
function	28973643	1	O
,	28973643	1	O
by	28973643	1	O
notably	28973643	1	O
reducing	28973643	1	O
Dll4	28973643	1	O
expression	28973643	1	O
.	28973643	1	O
In	28973643	1	O
these	28973643	1	O
cells	28973643	1	O
,	28973643	1	O
tacrolimus	28973643	1	O
also	28973643	1	O
inhibited	28973643	1	O
Akt	28973643	1	O
and	28973643	1	O
p38	28973643	1	O
stimulation	28973643	1	O
by	28973643	1	O
vascular	28973643	1	O
endothelial	28973643	1	O
growth	28973643	1	O
factor	28973643	1	O
,	28973643	1	O
a	28973643	1	O
major	28973643	1	O
driver	28973643	1	O
of	28973643	1	O
angiogenesis	28973643	1	O
.	28973643	1	O
In	28973643	1	O
the	28973643	1	O
BMP9	28973643	1	O
/	28973643	1	O
10	28973643	1	O
-	28973643	1	O
immunodepleted	28973643	1	O
postnatal	28973643	1	O
retina	28973643	1	O
-	28973643	1	O
a	28973643	1	O
mouse	28973643	1	O
model	28973643	1	O
of	28973643	1	O
HHT	28973643	1	O
vascular	28973643	1	O
pathology	28973643	1	O
-	28973643	1	O
tacrolimus	28973643	1	O
activated	28973643	1	O
endothelial	28973643	1	O
Smad1	28973643	1	O
/	28973643	1	O
5	28973643	1	O
/	28973643	1	O
8	28973643	1	O
and	28973643	1	O
prevented	28973643	1	O
the	28973643	1	O
Dll4	28973643	1	O
overexpression	28973643	1	O
and	28973643	1	O
hypervascularization	28973643	1	O
associated	28973643	1	O
with	28973643	1	O
this	28973643	1	O
model	28973643	1	O
.	28973643	1	O
Finally	28973643	1	O
,	28973643	1	O
tacrolimus	28973643	1	O
stimulated	28973643	1	O
Smad1	28973643	1	O
/	28973643	1	O
5	28973643	1	O
/	28973643	1	O
8	28973643	1	O
signaling	28973643	1	O
in	28973643	1	O
C2C12	28973643	1	O
cells	28973643	1	O
expressing	28973643	1	O
BMP9	28973643	1	O
-	28973643	1	O
unresponsive	28973643	1	O
ALK1	28973643	1	O
HHT	28973643	1	O
mutants	28973643	1	O
and	28973643	1	O
in	28973643	1	O
HHT	28973643	1	O
patient	28973643	1	O
blood	28973643	1	O
outgrowth	28973643	1	O
ECs	28973643	1	O
.	28973643	1	O
Tacrolimus	28973643	1	O
repurposing	28973643	1	O
has	28973643	1	O
therefore	28973643	1	O
therapeutic	28973643	1	O
potential	28973643	1	O
in	28973643	1	O
HHT	28973643	1	O
.	28973643	1	O

Zebrafish	28985365	1	O
cdc6	28985365	1	O
hypomorphic	28985365	1	O
mutation	28985365	1	O
causes	28985365	1	O
Meier	28985365	1	O
-	28985365	1	O
Gorlin	28985365	1	O
syndrome	28985365	1	O
-	28985365	1	O
like	28985365	1	O
phenotype	28985365	1	O
.	28985365	1	O
Cell	28985365	1	O
Division	28985365	1	O
Cycle	28985365	1	O
6	28985365	1	O
(	28985365	1	O
Cdc6	28985365	1	O
)	28985365	1	O
is	28985365	1	O
a	28985365	1	O
component	28985365	1	O
of	28985365	1	O
pre	28985365	1	O
-	28985365	1	O
replicative	28985365	1	O
complex	28985365	1	O
(	28985365	1	O
preRC	28985365	1	O
)	28985365	1	O
forming	28985365	1	O
on	28985365	1	O
DNA	28985365	1	O
replication	28985365	1	O
origins	28985365	1	O
in	28985365	1	O
eukaryotes	28985365	1	O
.	28985365	1	O
Recessive	28985365	1	O
mutations	28985365	1	B-Var
in	28985365	1	O
ORC1	28985365	1	B-Gene
,	28985365	1	O
ORC4	28985365	1	B-Gene
,	28985365	1	O
ORC6	28985365	1	B-Gene
,	28985365	1	O
CDT1	28985365	1	B-Gene
or	28985365	1	O
CDC6	28985365	1	B-Gene
of	28985365	1	O
the	28985365	1	O
preRC	28985365	1	O
in	28985365	1	O
human	28985365	1	O
cause	28985365	1	B-Reg
Meier	28985365	1	B-Disease
-	28985365	1	I-Disease
Gorlin	28985365	1	I-Disease
syndrome	28985365	1	I-Disease
(	28985365	1	O
MGS	28985365	1	O
)	28985365	1	O
that	28985365	1	O
is	28985365	1	O
characterized	28985365	1	O
by	28985365	1	O
impaired	28985365	1	O
post	28985365	1	O
-	28985365	1	O
natal	28985365	1	O
growth	28985365	1	O
,	28985365	1	O
short	28985365	1	O
stature	28985365	1	O
and	28985365	1	O
microcephaly	28985365	1	O
.	28985365	1	O
However	28985365	1	O
,	28985365	1	O
vertebrate	28985365	1	O
models	28985365	1	O
of	28985365	1	O
MGS	28985365	1	O
have	28985365	1	O
not	28985365	1	O
been	28985365	1	O
reported	28985365	1	O
.	28985365	1	O
Through	28985365	1	O
N	28985365	1	O
-	28985365	1	O
ethyl	28985365	1	O
-	28985365	1	O
N	28985365	1	O
-	28985365	1	O
nitrosourea	28985365	1	O
mutagenesis	28985365	1	O
and	28985365	1	O
Cas9	28985365	1	O
knockout	28985365	1	O
,	28985365	1	O
we	28985365	1	O
generate	28985365	1	O
several	28985365	1	O
cdc6	28985365	1	O
mutant	28985365	1	O
lines	28985365	1	O
in	28985365	1	O
zebrafish	28985365	1	O
.	28985365	1	O
Loss	28985365	1	B-NegReg
-	28985365	1	I-NegReg
of	28985365	1	I-NegReg
-	28985365	1	I-NegReg
function	28985365	1	I-NegReg
mutations	28985365	1	B-Var
of	28985365	1	O
cdc6	28985365	1	B-Gene
,	28985365	1	O
as	28985365	1	O
manifested	28985365	1	O
by	28985365	1	O
cdc6tsu4305	28985365	1	O
and	28985365	1	O
cdc6tsu7cd	28985365	1	O
mutants	28985365	1	O
,	28985365	1	O
lead	28985365	1	O
to	28985365	1	O
embryonic	28985365	1	B-CPA
lethality	28985365	1	I-CPA
due	28985365	1	O
to	28985365	1	O
cell	28985365	1	B-CPA
cycle	28985365	1	I-CPA
arrest	28985365	1	I-CPA
at	28985365	1	I-CPA
the	28985365	1	I-CPA
S	28985365	1	I-CPA
phase	28985365	1	I-CPA
and	28985365	1	O
extensive	28985365	1	O
apoptosis	28985365	1	B-CPA
.	28985365	1	O
Embryos	28985365	1	O
homozygous	28985365	1	O
for	28985365	1	O
a	28985365	1	O
cdc6	28985365	1	O
hypomorphic	28985365	1	O
mutation	28985365	1	O
,	28985365	1	O
cdc6tsu21cd	28985365	1	O
,	28985365	1	O
develop	28985365	1	O
normally	28985365	1	O
during	28985365	1	O
embryogenesis	28985365	1	O
.	28985365	1	O
Later	28985365	1	O
on	28985365	1	O
,	28985365	1	O
compared	28985365	1	O
with	28985365	1	O
their	28985365	1	O
wild	28985365	1	O
-	28985365	1	O
type	28985365	1	O
(	28985365	1	O
WT	28985365	1	O
)	28985365	1	O
siblings	28985365	1	O
,	28985365	1	O
cdc6tsu21cd	28985365	1	B-Var
mutant	28985365	1	I-Var
fish	28985365	1	O
show	28985365	1	O
growth	28985365	1	O
retardation	28985365	1	O
,	28985365	1	O
and	28985365	1	O
their	28985365	1	O
body	28985365	1	B-CPA
weight	28985365	1	I-CPA
and	28985365	1	I-CPA
length	28985365	1	I-CPA
in	28985365	1	O
adulthood	28985365	1	O
are	28985365	1	O
greatly	28985365	1	O
reduced	28985365	1	B-NegReg
,	28985365	1	O
which	28985365	1	O
resemble	28985365	1	O
human	28985365	1	O
MGS	28985365	1	O
.	28985365	1	O
Surprisingly	28985365	1	O
,	28985365	1	O
cdc6tsu21cd	28985365	1	B-Var
mutant	28985365	1	I-Var
fish	28985365	1	O
become	28985365	1	O
males	28985365	1	O
with	28985365	1	O
a	28985365	1	O
short	28985365	1	O
life	28985365	1	O
and	28985365	1	O
fail	28985365	1	O
to	28985365	1	O
mate	28985365	1	O
with	28985365	1	O
WT	28985365	1	O
females	28985365	1	O
,	28985365	1	O
suggesting	28985365	1	O
defective	28985365	1	B-NegReg
reproduction	28985365	1	B-CPA
.	28985365	1	O
Overexpression	28985365	1	O
of	28985365	1	O
Cdc6	28985365	1	O
mutant	28985365	1	O
forms	28985365	1	O
,	28985365	1	O
which	28985365	1	O
mimic	28985365	1	O
human	28985365	1	O
CDC6	28985365	1	B-Gene
(	28985365	1	I-Gene
T323R	28985365	1	I-Gene
)	28985365	1	I-Gene
mutation	28985365	1	B-Var
found	28985365	1	O
in	28985365	1	O
a	28985365	1	O
MGS	28985365	1	O
patient	28985365	1	O
,	28985365	1	O
in	28985365	1	O
zebrafish	28985365	1	O
cdc6tsu4305	28985365	1	O
mutant	28985365	1	O
embryos	28985365	1	O
partially	28985365	1	O
represses	28985365	1	B-NegReg
cell	28985365	1	B-CPA
death	28985365	1	I-CPA
phenotype	28985365	1	I-CPA
,	28985365	1	O
suggesting	28985365	1	O
that	28985365	1	O
the	28985365	1	O
human	28985365	1	O
CDC6	28985365	1	O
(	28985365	1	O
T323R	28985365	1	O
)	28985365	1	O
mutation	28985365	1	O
is	28985365	1	O
a	28985365	1	O
hypomorph	28985365	1	O
.	28985365	1	O
cdc6tsu21cd	28985365	1	O
mutant	28985365	1	O
fish	28985365	1	O
will	28985365	1	O
be	28985365	1	O
useful	28985365	1	O
to	28985365	1	O
detect	28985365	1	O
more	28985365	1	O
tissue	28985365	1	O
defects	28985365	1	O
and	28985365	1	O
develop	28985365	1	O
medical	28985365	1	O
treatment	28985365	1	O
strategies	28985365	1	O
for	28985365	1	O
MGS	28985365	1	O
patients	28985365	1	O
.	28985365	1	O

Three	28987752	2	O
Cases	28987752	2	O
of	28987752	2	O
KCNT1	28987752	2	O
Mutations	28987752	2	O
:	28987752	2	O
Malignant	28987752	2	O
Migrating	28987752	2	O
Partial	28987752	2	O
Seizures	28987752	2	O
in	28987752	2	O
Infancy	28987752	2	O
with	28987752	2	O
Massive	28987752	2	O
Systemic	28987752	2	O
to	28987752	2	O
Pulmonary	28987752	2	O
Collateral	28987752	2	O
Arteries	28987752	2	O
.	28987752	2	O
KCNT1	28987752	2	B-Gene
mutations	28987752	2	B-Var
are	28987752	2	O
gain	28987752	2	B-PosReg
-	28987752	2	I-PosReg
of	28987752	2	I-PosReg
-	28987752	2	I-PosReg
function	28987752	2	I-PosReg
mutations	28987752	2	O
in	28987752	2	O
potassium	28987752	2	O
channels	28987752	2	O
resulting	28987752	2	O
in	28987752	2	O
severe	28987752	2	O
infantile	28987752	2	B-Disease
epilepsy	28987752	2	I-Disease
.	28987752	2	O
Herein	28987752	2	O
we	28987752	2	O
describe	28987752	2	O
3	28987752	2	O
infants	28987752	2	O
with	28987752	2	O
malignant	28987752	2	O
migrating	28987752	2	O
partial	28987752	2	O
seizures	28987752	2	O
with	28987752	2	O
KCNT1	28987752	2	O
mutations	28987752	2	O
accompanied	28987752	2	O
by	28987752	2	O
massive	28987752	2	O
systemic	28987752	2	O
to	28987752	2	O
pulmonary	28987752	2	O
collateral	28987752	2	O
arteries	28987752	2	O
with	28987752	2	O
life	28987752	2	O
-	28987752	2	O
threatening	28987752	2	O
hemoptysis	28987752	2	O
and	28987752	2	O
heart	28987752	2	O
failure	28987752	2	O
.	28987752	2	O

Homozygous	28988429	1	B-Var
indel	28988429	1	I-Var
mutation	28988429	1	I-Var
in	28988429	1	O
CDH11	28988429	1	B-Gene
as	28988429	1	O
the	28988429	1	O
probable	28988429	1	O
cause	28988429	1	B-Reg
of	28988429	1	O
Elsahy	28988429	1	B-Disease
-	28988429	1	I-Disease
Waters	28988429	1	I-Disease
syndrome	28988429	1	I-Disease
.	28988429	1	O
Two	28988429	1	O
sisters	28988429	1	O
from	28988429	1	O
a	28988429	1	O
consanguineous	28988429	1	O
couple	28988429	1	O
were	28988429	1	O
seen	28988429	1	O
in	28988429	1	O
genetics	28988429	1	O
department	28988429	1	O
for	28988429	1	O
facial	28988429	1	O
dysmorphic	28988429	1	O
features	28988429	1	O
and	28988429	1	O
glaucoma	28988429	1	O
.	28988429	1	O
They	28988429	1	O
both	28988429	1	O
had	28988429	1	O
broad	28988429	1	O
foreheads	28988429	1	O
,	28988429	1	O
hypertelorism	28988429	1	O
,	28988429	1	O
megalocorneas	28988429	1	O
,	28988429	1	O
thick	28988429	1	O
eyebrows	28988429	1	O
with	28988429	1	O
synophrys	28988429	1	O
,	28988429	1	O
flat	28988429	1	O
malar	28988429	1	O
regions	28988429	1	O
,	28988429	1	O
broad	28988429	1	O
and	28988429	1	O
bulbous	28988429	1	O
noses	28988429	1	O
,	28988429	1	O
and	28988429	1	O
mild	28988429	1	O
prognathism	28988429	1	O
.	28988429	1	O
Both	28988429	1	O
had	28988429	1	O
glaucoma	28988429	1	O
,	28988429	1	O
younger	28988429	1	O
one	28988429	1	O
also	28988429	1	O
had	28988429	1	O
cataracts	28988429	1	O
and	28988429	1	O
phthisis	28988429	1	O
bulbi	28988429	1	O
.	28988429	1	O
Other	28988429	1	O
findings	28988429	1	O
included	28988429	1	O
bilateral	28988429	1	O
partial	28988429	1	O
cutaneous	28988429	1	O
syndactyly	28988429	1	O
of	28988429	1	O
2	28988429	1	O
nd	28988429	1	O
and	28988429	1	O
3	28988429	1	O
rd	28988429	1	O
fingers	28988429	1	O
,	28988429	1	O
history	28988429	1	O
of	28988429	1	O
impacted	28988429	1	O
teeth	28988429	1	O
with	28988429	1	O
dentigerous	28988429	1	O
cyst	28988429	1	O
in	28988429	1	O
the	28988429	1	O
elder	28988429	1	O
one	28988429	1	O
,	28988429	1	O
and	28988429	1	O
intellectual	28988429	1	O
disability	28988429	1	O
(	28988429	1	O
mild	28988429	1	O
and	28988429	1	O
borderline	28988429	1	O
)	28988429	1	O
.	28988429	1	O
The	28988429	1	O
sisters	28988429	1	O
were	28988429	1	O
considered	28988429	1	O
to	28988429	1	O
have	28988429	1	O
Elsahy	28988429	1	O
-	28988429	1	O
Waters	28988429	1	O
syndrome	28988429	1	O
.	28988429	1	O
In	28988429	1	O
order	28988429	1	O
to	28988429	1	O
elucidate	28988429	1	O
the	28988429	1	O
underlying	28988429	1	O
molecular	28988429	1	O
cause	28988429	1	O
,	28988429	1	O
sisters	28988429	1	O
and	28988429	1	O
their	28988429	1	O
healthy	28988429	1	O
parents	28988429	1	O
were	28988429	1	O
genotyped	28988429	1	O
by	28988429	1	O
SNP	28988429	1	O
arrays	28988429	1	O
,	28988429	1	O
followed	28988429	1	O
by	28988429	1	O
homozygosity	28988429	1	O
mapping	28988429	1	O
.	28988429	1	O
Homozygous	28988429	1	O
regions	28988429	1	O
were	28988429	1	O
further	28988429	1	O
analyzed	28988429	1	O
by	28988429	1	O
exome	28988429	1	O
sequencing	28988429	1	O
in	28988429	1	O
one	28988429	1	O
affected	28988429	1	O
individual	28988429	1	O
.	28988429	1	O
A	28988429	1	O
homozygous	28988429	1	O
indel	28988429	1	O
variant	28988429	1	O
segregating	28988429	1	O
with	28988429	1	O
the	28988429	1	O
condition	28988429	1	O
was	28988429	1	O
detected	28988429	1	O
in	28988429	1	O
CDH11	28988429	1	O
(	28988429	1	O
c.1116_1117delinsGATCATCAG	28988429	1	O
,	28988429	1	O
p	28988429	1	O
.	28988429	1	O
(	28988429	1	O
Ile372MetfsTer9	28988429	1	O
)	28988429	1	O
)	28988429	1	O
,	28988429	1	O
which	28988429	1	O
was	28988429	1	O
then	28988429	1	O
validated	28988429	1	O
by	28988429	1	O
using	28988429	1	O
Sanger	28988429	1	O
sequencing	28988429	1	O
.	28988429	1	O
CDH11	28988429	1	O
encodes	28988429	1	O
cadherin	28988429	1	O
11	28988429	1	O
(	28988429	1	O
osteo	28988429	1	O
-	28988429	1	O
cadherin	28988429	1	O
)	28988429	1	O
that	28988429	1	O
regulates	28988429	1	O
cell	28988429	1	O
-	28988429	1	O
cell	28988429	1	O
adhesion	28988429	1	O
,	28988429	1	O
cell	28988429	1	O
polarization	28988429	1	O
and	28988429	1	O
migration	28988429	1	O
,	28988429	1	O
as	28988429	1	O
well	28988429	1	O
as	28988429	1	O
osteogenic	28988429	1	O
differentiation	28988429	1	O
.	28988429	1	O
Further	28988429	1	O
experiments	28988429	1	O
revealed	28988429	1	O
that	28988429	1	O
CDH11	28988429	1	O
expression	28988429	1	O
was	28988429	1	O
decreased	28988429	1	O
in	28988429	1	O
patient	28988429	1	O
-	28988429	1	O
derived	28988429	1	O
fibroblasts	28988429	1	O
as	28988429	1	O
compared	28988429	1	O
to	28988429	1	O
the	28988429	1	O
heterozygous	28988429	1	O
parent	28988429	1	O
and	28988429	1	O
another	28988429	1	O
healthy	28988429	1	O
donor	28988429	1	O
.	28988429	1	O
Immunostaining	28988429	1	O
showed	28988429	1	O
absence	28988429	1	O
of	28988429	1	O
the	28988429	1	O
protein	28988429	1	O
expression	28988429	1	O
in	28988429	1	O
patient	28988429	1	O
fibroblasts	28988429	1	O
.	28988429	1	O
In	28988429	1	O
addition	28988429	1	O
,	28988429	1	O
cell	28988429	1	B-CPA
proliferation	28988429	1	I-CPA
rate	28988429	1	I-CPA
was	28988429	1	O
slow	28988429	1	B-NegReg
and	28988429	1	O
osteogenic	28988429	1	B-CPA
differentiation	28988429	1	I-CPA
potential	28988429	1	I-CPA
was	28988429	1	O
delayed	28988429	1	B-NegReg
.	28988429	1	O
We	28988429	1	O
consider	28988429	1	O
that	28988429	1	O
this	28988429	1	O
study	28988429	1	O
reveals	28988429	1	O
loss	28988429	1	O
-	28988429	1	O
of	28988429	1	O
-	28988429	1	O
function	28988429	1	O
mutations	28988429	1	B-Var
in	28988429	1	O
CDH11	28988429	1	B-Gene
as	28988429	1	O
a	28988429	1	O
probable	28988429	1	O
cause	28988429	1	O
of	28988429	1	O
this	28988429	1	O
phenotype	28988429	1	O
.	28988429	1	O
Next	28988429	1	O
generation	28988429	1	O
sequencing	28988429	1	O
in	28988429	1	O
further	28988429	1	O
patients	28988429	1	O
would	28988429	1	O
both	28988429	1	O
prove	28988429	1	O
this	28988429	1	O
gene	28988429	1	O
as	28988429	1	O
causative	28988429	1	O
,	28988429	1	O
and	28988429	1	O
finely	28988429	1	O
delineate	28988429	1	O
this	28988429	1	O
clinical	28988429	1	O
spectrum	28988429	1	O
further	28988429	1	O
contributing	28988429	1	O
in	28988429	1	O
identification	28988429	1	O
of	28988429	1	O
other	28988429	1	O
possibly	28988429	1	O
involved	28988429	1	O
gene	28988429	1	O
(	28988429	1	O
s	28988429	1	O
)	28988429	1	O
.	28988429	1	O

Effect	28993478	0	B-Reg
of	28993478	0	O
Mutant	28993478	0	B-Var
p53	28993478	0	B-Gene
Proteins	28993478	0	B-Protein
on	28993478	0	O
Glycolysis	28993478	0	B-MPA
and	28993478	0	O
Mitochondrial	28993478	0	B-MPA
Metabolism	28993478	0	I-MPA
.	28993478	0	O
TP53	28993478	0	O
is	28993478	0	O
one	28993478	0	O
of	28993478	0	O
the	28993478	0	O
most	28993478	0	O
commonly	28993478	0	O
mutated	28993478	0	O
genes	28993478	0	O
in	28993478	0	O
human	28993478	0	O
cancers	28993478	0	O
.	28993478	0	O
Unlike	28993478	0	O
other	28993478	0	O
tumor	28993478	0	O
suppressors	28993478	0	O
that	28993478	0	O
are	28993478	0	O
frequently	28993478	0	O
deleted	28993478	0	O
or	28993478	0	O
acquire	28993478	0	O
loss	28993478	0	O
-	28993478	0	O
of	28993478	0	O
-	28993478	0	O
function	28993478	0	O
mutations	28993478	0	O
,	28993478	0	O
the	28993478	0	O
majority	28993478	0	O
of	28993478	0	O
TP53	28993478	0	B-Gene
mutations	28993478	0	B-Var
in	28993478	0	O
tumors	28993478	0	O
are	28993478	0	O
missense	28993478	0	B-Var
substitutions	28993478	0	I-Var
,	28993478	0	O
which	28993478	0	O
lead	28993478	0	O
to	28993478	0	O
the	28993478	0	O
expression	28993478	0	B-MPA
of	28993478	0	O
full	28993478	0	O
-	28993478	0	O
length	28993478	0	O
mutant	28993478	0	B-Var
proteins	28993478	0	B-Protein
that	28993478	0	O
accumulate	28993478	0	B-PosReg
in	28993478	0	O
cancer	28993478	0	O
cells	28993478	0	O
and	28993478	0	O
may	28993478	0	O
confer	28993478	0	O
unique	28993478	0	O
gain	28993478	0	B-PosReg
-	28993478	0	I-PosReg
of	28993478	0	I-PosReg
-	28993478	0	I-PosReg
function	28993478	0	I-PosReg
(	28993478	0	O
GOF	28993478	0	O
)	28993478	0	O
activities	28993478	0	B-MPA
to	28993478	0	O
promote	28993478	0	B-PosReg
tumorigenic	28993478	0	B-CPA
events	28993478	0	I-CPA
.	28993478	0	O
Recently	28993478	0	O
,	28993478	0	O
mutant	28993478	0	B-Var
p53	28993478	0	B-Gene
proteins	28993478	0	B-Protein
have	28993478	0	O
been	28993478	0	O
shown	28993478	0	O
to	28993478	0	O
mediate	28993478	0	O
metabolic	28993478	0	B-CPA
changes	28993478	0	I-CPA
as	28993478	0	O
a	28993478	0	O
novel	28993478	0	O
GOF	28993478	0	B-PosReg
to	28993478	0	O
promote	28993478	0	B-PosReg
tumor	28993478	0	B-CPA
development	28993478	0	I-CPA
.	28993478	0	O
There	28993478	0	O
is	28993478	0	O
a	28993478	0	O
strong	28993478	0	O
rationale	28993478	0	O
that	28993478	0	O
the	28993478	0	O
GOF	28993478	0	O
activities	28993478	0	O
,	28993478	0	O
including	28993478	0	O
alterations	28993478	0	O
in	28993478	0	O
cellular	28993478	0	O
metabolism	28993478	0	O
,	28993478	0	O
might	28993478	0	O
vary	28993478	0	O
between	28993478	0	O
the	28993478	0	O
different	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
.	28993478	0	O
Accordingly	28993478	0	O
,	28993478	0	O
the	28993478	0	O
effect	28993478	0	O
of	28993478	0	O
different	28993478	0	O
mutant	28993478	0	O
p53	28993478	0	O
proteins	28993478	0	O
on	28993478	0	O
cancer	28993478	0	O
cell	28993478	0	O
metabolism	28993478	0	O
is	28993478	0	O
largely	28993478	0	O
unknown	28993478	0	O
.	28993478	0	O
In	28993478	0	O
this	28993478	0	O
study	28993478	0	O
,	28993478	0	O
we	28993478	0	O
have	28993478	0	O
metabolically	28993478	0	O
profiled	28993478	0	O
several	28993478	0	O
individual	28993478	0	O
frequently	28993478	0	O
occurring	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
in	28993478	0	O
cancers	28993478	0	O
,	28993478	0	O
focusing	28993478	0	O
on	28993478	0	O
glycolytic	28993478	0	O
and	28993478	0	O
mitochondrial	28993478	0	O
oxidative	28993478	0	O
phosphorylation	28993478	0	O
pathways	28993478	0	O
.	28993478	0	O
Our	28993478	0	O
investigation	28993478	0	O
highlights	28993478	0	O
the	28993478	0	O
diversity	28993478	0	O
of	28993478	0	O
different	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
in	28993478	0	O
terms	28993478	0	O
of	28993478	0	O
their	28993478	0	O
effect	28993478	0	O
on	28993478	0	O
metabolism	28993478	0	O
,	28993478	0	O
which	28993478	0	O
might	28993478	0	O
provide	28993478	0	O
a	28993478	0	O
foundation	28993478	0	O
for	28993478	0	O
the	28993478	0	O
development	28993478	0	O
of	28993478	0	O
more	28993478	0	O
effective	28993478	0	O
targeted	28993478	0	O
pharmacological	28993478	0	O
approaches	28993478	0	O
toward	28993478	0	O
variants	28993478	0	O
of	28993478	0	O
mutant	28993478	0	O
p53	28993478	0	O
.	28993478	0	O

The	29016901	0	O
Roles	29016901	0	O
of	29016901	0	O
the	29016901	0	O
Sole	29016901	0	O
Activator	29016901	0	O
-	29016901	0	O
Type	29016901	0	O
Auxin	29016901	0	O
Response	29016901	0	O
Factor	29016901	0	O
in	29016901	0	O
Pattern	29016901	0	O
Formation	29016901	0	O
of	29016901	0	O
Marchantia	29016901	0	O
polymorpha	29016901	0	O
.	29016901	0	O
Cell	29016901	0	O
division	29016901	0	O
patterning	29016901	0	O
is	29016901	0	O
important	29016901	0	O
to	29016901	0	O
determine	29016901	0	O
body	29016901	0	O
shape	29016901	0	O
in	29016901	0	O
plants	29016901	0	O
.	29016901	0	O
Nuclear	29016901	0	O
auxin	29016901	0	O
signaling	29016901	0	O
mediated	29016901	0	O
by	29016901	0	O
AUXIN	29016901	0	O
RESPONSE	29016901	0	O
FACTOR	29016901	0	O
(	29016901	0	O
ARF	29016901	0	O
)	29016901	0	O
transcription	29016901	0	O
factors	29016901	0	O
affects	29016901	0	O
plant	29016901	0	O
growth	29016901	0	O
and	29016901	0	O
development	29016901	0	O
through	29016901	0	O
regulation	29016901	0	O
of	29016901	0	O
cell	29016901	0	O
division	29016901	0	O
,	29016901	0	O
elongation	29016901	0	O
and	29016901	0	O
differentiation	29016901	0	O
.	29016901	0	O
The	29016901	0	O
evolutionary	29016901	0	O
origin	29016901	0	O
of	29016901	0	O
the	29016901	0	O
ARF	29016901	0	O
-	29016901	0	O
mediated	29016901	0	O
pathway	29016901	0	O
dates	29016901	0	O
back	29016901	0	O
to	29016901	0	O
at	29016901	0	O
least	29016901	0	O
the	29016901	0	O
common	29016901	0	O
ancestor	29016901	0	O
of	29016901	0	O
bryophytes	29016901	0	O
and	29016901	0	O
other	29016901	0	O
land	29016901	0	O
plants	29016901	0	O
.	29016901	0	O
The	29016901	0	O
liverwort	29016901	0	O
Marchantia	29016901	0	O
polymorpha	29016901	0	O
has	29016901	0	O
three	29016901	0	O
phylogenetically	29016901	0	O
distinct	29016901	0	O
ARFs	29016901	0	O
:	29016901	0	O
MpARF1	29016901	0	O
,	29016901	0	O
the	29016901	0	O
sole	29016901	0	O
'	29016901	0	O
activator	29016901	0	O
'	29016901	0	O
ARF	29016901	0	O
;	29016901	0	O
and	29016901	0	O
MpARF2	29016901	0	O
and	29016901	0	O
MpARF3	29016901	0	O
,	29016901	0	O
two	29016901	0	O
'	29016901	0	O
repressor	29016901	0	O
'	29016901	0	O
ARFs	29016901	0	O
.	29016901	0	O
Genetic	29016901	0	O
screens	29016901	0	O
for	29016901	0	O
auxin	29016901	0	O
-	29016901	0	O
resistant	29016901	0	O
mutants	29016901	0	O
revealed	29016901	0	O
that	29016901	0	O
loss	29016901	0	O
of	29016901	0	O
MpARF1	29016901	0	O
function	29016901	0	O
conferred	29016901	0	O
auxin	29016901	0	O
insensitivity	29016901	0	O
.	29016901	0	O
Mparf1	29016901	0	B-Gene
mutants	29016901	0	B-Var
showed	29016901	0	O
reduced	29016901	0	B-NegReg
auxin	29016901	0	B-Gene
-	29016901	0	I-Gene
inducible	29016901	0	I-Gene
gene	29016901	0	I-Gene
expression	29016901	0	B-MPA
and	29016901	0	O
various	29016901	0	O
developmental	29016901	0	B-CPA
defects	29016901	0	I-CPA
,	29016901	0	O
including	29016901	0	O
thallus	29016901	0	O
twisting	29016901	0	O
and	29016901	0	O
gemma	29016901	0	O
malformation	29016901	0	O
.	29016901	0	O
We	29016901	0	O
further	29016901	0	O
investigated	29016901	0	O
the	29016901	0	O
role	29016901	0	O
of	29016901	0	O
MpARF1	29016901	0	O
in	29016901	0	O
gemma	29016901	0	O
development	29016901	0	O
,	29016901	0	O
which	29016901	0	O
is	29016901	0	O
traceable	29016901	0	O
at	29016901	0	O
the	29016901	0	O
cellular	29016901	0	O
level	29016901	0	O
.	29016901	0	O
In	29016901	0	O
wild	29016901	0	O
-	29016901	0	O
type	29016901	0	O
plants	29016901	0	O
,	29016901	0	O
a	29016901	0	O
gemma	29016901	0	O
initial	29016901	0	O
first	29016901	0	O
undergoes	29016901	0	O
several	29016901	0	O
transverse	29016901	0	O
divisions	29016901	0	O
to	29016901	0	O
generate	29016901	0	O
a	29016901	0	O
single	29016901	0	O
-	29016901	0	O
celled	29016901	0	O
stalk	29016901	0	O
and	29016901	0	O
a	29016901	0	O
gemma	29016901	0	O
proper	29016901	0	O
,	29016901	0	O
followed	29016901	0	O
by	29016901	0	O
rather	29016901	0	O
synchronous	29016901	0	O
longitudinal	29016901	0	O
divisions	29016901	0	O
in	29016901	0	O
the	29016901	0	O
latter	29016901	0	O
.	29016901	0	O
Mparf1	29016901	0	O
mutants	29016901	0	O
often	29016901	0	O
contained	29016901	0	O
multicelled	29016901	0	O
stalks	29016901	0	O
and	29016901	0	O
showed	29016901	0	O
defects	29016901	0	O
in	29016901	0	O
the	29016901	0	O
execution	29016901	0	O
and	29016901	0	O
timing	29016901	0	O
of	29016901	0	O
the	29016901	0	O
longitudinal	29016901	0	O
divisions	29016901	0	O
.	29016901	0	O
While	29016901	0	O
wild	29016901	0	O
-	29016901	0	O
type	29016901	0	O
gemmae	29016901	0	O
finally	29016901	0	O
generate	29016901	0	O
two	29016901	0	O
meristem	29016901	0	O
notches	29016901	0	O
,	29016901	0	O
Mparf1	29016901	0	O
gemmae	29016901	0	O
displayed	29016901	0	O
various	29016901	0	O
numbers	29016901	0	O
of	29016901	0	O
ectopic	29016901	0	O
meristems	29016901	0	O
.	29016901	0	O
These	29016901	0	O
results	29016901	0	O
suggest	29016901	0	O
that	29016901	0	O
MpARF1	29016901	0	O
regulates	29016901	0	O
formative	29016901	0	O
cell	29016901	0	O
divisions	29016901	0	O
and	29016901	0	O
axis	29016901	0	O
formation	29016901	0	O
through	29016901	0	O
auxin	29016901	0	O
responses	29016901	0	O
.	29016901	0	O
The	29016901	0	O
mechanism	29016901	0	O
for	29016901	0	O
activator	29016901	0	O
ARF	29016901	0	O
regulation	29016901	0	O
of	29016901	0	O
pattern	29016901	0	O
formation	29016901	0	O
may	29016901	0	O
be	29016901	0	O
shared	29016901	0	O
in	29016901	0	O
land	29016901	0	O
plants	29016901	0	O
and	29016901	0	O
therefore	29016901	0	O
important	29016901	0	O
for	29016901	0	O
the	29016901	0	O
general	29016901	0	O
acquisition	29016901	0	O
of	29016901	0	O
three	29016901	0	O
-	29016901	0	O
dimensional	29016901	0	O
body	29016901	0	O
plans	29016901	0	O
.	29016901	0	O

Loss	29019082	0	O
of	29019082	0	O
the	29019082	0	O
nutrient	29019082	0	O
sensor	29019082	0	O
TAS1R3	29019082	0	O
leads	29019082	0	O
to	29019082	0	O
reduced	29019082	0	O
bone	29019082	0	O
resorption	29019082	0	O
.	29019082	0	O
The	29019082	0	O
taste	29019082	0	O
receptor	29019082	0	O
type	29019082	0	O
1	29019082	0	O
(	29019082	0	O
TAS1R	29019082	0	O
)	29019082	0	O
family	29019082	0	O
of	29019082	0	O
heterotrimeric	29019082	0	O
G	29019082	0	O
protein	29019082	0	O
-	29019082	0	O
coupled	29019082	0	O
receptors	29019082	0	O
participates	29019082	0	O
in	29019082	0	O
monitoring	29019082	0	O
energy	29019082	0	O
and	29019082	0	O
nutrient	29019082	0	O
status	29019082	0	O
.	29019082	0	O
TAS1R	29019082	0	O
member	29019082	0	O
3	29019082	0	O
(	29019082	0	O
TAS1R3	29019082	0	O
)	29019082	0	O
is	29019082	0	O
a	29019082	0	O
bi	29019082	0	O
-	29019082	0	O
functional	29019082	0	O
protein	29019082	0	O
that	29019082	0	O
recognizes	29019082	0	O
amino	29019082	0	O
acids	29019082	0	O
such	29019082	0	O
as	29019082	0	O
L	29019082	0	O
-	29019082	0	O
glycine	29019082	0	O
and	29019082	0	O
L	29019082	0	O
-	29019082	0	O
glutamate	29019082	0	O
or	29019082	0	O
sweet	29019082	0	O
molecules	29019082	0	O
such	29019082	0	O
as	29019082	0	O
sucrose	29019082	0	O
and	29019082	0	O
fructose	29019082	0	O
when	29019082	0	O
dimerized	29019082	0	O
with	29019082	0	O
TAS1R	29019082	0	O
member	29019082	0	O
1	29019082	0	O
(	29019082	0	O
TAS1R1	29019082	0	O
)	29019082	0	O
or	29019082	0	O
TAS1R	29019082	0	O
member	29019082	0	O
2	29019082	0	O
(	29019082	0	O
TAS1R2	29019082	0	O
)	29019082	0	O
,	29019082	0	O
respectively	29019082	0	O
.	29019082	0	O
It	29019082	0	O
was	29019082	0	O
recently	29019082	0	O
reported	29019082	0	O
that	29019082	0	O
deletion	29019082	0	B-Var
of	29019082	0	O
TAS1R3	29019082	0	B-Gene
expression	29019082	0	O
in	29019082	0	O
Tas1R3	29019082	0	O
mutant	29019082	0	O
mice	29019082	0	O
leads	29019082	0	O
to	29019082	0	O
increased	29019082	0	B-PosReg
cortical	29019082	0	B-CPA
bone	29019082	0	I-CPA
mass	29019082	0	I-CPA
but	29019082	0	O
the	29019082	0	O
underlying	29019082	0	O
cellular	29019082	0	O
mechanism	29019082	0	O
leading	29019082	0	O
to	29019082	0	O
this	29019082	0	O
phenotype	29019082	0	O
remains	29019082	0	O
unclear	29019082	0	O
.	29019082	0	O
Here	29019082	0	O
,	29019082	0	O
we	29019082	0	O
independently	29019082	0	O
corroborate	29019082	0	O
the	29019082	0	O
increased	29019082	0	B-PosReg
thickness	29019082	0	B-CPA
of	29019082	0	I-CPA
cortical	29019082	0	I-CPA
bone	29019082	0	I-CPA
in	29019082	0	O
femurs	29019082	0	O
of	29019082	0	O
20	29019082	0	O
-	29019082	0	O
week	29019082	0	O
-	29019082	0	O
old	29019082	0	O
male	29019082	0	O
Tas1R3	29019082	0	B-Gene
mutant	29019082	0	B-Var
mice	29019082	0	O
and	29019082	0	O
confirm	29019082	0	O
that	29019082	0	O
Tas1R3	29019082	0	O
is	29019082	0	O
expressed	29019082	0	O
in	29019082	0	O
the	29019082	0	O
bone	29019082	0	O
environment	29019082	0	O
.	29019082	0	O
Tas1R3	29019082	0	O
is	29019082	0	O
expressed	29019082	0	O
in	29019082	0	O
undifferentiated	29019082	0	O
bone	29019082	0	O
marrow	29019082	0	O
stromal	29019082	0	O
cells	29019082	0	O
(	29019082	0	O
BMSCs	29019082	0	O
)	29019082	0	O
in	29019082	0	O
vitro	29019082	0	O
and	29019082	0	O
its	29019082	0	O
expression	29019082	0	O
is	29019082	0	O
maintained	29019082	0	O
during	29019082	0	O
BMP2	29019082	0	O
-	29019082	0	O
induced	29019082	0	O
osteogenic	29019082	0	O
differentiation	29019082	0	O
.	29019082	0	O
However	29019082	0	O
,	29019082	0	O
levels	29019082	0	O
of	29019082	0	O
the	29019082	0	O
bone	29019082	0	O
formation	29019082	0	O
marker	29019082	0	O
procollagen	29019082	0	O
type	29019082	0	O
I	29019082	0	O
N	29019082	0	O
-	29019082	0	O
terminal	29019082	0	O
propeptide	29019082	0	O
(	29019082	0	O
PINP	29019082	0	O
)	29019082	0	O
are	29019082	0	O
unchanged	29019082	0	O
in	29019082	0	O
the	29019082	0	O
serum	29019082	0	O
of	29019082	0	O
20	29019082	0	O
-	29019082	0	O
week	29019082	0	O
-	29019082	0	O
old	29019082	0	O
Tas1R3	29019082	0	O
mutant	29019082	0	O
mice	29019082	0	O
as	29019082	0	O
compared	29019082	0	O
to	29019082	0	O
controls	29019082	0	O
.	29019082	0	O
In	29019082	0	O
contrast	29019082	0	O
,	29019082	0	O
levels	29019082	0	B-MPA
of	29019082	0	I-MPA
the	29019082	0	I-MPA
bone	29019082	0	I-MPA
resorption	29019082	0	I-MPA
marker	29019082	0	I-MPA
collagen	29019082	0	I-MPA
type	29019082	0	I-MPA
I	29019082	0	I-MPA
C	29019082	0	I-MPA
-	29019082	0	I-MPA
telopeptide	29019082	0	I-MPA
are	29019082	0	O
reduced	29019082	0	B-NegReg
greater	29019082	0	O
than	29019082	0	O
60%	29019082	0	O
in	29019082	0	O
Tas1R3	29019082	0	B-Gene
mutant	29019082	0	B-Var
mice	29019082	0	O
.	29019082	0	O
Consistent	29019082	0	O
with	29019082	0	O
this	29019082	0	O
,	29019082	0	O
Tas1R3	29019082	0	O
and	29019082	0	O
its	29019082	0	O
putative	29019082	0	O
signaling	29019082	0	O
partner	29019082	0	O
Tas1R2	29019082	0	O
are	29019082	0	O
expressed	29019082	0	O
in	29019082	0	O
primary	29019082	0	O
osteoclasts	29019082	0	O
and	29019082	0	O
their	29019082	0	O
expression	29019082	0	O
levels	29019082	0	O
positively	29019082	0	O
correlate	29019082	0	O
with	29019082	0	O
differentiation	29019082	0	O
status	29019082	0	O
.	29019082	0	O
Collectively	29019082	0	O
,	29019082	0	O
these	29019082	0	O
findings	29019082	0	O
suggest	29019082	0	O
that	29019082	0	O
high	29019082	0	B-PosReg
bone	29019082	0	B-CPA
mass	29019082	0	I-CPA
in	29019082	0	O
Tas1R3	29019082	0	B-Gene
mutant	29019082	0	B-Var
mice	29019082	0	O
is	29019082	0	O
due	29019082	0	O
to	29019082	0	O
uncoupled	29019082	0	O
bone	29019082	0	O
remodeling	29019082	0	O
with	29019082	0	O
reduced	29019082	0	B-NegReg
osteoclast	29019082	0	B-CPA
function	29019082	0	I-CPA
and	29019082	0	O
provide	29019082	0	O
rationale	29019082	0	O
for	29019082	0	O
future	29019082	0	O
experiments	29019082	0	O
examining	29019082	0	O
the	29019082	0	O
cell	29019082	0	O
-	29019082	0	O
type	29019082	0	O
-	29019082	0	O
dependent	29019082	0	O
role	29019082	0	O
for	29019082	0	O
TAS1R	29019082	0	O
family	29019082	0	O
members	29019082	0	O
in	29019082	0	O
nutrient	29019082	0	O
sensing	29019082	0	O
in	29019082	0	O
postnatal	29019082	0	O
bone	29019082	0	O
remodeling	29019082	0	O
.	29019082	0	O

Molecular	29024003	0	O
characterization	29024003	0	O
of	29024003	0	O
the	29024003	0	O
llama	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
and	29024003	0	O
identification	29024003	0	O
of	29024003	0	O
putative	29024003	0	O
loss	29024003	0	O
of	29024003	0	O
function	29024003	0	O
mutations	29024003	0	O
.	29024003	0	O
Llama	29024003	0	O
,	29024003	0	O
the	29024003	0	O
most	29024003	0	O
numerous	29024003	0	O
domestic	29024003	0	O
camelid	29024003	0	O
in	29024003	0	O
Argentina	29024003	0	O
,	29024003	0	O
has	29024003	0	O
good	29024003	0	O
fiber	29024003	0	O
-	29024003	0	O
production	29024003	0	O
ability	29024003	0	O
.	29024003	0	O
Although	29024003	0	O
a	29024003	0	O
few	29024003	0	O
genes	29024003	0	O
related	29024003	0	O
to	29024003	0	O
other	29024003	0	O
productive	29024003	0	O
traits	29024003	0	O
have	29024003	0	O
been	29024003	0	O
characterized	29024003	0	O
,	29024003	0	O
the	29024003	0	O
molecular	29024003	0	O
genetic	29024003	0	O
basis	29024003	0	O
of	29024003	0	O
fiber	29024003	0	O
growth	29024003	0	O
control	29024003	0	O
in	29024003	0	O
camelids	29024003	0	O
is	29024003	0	O
still	29024003	0	O
poorly	29024003	0	O
understood	29024003	0	O
.	29024003	0	O
Fibroblast	29024003	0	O
growth	29024003	0	O
factor	29024003	0	O
5	29024003	0	O
(	29024003	0	O
FGF5	29024003	0	O
)	29024003	0	O
is	29024003	0	O
a	29024003	0	O
secreted	29024003	0	O
signaling	29024003	0	O
protein	29024003	0	O
that	29024003	0	O
controls	29024003	0	O
hair	29024003	0	O
growth	29024003	0	O
in	29024003	0	O
humans	29024003	0	O
and	29024003	0	O
other	29024003	0	O
mammals	29024003	0	O
.	29024003	0	O
Mutations	29024003	0	O
in	29024003	0	O
the	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
have	29024003	0	O
been	29024003	0	O
associated	29024003	0	O
with	29024003	0	O
long	29024003	0	O
-	29024003	0	O
hair	29024003	0	O
phenotypes	29024003	0	O
in	29024003	0	O
several	29024003	0	O
species	29024003	0	O
.	29024003	0	O
Here	29024003	0	O
,	29024003	0	O
we	29024003	0	O
sequenced	29024003	0	O
the	29024003	0	O
llama	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
,	29024003	0	O
which	29024003	0	O
consists	29024003	0	O
of	29024003	0	O
three	29024003	0	O
exons	29024003	0	O
encoding	29024003	0	O
813	29024003	0	O
bp	29024003	0	O
.	29024003	0	O
cDNA	29024003	0	O
analysis	29024003	0	O
from	29024003	0	O
hair	29024003	0	O
follicles	29024003	0	O
revealed	29024003	0	O
the	29024003	0	O
expression	29024003	0	O
of	29024003	0	O
two	29024003	0	O
FGF5	29024003	0	O
alternative	29024003	0	O
spliced	29024003	0	O
transcripts	29024003	0	O
,	29024003	0	O
in	29024003	0	O
one	29024003	0	O
of	29024003	0	O
which	29024003	0	O
exon	29024003	0	O
2	29024003	0	O
is	29024003	0	O
absent	29024003	0	O
.	29024003	0	O
DNA	29024003	0	O
variation	29024003	0	O
analysis	29024003	0	O
showed	29024003	0	O
four	29024003	0	O
polymorphisms	29024003	0	O
in	29024003	0	O
the	29024003	0	O
coding	29024003	0	O
region	29024003	0	O
:	29024003	0	O
a	29024003	0	O
synonymous	29024003	0	O
SNP	29024003	0	O
(	29024003	0	O
c.210A	29024003	0	O
>	29024003	0	O
G	29024003	0	O
)	29024003	0	O
,	29024003	0	O
a	29024003	0	O
single	29024003	0	O
base	29024003	0	O
deletion	29024003	0	O
(	29024003	0	B-Var
c.348delA	29024003	0	I-Var
)	29024003	0	I-Var
,	29024003	0	O
a	29024003	0	O
12	29024003	0	O
-	29024003	0	O
bp	29024003	0	O
insertion	29024003	0	O
(	29024003	0	O
c.351_352insCATATAACATAG	29024003	0	O
)	29024003	0	O
and	29024003	0	O
a	29024003	0	O
non	29024003	0	O
-	29024003	0	O
sense	29024003	0	O
mutation	29024003	0	O
(	29024003	0	O
c.499C	29024003	0	O
>	29024003	0	O
T	29024003	0	O
)	29024003	0	O
.	29024003	0	O
The	29024003	0	O
deletion	29024003	0	O
was	29024003	0	O
always	29024003	0	O
found	29024003	0	O
together	29024003	0	O
with	29024003	0	O
the	29024003	0	O
insertion	29024003	0	O
forming	29024003	0	O
a	29024003	0	O
haplotype	29024003	0	O
and	29024003	0	O
producing	29024003	0	O
a	29024003	0	O
putative	29024003	0	O
truncated	29024003	0	O
protein	29024003	0	O
of	29024003	0	O
123	29024003	0	O
amino	29024003	0	O
acids	29024003	0	O
.	29024003	0	O
The	29024003	0	O
c.499C	29024003	0	B-Var
>	29024003	0	I-Var
T	29024003	0	I-Var
mutation	29024003	0	O
also	29024003	0	O
leads	29024003	0	O
to	29024003	0	O
a	29024003	0	O
premature	29024003	0	O
stop	29024003	0	O
codon	29024003	0	O
at	29024003	0	O
position	29024003	0	O
168	29024003	0	O
.	29024003	0	O
In	29024003	0	O
both	29024003	0	O
cases	29024003	0	O
,	29024003	0	O
critical	29024003	0	B-MPA
functional	29024003	0	I-MPA
domains	29024003	0	I-MPA
of	29024003	0	O
FGF5	29024003	0	B-Gene
,	29024003	0	O
including	29024003	0	O
one	29024003	0	O
heparin	29024003	0	B-MPA
binding	29024003	0	I-MPA
site	29024003	0	I-MPA
,	29024003	0	O
are	29024003	0	O
lost	29024003	0	B-NegReg
.	29024003	0	O
All	29024003	0	O
animals	29024003	0	O
analyzed	29024003	0	O
were	29024003	0	O
homozygous	29024003	0	O
for	29024003	0	O
one	29024003	0	O
of	29024003	0	O
the	29024003	0	O
deleterious	29024003	0	O
mutations	29024003	0	O
or	29024003	0	O
compound	29024003	0	O
heterozygous	29024003	0	O
for	29024003	0	O
both	29024003	0	O
(	29024003	0	O
i	29024003	0	O
.	29024003	0	O
e	29024003	0	O
.	29024003	0	O
c.348delA	29024003	0	O
,	29024003	0	O
c.351_352insCATATAACATAG	29024003	0	O
/	29024003	0	O
c.499T	29024003	0	O
)	29024003	0	O
.	29024003	0	O
Sequencing	29024003	0	O
of	29024003	0	O
guanaco	29024003	0	O
samples	29024003	0	O
showed	29024003	0	O
that	29024003	0	O
the	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
encodes	29024003	0	O
a	29024003	0	O
full	29024003	0	O
-	29024003	0	O
length	29024003	0	O
270	29024003	0	O
-	29024003	0	O
amino	29024003	0	O
acid	29024003	0	O
protein	29024003	0	O
.	29024003	0	O
These	29024003	0	O
results	29024003	0	O
suggest	29024003	0	O
that	29024003	0	O
FGF5	29024003	0	O
is	29024003	0	O
likely	29024003	0	O
functional	29024003	0	O
in	29024003	0	O
short	29024003	0	O
-	29024003	0	O
haired	29024003	0	O
wild	29024003	0	O
species	29024003	0	O
and	29024003	0	O
non	29024003	0	O
-	29024003	0	O
functional	29024003	0	O
in	29024003	0	O
the	29024003	0	O
domestic	29024003	0	O
fiber	29024003	0	O
-	29024003	0	O
producing	29024003	0	O
species	29024003	0	O
,	29024003	0	O
the	29024003	0	O
llama	29024003	0	O
.	29024003	0	O

Differential	29024177	1	O
regulation	29024177	1	O
of	29024177	1	O
two	29024177	1	O
FLNA	29024177	1	O
transcripts	29024177	1	O
explains	29024177	1	O
some	29024177	1	O
of	29024177	1	O
the	29024177	1	O
phenotypic	29024177	1	O
heterogeneity	29024177	1	O
in	29024177	1	O
the	29024177	1	O
loss	29024177	1	O
-	29024177	1	O
of	29024177	1	O
-	29024177	1	O
function	29024177	1	O
filaminopathies	29024177	1	O
.	29024177	1	O
Loss	29024177	1	B-NegReg
-	29024177	1	I-NegReg
of	29024177	1	I-NegReg
-	29024177	1	I-NegReg
function	29024177	1	I-NegReg
mutations	29024177	1	B-Var
in	29024177	1	O
the	29024177	1	O
X	29024177	1	O
-	29024177	1	O
linked	29024177	1	O
gene	29024177	1	O
FLNA	29024177	1	B-Gene
can	29024177	1	O
lead	29024177	1	O
to	29024177	1	O
abnormal	29024177	1	B-CPA
neuronal	29024177	1	I-CPA
migration	29024177	1	I-CPA
,	29024177	1	O
vascular	29024177	1	B-CPA
and	29024177	1	I-CPA
cardiac	29024177	1	I-CPA
defects	29024177	1	I-CPA
,	29024177	1	O
and	29024177	1	O
congenital	29024177	1	B-Disease
intestinal	29024177	1	I-Disease
pseudo	29024177	1	I-Disease
-	29024177	1	I-Disease
obstruction	29024177	1	I-Disease
(	29024177	1	O
CIPO	29024177	1	O
)	29024177	1	O
,	29024177	1	O
the	29024177	1	O
latter	29024177	1	O
characterized	29024177	1	O
by	29024177	1	O
anomalous	29024177	1	O
intestinal	29024177	1	O
smooth	29024177	1	O
muscle	29024177	1	O
layering	29024177	1	O
.	29024177	1	O
Survival	29024177	1	O
in	29024177	1	O
male	29024177	1	O
hemizygotes	29024177	1	O
for	29024177	1	O
such	29024177	1	O
mutations	29024177	1	O
is	29024177	1	O
dependent	29024177	1	O
on	29024177	1	O
retention	29024177	1	O
of	29024177	1	O
residual	29024177	1	O
FLNA	29024177	1	O
function	29024177	1	O
but	29024177	1	O
it	29024177	1	O
is	29024177	1	O
unclear	29024177	1	O
why	29024177	1	O
a	29024177	1	O
subgroup	29024177	1	O
of	29024177	1	O
males	29024177	1	O
with	29024177	1	O
mutations	29024177	1	O
in	29024177	1	O
the	29024177	1	O
5	29024177	1	O
'	29024177	1	O
end	29024177	1	O
of	29024177	1	O
the	29024177	1	O
gene	29024177	1	O
can	29024177	1	O
present	29024177	1	O
with	29024177	1	O
CIPO	29024177	1	O
alone	29024177	1	O
.	29024177	1	O
Here	29024177	1	O
,	29024177	1	O
we	29024177	1	O
demonstrate	29024177	1	O
evidence	29024177	1	O
for	29024177	1	O
the	29024177	1	O
presence	29024177	1	O
of	29024177	1	O
two	29024177	1	O
FLNA	29024177	1	O
isoforms	29024177	1	O
differing	29024177	1	O
by	29024177	1	O
28	29024177	1	O
residues	29024177	1	O
at	29024177	1	O
the	29024177	1	O
N	29024177	1	O
-	29024177	1	O
terminus	29024177	1	O
initiated	29024177	1	O
at	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
and	29024177	1	O
ATG	29024177	1	O
82	29024177	1	O
.	29024177	1	O
A	29024177	1	O
male	29024177	1	O
with	29024177	1	O
CIPO	29024177	1	O
(	29024177	1	O
c.18_19del	29024177	1	O
)	29024177	1	O
exclusively	29024177	1	O
expressed	29024177	1	O
FLNA	29024177	1	O
ATG	29024177	1	O
82	29024177	1	O
,	29024177	1	O
implicating	29024177	1	O
the	29024177	1	O
longer	29024177	1	O
protein	29024177	1	O
isoform	29024177	1	O
(	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
)	29024177	1	O
in	29024177	1	O
smooth	29024177	1	O
muscle	29024177	1	O
development	29024177	1	O
.	29024177	1	O
In	29024177	1	O
contrast	29024177	1	O
,	29024177	1	O
mutations	29024177	1	O
leading	29024177	1	O
to	29024177	1	O
reduction	29024177	1	O
of	29024177	1	O
both	29024177	1	O
isoforms	29024177	1	O
are	29024177	1	O
associated	29024177	1	O
with	29024177	1	O
compound	29024177	1	O
phenotypes	29024177	1	O
affecting	29024177	1	O
the	29024177	1	O
brain	29024177	1	O
,	29024177	1	O
heart	29024177	1	O
,	29024177	1	O
and	29024177	1	O
intestine	29024177	1	O
.	29024177	1	O
RNA	29024177	1	O
-	29024177	1	O
seq	29024177	1	O
data	29024177	1	O
revealed	29024177	1	O
three	29024177	1	O
distinct	29024177	1	O
transcription	29024177	1	O
start	29024177	1	O
sites	29024177	1	O
,	29024177	1	O
two	29024177	1	O
of	29024177	1	O
which	29024177	1	O
produce	29024177	1	O
a	29024177	1	O
protein	29024177	1	O
isoform	29024177	1	O
utilizing	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
while	29024177	1	O
the	29024177	1	O
third	29024177	1	O
utilizes	29024177	1	O
ATG	29024177	1	O
82	29024177	1	O
.	29024177	1	O
Transcripts	29024177	1	O
sponsoring	29024177	1	O
translational	29024177	1	O
initiation	29024177	1	O
at	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
predominate	29024177	1	O
in	29024177	1	O
intestinal	29024177	1	O
smooth	29024177	1	O
muscle	29024177	1	O
,	29024177	1	O
and	29024177	1	O
are	29024177	1	O
more	29024177	1	O
abundant	29024177	1	O
compared	29024177	1	O
with	29024177	1	O
the	29024177	1	O
level	29024177	1	O
measured	29024177	1	O
in	29024177	1	O
fibroblasts	29024177	1	O
.	29024177	1	O
Together	29024177	1	O
these	29024177	1	O
observations	29024177	1	O
describe	29024177	1	O
a	29024177	1	O
new	29024177	1	O
mechanism	29024177	1	O
of	29024177	1	O
tissue	29024177	1	O
-	29024177	1	O
specific	29024177	1	O
regulation	29024177	1	O
of	29024177	1	O
FLNA	29024177	1	O
that	29024177	1	O
could	29024177	1	O
reflect	29024177	1	O
the	29024177	1	O
differing	29024177	1	O
mechanical	29024177	1	O
requirements	29024177	1	O
of	29024177	1	O
these	29024177	1	O
cell	29024177	1	O
types	29024177	1	O
during	29024177	1	O
development	29024177	1	O
.	29024177	1	O

A	29036710	0	O
disulfide	29036710	0	O
bond	29036710	0	O
A	29036710	0	O
-	29036710	0	O
like	29036710	0	O
oxidoreductase	29036710	0	O
is	29036710	0	O
a	29036710	0	O
strong	29036710	0	O
candidate	29036710	0	O
gene	29036710	0	O
for	29036710	0	O
self	29036710	0	O
-	29036710	0	O
incompatibility	29036710	0	O
in	29036710	0	O
apricot	29036710	0	O
(	29036710	0	O
Prunus	29036710	0	O
armeniaca	29036710	0	O
)	29036710	0	O
pollen	29036710	0	O
.	29036710	0	O
S	29036710	0	O
-	29036710	0	O
RNase	29036710	0	O
based	29036710	0	O
gametophytic	29036710	0	O
self	29036710	0	O
-	29036710	0	O
incompatibility	29036710	0	O
(	29036710	0	O
SI	29036710	0	O
)	29036710	0	O
is	29036710	0	O
a	29036710	0	O
widespread	29036710	0	O
prezygotic	29036710	0	O
reproductive	29036710	0	O
barrier	29036710	0	O
in	29036710	0	O
flowering	29036710	0	O
plants	29036710	0	O
.	29036710	0	O
In	29036710	0	O
the	29036710	0	O
Solanaceae	29036710	0	O
,	29036710	0	O
Plantaginaceae	29036710	0	O
and	29036710	0	O
Rosaceae	29036710	0	O
gametophytic	29036710	0	O
SI	29036710	0	O
is	29036710	0	O
controlled	29036710	0	O
by	29036710	0	O
the	29036710	0	O
pistil	29036710	0	O
-	29036710	0	O
specific	29036710	0	O
S	29036710	0	O
-	29036710	0	O
RNases	29036710	0	O
and	29036710	0	O
the	29036710	0	O
pollen	29036710	0	O
S	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
F	29036710	0	O
-	29036710	0	O
box	29036710	0	O
proteins	29036710	0	O
but	29036710	0	O
non	29036710	0	O
-	29036710	0	O
S	29036710	0	O
-	29036710	0	O
specific	29036710	0	O
factors	29036710	0	O
,	29036710	0	O
namely	29036710	0	O
modifiers	29036710	0	O
,	29036710	0	O
are	29036710	0	O
also	29036710	0	O
required	29036710	0	O
.	29036710	0	O
In	29036710	0	O
apricot	29036710	0	O
,	29036710	0	O
Prunus	29036710	0	O
armeniaca	29036710	0	O
(	29036710	0	O
Rosaceae	29036710	0	O
)	29036710	0	O
,	29036710	0	O
we	29036710	0	O
previously	29036710	0	O
mapped	29036710	0	O
two	29036710	0	O
pollen	29036710	0	O
-	29036710	0	O
part	29036710	0	O
mutations	29036710	0	B-Var
that	29036710	0	O
confer	29036710	0	B-Reg
self	29036710	0	B-MPA
-	29036710	0	I-MPA
compatibility	29036710	0	I-MPA
in	29036710	0	O
cultivars	29036710	0	O
Canino	29036710	0	O
and	29036710	0	O
Katy	29036710	0	O
at	29036710	0	O
the	29036710	0	O
distal	29036710	0	O
end	29036710	0	O
of	29036710	0	O
chromosome	29036710	0	O
3	29036710	0	O
(	29036710	0	O
M	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
)	29036710	0	O
unlinked	29036710	0	O
to	29036710	0	O
the	29036710	0	O
S	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
.	29036710	0	O
Here	29036710	0	O
,	29036710	0	O
we	29036710	0	O
used	29036710	0	O
high	29036710	0	O
-	29036710	0	O
resolution	29036710	0	O
mapping	29036710	0	O
to	29036710	0	O
identify	29036710	0	O
the	29036710	0	O
M	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
with	29036710	0	O
an	29036710	0	O
134	29036710	0	O
kb	29036710	0	O
segment	29036710	0	O
containing	29036710	0	O
ParM-1	29036710	0	O
-	29036710	0	O
16	29036710	0	O
genes	29036710	0	O
.	29036710	0	O
Gene	29036710	0	O
expression	29036710	0	O
analysis	29036710	0	O
identified	29036710	0	O
four	29036710	0	O
genes	29036710	0	O
preferentially	29036710	0	O
expressed	29036710	0	O
in	29036710	0	O
anthers	29036710	0	O
as	29036710	0	O
modifier	29036710	0	O
gene	29036710	0	O
candidates	29036710	0	O
,	29036710	0	O
ParM-6	29036710	0	O
,	29036710	0	O
-	29036710	0	O
7	29036710	0	O
,	29036710	0	O
-	29036710	0	O
9	29036710	0	O
and	29036710	0	O
-	29036710	0	O
14	29036710	0	O
.	29036710	0	O
Variant	29036710	0	O
calling	29036710	0	O
of	29036710	0	O
WGS	29036710	0	O
Illumina	29036710	0	O
data	29036710	0	O
from	29036710	0	O
Canino	29036710	0	O
,	29036710	0	O
Katy	29036710	0	O
,	29036710	0	O
and	29036710	0	O
10	29036710	0	O
self	29036710	0	O
-	29036710	0	O
incompatible	29036710	0	O
cultivars	29036710	0	O
detected	29036710	0	O
a	29036710	0	O
358	29036710	0	O
bp	29036710	0	O
miniature	29036710	0	O
inverted	29036710	0	O
-	29036710	0	O
repeat	29036710	0	O
transposable	29036710	0	O
element	29036710	0	O
(	29036710	0	O
MITE	29036710	0	O
)	29036710	0	O
insertion	29036710	0	O
in	29036710	0	O
ParM-7	29036710	0	O
shared	29036710	0	O
only	29036710	0	O
by	29036710	0	O
self	29036710	0	O
-	29036710	0	O
compatible	29036710	0	O
apricots	29036710	0	O
,	29036710	0	O
supporting	29036710	0	O
ParM-7	29036710	0	O
as	29036710	0	O
strong	29036710	0	O
candidate	29036710	0	O
gene	29036710	0	O
required	29036710	0	O
for	29036710	0	O
SI	29036710	0	O
.	29036710	0	O
ParM-7	29036710	0	O
encodes	29036710	0	O
a	29036710	0	O
disulfide	29036710	0	O
bond	29036710	0	O
A	29036710	0	O
-	29036710	0	O
like	29036710	0	O
oxidoreductase	29036710	0	O
protein	29036710	0	O
,	29036710	0	O
which	29036710	0	O
we	29036710	0	O
named	29036710	0	O
ParMDO	29036710	0	O
.	29036710	0	O
The	29036710	0	O
MITE	29036710	0	B-Gene
insertion	29036710	0	B-Var
truncates	29036710	0	B-NegReg
the	29036710	0	O
ParMDO	29036710	0	B-MPA
ORF	29036710	0	I-MPA
and	29036710	0	O
produces	29036710	0	O
a	29036710	0	O
loss	29036710	0	B-NegReg
of	29036710	0	O
SI	29036710	0	B-MPA
function	29036710	0	I-MPA
,	29036710	0	O
suggesting	29036710	0	O
that	29036710	0	O
pollen	29036710	0	O
rejection	29036710	0	O
in	29036710	0	O
Prunus	29036710	0	O
is	29036710	0	O
dependent	29036710	0	O
on	29036710	0	O
redox	29036710	0	O
regulation	29036710	0	O
.	29036710	0	O
Based	29036710	0	O
on	29036710	0	O
phylogentic	29036710	0	O
analyses	29036710	0	O
we	29036710	0	O
also	29036710	0	O
suggest	29036710	0	O
that	29036710	0	O
ParMDO	29036710	0	O
may	29036710	0	O
have	29036710	0	O
originated	29036710	0	O
from	29036710	0	O
a	29036710	0	O
tandem	29036710	0	O
duplication	29036710	0	O
followed	29036710	0	O
by	29036710	0	O
subfunctionalization	29036710	0	O
and	29036710	0	O
pollen	29036710	0	O
-	29036710	0	O
specific	29036710	0	O
expression	29036710	0	O
.	29036710	0	O

The	29038237	2	O
Gain	29038237	2	B-PosReg
-	29038237	2	I-PosReg
of	29038237	2	I-PosReg
-	29038237	2	I-PosReg
Function	29038237	2	I-PosReg
Integrin	29038237	2	O
β3	29038237	2	O
Pro33	29038237	2	O
Variant	29038237	2	B-Var
Alters	29038237	2	O
the	29038237	2	O
Serotonin	29038237	2	B-MPA
System	29038237	2	I-MPA
in	29038237	2	O
the	29038237	2	O
Mouse	29038237	2	O
Brain	29038237	2	O
.	29038237	2	O
Engagement	29038237	2	O
of	29038237	2	O
integrins	29038237	2	O
by	29038237	2	O
the	29038237	2	O
extracellular	29038237	2	O
matrix	29038237	2	O
initiates	29038237	2	O
signaling	29038237	2	O
cascades	29038237	2	O
that	29038237	2	O
drive	29038237	2	O
a	29038237	2	O
variety	29038237	2	O
of	29038237	2	O
cellular	29038237	2	O
functions	29038237	2	O
,	29038237	2	O
including	29038237	2	O
neuronal	29038237	2	O
migration	29038237	2	O
and	29038237	2	O
axonal	29038237	2	O
pathfinding	29038237	2	O
in	29038237	2	O
the	29038237	2	O
brain	29038237	2	O
.	29038237	2	O
Multiple	29038237	2	O
lines	29038237	2	O
of	29038237	2	O
evidence	29038237	2	O
link	29038237	2	O
the	29038237	2	O
ITGB3	29038237	2	O
gene	29038237	2	O
encoding	29038237	2	O
the	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
subunit	29038237	2	O
with	29038237	2	O
the	29038237	2	O
serotonin	29038237	2	O
(	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
)	29038237	2	O
system	29038237	2	O
,	29038237	2	O
likely	29038237	2	O
via	29038237	2	O
its	29038237	2	O
modulation	29038237	2	O
of	29038237	2	O
the	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
transporter	29038237	2	O
(	29038237	2	O
SERT	29038237	2	O
)	29038237	2	O
.	29038237	2	O
The	29038237	2	O
ITGB3	29038237	2	B-Gene
coding	29038237	2	O
polymorphism	29038237	2	O
Leu33Pro	29038237	2	B-Var
(	29038237	2	O
rs5918	29038237	2	O
,	29038237	2	O
PlA2	29038237	2	O
)	29038237	2	O
produces	29038237	2	O
hyperactive	29038237	2	B-PosReg
αvβ3	29038237	2	B-Protein
receptors	29038237	2	I-Protein
that	29038237	2	O
influence	29038237	2	B-Reg
whole	29038237	2	B-MPA
-	29038237	2	I-MPA
blood	29038237	2	I-MPA
5	29038237	2	I-MPA
-	29038237	2	I-MPA
HT	29038237	2	I-MPA
levels	29038237	2	I-MPA
and	29038237	2	O
may	29038237	2	O
influence	29038237	2	B-Reg
the	29038237	2	O
risk	29038237	2	O
for	29038237	2	O
autism	29038237	2	B-Disease
spectrum	29038237	2	I-Disease
disorder	29038237	2	I-Disease
(	29038237	2	O
ASD	29038237	2	O
)	29038237	2	O
.	29038237	2	O
Using	29038237	2	O
a	29038237	2	O
phenome	29038237	2	O
-	29038237	2	O
wide	29038237	2	O
scan	29038237	2	O
of	29038237	2	O
psychiatric	29038237	2	O
diagnoses	29038237	2	O
,	29038237	2	O
we	29038237	2	O
found	29038237	2	O
significant	29038237	2	O
,	29038237	2	O
male	29038237	2	O
-	29038237	2	O
specific	29038237	2	O
associations	29038237	2	O
between	29038237	2	O
the	29038237	2	O
Pro33	29038237	2	O
allele	29038237	2	O
and	29038237	2	O
attention	29038237	2	O
-	29038237	2	O
deficit	29038237	2	O
hyperactivity	29038237	2	O
disorder	29038237	2	O
and	29038237	2	O
ASDs	29038237	2	O
.	29038237	2	O
Here	29038237	2	O
,	29038237	2	O
we	29038237	2	O
used	29038237	2	O
knock	29038237	2	O
-	29038237	2	O
in	29038237	2	O
(	29038237	2	O
KI	29038237	2	O
)	29038237	2	O
mice	29038237	2	O
expressing	29038237	2	O
an	29038237	2	O
Itgb3	29038237	2	B-Gene
variant	29038237	2	B-Var
that	29038237	2	O
phenocopies	29038237	2	O
the	29038237	2	O
human	29038237	2	O
Pro33	29038237	2	O
variant	29038237	2	O
to	29038237	2	O
elucidate	29038237	2	O
the	29038237	2	O
consequences	29038237	2	O
of	29038237	2	O
constitutively	29038237	2	O
enhanced	29038237	2	B-PosReg
αvβ3	29038237	2	B-MPA
signaling	29038237	2	I-MPA
to	29038237	2	I-MPA
the	29038237	2	I-MPA
5	29038237	2	I-MPA
-	29038237	2	I-MPA
HT	29038237	2	I-MPA
system	29038237	2	I-MPA
in	29038237	2	O
the	29038237	2	O
brain	29038237	2	O
.	29038237	2	O
KI	29038237	2	O
mice	29038237	2	O
displayed	29038237	2	O
deficits	29038237	2	O
in	29038237	2	O
multiple	29038237	2	O
behaviors	29038237	2	O
,	29038237	2	O
including	29038237	2	O
anxiety	29038237	2	O
,	29038237	2	O
repetitive	29038237	2	O
,	29038237	2	O
and	29038237	2	O
social	29038237	2	O
behaviors	29038237	2	O
.	29038237	2	O
Anatomical	29038237	2	O
studies	29038237	2	O
revealed	29038237	2	O
a	29038237	2	O
significant	29038237	2	O
decrease	29038237	2	O
in	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
synapses	29038237	2	O
in	29038237	2	O
the	29038237	2	O
midbrain	29038237	2	O
,	29038237	2	O
accompanied	29038237	2	O
by	29038237	2	O
decreases	29038237	2	O
in	29038237	2	O
SERT	29038237	2	O
activity	29038237	2	O
and	29038237	2	O
reduced	29038237	2	O
localization	29038237	2	O
of	29038237	2	O
SERTs	29038237	2	O
to	29038237	2	O
integrin	29038237	2	O
adhesion	29038237	2	O
complexes	29038237	2	O
in	29038237	2	O
synapses	29038237	2	O
of	29038237	2	O
KI	29038237	2	O
mice	29038237	2	O
.	29038237	2	O
Inhibition	29038237	2	O
of	29038237	2	O
focal	29038237	2	O
adhesion	29038237	2	O
kinase	29038237	2	O
(	29038237	2	O
FAK	29038237	2	O
)	29038237	2	O
rescued	29038237	2	O
SERT	29038237	2	O
function	29038237	2	O
in	29038237	2	O
synapses	29038237	2	O
of	29038237	2	O
KI	29038237	2	O
mice	29038237	2	O
,	29038237	2	O
demonstrating	29038237	2	O
that	29038237	2	O
constitutive	29038237	2	O
active	29038237	2	O
FAK	29038237	2	O
signaling	29038237	2	O
downstream	29038237	2	O
of	29038237	2	O
the	29038237	2	O
Pro32Pro33	29038237	2	O
integrin	29038237	2	O
αvβ3	29038237	2	O
suppresses	29038237	2	O
SERT	29038237	2	O
activity	29038237	2	O
.	29038237	2	O
Our	29038237	2	O
studies	29038237	2	O
identify	29038237	2	O
a	29038237	2	O
complex	29038237	2	O
regulation	29038237	2	O
of	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
homeostasis	29038237	2	O
and	29038237	2	O
behaviors	29038237	2	O
by	29038237	2	O
integrin	29038237	2	O
αvβ3	29038237	2	O
,	29038237	2	O
revealing	29038237	2	O
an	29038237	2	O
important	29038237	2	O
role	29038237	2	O
for	29038237	2	O
integrins	29038237	2	O
in	29038237	2	O
modulating	29038237	2	O
risk	29038237	2	O
for	29038237	2	O
neuropsychiatric	29038237	2	O
disorders	29038237	2	O
.	29038237	2	O
SIGNIFICANCE	29038237	2	O
STATEMENT	29038237	2	O
The	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
Leu33Pro	29038237	2	O
coding	29038237	2	O
polymorphism	29038237	2	O
has	29038237	2	O
been	29038237	2	O
associated	29038237	2	O
with	29038237	2	O
autism	29038237	2	O
spectrum	29038237	2	O
disorders	29038237	2	O
(	29038237	2	O
ASDs	29038237	2	O
)	29038237	2	O
within	29038237	2	O
a	29038237	2	O
subgroup	29038237	2	O
of	29038237	2	O
patients	29038237	2	O
with	29038237	2	O
elevated	29038237	2	O
blood	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
levels	29038237	2	O
,	29038237	2	O
linking	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
,	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
,	29038237	2	O
and	29038237	2	O
ASD	29038237	2	O
risk	29038237	2	O
.	29038237	2	O
We	29038237	2	O
capitalized	29038237	2	O
on	29038237	2	O
these	29038237	2	O
interactions	29038237	2	O
to	29038237	2	O
demonstrate	29038237	2	O
that	29038237	2	O
the	29038237	2	O
Pro33	29038237	2	O
coding	29038237	2	O
variation	29038237	2	O
in	29038237	2	O
the	29038237	2	O
murine	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
recapitulates	29038237	2	O
the	29038237	2	O
sex	29038237	2	O
-	29038237	2	O
dependent	29038237	2	O
neurochemical	29038237	2	O
and	29038237	2	O
behavioral	29038237	2	O
attributes	29038237	2	O
of	29038237	2	O
ASD	29038237	2	O
.	29038237	2	O
Using	29038237	2	O
state	29038237	2	O
-	29038237	2	O
of	29038237	2	O
-	29038237	2	O
the	29038237	2	O
-	29038237	2	O
art	29038237	2	O
techniques	29038237	2	O
,	29038237	2	O
we	29038237	2	O
show	29038237	2	O
that	29038237	2	O
presynaptic	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
function	29038237	2	O
is	29038237	2	O
altered	29038237	2	O
in	29038237	2	O
these	29038237	2	O
mice	29038237	2	O
,	29038237	2	O
and	29038237	2	O
that	29038237	2	O
the	29038237	2	O
localization	29038237	2	O
of	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
transporters	29038237	2	O
to	29038237	2	O
specific	29038237	2	O
compartments	29038237	2	O
within	29038237	2	O
the	29038237	2	O
synapse	29038237	2	O
,	29038237	2	O
disrupted	29038237	2	O
by	29038237	2	O
the	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
Pro33	29038237	2	O
mutation	29038237	2	O
,	29038237	2	O
is	29038237	2	O
critical	29038237	2	O
for	29038237	2	O
appropriate	29038237	2	O
reuptake	29038237	2	O
of	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
.	29038237	2	O
Our	29038237	2	O
studies	29038237	2	O
provide	29038237	2	O
fundamental	29038237	2	O
insight	29038237	2	O
into	29038237	2	O
the	29038237	2	O
genetic	29038237	2	O
network	29038237	2	O
regulating	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
neurotransmission	29038237	2	O
in	29038237	2	O
the	29038237	2	O
CNS	29038237	2	O
that	29038237	2	O
is	29038237	2	O
also	29038237	2	O
associated	29038237	2	O
with	29038237	2	O
ASD	29038237	2	O
risk	29038237	2	O
.	29038237	2	O

Parkin	29040870	2	B-Gene
absence	29040870	2	B-Var
accelerates	29040870	2	B-PosReg
microtubule	29040870	2	B-MPA
aging	29040870	2	I-MPA
in	29040870	2	I-MPA
dopaminergic	29040870	2	I-MPA
neurons	29040870	2	I-MPA
.	29040870	2	O
Loss	29040870	2	B-NegReg
-	29040870	2	I-NegReg
of	29040870	2	I-NegReg
-	29040870	2	I-NegReg
function	29040870	2	I-NegReg
caused	29040870	2	O
by	29040870	2	O
mutations	29040870	2	B-Var
in	29040870	2	O
the	29040870	2	O
parkin	29040870	2	O
gene	29040870	2	O
(	29040870	2	B-Gene
PARK2	29040870	2	I-Gene
)	29040870	2	I-Gene
lead	29040870	2	O
to	29040870	2	O
early	29040870	2	B-Disease
-	29040870	2	I-Disease
onset	29040870	2	I-Disease
familial	29040870	2	I-Disease
Parkinson	29040870	2	I-Disease
'	29040870	2	I-Disease
s	29040870	2	I-Disease
disease	29040870	2	I-Disease
.	29040870	2	O
Recently	29040870	2	O
,	29040870	2	O
mechanistic	29040870	2	O
studies	29040870	2	O
proved	29040870	2	O
the	29040870	2	O
ability	29040870	2	O
of	29040870	2	O
parkin	29040870	2	O
in	29040870	2	O
regulating	29040870	2	O
mitochondria	29040870	2	O
homeostasis	29040870	2	O
and	29040870	2	O
microtubule	29040870	2	O
(	29040870	2	O
MT	29040870	2	O
)	29040870	2	O
stability	29040870	2	O
.	29040870	2	O
Looking	29040870	2	O
at	29040870	2	O
these	29040870	2	O
systems	29040870	2	O
during	29040870	2	O
aging	29040870	2	O
of	29040870	2	O
PARK2	29040870	2	O
knockout	29040870	2	O
mice	29040870	2	O
,	29040870	2	O
we	29040870	2	O
found	29040870	2	O
that	29040870	2	O
loss	29040870	2	B-Var
of	29040870	2	O
parkin	29040870	2	B-Gene
induced	29040870	2	O
an	29040870	2	O
accelerated	29040870	2	B-PosReg
(	29040870	2	B-MPA
over	29040870	2	I-MPA
)	29040870	2	I-MPA
acetylation	29040870	2	I-MPA
of	29040870	2	O
MT	29040870	2	O
system	29040870	2	O
both	29040870	2	O
in	29040870	2	O
dopaminergic	29040870	2	O
neuron	29040870	2	O
cell	29040870	2	O
bodies	29040870	2	O
and	29040870	2	O
fibers	29040870	2	O
,	29040870	2	O
localized	29040870	2	O
in	29040870	2	O
the	29040870	2	O
substantia	29040870	2	O
nigra	29040870	2	O
and	29040870	2	O
corpus	29040870	2	O
striatum	29040870	2	O
,	29040870	2	O
respectively	29040870	2	O
.	29040870	2	O
Interestingly	29040870	2	O
,	29040870	2	O
in	29040870	2	O
PARK2	29040870	2	O
knockout	29040870	2	O
mice	29040870	2	O
,	29040870	2	O
changes	29040870	2	O
of	29040870	2	O
MT	29040870	2	O
stability	29040870	2	O
preceded	29040870	2	O
the	29040870	2	O
alteration	29040870	2	O
of	29040870	2	O
mitochondria	29040870	2	O
transport	29040870	2	O
.	29040870	2	O
Moreover	29040870	2	O
,	29040870	2	O
in	29040870	2	O
-	29040870	2	O
cell	29040870	2	O
experiments	29040870	2	O
confirmed	29040870	2	O
that	29040870	2	O
loss	29040870	2	B-Var
of	29040870	2	O
parkin	29040870	2	B-Gene
affects	29040870	2	B-Reg
mitochondria	29040870	2	B-MPA
mobility	29040870	2	I-MPA
and	29040870	2	O
showed	29040870	2	O
that	29040870	2	O
this	29040870	2	O
defect	29040870	2	O
depends	29040870	2	O
on	29040870	2	O
MT	29040870	2	O
system	29040870	2	O
as	29040870	2	O
it	29040870	2	O
is	29040870	2	O
rescued	29040870	2	O
by	29040870	2	O
paclitaxel	29040870	2	O
,	29040870	2	O
a	29040870	2	O
well	29040870	2	O
-	29040870	2	O
known	29040870	2	O
MT	29040870	2	O
-	29040870	2	O
targeted	29040870	2	O
agent	29040870	2	O
.	29040870	2	O
Furthermore	29040870	2	O
,	29040870	2	O
both	29040870	2	O
in	29040870	2	O
PC12	29040870	2	O
neuronal	29040870	2	O
cells	29040870	2	O
and	29040870	2	O
in	29040870	2	O
patients	29040870	2	O
'	29040870	2	O
induced	29040870	2	O
pluripotent	29040870	2	O
stem	29040870	2	O
cell	29040870	2	O
-	29040870	2	O
derived	29040870	2	O
midbrain	29040870	2	O
neurons	29040870	2	O
,	29040870	2	O
we	29040870	2	O
observed	29040870	2	O
that	29040870	2	O
parkin	29040870	2	O
deficiencies	29040870	2	O
cause	29040870	2	O
the	29040870	2	O
fragmentation	29040870	2	O
of	29040870	2	O
stable	29040870	2	O
MTs	29040870	2	O
.	29040870	2	O
Therefore	29040870	2	O
,	29040870	2	O
we	29040870	2	O
suggest	29040870	2	O
that	29040870	2	O
parkin	29040870	2	O
acts	29040870	2	O
as	29040870	2	O
a	29040870	2	O
regulator	29040870	2	O
of	29040870	2	O
MT	29040870	2	O
system	29040870	2	O
during	29040870	2	O
neuronal	29040870	2	O
aging	29040870	2	O
,	29040870	2	O
and	29040870	2	O
we	29040870	2	O
endorse	29040870	2	O
the	29040870	2	O
hypothesis	29040870	2	O
that	29040870	2	O
MT	29040870	2	O
dysfunction	29040870	2	O
may	29040870	2	O
be	29040870	2	O
crucial	29040870	2	O
in	29040870	2	O
the	29040870	2	O
pathogenesis	29040870	2	O
of	29040870	2	O
Parkinson	29040870	2	O
'	29040870	2	O
s	29040870	2	O
disease	29040870	2	O
.	29040870	2	O

Parkinson	29054882	1	B-Disease
'	29054882	1	I-Disease
s	29054882	1	I-Disease
Disease	29054882	1	I-Disease
-	29054882	1	I-Disease
Associated	29054882	1	I-Disease
LRRK2	29054882	1	B-Gene
Hyperactive	29054882	1	O
Kinase	29054882	1	O
Mutant	29054882	1	B-Var
Disrupts	29054882	1	B-NegReg
Synaptic	29054882	1	B-MPA
Vesicle	29054882	1	I-MPA
Trafficking	29054882	1	I-MPA
in	29054882	1	I-MPA
Ventral	29054882	1	I-MPA
Midbrain	29054882	1	I-MPA
Neurons	29054882	1	I-MPA
.	29054882	1	O
Parkinson	29054882	1	O
'	29054882	1	O
s	29054882	1	O
disease	29054882	1	O
(	29054882	1	O
PD	29054882	1	O
)	29054882	1	O
is	29054882	1	O
characterized	29054882	1	O
pathologically	29054882	1	O
by	29054882	1	O
the	29054882	1	O
selective	29054882	1	O
loss	29054882	1	O
of	29054882	1	O
substantia	29054882	1	O
nigra	29054882	1	O
(	29054882	1	O
SN	29054882	1	O
)	29054882	1	O
dopaminergic	29054882	1	O
(	29054882	1	O
DAergic	29054882	1	O
)	29054882	1	O
neurons	29054882	1	O
.	29054882	1	O
Recent	29054882	1	O
evidence	29054882	1	O
has	29054882	1	O
suggested	29054882	1	O
a	29054882	1	O
role	29054882	1	O
of	29054882	1	O
LRRK2	29054882	1	O
,	29054882	1	O
linked	29054882	1	O
to	29054882	1	O
the	29054882	1	O
most	29054882	1	O
frequent	29054882	1	O
familial	29054882	1	O
PD	29054882	1	O
,	29054882	1	O
in	29054882	1	O
regulating	29054882	1	O
synaptic	29054882	1	O
vesicle	29054882	1	O
(	29054882	1	O
SV	29054882	1	O
)	29054882	1	O
trafficking	29054882	1	O
.	29054882	1	O
However	29054882	1	O
,	29054882	1	O
the	29054882	1	O
mechanism	29054882	1	O
whereby	29054882	1	O
LRRK2	29054882	1	B-Gene
mutants	29054882	1	B-Var
contribute	29054882	1	B-Reg
to	29054882	1	O
nigral	29054882	1	B-MPA
vulnerability	29054882	1	I-MPA
remains	29054882	1	O
unclear	29054882	1	O
.	29054882	1	O
Here	29054882	1	O
we	29054882	1	O
show	29054882	1	O
that	29054882	1	O
the	29054882	1	O
most	29054882	1	O
common	29054882	1	O
PD	29054882	1	O
mutation	29054882	1	B-Var
LRRK2	29054882	1	B-Gene
G2019S	29054882	1	O
impairs	29054882	1	B-NegReg
SV	29054882	1	B-MPA
endocytosis	29054882	1	I-MPA
in	29054882	1	I-MPA
ventral	29054882	1	I-MPA
midbrain	29054882	1	I-MPA
(	29054882	1	I-MPA
MB	29054882	1	I-MPA
)	29054882	1	I-MPA
neurons	29054882	1	I-MPA
,	29054882	1	O
including	29054882	1	I-MPA
DA	29054882	1	I-MPA
neurons	29054882	1	I-MPA
,	29054882	1	O
and	29054882	1	O
the	29054882	1	O
slowed	29054882	1	O
endocytosis	29054882	1	O
can	29054882	1	O
be	29054882	1	O
rescued	29054882	1	O
by	29054882	1	O
inhibition	29054882	1	O
of	29054882	1	O
LRRK2	29054882	1	O
kinase	29054882	1	O
activity	29054882	1	O
.	29054882	1	O
A	29054882	1	O
similar	29054882	1	O
endocytic	29054882	1	O
defect	29054882	1	O
,	29054882	1	O
however	29054882	1	O
,	29054882	1	O
was	29054882	1	O
not	29054882	1	O
observed	29054882	1	O
in	29054882	1	O
LRRK2	29054882	1	O
mutant	29054882	1	O
neurons	29054882	1	O
from	29054882	1	O
the	29054882	1	O
neocortex	29054882	1	O
(	29054882	1	O
hereafter	29054882	1	O
,	29054882	1	O
cortical	29054882	1	O
neurons	29054882	1	O
)	29054882	1	O
or	29054882	1	O
the	29054882	1	O
hippocampus	29054882	1	O
,	29054882	1	O
suggesting	29054882	1	O
a	29054882	1	O
brain	29054882	1	O
region	29054882	1	O
-	29054882	1	O
specific	29054882	1	O
vulnerability	29054882	1	O
to	29054882	1	O
the	29054882	1	O
G2019S	29054882	1	O
mutation	29054882	1	O
.	29054882	1	O
Additionally	29054882	1	O
,	29054882	1	O
we	29054882	1	O
found	29054882	1	O
MB	29054882	1	O
-	29054882	1	O
specific	29054882	1	O
impairment	29054882	1	B-NegReg
of	29054882	1	O
SV	29054882	1	B-MPA
endocytosis	29054882	1	I-MPA
in	29054882	1	I-MPA
neurons	29054882	1	I-MPA
carrying	29054882	1	O
heterozygous	29054882	1	O
deletion	29054882	1	B-Var
of	29054882	1	O
SYNJ1	29054882	1	B-Gene
(	29054882	1	O
PARK20	29054882	1	O
)	29054882	1	O
,	29054882	1	O
a	29054882	1	O
gene	29054882	1	O
that	29054882	1	O
is	29054882	1	O
associated	29054882	1	O
with	29054882	1	O
recessive	29054882	1	O
Parkinsonism	29054882	1	O
.	29054882	1	O
Combining	29054882	1	O
SYNJ1	29054882	1	B-Var
/	29054882	1	I-Var
-	29054882	1	I-Var
and	29054882	1	O
LRRK2	29054882	1	B-Var
G2019S	29054882	1	I-Var
does	29054882	1	O
not	29054882	1	O
exacerbate	29054882	1	O
SV	29054882	1	O
endocytosis	29054882	1	O
but	29054882	1	O
impairs	29054882	1	B-NegReg
sustained	29054882	1	B-MPA
exocytosis	29054882	1	I-MPA
in	29054882	1	I-MPA
MB	29054882	1	I-MPA
neurons	29054882	1	I-MPA
and	29054882	1	O
alters	29054882	1	B-Reg
specific	29054882	1	B-MPA
motor	29054882	1	I-MPA
functions	29054882	1	I-MPA
of	29054882	1	O
1	29054882	1	O
-	29054882	1	O
year	29054882	1	O
-	29054882	1	O
old	29054882	1	O
male	29054882	1	O
mice	29054882	1	O
.	29054882	1	O
Interestingly	29054882	1	O
,	29054882	1	O
we	29054882	1	O
show	29054882	1	O
that	29054882	1	O
LRRK2	29054882	1	B-Var
directly	29054882	1	O
phosphorylates	29054882	1	O
synaptojanin1	29054882	1	O
in	29054882	1	O
vitro	29054882	1	O
,	29054882	1	O
resulting	29054882	1	B-Reg
in	29054882	1	I-Reg
the	29054882	1	O
disruption	29054882	1	B-MPA
of	29054882	1	I-MPA
endophilin	29054882	1	I-MPA
-	29054882	1	I-MPA
synaptojanin1	29054882	1	I-MPA
interaction	29054882	1	I-MPA
required	29054882	1	I-MPA
for	29054882	1	I-MPA
SV	29054882	1	I-MPA
endocytosis	29054882	1	I-MPA
.	29054882	1	O
Our	29054882	1	O
work	29054882	1	O
suggests	29054882	1	O
a	29054882	1	O
merge	29054882	1	O
of	29054882	1	O
LRRK2	29054882	1	O
and	29054882	1	O
SYNJ1	29054882	1	O
pathogenic	29054882	1	O
pathways	29054882	1	O
in	29054882	1	O
deregulating	29054882	1	O
SV	29054882	1	O
trafficking	29054882	1	O
in	29054882	1	O
MB	29054882	1	O
neurons	29054882	1	O
as	29054882	1	O
an	29054882	1	O
underlying	29054882	1	O
molecular	29054882	1	O
mechanism	29054882	1	O
of	29054882	1	O
early	29054882	1	O
PD	29054882	1	O
pathogenesis	29054882	1	O
.	29054882	1	O
SIGNIFICANCE	29054882	1	O
STATEMENT	29054882	1	O
Understanding	29054882	1	O
midbrain	29054882	1	O
dopaminergic	29054882	1	O
(	29054882	1	O
DAergic	29054882	1	O
)	29054882	1	O
neuron	29054882	1	O
-	29054882	1	O
selective	29054882	1	O
vulnerability	29054882	1	O
in	29054882	1	O
PD	29054882	1	O
is	29054882	1	O
essential	29054882	1	O
for	29054882	1	O
the	29054882	1	O
development	29054882	1	O
of	29054882	1	O
targeted	29054882	1	O
therapeutics	29054882	1	O
.	29054882	1	O
We	29054882	1	O
report	29054882	1	O
,	29054882	1	O
for	29054882	1	O
the	29054882	1	O
first	29054882	1	O
time	29054882	1	O
,	29054882	1	O
a	29054882	1	O
nerve	29054882	1	O
terminal	29054882	1	O
impairment	29054882	1	O
in	29054882	1	O
SV	29054882	1	O
trafficking	29054882	1	O
selectively	29054882	1	O
in	29054882	1	O
MB	29054882	1	O
neurons	29054882	1	O
but	29054882	1	O
not	29054882	1	O
cortical	29054882	1	O
neurons	29054882	1	O
caused	29054882	1	O
by	29054882	1	O
two	29054882	1	O
PARK	29054882	1	O
genes	29054882	1	O
:	29054882	1	O
LRRK2	29054882	1	O
(	29054882	1	O
PARK8	29054882	1	O
)	29054882	1	O
and	29054882	1	O
SYNJ1	29054882	1	O
(	29054882	1	O
PARK20	29054882	1	O
)	29054882	1	O
.	29054882	1	O
We	29054882	1	O
demonstrate	29054882	1	O
that	29054882	1	O
the	29054882	1	O
enhanced	29054882	1	B-PosReg
kinase	29054882	1	B-MPA
activity	29054882	1	I-MPA
resulting	29054882	1	O
from	29054882	1	O
the	29054882	1	O
most	29054882	1	O
frequent	29054882	1	O
G2019S	29054882	1	B-Var
mutation	29054882	1	O
in	29054882	1	O
LRRK2	29054882	1	B-Gene
is	29054882	1	O
the	29054882	1	O
key	29054882	1	O
to	29054882	1	O
this	29054882	1	O
impairment	29054882	1	O
.	29054882	1	O
We	29054882	1	O
provide	29054882	1	O
evidence	29054882	1	O
suggesting	29054882	1	O
that	29054882	1	O
LRRK2	29054882	1	B-Gene
G2019S	29054882	1	B-Var
and	29054882	1	O
SYNJ1	29054882	1	B-Gene
loss	29054882	1	B-NegReg
of	29054882	1	I-NegReg
function	29054882	1	I-NegReg
share	29054882	1	O
a	29054882	1	O
similar	29054882	1	O
pathogenic	29054882	1	O
pathway	29054882	1	O
in	29054882	1	O
deregulating	29054882	1	B-MPA
DAergic	29054882	1	I-MPA
neuron	29054882	1	I-MPA
SV	29054882	1	I-MPA
endocytosis	29054882	1	I-MPA
and	29054882	1	O
that	29054882	1	O
they	29054882	1	O
play	29054882	1	B-Reg
additive	29054882	1	I-Reg
roles	29054882	1	I-Reg
in	29054882	1	O
facilitating	29054882	1	O
each	29054882	1	O
other	29054882	1	O
'	29054882	1	O
s	29054882	1	O
pathogenic	29054882	1	O
functions	29054882	1	O
in	29054882	1	O
PD	29054882	1	B-Disease
.	29054882	1	O

From	29058783	0	O
mutational	29058783	0	O
inactivation	29058783	0	O
to	29058783	0	O
aberrant	29058783	0	O
gain	29058783	0	O
-	29058783	0	O
of	29058783	0	O
-	29058783	0	O
function	29058783	0	O
:	29058783	0	O
Unraveling	29058783	0	O
the	29058783	0	O
structural	29058783	0	O
basis	29058783	0	O
of	29058783	0	O
mutant	29058783	0	O
p53	29058783	0	O
oncogenic	29058783	0	O
transition	29058783	0	O
.	29058783	0	O
Various	29058783	0	O
evidence	29058783	0	O
has	29058783	0	O
revealed	29058783	0	O
that	29058783	0	O
mutations	29058783	0	B-Var
in	29058783	0	O
p53	29058783	0	B-Gene
exert	29058783	0	O
activities	29058783	0	O
that	29058783	0	O
go	29058783	0	O
beyond	29058783	0	O
simply	29058783	0	O
inactivation	29058783	0	B-PosReg
of	29058783	0	O
wildtype	29058783	0	B-MPA
functions	29058783	0	I-MPA
but	29058783	0	O
rather	29058783	0	O
elicits	29058783	0	B-Reg
downstream	29058783	0	O
interactions	29058783	0	B-Interaction
that	29058783	0	O
promote	29058783	0	B-PosReg
malignancy	29058783	0	B-Disease
described	29058783	0	O
as	29058783	0	O
mutant	29058783	0	B-Var
p53	29058783	0	B-Gene
gain	29058783	0	B-PosReg
-	29058783	0	I-PosReg
of	29058783	0	I-PosReg
-	29058783	0	I-PosReg
function	29058783	0	I-PosReg
(	29058783	0	O
GOF	29058783	0	O
)	29058783	0	O
.	29058783	0	O
Here	29058783	0	O
we	29058783	0	O
report	29058783	0	O
the	29058783	0	O
first	29058783	0	O
account	29058783	0	O
of	29058783	0	O
the	29058783	0	O
dynamics	29058783	0	O
of	29058783	0	O
mutation	29058783	0	O
-	29058783	0	O
induced	29058783	0	O
structural	29058783	0	O
transition	29058783	0	O
of	29058783	0	O
native	29058783	0	O
p53	29058783	0	O
to	29058783	0	O
an	29058783	0	O
aberrant	29058783	0	O
gain	29058783	0	O
-	29058783	0	O
of	29058783	0	O
-	29058783	0	O
function	29058783	0	O
state	29058783	0	O
,	29058783	0	O
studying	29058783	0	O
the	29058783	0	O
wildtype	29058783	0	O
(	29058783	0	O
WT	29058783	0	O
)	29058783	0	O
and	29058783	0	O
high	29058783	0	O
incidence	29058783	0	O
contact	29058783	0	O
(	29058783	0	B-Var
R273C	29058783	0	I-Var
)	29058783	0	I-Var
and	29058783	0	O
structural	29058783	0	O
(	29058783	0	B-Var
R175H	29058783	0	I-Var
)	29058783	0	I-Var
mutant	29058783	0	O
p53	29058783	0	B-Gene
(	29058783	0	O
mutp53	29058783	0	O
)	29058783	0	O
through	29058783	0	O
molecular	29058783	0	O
dynamics	29058783	0	O
simulation	29058783	0	O
.	29058783	0	O
Result	29058783	0	O
analysis	29058783	0	O
revealed	29058783	0	O
that	29058783	0	O
both	29058783	0	O
mutants	29058783	0	O
exhibited	29058783	0	B-Reg
structural	29058783	0	B-Var
distortion	29058783	0	I-Var
and	29058783	0	O
reduced	29058783	0	B-NegReg
flexibility	29058783	0	B-MPA
,	29058783	0	O
indicative	29058783	0	O
of	29058783	0	O
rigidity	29058783	0	O
and	29058783	0	O
kinetic	29058783	0	O
stability	29058783	0	O
.	29058783	0	O
In	29058783	0	O
addition	29058783	0	O
,	29058783	0	O
surface	29058783	0	O
analysis	29058783	0	O
revealed	29058783	0	O
an	29058783	0	O
increase	29058783	0	O
in	29058783	0	O
the	29058783	0	O
accessible	29058783	0	O
surface	29058783	0	O
area	29058783	0	O
in	29058783	0	O
the	29058783	0	O
p53	29058783	0	O
mutants	29058783	0	O
.	29058783	0	O
This	29058783	0	O
suggests	29058783	0	O
that	29058783	0	O
the	29058783	0	O
GOF	29058783	0	O
transition	29058783	0	O
involves	29058783	0	O
protein	29058783	0	O
unfolding	29058783	0	O
and	29058783	0	O
exposure	29058783	0	O
of	29058783	0	O
buried	29058783	0	O
hydrophobic	29058783	0	O
surface	29058783	0	O
essential	29058783	0	O
for	29058783	0	O
interaction	29058783	0	O
with	29058783	0	O
HSF-1	29058783	0	O
oncogenic	29058783	0	O
partner	29058783	0	O
and	29058783	0	O
wildtype	29058783	0	O
p63	29058783	0	O
,	29058783	0	O
and	29058783	0	O
p73	29058783	0	O
homologs	29058783	0	O
.	29058783	0	O
Further	29058783	0	O
validation	29058783	0	O
revealed	29058783	0	O
binding	29058783	0	O
cavities	29058783	0	O
,	29058783	0	O
similar	29058783	0	O
in	29058783	0	O
the	29058783	0	O
mutants	29058783	0	O
but	29058783	0	O
dissimilar	29058783	0	O
to	29058783	0	O
the	29058783	0	O
WT	29058783	0	O
.	29058783	0	O
Taken	29058783	0	O
together	29058783	0	O
,	29058783	0	O
this	29058783	0	O
study	29058783	0	O
complements	29058783	0	O
experimental	29058783	0	O
findings	29058783	0	O
and	29058783	0	O
reveals	29058783	0	O
the	29058783	0	O
interplay	29058783	0	O
between	29058783	0	O
mutation	29058783	0	B-Reg
-	29058783	0	I-Reg
induced	29058783	0	I-Reg
structural	29058783	0	B-Var
distortion	29058783	0	I-Var
,	29058783	0	O
loss	29058783	0	B-NegReg
of	29058783	0	O
flexibility	29058783	0	B-MPA
,	29058783	0	O
rigidity	29058783	0	B-MPA
,	29058783	0	O
enhanced	29058783	0	B-PosReg
stability	29058783	0	B-MPA
,	29058783	0	O
protein	29058783	0	O
unfolding	29058783	0	O
and	29058783	0	O
ultimately	29058783	0	O
,	29058783	0	O
exposure	29058783	0	O
of	29058783	0	O
binding	29058783	0	O
surfaces	29058783	0	O
as	29058783	0	O
conformational	29058783	0	O
attributes	29058783	0	O
that	29058783	0	O
characterize	29058783	0	O
mutP53	29058783	0	O
structure	29058783	0	O
-	29058783	0	O
GOF	29058783	0	O
activities	29058783	0	O
.	29058783	0	O
This	29058783	0	O
insight	29058783	0	O
is	29058783	0	O
,	29058783	0	O
therefore	29058783	0	O
,	29058783	0	O
of	29058783	0	O
great	29058783	0	O
importance	29058783	0	O
as	29058783	0	O
it	29058783	0	O
opens	29058783	0	O
up	29058783	0	O
a	29058783	0	O
novel	29058783	0	O
therapeutic	29058783	0	O
approach	29058783	0	O
toward	29058783	0	O
the	29058783	0	O
structure	29058783	0	O
based	29058783	0	O
targeting	29058783	0	O
of	29058783	0	O
mutP53	29058783	0	O
oncogenic	29058783	0	O
involvement	29058783	0	O
beyond	29058783	0	O
wildtype	29058783	0	O
inactivation	29058783	0	O
.	29058783	0	O
Furthermore	29058783	0	O
,	29058783	0	O
"	29058783	0	O
exposed	29058783	0	O
"	29058783	0	O
binding	29058783	0	O
site	29058783	0	O
information	29058783	0	O
obtained	29058783	0	O
from	29058783	0	O
this	29058783	0	O
study	29058783	0	O
can	29058783	0	O
be	29058783	0	O
explored	29058783	0	O
for	29058783	0	O
structure	29058783	0	O
-	29058783	0	O
based	29058783	0	O
design	29058783	0	O
of	29058783	0	O
substances	29058783	0	O
best	29058783	0	O
described	29058783	0	O
as	29058783	0	O
"	29058783	0	O
destabilizers	29058783	0	O
"	29058783	0	O
to	29058783	0	O
disrupt	29058783	0	O
the	29058783	0	O
GOF	29058783	0	O
interaction	29058783	0	O
of	29058783	0	O
mutp53	29058783	0	O
.	29058783	0	O

Gain	29064616	2	B-PosReg
-	29064616	2	I-PosReg
of	29064616	2	I-PosReg
-	29064616	2	I-PosReg
function	29064616	2	I-PosReg
HCN2	29064616	2	B-Gene
variants	29064616	2	B-Var
in	29064616	2	O
genetic	29064616	2	O
epilepsy	29064616	2	B-Disease
.	29064616	2	O
Genetic	29064616	2	O
generalized	29064616	2	O
epilepsy	29064616	2	O
(	29064616	2	O
GGE	29064616	2	O
)	29064616	2	O
is	29064616	2	O
a	29064616	2	O
common	29064616	2	O
epilepsy	29064616	2	O
syndrome	29064616	2	O
that	29064616	2	O
encompasses	29064616	2	O
seizure	29064616	2	O
disorders	29064616	2	O
characterized	29064616	2	O
by	29064616	2	O
spike	29064616	2	O
-	29064616	2	O
and	29064616	2	O
-	29064616	2	O
wave	29064616	2	O
discharges	29064616	2	O
(	29064616	2	O
SWDs	29064616	2	O
)	29064616	2	O
.	29064616	2	O
Pacemaker	29064616	2	O
hyperpolarization	29064616	2	O
-	29064616	2	O
activated	29064616	2	O
cyclic	29064616	2	O
nucleotide	29064616	2	O
-	29064616	2	O
gated	29064616	2	O
channels	29064616	2	O
(	29064616	2	O
HCN	29064616	2	O
)	29064616	2	O
are	29064616	2	O
considered	29064616	2	O
integral	29064616	2	O
to	29064616	2	O
SWD	29064616	2	O
genesis	29064616	2	O
,	29064616	2	O
making	29064616	2	O
them	29064616	2	O
an	29064616	2	O
ideal	29064616	2	O
gene	29064616	2	O
candidate	29064616	2	O
for	29064616	2	O
GGE	29064616	2	O
.	29064616	2	O
We	29064616	2	O
identified	29064616	2	O
HCN2	29064616	2	O
missense	29064616	2	O
variants	29064616	2	O
from	29064616	2	O
a	29064616	2	O
large	29064616	2	O
cohort	29064616	2	O
of	29064616	2	O
585	29064616	2	O
GGE	29064616	2	O
patients	29064616	2	O
,	29064616	2	O
recruited	29064616	2	O
by	29064616	2	O
the	29064616	2	O
Epilepsy	29064616	2	O
Phenome	29064616	2	O
-	29064616	2	O
Genome	29064616	2	O
Project	29064616	2	O
(	29064616	2	O
EPGP	29064616	2	O
)	29064616	2	O
,	29064616	2	O
and	29064616	2	O
performed	29064616	2	O
functional	29064616	2	O
analysis	29064616	2	O
using	29064616	2	O
two	29064616	2	O
-	29064616	2	O
electrode	29064616	2	O
voltage	29064616	2	O
clamp	29064616	2	O
recordings	29064616	2	O
from	29064616	2	O
Xenopus	29064616	2	O
oocytes	29064616	2	O
.	29064616	2	O
The	29064616	2	O
p.S632W	29064616	2	O
variant	29064616	2	O
was	29064616	2	O
identified	29064616	2	O
in	29064616	2	O
a	29064616	2	O
patient	29064616	2	O
with	29064616	2	O
idiopathic	29064616	2	O
photosensitive	29064616	2	O
occipital	29064616	2	O
epilepsy	29064616	2	O
and	29064616	2	O
segregated	29064616	2	O
in	29064616	2	O
the	29064616	2	O
family	29064616	2	O
.	29064616	2	O
This	29064616	2	O
variant	29064616	2	O
was	29064616	2	O
also	29064616	2	O
independently	29064616	2	O
identified	29064616	2	O
in	29064616	2	O
an	29064616	2	O
unrelated	29064616	2	O
patient	29064616	2	O
with	29064616	2	O
childhood	29064616	2	O
absence	29064616	2	O
seizures	29064616	2	O
from	29064616	2	O
a	29064616	2	O
European	29064616	2	O
cohort	29064616	2	O
of	29064616	2	O
238	29064616	2	O
familial	29064616	2	O
GGE	29064616	2	O
cases	29064616	2	O
.	29064616	2	O
The	29064616	2	O
p.V246M	29064616	2	O
variant	29064616	2	O
was	29064616	2	O
identified	29064616	2	O
in	29064616	2	O
a	29064616	2	O
patient	29064616	2	O
with	29064616	2	O
photo	29064616	2	O
-	29064616	2	O
sensitive	29064616	2	O
GGE	29064616	2	O
and	29064616	2	O
his	29064616	2	O
father	29064616	2	O
diagnosed	29064616	2	O
with	29064616	2	O
juvenile	29064616	2	O
myoclonic	29064616	2	O
epilepsy	29064616	2	O
.	29064616	2	O
Functional	29064616	2	O
studies	29064616	2	O
revealed	29064616	2	O
that	29064616	2	O
both	29064616	2	O
p.S632W	29064616	2	B-Var
and	29064616	2	O
p.V246M	29064616	2	B-Var
had	29064616	2	O
an	29064616	2	O
identical	29064616	2	O
functional	29064616	2	O
impact	29064616	2	O
including	29064616	2	O
a	29064616	2	O
depolarizing	29064616	2	B-MPA
shift	29064616	2	I-MPA
in	29064616	2	I-MPA
the	29064616	2	I-MPA
voltage	29064616	2	I-MPA
dependence	29064616	2	I-MPA
of	29064616	2	O
activation	29064616	2	B-PosReg
that	29064616	2	O
is	29064616	2	O
consistent	29064616	2	O
with	29064616	2	O
a	29064616	2	O
gain	29064616	2	O
-	29064616	2	O
of	29064616	2	O
-	29064616	2	O
function	29064616	2	O
.	29064616	2	O
In	29064616	2	O
contrast	29064616	2	O
,	29064616	2	O
no	29064616	2	O
biophysical	29064616	2	O
changes	29064616	2	O
resulted	29064616	2	O
from	29064616	2	O
the	29064616	2	O
introduction	29064616	2	O
of	29064616	2	O
common	29064616	2	O
population	29064616	2	O
variants	29064616	2	O
,	29064616	2	O
p.E280K	29064616	2	O
and	29064616	2	O
p.A705T	29064616	2	O
,	29064616	2	O
and	29064616	2	O
the	29064616	2	O
p.R756C	29064616	2	O
variant	29064616	2	O
from	29064616	2	O
EPGP	29064616	2	O
that	29064616	2	O
did	29064616	2	O
not	29064616	2	O
segregate	29064616	2	O
with	29064616	2	O
disease	29064616	2	O
.	29064616	2	O
Our	29064616	2	O
data	29064616	2	O
suggest	29064616	2	O
that	29064616	2	O
HCN2	29064616	2	B-Gene
variants	29064616	2	B-Var
can	29064616	2	O
confer	29064616	2	O
susceptibility	29064616	2	B-MPA
to	29064616	2	O
GGE	29064616	2	O
via	29064616	2	O
a	29064616	2	O
gain	29064616	2	B-PosReg
-	29064616	2	I-PosReg
of	29064616	2	I-PosReg
-	29064616	2	I-PosReg
function	29064616	2	I-PosReg
mechanism	29064616	2	O
.	29064616	2	O

Polymorphism	29067933	2	O
of	29067933	2	O
glutathione	29067933	2	O
S	29067933	2	O
-	29067933	2	O
transferase	29067933	2	O
M1	29067933	2	O
and	29067933	2	O
T1	29067933	2	O
genes	29067933	2	O
and	29067933	2	O
susceptibility	29067933	2	O
to	29067933	2	O
psoriasis	29067933	2	O
disease	29067933	2	O
:	29067933	2	O
A	29067933	2	O
study	29067933	2	O
from	29067933	2	O
North	29067933	2	O
India	29067933	2	O
.	29067933	2	O
BACKGROUND	29067933	2	O
:	29067933	2	O
Increased	29067933	2	O
oxidative	29067933	2	O
stress	29067933	2	O
and	29067933	2	O
resulting	29067933	2	O
inflammation	29067933	2	O
has	29067933	2	O
been	29067933	2	O
emphasized	29067933	2	O
as	29067933	2	O
a	29067933	2	O
factor	29067933	2	O
in	29067933	2	O
the	29067933	2	O
pathogenesis	29067933	2	O
of	29067933	2	O
many	29067933	2	O
diseases	29067933	2	O
including	29067933	2	O
psoriasis	29067933	2	O
.	29067933	2	O
Glutathione	29067933	2	O
S	29067933	2	O
-	29067933	2	O
transferases	29067933	2	O
(	29067933	2	O
GSTs	29067933	2	O
)	29067933	2	O
protect	29067933	2	O
against	29067933	2	O
oxidative	29067933	2	O
stress	29067933	2	O
,	29067933	2	O
inflammation	29067933	2	O
,	29067933	2	O
and	29067933	2	O
genotoxicity	29067933	2	O
.	29067933	2	O
Polymorphisms	29067933	2	B-Var
in	29067933	2	O
the	29067933	2	O
GST	29067933	2	B-Gene
genes	29067933	2	O
may	29067933	2	O
lead	29067933	2	B-Reg
to	29067933	2	I-Reg
an	29067933	2	O
imbalance	29067933	2	B-MPA
in	29067933	2	I-MPA
pro	29067933	2	I-MPA
-	29067933	2	I-MPA
and	29067933	2	I-MPA
antioxidant	29067933	2	I-MPA
systems	29067933	2	I-MPA
resulting	29067933	2	O
in	29067933	2	O
the	29067933	2	O
increased	29067933	2	B-PosReg
production	29067933	2	B-MPA
of	29067933	2	I-MPA
reactive	29067933	2	I-MPA
oxygen	29067933	2	I-MPA
species	29067933	2	I-MPA
that	29067933	2	O
could	29067933	2	O
influence	29067933	2	B-Reg
the	29067933	2	O
pathogenesis	29067933	2	O
of	29067933	2	O
psoriasis	29067933	2	B-Disease
.	29067933	2	O
AIM	29067933	2	O
:	29067933	2	O
The	29067933	2	O
aim	29067933	2	O
of	29067933	2	O
this	29067933	2	O
study	29067933	2	O
was	29067933	2	O
to	29067933	2	O
investigate	29067933	2	O
the	29067933	2	O
association	29067933	2	O
between	29067933	2	O
GSTs	29067933	2	O
(	29067933	2	O
GSTM1	29067933	2	O
and	29067933	2	O
GSTT1	29067933	2	O
)	29067933	2	O
gene	29067933	2	O
polymorphism	29067933	2	O
in	29067933	2	O
patients	29067933	2	O
with	29067933	2	O
chronic	29067933	2	O
plaque	29067933	2	O
psoriasis	29067933	2	O
as	29067933	2	O
a	29067933	2	O
factor	29067933	2	O
in	29067933	2	O
the	29067933	2	O
susceptibility	29067933	2	O
and	29067933	2	O
development	29067933	2	O
of	29067933	2	O
psoriasis	29067933	2	O
.	29067933	2	O
MATERIALS	29067933	2	O
AND	29067933	2	O
METHODS	29067933	2	O
:	29067933	2	O
We	29067933	2	O
assessed	29067933	2	O
128	29067933	2	O
patients	29067933	2	O
with	29067933	2	O
psoriasis	29067933	2	O
and	29067933	2	O
250	29067933	2	O
age	29067933	2	O
-	29067933	2	O
and	29067933	2	O
sex	29067933	2	O
-	29067933	2	O
matched	29067933	2	O
healthy	29067933	2	O
controls	29067933	2	O
.	29067933	2	O
Genomic	29067933	2	O
DNA	29067933	2	O
was	29067933	2	O
extracted	29067933	2	O
from	29067933	2	O
peripheral	29067933	2	O
blood	29067933	2	O
by	29067933	2	O
the	29067933	2	O
phenol	29067933	2	O
chloroform	29067933	2	O
method	29067933	2	O
.	29067933	2	O
The	29067933	2	O
null	29067933	2	O
GSTT1	29067933	2	O
and	29067933	2	O
GSTM1	29067933	2	O
genotypes	29067933	2	O
were	29067933	2	O
identified	29067933	2	O
by	29067933	2	O
multiplex	29067933	2	O
polymerase	29067933	2	O
chain	29067933	2	O
reaction	29067933	2	O
(	29067933	2	O
PCR	29067933	2	O
)	29067933	2	O
method	29067933	2	O
.	29067933	2	O
RESULTS	29067933	2	O
:	29067933	2	O
The	29067933	2	O
null	29067933	2	O
genotype	29067933	2	O
of	29067933	2	O
GSTM1	29067933	2	O
and	29067933	2	O
GSTT1	29067933	2	O
was	29067933	2	O
seen	29067933	2	O
in	29067933	2	O
45.3%	29067933	2	O
and	29067933	2	O
40.6%	29067933	2	O
in	29067933	2	O
psoriasis	29067933	2	O
patients	29067933	2	O
whereas	29067933	2	O
in	29067933	2	O
the	29067933	2	O
controls	29067933	2	O
it	29067933	2	O
was	29067933	2	O
34.4%	29067933	2	O
and	29067933	2	O
20.0%	29067933	2	O
,	29067933	2	O
respectively	29067933	2	O
.	29067933	2	O
A	29067933	2	O
significant	29067933	2	O
association	29067933	2	O
was	29067933	2	O
seen	29067933	2	O
between	29067933	2	O
the	29067933	2	O
null	29067933	2	O
alleles	29067933	2	O
of	29067933	2	O
the	29067933	2	O
GSTT1	29067933	2	O
(	29067933	2	O
OR	29067933	2	O
=	29067933	2	O
2.74	29067933	2	O
)	29067933	2	O
and	29067933	2	O
GSTM1	29067933	2	O
(	29067933	2	O
OR	29067933	2	O
=	29067933	2	O
1.58	29067933	2	O
)	29067933	2	O
alone	29067933	2	O
or	29067933	2	O
in	29067933	2	O
combination	29067933	2	O
with	29067933	2	O
tobacco	29067933	2	O
use	29067933	2	O
(	29067933	2	O
P	29067933	2	O
<	29067933	2	O
0.001	29067933	2	O
)	29067933	2	O
and	29067933	2	O
psoriasis	29067933	2	O
risk	29067933	2	O
.	29067933	2	O
The	29067933	2	O
presence	29067933	2	B-Var
of	29067933	2	O
both	29067933	2	O
null	29067933	2	O
genotypes	29067933	2	O
of	29067933	2	O
GSTM1	29067933	2	B-Gene
and	29067933	2	O
GSTT1	29067933	2	B-Gene
further	29067933	2	O
increased	29067933	2	B-PosReg
the	29067933	2	O
risk	29067933	2	O
of	29067933	2	O
psoriasis	29067933	2	B-Disease
(	29067933	2	O
OR	29067933	2	O
=	29067933	2	O
3.52	29067933	2	O
)	29067933	2	O
when	29067933	2	O
compared	29067933	2	O
with	29067933	2	O
the	29067933	2	O
positive	29067933	2	O
genotypes	29067933	2	O
of	29067933	2	O
GSTM1	29067933	2	O
and	29067933	2	O
GSTT1	29067933	2	O
.	29067933	2	O
LIMITATIONS	29067933	2	O
:	29067933	2	O
A	29067933	2	O
major	29067933	2	O
limitation	29067933	2	O
of	29067933	2	O
this	29067933	2	O
study	29067933	2	O
was	29067933	2	O
the	29067933	2	O
small	29067933	2	O
sample	29067933	2	O
size	29067933	2	O
.	29067933	2	O
A	29067933	2	O
large	29067933	2	O
epidemiological	29067933	2	O
study	29067933	2	O
is	29067933	2	O
necessary	29067933	2	O
to	29067933	2	O
confirm	29067933	2	O
these	29067933	2	O
findings	29067933	2	O
.	29067933	2	O
CONCLUSIONS	29067933	2	O
:	29067933	2	O
The	29067933	2	O
null	29067933	2	O
genotype	29067933	2	O
of	29067933	2	O
GSTT1	29067933	2	O
is	29067933	2	O
a	29067933	2	O
strong	29067933	2	O
predisposing	29067933	2	O
factor	29067933	2	O
for	29067933	2	O
psoriasis	29067933	2	O
in	29067933	2	O
North	29067933	2	O
India	29067933	2	O
.	29067933	2	O

Loss	29086445	0	O
-	29086445	0	O
of	29086445	0	O
-	29086445	0	O
function	29086445	0	O
of	29086445	0	O
ASPARTIC	29086445	0	O
PEPTIDASE	29086445	0	O
NODULE	29086445	0	O
-	29086445	0	O
INDUCED	29086445	0	O
1	29086445	0	O
(	29086445	0	O
APN1	29086445	0	O
)	29086445	0	O
in	29086445	0	O
Lotus	29086445	0	O
japonicus	29086445	0	O
restricts	29086445	0	O
efficient	29086445	0	O
nitrogen	29086445	0	O
-	29086445	0	O
fixing	29086445	0	O
symbiosis	29086445	0	O
with	29086445	0	O
specific	29086445	0	O
Mesorhizobium	29086445	0	O
loti	29086445	0	O
strains	29086445	0	O
.	29086445	0	O
The	29086445	0	O
nitrogen	29086445	0	O
-	29086445	0	O
fixing	29086445	0	O
symbiosis	29086445	0	O
of	29086445	0	O
legumes	29086445	0	O
and	29086445	0	O
Rhizobium	29086445	0	O
bacteria	29086445	0	O
is	29086445	0	O
established	29086445	0	O
by	29086445	0	O
complex	29086445	0	O
interactions	29086445	0	O
between	29086445	0	O
the	29086445	0	O
two	29086445	0	O
symbiotic	29086445	0	O
partners	29086445	0	O
.	29086445	0	O
Legume	29086445	0	O
Fix	29086445	0	O
-	29086445	0	O
mutants	29086445	0	O
form	29086445	0	O
apparently	29086445	0	O
normal	29086445	0	O
nodules	29086445	0	O
with	29086445	0	O
endosymbiotic	29086445	0	O
rhizobia	29086445	0	O
but	29086445	0	O
fail	29086445	0	O
to	29086445	0	O
induce	29086445	0	O
rhizobial	29086445	0	O
nitrogen	29086445	0	O
fixation	29086445	0	O
.	29086445	0	O
These	29086445	0	O
mutants	29086445	0	O
are	29086445	0	O
useful	29086445	0	O
for	29086445	0	O
identifying	29086445	0	O
the	29086445	0	O
legume	29086445	0	O
genes	29086445	0	O
involved	29086445	0	O
in	29086445	0	O
the	29086445	0	O
interactions	29086445	0	O
essential	29086445	0	O
for	29086445	0	O
symbiotic	29086445	0	O
nitrogen	29086445	0	O
fixation	29086445	0	O
.	29086445	0	O
We	29086445	0	O
describe	29086445	0	O
here	29086445	0	O
a	29086445	0	O
Fix	29086445	0	O
-	29086445	0	O
mutant	29086445	0	O
of	29086445	0	O
Lotus	29086445	0	O
japonicus	29086445	0	O
,	29086445	0	O
apn1	29086445	0	O
,	29086445	0	O
which	29086445	0	O
showed	29086445	0	O
a	29086445	0	O
very	29086445	0	O
specific	29086445	0	O
symbiotic	29086445	0	O
phenotype	29086445	0	O
.	29086445	0	O
It	29086445	0	O
formed	29086445	0	O
ineffective	29086445	0	O
nodules	29086445	0	O
when	29086445	0	O
inoculated	29086445	0	O
with	29086445	0	O
the	29086445	0	O
Mesorhizobium	29086445	0	O
loti	29086445	0	O
strain	29086445	0	O
TONO	29086445	0	O
.	29086445	0	O
In	29086445	0	O
these	29086445	0	O
nodules	29086445	0	O
,	29086445	0	O
infected	29086445	0	O
cells	29086445	0	O
disintegrated	29086445	0	O
and	29086445	0	O
successively	29086445	0	O
became	29086445	0	O
necrotic	29086445	0	O
,	29086445	0	O
indicating	29086445	0	B-Reg
premature	29086445	0	B-MPA
senescence	29086445	0	I-MPA
typical	29086445	0	O
of	29086445	0	O
Fix	29086445	0	B-Var
-	29086445	0	I-Var
mutants	29086445	0	I-Var
.	29086445	0	O
However	29086445	0	O
,	29086445	0	O
it	29086445	0	O
formed	29086445	0	O
effective	29086445	0	O
nodules	29086445	0	O
when	29086445	0	O
inoculated	29086445	0	O
with	29086445	0	O
the	29086445	0	O
M.	29086445	0	O
loti	29086445	0	O
strain	29086445	0	O
MAFF303099	29086445	0	O
.	29086445	0	O
Among	29086445	0	O
nine	29086445	0	O
different	29086445	0	O
M.	29086445	0	O
loti	29086445	0	O
strains	29086445	0	O
tested	29086445	0	O
,	29086445	0	O
four	29086445	0	O
formed	29086445	0	O
ineffective	29086445	0	O
nodules	29086445	0	O
and	29086445	0	O
five	29086445	0	O
formed	29086445	0	O
effective	29086445	0	O
nodules	29086445	0	O
on	29086445	0	O
apn1	29086445	0	O
roots	29086445	0	O
.	29086445	0	O
The	29086445	0	O
identified	29086445	0	O
causal	29086445	0	O
gene	29086445	0	O
,	29086445	0	O
ASPARTIC	29086445	0	O
PEPTIDASE	29086445	0	O
NODULE	29086445	0	O
-	29086445	0	O
INDUCED	29086445	0	O
1	29086445	0	O
(	29086445	0	O
LjAPN1	29086445	0	O
)	29086445	0	O
,	29086445	0	O
encodes	29086445	0	O
a	29086445	0	O
nepenthesin	29086445	0	O
-	29086445	0	O
type	29086445	0	O
aspartic	29086445	0	O
peptidase	29086445	0	O
.	29086445	0	O
The	29086445	0	O
well	29086445	0	O
characterized	29086445	0	O
Arabidopsis	29086445	0	O
aspartic	29086445	0	O
peptidase	29086445	0	O
CDR1	29086445	0	O
could	29086445	0	O
complement	29086445	0	O
the	29086445	0	O
strain	29086445	0	O
-	29086445	0	O
specific	29086445	0	O
Fix	29086445	0	O
-	29086445	0	O
phenotype	29086445	0	O
of	29086445	0	O
apn1	29086445	0	O
.	29086445	0	O
LjAPN1	29086445	0	O
is	29086445	0	O
a	29086445	0	O
typical	29086445	0	O
late	29086445	0	O
nodulin	29086445	0	O
;	29086445	0	O
its	29086445	0	O
gene	29086445	0	O
expression	29086445	0	O
was	29086445	0	O
exclusively	29086445	0	O
induced	29086445	0	O
during	29086445	0	O
nodule	29086445	0	O
development	29086445	0	O
.	29086445	0	O
LjAPN1	29086445	0	O
was	29086445	0	O
most	29086445	0	O
abundantly	29086445	0	O
expressed	29086445	0	O
in	29086445	0	O
the	29086445	0	O
infected	29086445	0	O
cells	29086445	0	O
in	29086445	0	O
the	29086445	0	O
nodules	29086445	0	O
.	29086445	0	O
Our	29086445	0	O
findings	29086445	0	O
indicate	29086445	0	O
that	29086445	0	O
LjAPN1	29086445	0	O
is	29086445	0	O
required	29086445	0	O
for	29086445	0	O
the	29086445	0	O
development	29086445	0	O
and	29086445	0	O
persistence	29086445	0	O
of	29086445	0	O
functional	29086445	0	O
(	29086445	0	O
nitrogen	29086445	0	O
-	29086445	0	O
fixing	29086445	0	O
)	29086445	0	O
symbiosis	29086445	0	O
in	29086445	0	O
a	29086445	0	O
rhizobial	29086445	0	O
strain	29086445	0	O
-	29086445	0	O
dependent	29086445	0	O
manner	29086445	0	O
,	29086445	0	O
and	29086445	0	O
thus	29086445	0	O
determines	29086445	0	O
compatibility	29086445	0	O
between	29086445	0	O
M.	29086445	0	O
loti	29086445	0	O
and	29086445	0	O
L.	29086445	0	O
japonicus	29086445	0	O
at	29086445	0	O
the	29086445	0	O
level	29086445	0	O
of	29086445	0	O
nitrogen	29086445	0	O
fixation	29086445	0	O
.	29086445	0	O

[	29087092	2	O
FILAGGRIN	29087092	2	O
GENE	29087092	2	O
NULL	29087092	2	O
-	29087092	2	O
MUTATIONS	29087092	2	O
AND	29087092	2	O
ATOPIC	29087092	2	O
DISEASES	29087092	2	O
]	29087092	2	O
.	29087092	2	O
Null	29087092	2	B-Var
-	29087092	2	I-Var
mutations	29087092	2	I-Var
which	29087092	2	O
cause	29087092	2	O
loss	29087092	2	B-NegReg
of	29087092	2	I-NegReg
function	29087092	2	I-NegReg
of	29087092	2	O
the	29087092	2	O
gene	29087092	2	O
encoding	29087092	2	O
filaggrin	29087092	2	O
(	29087092	2	B-Gene
FLG	29087092	2	I-Gene
)	29087092	2	I-Gene
have	29087092	2	O
been	29087092	2	O
strongly	29087092	2	O
linked	29087092	2	B-Reg
to	29087092	2	O
the	29087092	2	O
development	29087092	2	O
of	29087092	2	O
atopic	29087092	2	O
disorders	29087092	2	O
,	29087092	2	O
predominantly	29087092	2	O
atopic	29087092	2	B-Disease
eczema	29087092	2	I-Disease
/	29087092	2	I-Disease
dermatitis	29087092	2	I-Disease
syndrome	29087092	2	I-Disease
(	29087092	2	O
AEDS	29087092	2	O
)	29087092	2	O
.	29087092	2	O
Filaggrin	29087092	2	O
plays	29087092	2	O
a	29087092	2	O
key	29087092	2	O
role	29087092	2	O
in	29087092	2	O
epidermal	29087092	2	O
barrier	29087092	2	O
function	29087092	2	O
by	29087092	2	O
upholding	29087092	2	O
epidermal	29087092	2	O
structure	29087092	2	O
and	29087092	2	O
moisturization	29087092	2	O
.	29087092	2	O
Up	29087092	2	O
to	29087092	2	O
now	29087092	2	O
,	29087092	2	O
around	29087092	2	O
40	29087092	2	O
variants	29087092	2	O
of	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
have	29087092	2	O
been	29087092	2	O
genotyped	29087092	2	O
among	29087092	2	O
different	29087092	2	O
world	29087092	2	O
populations	29087092	2	O
.	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
are	29087092	2	O
present	29087092	2	O
in	29087092	2	O
up	29087092	2	O
to	29087092	2	O
10%	29087092	2	O
of	29087092	2	O
the	29087092	2	O
Caucasian	29087092	2	O
population	29087092	2	O
in	29087092	2	O
Western	29087092	2	O
Europe	29087092	2	O
and	29087092	2	O
North	29087092	2	O
America	29087092	2	O
,	29087092	2	O
with	29087092	2	O
R05X	29087092	2	O
and	29087092	2	O
2282	29087092	2	O
del4	29087092	2	O
as	29087092	2	O
the	29087092	2	O
most	29087092	2	O
common	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
.	29087092	2	O
Epidemiological	29087092	2	O
studies	29087092	2	O
conducted	29087092	2	O
in	29087092	2	O
Europe	29087092	2	O
indicate	29087092	2	O
a	29087092	2	O
latitude	29087092	2	O
dependent	29087092	2	O
distribution	29087092	2	O
of	29087092	2	O
common	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
with	29087092	2	O
a	29087092	2	O
decreasing	29087092	2	O
north	29087092	2	O
-	29087092	2	O
south	29087092	2	O
gradient	29087092	2	O
of	29087092	2	O
R501X	29087092	2	O
and	29087092	2	O
2282	29087092	2	O
del4	29087092	2	O
mutation	29087092	2	O
frequencies	29087092	2	O
.	29087092	2	O
FLG	29087092	2	B-Gene
null	29087092	2	B-Var
-	29087092	2	I-Var
mutation	29087092	2	I-Var
carriers	29087092	2	O
are	29087092	2	O
prone	29087092	2	O
to	29087092	2	O
develop	29087092	2	B-PosReg
unspecific	29087092	2	B-Disease
skin	29087092	2	I-Disease
symptoms	29087092	2	I-Disease
related	29087092	2	O
to	29087092	2	O
atopic	29087092	2	O
and	29087092	2	O
non	29087092	2	O
-	29087092	2	O
atopic	29087092	2	O
skin	29087092	2	O
disorders	29087092	2	O
due	29087092	2	O
to	29087092	2	O
their	29087092	2	O
defect	29087092	2	O
of	29087092	2	O
epidermal	29087092	2	O
barrier	29087092	2	O
function	29087092	2	O
,	29087092	2	O
which	29087092	2	O
allows	29087092	2	O
greater	29087092	2	O
skin	29087092	2	O
penetration	29087092	2	O
of	29087092	2	O
various	29087092	2	O
hazards	29087092	2	O
.	29087092	2	O
Epidemiological	29087092	2	O
studies	29087092	2	O
indicate	29087092	2	O
an	29087092	2	O
association	29087092	2	B-Interaction
of	29087092	2	O
FLG	29087092	2	B-Gene
null	29087092	2	B-Var
-	29087092	2	I-Var
mutations	29087092	2	I-Var
with	29087092	2	O
AEDS	29087092	2	B-Disease
,	29087092	2	O
whereas	29087092	2	O
results	29087092	2	O
regarding	29087092	2	O
an	29087092	2	O
association	29087092	2	O
of	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
with	29087092	2	O
sensitization	29087092	2	O
to	29087092	2	O
common	29087092	2	O
inhalant	29087092	2	O
allergens	29087092	2	O
and	29087092	2	O
development	29087092	2	O
of	29087092	2	O
rhinitis	29087092	2	O
and	29087092	2	O
asthma	29087092	2	O
are	29087092	2	O
incoherent	29087092	2	O
.	29087092	2	O
A	29087092	2	O
study	29087092	2	O
conducted	29087092	2	O
in	29087092	2	O
Croatia	29087092	2	O
found	29087092	2	O
a	29087092	2	O
low	29087092	2	O
frequency	29087092	2	O
of	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
in	29087092	2	O
general	29087092	2	O
population	29087092	2	O
(	29087092	2	O
2.6%	29087092	2	O
)	29087092	2	O
and	29087092	2	O
did	29087092	2	O
not	29087092	2	O
confirm	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
as	29087092	2	O
an	29087092	2	O
etiological	29087092	2	O
factor	29087092	2	O
for	29087092	2	O
atopy	29087092	2	O
and	29087092	2	O
atopic	29087092	2	O
disease	29087092	2	O
in	29087092	2	O
the	29087092	2	O
studied	29087092	2	O
population	29087092	2	O
.	29087092	2	O

FGF	29097598	0	O
-	29097598	0	O
FGFR	29097598	0	O
Mediates	29097598	0	O
the	29097598	0	O
Activity	29097598	0	O
-	29097598	0	O
Dependent	29097598	0	O
Dendritogenesis	29097598	0	O
of	29097598	0	O
Layer	29097598	0	O
IV	29097598	0	O
Neurons	29097598	0	O
during	29097598	0	O
Barrel	29097598	0	O
Formation	29097598	0	O
.	29097598	0	O
Fibroblast	29097598	0	O
growth	29097598	0	O
factors	29097598	0	O
(	29097598	0	O
FGFs	29097598	0	O
)	29097598	0	O
and	29097598	0	O
FGF	29097598	0	O
receptors	29097598	0	O
(	29097598	0	O
FGFRs	29097598	0	O
)	29097598	0	O
are	29097598	0	O
known	29097598	0	O
for	29097598	0	O
their	29097598	0	O
potent	29097598	0	O
effects	29097598	0	O
on	29097598	0	O
cell	29097598	0	O
proliferation	29097598	0	O
/	29097598	0	O
differentiation	29097598	0	O
and	29097598	0	O
cortical	29097598	0	O
patterning	29097598	0	O
in	29097598	0	O
the	29097598	0	O
developing	29097598	0	O
brain	29097598	0	O
.	29097598	0	O
However	29097598	0	O
,	29097598	0	O
little	29097598	0	O
is	29097598	0	O
known	29097598	0	O
regarding	29097598	0	O
the	29097598	0	O
roles	29097598	0	O
of	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
in	29097598	0	O
cortical	29097598	0	O
circuit	29097598	0	O
formation	29097598	0	O
.	29097598	0	O
Here	29097598	0	O
we	29097598	0	O
show	29097598	0	O
that	29097598	0	O
Fgfr1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
and	29097598	0	O
Fgf7	29097598	0	O
/	29097598	0	O
9	29097598	0	O
/	29097598	0	O
10	29097598	0	O
/	29097598	0	O
22	29097598	0	O
mRNAs	29097598	0	O
are	29097598	0	O
expressed	29097598	0	O
in	29097598	0	O
the	29097598	0	O
developing	29097598	0	O
primary	29097598	0	O
somatosensory	29097598	0	O
(	29097598	0	O
S1	29097598	0	O
)	29097598	0	O
barrel	29097598	0	O
cortex	29097598	0	O
.	29097598	0	O
Barrel	29097598	0	O
cortex	29097598	0	O
layer	29097598	0	O
IV	29097598	0	O
spiny	29097598	0	O
stellate	29097598	0	O
cells	29097598	0	O
(	29097598	0	O
bSCs	29097598	0	O
)	29097598	0	O
are	29097598	0	O
the	29097598	0	O
primary	29097598	0	O
recipients	29097598	0	O
of	29097598	0	O
ascending	29097598	0	O
sensory	29097598	0	O
information	29097598	0	O
via	29097598	0	O
thalamocortical	29097598	0	O
axons	29097598	0	O
(	29097598	0	O
TCAs	29097598	0	O
)	29097598	0	O
.	29097598	0	O
Detail	29097598	0	O
quantification	29097598	0	O
revealed	29097598	0	O
distinctive	29097598	0	O
phases	29097598	0	O
for	29097598	0	O
bSC	29097598	0	O
dendritogenesis	29097598	0	O
:	29097598	0	O
orienting	29097598	0	O
dendrites	29097598	0	O
toward	29097598	0	O
TCAs	29097598	0	O
,	29097598	0	O
adding	29097598	0	O
de	29097598	0	O
novo	29097598	0	O
dendritic	29097598	0	O
segments	29097598	0	O
,	29097598	0	O
and	29097598	0	O
elongating	29097598	0	O
dendritic	29097598	0	O
length	29097598	0	O
,	29097598	0	O
while	29097598	0	O
maintaining	29097598	0	O
dendritic	29097598	0	O
patterns	29097598	0	O
.	29097598	0	O
Deleting	29097598	0	O
Fgfr1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
in	29097598	0	O
bSCs	29097598	0	O
had	29097598	0	O
minimal	29097598	0	O
impact	29097598	0	O
on	29097598	0	O
dendritic	29097598	0	O
polarity	29097598	0	O
but	29097598	0	O
transiently	29097598	0	O
increased	29097598	0	O
the	29097598	0	O
number	29097598	0	O
of	29097598	0	O
dendritic	29097598	0	O
segments	29097598	0	O
.	29097598	0	O
However	29097598	0	O
,	29097598	0	O
6	29097598	0	O
d	29097598	0	O
later	29097598	0	O
,	29097598	0	O
FGFR1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
loss	29097598	0	O
of	29097598	0	O
function	29097598	0	O
reduced	29097598	0	O
dendritic	29097598	0	O
branch	29097598	0	O
numbers	29097598	0	O
.	29097598	0	O
These	29097598	0	O
data	29097598	0	O
suggest	29097598	0	O
that	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
have	29097598	0	O
a	29097598	0	O
role	29097598	0	O
in	29097598	0	O
stabilizing	29097598	0	O
dendritic	29097598	0	O
patterning	29097598	0	O
.	29097598	0	O
Depolarization	29097598	0	O
of	29097598	0	O
cultured	29097598	0	O
mouse	29097598	0	O
cortical	29097598	0	O
neurons	29097598	0	O
upregulated	29097598	0	O
the	29097598	0	O
levels	29097598	0	O
of	29097598	0	O
several	29097598	0	O
Fgf	29097598	0	O
/	29097598	0	O
Fgfr	29097598	0	O
mRNAs	29097598	0	O
within	29097598	0	O
2	29097598	0	O
h	29097598	0	O
.	29097598	0	O
In	29097598	0	O
vivo	29097598	0	O
,	29097598	0	O
within	29097598	0	O
6	29097598	0	O
h	29097598	0	O
of	29097598	0	O
systemic	29097598	0	O
kainic	29097598	0	O
acid	29097598	0	O
administration	29097598	0	O
at	29097598	0	O
postnatal	29097598	0	O
day	29097598	0	O
6	29097598	0	O
,	29097598	0	O
mRNA	29097598	0	O
levels	29097598	0	O
of	29097598	0	O
Fgf9	29097598	0	O
,	29097598	0	O
Fgf10	29097598	0	O
,	29097598	0	O
Fgfr2c	29097598	0	O
,	29097598	0	O
and	29097598	0	O
Fgfr3b	29097598	0	O
in	29097598	0	O
S1	29097598	0	O
cortices	29097598	0	O
were	29097598	0	O
enhanced	29097598	0	O
,	29097598	0	O
and	29097598	0	O
this	29097598	0	O
was	29097598	0	O
accompanied	29097598	0	O
by	29097598	0	O
exuberant	29097598	0	O
dendritogenesis	29097598	0	O
of	29097598	0	O
bSCs	29097598	0	O
by	29097598	0	O
24	29097598	0	O
h	29097598	0	O
.	29097598	0	O
Deleting	29097598	0	O
Fgfr1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
abolished	29097598	0	O
kainic	29097598	0	O
acid	29097598	0	O
-	29097598	0	O
induced	29097598	0	O
bSC	29097598	0	O
dendritic	29097598	0	O
overgrowth	29097598	0	O
.	29097598	0	O
Finally	29097598	0	O
,	29097598	0	O
FGF9	29097598	0	O
/	29097598	0	O
10	29097598	0	O
gain	29097598	0	O
of	29097598	0	O
function	29097598	0	O
also	29097598	0	O
resulted	29097598	0	O
in	29097598	0	O
extensive	29097598	0	O
dendritogenesis	29097598	0	O
.	29097598	0	O
Together	29097598	0	O
,	29097598	0	O
our	29097598	0	O
data	29097598	0	O
suggest	29097598	0	O
that	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
can	29097598	0	O
be	29097598	0	O
regulated	29097598	0	O
by	29097598	0	O
glutamate	29097598	0	O
transmission	29097598	0	O
to	29097598	0	O
modulate	29097598	0	O
/	29097598	0	O
stabilize	29097598	0	O
bSC	29097598	0	O
dendritic	29097598	0	O
complexity	29097598	0	O
.	29097598	0	O
Both	29097598	0	O
male	29097598	0	O
and	29097598	0	O
female	29097598	0	O
mice	29097598	0	O
were	29097598	0	O
used	29097598	0	O
for	29097598	0	O
our	29097598	0	O
study	29097598	0	O
.	29097598	0	O
SIGNIFICANCE	29097598	0	O
STATEMENT	29097598	0	O
Glutamatergic	29097598	0	O
transmission	29097598	0	O
plays	29097598	0	O
critical	29097598	0	O
roles	29097598	0	O
in	29097598	0	O
cortical	29097598	0	O
circuit	29097598	0	O
formation	29097598	0	O
.	29097598	0	O
Its	29097598	0	O
dysregulation	29097598	0	O
has	29097598	0	O
been	29097598	0	O
proposed	29097598	0	O
as	29097598	0	O
a	29097598	0	O
core	29097598	0	O
factor	29097598	0	O
in	29097598	0	O
the	29097598	0	O
etiology	29097598	0	O
of	29097598	0	O
many	29097598	0	O
neurological	29097598	0	O
diseases	29097598	0	O
.	29097598	0	O
We	29097598	0	O
found	29097598	0	O
that	29097598	0	O
excessive	29097598	0	O
glutamate	29097598	0	O
transmission	29097598	0	O
upregulated	29097598	0	O
mRNA	29097598	0	O
expression	29097598	0	O
of	29097598	0	O
Fgfrs	29097598	0	O
and	29097598	0	O
their	29097598	0	O
ligands	29097598	0	O
Fgfs	29097598	0	O
Deleting	29097598	0	B-Var
Fgfr1	29097598	0	B-Gene
/	29097598	0	I-Gene
2	29097598	0	I-Gene
/	29097598	0	I-Gene
3	29097598	0	I-Gene
not	29097598	0	O
only	29097598	0	O
impaired	29097598	0	B-NegReg
bSC	29097598	0	B-MPA
dendritogenesis	29097598	0	I-MPA
but	29097598	0	O
also	29097598	0	O
abolished	29097598	0	B-NegReg
glutamate	29097598	0	B-MPA
transmission	29097598	0	I-MPA
-	29097598	0	I-MPA
induced	29097598	0	I-MPA
dendritic	29097598	0	I-MPA
overgrowth	29097598	0	I-MPA
.	29097598	0	O
Overexpressing	29097598	0	O
FGF9	29097598	0	O
or	29097598	0	O
FGF10	29097598	0	O
in	29097598	0	O
cortical	29097598	0	O
glutamatergic	29097598	0	O
neurons	29097598	0	O
results	29097598	0	O
in	29097598	0	O
excessive	29097598	0	O
dendritic	29097598	0	O
outgrowth	29097598	0	O
within	29097598	0	O
24	29097598	0	O
h	29097598	0	O
,	29097598	0	O
resembling	29097598	0	O
the	29097598	0	O
changes	29097598	0	O
induced	29097598	0	O
by	29097598	0	O
excessive	29097598	0	O
glutamate	29097598	0	O
transmission	29097598	0	O
.	29097598	0	O
Our	29097598	0	O
findings	29097598	0	O
provide	29097598	0	O
strong	29097598	0	O
evidence	29097598	0	O
for	29097598	0	O
the	29097598	0	O
physiological	29097598	0	O
role	29097598	0	O
of	29097598	0	O
fibroblast	29097598	0	O
growth	29097598	0	O
factors	29097598	0	O
(	29097598	0	O
FGFs	29097598	0	O
)	29097598	0	O
and	29097598	0	O
FGF	29097598	0	O
receptors	29097598	0	O
(	29097598	0	O
FGFRs	29097598	0	O
)	29097598	0	O
in	29097598	0	O
establishing	29097598	0	O
and	29097598	0	O
maintaining	29097598	0	O
cortical	29097598	0	O
circuits	29097598	0	O
.	29097598	0	O
Perturbing	29097598	0	O
the	29097598	0	O
expression	29097598	0	O
levels	29097598	0	O
of	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
by	29097598	0	O
excessive	29097598	0	O
glutamatergic	29097598	0	O
neurotransmission	29097598	0	O
could	29097598	0	O
lead	29097598	0	O
to	29097598	0	O
abnormal	29097598	0	O
neuronal	29097598	0	O
circuits	29097598	0	O
,	29097598	0	O
which	29097598	0	O
may	29097598	0	O
contribute	29097598	0	O
to	29097598	0	O
neurological	29097598	0	O
and	29097598	0	O
psychiatric	29097598	0	O
disease	29097598	0	O
.	29097598	0	O

Why	29099487	2	O
are	29099487	2	O
there	29099487	2	O
hotspot	29099487	2	O
mutations	29099487	2	O
in	29099487	2	O
the	29099487	2	O
TP53	29099487	2	O
gene	29099487	2	O
in	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
?	29099487	2	O
The	29099487	2	O
p53	29099487	2	O
gene	29099487	2	O
contains	29099487	2	O
homozygous	29099487	2	O
mutations	29099487	2	O
in	29099487	2	O
50	29099487	2	O
-	29099487	2	O
60%	29099487	2	O
of	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
.	29099487	2	O
About	29099487	2	O
90%	29099487	2	O
of	29099487	2	O
these	29099487	2	O
mutations	29099487	2	O
encode	29099487	2	O
missense	29099487	2	O
mutant	29099487	2	O
proteins	29099487	2	O
that	29099487	2	O
span	29099487	2	O
190	29099487	2	O
different	29099487	2	O
codons	29099487	2	O
localized	29099487	2	O
in	29099487	2	O
the	29099487	2	O
DNA	29099487	2	O
-	29099487	2	O
binding	29099487	2	O
domain	29099487	2	O
of	29099487	2	O
the	29099487	2	O
gene	29099487	2	O
and	29099487	2	O
protein	29099487	2	O
.	29099487	2	O
These	29099487	2	O
mutations	29099487	2	B-Var
produce	29099487	2	O
a	29099487	2	O
protein	29099487	2	O
with	29099487	2	O
a	29099487	2	O
reduced	29099487	2	O
capacity	29099487	2	O
to	29099487	2	O
bind	29099487	2	O
to	29099487	2	O
a	29099487	2	O
specific	29099487	2	O
DNA	29099487	2	O
sequence	29099487	2	O
that	29099487	2	O
regulates	29099487	2	B-Reg
the	29099487	2	O
p53	29099487	2	B-Pathway
transcriptional	29099487	2	I-Pathway
pathway	29099487	2	I-Pathway
.	29099487	2	O
Eight	29099487	2	O
of	29099487	2	O
these	29099487	2	O
mutations	29099487	2	O
are	29099487	2	O
localized	29099487	2	O
in	29099487	2	O
codons	29099487	2	O
that	29099487	2	O
account	29099487	2	O
for	29099487	2	O
28%	29099487	2	O
of	29099487	2	O
the	29099487	2	O
total	29099487	2	O
p53	29099487	2	O
mutations	29099487	2	O
and	29099487	2	O
these	29099487	2	O
alleles	29099487	2	O
appear	29099487	2	O
to	29099487	2	O
be	29099487	2	O
selected	29099487	2	O
for	29099487	2	O
preferentially	29099487	2	O
in	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
of	29099487	2	O
many	29099487	2	O
tissue	29099487	2	O
types	29099487	2	O
.	29099487	2	O
This	29099487	2	O
article	29099487	2	O
explores	29099487	2	O
the	29099487	2	O
question	29099487	2	O
'	29099487	2	O
Why	29099487	2	O
are	29099487	2	O
there	29099487	2	O
hotspot	29099487	2	O
mutations	29099487	2	O
in	29099487	2	O
the	29099487	2	O
p53	29099487	2	O
gene	29099487	2	O
in	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
?	29099487	2	O
'	29099487	2	O
Four	29099487	2	O
possible	29099487	2	O
reasons	29099487	2	O
for	29099487	2	O
this	29099487	2	O
are	29099487	2	O
considered	29099487	2	O
;	29099487	2	O
(	29099487	2	O
1	29099487	2	O
)	29099487	2	O
the	29099487	2	O
hotspot	29099487	2	O
mutant	29099487	2	B-Var
alleles	29099487	2	O
produce	29099487	2	O
a	29099487	2	O
protein	29099487	2	O
that	29099487	2	O
has	29099487	2	O
a	29099487	2	O
highly	29099487	2	O
altered	29099487	2	B-Reg
structure	29099487	2	B-MPA
,	29099487	2	O
(	29099487	2	O
2	29099487	2	O
)	29099487	2	O
environmental	29099487	2	O
mutagens	29099487	2	O
produce	29099487	2	O
allele	29099487	2	O
-	29099487	2	O
specific	29099487	2	O
changes	29099487	2	O
in	29099487	2	O
the	29099487	2	O
p53	29099487	2	O
gene	29099487	2	O
,	29099487	2	O
(	29099487	2	O
3	29099487	2	O
)	29099487	2	O
these	29099487	2	O
mutations	29099487	2	O
arise	29099487	2	O
at	29099487	2	O
selected	29099487	2	O
sites	29099487	2	O
in	29099487	2	O
the	29099487	2	O
gene	29099487	2	O
due	29099487	2	O
to	29099487	2	O
a	29099487	2	O
specific	29099487	2	O
DNA	29099487	2	O
sequence	29099487	2	O
,	29099487	2	O
such	29099487	2	O
as	29099487	2	O
a	29099487	2	O
methylated	29099487	2	O
cytosine	29099487	2	O
residue	29099487	2	O
in	29099487	2	O
a	29099487	2	O
CpG	29099487	2	O
dinucleotide	29099487	2	O
,	29099487	2	O
which	29099487	2	O
has	29099487	2	O
a	29099487	2	O
higher	29099487	2	O
mutation	29099487	2	O
rate	29099487	2	O
changing	29099487	2	O
C	29099487	2	O
to	29099487	2	O
T	29099487	2	O
nucleotides	29099487	2	O
,	29099487	2	O
(	29099487	2	O
4	29099487	2	O
)	29099487	2	O
along	29099487	2	O
with	29099487	2	O
the	29099487	2	O
observed	29099487	2	O
change	29099487	2	O
in	29099487	2	O
mutant	29099487	2	O
p53	29099487	2	O
proteins	29099487	2	O
,	29099487	2	O
which	29099487	2	O
produce	29099487	2	O
a	29099487	2	O
loss	29099487	2	O
of	29099487	2	O
function	29099487	2	O
(	29099487	2	O
DNA	29099487	2	O
binding	29099487	2	O
and	29099487	2	O
transcription	29099487	2	O
)	29099487	2	O
,	29099487	2	O
some	29099487	2	O
mutant	29099487	2	B-Var
proteins	29099487	2	B-Protein
have	29099487	2	O
an	29099487	2	O
allele	29099487	2	O
-	29099487	2	O
specific	29099487	2	O
gain	29099487	2	B-PosReg
of	29099487	2	I-PosReg
function	29099487	2	I-PosReg
that	29099487	2	O
promotes	29099487	2	O
cancer	29099487	2	B-Disease
.	29099487	2	O
Evidence	29099487	2	O
is	29099487	2	O
presented	29099487	2	O
that	29099487	2	O
demonstrates	29099487	2	O
the	29099487	2	O
first	29099487	2	O
three	29099487	2	O
possibilities	29099487	2	O
all	29099487	2	O
contribute	29099487	2	O
some	29099487	2	O
property	29099487	2	O
to	29099487	2	O
this	29099487	2	O
list	29099487	2	O
of	29099487	2	O
hotspot	29099487	2	O
mutations	29099487	2	O
.	29099487	2	O
The	29099487	2	O
fourth	29099487	2	O
possibility	29099487	2	O
remains	29099487	2	O
to	29099487	2	O
be	29099487	2	O
tested	29099487	2	O
.	29099487	2	O

Mutant	29099488	0	O
p53	29099488	0	O
partners	29099488	0	O
in	29099488	0	O
crime	29099488	0	O
.	29099488	0	O
Mutant	29099488	0	B-Var
p53	29099488	0	B-Gene
proteins	29099488	0	B-Protein
impart	29099488	0	O
changes	29099488	0	B-Reg
in	29099488	0	O
cellular	29099488	0	B-MPA
behavior	29099488	0	I-MPA
and	29099488	0	O
function	29099488	0	B-MPA
through	29099488	0	O
interactions	29099488	0	B-Interaction
with	29099488	0	O
proteins	29099488	0	B-Protein
that	29099488	0	O
alter	29099488	0	O
gene	29099488	0	O
expression	29099488	0	O
.	29099488	0	O
The	29099488	0	O
milieu	29099488	0	O
of	29099488	0	O
intracellular	29099488	0	O
proteins	29099488	0	O
available	29099488	0	O
to	29099488	0	O
interact	29099488	0	O
with	29099488	0	O
mutant	29099488	0	O
p53	29099488	0	O
is	29099488	0	O
context	29099488	0	O
specific	29099488	0	O
and	29099488	0	O
changes	29099488	0	O
with	29099488	0	O
disease	29099488	0	O
,	29099488	0	O
cell	29099488	0	O
type	29099488	0	O
,	29099488	0	O
and	29099488	0	O
environmental	29099488	0	O
conditions	29099488	0	O
.	29099488	0	O
Varying	29099488	0	O
conformations	29099488	0	O
of	29099488	0	O
mutant	29099488	0	B-Var
p53	29099488	0	B-Gene
largely	29099488	0	O
dictate	29099488	0	B-Reg
protein	29099488	0	B-MPA
-	29099488	0	I-MPA
protein	29099488	0	I-MPA
interactions	29099488	0	I-MPA
as	29099488	0	O
different	29099488	0	O
point	29099488	0	O
mutations	29099488	0	O
within	29099488	0	O
protein	29099488	0	O
-	29099488	0	O
coding	29099488	0	O
regions	29099488	0	O
greatly	29099488	0	O
alter	29099488	0	O
the	29099488	0	O
extent	29099488	0	O
and	29099488	0	O
array	29099488	0	O
of	29099488	0	O
gain	29099488	0	O
-	29099488	0	O
of	29099488	0	O
-	29099488	0	O
function	29099488	0	O
(	29099488	0	O
GOF	29099488	0	O
)	29099488	0	O
activities	29099488	0	O
.	29099488	0	O
Given	29099488	0	O
such	29099488	0	O
variables	29099488	0	O
,	29099488	0	O
how	29099488	0	O
can	29099488	0	O
knowledge	29099488	0	O
regarding	29099488	0	O
p53	29099488	0	O
missense	29099488	0	O
mutations	29099488	0	O
be	29099488	0	O
translated	29099488	0	O
into	29099488	0	O
predicting	29099488	0	O
or	29099488	0	O
altering	29099488	0	O
biologic	29099488	0	O
activity	29099488	0	O
for	29099488	0	O
therapy	29099488	0	O
?	29099488	0	O
How	29099488	0	O
may	29099488	0	O
knowledge	29099488	0	O
regarding	29099488	0	O
mutant	29099488	0	O
p53	29099488	0	O
functions	29099488	0	O
within	29099488	0	O
certain	29099488	0	O
disease	29099488	0	O
contexts	29099488	0	O
be	29099488	0	O
harnessed	29099488	0	O
to	29099488	0	O
blunt	29099488	0	O
or	29099488	0	O
ablate	29099488	0	O
mutant	29099488	0	O
p53	29099488	0	O
GOF	29099488	0	O
for	29099488	0	O
therapy	29099488	0	O
?	29099488	0	O
In	29099488	0	O
this	29099488	0	O
article	29099488	0	O
,	29099488	0	O
we	29099488	0	O
review	29099488	0	O
known	29099488	0	O
proteins	29099488	0	O
that	29099488	0	O
interact	29099488	0	O
with	29099488	0	O
mutant	29099488	0	B-Var
p53	29099488	0	B-Gene
and	29099488	0	O
result	29099488	0	O
in	29099488	0	O
the	29099488	0	O
activation	29099488	0	B-PosReg
of	29099488	0	O
genes	29099488	0	B-Gene
that	29099488	0	O
contribute	29099488	0	O
to	29099488	0	O
p53	29099488	0	O
GOF	29099488	0	O
with	29099488	0	O
particular	29099488	0	O
emphasis	29099488	0	O
on	29099488	0	O
context	29099488	0	O
dependency	29099488	0	O
and	29099488	0	O
an	29099488	0	O
evolving	29099488	0	O
appreciation	29099488	0	O
of	29099488	0	O
GOF	29099488	0	O
mechanisms	29099488	0	O
.	29099488	0	O

Exceptional	29118224	0	O
Response	29118224	0	O
to	29118224	0	O
Temsirolimus	29118224	0	O
in	29118224	0	O
a	29118224	0	O
Metastatic	29118224	0	O
Clear	29118224	0	O
Cell	29118224	0	O
Renal	29118224	0	O
Cell	29118224	0	O
Carcinoma	29118224	0	O
With	29118224	0	O
an	29118224	0	O
Early	29118224	0	O
Novel	29118224	0	O
MTOR	29118224	0	O
-	29118224	0	O
Activating	29118224	0	O
Mutation	29118224	0	O
.	29118224	0	O
mTOR	29118224	0	O
pathway	29118224	0	O
inhibitors	29118224	0	O
are	29118224	0	O
important	29118224	0	O
drugs	29118224	0	O
for	29118224	0	O
the	29118224	0	O
treatment	29118224	0	O
of	29118224	0	O
advanced	29118224	0	O
renal	29118224	0	O
cell	29118224	0	O
carcinoma	29118224	0	O
(	29118224	0	O
RCC	29118224	0	O
)	29118224	0	O
.	29118224	0	O
However	29118224	0	O
,	29118224	0	O
no	29118224	0	O
valid	29118224	0	O
predictive	29118224	0	O
markers	29118224	0	O
have	29118224	0	O
been	29118224	0	O
identified	29118224	0	O
to	29118224	0	O
guide	29118224	0	O
treatment	29118224	0	O
selection	29118224	0	O
and	29118224	0	O
identify	29118224	0	O
patients	29118224	0	O
who	29118224	0	O
are	29118224	0	O
sensitive	29118224	0	O
to	29118224	0	O
these	29118224	0	O
drugs	29118224	0	O
.	29118224	0	O
Mutations	29118224	0	O
activating	29118224	0	O
the	29118224	0	O
mTOR	29118224	0	O
pathway	29118224	0	O
have	29118224	0	O
been	29118224	0	O
suggested	29118224	0	O
to	29118224	0	O
predict	29118224	0	O
response	29118224	0	O
;	29118224	0	O
however	29118224	0	O
,	29118224	0	O
their	29118224	0	O
predictive	29118224	0	O
value	29118224	0	O
is	29118224	0	O
still	29118224	0	O
unclear	29118224	0	O
.	29118224	0	O
Here	29118224	0	O
,	29118224	0	O
we	29118224	0	O
present	29118224	0	O
the	29118224	0	O
genomic	29118224	0	O
and	29118224	0	O
functional	29118224	0	O
characterization	29118224	0	O
of	29118224	0	O
a	29118224	0	O
patient	29118224	0	O
with	29118224	0	O
metastatic	29118224	0	O
clear	29118224	0	O
cell	29118224	0	O
RCC	29118224	0	O
(	29118224	0	O
ccRCC	29118224	0	O
)	29118224	0	O
who	29118224	0	O
experienced	29118224	0	O
a	29118224	0	O
partial	29118224	0	O
response	29118224	0	O
to	29118224	0	O
temsirolimus	29118224	0	O
after	29118224	0	O
a	29118224	0	O
poor	29118224	0	O
response	29118224	0	O
to	29118224	0	O
2	29118224	0	O
previous	29118224	0	O
lines	29118224	0	O
of	29118224	0	O
treatment	29118224	0	O
.	29118224	0	O
At	29118224	0	O
the	29118224	0	O
time	29118224	0	O
of	29118224	0	O
publication	29118224	0	O
,	29118224	0	O
the	29118224	0	O
patient	29118224	0	O
was	29118224	0	O
disease	29118224	0	O
-	29118224	0	O
free	29118224	0	O
8	29118224	0	O
years	29118224	0	O
after	29118224	0	O
temsirolimus	29118224	0	O
treatment	29118224	0	O
.	29118224	0	O
Multiregion	29118224	0	O
whole	29118224	0	O
-	29118224	0	O
exome	29118224	0	O
sequencing	29118224	0	O
(	29118224	0	O
WES	29118224	0	O
)	29118224	0	O
on	29118224	0	O
3	29118224	0	O
regions	29118224	0	O
of	29118224	0	O
the	29118224	0	O
primary	29118224	0	O
tumor	29118224	0	O
,	29118224	0	O
1	29118224	0	O
metastasis	29118224	0	O
,	29118224	0	O
and	29118224	0	O
blood	29118224	0	O
revealed	29118224	0	O
tumor	29118224	0	O
mutations	29118224	0	O
in	29118224	0	O
driver	29118224	0	O
genes	29118224	0	O
in	29118224	0	O
ccRCC	29118224	0	O
:	29118224	0	O
a	29118224	0	O
missense	29118224	0	O
mutation	29118224	0	O
in	29118224	0	O
VHL	29118224	0	O
(	29118224	0	O
p.W88L	29118224	0	O
)	29118224	0	O
,	29118224	0	O
a	29118224	0	O
loss	29118224	0	O
-	29118224	0	O
of	29118224	0	O
-	29118224	0	O
function	29118224	0	O
mutation	29118224	0	O
in	29118224	0	O
BAP1	29118224	0	O
(	29118224	0	O
p.E454Rfs	29118224	0	O
15	29118224	0	O
)	29118224	0	O
,	29118224	0	O
and	29118224	0	O
a	29118224	0	O
novel	29118224	0	O
missense	29118224	0	O
mutation	29118224	0	O
in	29118224	0	O
MTOR	29118224	0	O
(	29118224	0	O
p.Y1974H	29118224	0	O
)	29118224	0	O
.	29118224	0	O
The	29118224	0	O
MTOR	29118224	0	O
mutation	29118224	0	O
was	29118224	0	O
present	29118224	0	O
in	29118224	0	O
all	29118224	0	O
tumor	29118224	0	O
regions	29118224	0	O
,	29118224	0	O
with	29118224	0	O
similar	29118224	0	O
allele	29118224	0	O
frequency	29118224	0	O
as	29118224	0	O
the	29118224	0	O
VHL	29118224	0	O
mutation	29118224	0	O
,	29118224	0	O
and	29118224	0	O
in	29118224	0	O
vitro	29118224	0	O
functional	29118224	0	O
assessment	29118224	0	O
of	29118224	0	O
the	29118224	0	O
MTOR	29118224	0	B-Gene
variant	29118224	0	B-Var
demonstrated	29118224	0	O
that	29118224	0	O
it	29118224	0	O
increased	29118224	0	B-PosReg
mTORC1	29118224	0	B-MPA
activity	29118224	0	I-MPA
.	29118224	0	O
Consistently	29118224	0	O
,	29118224	0	O
immunohistochemistry	29118224	0	O
in	29118224	0	O
the	29118224	0	O
tumor	29118224	0	O
samples	29118224	0	O
demonstrated	29118224	0	O
increased	29118224	0	O
levels	29118224	0	O
of	29118224	0	O
phospho	29118224	0	O
-	29118224	0	O
S6	29118224	0	O
.	29118224	0	O
In	29118224	0	O
conclusion	29118224	0	O
,	29118224	0	O
multiregion	29118224	0	O
WES	29118224	0	O
identified	29118224	0	O
a	29118224	0	O
novel	29118224	0	O
MTOR	29118224	0	B-Gene
mutation	29118224	0	B-Var
acquired	29118224	0	O
early	29118224	0	O
during	29118224	0	O
tumor	29118224	0	O
development	29118224	0	O
as	29118224	0	O
the	29118224	0	O
event	29118224	0	O
leading	29118224	0	B-Reg
to	29118224	0	I-Reg
a	29118224	0	O
high	29118224	0	B-MPA
sensitivity	29118224	0	I-MPA
to	29118224	0	I-MPA
temsirolimus	29118224	0	I-MPA
treatment	29118224	0	I-MPA
.	29118224	0	O
This	29118224	0	O
study	29118224	0	O
supports	29118224	0	O
tumor	29118224	0	O
multiregion	29118224	0	O
sequencing	29118224	0	O
to	29118224	0	O
detect	29118224	0	O
truncal	29118224	0	O
mutations	29118224	0	O
in	29118224	0	O
the	29118224	0	O
mTOR	29118224	0	O
pathway	29118224	0	O
to	29118224	0	O
identify	29118224	0	O
patients	29118224	0	O
sensitive	29118224	0	O
to	29118224	0	O
mTOR	29118224	0	O
inhibitors	29118224	0	O
.	29118224	0	O

Loss	29121062	1	O
of	29121062	1	O
function	29121062	1	O
JAK1	29121062	1	O
mutations	29121062	1	O
occur	29121062	1	O
at	29121062	1	O
high	29121062	1	O
frequency	29121062	1	O
in	29121062	1	O
cancers	29121062	1	O
with	29121062	1	O
microsatellite	29121062	1	O
instability	29121062	1	O
and	29121062	1	O
are	29121062	1	O
suggestive	29121062	1	O
of	29121062	1	O
immune	29121062	1	O
evasion	29121062	1	O
.	29121062	1	O
Immune	29121062	1	O
evasion	29121062	1	O
is	29121062	1	O
a	29121062	1	O
well	29121062	1	O
-	29121062	1	O
recognized	29121062	1	O
hallmark	29121062	1	O
of	29121062	1	O
cancer	29121062	1	O
and	29121062	1	O
recent	29121062	1	O
studies	29121062	1	O
with	29121062	1	O
immunotherapy	29121062	1	O
agents	29121062	1	O
have	29121062	1	O
suggested	29121062	1	O
that	29121062	1	O
tumors	29121062	1	O
with	29121062	1	O
increased	29121062	1	O
numbers	29121062	1	O
of	29121062	1	O
neoantigens	29121062	1	O
elicit	29121062	1	O
greater	29121062	1	O
immune	29121062	1	O
responses	29121062	1	O
.	29121062	1	O
We	29121062	1	O
hypothesized	29121062	1	O
that	29121062	1	O
the	29121062	1	O
immune	29121062	1	O
system	29121062	1	O
presents	29121062	1	O
a	29121062	1	O
common	29121062	1	O
selective	29121062	1	O
pressure	29121062	1	O
on	29121062	1	O
high	29121062	1	O
mutation	29121062	1	O
burden	29121062	1	O
tumors	29121062	1	O
and	29121062	1	O
therefore	29121062	1	O
immune	29121062	1	O
evasion	29121062	1	O
mutations	29121062	1	O
would	29121062	1	O
be	29121062	1	O
enriched	29121062	1	O
in	29121062	1	O
high	29121062	1	O
mutation	29121062	1	O
burden	29121062	1	O
tumors	29121062	1	O
.	29121062	1	O
The	29121062	1	O
JAK	29121062	1	O
family	29121062	1	O
of	29121062	1	O
kinases	29121062	1	O
is	29121062	1	O
required	29121062	1	O
for	29121062	1	O
the	29121062	1	O
signaling	29121062	1	O
of	29121062	1	O
a	29121062	1	O
host	29121062	1	O
of	29121062	1	O
immune	29121062	1	O
modulators	29121062	1	O
in	29121062	1	O
tumor	29121062	1	O
,	29121062	1	O
stromal	29121062	1	O
,	29121062	1	O
and	29121062	1	O
immune	29121062	1	O
cells	29121062	1	O
.	29121062	1	O
Therefore	29121062	1	O
,	29121062	1	O
we	29121062	1	O
analyzed	29121062	1	O
alterations	29121062	1	O
in	29121062	1	O
this	29121062	1	O
family	29121062	1	O
for	29121062	1	O
the	29121062	1	O
hypothesized	29121062	1	O
signature	29121062	1	O
of	29121062	1	O
an	29121062	1	O
immune	29121062	1	O
evasion	29121062	1	O
mutation	29121062	1	O
.	29121062	1	O
Here	29121062	1	O
,	29121062	1	O
we	29121062	1	O
searched	29121062	1	O
a	29121062	1	O
database	29121062	1	O
of	29121062	1	O
61	29121062	1	O
,	29121062	1	O
704	29121062	1	O
unique	29121062	1	O
solid	29121062	1	O
tumors	29121062	1	O
for	29121062	1	O
alterations	29121062	1	O
in	29121062	1	O
the	29121062	1	O
JAK	29121062	1	O
family	29121062	1	O
kinases	29121062	1	O
(	29121062	1	O
JAK1	29121062	1	O
/	29121062	1	O
2	29121062	1	O
/	29121062	1	O
3	29121062	1	O
,	29121062	1	O
TYK2	29121062	1	O
)	29121062	1	O
.	29121062	1	O
We	29121062	1	O
used	29121062	1	O
The	29121062	1	O
Cancer	29121062	1	O
Genome	29121062	1	O
Atlas	29121062	1	O
and	29121062	1	O
Cancer	29121062	1	O
Cell	29121062	1	O
Line	29121062	1	O
Encyclopedia	29121062	1	O
data	29121062	1	O
to	29121062	1	O
confirm	29121062	1	O
and	29121062	1	O
extend	29121062	1	O
our	29121062	1	O
findings	29121062	1	O
by	29121062	1	O
analyzing	29121062	1	O
gene	29121062	1	O
expression	29121062	1	O
patterns	29121062	1	O
.	29121062	1	O
Recurrent	29121062	1	O
frameshift	29121062	1	B-Var
mutations	29121062	1	I-Var
in	29121062	1	O
JAK1	29121062	1	B-Gene
were	29121062	1	O
associated	29121062	1	B-Reg
with	29121062	1	O
high	29121062	1	B-MPA
mutation	29121062	1	I-MPA
burden	29121062	1	I-MPA
and	29121062	1	O
microsatellite	29121062	1	B-MPA
instability	29121062	1	I-MPA
.	29121062	1	O
These	29121062	1	O
mutations	29121062	1	B-Var
occurred	29121062	1	B-Reg
in	29121062	1	O
multiple	29121062	1	O
tumor	29121062	1	O
types	29121062	1	O
including	29121062	1	O
endometrial	29121062	1	B-Disease
,	29121062	1	O
colorectal	29121062	1	B-Disease
,	29121062	1	O
stomach	29121062	1	B-Disease
,	29121062	1	O
and	29121062	1	O
prostate	29121062	1	B-Disease
carcinomas	29121062	1	B-Disease
.	29121062	1	O
Analyzing	29121062	1	O
gene	29121062	1	O
expression	29121062	1	O
signatures	29121062	1	O
in	29121062	1	O
endometrial	29121062	1	O
and	29121062	1	O
stomach	29121062	1	O
adenocarcinomas	29121062	1	O
revealed	29121062	1	O
that	29121062	1	O
tumors	29121062	1	O
with	29121062	1	O
a	29121062	1	O
JAK1	29121062	1	O
frameshift	29121062	1	O
exhibited	29121062	1	O
reduced	29121062	1	O
expression	29121062	1	O
of	29121062	1	O
interferon	29121062	1	O
response	29121062	1	O
signatures	29121062	1	O
and	29121062	1	O
multiple	29121062	1	O
anti	29121062	1	O
-	29121062	1	O
tumor	29121062	1	O
immune	29121062	1	O
signatures	29121062	1	O
.	29121062	1	O
Importantly	29121062	1	O
,	29121062	1	O
endometrial	29121062	1	O
cancer	29121062	1	O
cell	29121062	1	O
lines	29121062	1	O
exhibited	29121062	1	O
similar	29121062	1	O
gene	29121062	1	O
expression	29121062	1	O
changes	29121062	1	O
that	29121062	1	O
were	29121062	1	O
expected	29121062	1	O
to	29121062	1	O
be	29121062	1	O
tumor	29121062	1	O
cell	29121062	1	O
intrinsic	29121062	1	O
(	29121062	1	O
e	29121062	1	O
.	29121062	1	O
g	29121062	1	O
.	29121062	1	O
interferon	29121062	1	O
response	29121062	1	O
)	29121062	1	O
but	29121062	1	O
not	29121062	1	O
those	29121062	1	O
expected	29121062	1	O
to	29121062	1	O
be	29121062	1	O
tumor	29121062	1	O
cell	29121062	1	O
extrinsic	29121062	1	O
(	29121062	1	O
e	29121062	1	O
.	29121062	1	O
g	29121062	1	O
.	29121062	1	O
NK	29121062	1	O
cells	29121062	1	O
)	29121062	1	O
.	29121062	1	O
From	29121062	1	O
these	29121062	1	O
data	29121062	1	O
,	29121062	1	O
we	29121062	1	O
derive	29121062	1	O
two	29121062	1	O
primary	29121062	1	O
conclusions	29121062	1	O
:	29121062	1	O
1	29121062	1	O
)	29121062	1	O
JAK1	29121062	1	O
frameshifts	29121062	1	O
are	29121062	1	O
loss	29121062	1	O
of	29121062	1	O
function	29121062	1	O
alterations	29121062	1	O
that	29121062	1	O
represent	29121062	1	O
a	29121062	1	O
potential	29121062	1	O
pan	29121062	1	O
-	29121062	1	O
cancer	29121062	1	O
adaptation	29121062	1	O
to	29121062	1	O
immune	29121062	1	O
responses	29121062	1	O
against	29121062	1	O
tumors	29121062	1	O
with	29121062	1	O
microsatellite	29121062	1	O
instability	29121062	1	O
;	29121062	1	O
2	29121062	1	O
)	29121062	1	O
The	29121062	1	O
mechanism	29121062	1	O
by	29121062	1	O
which	29121062	1	O
JAK1	29121062	1	B-Var
loss	29121062	1	B-NegReg
of	29121062	1	I-NegReg
function	29121062	1	I-NegReg
contributes	29121062	1	O
to	29121062	1	O
tumor	29121062	1	B-MPA
immune	29121062	1	I-MPA
evasion	29121062	1	I-MPA
is	29121062	1	O
likely	29121062	1	O
associated	29121062	1	O
with	29121062	1	O
loss	29121062	1	O
of	29121062	1	O
the	29121062	1	O
JAK1	29121062	1	O
-	29121062	1	O
mediated	29121062	1	O
interferon	29121062	1	O
response	29121062	1	O
.	29121062	1	O

Gain	29124309	2	B-PosReg
of	29124309	2	I-PosReg
function	29124309	2	I-PosReg
of	29124309	2	O
TMEM16E	29124309	2	B-Gene
/	29124309	2	I-Gene
ANO5	29124309	2	I-Gene
scrambling	29124309	2	B-MPA
activity	29124309	2	I-MPA
caused	29124309	2	O
by	29124309	2	O
a	29124309	2	O
mutation	29124309	2	B-Var
associated	29124309	2	O
with	29124309	2	O
gnathodiaphyseal	29124309	2	B-Disease
dysplasia	29124309	2	I-Disease
.	29124309	2	O
Mutations	29124309	2	B-Var
in	29124309	2	O
the	29124309	2	O
human	29124309	2	O
TMEM16E	29124309	2	B-Gene
(	29124309	2	O
ANO5	29124309	2	O
)	29124309	2	O
gene	29124309	2	O
are	29124309	2	O
associated	29124309	2	B-Reg
both	29124309	2	O
with	29124309	2	O
the	29124309	2	O
bone	29124309	2	B-Disease
disease	29124309	2	I-Disease
gnathodiaphyseal	29124309	2	B-Disease
dysplasia	29124309	2	I-Disease
(	29124309	2	O
GDD	29124309	2	O
;	29124309	2	O
OMIM	29124309	2	O
:	29124309	2	O
166260	29124309	2	O
)	29124309	2	O
and	29124309	2	O
muscle	29124309	2	B-Disease
dystrophies	29124309	2	I-Disease
(	29124309	2	O
OMIM	29124309	2	O
:	29124309	2	O
611307	29124309	2	O
,	29124309	2	O
613319	29124309	2	O
)	29124309	2	O
.	29124309	2	O
However	29124309	2	O
,	29124309	2	O
the	29124309	2	O
physiological	29124309	2	O
function	29124309	2	O
of	29124309	2	O
TMEM16E	29124309	2	O
has	29124309	2	O
remained	29124309	2	O
unclear	29124309	2	O
.	29124309	2	O
We	29124309	2	O
show	29124309	2	O
here	29124309	2	O
that	29124309	2	O
human	29124309	2	O
TMEM16E	29124309	2	O
,	29124309	2	O
when	29124309	2	O
overexpressed	29124309	2	O
in	29124309	2	O
mammalian	29124309	2	O
cell	29124309	2	O
lines	29124309	2	O
,	29124309	2	O
displayed	29124309	2	O
partial	29124309	2	O
plasma	29124309	2	O
membrane	29124309	2	O
localization	29124309	2	O
and	29124309	2	O
gave	29124309	2	O
rise	29124309	2	O
to	29124309	2	O
phospholipid	29124309	2	O
scrambling	29124309	2	O
(	29124309	2	O
PLS	29124309	2	O
)	29124309	2	O
as	29124309	2	O
well	29124309	2	O
as	29124309	2	O
non	29124309	2	O
-	29124309	2	O
selective	29124309	2	O
ionic	29124309	2	O
currents	29124309	2	O
with	29124309	2	O
slow	29124309	2	O
time	29124309	2	O
-	29124309	2	O
dependent	29124309	2	O
activation	29124309	2	O
at	29124309	2	O
highly	29124309	2	O
depolarized	29124309	2	O
membrane	29124309	2	O
potentials	29124309	2	O
.	29124309	2	O
While	29124309	2	O
the	29124309	2	O
activity	29124309	2	O
of	29124309	2	O
wild	29124309	2	O
-	29124309	2	O
type	29124309	2	O
TMEM16E	29124309	2	O
depended	29124309	2	O
on	29124309	2	O
elevated	29124309	2	O
cytosolic	29124309	2	O
Ca2	29124309	2	O
levels	29124309	2	O
,	29124309	2	O
a	29124309	2	O
mutant	29124309	2	O
form	29124309	2	O
carrying	29124309	2	O
the	29124309	2	O
GDD	29124309	2	O
-	29124309	2	O
causing	29124309	2	O
T513I	29124309	2	O
substitution	29124309	2	O
showed	29124309	2	O
PLS	29124309	2	O
and	29124309	2	O
large	29124309	2	O
time	29124309	2	O
-	29124309	2	O
dependent	29124309	2	O
ion	29124309	2	O
currents	29124309	2	O
even	29124309	2	O
at	29124309	2	O
low	29124309	2	O
cytosolic	29124309	2	O
Ca2	29124309	2	O
concentrations	29124309	2	O
.	29124309	2	O
Contrarily	29124309	2	O
,	29124309	2	O
mutation	29124309	2	O
of	29124309	2	O
the	29124309	2	O
homologous	29124309	2	O
position	29124309	2	O
in	29124309	2	O
the	29124309	2	O
Ca2	29124309	2	O
-	29124309	2	O
activated	29124309	2	O
Cl	29124309	2	O
-	29124309	2	O
channel	29124309	2	O
TMEM16B	29124309	2	O
paralog	29124309	2	O
hardly	29124309	2	O
affected	29124309	2	O
its	29124309	2	O
function	29124309	2	O
.	29124309	2	O
In	29124309	2	O
summary	29124309	2	O
,	29124309	2	O
these	29124309	2	O
data	29124309	2	O
provide	29124309	2	O
the	29124309	2	O
first	29124309	2	O
direct	29124309	2	O
demonstration	29124309	2	O
of	29124309	2	O
Ca2	29124309	2	O
-	29124309	2	O
dependent	29124309	2	O
PLS	29124309	2	O
activity	29124309	2	O
for	29124309	2	O
TMEM16E	29124309	2	O
and	29124309	2	O
suggest	29124309	2	O
a	29124309	2	O
gain	29124309	2	O
-	29124309	2	O
of	29124309	2	O
-	29124309	2	O
function	29124309	2	O
phenotype	29124309	2	O
related	29124309	2	O
to	29124309	2	O
a	29124309	2	O
GDD	29124309	2	O
mutation	29124309	2	O
.	29124309	2	O

Multiple	29133401	0	O
Legionella	29133401	0	O
pneumophila	29133401	0	O
effector	29133401	0	O
virulence	29133401	0	O
phenotypes	29133401	0	O
revealed	29133401	0	O
through	29133401	0	O
high	29133401	0	O
-	29133401	0	O
throughput	29133401	0	O
analysis	29133401	0	O
of	29133401	0	O
targeted	29133401	0	O
mutant	29133401	0	O
libraries	29133401	0	O
.	29133401	0	O
Legionella	29133401	0	O
pneumophila	29133401	0	O
is	29133401	0	O
the	29133401	0	O
causative	29133401	0	O
agent	29133401	0	O
of	29133401	0	O
a	29133401	0	O
severe	29133401	0	O
pneumonia	29133401	0	O
called	29133401	0	O
Legionnaires	29133401	0	O
'	29133401	0	O
disease	29133401	0	O
.	29133401	0	O
A	29133401	0	O
single	29133401	0	O
strain	29133401	0	O
of	29133401	0	O
L.	29133401	0	O
pneumophila	29133401	0	O
encodes	29133401	0	O
a	29133401	0	O
repertoire	29133401	0	O
of	29133401	0	O
over	29133401	0	O
300	29133401	0	O
different	29133401	0	O
effector	29133401	0	O
proteins	29133401	0	O
that	29133401	0	O
are	29133401	0	O
delivered	29133401	0	O
into	29133401	0	O
host	29133401	0	O
cells	29133401	0	O
by	29133401	0	O
the	29133401	0	O
Dot	29133401	0	O
/	29133401	0	O
Icm	29133401	0	O
type	29133401	0	O
IV	29133401	0	O
secretion	29133401	0	O
system	29133401	0	O
during	29133401	0	O
infection	29133401	0	O
.	29133401	0	O
The	29133401	0	O
large	29133401	0	O
number	29133401	0	O
of	29133401	0	O
L.	29133401	0	O
pneumophila	29133401	0	O
effectors	29133401	0	O
has	29133401	0	O
been	29133401	0	O
a	29133401	0	O
limiting	29133401	0	O
factor	29133401	0	O
in	29133401	0	O
assessing	29133401	0	O
the	29133401	0	O
importance	29133401	0	O
of	29133401	0	O
individual	29133401	0	O
effectors	29133401	0	O
for	29133401	0	O
virulence	29133401	0	O
.	29133401	0	O
Here	29133401	0	O
,	29133401	0	O
a	29133401	0	O
transposon	29133401	0	O
insertion	29133401	0	O
sequencing	29133401	0	O
technology	29133401	0	O
called	29133401	0	O
INSeq	29133401	0	O
was	29133401	0	O
used	29133401	0	O
to	29133401	0	O
analyze	29133401	0	O
replication	29133401	0	O
of	29133401	0	O
a	29133401	0	O
pool	29133401	0	O
of	29133401	0	O
effector	29133401	0	O
mutants	29133401	0	O
in	29133401	0	O
parallel	29133401	0	O
both	29133401	0	O
in	29133401	0	O
a	29133401	0	O
mouse	29133401	0	O
model	29133401	0	O
of	29133401	0	O
infection	29133401	0	O
and	29133401	0	O
in	29133401	0	O
cultured	29133401	0	O
host	29133401	0	O
cells	29133401	0	O
.	29133401	0	O
Loss	29133401	0	B-NegReg
-	29133401	0	I-NegReg
of	29133401	0	I-NegReg
-	29133401	0	I-NegReg
function	29133401	0	I-NegReg
mutations	29133401	0	B-Var
in	29133401	0	O
genes	29133401	0	O
encoding	29133401	0	O
effector	29133401	0	O
proteins	29133401	0	O
resulted	29133401	0	O
in	29133401	0	O
host	29133401	0	B-MPA
-	29133401	0	I-MPA
specific	29133401	0	I-MPA
or	29133401	0	O
broad	29133401	0	B-MPA
virulence	29133401	0	I-MPA
phenotypes	29133401	0	I-MPA
.	29133401	0	O
Screen	29133401	0	O
results	29133401	0	O
were	29133401	0	O
validated	29133401	0	O
for	29133401	0	O
several	29133401	0	O
effector	29133401	0	O
mutants	29133401	0	O
displaying	29133401	0	O
different	29133401	0	O
virulence	29133401	0	O
phenotypes	29133401	0	O
using	29133401	0	O
genetic	29133401	0	O
complementation	29133401	0	O
studies	29133401	0	O
and	29133401	0	O
infection	29133401	0	O
assays	29133401	0	O
.	29133401	0	O
Specifically	29133401	0	O
,	29133401	0	O
loss	29133401	0	B-NegReg
-	29133401	0	I-NegReg
of	29133401	0	I-NegReg
-	29133401	0	I-NegReg
function	29133401	0	I-NegReg
mutations	29133401	0	B-Var
in	29133401	0	O
the	29133401	0	O
gene	29133401	0	O
encoding	29133401	0	O
LegC4	29133401	0	B-Gene
resulted	29133401	0	O
in	29133401	0	O
enhanced	29133401	0	B-PosReg
L.	29133401	0	B-CPA
pneumophila	29133401	0	I-CPA
in	29133401	0	O
the	29133401	0	O
lungs	29133401	0	O
of	29133401	0	O
infected	29133401	0	O
mice	29133401	0	O
but	29133401	0	O
not	29133401	0	O
within	29133401	0	O
cultured	29133401	0	O
host	29133401	0	O
cells	29133401	0	O
,	29133401	0	O
which	29133401	0	O
indicates	29133401	0	O
LegC4	29133401	0	B-Var
augments	29133401	0	B-PosReg
bacterial	29133401	0	B-CPA
clearance	29133401	0	I-CPA
by	29133401	0	O
the	29133401	0	O
host	29133401	0	O
immune	29133401	0	O
system	29133401	0	O
.	29133401	0	O
The	29133401	0	O
effector	29133401	0	O
proteins	29133401	0	O
RavY	29133401	0	O
and	29133401	0	O
Lpg2505	29133401	0	O
were	29133401	0	O
important	29133401	0	O
for	29133401	0	O
efficient	29133401	0	O
replication	29133401	0	O
within	29133401	0	O
both	29133401	0	O
mammalian	29133401	0	O
and	29133401	0	O
protozoan	29133401	0	O
hosts	29133401	0	O
.	29133401	0	O
Further	29133401	0	O
analysis	29133401	0	O
of	29133401	0	O
Lpg2505	29133401	0	O
revealed	29133401	0	O
that	29133401	0	O
this	29133401	0	O
protein	29133401	0	O
functions	29133401	0	O
as	29133401	0	O
a	29133401	0	O
metaeffector	29133401	0	O
that	29133401	0	O
counteracts	29133401	0	O
host	29133401	0	O
cytotoxicity	29133401	0	O
displayed	29133401	0	O
by	29133401	0	O
the	29133401	0	O
effector	29133401	0	O
protein	29133401	0	O
SidI	29133401	0	O
.	29133401	0	O
Thus	29133401	0	O
,	29133401	0	O
this	29133401	0	O
study	29133401	0	O
identified	29133401	0	O
a	29133401	0	O
large	29133401	0	O
cohort	29133401	0	O
of	29133401	0	O
effectors	29133401	0	O
that	29133401	0	O
contribute	29133401	0	O
to	29133401	0	O
L.	29133401	0	O
pneumophila	29133401	0	O
virulence	29133401	0	O
positively	29133401	0	O
or	29133401	0	O
negatively	29133401	0	O
and	29133401	0	O
has	29133401	0	O
demonstrated	29133401	0	O
regulation	29133401	0	O
of	29133401	0	O
effector	29133401	0	O
protein	29133401	0	O
activities	29133401	0	O
by	29133401	0	O
cognate	29133401	0	O
metaeffectors	29133401	0	O
as	29133401	0	O
being	29133401	0	O
critical	29133401	0	O
for	29133401	0	O
host	29133401	0	O
pathogenesis	29133401	0	O
.	29133401	0	O

A	29141982	0	O
Partial	29141982	0	O
Loss	29141982	0	B-NegReg
-	29141982	0	I-NegReg
of	29141982	0	I-NegReg
-	29141982	0	I-NegReg
Function	29141982	0	I-NegReg
Variant	29141982	0	B-Var
in	29141982	0	O
AKT2	29141982	0	B-Gene
Is	29141982	0	O
Associated	29141982	0	O
With	29141982	0	O
Reduced	29141982	0	B-NegReg
Insulin	29141982	0	B-CPA
-	29141982	0	I-CPA
Mediated	29141982	0	I-CPA
Glucose	29141982	0	I-CPA
Uptake	29141982	0	I-CPA
in	29141982	0	O
Multiple	29141982	0	O
Insulin	29141982	0	O
-	29141982	0	O
Sensitive	29141982	0	O
Tissues	29141982	0	O
:	29141982	0	O
A	29141982	0	O
Genotype	29141982	0	O
-	29141982	0	O
Based	29141982	0	O
Callback	29141982	0	O
Positron	29141982	0	O
Emission	29141982	0	O
Tomography	29141982	0	O
Study	29141982	0	O
.	29141982	0	O
Rare	29141982	0	O
fully	29141982	0	O
penetrant	29141982	0	O
mutations	29141982	0	O
in	29141982	0	O
AKT2	29141982	0	O
are	29141982	0	O
an	29141982	0	O
established	29141982	0	O
cause	29141982	0	O
of	29141982	0	O
monogenic	29141982	0	O
disorders	29141982	0	O
of	29141982	0	O
glucose	29141982	0	O
metabolism	29141982	0	O
.	29141982	0	O
Recently	29141982	0	O
,	29141982	0	O
a	29141982	0	O
novel	29141982	0	O
partial	29141982	0	O
loss	29141982	0	O
-	29141982	0	O
of	29141982	0	O
-	29141982	0	O
function	29141982	0	O
AKT2	29141982	0	O
coding	29141982	0	O
variant	29141982	0	O
(	29141982	0	O
p.Pro50Thr	29141982	0	O
)	29141982	0	O
was	29141982	0	O
identified	29141982	0	O
that	29141982	0	O
is	29141982	0	O
nearly	29141982	0	O
specific	29141982	0	O
to	29141982	0	O
Finns	29141982	0	O
(	29141982	0	O
frequency	29141982	0	O
1.1%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
with	29141982	0	O
the	29141982	0	O
low	29141982	0	O
-	29141982	0	O
frequency	29141982	0	O
allele	29141982	0	O
associated	29141982	0	O
with	29141982	0	O
an	29141982	0	O
increase	29141982	0	O
in	29141982	0	O
fasting	29141982	0	O
plasma	29141982	0	O
insulin	29141982	0	O
level	29141982	0	O
and	29141982	0	O
risk	29141982	0	O
of	29141982	0	O
type	29141982	0	O
2	29141982	0	O
diabetes	29141982	0	O
.	29141982	0	O
The	29141982	0	O
effects	29141982	0	O
of	29141982	0	O
the	29141982	0	O
p.Pro50Thr	29141982	0	O
AKT2	29141982	0	O
variant	29141982	0	O
(	29141982	0	O
p.P50T	29141982	0	O
/	29141982	0	O
AKT2	29141982	0	O
)	29141982	0	O
on	29141982	0	O
insulin	29141982	0	O
-	29141982	0	O
stimulated	29141982	0	O
glucose	29141982	0	O
uptake	29141982	0	O
(	29141982	0	O
GU	29141982	0	O
)	29141982	0	O
in	29141982	0	O
the	29141982	0	O
whole	29141982	0	O
body	29141982	0	O
and	29141982	0	O
in	29141982	0	O
different	29141982	0	O
tissues	29141982	0	O
have	29141982	0	O
not	29141982	0	O
previously	29141982	0	O
been	29141982	0	O
investigated	29141982	0	O
.	29141982	0	O
We	29141982	0	O
identified	29141982	0	O
carriers	29141982	0	O
(	29141982	0	O
N	29141982	0	O
=	29141982	0	O
20	29141982	0	O
)	29141982	0	O
and	29141982	0	O
matched	29141982	0	O
noncarriers	29141982	0	O
(	29141982	0	O
N	29141982	0	O
=	29141982	0	O
25	29141982	0	O
)	29141982	0	O
for	29141982	0	O
this	29141982	0	O
allele	29141982	0	O
in	29141982	0	O
the	29141982	0	O
population	29141982	0	O
-	29141982	0	O
based	29141982	0	O
Metabolic	29141982	0	O
Syndrome	29141982	0	O
in	29141982	0	O
Men	29141982	0	O
(	29141982	0	O
METSIM	29141982	0	O
)	29141982	0	O
study	29141982	0	O
and	29141982	0	O
invited	29141982	0	O
these	29141982	0	O
individuals	29141982	0	O
back	29141982	0	O
for	29141982	0	O
positron	29141982	0	O
emission	29141982	0	O
tomography	29141982	0	O
study	29141982	0	O
with	29141982	0	O
[	29141982	0	O
18	29141982	0	O
F	29141982	0	O
]	29141982	0	O
-	29141982	0	O
fluorodeoxyglucose	29141982	0	O
during	29141982	0	O
euglycemic	29141982	0	O
hyperinsulinemia	29141982	0	O
.	29141982	0	O
When	29141982	0	O
we	29141982	0	O
compared	29141982	0	O
p.P50T	29141982	0	O
/	29141982	0	O
AKT2	29141982	0	O
carriers	29141982	0	O
to	29141982	0	O
noncarriers	29141982	0	O
,	29141982	0	O
we	29141982	0	O
found	29141982	0	O
a	29141982	0	O
39.4%	29141982	0	O
reduction	29141982	0	O
in	29141982	0	O
whole	29141982	0	O
-	29141982	0	O
body	29141982	0	O
GU	29141982	0	O
(	29141982	0	O
P	29141982	0	O
=	29141982	0	O
0.006	29141982	0	O
)	29141982	0	O
and	29141982	0	O
a	29141982	0	O
55.6%	29141982	0	O
increase	29141982	0	O
in	29141982	0	O
the	29141982	0	O
rate	29141982	0	O
of	29141982	0	O
endogenous	29141982	0	O
glucose	29141982	0	O
production	29141982	0	O
(	29141982	0	O
P	29141982	0	O
=	29141982	0	O
0.038	29141982	0	O
)	29141982	0	O
.	29141982	0	O
We	29141982	0	O
found	29141982	0	O
significant	29141982	0	O
reductions	29141982	0	O
in	29141982	0	O
GU	29141982	0	O
in	29141982	0	O
multiple	29141982	0	O
tissues	29141982	0	O
-	29141982	0	O
skeletal	29141982	0	O
muscle	29141982	0	O
(	29141982	0	O
36.4%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
liver	29141982	0	O
(	29141982	0	O
16.1%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
brown	29141982	0	O
adipose	29141982	0	O
(	29141982	0	O
29.7%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
and	29141982	0	O
bone	29141982	0	O
marrow	29141982	0	O
(	29141982	0	O
32.9%	29141982	0	O
)	29141982	0	O
-	29141982	0	O
and	29141982	0	O
increases	29141982	0	O
of	29141982	0	O
16.8	29141982	0	O
-	29141982	0	O
19.1%	29141982	0	O
in	29141982	0	O
seven	29141982	0	O
tested	29141982	0	O
brain	29141982	0	O
regions	29141982	0	O
.	29141982	0	O
These	29141982	0	O
data	29141982	0	O
demonstrate	29141982	0	O
that	29141982	0	O
the	29141982	0	O
p.P50T	29141982	0	B-Var
substitution	29141982	0	O
of	29141982	0	O
AKT2	29141982	0	B-Gene
influences	29141982	0	B-Reg
insulin	29141982	0	B-MPA
-	29141982	0	I-MPA
mediated	29141982	0	I-MPA
GU	29141982	0	I-MPA
in	29141982	0	O
multiple	29141982	0	O
insulin	29141982	0	O
-	29141982	0	O
sensitive	29141982	0	O
tissues	29141982	0	O
and	29141982	0	O
may	29141982	0	O
explain	29141982	0	O
,	29141982	0	O
at	29141982	0	O
least	29141982	0	O
in	29141982	0	O
part	29141982	0	O
,	29141982	0	O
the	29141982	0	O
increased	29141982	0	O
risk	29141982	0	O
of	29141982	0	O
type	29141982	0	O
2	29141982	0	O
diabetes	29141982	0	O
in	29141982	0	O
p.P50T	29141982	0	O
/	29141982	0	O
AKT2	29141982	0	O
carriers	29141982	0	O
.	29141982	0	O

Common	29146049	1	O
and	29146049	1	O
rare	29146049	1	O
TBK1	29146049	1	B-Gene
variants	29146049	1	B-Var
in	29146049	1	B-Reg
early	29146049	1	B-Disease
-	29146049	1	I-Disease
onset	29146049	1	I-Disease
Alzheimer	29146049	1	I-Disease
disease	29146049	1	I-Disease
in	29146049	1	O
a	29146049	1	O
European	29146049	1	O
cohort	29146049	1	O
.	29146049	1	O
TANK	29146049	1	O
-	29146049	1	O
binding	29146049	1	O
kinase	29146049	1	O
1	29146049	1	O
(	29146049	1	B-Gene
TBK1	29146049	1	I-Gene
)	29146049	1	I-Gene
loss	29146049	1	B-NegReg
-	29146049	1	I-NegReg
of	29146049	1	I-NegReg
-	29146049	1	I-NegReg
function	29146049	1	I-NegReg
(	29146049	1	O
LoF	29146049	1	O
)	29146049	1	O
mutations	29146049	1	B-Var
are	29146049	1	O
known	29146049	1	O
to	29146049	1	O
cause	29146049	1	O
frontotemporal	29146049	1	B-Disease
dementia	29146049	1	I-Disease
(	29146049	1	O
FTD	29146049	1	O
)	29146049	1	O
and	29146049	1	O
amyotrophic	29146049	1	B-Disease
lateral	29146049	1	I-Disease
sclerosis	29146049	1	I-Disease
(	29146049	1	O
ALS	29146049	1	O
)	29146049	1	O
,	29146049	1	O
often	29146049	1	O
combined	29146049	1	O
with	29146049	1	O
memory	29146049	1	O
deficits	29146049	1	O
early	29146049	1	O
in	29146049	1	O
the	29146049	1	O
disease	29146049	1	O
course	29146049	1	O
.	29146049	1	O
We	29146049	1	O
performed	29146049	1	O
targeted	29146049	1	O
resequencing	29146049	1	O
of	29146049	1	O
TBK1	29146049	1	O
in	29146049	1	O
1253	29146049	1	O
early	29146049	1	O
onset	29146049	1	O
Alzheimer	29146049	1	O
'	29146049	1	O
s	29146049	1	O
disease	29146049	1	O
(	29146049	1	O
EOAD	29146049	1	O
)	29146049	1	O
patients	29146049	1	O
from	29146049	1	O
8	29146049	1	O
European	29146049	1	O
countries	29146049	1	O
to	29146049	1	O
investigate	29146049	1	O
whether	29146049	1	O
pathogenic	29146049	1	O
TBK1	29146049	1	O
mutations	29146049	1	O
are	29146049	1	O
enriched	29146049	1	O
among	29146049	1	O
patients	29146049	1	O
with	29146049	1	O
clinical	29146049	1	O
diagnosis	29146049	1	O
of	29146049	1	O
EOAD	29146049	1	O
.	29146049	1	O
Variant	29146049	1	O
frequencies	29146049	1	O
were	29146049	1	O
compared	29146049	1	O
against	29146049	1	O
2117	29146049	1	O
origin	29146049	1	O
-	29146049	1	O
matched	29146049	1	O
controls	29146049	1	O
.	29146049	1	O
We	29146049	1	O
identified	29146049	1	O
only	29146049	1	O
1	29146049	1	O
LoF	29146049	1	O
mutation	29146049	1	O
(	29146049	1	O
p.Thr79del	29146049	1	O
)	29146049	1	O
in	29146049	1	O
a	29146049	1	O
patient	29146049	1	O
clinically	29146049	1	O
diagnosed	29146049	1	O
with	29146049	1	O
Alzheimer	29146049	1	O
'	29146049	1	O
s	29146049	1	O
disease	29146049	1	O
and	29146049	1	O
a	29146049	1	O
positive	29146049	1	O
family	29146049	1	O
history	29146049	1	O
of	29146049	1	O
ALS	29146049	1	O
.	29146049	1	O
We	29146049	1	O
did	29146049	1	O
not	29146049	1	O
observe	29146049	1	O
enrichment	29146049	1	O
of	29146049	1	O
rare	29146049	1	O
variants	29146049	1	O
in	29146049	1	O
EOAD	29146049	1	O
patients	29146049	1	O
compared	29146049	1	O
to	29146049	1	O
controls	29146049	1	O
,	29146049	1	O
nor	29146049	1	O
of	29146049	1	O
rare	29146049	1	O
variants	29146049	1	O
affecting	29146049	1	O
NFκB	29146049	1	O
induction	29146049	1	O
.	29146049	1	O
Of	29146049	1	O
3	29146049	1	O
common	29146049	1	O
coding	29146049	1	O
variants	29146049	1	O
,	29146049	1	O
rs7486100	29146049	1	O
showed	29146049	1	O
evidence	29146049	1	O
of	29146049	1	O
association	29146049	1	O
(	29146049	1	O
OR	29146049	1	O
1.46	29146049	1	O
[	29146049	1	O
95%	29146049	1	O
CI	29146049	1	O
1.13	29146049	1	O
-	29146049	1	O
1.9	29146049	1	O
]	29146049	1	O
;	29146049	1	O
p	29146049	1	O
-	29146049	1	O
value	29146049	1	O
0.01	29146049	1	O
)	29146049	1	O
.	29146049	1	O
Homozygous	29146049	1	O
carriers	29146049	1	O
of	29146049	1	O
the	29146049	1	O
risk	29146049	1	O
allele	29146049	1	O
showed	29146049	1	O
reduced	29146049	1	O
expression	29146049	1	O
of	29146049	1	O
TBK1	29146049	1	O
(	29146049	1	O
p	29146049	1	O
-	29146049	1	O
value	29146049	1	O
0.03	29146049	1	O
)	29146049	1	O
.	29146049	1	O
Our	29146049	1	O
findings	29146049	1	O
are	29146049	1	O
not	29146049	1	O
indicative	29146049	1	O
of	29146049	1	O
a	29146049	1	O
significant	29146049	1	O
role	29146049	1	O
for	29146049	1	O
TBK1	29146049	1	O
mutations	29146049	1	O
in	29146049	1	O
EOAD	29146049	1	O
.	29146049	1	O
The	29146049	1	O
association	29146049	1	O
between	29146049	1	O
common	29146049	1	O
variants	29146049	1	O
in	29146049	1	O
TBK1	29146049	1	O
,	29146049	1	O
disease	29146049	1	O
risk	29146049	1	O
and	29146049	1	O
reduced	29146049	1	O
TBK1	29146049	1	O
expression	29146049	1	O
warrants	29146049	1	O
follow	29146049	1	O
-	29146049	1	O
up	29146049	1	O
in	29146049	1	O
FTD	29146049	1	O
/	29146049	1	O
ALS	29146049	1	O
cohorts	29146049	1	O
.	29146049	1	O

Polymorphisms	29154202	3	O
in	29154202	3	O
inflammasome	29154202	3	O
genes	29154202	3	O
and	29154202	3	O
risk	29154202	3	O
of	29154202	3	O
asthma	29154202	3	O
in	29154202	3	O
Brazilian	29154202	3	O
children	29154202	3	O
.	29154202	3	O
Considering	29154202	3	O
its	29154202	3	O
role	29154202	3	O
in	29154202	3	O
inflammation	29154202	3	O
and	29154202	3	O
recently	29154202	3	O
described	29154202	3	O
"	29154202	3	O
alternative	29154202	3	O
"	29154202	3	O
roles	29154202	3	O
in	29154202	3	O
epithelial	29154202	3	O
homeostasis	29154202	3	O
and	29154202	3	O
Th1	29154202	3	O
/	29154202	3	O
Th2	29154202	3	O
balance	29154202	3	O
,	29154202	3	O
we	29154202	3	O
hypothesize	29154202	3	O
that	29154202	3	O
inflammasome	29154202	3	O
genetics	29154202	3	O
could	29154202	3	O
contribute	29154202	3	O
to	29154202	3	O
the	29154202	3	O
development	29154202	3	O
of	29154202	3	O
asthma	29154202	3	O
.	29154202	3	O
Selected	29154202	3	O
functional	29154202	3	O
polymorphisms	29154202	3	O
in	29154202	3	O
inflammasome	29154202	3	O
genes	29154202	3	O
are	29154202	3	O
evaluated	29154202	3	O
in	29154202	3	O
a	29154202	3	O
cohort	29154202	3	O
of	29154202	3	O
asthmatic	29154202	3	O
children	29154202	3	O
and	29154202	3	O
their	29154202	3	O
families	29154202	3	O
.	29154202	3	O
Gain	29154202	3	B-PosReg
-	29154202	3	I-PosReg
of	29154202	3	I-PosReg
-	29154202	3	I-PosReg
function	29154202	3	I-PosReg
NLRP1	29154202	3	B-Gene
variants	29154202	3	B-Var
rs11651270	29154202	3	B-Var
,	29154202	3	O
rs12150220	29154202	3	B-Var
and	29154202	3	O
rs2670660	29154202	3	B-Var
resulted	29154202	3	O
significantly	29154202	3	O
associated	29154202	3	O
to	29154202	3	O
asthma	29154202	3	B-Disease
in	29154202	3	O
trios	29154202	3	O
(	29154202	3	O
TDT	29154202	3	O
)	29154202	3	O
analysis	29154202	3	O
;	29154202	3	O
and	29154202	3	O
rs11651270	29154202	3	B-Var
and	29154202	3	O
rs2670660	29154202	3	B-Var
also	29154202	3	O
with	29154202	3	B-Reg
asthma	29154202	3	B-Disease
severity	29154202	3	O
and	29154202	3	O
total	29154202	3	O
IgE	29154202	3	B-MPA
level	29154202	3	I-MPA
in	29154202	3	O
asthmatic	29154202	3	O
children	29154202	3	O
.	29154202	3	O
NLRP1	29154202	3	O
activators	29154202	3	O
in	29154202	3	O
humans	29154202	3	O
are	29154202	3	O
still	29154202	3	O
unknown	29154202	3	O
,	29154202	3	O
however	29154202	3	O
we	29154202	3	O
hypothesized	29154202	3	O
that	29154202	3	O
individuals	29154202	3	O
with	29154202	3	O
gain	29154202	3	B-PosReg
-	29154202	3	I-PosReg
of	29154202	3	I-PosReg
-	29154202	3	I-PosReg
function	29154202	3	I-PosReg
SNPs	29154202	3	B-Var
in	29154202	3	O
NLRP1	29154202	3	B-Gene
could	29154202	3	O
be	29154202	3	O
more	29154202	3	O
prone	29154202	3	B-PosReg
in	29154202	3	O
activating	29154202	3	B-MPA
inflammasome	29154202	3	I-MPA
in	29154202	3	O
the	29154202	3	O
presence	29154202	3	O
of	29154202	3	O
asthma	29154202	3	O
-	29154202	3	O
related	29154202	3	O
cell	29154202	3	O
stressors	29154202	3	O
(	29154202	3	O
i	29154202	3	O
.	29154202	3	O
e	29154202	3	O
.	29154202	3	O
ER	29154202	3	O
stress	29154202	3	O
or	29154202	3	O
ROS	29154202	3	O
)	29154202	3	O
,	29154202	3	O
and	29154202	3	O
this	29154202	3	O
activation	29154202	3	O
contribute	29154202	3	O
to	29154202	3	O
exacerbate	29154202	3	B-PosReg
inflammatory	29154202	3	B-CPA
response	29154202	3	I-CPA
and	29154202	3	O
asthma	29154202	3	B-CPA
development	29154202	3	I-CPA
.	29154202	3	O
Gain	29154202	3	O
-	29154202	3	O
of	29154202	3	O
-	29154202	3	O
function	29154202	3	O
IL1A	29154202	3	B-Gene
rs17561	29154202	3	B-Var
resulted	29154202	3	O
significantly	29154202	3	O
associated	29154202	3	O
with	29154202	3	O
a	29154202	3	O
reduced	29154202	3	B-NegReg
pulmonary	29154202	3	B-CPA
capacity	29154202	3	I-CPA
in	29154202	3	O
asthmatic	29154202	3	O
children	29154202	3	O
.	29154202	3	O
IL18	29154202	3	B-Gene
rs5744256	29154202	3	B-Var
which	29154202	3	O
lead	29154202	3	O
to	29154202	3	O
lower	29154202	3	B-NegReg
serum	29154202	3	B-MPA
level	29154202	3	I-MPA
of	29154202	3	I-MPA
IL-18	29154202	3	I-MPA
appeared	29154202	3	O
to	29154202	3	O
be	29154202	3	O
associated	29154202	3	O
to	29154202	3	O
a	29154202	3	O
worse	29154202	3	O
response	29154202	3	O
to	29154202	3	O
bronchodilators	29154202	3	O
.	29154202	3	O
Concluding	29154202	3	O
,	29154202	3	O
this	29154202	3	O
work	29154202	3	O
provides	29154202	3	O
evidences	29154202	3	O
about	29154202	3	O
the	29154202	3	O
contribution	29154202	3	O
of	29154202	3	O
inflammasome	29154202	3	O
genetics	29154202	3	O
in	29154202	3	O
the	29154202	3	O
development	29154202	3	O
of	29154202	3	O
paediatric	29154202	3	O
asthma	29154202	3	O
,	29154202	3	O
both	29154202	3	O
considering	29154202	3	O
its	29154202	3	O
inflammatory	29154202	3	O
role	29154202	3	O
in	29154202	3	O
alveolar	29154202	3	O
macrophages	29154202	3	O
(	29154202	3	O
i	29154202	3	O
.	29154202	3	O
e	29154202	3	O
.	29154202	3	O
:	29154202	3	O
NLRP1	29154202	3	O
)	29154202	3	O
or	29154202	3	O
its	29154202	3	O
homeostatic	29154202	3	O
role	29154202	3	O
in	29154202	3	O
lung	29154202	3	O
epithelial	29154202	3	O
cells	29154202	3	O
(	29154202	3	O
i	29154202	3	O
.	29154202	3	O
e	29154202	3	O
.	29154202	3	O
:	29154202	3	O
IL1A	29154202	3	O
,	29154202	3	O
IL18	29154202	3	O
)	29154202	3	O
.	29154202	3	O

MED13L	29159987	3	B-Gene
loss	29159987	3	B-NegReg
-	29159987	3	I-NegReg
of	29159987	3	I-NegReg
-	29159987	3	I-NegReg
function	29159987	3	I-NegReg
variants	29159987	3	B-Var
in	29159987	3	O
two	29159987	3	O
patients	29159987	3	O
with	29159987	3	O
syndromic	29159987	3	O
Pierre	29159987	3	B-Disease
Robin	29159987	3	I-Disease
sequence	29159987	3	I-Disease
.	29159987	3	O
We	29159987	3	O
report	29159987	3	O
two	29159987	3	O
unrelated	29159987	3	O
patients	29159987	3	O
with	29159987	3	O
Pierre	29159987	3	O
Robin	29159987	3	O
sequence	29159987	3	O
(	29159987	3	O
PRS	29159987	3	O
)	29159987	3	O
and	29159987	3	O
a	29159987	3	O
strikingly	29159987	3	O
similar	29159987	3	O
combination	29159987	3	O
of	29159987	3	O
associated	29159987	3	O
features	29159987	3	O
.	29159987	3	O
Whole	29159987	3	O
exome	29159987	3	O
sequencing	29159987	3	O
was	29159987	3	O
performed	29159987	3	O
for	29159987	3	O
both	29159987	3	O
patients	29159987	3	O
.	29159987	3	O
No	29159987	3	O
single	29159987	3	O
gene	29159987	3	O
containing	29159987	3	O
likely	29159987	3	O
pathogenic	29159987	3	O
point	29159987	3	O
mutations	29159987	3	O
in	29159987	3	O
both	29159987	3	O
patients	29159987	3	O
could	29159987	3	O
be	29159987	3	O
identified	29159987	3	O
,	29159987	3	O
but	29159987	3	O
the	29159987	3	O
finding	29159987	3	O
of	29159987	3	O
an	29159987	3	O
essential	29159987	3	O
splice	29159987	3	O
site	29159987	3	O
mutation	29159987	3	O
in	29159987	3	O
mediator	29159987	3	O
complex	29159987	3	O
subunit	29159987	3	O
13	29159987	3	O
like	29159987	3	O
(	29159987	3	O
MED13L	29159987	3	O
)	29159987	3	O
in	29159987	3	O
one	29159987	3	O
patient	29159987	3	O
prompted	29159987	3	O
the	29159987	3	O
investigation	29159987	3	O
of	29159987	3	O
copy	29159987	3	O
number	29159987	3	O
variants	29159987	3	O
in	29159987	3	O
MED13L	29159987	3	O
in	29159987	3	O
the	29159987	3	O
other	29159987	3	O
,	29159987	3	O
leading	29159987	3	O
to	29159987	3	O
the	29159987	3	O
identification	29159987	3	O
of	29159987	3	O
an	29159987	3	O
intragenic	29159987	3	O
deletion	29159987	3	O
.	29159987	3	O
Disruption	29159987	3	B-Var
of	29159987	3	O
MED13L	29159987	3	B-Gene
,	29159987	3	O
encoding	29159987	3	O
a	29159987	3	O
component	29159987	3	O
of	29159987	3	O
the	29159987	3	O
Mediator	29159987	3	O
complex	29159987	3	O
,	29159987	3	O
is	29159987	3	O
increasingly	29159987	3	O
recognized	29159987	3	O
as	29159987	3	O
the	29159987	3	O
cause	29159987	3	B-Reg
of	29159987	3	O
an	29159987	3	O
intellectual	29159987	3	B-Disease
disability	29159987	3	I-Disease
syndrome	29159987	3	I-Disease
with	29159987	3	O
associated	29159987	3	O
facial	29159987	3	B-Disease
dysmorphism	29159987	3	I-Disease
.	29159987	3	O
Our	29159987	3	O
findings	29159987	3	O
suggest	29159987	3	O
that	29159987	3	O
MED13L	29159987	3	O
-	29159987	3	O
related	29159987	3	O
disorders	29159987	3	O
are	29159987	3	O
a	29159987	3	O
possible	29159987	3	O
differential	29159987	3	O
diagnosis	29159987	3	O
for	29159987	3	O
syndromic	29159987	3	O
PRS	29159987	3	O
.	29159987	3	O

Loss	29167417	1	B-Var
-	29167417	1	I-Var
of	29167417	1	I-Var
-	29167417	1	I-Var
activity	29167417	1	I-Var
-	29167417	1	I-Var
mutation	29167417	1	I-Var
in	29167417	1	O
the	29167417	1	O
cardiac	29167417	1	B-MPA
chloride	29167417	1	I-MPA
-	29167417	1	I-MPA
bicarbonate	29167417	1	I-MPA
exchanger	29167417	1	I-MPA
AE3	29167417	1	I-MPA
causes	29167417	1	O
short	29167417	1	B-Disease
QT	29167417	1	I-Disease
syndrome	29167417	1	I-Disease
.	29167417	1	O
Patients	29167417	1	O
with	29167417	1	O
short	29167417	1	O
QT	29167417	1	O
syndrome	29167417	1	O
(	29167417	1	O
SQTS	29167417	1	O
)	29167417	1	O
may	29167417	1	O
present	29167417	1	O
with	29167417	1	O
syncope	29167417	1	O
,	29167417	1	O
ventricular	29167417	1	O
fibrillation	29167417	1	O
or	29167417	1	O
sudden	29167417	1	O
cardiac	29167417	1	O
death	29167417	1	O
.	29167417	1	O
Six	29167417	1	O
SQTS	29167417	1	O
susceptibility	29167417	1	O
genes	29167417	1	O
,	29167417	1	O
encoding	29167417	1	O
cation	29167417	1	O
channels	29167417	1	O
,	29167417	1	O
explain	29167417	1	O
<	29167417	1	O
25%	29167417	1	O
of	29167417	1	O
SQTS	29167417	1	O
cases	29167417	1	O
.	29167417	1	O
Here	29167417	1	O
we	29167417	1	O
identify	29167417	1	O
a	29167417	1	O
missense	29167417	1	B-Var
mutation	29167417	1	I-Var
in	29167417	1	O
the	29167417	1	O
anion	29167417	1	O
exchanger	29167417	1	O
(	29167417	1	O
AE3	29167417	1	O
)	29167417	1	O
-	29167417	1	O
encoding	29167417	1	O
SLC4A3	29167417	1	B-Gene
gene	29167417	1	O
in	29167417	1	O
two	29167417	1	O
unrelated	29167417	1	O
families	29167417	1	O
with	29167417	1	O
SQTS	29167417	1	O
.	29167417	1	O
The	29167417	1	O
mutation	29167417	1	O
causes	29167417	1	O
reduced	29167417	1	B-NegReg
surface	29167417	1	B-MPA
expression	29167417	1	I-MPA
of	29167417	1	I-MPA
AE3	29167417	1	I-MPA
and	29167417	1	O
reduced	29167417	1	B-NegReg
membrane	29167417	1	B-MPA
bicarbonate	29167417	1	I-MPA
transport	29167417	1	I-MPA
.	29167417	1	O
Slc4a3	29167417	1	O
knockdown	29167417	1	O
in	29167417	1	O
zebrafish	29167417	1	O
causes	29167417	1	O
increased	29167417	1	O
cardiac	29167417	1	O
pHi	29167417	1	O
,	29167417	1	O
short	29167417	1	O
QTc	29167417	1	O
,	29167417	1	O
and	29167417	1	O
reduced	29167417	1	O
systolic	29167417	1	O
duration	29167417	1	O
,	29167417	1	O
which	29167417	1	O
is	29167417	1	O
rescued	29167417	1	O
by	29167417	1	O
wildtype	29167417	1	O
but	29167417	1	O
not	29167417	1	O
mutated	29167417	1	O
SLC4A3	29167417	1	O
.	29167417	1	O
Mechanistic	29167417	1	O
analyses	29167417	1	O
suggest	29167417	1	O
that	29167417	1	O
an	29167417	1	O
increase	29167417	1	O
in	29167417	1	O
pHi	29167417	1	O
and	29167417	1	O
decrease	29167417	1	O
in	29167417	1	O
[	29167417	1	O
Cl	29167417	1	O
-	29167417	1	O
]	29167417	1	O
i	29167417	1	O
shortened	29167417	1	O
the	29167417	1	O
action	29167417	1	O
potential	29167417	1	O
duration	29167417	1	O
.	29167417	1	O
However	29167417	1	O
,	29167417	1	O
other	29167417	1	O
mechanisms	29167417	1	O
may	29167417	1	O
also	29167417	1	O
play	29167417	1	O
a	29167417	1	O
role	29167417	1	O
.	29167417	1	O
Altered	29167417	1	O
anion	29167417	1	O
transport	29167417	1	O
represents	29167417	1	O
a	29167417	1	O
mechanism	29167417	1	O
for	29167417	1	O
development	29167417	1	O
of	29167417	1	O
arrhythmia	29167417	1	O
and	29167417	1	O
may	29167417	1	O
provide	29167417	1	O
new	29167417	1	O
therapeutic	29167417	1	O
possibilities	29167417	1	O
.	29167417	1	O

Molecular	29203834	4	O
and	29203834	4	O
cellular	29203834	4	O
issues	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	B-Gene
variants	29203834	4	B-Var
involved	29203834	4	B-Reg
in	29203834	4	I-Reg
Wiedemann	29203834	4	B-Disease
-	29203834	4	I-Disease
Steiner	29203834	4	I-Disease
syndrome	29203834	4	I-Disease
.	29203834	4	O
Variants	29203834	4	B-Var
in	29203834	4	O
KMT2A	29203834	4	B-Gene
,	29203834	4	O
encoding	29203834	4	O
the	29203834	4	O
histone	29203834	4	O
methyltransferase	29203834	4	O
KMT2A	29203834	4	O
,	29203834	4	O
are	29203834	4	O
a	29203834	4	O
growing	29203834	4	O
cause	29203834	4	B-Reg
of	29203834	4	O
intellectual	29203834	4	B-Disease
disability	29203834	4	I-Disease
(	29203834	4	O
ID	29203834	4	O
)	29203834	4	O
.	29203834	4	O
Up	29203834	4	O
to	29203834	4	O
now	29203834	4	O
,	29203834	4	O
the	29203834	4	O
majority	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	B-Gene
variants	29203834	4	B-Var
are	29203834	4	O
non	29203834	4	B-Var
-	29203834	4	I-Var
sense	29203834	4	I-Var
and	29203834	4	O
frameshift	29203834	4	B-Var
variants	29203834	4	O
causing	29203834	4	B-Reg
a	29203834	4	O
typical	29203834	4	O
form	29203834	4	O
of	29203834	4	O
Wiedemann	29203834	4	B-Disease
-	29203834	4	I-Disease
Steiner	29203834	4	I-Disease
syndrome	29203834	4	I-Disease
.	29203834	4	O
We	29203834	4	O
studied	29203834	4	O
KMT2A	29203834	4	O
gene	29203834	4	O
in	29203834	4	O
a	29203834	4	O
cohort	29203834	4	O
of	29203834	4	O
200	29203834	4	O
patients	29203834	4	O
with	29203834	4	O
unexplained	29203834	4	O
syndromic	29203834	4	O
and	29203834	4	O
non	29203834	4	O
-	29203834	4	O
syndromic	29203834	4	O
ID	29203834	4	O
and	29203834	4	O
identified	29203834	4	O
four	29203834	4	O
novel	29203834	4	O
variants	29203834	4	O
,	29203834	4	O
one	29203834	4	O
splice	29203834	4	O
and	29203834	4	O
three	29203834	4	O
missense	29203834	4	O
variants	29203834	4	O
,	29203834	4	O
possibly	29203834	4	O
deleterious	29203834	4	O
.	29203834	4	O
We	29203834	4	O
used	29203834	4	O
primary	29203834	4	O
cells	29203834	4	O
from	29203834	4	O
the	29203834	4	O
patients	29203834	4	O
and	29203834	4	O
molecular	29203834	4	O
approaches	29203834	4	O
to	29203834	4	O
determine	29203834	4	O
the	29203834	4	O
deleterious	29203834	4	O
effects	29203834	4	B-Reg
of	29203834	4	O
those	29203834	4	O
variants	29203834	4	B-Var
on	29203834	4	O
KMT2A	29203834	4	B-Gene
expression	29203834	4	B-MPA
and	29203834	4	O
function	29203834	4	B-MPA
.	29203834	4	O
For	29203834	4	O
the	29203834	4	O
putative	29203834	4	O
splice	29203834	4	O
variant	29203834	4	O
c.11322	29203834	4	B-Var
-	29203834	4	I-Var
1	29203834	4	I-Var
G	29203834	4	I-Var
>	29203834	4	I-Var
A	29203834	4	I-Var
,	29203834	4	O
we	29203834	4	O
showed	29203834	4	O
that	29203834	4	O
it	29203834	4	O
led	29203834	4	O
to	29203834	4	O
only	29203834	4	O
one	29203834	4	O
nucleotide	29203834	4	O
deletion	29203834	4	O
and	29203834	4	O
loss	29203834	4	B-NegReg
of	29203834	4	O
the	29203834	4	O
C	29203834	4	B-MPA
-	29203834	4	I-MPA
terminal	29203834	4	I-MPA
part	29203834	4	I-MPA
of	29203834	4	I-MPA
the	29203834	4	I-MPA
protein	29203834	4	I-MPA
.	29203834	4	O
For	29203834	4	O
two	29203834	4	O
studied	29203834	4	O
KMT2A	29203834	4	B-Gene
missense	29203834	4	O
variants	29203834	4	O
,	29203834	4	O
c.3460C	29203834	4	B-Var
>	29203834	4	I-Var
T	29203834	4	I-Var
(	29203834	4	O
p	29203834	4	O
.	29203834	4	O
(	29203834	4	O
Arg1154Trp	29203834	4	O
)	29203834	4	O
)	29203834	4	O
and	29203834	4	O
c.8558T	29203834	4	B-Var
>	29203834	4	I-Var
G	29203834	4	I-Var
(	29203834	4	O
p	29203834	4	O
.	29203834	4	O
(	29203834	4	O
Met2853Arg	29203834	4	O
)	29203834	4	O
)	29203834	4	O
,	29203834	4	O
located	29203834	4	O
at	29203834	4	O
the	29203834	4	O
cysteine	29203834	4	O
-	29203834	4	O
rich	29203834	4	O
CXXC	29203834	4	O
domain	29203834	4	O
and	29203834	4	O
the	29203834	4	O
transactivation	29203834	4	O
domain	29203834	4	O
of	29203834	4	O
the	29203834	4	O
protein	29203834	4	O
,	29203834	4	O
respectively	29203834	4	O
,	29203834	4	O
we	29203834	4	O
found	29203834	4	O
altered	29203834	4	B-Reg
KMT2A	29203834	4	O
target	29203834	4	O
genes	29203834	4	O
expression	29203834	4	B-MPA
in	29203834	4	O
patient	29203834	4	O
'	29203834	4	O
s	29203834	4	O
fibroblasts	29203834	4	O
compared	29203834	4	O
to	29203834	4	O
controls	29203834	4	O
.	29203834	4	O
Furthermore	29203834	4	O
,	29203834	4	O
we	29203834	4	O
found	29203834	4	O
a	29203834	4	O
disturbed	29203834	4	B-Reg
subcellular	29203834	4	B-MPA
distribution	29203834	4	I-MPA
of	29203834	4	O
KMT2A	29203834	4	B-Gene
for	29203834	4	O
the	29203834	4	O
c.3460C	29203834	4	B-Var
>	29203834	4	I-Var
T	29203834	4	I-Var
mutant	29203834	4	O
.	29203834	4	O
Taken	29203834	4	O
together	29203834	4	O
,	29203834	4	O
our	29203834	4	O
results	29203834	4	O
demonstrated	29203834	4	O
the	29203834	4	O
deleterious	29203834	4	O
impact	29203834	4	O
of	29203834	4	O
the	29203834	4	O
splice	29203834	4	O
variant	29203834	4	O
and	29203834	4	O
of	29203834	4	O
the	29203834	4	O
missense	29203834	4	O
variants	29203834	4	O
located	29203834	4	O
at	29203834	4	O
two	29203834	4	O
different	29203834	4	O
functional	29203834	4	O
domains	29203834	4	O
and	29203834	4	O
suggested	29203834	4	O
reduction	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	O
function	29203834	4	O
as	29203834	4	O
the	29203834	4	O
disease	29203834	4	O
-	29203834	4	O
causing	29203834	4	O
mechanism	29203834	4	O
.	29203834	4	O

First	29216801	4	O
Report	29216801	4	O
of	29216801	4	O
Prenatal	29216801	4	O
Ascertainment	29216801	4	O
of	29216801	4	O
a	29216801	4	O
Fetus	29216801	4	O
With	29216801	4	O
Homozygous	29216801	4	O
Loss	29216801	4	O
of	29216801	4	O
the	29216801	4	O
SOX10	29216801	4	O
Gene	29216801	4	O
and	29216801	4	O
Phenotypic	29216801	4	O
Correlation	29216801	4	O
by	29216801	4	O
Autopsy	29216801	4	O
Examination	29216801	4	O
.	29216801	4	O
The	29216801	4	O
SOX10	29216801	4	O
gene	29216801	4	O
plays	29216801	4	O
a	29216801	4	O
vital	29216801	4	O
role	29216801	4	O
in	29216801	4	O
neural	29216801	4	O
crest	29216801	4	O
cell	29216801	4	O
development	29216801	4	O
and	29216801	4	O
migration	29216801	4	O
.	29216801	4	O
Abnormalities	29216801	4	B-Var
in	29216801	4	O
SOX10	29216801	4	B-Gene
are	29216801	4	O
associated	29216801	4	B-Reg
with	29216801	4	O
Waardenburg	29216801	4	B-Disease
syndrome	29216801	4	I-Disease
Types	29216801	4	B-Disease
II	29216801	4	I-Disease
and	29216801	4	O
IV	29216801	4	B-Disease
,	29216801	4	O
and	29216801	4	O
these	29216801	4	O
patients	29216801	4	O
have	29216801	4	O
recognizable	29216801	4	O
clinical	29216801	4	O
features	29216801	4	O
.	29216801	4	O
This	29216801	4	O
case	29216801	4	O
report	29216801	4	O
highlights	29216801	4	O
the	29216801	4	O
first	29216801	4	O
ever	29216801	4	O
reported	29216801	4	O
homozygous	29216801	4	O
loss	29216801	4	O
of	29216801	4	O
function	29216801	4	O
of	29216801	4	O
the	29216801	4	O
SOX10	29216801	4	O
gene	29216801	4	O
in	29216801	4	O
a	29216801	4	O
human	29216801	4	O
.	29216801	4	O
This	29216801	4	O
deletion	29216801	4	O
is	29216801	4	O
correlated	29216801	4	O
using	29216801	4	O
family	29216801	4	O
history	29216801	4	O
,	29216801	4	O
prenatal	29216801	4	O
ultrasound	29216801	4	O
,	29216801	4	O
microarray	29216801	4	O
analysis	29216801	4	O
of	29216801	4	O
amniotic	29216801	4	O
fluid	29216801	4	O
,	29216801	4	O
and	29216801	4	O
ultimately	29216801	4	O
,	29216801	4	O
a	29216801	4	O
medical	29216801	4	O
autopsy	29216801	4	O
examination	29216801	4	O
to	29216801	4	O
further	29216801	4	O
elucidate	29216801	4	O
phenotypic	29216801	4	O
effects	29216801	4	O
of	29216801	4	O
this	29216801	4	O
genetic	29216801	4	O
variation	29216801	4	O
.	29216801	4	O
Incorporating	29216801	4	O
the	29216801	4	O
use	29216801	4	O
of	29216801	4	O
molecular	29216801	4	O
pathology	29216801	4	O
into	29216801	4	O
the	29216801	4	O
autopsy	29216801	4	O
examination	29216801	4	O
of	29216801	4	O
fetuses	29216801	4	O
with	29216801	4	O
suspected	29216801	4	O
congenital	29216801	4	O
anomalies	29216801	4	O
is	29216801	4	O
vital	29216801	4	O
for	29216801	4	O
appropriate	29216801	4	O
family	29216801	4	O
counseling	29216801	4	O
,	29216801	4	O
and	29216801	4	O
with	29216801	4	O
the	29216801	4	O
ability	29216801	4	O
to	29216801	4	O
use	29216801	4	O
formalin	29216801	4	O
-	29216801	4	O
fixed	29216801	4	O
and	29216801	4	O
paraffin	29216801	4	O
-	29216801	4	O
embedded	29216801	4	O
tissues	29216801	4	O
,	29216801	4	O
has	29216801	4	O
become	29216801	4	O
a	29216801	4	O
practical	29216801	4	O
approach	29216801	4	O
in	29216801	4	O
autopsy	29216801	4	O
pathology	29216801	4	O
.	29216801	4	O

A	29222010	1	O
novel	29222010	1	O
NR2F2	29222010	1	B-Gene
loss	29222010	1	B-NegReg
-	29222010	1	I-NegReg
of	29222010	1	I-NegReg
-	29222010	1	I-NegReg
function	29222010	1	I-NegReg
mutation	29222010	1	B-Var
predisposes	29222010	1	O
to	29222010	1	O
congenital	29222010	1	B-Disease
heart	29222010	1	I-Disease
defect	29222010	1	I-Disease
.	29222010	1	O
Congenital	29222010	1	O
heart	29222010	1	O
defect	29222010	1	O
(	29222010	1	O
CHD	29222010	1	O
)	29222010	1	O
is	29222010	1	O
the	29222010	1	O
most	29222010	1	O
common	29222010	1	O
type	29222010	1	O
of	29222010	1	O
birth	29222010	1	O
defect	29222010	1	O
in	29222010	1	O
humans	29222010	1	O
and	29222010	1	O
a	29222010	1	O
leading	29222010	1	O
cause	29222010	1	O
of	29222010	1	O
infant	29222010	1	O
morbidity	29222010	1	O
and	29222010	1	O
mortality	29222010	1	O
.	29222010	1	O
Previous	29222010	1	O
studies	29222010	1	O
have	29222010	1	O
demonstrated	29222010	1	O
that	29222010	1	O
genetic	29222010	1	O
defects	29222010	1	O
play	29222010	1	O
a	29222010	1	O
pivotal	29222010	1	O
role	29222010	1	O
in	29222010	1	O
the	29222010	1	O
pathogenesis	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
.	29222010	1	O
However	29222010	1	O
,	29222010	1	O
the	29222010	1	O
genetic	29222010	1	O
basis	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
remains	29222010	1	O
poorly	29222010	1	O
understood	29222010	1	O
due	29222010	1	O
to	29222010	1	O
substantial	29222010	1	O
genetic	29222010	1	O
heterogeneity	29222010	1	O
.	29222010	1	O
In	29222010	1	O
this	29222010	1	O
study	29222010	1	O
,	29222010	1	O
the	29222010	1	O
coding	29222010	1	O
exons	29222010	1	O
and	29222010	1	O
splicing	29222010	1	O
boundaries	29222010	1	O
of	29222010	1	O
the	29222010	1	O
NR2F2	29222010	1	O
gene	29222010	1	O
,	29222010	1	O
which	29222010	1	O
encodes	29222010	1	O
a	29222010	1	O
pleiotropic	29222010	1	O
transcription	29222010	1	O
factor	29222010	1	O
required	29222010	1	O
for	29222010	1	O
normal	29222010	1	O
cardiovascular	29222010	1	O
development	29222010	1	O
,	29222010	1	O
were	29222010	1	O
sequenced	29222010	1	O
in	29222010	1	O
168	29222010	1	O
unrelated	29222010	1	O
patients	29222010	1	O
with	29222010	1	O
CHD	29222010	1	O
,	29222010	1	O
and	29222010	1	O
a	29222010	1	O
novel	29222010	1	O
mutation	29222010	1	O
(	29222010	1	O
c.247G	29222010	1	O
>	29222010	1	O
T	29222010	1	O
,	29222010	1	O
equivalent	29222010	1	O
to	29222010	1	O
p.G83X	29222010	1	O
)	29222010	1	O
was	29222010	1	O
detected	29222010	1	O
in	29222010	1	O
a	29222010	1	O
patient	29222010	1	O
with	29222010	1	O
double	29222010	1	O
outlet	29222010	1	O
right	29222010	1	O
ventricle	29222010	1	O
as	29222010	1	O
well	29222010	1	O
as	29222010	1	O
ventricular	29222010	1	O
septal	29222010	1	O
defect	29222010	1	O
.	29222010	1	O
Genetic	29222010	1	O
scanning	29222010	1	O
of	29222010	1	O
the	29222010	1	O
mutation	29222010	1	O
carrier	29222010	1	O
'	29222010	1	O
s	29222010	1	O
relatives	29222010	1	O
available	29222010	1	O
showed	29222010	1	O
that	29222010	1	O
the	29222010	1	O
mutation	29222010	1	O
was	29222010	1	O
present	29222010	1	O
in	29222010	1	O
all	29222010	1	O
affected	29222010	1	O
family	29222010	1	O
members	29222010	1	O
but	29222010	1	O
absent	29222010	1	O
in	29222010	1	O
unaffected	29222010	1	O
family	29222010	1	O
members	29222010	1	O
.	29222010	1	O
Analysis	29222010	1	O
of	29222010	1	O
the	29222010	1	O
index	29222010	1	O
patient	29222010	1	O
'	29222010	1	O
s	29222010	1	O
pedigree	29222010	1	O
displayed	29222010	1	O
that	29222010	1	O
the	29222010	1	O
mutation	29222010	1	O
co	29222010	1	O
-	29222010	1	O
segregated	29222010	1	O
with	29222010	1	O
CHD	29222010	1	O
,	29222010	1	O
which	29222010	1	O
was	29222010	1	O
transmitted	29222010	1	O
as	29222010	1	O
an	29222010	1	O
autosomal	29222010	1	O
dominant	29222010	1	O
trait	29222010	1	O
with	29222010	1	O
complete	29222010	1	O
penetrance	29222010	1	O
.	29222010	1	O
The	29222010	1	O
nonsense	29222010	1	O
mutation	29222010	1	O
was	29222010	1	O
absent	29222010	1	O
in	29222010	1	O
230	29222010	1	O
unrelated	29222010	1	O
,	29222010	1	O
ethnically	29222010	1	O
-	29222010	1	O
matched	29222010	1	O
healthy	29222010	1	O
individuals	29222010	1	O
used	29222010	1	O
as	29222010	1	O
controls	29222010	1	O
.	29222010	1	O
Functional	29222010	1	O
deciphers	29222010	1	O
by	29222010	1	O
using	29222010	1	O
a	29222010	1	O
dual	29222010	1	O
-	29222010	1	O
luciferase	29222010	1	O
reporter	29222010	1	O
assay	29222010	1	O
system	29222010	1	O
revealed	29222010	1	O
that	29222010	1	O
the	29222010	1	O
mutant	29222010	1	B-Var
NR2F2	29222010	1	B-Gene
protein	29222010	1	O
had	29222010	1	O
no	29222010	1	B-NegReg
transcriptional	29222010	1	B-MPA
activity	29222010	1	I-MPA
as	29222010	1	O
compared	29222010	1	O
with	29222010	1	O
its	29222010	1	O
wild	29222010	1	O
-	29222010	1	O
type	29222010	1	O
counterpart	29222010	1	O
.	29222010	1	O
Furthermore	29222010	1	O
,	29222010	1	O
the	29222010	1	O
mutation	29222010	1	B-Var
abrogated	29222010	1	B-NegReg
the	29222010	1	O
synergistic	29222010	1	B-MPA
transcriptional	29222010	1	I-MPA
activation	29222010	1	I-MPA
between	29222010	1	O
NR2F2	29222010	1	B-Gene
and	29222010	1	O
GATA4	29222010	1	B-Gene
,	29222010	1	O
another	29222010	1	O
core	29222010	1	O
cardiac	29222010	1	O
transcription	29222010	1	O
factor	29222010	1	O
associated	29222010	1	O
with	29222010	1	O
CHD	29222010	1	O
.	29222010	1	O
This	29222010	1	O
study	29222010	1	O
firstly	29222010	1	O
associates	29222010	1	O
NR2F2	29222010	1	O
loss	29222010	1	O
-	29222010	1	O
of	29222010	1	O
-	29222010	1	O
function	29222010	1	O
mutation	29222010	1	O
with	29222010	1	O
an	29222010	1	O
increased	29222010	1	O
susceptibility	29222010	1	O
to	29222010	1	O
double	29222010	1	O
outlet	29222010	1	O
right	29222010	1	O
ventricle	29222010	1	O
in	29222010	1	O
humans	29222010	1	O
,	29222010	1	O
which	29222010	1	O
provides	29222010	1	O
further	29222010	1	O
significant	29222010	1	O
insight	29222010	1	O
into	29222010	1	O
the	29222010	1	O
molecular	29222010	1	O
mechanisms	29222010	1	O
underpinning	29222010	1	O
CHD	29222010	1	O
,	29222010	1	O
suggesting	29222010	1	O
potential	29222010	1	O
implications	29222010	1	O
for	29222010	1	O
genetic	29222010	1	O
counseling	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
families	29222010	1	O
and	29222010	1	O
personalized	29222010	1	O
treatment	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
patients	29222010	1	O
.	29222010	1	O

Potential	29223504	4	O
pathogenic	29223504	4	O
mechanisms	29223504	4	O
underlying	29223504	4	O
Fragile	29223504	4	O
X	29223504	4	O
Tremor	29223504	4	O
Ataxia	29223504	4	O
Syndrome	29223504	4	O
:	29223504	4	O
RAN	29223504	4	O
translation	29223504	4	O
and	29223504	4	O
/	29223504	4	O
or	29223504	4	O
RNA	29223504	4	O
gain	29223504	4	O
-	29223504	4	O
of	29223504	4	O
-	29223504	4	O
function	29223504	4	O
?	29223504	4	O
Fragile	29223504	4	B-Disease
X	29223504	4	I-Disease
-	29223504	4	I-Disease
associated	29223504	4	I-Disease
tremor	29223504	4	I-Disease
/	29223504	4	I-Disease
ataxia	29223504	4	I-Disease
syndrome	29223504	4	I-Disease
(	29223504	4	O
FXTAS	29223504	4	O
)	29223504	4	O
is	29223504	4	O
an	29223504	4	O
inherited	29223504	4	O
neurodegenerative	29223504	4	O
disease	29223504	4	O
caused	29223504	4	B-Reg
by	29223504	4	I-Reg
an	29223504	4	O
expansion	29223504	4	B-Var
of	29223504	4	I-Var
55	29223504	4	I-Var
-	29223504	4	I-Var
200	29223504	4	I-Var
CGG	29223504	4	I-Var
repeats	29223504	4	I-Var
located	29223504	4	O
in	29223504	4	O
the	29223504	4	O
FMR1	29223504	4	B-Gene
gene	29223504	4	O
.	29223504	4	O
The	29223504	4	O
main	29223504	4	O
clinical	29223504	4	O
and	29223504	4	O
neuropathological	29223504	4	O
features	29223504	4	O
of	29223504	4	O
FXTAS	29223504	4	O
are	29223504	4	O
progressive	29223504	4	O
intention	29223504	4	O
tremor	29223504	4	O
and	29223504	4	O
gait	29223504	4	O
ataxia	29223504	4	O
associated	29223504	4	O
with	29223504	4	O
brain	29223504	4	O
atrophy	29223504	4	O
,	29223504	4	O
neuronal	29223504	4	O
cell	29223504	4	O
loss	29223504	4	O
and	29223504	4	O
presence	29223504	4	O
of	29223504	4	O
ubiquitin	29223504	4	O
-	29223504	4	O
positive	29223504	4	O
intranuclear	29223504	4	O
inclusions	29223504	4	O
in	29223504	4	O
both	29223504	4	O
neurons	29223504	4	O
and	29223504	4	O
astrocytes	29223504	4	O
.	29223504	4	O
At	29223504	4	O
the	29223504	4	O
molecular	29223504	4	O
level	29223504	4	O
,	29223504	4	O
FXTAS	29223504	4	O
is	29223504	4	O
characterized	29223504	4	O
by	29223504	4	O
increased	29223504	4	O
expression	29223504	4	O
of	29223504	4	O
FMR1	29223504	4	O
sense	29223504	4	O
and	29223504	4	O
antisense	29223504	4	O
RNA	29223504	4	O
containing	29223504	4	O
expanded	29223504	4	O
CGG	29223504	4	O
or	29223504	4	O
GGC	29223504	4	O
repeats	29223504	4	O
,	29223504	4	O
respectively	29223504	4	O
.	29223504	4	O
Here	29223504	4	O
,	29223504	4	O
we	29223504	4	O
discuss	29223504	4	O
the	29223504	4	O
putative	29223504	4	O
molecular	29223504	4	O
mechanisms	29223504	4	O
underlying	29223504	4	O
FXTAS	29223504	4	O
and	29223504	4	O
notably	29223504	4	O
recent	29223504	4	O
reports	29223504	4	O
that	29223504	4	O
expanded	29223504	4	O
CGG	29223504	4	O
and	29223504	4	O
GGC	29223504	4	O
repeats	29223504	4	O
may	29223504	4	O
be	29223504	4	O
pathogenic	29223504	4	O
through	29223504	4	O
RAN	29223504	4	O
translation	29223504	4	O
into	29223504	4	O
toxic	29223504	4	O
proteins	29223504	4	O
.	29223504	4	O

Deleterious	29224215	4	O
variants	29224215	4	B-Var
in	29224215	4	O
DCHS1	29224215	4	B-Gene
are	29224215	4	O
prevalent	29224215	4	B-Reg
in	29224215	4	O
sporadic	29224215	4	O
cases	29224215	4	O
of	29224215	4	O
mitral	29224215	4	B-Disease
valve	29224215	4	I-Disease
prolapse	29224215	4	I-Disease
.	29224215	4	O
BACKGROUND	29224215	4	O
:	29224215	4	O
A	29224215	4	O
recent	29224215	4	O
study	29224215	4	O
identified	29224215	4	O
DCHS1	29224215	4	O
as	29224215	4	O
a	29224215	4	O
causal	29224215	4	O
gene	29224215	4	O
for	29224215	4	O
mitral	29224215	4	O
valve	29224215	4	O
prolapse	29224215	4	O
.	29224215	4	O
The	29224215	4	O
goal	29224215	4	O
of	29224215	4	O
this	29224215	4	O
study	29224215	4	O
is	29224215	4	O
to	29224215	4	O
investigate	29224215	4	O
the	29224215	4	O
presence	29224215	4	O
and	29224215	4	O
frequency	29224215	4	O
of	29224215	4	O
known	29224215	4	O
and	29224215	4	O
novel	29224215	4	O
variants	29224215	4	O
in	29224215	4	O
this	29224215	4	O
gene	29224215	4	O
in	29224215	4	O
100	29224215	4	O
asymptomatic	29224215	4	O
patients	29224215	4	O
with	29224215	4	O
moderate	29224215	4	O
to	29224215	4	O
severe	29224215	4	O
organic	29224215	4	O
mitral	29224215	4	O
regurgitation	29224215	4	O
.	29224215	4	O
METHODS	29224215	4	O
:	29224215	4	O
DNA	29224215	4	O
sequencing	29224215	4	O
assays	29224215	4	O
were	29224215	4	O
developed	29224215	4	O
for	29224215	4	O
two	29224215	4	O
previously	29224215	4	O
identified	29224215	4	O
functional	29224215	4	O
missense	29224215	4	O
variants	29224215	4	O
,	29224215	4	O
namely	29224215	4	O
p.R2330C	29224215	4	B-Var
and	29224215	4	O
p.R2513H	29224215	4	B-Var
,	29224215	4	O
and	29224215	4	O
all	29224215	4	O
21	29224215	4	O
exons	29224215	4	O
of	29224215	4	O
DCHS1	29224215	4	B-Gene
.	29224215	4	O
Pathogenicity	29224215	4	O
of	29224215	4	O
variants	29224215	4	O
was	29224215	4	O
evaluated	29224215	4	O
in	29224215	4	O
silico	29224215	4	O
.	29224215	4	O
RESULTS	29224215	4	O
:	29224215	4	O
p.R2330C	29224215	4	O
and	29224215	4	O
p.R2513H	29224215	4	O
were	29224215	4	O
not	29224215	4	O
identified	29224215	4	O
in	29224215	4	O
this	29224215	4	O
cohort	29224215	4	O
.	29224215	4	O
Sequencing	29224215	4	O
all	29224215	4	O
coding	29224215	4	O
regions	29224215	4	O
revealed	29224215	4	O
eight	29224215	4	O
missense	29224215	4	O
variants	29224215	4	O
including	29224215	4	O
six	29224215	4	O
considered	29224215	4	O
deleterious	29224215	4	O
.	29224215	4	O
This	29224215	4	O
includes	29224215	4	O
one	29224215	4	O
novel	29224215	4	O
variant	29224215	4	O
(	29224215	4	O
p.A2464P	29224215	4	O
)	29224215	4	O
and	29224215	4	O
two	29224215	4	O
rare	29224215	4	O
variants	29224215	4	O
(	29224215	4	O
p.R2770Q	29224215	4	O
and	29224215	4	O
p.R2462Q	29224215	4	O
)	29224215	4	O
.	29224215	4	O
These	29224215	4	O
variants	29224215	4	O
are	29224215	4	O
predicted	29224215	4	O
to	29224215	4	O
be	29224215	4	O
deleterious	29224215	4	O
with	29224215	4	O
combined	29224215	4	O
annotation	29224215	4	O
-	29224215	4	O
dependent	29224215	4	O
depletion	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
)	29224215	4	O
scores	29224215	4	O
greater	29224215	4	O
than	29224215	4	O
25	29224215	4	O
,	29224215	4	O
which	29224215	4	O
are	29224215	4	O
in	29224215	4	O
the	29224215	4	O
same	29224215	4	O
range	29224215	4	O
as	29224215	4	O
p.R2330C	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
=	29224215	4	O
28.0	29224215	4	O
)	29224215	4	O
and	29224215	4	O
p.R2513H	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
=	29224215	4	O
24.3	29224215	4	O
)	29224215	4	O
.	29224215	4	O
More	29224215	4	O
globally	29224215	4	O
,	29224215	4	O
24	29224215	4	O
of	29224215	4	O
100	29224215	4	O
cases	29224215	4	O
were	29224215	4	O
carriers	29224215	4	O
of	29224215	4	O
at	29224215	4	O
least	29224215	4	O
one	29224215	4	O
in	29224215	4	O
silico	29224215	4	O
-	29224215	4	O
predicted	29224215	4	O
deleterious	29224215	4	O
missense	29224215	4	O
variant	29224215	4	O
in	29224215	4	O
DCHS1	29224215	4	O
,	29224215	4	O
suggesting	29224215	4	O
that	29224215	4	O
this	29224215	4	O
single	29224215	4	O
gene	29224215	4	O
may	29224215	4	O
account	29224215	4	O
for	29224215	4	O
a	29224215	4	O
substantial	29224215	4	O
portion	29224215	4	O
of	29224215	4	O
cases	29224215	4	O
.	29224215	4	O
CONCLUSION	29224215	4	O
:	29224215	4	O
This	29224215	4	O
study	29224215	4	O
reveals	29224215	4	O
an	29224215	4	O
important	29224215	4	O
contribution	29224215	4	O
of	29224215	4	O
germline	29224215	4	O
variants	29224215	4	O
in	29224215	4	O
DCHS1	29224215	4	O
in	29224215	4	O
unrelated	29224215	4	O
patients	29224215	4	O
with	29224215	4	O
mitral	29224215	4	O
valve	29224215	4	O
prolapse	29224215	4	O
and	29224215	4	O
supports	29224215	4	O
genetic	29224215	4	O
testing	29224215	4	O
of	29224215	4	O
this	29224215	4	O
gene	29224215	4	O
to	29224215	4	O
screen	29224215	4	O
individuals	29224215	4	O
at	29224215	4	O
risk	29224215	4	O
.	29224215	4	O

Primary	29240891	4	B-Disease
Ovarian	29240891	4	I-Disease
Insufficiency	29240891	4	I-Disease
and	29240891	4	O
Azoospermia	29240891	4	B-Disease
in	29240891	4	O
Carriers	29240891	4	B-Reg
of	29240891	4	O
a	29240891	4	O
Homozygous	29240891	4	O
PSMC3IP	29240891	4	B-Gene
Stop	29240891	4	O
Gain	29240891	4	O
Mutation	29240891	4	B-Var
.	29240891	4	O
Context	29240891	4	O
:	29240891	4	O
The	29240891	4	O
etiology	29240891	4	O
of	29240891	4	O
primary	29240891	4	O
ovarian	29240891	4	O
insufficiency	29240891	4	O
(	29240891	4	O
POI	29240891	4	O
)	29240891	4	O
remains	29240891	4	O
unknown	29240891	4	O
in	29240891	4	O
most	29240891	4	O
cases	29240891	4	O
.	29240891	4	O
Objective	29240891	4	O
:	29240891	4	O
We	29240891	4	O
sought	29240891	4	O
to	29240891	4	O
identify	29240891	4	O
the	29240891	4	O
genes	29240891	4	O
causing	29240891	4	O
POI	29240891	4	O
.	29240891	4	O
Design	29240891	4	O
:	29240891	4	O
The	29240891	4	O
study	29240891	4	O
was	29240891	4	O
a	29240891	4	O
familial	29240891	4	O
genetic	29240891	4	O
study	29240891	4	O
.	29240891	4	O
Setting	29240891	4	O
:	29240891	4	O
The	29240891	4	O
study	29240891	4	O
was	29240891	4	O
performed	29240891	4	O
at	29240891	4	O
two	29240891	4	O
academic	29240891	4	O
institutions	29240891	4	O
.	29240891	4	O
Patients	29240891	4	O
:	29240891	4	O
We	29240891	4	O
identified	29240891	4	O
a	29240891	4	O
consanguineous	29240891	4	O
Yemeni	29240891	4	O
family	29240891	4	O
in	29240891	4	O
which	29240891	4	O
four	29240891	4	O
daughters	29240891	4	O
had	29240891	4	O
POI	29240891	4	O
.	29240891	4	O
A	29240891	4	O
brother	29240891	4	O
had	29240891	4	O
azoospermia	29240891	4	O
.	29240891	4	O
Intervention	29240891	4	O
:	29240891	4	O
DNA	29240891	4	O
was	29240891	4	O
subjected	29240891	4	O
to	29240891	4	O
whole	29240891	4	O
genome	29240891	4	O
sequencing	29240891	4	O
.	29240891	4	O
Shared	29240891	4	O
regions	29240891	4	O
of	29240891	4	O
homozygosity	29240891	4	O
were	29240891	4	O
identified	29240891	4	O
using	29240891	4	O
Truploidy	29240891	4	O
and	29240891	4	O
prioritized	29240891	4	O
using	29240891	4	O
the	29240891	4	O
Variant	29240891	4	O
Annotation	29240891	4	O
,	29240891	4	O
Analysis	29240891	4	O
,	29240891	4	O
and	29240891	4	O
Search	29240891	4	O
Tool	29240891	4	O
with	29240891	4	O
control	29240891	4	O
data	29240891	4	O
from	29240891	4	O
387	29240891	4	O
healthy	29240891	4	O
subjects	29240891	4	O
.	29240891	4	O
Imaging	29240891	4	O
and	29240891	4	O
quantification	29240891	4	O
of	29240891	4	O
protein	29240891	4	O
localization	29240891	4	O
and	29240891	4	O
mitochondrial	29240891	4	O
function	29240891	4	O
were	29240891	4	O
examined	29240891	4	O
in	29240891	4	O
cell	29240891	4	O
lines	29240891	4	O
.	29240891	4	O
Main	29240891	4	O
Outcome	29240891	4	O
:	29240891	4	O
Homozygous	29240891	4	O
recessive	29240891	4	O
gene	29240891	4	O
variants	29240891	4	O
shared	29240891	4	O
by	29240891	4	O
the	29240891	4	O
four	29240891	4	O
sisters	29240891	4	O
.	29240891	4	O
Results	29240891	4	O
:	29240891	4	O
The	29240891	4	O
sisters	29240891	4	O
shared	29240891	4	O
a	29240891	4	O
homozygous	29240891	4	O
stop	29240891	4	O
gain	29240891	4	O
mutation	29240891	4	O
in	29240891	4	O
exon	29240891	4	O
6	29240891	4	O
of	29240891	4	O
PSMC3IP	29240891	4	O
(	29240891	4	O
c.489	29240891	4	O
C	29240891	4	O
>	29240891	4	O
G	29240891	4	O
,	29240891	4	O
p.Tyr163Ter	29240891	4	O
)	29240891	4	O
and	29240891	4	O
a	29240891	4	O
missense	29240891	4	O
variant	29240891	4	O
in	29240891	4	O
exon	29240891	4	O
1	29240891	4	O
of	29240891	4	O
CLPP	29240891	4	O
(	29240891	4	B-Var
c.100C	29240891	4	I-Var
>	29240891	4	I-Var
T	29240891	4	I-Var
,	29240891	4	O
p.Pro34Ser	29240891	4	O
)	29240891	4	O
.	29240891	4	O
The	29240891	4	O
affected	29240891	4	O
brother	29240891	4	O
also	29240891	4	O
carried	29240891	4	O
the	29240891	4	O
homozygous	29240891	4	O
PSMC3IP	29240891	4	O
mutation	29240891	4	O
.	29240891	4	O
Functional	29240891	4	O
studies	29240891	4	O
demonstrated	29240891	4	B-Reg
mitochondrial	29240891	4	B-CPA
fragmentation	29240891	4	I-CPA
in	29240891	4	O
cells	29240891	4	O
infected	29240891	4	O
with	29240891	4	O
the	29240891	4	O
CLPP	29240891	4	B-Gene
mutation	29240891	4	B-Var
.	29240891	4	O
However	29240891	4	O
,	29240891	4	O
no	29240891	4	O
abnormality	29240891	4	O
was	29240891	4	O
found	29240891	4	O
in	29240891	4	O
mitochondrial	29240891	4	O
targeting	29240891	4	O
or	29240891	4	O
respiration	29240891	4	O
.	29240891	4	O
Conclusions	29240891	4	O
:	29240891	4	O
The	29240891	4	O
PSMC3IP	29240891	4	O
mutation	29240891	4	O
provides	29240891	4	O
additional	29240891	4	O
evidence	29240891	4	O
that	29240891	4	O
mutations	29240891	4	O
in	29240891	4	O
meiotic	29240891	4	O
homologous	29240891	4	O
recombination	29240891	4	O
and	29240891	4	O
DNA	29240891	4	O
repair	29240891	4	O
genes	29240891	4	O
result	29240891	4	O
in	29240891	4	O
distinct	29240891	4	O
female	29240891	4	O
and	29240891	4	O
male	29240891	4	O
reproductive	29240891	4	O
phenotypes	29240891	4	O
,	29240891	4	O
including	29240891	4	O
delayed	29240891	4	O
puberty	29240891	4	O
and	29240891	4	O
primary	29240891	4	O
amenorrhea	29240891	4	O
caused	29240891	4	O
by	29240891	4	O
POI	29240891	4	O
(	29240891	4	O
XX	29240891	4	O
gonadal	29240891	4	O
dysgenesis	29240891	4	O
)	29240891	4	O
in	29240891	4	O
females	29240891	4	O
but	29240891	4	O
isolated	29240891	4	O
azoospermia	29240891	4	O
with	29240891	4	O
normal	29240891	4	O
pubertal	29240891	4	O
development	29240891	4	O
in	29240891	4	O
males	29240891	4	O
.	29240891	4	O
The	29240891	4	O
findings	29240891	4	O
also	29240891	4	O
suggest	29240891	4	O
that	29240891	4	O
the	29240891	4	O
N	29240891	4	O
-	29240891	4	O
terminal	29240891	4	O
missense	29240891	4	O
mutation	29240891	4	O
in	29240891	4	O
CLPP	29240891	4	O
does	29240891	4	O
not	29240891	4	O
cause	29240891	4	O
substantial	29240891	4	O
mitochondrial	29240891	4	O
dysfunction	29240891	4	O
or	29240891	4	O
contribute	29240891	4	O
to	29240891	4	O
ovarian	29240891	4	O
insufficiency	29240891	4	O
in	29240891	4	O
an	29240891	4	O
oligogenic	29240891	4	O
manner	29240891	4	O
.	29240891	4	O

Patients	29255178	1	O
with	29255178	1	O
a	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
phenotype	29255178	1	O
demonstrate	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
abnormalities	29255178	1	O
.	29255178	1	O
Kabuki	29255178	1	B-Disease
syndrome	29255178	1	I-Disease
is	29255178	1	O
a	29255178	1	O
monogenic	29255178	1	O
disorder	29255178	1	O
caused	29255178	1	O
by	29255178	1	O
loss	29255178	1	B-NegReg
of	29255178	1	I-NegReg
function	29255178	1	I-NegReg
variants	29255178	1	B-Var
in	29255178	1	O
either	29255178	1	O
of	29255178	1	O
two	29255178	1	O
genes	29255178	1	O
encoding	29255178	1	O
histone	29255178	1	O
-	29255178	1	O
modifying	29255178	1	O
enzymes	29255178	1	O
.	29255178	1	O
We	29255178	1	O
performed	29255178	1	O
targeted	29255178	1	O
sequencing	29255178	1	O
in	29255178	1	O
a	29255178	1	O
cohort	29255178	1	O
of	29255178	1	O
27	29255178	1	O
probands	29255178	1	O
with	29255178	1	O
a	29255178	1	O
clinical	29255178	1	O
diagnosis	29255178	1	O
of	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
.	29255178	1	O
Of	29255178	1	O
these	29255178	1	O
,	29255178	1	O
12	29255178	1	O
had	29255178	1	O
causative	29255178	1	O
variants	29255178	1	O
in	29255178	1	O
the	29255178	1	O
two	29255178	1	O
known	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
genes	29255178	1	O
.	29255178	1	O
In	29255178	1	O
2	29255178	1	O
,	29255178	1	O
we	29255178	1	O
identified	29255178	1	O
presumptive	29255178	1	O
loss	29255178	1	O
of	29255178	1	O
function	29255178	1	O
de	29255178	1	O
novo	29255178	1	O
variants	29255178	1	B-Var
in	29255178	1	O
KMT2A	29255178	1	B-Gene
(	29255178	1	O
missense	29255178	1	O
and	29255178	1	O
splice	29255178	1	O
site	29255178	1	O
variants	29255178	1	O
)	29255178	1	O
,	29255178	1	O
a	29255178	1	O
gene	29255178	1	O
that	29255178	1	O
encodes	29255178	1	O
another	29255178	1	O
histone	29255178	1	O
modifying	29255178	1	O
enzyme	29255178	1	O
previously	29255178	1	O
exclusively	29255178	1	O
associated	29255178	1	B-Reg
with	29255178	1	O
Wiedermann	29255178	1	B-Disease
-	29255178	1	I-Disease
Steiner	29255178	1	I-Disease
syndrome	29255178	1	I-Disease
.	29255178	1	O
Although	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
is	29255178	1	O
a	29255178	1	O
disorder	29255178	1	O
of	29255178	1	O
histone	29255178	1	O
modification	29255178	1	O
,	29255178	1	O
we	29255178	1	O
also	29255178	1	O
find	29255178	1	O
alterations	29255178	1	O
in	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
among	29255178	1	O
individuals	29255178	1	O
with	29255178	1	O
a	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
diagnosis	29255178	1	O
relative	29255178	1	O
to	29255178	1	O
matched	29255178	1	O
normal	29255178	1	O
controls	29255178	1	O
,	29255178	1	O
regardless	29255178	1	O
of	29255178	1	O
whether	29255178	1	O
they	29255178	1	O
carry	29255178	1	O
a	29255178	1	O
variant	29255178	1	O
in	29255178	1	O
KMT2A	29255178	1	O
or	29255178	1	O
KMT2D	29255178	1	O
or	29255178	1	O
not	29255178	1	O
.	29255178	1	O
Furthermore	29255178	1	O
,	29255178	1	O
we	29255178	1	O
observed	29255178	1	O
characteristic	29255178	1	O
global	29255178	1	O
abnormalities	29255178	1	O
of	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
that	29255178	1	O
distinguished	29255178	1	O
patients	29255178	1	O
with	29255178	1	O
a	29255178	1	O
loss	29255178	1	O
of	29255178	1	O
function	29255178	1	O
variant	29255178	1	O
in	29255178	1	O
KMT2D	29255178	1	O
or	29255178	1	O
missense	29255178	1	O
or	29255178	1	O
splice	29255178	1	O
site	29255178	1	O
variants	29255178	1	O
in	29255178	1	O
either	29255178	1	O
KMT2D	29255178	1	O
or	29255178	1	O
KMT2A	29255178	1	O
from	29255178	1	O
normal	29255178	1	O
controls	29255178	1	O
.	29255178	1	O
Our	29255178	1	O
results	29255178	1	O
provide	29255178	1	O
new	29255178	1	O
insights	29255178	1	O
into	29255178	1	O
the	29255178	1	O
relationship	29255178	1	O
of	29255178	1	O
genotype	29255178	1	O
to	29255178	1	O
epigenotype	29255178	1	O
and	29255178	1	O
phenotype	29255178	1	O
and	29255178	1	O
indicate	29255178	1	O
cross	29255178	1	O
-	29255178	1	O
talk	29255178	1	O
between	29255178	1	O
histone	29255178	1	O
and	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
machineries	29255178	1	O
exposed	29255178	1	O
by	29255178	1	O
inborn	29255178	1	O
errors	29255178	1	O
of	29255178	1	O
the	29255178	1	O
epigenetic	29255178	1	O
apparatus	29255178	1	O
.	29255178	1	O

A	29255182	1	O
novel	29255182	1	O
homozygous	29255182	1	O
ARL13B	29255182	1	B-Gene
variant	29255182	1	B-Var
in	29255182	1	O
patients	29255182	1	O
with	29255182	1	O
Joubert	29255182	1	O
syndrome	29255182	1	O
impairs	29255182	1	B-NegReg
its	29255182	1	O
guanine	29255182	1	B-MPA
nucleotide	29255182	1	I-MPA
-	29255182	1	I-MPA
exchange	29255182	1	I-MPA
factor	29255182	1	I-MPA
activity	29255182	1	I-MPA
.	29255182	1	O
ARL13B	29255182	1	O
encodes	29255182	1	O
for	29255182	1	O
the	29255182	1	O
ADP	29255182	1	O
-	29255182	1	O
ribosylation	29255182	1	O
factor	29255182	1	O
-	29255182	1	O
like	29255182	1	O
13	29255182	1	O
B	29255182	1	O
GTPase	29255182	1	O
,	29255182	1	O
which	29255182	1	O
is	29255182	1	O
required	29255182	1	O
for	29255182	1	O
normal	29255182	1	O
cilia	29255182	1	O
structure	29255182	1	O
and	29255182	1	O
Sonic	29255182	1	O
hedgehog	29255182	1	O
(	29255182	1	O
Shh	29255182	1	O
)	29255182	1	O
signaling	29255182	1	O
.	29255182	1	O
Disruptions	29255182	1	O
in	29255182	1	O
cilia	29255182	1	O
structure	29255182	1	O
or	29255182	1	O
function	29255182	1	O
lead	29255182	1	O
to	29255182	1	O
a	29255182	1	O
class	29255182	1	O
of	29255182	1	O
human	29255182	1	O
disorders	29255182	1	O
called	29255182	1	O
ciliopathies	29255182	1	O
.	29255182	1	O
Joubert	29255182	1	O
syndrome	29255182	1	O
is	29255182	1	O
characterized	29255182	1	O
by	29255182	1	O
a	29255182	1	O
wide	29255182	1	O
spectrum	29255182	1	O
of	29255182	1	O
symptoms	29255182	1	O
,	29255182	1	O
including	29255182	1	O
a	29255182	1	O
variable	29255182	1	O
degree	29255182	1	O
of	29255182	1	O
intellectual	29255182	1	O
disability	29255182	1	O
,	29255182	1	O
ataxia	29255182	1	O
,	29255182	1	O
and	29255182	1	O
ocular	29255182	1	O
abnormalities	29255182	1	O
.	29255182	1	O
Here	29255182	1	O
we	29255182	1	O
report	29255182	1	O
a	29255182	1	O
novel	29255182	1	O
homozygous	29255182	1	O
missense	29255182	1	O
variant	29255182	1	O
c	29255182	1	O
.	29255182	1	O
[	29255182	1	O
223	29255182	1	O
G	29255182	1	O
>	29255182	1	O
A	29255182	1	O
]	29255182	1	O
(	29255182	1	O
p	29255182	1	O
.	29255182	1	O
(	29255182	1	O
Gly75Arg	29255182	1	O
)	29255182	1	O
in	29255182	1	O
the	29255182	1	O
ARL13B	29255182	1	O
gene	29255182	1	O
,	29255182	1	O
which	29255182	1	O
was	29255182	1	O
identified	29255182	1	O
by	29255182	1	O
whole	29255182	1	O
-	29255182	1	O
exome	29255182	1	O
sequencing	29255182	1	O
of	29255182	1	O
a	29255182	1	O
trio	29255182	1	O
from	29255182	1	O
a	29255182	1	O
consanguineous	29255182	1	O
family	29255182	1	O
with	29255182	1	O
multiple	29255182	1	O
-	29255182	1	O
affected	29255182	1	O
individuals	29255182	1	O
suffering	29255182	1	O
from	29255182	1	O
intellectual	29255182	1	O
disability	29255182	1	O
,	29255182	1	O
ataxia	29255182	1	O
,	29255182	1	O
ocular	29255182	1	O
defects	29255182	1	O
,	29255182	1	O
and	29255182	1	O
epilepsy	29255182	1	O
.	29255182	1	O
The	29255182	1	O
same	29255182	1	O
variant	29255182	1	O
was	29255182	1	O
also	29255182	1	O
identified	29255182	1	O
in	29255182	1	O
a	29255182	1	O
second	29255182	1	O
family	29255182	1	O
.	29255182	1	O
We	29255182	1	O
saw	29255182	1	O
a	29255182	1	O
striking	29255182	1	O
difference	29255182	1	O
in	29255182	1	O
the	29255182	1	O
severity	29255182	1	O
of	29255182	1	O
ataxia	29255182	1	O
between	29255182	1	O
affected	29255182	1	O
male	29255182	1	O
and	29255182	1	O
female	29255182	1	O
individuals	29255182	1	O
in	29255182	1	O
both	29255182	1	O
families	29255182	1	O
.	29255182	1	O
Both	29255182	1	O
ARL13B	29255182	1	O
and	29255182	1	O
ARL13B	29255182	1	O
-	29255182	1	O
c	29255182	1	O
.	29255182	1	O
[	29255182	1	O
223	29255182	1	O
G	29255182	1	O
>	29255182	1	O
A	29255182	1	O
]	29255182	1	O
(	29255182	1	O
p	29255182	1	O
.	29255182	1	O
(	29255182	1	O
Gly75Arg	29255182	1	O
)	29255182	1	O
expression	29255182	1	O
rescued	29255182	1	O
the	29255182	1	O
cilia	29255182	1	O
length	29255182	1	O
and	29255182	1	O
Shh	29255182	1	O
defects	29255182	1	O
displayed	29255182	1	O
by	29255182	1	O
Arl13b	29255182	1	O
hennin	29255182	1	O
(	29255182	1	O
null	29255182	1	O
)	29255182	1	O
cells	29255182	1	O
,	29255182	1	O
indicating	29255182	1	O
that	29255182	1	O
the	29255182	1	O
variant	29255182	1	O
did	29255182	1	O
not	29255182	1	O
disrupt	29255182	1	O
either	29255182	1	O
ARL13B	29255182	1	O
function	29255182	1	O
.	29255182	1	O
In	29255182	1	O
contrast	29255182	1	O
,	29255182	1	O
ARL13B	29255182	1	B-Var
-	29255182	1	I-Var
c	29255182	1	I-Var
.	29255182	1	I-Var
[	29255182	1	I-Var
223	29255182	1	I-Var
G	29255182	1	I-Var
>	29255182	1	I-Var
A	29255182	1	I-Var
]	29255182	1	I-Var
(	29255182	1	O
p	29255182	1	O
.	29255182	1	O
(	29255182	1	O
Gly75Arg	29255182	1	O
)	29255182	1	O
displayed	29255182	1	O
a	29255182	1	O
marked	29255182	1	O
loss	29255182	1	B-NegReg
of	29255182	1	O
ARL3	29255182	1	B-MPA
guanine	29255182	1	I-MPA
nucleotide	29255182	1	I-MPA
-	29255182	1	I-MPA
exchange	29255182	1	I-MPA
factor	29255182	1	I-MPA
activity	29255182	1	I-MPA
,	29255182	1	O
with	29255182	1	O
retention	29255182	1	O
of	29255182	1	O
its	29255182	1	O
GTPase	29255182	1	O
activities	29255182	1	O
,	29255182	1	O
highlighting	29255182	1	O
the	29255182	1	O
correlation	29255182	1	O
between	29255182	1	O
its	29255182	1	O
loss	29255182	1	O
of	29255182	1	O
function	29255182	1	O
as	29255182	1	O
an	29255182	1	O
ARL3	29255182	1	O
guanine	29255182	1	O
nucleotide	29255182	1	O
-	29255182	1	O
exchange	29255182	1	O
factor	29255182	1	O
and	29255182	1	O
Joubert	29255182	1	B-Disease
syndrome	29255182	1	I-Disease
.	29255182	1	O

Rare	29317596	1	O
loss	29317596	1	B-NegReg
of	29317596	1	I-NegReg
function	29317596	1	I-NegReg
mutations	29317596	1	B-Var
in	29317596	1	O
N	29317596	1	B-Protein
-	29317596	1	I-Protein
methyl	29317596	1	I-Protein
-	29317596	1	I-Protein
D	29317596	1	I-Protein
-	29317596	1	I-Protein
aspartate	29317596	1	I-Protein
glutamate	29317596	1	I-Protein
receptors	29317596	1	I-Protein
and	29317596	1	O
their	29317596	1	O
contributions	29317596	1	O
to	29317596	1	O
schizophrenia	29317596	1	B-Disease
susceptibility	29317596	1	O
.	29317596	1	O
In	29317596	1	O
schizophrenia	29317596	1	O
(	29317596	1	O
SCZ	29317596	1	O
)	29317596	1	O
and	29317596	1	O
autism	29317596	1	O
spectrum	29317596	1	O
disorder	29317596	1	O
(	29317596	1	O
ASD	29317596	1	O
)	29317596	1	O
,	29317596	1	O
the	29317596	1	O
dysregulation	29317596	1	O
of	29317596	1	O
glutamate	29317596	1	O
transmission	29317596	1	O
through	29317596	1	O
N	29317596	1	O
-	29317596	1	O
methyl	29317596	1	O
-	29317596	1	O
D	29317596	1	O
-	29317596	1	O
aspartate	29317596	1	O
receptors	29317596	1	O
(	29317596	1	O
NMDARs	29317596	1	O
)	29317596	1	O
has	29317596	1	O
been	29317596	1	O
implicated	29317596	1	O
as	29317596	1	O
a	29317596	1	O
potential	29317596	1	O
etiological	29317596	1	O
mechanism	29317596	1	O
.	29317596	1	O
Previous	29317596	1	O
studies	29317596	1	O
have	29317596	1	O
accumulated	29317596	1	O
evidence	29317596	1	O
supporting	29317596	1	O
NMDAR	29317596	1	O
-	29317596	1	O
encoding	29317596	1	O
genes	29317596	1	O
'	29317596	1	O
role	29317596	1	O
in	29317596	1	O
etiology	29317596	1	O
of	29317596	1	O
SCZ	29317596	1	O
and	29317596	1	O
ASD	29317596	1	O
.	29317596	1	O
We	29317596	1	O
performed	29317596	1	O
a	29317596	1	O
screening	29317596	1	O
study	29317596	1	O
for	29317596	1	O
exonic	29317596	1	O
regions	29317596	1	O
of	29317596	1	O
GRIN1	29317596	1	O
,	29317596	1	O
GRIN2A	29317596	1	O
,	29317596	1	O
GRIN2C	29317596	1	O
,	29317596	1	O
GRIN2D	29317596	1	O
,	29317596	1	O
GRIN3A	29317596	1	O
,	29317596	1	O
and	29317596	1	O
GRIN3B	29317596	1	O
,	29317596	1	O
which	29317596	1	O
encode	29317596	1	O
NMDAR	29317596	1	O
subunits	29317596	1	O
,	29317596	1	O
in	29317596	1	O
562	29317596	1	O
participates	29317596	1	O
(	29317596	1	O
370	29317596	1	O
SCZ	29317596	1	O
and	29317596	1	O
192	29317596	1	O
ASD	29317596	1	O
)	29317596	1	O
.	29317596	1	O
Forty	29317596	1	O
rare	29317596	1	O
variants	29317596	1	O
were	29317596	1	O
identified	29317596	1	O
including	29317596	1	O
38	29317596	1	O
missense	29317596	1	O
,	29317596	1	O
1	29317596	1	O
frameshift	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2C	29317596	1	O
and	29317596	1	O
1	29317596	1	O
splice	29317596	1	O
site	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2D	29317596	1	O
.	29317596	1	O
We	29317596	1	O
conducted	29317596	1	O
in	29317596	1	O
silico	29317596	1	O
analysis	29317596	1	O
for	29317596	1	O
all	29317596	1	O
variants	29317596	1	O
and	29317596	1	O
detected	29317596	1	O
seven	29317596	1	O
missense	29317596	1	O
variants	29317596	1	O
with	29317596	1	O
deleterious	29317596	1	O
prediction	29317596	1	O
.	29317596	1	O
De	29317596	1	O
novo	29317596	1	O
analysis	29317596	1	O
was	29317596	1	O
conducted	29317596	1	O
if	29317596	1	O
pedigree	29317596	1	O
samples	29317596	1	O
were	29317596	1	O
available	29317596	1	O
.	29317596	1	O
The	29317596	1	O
splice	29317596	1	O
site	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2D	29317596	1	O
is	29317596	1	O
predicted	29317596	1	O
to	29317596	1	O
result	29317596	1	O
in	29317596	1	O
intron	29317596	1	O
retention	29317596	1	O
by	29317596	1	O
minigene	29317596	1	O
assay	29317596	1	O
.	29317596	1	O
Furthermore	29317596	1	O
,	29317596	1	O
the	29317596	1	O
frameshift	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2C	29317596	1	O
and	29317596	1	O
splice	29317596	1	O
site	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2D	29317596	1	O
were	29317596	1	O
genotyped	29317596	1	O
in	29317596	1	O
an	29317596	1	O
independent	29317596	1	O
sample	29317596	1	O
set	29317596	1	O
comprising	29317596	1	O
1877	29317596	1	O
SCZ	29317596	1	O
cases	29317596	1	O
,	29317596	1	O
382	29317596	1	O
ASD	29317596	1	O
cases	29317596	1	O
,	29317596	1	O
and	29317596	1	O
2040	29317596	1	O
controls	29317596	1	O
.	29317596	1	O
Both	29317596	1	O
of	29317596	1	O
them	29317596	1	O
were	29317596	1	O
revealed	29317596	1	O
to	29317596	1	O
be	29317596	1	O
singleton	29317596	1	O
.	29317596	1	O
Our	29317596	1	O
study	29317596	1	O
gives	29317596	1	O
evidence	29317596	1	O
in	29317596	1	O
support	29317596	1	O
of	29317596	1	O
the	29317596	1	O
view	29317596	1	O
that	29317596	1	O
ultra	29317596	1	O
-	29317596	1	O
rare	29317596	1	O
variants	29317596	1	O
with	29317596	1	O
loss	29317596	1	B-NegReg
of	29317596	1	I-NegReg
function	29317596	1	I-NegReg
(	29317596	1	B-Var
frameshift	29317596	1	I-Var
,	29317596	1	O
nonsense	29317596	1	B-Var
or	29317596	1	I-Var
splice	29317596	1	I-Var
site	29317596	1	I-Var
)	29317596	1	I-Var
in	29317596	1	O
NMDARs	29317596	1	B-Gene
genes	29317596	1	O
may	29317596	1	O
contribute	29317596	1	O
to	29317596	1	O
possible	29317596	1	O
risk	29317596	1	O
of	29317596	1	O
SCZ	29317596	1	B-Disease
.	29317596	1	O

Biallelic	29343805	1	B-Var
variants	29343805	1	I-Var
in	29343805	1	O
KIF14	29343805	1	B-Gene
cause	29343805	1	B-Reg
intellectual	29343805	1	B-Disease
disability	29343805	1	I-Disease
with	29343805	1	O
microcephaly	29343805	1	B-Disease
.	29343805	1	O
Kinesin	29343805	1	O
proteins	29343805	1	O
are	29343805	1	O
critical	29343805	1	O
for	29343805	1	O
various	29343805	1	O
cellular	29343805	1	O
functions	29343805	1	O
such	29343805	1	O
as	29343805	1	O
intracellular	29343805	1	O
transport	29343805	1	O
and	29343805	1	O
cell	29343805	1	O
division	29343805	1	O
,	29343805	1	O
and	29343805	1	O
many	29343805	1	O
members	29343805	1	O
of	29343805	1	O
the	29343805	1	O
family	29343805	1	O
have	29343805	1	O
been	29343805	1	O
linked	29343805	1	O
to	29343805	1	O
monogenic	29343805	1	O
disorders	29343805	1	O
and	29343805	1	O
cancer	29343805	1	O
.	29343805	1	O
We	29343805	1	O
report	29343805	1	O
eight	29343805	1	O
individuals	29343805	1	O
with	29343805	1	O
intellectual	29343805	1	O
disability	29343805	1	O
and	29343805	1	O
microcephaly	29343805	1	O
from	29343805	1	O
four	29343805	1	O
unrelated	29343805	1	O
families	29343805	1	O
with	29343805	1	O
parental	29343805	1	O
consanguinity	29343805	1	O
.	29343805	1	O
In	29343805	1	O
the	29343805	1	O
affected	29343805	1	O
individuals	29343805	1	O
of	29343805	1	O
each	29343805	1	O
family	29343805	1	O
,	29343805	1	O
homozygosity	29343805	1	O
for	29343805	1	O
likely	29343805	1	O
pathogenic	29343805	1	B-CPA
variants	29343805	1	O
in	29343805	1	O
KIF14	29343805	1	B-Gene
were	29343805	1	O
detected	29343805	1	O
;	29343805	1	O
two	29343805	1	O
loss	29343805	1	B-NegReg
-	29343805	1	I-NegReg
of	29343805	1	I-NegReg
-	29343805	1	I-NegReg
function	29343805	1	I-NegReg
(	29343805	1	B-Var
p.Asn83Ilefs	29343805	1	I-Var
3	29343805	1	I-Var
and	29343805	1	O
p.Ser1478fs	29343805	1	B-Var
)	29343805	1	I-Var
,	29343805	1	O
and	29343805	1	O
two	29343805	1	O
missense	29343805	1	B-Reg
substitutions	29343805	1	I-Reg
(	29343805	1	B-Var
p.Ser841Phe	29343805	1	I-Var
and	29343805	1	O
p.Gly459Arg	29343805	1	B-Var
)	29343805	1	I-Var
.	29343805	1	O
KIF14	29343805	1	O
is	29343805	1	O
a	29343805	1	O
mitotic	29343805	1	O
motor	29343805	1	O
protein	29343805	1	O
that	29343805	1	O
is	29343805	1	O
required	29343805	1	O
for	29343805	1	O
spindle	29343805	1	O
localization	29343805	1	O
of	29343805	1	O
the	29343805	1	O
mitotic	29343805	1	O
citron	29343805	1	O
rho	29343805	1	O
-	29343805	1	O
interacting	29343805	1	O
kinase	29343805	1	O
,	29343805	1	O
CIT	29343805	1	B-Gene
,	29343805	1	O
also	29343805	1	O
mutated	29343805	1	B-Var
in	29343805	1	B-Reg
microcephaly	29343805	1	B-Disease
.	29343805	1	O
Our	29343805	1	O
results	29343805	1	O
demonstrate	29343805	1	O
the	29343805	1	O
involvement	29343805	1	O
of	29343805	1	O
KIF14	29343805	1	O
in	29343805	1	O
development	29343805	1	O
and	29343805	1	O
reveal	29343805	1	O
a	29343805	1	O
wide	29343805	1	O
phenotypic	29343805	1	O
variability	29343805	1	O
ranging	29343805	1	O
from	29343805	1	O
fetal	29343805	1	O
lethality	29343805	1	O
to	29343805	1	O
moderate	29343805	1	O
developmental	29343805	1	O
delay	29343805	1	O
and	29343805	1	O
microcephaly	29343805	1	O
.	29343805	1	O

Key	29358613	1	O
apoptotic	29358613	1	B-Gene
genes	29358613	1	I-Gene
APAF1	29358613	1	B-Gene
and	29358613	1	O
CASP9	29358613	1	B-Gene
implicated	29358613	1	O
in	29358613	1	O
recurrent	29358613	1	O
folate	29358613	1	O
-	29358613	1	O
resistant	29358613	1	O
neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
.	29358613	1	O
Neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
(	29358613	1	O
NTDs	29358613	1	O
)	29358613	1	O
remain	29358613	1	O
one	29358613	1	O
of	29358613	1	O
the	29358613	1	O
most	29358613	1	O
serious	29358613	1	O
birth	29358613	1	O
defects	29358613	1	O
,	29358613	1	O
and	29358613	1	O
although	29358613	1	O
genes	29358613	1	O
in	29358613	1	O
several	29358613	1	O
pathways	29358613	1	O
have	29358613	1	O
been	29358613	1	O
implicated	29358613	1	O
as	29358613	1	O
risk	29358613	1	O
factors	29358613	1	O
for	29358613	1	O
neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
via	29358613	1	O
knockout	29358613	1	O
mouse	29358613	1	O
models	29358613	1	O
,	29358613	1	O
very	29358613	1	O
few	29358613	1	O
molecular	29358613	1	O
causes	29358613	1	O
in	29358613	1	O
humans	29358613	1	O
have	29358613	1	O
been	29358613	1	O
identified	29358613	1	O
.	29358613	1	O
Whole	29358613	1	O
exome	29358613	1	O
sequencing	29358613	1	O
identified	29358613	1	O
deleterious	29358613	1	O
variants	29358613	1	O
in	29358613	1	O
key	29358613	1	O
apoptotic	29358613	1	O
genes	29358613	1	O
in	29358613	1	O
two	29358613	1	O
families	29358613	1	O
with	29358613	1	O
recurrent	29358613	1	O
neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
.	29358613	1	O
Functional	29358613	1	O
studies	29358613	1	O
in	29358613	1	O
fibroblasts	29358613	1	O
indicate	29358613	1	O
that	29358613	1	O
these	29358613	1	O
variants	29358613	1	B-Var
are	29358613	1	O
loss	29358613	1	B-NegReg
-	29358613	1	I-NegReg
of	29358613	1	I-NegReg
-	29358613	1	I-NegReg
function	29358613	1	I-NegReg
,	29358613	1	O
as	29358613	1	O
apoptosis	29358613	1	B-CPA
is	29358613	1	O
significantly	29358613	1	O
reduced	29358613	1	B-NegReg
.	29358613	1	O
This	29358613	1	O
is	29358613	1	O
the	29358613	1	O
first	29358613	1	O
report	29358613	1	O
of	29358613	1	O
variants	29358613	1	B-Var
in	29358613	1	O
apoptotic	29358613	1	B-Gene
genes	29358613	1	I-Gene
contributing	29358613	1	B-Reg
to	29358613	1	O
neural	29358613	1	B-Disease
tube	29358613	1	I-Disease
defect	29358613	1	I-Disease
risk	29358613	1	O
in	29358613	1	O
humans	29358613	1	O
.	29358613	1	O

Congenital	29358614	1	O
diaphragmatic	29358614	1	O
hernia	29358614	1	O
as	29358614	1	O
a	29358614	1	O
part	29358614	1	O
of	29358614	1	O
Nance	29358614	1	O
-	29358614	1	O
Horan	29358614	1	O
syndrome	29358614	1	O
?	29358614	1	O
Nance	29358614	1	O
-	29358614	1	O
Horan	29358614	1	O
syndrome	29358614	1	O
is	29358614	1	O
a	29358614	1	O
rare	29358614	1	O
X	29358614	1	O
-	29358614	1	O
linked	29358614	1	O
developmental	29358614	1	O
disorder	29358614	1	O
characterized	29358614	1	O
by	29358614	1	O
bilateral	29358614	1	O
congenital	29358614	1	O
cataract	29358614	1	O
,	29358614	1	O
dental	29358614	1	O
anomalies	29358614	1	O
,	29358614	1	O
facial	29358614	1	O
dysmorphism	29358614	1	O
,	29358614	1	O
and	29358614	1	O
intellectual	29358614	1	O
disability	29358614	1	O
.	29358614	1	O
Here	29358614	1	O
,	29358614	1	O
we	29358614	1	O
identify	29358614	1	O
a	29358614	1	O
patient	29358614	1	O
with	29358614	1	O
Nance	29358614	1	B-Disease
-	29358614	1	I-Disease
Horan	29358614	1	I-Disease
syndrome	29358614	1	I-Disease
caused	29358614	1	B-Reg
by	29358614	1	I-Reg
a	29358614	1	O
new	29358614	1	O
nonsense	29358614	1	B-Var
NHS	29358614	1	B-Gene
variant	29358614	1	O
.	29358614	1	O
In	29358614	1	O
addition	29358614	1	O
,	29358614	1	O
the	29358614	1	O
patient	29358614	1	O
presented	29358614	1	O
congenital	29358614	1	B-Disease
diaphragmatic	29358614	1	I-Disease
hernia	29358614	1	I-Disease
.	29358614	1	O
NHS	29358614	1	O
gene	29358614	1	O
expression	29358614	1	O
in	29358614	1	O
murine	29358614	1	O
fetal	29358614	1	O
diaphragm	29358614	1	O
was	29358614	1	O
demonstrated	29358614	1	O
,	29358614	1	O
suggesting	29358614	1	O
a	29358614	1	O
possible	29358614	1	O
involvement	29358614	1	O
of	29358614	1	O
NHS	29358614	1	O
in	29358614	1	O
diaphragm	29358614	1	O
development	29358614	1	O
.	29358614	1	O
Congenital	29358614	1	B-Disease
diaphragmatic	29358614	1	I-Disease
hernia	29358614	1	I-Disease
could	29358614	1	O
result	29358614	1	B-Reg
from	29358614	1	I-Reg
NHS	29358614	1	B-Gene
loss	29358614	1	B-NegReg
of	29358614	1	I-NegReg
function	29358614	1	I-NegReg
in	29358614	1	O
pleuroperitoneal	29358614	1	O
fold	29358614	1	O
or	29358614	1	O
in	29358614	1	O
somites	29358614	1	O
-	29358614	1	O
derived	29358614	1	O
muscle	29358614	1	O
progenitor	29358614	1	O
cells	29358614	1	O
leading	29358614	1	O
to	29358614	1	O
an	29358614	1	O
impairment	29358614	1	O
of	29358614	1	O
their	29358614	1	O
cells	29358614	1	B-CPA
migration	29358614	1	I-CPA
.	29358614	1	O

[	29367526	1	O
The	29367526	1	O
formation	29367526	1	O
of	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
and	29367526	1	O
defective	29367526	1	O
barrier	29367526	1	O
-	29367526	1	O
associated	29367526	1	O
skin	29367526	1	O
diseases	29367526	1	O
]	29367526	1	O
.	29367526	1	O
Since	29367526	1	O
the	29367526	1	O
discovery	29367526	1	O
of	29367526	1	O
loss	29367526	1	B-NegReg
-	29367526	1	I-NegReg
of	29367526	1	I-NegReg
-	29367526	1	I-NegReg
function	29367526	1	I-NegReg
mutations	29367526	1	B-Var
in	29367526	1	O
filaggrin	29367526	1	O
(	29367526	1	B-Gene
FLG	29367526	1	I-Gene
)	29367526	1	I-Gene
gene	29367526	1	O
in	29367526	1	O
atopic	29367526	1	B-Disease
dermatitis	29367526	1	I-Disease
(	29367526	1	O
AD	29367526	1	O
)	29367526	1	O
individuals	29367526	1	O
,	29367526	1	O
significant	29367526	1	O
attention	29367526	1	O
has	29367526	1	O
been	29367526	1	O
paid	29367526	1	O
against	29367526	1	O
the	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
as	29367526	1	O
an	29367526	1	O
initial	29367526	1	O
starting	29367526	1	O
point	29367526	1	O
of	29367526	1	O
atopic	29367526	1	O
march	29367526	1	O
.	29367526	1	O
Although	29367526	1	O
FLG	29367526	1	O
is	29367526	1	O
a	29367526	1	O
significant	29367526	1	O
cornification	29367526	1	O
-	29367526	1	O
associated	29367526	1	O
gene	29367526	1	O
,	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
formation	29367526	1	O
is	29367526	1	O
a	29367526	1	O
complex	29367526	1	O
process	29367526	1	O
mediated	29367526	1	O
by	29367526	1	O
an	29367526	1	O
array	29367526	1	O
of	29367526	1	O
genes	29367526	1	O
with	29367526	1	O
specific	29367526	1	O
functions	29367526	1	O
.	29367526	1	O
In	29367526	1	O
this	29367526	1	O
article	29367526	1	O
,	29367526	1	O
the	29367526	1	O
mechanism	29367526	1	O
of	29367526	1	O
physical	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
formation	29367526	1	O
is	29367526	1	O
reviewed	29367526	1	O
in	29367526	1	O
detail	29367526	1	O
,	29367526	1	O
focusing	29367526	1	O
on	29367526	1	O
specific	29367526	1	O
gene	29367526	1	O
functions	29367526	1	O
and	29367526	1	O
inherited	29367526	1	O
disorders	29367526	1	O
caused	29367526	1	O
by	29367526	1	O
genetic	29367526	1	O
aberrations	29367526	1	O
.	29367526	1	O
Additionally	29367526	1	O
,	29367526	1	O
the	29367526	1	O
mechanism	29367526	1	O
of	29367526	1	O
percutaneous	29367526	1	O
sensitization	29367526	1	O
with	29367526	1	O
environmental	29367526	1	O
allergens	29367526	1	O
in	29367526	1	O
association	29367526	1	O
with	29367526	1	O
FLG	29367526	1	O
-	29367526	1	O
deficiency	29367526	1	O
is	29367526	1	O
reviewed	29367526	1	O
in	29367526	1	O
order	29367526	1	O
to	29367526	1	O
clarify	29367526	1	O
the	29367526	1	O
link	29367526	1	O
between	29367526	1	O
defective	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
and	29367526	1	O
atopic	29367526	1	O
march	29367526	1	O
.	29367526	1	O
Finally	29367526	1	O
,	29367526	1	O
updated	29367526	1	O
knowledge	29367526	1	O
of	29367526	1	O
psoriasis	29367526	1	O
pathophysiology	29367526	1	O
in	29367526	1	O
connection	29367526	1	O
with	29367526	1	O
genetic	29367526	1	O
defect	29367526	1	O
in	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
is	29367526	1	O
reviewed	29367526	1	O
.	29367526	1	O
This	29367526	1	O
article	29367526	1	O
would	29367526	1	O
provide	29367526	1	O
a	29367526	1	O
novel	29367526	1	O
opportunity	29367526	1	O
to	29367526	1	O
understand	29367526	1	O
the	29367526	1	O
allergic	29367526	1	O
/	29367526	1	O
autoimmune	29367526	1	O
disorders	29367526	1	O
from	29367526	1	O
the	29367526	1	O
viewpoint	29367526	1	O
of	29367526	1	O
non	29367526	1	O
-	29367526	1	O
classical	29367526	1	O
immune	29367526	1	O
cells	29367526	1	O
.	29367526	1	O

Loss	29478779	3	O
of	29478779	3	O
Function	29478779	3	O
of	29478779	3	O
the	29478779	3	O
Nuclear	29478779	3	O
Receptor	29478779	3	O
NR2F2	29478779	3	O
,	29478779	3	O
Encoding	29478779	3	O
COUP	29478779	3	O
-	29478779	3	O
TF2	29478779	3	O
,	29478779	3	O
Causes	29478779	3	O
Testis	29478779	3	O
Development	29478779	3	O
and	29478779	3	O
Cardiac	29478779	3	O
Defects	29478779	3	O
in	29478779	3	O
46	29478779	3	O
,	29478779	3	O
XX	29478779	3	O
Children	29478779	3	O
.	29478779	3	O
Emerging	29478779	3	O
evidence	29478779	3	O
from	29478779	3	O
murine	29478779	3	O
studies	29478779	3	O
suggests	29478779	3	O
that	29478779	3	O
mammalian	29478779	3	O
sex	29478779	3	O
determination	29478779	3	O
is	29478779	3	O
the	29478779	3	O
outcome	29478779	3	O
of	29478779	3	O
an	29478779	3	O
imbalance	29478779	3	O
between	29478779	3	O
mutually	29478779	3	O
antagonistic	29478779	3	O
male	29478779	3	O
and	29478779	3	O
female	29478779	3	O
regulatory	29478779	3	O
networks	29478779	3	O
that	29478779	3	O
canalize	29478779	3	O
development	29478779	3	O
down	29478779	3	O
one	29478779	3	O
pathway	29478779	3	O
while	29478779	3	O
actively	29478779	3	O
repressing	29478779	3	O
the	29478779	3	O
other	29478779	3	O
.	29478779	3	O
However	29478779	3	O
,	29478779	3	O
in	29478779	3	O
contrast	29478779	3	O
to	29478779	3	O
testis	29478779	3	O
formation	29478779	3	O
,	29478779	3	O
the	29478779	3	O
gene	29478779	3	O
regulatory	29478779	3	O
pathways	29478779	3	O
governing	29478779	3	O
mammalian	29478779	3	O
ovary	29478779	3	O
development	29478779	3	O
have	29478779	3	O
remained	29478779	3	O
elusive	29478779	3	O
.	29478779	3	O
We	29478779	3	O
performed	29478779	3	O
exome	29478779	3	O
or	29478779	3	O
Sanger	29478779	3	O
sequencing	29478779	3	O
on	29478779	3	O
79	29478779	3	O
46	29478779	3	O
,	29478779	3	O
XX	29478779	3	O
SRY	29478779	3	O
-	29478779	3	O
negative	29478779	3	O
individuals	29478779	3	O
with	29478779	3	O
either	29478779	3	O
unexplained	29478779	3	O
virilization	29478779	3	O
or	29478779	3	O
with	29478779	3	O
testicular	29478779	3	O
/	29478779	3	O
ovotesticular	29478779	3	O
disorders	29478779	3	O
/	29478779	3	O
differences	29478779	3	O
of	29478779	3	O
sex	29478779	3	O
development	29478779	3	O
(	29478779	3	O
TDSD	29478779	3	O
/	29478779	3	O
OTDSD	29478779	3	O
)	29478779	3	O
.	29478779	3	O
We	29478779	3	O
identified	29478779	3	O
heterozygous	29478779	3	O
frameshift	29478779	3	O
mutations	29478779	3	O
in	29478779	3	O
NR2F2	29478779	3	B-Gene
,	29478779	3	O
encoding	29478779	3	O
COUP	29478779	3	O
-	29478779	3	O
TF2	29478779	3	O
,	29478779	3	O
in	29478779	3	O
three	29478779	3	O
children	29478779	3	O
.	29478779	3	O
One	29478779	3	O
carried	29478779	3	O
a	29478779	3	O
c.103_109delGGCGCCC	29478779	3	O
(	29478779	3	B-Var
p.Gly35Argfs	29478779	3	I-Var
75	29478779	3	I-Var
)	29478779	3	I-Var
mutation	29478779	3	O
,	29478779	3	O
while	29478779	3	O
two	29478779	3	O
others	29478779	3	O
carried	29478779	3	O
a	29478779	3	O
c.97_103delCCGCCCG	29478779	3	O
(	29478779	3	B-Var
p.Pro33Alafs	29478779	3	I-Var
77	29478779	3	I-Var
)	29478779	3	I-Var
mutation	29478779	3	O
.	29478779	3	O
In	29478779	3	O
two	29478779	3	O
of	29478779	3	O
three	29478779	3	O
children	29478779	3	O
the	29478779	3	O
mutation	29478779	3	O
was	29478779	3	O
de	29478779	3	O
novo	29478779	3	O
.	29478779	3	O
All	29478779	3	O
three	29478779	3	O
children	29478779	3	O
presented	29478779	3	B-Reg
with	29478779	3	I-Reg
congenital	29478779	3	B-Disease
heart	29478779	3	I-Disease
disease	29478779	3	I-Disease
(	29478779	3	O
CHD	29478779	3	O
)	29478779	3	O
,	29478779	3	O
one	29478779	3	O
child	29478779	3	O
with	29478779	3	O
congenital	29478779	3	O
diaphragmatic	29478779	3	O
hernia	29478779	3	O
(	29478779	3	O
CDH	29478779	3	O
)	29478779	3	O
,	29478779	3	O
and	29478779	3	O
two	29478779	3	O
children	29478779	3	O
with	29478779	3	O
blepharophimosis	29478779	3	O
-	29478779	3	O
ptosis	29478779	3	O
-	29478779	3	O
epicanthus	29478779	3	O
inversus	29478779	3	O
syndrome	29478779	3	O
(	29478779	3	O
BPES	29478779	3	O
)	29478779	3	O
.	29478779	3	O
The	29478779	3	O
three	29478779	3	O
children	29478779	3	O
had	29478779	3	O
androgen	29478779	3	O
production	29478779	3	O
,	29478779	3	O
virilization	29478779	3	O
of	29478779	3	O
external	29478779	3	O
genitalia	29478779	3	O
,	29478779	3	O
and	29478779	3	O
biochemical	29478779	3	O
or	29478779	3	O
histological	29478779	3	O
evidence	29478779	3	O
of	29478779	3	O
testicular	29478779	3	O
tissue	29478779	3	O
.	29478779	3	O
We	29478779	3	O
demonstrate	29478779	3	O
a	29478779	3	O
highly	29478779	3	O
significant	29478779	3	O
association	29478779	3	O
between	29478779	3	O
the	29478779	3	O
NR2F2	29478779	3	B-Gene
loss	29478779	3	B-NegReg
-	29478779	3	I-NegReg
of	29478779	3	I-NegReg
-	29478779	3	I-NegReg
function	29478779	3	I-NegReg
mutations	29478779	3	B-Var
and	29478779	3	O
this	29478779	3	O
syndromic	29478779	3	B-Disease
form	29478779	3	I-Disease
of	29478779	3	I-Disease
DSD	29478779	3	I-Disease
(	29478779	3	O
p	29478779	3	O
=	29478779	3	O
2.44	29478779	3	O
10	29478779	3	O
-	29478779	3	O
8	29478779	3	O
)	29478779	3	O
.	29478779	3	O
We	29478779	3	O
show	29478779	3	O
that	29478779	3	O
COUP	29478779	3	O
-	29478779	3	O
TF2	29478779	3	O
is	29478779	3	O
highly	29478779	3	O
abundant	29478779	3	O
in	29478779	3	O
a	29478779	3	O
FOXL2	29478779	3	O
-	29478779	3	O
negative	29478779	3	O
stromal	29478779	3	O
cell	29478779	3	O
population	29478779	3	O
of	29478779	3	O
the	29478779	3	O
fetal	29478779	3	O
human	29478779	3	O
ovary	29478779	3	O
.	29478779	3	O
In	29478779	3	O
contrast	29478779	3	O
to	29478779	3	O
the	29478779	3	O
mouse	29478779	3	O
,	29478779	3	O
these	29478779	3	O
data	29478779	3	O
establish	29478779	3	O
COUP	29478779	3	O
-	29478779	3	O
TF2	29478779	3	O
as	29478779	3	O
a	29478779	3	O
human	29478779	3	O
"	29478779	3	O
pro	29478779	3	O
-	29478779	3	O
ovary	29478779	3	O
"	29478779	3	O
and	29478779	3	O
"	29478779	3	O
anti	29478779	3	O
-	29478779	3	O
testis	29478779	3	O
"	29478779	3	O
sex	29478779	3	O
-	29478779	3	O
determining	29478779	3	O
factor	29478779	3	O
in	29478779	3	O
female	29478779	3	O
gonads	29478779	3	O
.	29478779	3	O
Furthermore	29478779	3	O
,	29478779	3	O
the	29478779	3	O
data	29478779	3	O
presented	29478779	3	O
here	29478779	3	O
provide	29478779	3	O
additional	29478779	3	O
evidence	29478779	3	O
of	29478779	3	O
the	29478779	3	O
emerging	29478779	3	O
importance	29478779	3	O
of	29478779	3	O
nuclear	29478779	3	O
receptors	29478779	3	O
in	29478779	3	O
establishing	29478779	3	O
human	29478779	3	O
ovarian	29478779	3	O
identity	29478779	3	O
and	29478779	3	O
indicate	29478779	3	O
that	29478779	3	O
nuclear	29478779	3	O
receptors	29478779	3	O
may	29478779	3	O
have	29478779	3	O
divergent	29478779	3	O
functions	29478779	3	O
in	29478779	3	O
mouse	29478779	3	O
and	29478779	3	O
human	29478779	3	O
biology	29478779	3	O
.	29478779	3	O

Single	30296255	4	O
copy	30296255	4	O
/	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
of	30296255	4	O
ALS	30296255	4	O
SOD1	30296255	4	O
in	30296255	4	O
C.	30296255	4	O
elegans	30296255	4	O
suggest	30296255	4	O
loss	30296255	4	O
and	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
function	30296255	4	O
have	30296255	4	O
different	30296255	4	O
contributions	30296255	4	O
to	30296255	4	O
cholinergic	30296255	4	O
and	30296255	4	O
glutamatergic	30296255	4	O
neurodegeneration	30296255	4	O
.	30296255	4	O
Mutations	30296255	4	B-Var
in	30296255	4	O
Cu	30296255	4	O
/	30296255	4	O
Zn	30296255	4	O
superoxide	30296255	4	O
dismutase	30296255	4	O
1	30296255	4	O
(	30296255	4	B-Gene
SOD1	30296255	4	I-Gene
)	30296255	4	I-Gene
lead	30296255	4	B-Reg
to	30296255	4	I-Reg
Amyotrophic	30296255	4	B-Disease
Lateral	30296255	4	I-Disease
Sclerosis	30296255	4	I-Disease
(	30296255	4	O
ALS	30296255	4	O
)	30296255	4	O
,	30296255	4	O
a	30296255	4	O
neurodegenerative	30296255	4	O
disease	30296255	4	O
that	30296255	4	O
disproportionately	30296255	4	O
affects	30296255	4	O
glutamatergic	30296255	4	O
and	30296255	4	O
cholinergic	30296255	4	O
motor	30296255	4	O
neurons	30296255	4	O
.	30296255	4	O
Previous	30296255	4	O
work	30296255	4	O
with	30296255	4	O
SOD1	30296255	4	O
overexpression	30296255	4	O
models	30296255	4	O
supports	30296255	4	O
a	30296255	4	O
role	30296255	4	O
for	30296255	4	O
SOD1	30296255	4	O
toxic	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
ALS	30296255	4	O
pathogenesis	30296255	4	O
.	30296255	4	O
However	30296255	4	O
,	30296255	4	O
the	30296255	4	O
impact	30296255	4	O
of	30296255	4	O
SOD1	30296255	4	O
loss	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
ALS	30296255	4	O
cannot	30296255	4	O
be	30296255	4	O
directly	30296255	4	O
examined	30296255	4	O
in	30296255	4	O
overexpression	30296255	4	O
models	30296255	4	O
.	30296255	4	O
In	30296255	4	O
addition	30296255	4	O
,	30296255	4	O
overexpression	30296255	4	O
may	30296255	4	O
obscure	30296255	4	O
the	30296255	4	O
contribution	30296255	4	O
of	30296255	4	O
SOD1	30296255	4	O
loss	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
the	30296255	4	O
degeneration	30296255	4	O
of	30296255	4	O
different	30296255	4	O
neuronal	30296255	4	O
populations	30296255	4	O
.	30296255	4	O
Here	30296255	4	O
,	30296255	4	O
we	30296255	4	O
report	30296255	4	O
the	30296255	4	O
first	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
,	30296255	4	O
ALS	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
in	30296255	4	O
C.	30296255	4	O
elegans	30296255	4	O
generated	30296255	4	O
by	30296255	4	O
transposon	30296255	4	O
-	30296255	4	O
or	30296255	4	O
CRISPR	30296255	4	O
/	30296255	4	O
Cas9	30296255	4	O
-	30296255	4	O
mediated	30296255	4	O
genome	30296255	4	O
editing	30296255	4	O
of	30296255	4	O
the	30296255	4	O
endogenous	30296255	4	O
sod-1	30296255	4	O
gene	30296255	4	O
.	30296255	4	O
Introduction	30296255	4	O
of	30296255	4	O
ALS	30296255	4	O
patient	30296255	4	O
amino	30296255	4	O
acid	30296255	4	O
changes	30296255	4	O
A4V	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
L84V	30296255	4	O
,	30296255	4	O
G85R	30296255	4	O
or	30296255	4	O
G93A	30296255	4	O
into	30296255	4	O
the	30296255	4	O
C.	30296255	4	O
elegans	30296255	4	O
sod-1	30296255	4	O
gene	30296255	4	O
yielded	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
/	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
ALS	30296255	4	O
SOD1	30296255	4	O
models	30296255	4	O
.	30296255	4	O
These	30296255	4	O
differ	30296255	4	O
from	30296255	4	O
previously	30296255	4	O
reported	30296255	4	O
overexpression	30296255	4	O
models	30296255	4	O
in	30296255	4	O
multiple	30296255	4	O
assays	30296255	4	O
.	30296255	4	O
In	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
/	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
,	30296255	4	O
we	30296255	4	O
observed	30296255	4	O
differential	30296255	4	O
impact	30296255	4	O
of	30296255	4	O
sod-1	30296255	4	O
ALS	30296255	4	O
alleles	30296255	4	O
on	30296255	4	O
glutamatergic	30296255	4	O
and	30296255	4	O
cholinergic	30296255	4	O
neurodegeneration	30296255	4	O
.	30296255	4	O
A4V	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
G85R	30296255	4	O
,	30296255	4	O
and	30296255	4	O
G93A	30296255	4	O
animals	30296255	4	O
showed	30296255	4	O
increased	30296255	4	O
SOD1	30296255	4	O
protein	30296255	4	O
accumulation	30296255	4	O
and	30296255	4	O
oxidative	30296255	4	O
stress	30296255	4	O
induced	30296255	4	O
degeneration	30296255	4	O
,	30296255	4	O
consistent	30296255	4	O
with	30296255	4	O
a	30296255	4	O
toxic	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
cholinergic	30296255	4	O
motor	30296255	4	O
neurons	30296255	4	O
.	30296255	4	O
By	30296255	4	O
contrast	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
L84V	30296255	4	O
,	30296255	4	O
and	30296255	4	O
G85R	30296255	4	O
lead	30296255	4	O
to	30296255	4	O
glutamatergic	30296255	4	O
neuron	30296255	4	O
degeneration	30296255	4	O
due	30296255	4	O
to	30296255	4	O
sod-1	30296255	4	O
loss	30296255	4	O
of	30296255	4	O
function	30296255	4	O
after	30296255	4	O
oxidative	30296255	4	O
stress	30296255	4	O
.	30296255	4	O
However	30296255	4	O
,	30296255	4	O
dopaminergic	30296255	4	O
and	30296255	4	O
serotonergic	30296255	4	O
neuronal	30296255	4	O
populations	30296255	4	O
were	30296255	4	O
spared	30296255	4	O
in	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
ALS	30296255	4	O
models	30296255	4	O
,	30296255	4	O
suggesting	30296255	4	O
a	30296255	4	O
neuronal	30296255	4	O
-	30296255	4	O
subtype	30296255	4	O
specificity	30296255	4	O
previously	30296255	4	O
not	30296255	4	O
reported	30296255	4	O
in	30296255	4	O
invertebrate	30296255	4	O
ALS	30296255	4	O
SOD1	30296255	4	O
models	30296255	4	O
.	30296255	4	O
Combined	30296255	4	O
,	30296255	4	O
these	30296255	4	O
results	30296255	4	O
suggest	30296255	4	O
that	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
may	30296255	4	O
reproduce	30296255	4	O
the	30296255	4	O
neurotransmitter	30296255	4	O
-	30296255	4	O
type	30296255	4	O
specificity	30296255	4	O
of	30296255	4	O
ALS	30296255	4	O
and	30296255	4	O
that	30296255	4	O
both	30296255	4	O
SOD1	30296255	4	O
loss	30296255	4	O
and	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
toxic	30296255	4	O
function	30296255	4	O
differentially	30296255	4	O
contribute	30296255	4	O
to	30296255	4	O
ALS	30296255	4	O
pathogenesis	30296255	4	O
in	30296255	4	O
different	30296255	4	O
neuronal	30296255	4	O
populations	30296255	4	O
.	30296255	4	O

